data_2m0k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m0k _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.54 -179.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.55 165.27 25.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -70.09 169.4 13.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.075 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.425 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -54.87 -30.29 57.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.518 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -56.88 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.31 -45.32 91.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.481 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.425 HG22 ' HA ' ' A' ' 6' ' ' GLU . 13.0 tt -65.17 -26.65 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.955 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.68 -44.04 62.96 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.442 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.21 -32.71 72.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.257 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -67.6 -49.7 61.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.328 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -44.74 92.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.254 0.55 . . . . 0.0 110.043 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.42 -47.88 74.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.704 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.4 -41.97 63.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -56.76 -35.12 68.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.043 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -77.86 -14.64 59.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.927 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.66 -38.5 15.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.554 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.26 -65.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.01 132.33 48.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.741 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -37.89 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.01 -12.15 29.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.51 36.76 79.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.654 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -74.67 -5.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.523 0.201 . . . . 0.0 111.501 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.18 2.29 44.9 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.1 p -149.43 132.53 16.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -108.97 126.56 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 t -101.03 167.82 10.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 p -54.01 -30.44 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.48 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -62.79 -50.39 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.204 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.73 -36.28 51.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.798 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.37 -58.35 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.703 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.25 -27.49 69.27 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -70.99 -60.99 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.12 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 19' ' ' PHE . 7.1 p -64.71 -30.76 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.7 ttt -60.22 -55.22 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -25.63 64.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 t -56.04 -38.37 70.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.92 -62.3 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.65 41.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -142.56 167.8 21.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -134.97 59.66 35.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.71 -169.98 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.588 2.192 . . . . 0.0 112.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 p -116.46 167.57 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.78 -32.05 71.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.8 -45.62 59.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.405 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -43.4 95.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.302 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -55.25 -50.58 69.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.09 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -64.56 -57.03 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -51.19 67.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.182 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.511 ' O ' HG21 ' A' ' 55' ' ' VAL . 15.7 mtt -57.64 -47.06 83.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.507 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -61.58 -45.68 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.159 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -56.36 -26.53 53.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.529 0.68 . . . . 0.0 110.113 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 51' ' ' MET . 6.6 mt-10 -81.53 -2.14 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.351 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -127.0 -33.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 112.04 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.49 148.5 45.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.251 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.5 -53.57 7.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.54 -8.63 58.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.34 48.55 79.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.931 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -96.6 -0.22 48.95 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.643 0.222 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.25 15.13 22.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.922 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -149.88 139.89 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.56 0.18 . . . . 0.0 110.565 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.567 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.71 147.34 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.497 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.52 179.08 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.882 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -60.93 -61.69 7.48 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.0 Cg_endo -66.93 -30.94 39.0 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.435 2.09 . . . . 0.0 112.197 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mt-10 -65.74 -40.61 92.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.454 ' HB2' HG23 ' A' ' 63' ' ' ILE . 2.1 t80 -75.14 -41.95 57.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -71.17 -53.1 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.482 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.4 m -51.58 -46.34 63.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.182 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 tpp -56.65 -48.33 77.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.932 0.396 . . . . 0.0 110.936 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.9 mmt -85.95 0.15 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.66 -38.89 11.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.93 0.395 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -55.04 -30.48 59.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -151.75 174.44 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -152.17 155.46 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -54.64 -24.29 20.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 -38.68 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 53.5 mt-10 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.026 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.648 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.29 -38.88 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -49.35 33.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.06 -45.49 94.55 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.47 -53.33 53.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.997 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.36 -38.88 55.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.833 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -31.46 68.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.25 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.39 -36.68 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.558 ' N ' HG23 ' A' ' 91' ' ' VAL . 5.9 m-85 -71.93 -62.9 1.26 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -85.25 129.93 34.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -75.67 -52.6 10.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.37 -9.6 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.481 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.21 70.44 0.62 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.898 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -93.43 15.32 16.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.3 68.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.2 m-85 -166.35 116.34 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.66 129.11 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.787 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -104.08 156.5 17.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.197 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.474 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.93 -38.88 17.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.385 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.85 -59.01 6.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.057 0.456 . . . . 0.0 110.864 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -36.87 72.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.689 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.57 HD13 HD13 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.56 -49.31 77.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.75 -44.49 81.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.205 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -58.76 -37.52 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.17 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.87 -53.77 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.674 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.0 mmt -50.35 -54.12 23.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.815 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -67.29 -24.87 65.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.38 -29.99 67.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.61 -28.84 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.75 43.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.96 125.75 18.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -92.31 95.6 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.79 150.84 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 m -98.24 159.05 15.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.08 -44.38 87.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -34.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -65.52 -54.87 22.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 m -64.66 -38.82 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.68 -42.04 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.39 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.42 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.1 mt-10 -73.03 -30.11 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.444 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.5 mmt -71.18 -35.07 71.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.57 HD13 HD13 ' A' ' 105' ' ' LEU . 2.4 mm -80.35 -54.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.42 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.3 ptm180 -54.04 -31.86 52.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.302 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -22.87 57.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.743 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.46 -11.17 18.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -96.35 97.79 9.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.484 0.659 . . . . 0.0 111.214 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -30.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 6.6 p30 -95.74 -9.51 31.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.972 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 45.98 62.43 3.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.505 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -113.68 3.2 15.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.584 0.23 . . . . 0.0 111.447 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.34 2.96 47.79 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.09 -177.33 5.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.094 0.447 . . . . 0.0 110.966 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.545 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.2 t -130.78 128.58 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.145 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -99.52 -175.07 2.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.736 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.545 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.7 t80 -56.82 -72.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.018 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.601 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.37 -43.26 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.152 0.501 . . . . 0.0 110.91 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.55 -36.17 71.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.38 -49.67 12.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.134 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.648 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.6 m -53.97 -42.41 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.6 pt20 -70.93 -48.6 52.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.231 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.438 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.74 -15.76 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.459 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 1.2 mtt -89.83 -42.96 10.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.332 -0.195 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.502 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.55 -71.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.603 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.57 -50.29 49.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.601 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -58.3 -67.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.606 0.241 . . . . 0.0 110.514 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.438 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.99 -35.99 48.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.298 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -56.38 -49.86 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.601 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.35 -42.19 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.006 178.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.473 HG21 ' O ' ' B' ' 68' ' ' PHE . 98.5 t -50.72 -50.31 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.558 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -45.88 63.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 19.5 mt -55.87 -50.61 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 13.3 p -63.02 -47.8 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 110.414 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.418 ' N ' HG11 ' B' ' 75' ' ' VAL . . . -56.95 -29.6 59.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.165 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 92.5 t -76.76 -56.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.629 0.252 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.515 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -59.9 -43.69 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.515 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.9 mmm180 -57.81 -35.09 70.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.236 0.541 . . . . 0.0 109.673 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.86 -35.77 81.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.109 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.51 ' CH2' HD13 ' A' ' 105' ' ' LEU . 2.4 t90 -95.19 -9.97 31.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.774 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.77 -36.94 50.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.281 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.018 -179.551 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.0 p30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.823 0.344 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.39 -175.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.04 165.17 26.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -69.78 171.4 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 11.9 pt-20 -54.97 -35.81 64.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -56.88 4.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -41.26 84.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.699 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.5 tt -71.4 -26.38 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.029 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.39 -43.22 61.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.514 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.34 -33.44 73.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -65.96 -49.65 67.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.467 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.56 -44.82 89.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.202 0.525 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.03 -48.86 72.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.703 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.548 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.34 -41.45 63.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.497 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -57.51 -31.73 66.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.957 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -79.7 -15.08 58.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.64 -38.79 15.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -67.04 -65.84 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.35 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -66.57 132.69 48.74 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 110.702 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -37.3 74.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.92 -12.28 29.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.49 37.08 80.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.64 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -75.21 -4.2 37.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.505 0.193 . . . . 0.0 111.473 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 -0.23 44.01 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.059 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.3 p -149.54 132.59 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.803 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.592 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mp -107.54 128.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -103.28 165.13 11.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.737 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 p -52.78 -26.65 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.688 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -67.53 -50.5 58.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 15.3 mm-40 -77.46 -35.41 53.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.752 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.592 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.27 -58.36 7.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.773 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.0 -27.3 66.89 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.919 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -69.89 -56.52 6.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 111.52 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.81 -33.78 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.484 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -59.05 -53.1 62.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.713 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -25.77 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.984 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -60.41 -36.71 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.7 mt -58.31 -30.65 66.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.23 42.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.524 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -142.6 161.59 37.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.23 62.75 8.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.73 -174.13 1.21 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.571 2.181 . . . . 0.0 112.355 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -122.12 167.29 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.79 -32.26 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.183 0.516 . . . . 0.0 110.084 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.487 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -41.92 95.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.394 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.41 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -56.34 -50.79 70.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -65.46 -50.03 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.54 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.08 71.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.578 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.6 -49.89 75.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.698 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.526 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -58.88 -42.32 85.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.261 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -59.18 -26.34 64.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.56 0.695 . . . . 0.0 110.06 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -83.79 -2.16 55.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.86 -33.06 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -71.15 148.02 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.5 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.85 -53.45 6.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.646 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.36 -8.76 58.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.49 48.75 78.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -96.96 -1.42 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 111.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.21 15.24 22.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.86 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -149.88 139.81 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.547 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.3 mm -95.33 147.21 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.473 . . . . 0.0 111.663 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.49 176.92 5.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.929 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 3.3 m-85 -60.21 -61.62 7.56 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 33.4 Cg_endo -64.48 -30.94 61.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.411 2.074 . . . . 0.0 111.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 1.9 mt-10 -69.03 -37.09 78.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.336 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.3 t80 -75.12 -39.97 60.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 6.6 tp -76.79 -54.57 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.604 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.1 m -51.58 -44.02 62.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.613 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -54.17 47.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.864 0.364 . . . . 0.0 111.011 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.402 ' HE1' ' CZ ' ' A' ' 68' ' ' PHE . 22.9 mtt -80.31 -8.06 59.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.604 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.82 -42.68 12.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.842 0.353 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -59.5 -29.88 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.921 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.03 163.29 37.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 157.55 43.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -57.44 -27.78 62.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.2 -34.43 61.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 19.2 mt-10 -61.48 -33.84 74.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.41 -39.02 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.298 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -49.32 33.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.9 -44.94 96.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.66 -52.87 58.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.883 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.28 -38.85 55.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.865 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -71.49 -31.44 67.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.43 -36.68 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.545 ' N ' HG23 ' A' ' 91' ' ' VAL . 7.8 m-85 -73.51 -62.81 1.35 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.934 0.397 . . . . 0.0 110.394 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -84.81 118.14 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -64.8 -52.64 55.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.27 -9.63 59.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.541 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.81 70.97 0.56 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.21 15.14 16.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.45 66.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.617 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.9 m-85 -165.67 116.36 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mt -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 111.866 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -104.04 156.39 17.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.929 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.463 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.97 -36.63 12.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.446 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -59.06 5.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.105 0.479 . . . . 0.0 110.978 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -58.75 -38.92 79.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.749 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.17 -48.36 82.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.842 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -56.91 -45.53 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.14 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.9 -36.63 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.148 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.43 -54.44 23.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.66 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.1 mmt -50.36 -54.01 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -67.63 -25.57 65.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.606 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.5 -31.23 71.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.82 -28.79 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.035 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.18 42.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.552 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -146.72 110.68 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.838 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -88.0 86.01 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.13 175.64 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -98.41 158.68 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.95 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.111 0.481 . . . . 0.0 110.209 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -71.76 -32.98 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.196 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.18 -52.98 56.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.54 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -66.95 -39.18 82.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.48 -45.15 88.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.046 0.45 . . . . 0.0 110.373 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 24.3 mt-10 -72.97 -30.16 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.622 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -34.46 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.755 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.573 HD13 HD13 ' A' ' 105' ' ' LEU . 2.0 mm -80.27 -54.73 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.463 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.2 ptm180 -53.91 -31.88 51.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 110.284 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.33 -23.48 57.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.688 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.03 -4.99 25.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.442 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -101.45 96.45 7.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.469 0.652 . . . . 0.0 111.273 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -30.84 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.611 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 5.0 p30 -95.82 -9.37 31.75 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 46.7 62.66 3.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.6 p30 -113.7 1.99 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.568 0.223 . . . . 0.0 111.434 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.28 4.57 47.09 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -149.98 -177.59 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 0.0 111.064 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.4 t -130.78 128.69 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.2 t30 -101.13 -174.03 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.549 ' O ' HG13 ' A' ' 142' ' ' VAL . 24.4 t80 -57.06 -73.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.575 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.38 -42.73 42.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.43 -37.24 72.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.326 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -79.43 -49.74 11.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.189 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.637 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.5 m -53.68 -42.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.3 pt20 -70.94 -48.18 54.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.267 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.441 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.66 -15.56 52.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.473 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.463 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 1.6 mtt -90.59 -42.62 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.751 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.422 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.406 ' CZ ' ' HB2' ' B' ' 65' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.873 0.368 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.67 -70.46 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.86 91.94 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.606 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.728 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.2 OUTLIER -52.23 -64.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.295 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.03 -31.57 61.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 0.0 110.005 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -54.0 -53.57 51.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.728 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -38.62 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.554 HG21 ' O ' ' B' ' 68' ' ' PHE . 98.0 t -50.85 -43.11 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.351 0.596 . . . . 0.0 110.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.413 ' CD ' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -74.67 -48.16 27.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.121 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -55.75 -46.77 77.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.548 HG13 ' HB3' ' A' ' 15' ' ' ALA . 14.8 p -66.28 -46.72 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.593 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -58.16 -30.7 64.4 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.156 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 69.0 t -76.77 -55.05 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.645 0.26 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -61.39 -43.03 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.501 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.608 ' HG2' HD11 ' B' ' 78' ' ' ILE . 9.8 mmp_? -56.58 -37.4 70.56 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.381 0.61 . . . . 0.0 109.518 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -35.74 79.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.374 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.545 ' CH2' HD13 ' A' ' 105' ' ' LEU . 2.1 t90 -95.03 -9.92 32.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.685 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.53 -36.55 52.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.385 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -176.98 -178.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.68 165.32 23.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.7 t -70.6 177.05 3.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 20.6 pt-20 -59.0 -37.99 78.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.48 -56.82 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.942 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.71 -40.72 80.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.422 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.1 tt -72.28 -26.57 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.981 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.64 -43.74 62.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.525 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.11 -33.05 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.15 -49.69 63.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.229 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -59.69 -44.93 93.44 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.218 0.532 . . . . 0.0 109.906 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -63.68 -48.21 78.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.409 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.43 -41.83 63.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.285 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.56 -38.61 69.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -74.0 -15.66 61.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -87.07 -38.3 16.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.36 -65.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.276 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -66.1 134.02 51.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -37.91 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.256 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.24 -12.14 28.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.824 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.57 79.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.724 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.58 -5.51 43.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.523 0.201 . . . . 0.0 111.45 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 3.72 44.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.044 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -149.45 132.59 16.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -110.64 126.93 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 t -100.42 168.27 9.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -54.32 -30.34 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.44 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -64.12 -50.41 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.185 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.79 -35.29 57.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.477 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.58 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.41 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.805 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -64.08 -27.46 71.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.803 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.5 m -66.89 -60.24 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.194 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.03 -30.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.1 ttt -62.02 -47.2 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.66 -25.72 44.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.998 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -57.7 -36.33 71.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.15 -61.52 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -142.63 161.89 36.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -130.05 60.06 49.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.0 -170.07 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.8 p -117.52 167.45 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.78 -32.11 71.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.69 59.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.338 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -44.85 92.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.262 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.9 mt -53.57 -50.59 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.86 -53.04 52.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -56.85 -51.13 70.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.566 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.06 -48.31 82.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.679 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -59.52 -43.65 91.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.79 -26.38 64.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.559 0.695 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -82.83 -2.24 54.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.663 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.78 -33.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -70.2 153.92 42.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.17 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.68 -53.5 6.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.855 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.58 -8.54 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.56 52.02 55.6 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.859 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.43 0.11 44.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.577 0.227 . . . . 0.0 111.45 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.39 24.38 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 p -149.98 139.9 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.542 0.21 . . . . 0.0 110.633 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.588 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.66 149.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.039 0.447 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 178.26 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.722 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.6 m-85 -60.79 -61.59 7.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.521 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.5 Cg_endo -67.22 -32.68 32.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.48 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -65.04 -38.76 91.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.6 t80 -75.35 -41.17 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.438 . . . . 0.0 110.036 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 8.3 tp -68.4 -56.28 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.4 m -51.72 -46.11 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.514 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.0 tpp -55.89 -49.6 72.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 111.087 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.0 mmt -81.14 -13.39 58.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 -35.17 20.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 110.978 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -38.65 90.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.28 159.5 35.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -150.25 154.0 37.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -55.17 -26.64 40.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.6 -34.05 67.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.77 -32.39 73.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.659 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.25 -38.92 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.2 -49.41 43.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.388 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.5 -45.84 92.52 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.65 -49.32 68.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.978 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.1 -38.42 51.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.97 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -30.47 57.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.822 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.14 -37.05 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.551 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.6 m-85 -73.74 -62.95 1.32 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.855 0.36 . . . . 0.0 110.483 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -84.42 128.48 34.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.787 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -73.17 -52.63 13.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.254 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -78.57 -9.62 59.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.528 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.72 70.61 0.57 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.956 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -93.67 14.87 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 111.219 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.73 68.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.6 m-85 -162.99 116.94 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 mt -111.77 126.67 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.499 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -103.96 156.94 17.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.133 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.62 -41.54 22.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.334 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -58.91 6.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.056 0.455 . . . . 0.0 110.863 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.71 -38.46 69.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.754 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.545 HD13 HD13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.71 -50.76 72.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.834 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.3 tpt85 -55.74 -44.15 77.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.06 -37.51 74.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.333 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.78 -53.88 22.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.1 mmt -49.74 -54.11 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -66.45 -25.42 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.4 -29.87 68.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.41 -28.76 13.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.22 43.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.536 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -149.66 114.15 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.06 103.08 15.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.32 163.6 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.768 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -98.28 158.82 15.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.5 -42.34 91.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.81 -35.42 74.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.32 -54.83 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 m -64.06 -39.9 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.85 -41.69 98.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.2 mt-10 -72.57 -30.1 64.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.356 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.421 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 53.9 ttm -70.85 -34.88 72.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.678 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 105' ' ' LEU . 3.2 mm -80.38 -54.93 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.659 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm85 -54.26 -31.78 54.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.41 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -22.02 55.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.897 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.72 15.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.576 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -83.88 90.82 7.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.472 0.654 . . . . 0.0 111.06 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.728 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -64.1 -30.74 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.411 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.601 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.74 -9.46 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.17 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.3 54.49 19.67 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.9 p30 -113.86 -5.33 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.206 0.503 . . . . 0.0 111.371 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.5 6.49 44.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.185 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.38 -174.89 4.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.895 0.348 . . . . 0.0 110.566 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.561 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.3 t -128.94 123.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.409 . . . . 0.0 111.326 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.2 -164.73 1.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.855 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.537 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 t80 -63.12 -73.9 0.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.587 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.6 -44.27 47.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.346 0.593 . . . . 0.0 110.302 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.728 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.43 -36.06 68.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.007 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.561 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -48.66 13.56 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.906 0.384 . . . . 0.0 111.496 -179.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.9 m -57.85 -41.2 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.363 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.34 -35.3 71.13 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.578 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.41 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -81.66 6.31 15.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.337 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.452 ' HE2' ' CZ ' ' A' ' 141' ' ' PHE . 2.9 mtt -115.75 -31.97 5.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.287 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.604 0.24 . . . . 0.0 111.628 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.827 0.346 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.06 -67.94 1.95 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.851 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.31 70.1 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.598 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.588 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -56.69 -66.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.493 0.187 . . . . 0.0 111.004 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.41 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.74 -36.78 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.507 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.5 tpt180 -55.88 -50.27 71.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.12 -41.75 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.138 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.512 HG21 ' O ' ' B' ' 68' ' ' PHE . 96.8 t -50.45 -52.4 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.581 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.41 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.1 mpt_? -70.69 -44.38 67.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.423 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 15.2 mt -56.03 -51.34 68.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.8 p -63.66 -48.09 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.419 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.24 -28.87 59.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.042 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 78.6 t -76.84 -54.6 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.625 0.25 . . . . 0.0 111.398 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.538 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.9 -44.09 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.538 ' N ' HD11 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.23 -35.37 71.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.224 0.535 . . . . 0.0 109.793 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.66 -36.99 80.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.194 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.513 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 2.9 t90 -95.28 -11.14 28.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.798 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 78' ' ' ILE . . . -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.368 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.112 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.885 0.374 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -173.82 -178.59 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.3 165.37 24.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 t -70.21 176.85 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.138 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -59.06 -38.01 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.322 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -56.79 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.996 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.65 -40.75 80.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.4 tt -72.27 -26.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.62 -43.86 62.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.516 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -67.79 -33.48 74.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.205 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.02 -49.61 64.74 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.239 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.74 -44.86 93.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 109.887 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.1 -49.06 75.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.41 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.35 -41.43 63.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.83 -38.0 69.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -75.05 -15.47 60.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.33 -37.7 16.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 110.31 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.92 -65.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.249 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.01 133.42 50.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.66 77.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.36 -12.2 28.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.55 36.69 79.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.694 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -74.8 -5.26 42.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.406 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.18 44.81 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.069 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -149.48 132.62 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.68 126.63 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.269 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -99.5 167.3 10.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.3 p -53.5 -32.14 49.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -62.67 -50.51 70.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.336 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -75.82 -36.37 59.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.38 -58.23 8.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.699 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.41 -30.88 77.6 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.665 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.6 m -63.84 -60.95 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.361 . . . . 0.0 111.086 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.68 -30.55 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.5 mtp -59.68 -52.14 66.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.626 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.35 -25.66 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -55.85 -38.97 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 mt -58.06 -63.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.14 40.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -141.09 168.37 19.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.05 59.48 34.1 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.43 -169.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.277 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.9 p -118.1 167.47 11.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.82 -32.07 71.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.191 0.519 . . . . 0.0 110.064 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.76 -45.74 59.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -44.55 93.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.279 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -54.03 -50.54 66.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.234 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -64.86 -52.7 55.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.534 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.17 -51.03 70.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.275 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.559 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.21 -48.38 81.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.508 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -59.35 -43.61 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.112 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.71 -26.34 63.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.532 0.682 . . . . 0.0 109.991 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 51' ' ' MET . 5.9 mt-10 -82.61 -2.26 53.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.591 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.6 -33.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.95 152.83 43.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.03 -53.46 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.861 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.09 -8.67 53.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.4 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.37 51.64 57.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.909 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.28 0.24 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.581 0.229 . . . . 0.0 111.402 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.51 24.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.866 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -150.0 139.88 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.536 0.208 . . . . 0.0 110.644 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.5 149.34 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 111.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.26 178.2 4.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.762 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -61.17 -61.59 7.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.5 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.8 Cg_endo -67.1 -31.22 37.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.481 2.12 . . . . 0.0 112.468 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -66.58 -38.78 87.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.977 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 63' ' ' ILE . 1.8 t80 -75.27 -41.01 58.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 110.038 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 8.9 tp -68.81 -56.23 8.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.485 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 m -51.65 -44.57 63.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.525 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -57.21 -49.92 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 mmt -79.21 -18.23 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.43 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -82.87 -32.75 27.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -45.16 89.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -127.43 177.8 6.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.981 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -161.29 154.15 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.84 -26.95 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.59 -37.1 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.7 -30.38 70.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.642 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.31 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.252 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -49.36 41.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.425 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -45.83 92.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.412 0.625 . . . . 0.0 109.445 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.59 -49.43 67.79 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.956 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.98 -38.68 52.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.018 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.16 -30.48 58.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.31 -37.12 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.552 ' N ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.55 -63.01 1.24 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.864 0.364 . . . . 0.0 110.465 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.07 113.71 20.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.11 -52.56 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 -9.6 59.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.3 71.79 0.47 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.83 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -94.85 13.46 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 111.213 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.08 68.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -162.65 116.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.5 123.22 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 111.531 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -104.2 161.4 14.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.979 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.584 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.71 -43.92 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.189 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -58.81 6.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.068 0.461 . . . . 0.0 110.908 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -55.11 -37.59 67.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.733 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.503 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.66 -50.88 71.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.835 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.2 tpt85 -56.02 -42.8 77.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -59.09 -37.88 78.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.92 -54.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -49.08 -54.03 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 t -67.21 -25.2 66.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.493 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.33 -30.26 69.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.731 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.38 -28.8 14.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.7 43.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.98 117.05 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -89.92 107.01 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.41 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.6 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.93 -41.16 91.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.686 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.535 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.4 -54.93 25.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.89 -41.24 91.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.19 -39.48 90.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 110.191 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 11.2 mt-10 -73.1 -30.22 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.329 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -35.4 71.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.584 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.7 mm -80.28 -54.89 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.5 ptm180 -53.74 -31.73 49.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 0.0 110.389 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -21.18 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.965 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.94 -9.12 16.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.417 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.5 t0 -87.37 110.22 20.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.418 0.627 . . . . 0.0 111.203 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.696 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.86 -31.18 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.781 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.1 -9.12 43.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.614 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.08 57.69 9.69 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 114.57 0.588 . . . . 0.0 114.57 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -114.27 -4.27 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.053 0.427 . . . . 0.0 111.505 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.7 42.17 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.968 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.94 4.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 110.552 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.577 HG11 ' CD1' ' A' ' 141' ' ' PHE . 52.2 t -128.31 125.42 64.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.935 0.397 . . . . 0.0 111.156 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.7 t-20 -105.31 -166.32 1.21 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.597 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.2 t80 -59.09 -73.9 0.08 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.588 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.57 -45.04 47.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.351 0.595 . . . . 0.0 110.33 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.696 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.7 mt-10 -57.22 -36.65 71.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.176 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.577 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -49.08 12.85 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 111.877 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.642 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -55.83 -38.88 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -34.25 70.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.743 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.37 12.45 10.1 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 111.165 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 2.3 mtt -121.24 -38.98 2.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.984 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.315 -179.837 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.783 0.325 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -66.58 2.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.71 -49.37 77.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -56.84 -67.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.546 0.212 . . . . 0.0 110.89 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -51.7 -37.02 48.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.522 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.3 tpp85 -55.9 -51.0 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.573 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.06 -41.61 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.517 HG21 ' O ' ' B' ' 68' ' ' PHE . 95.6 t -50.46 -53.4 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.623 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.418 ' HD3' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -70.52 -43.71 69.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 16.3 mt -56.22 -53.21 59.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 110.573 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.474 HG12 ' O ' ' B' ' 72' ' ' VAL . 14.5 p -61.6 -46.52 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.719 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -60.38 -28.32 67.02 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.245 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 77.7 t -75.92 -53.27 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.62 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -66.35 -40.99 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.2 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.62 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.1 mmp_? -57.19 -37.59 72.38 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.363 0.601 . . . . 0.0 109.551 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.53 79.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.503 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.6 t90 -95.12 -9.86 32.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.814 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.65 -36.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.287 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.025 -179.553 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.807 0.337 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.85 -179.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 165.32 25.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -70.09 176.42 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.142 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 12.9 pt-20 -58.38 -37.89 76.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.369 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -56.84 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -42.23 85.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.713 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.413 HG21 ' N ' ' A' ' 10' ' ' ALA . 12.2 tt -70.43 -26.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.79 -44.12 63.32 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.498 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.13 -32.83 71.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -66.88 -49.76 64.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -44.87 90.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.244 0.545 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -65.48 -47.48 75.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.39 -42.15 63.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -57.21 -34.5 68.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.119 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mt -87.24 -38.3 16.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.949 0.404 . . . . 0.0 110.245 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -67.97 -65.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.39 132.35 48.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.808 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -38.11 80.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.22 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.89 -12.25 29.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.84 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.686 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -74.73 -5.16 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.421 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 2.44 44.73 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 p -149.47 132.62 16.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.577 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.21 127.05 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 t -100.62 167.59 10.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 p -54.4 -28.75 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -64.53 -50.47 67.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -77.15 -36.21 55.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.577 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.35 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.572 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.54 70.57 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.732 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -67.04 -53.28 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.45 -31.57 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.351 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -45.13 93.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.669 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -29.47 45.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.1 t -61.82 -35.11 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.05 -31.09 66.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.57 42.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -141.55 172.56 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.08 59.96 41.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.43 -170.23 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.591 2.194 . . . . 0.0 112.253 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -122.12 165.04 16.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.75 -31.15 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 0.0 110.141 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.67 60.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -45.25 88.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.7 mt -53.28 -50.64 64.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -64.98 -53.88 39.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.606 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.33 -51.14 69.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.303 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.563 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.28 -47.72 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.669 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -59.74 -44.32 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.89 -26.37 62.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.529 0.681 . . . . 0.0 109.978 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.65 -2.2 53.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.634 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.62 -33.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 112.043 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.07 148.27 45.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.267 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.36 -53.54 7.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.684 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.67 -8.66 58.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.326 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.3 48.69 78.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.967 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -96.81 -0.19 48.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.589 0.233 . . . . 0.0 111.535 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.3 15.08 22.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.895 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -149.92 139.88 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.559 0.218 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.576 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.94 147.44 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.08 0.467 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.15 178.33 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.786 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.45 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -60.28 -61.7 7.41 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.452 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -67.11 -31.51 36.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.219 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 mt-10 -64.7 -39.84 94.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' HB2' HG23 ' A' ' 63' ' ' ILE . 1.9 t80 -75.17 -45.03 43.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 110.29 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -67.92 -52.6 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.279 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 m -51.6 -49.58 61.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.161 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpp -54.53 -49.5 70.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.0 2.04 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.569 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.57 -42.13 9.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.899 0.38 . . . . 0.0 110.999 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -53.69 -33.27 54.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.158 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -141.52 163.62 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 152.22 32.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -26.77 19.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.157 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.66 -35.7 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.33 -30.97 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.66 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.34 -37.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.119 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -49.46 35.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.519 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.88 -46.01 91.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.359 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.62 -48.64 69.13 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.839 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -50.86 -43.08 59.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.031 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -70.8 -31.59 68.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.701 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 m -75.54 -37.15 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 111.064 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.547 ' N ' HG23 ' A' ' 91' ' ' VAL . 3.5 m-85 -76.6 -62.93 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.871 0.367 . . . . 0.0 110.509 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -83.44 121.9 27.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.782 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -71.24 -52.63 17.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.45 -9.58 59.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.5 68.65 0.86 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.936 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -94.41 15.84 16.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.641 0.257 . . . . 0.0 111.272 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.5 69.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.633 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.5 m-85 -162.47 116.97 1.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -110.63 123.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.979 0.419 . . . . 0.0 111.278 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -103.96 157.05 17.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.248 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -41.45 22.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.79 6.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -55.1 -39.31 69.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.677 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.18 -50.9 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.922 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 5.6 tpt85 -56.55 -42.81 79.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.286 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -36.42 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.404 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -72.73 -54.79 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.3 mmt -49.11 -54.02 18.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 t -66.9 -25.18 66.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.96 -29.97 68.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.63 -28.78 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.68 43.75 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -149.88 112.95 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -90.85 102.23 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.47 164.48 12.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.794 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.6 m -98.32 158.81 15.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -59.32 -42.17 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.31 -54.87 22.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.756 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.406 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 2.2 m -63.52 -40.66 89.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.65 -41.03 96.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.433 . . . . 0.0 110.275 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.411 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 26.8 mt-10 -72.63 -30.12 64.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.373 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -33.94 69.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.611 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.55 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.3 mm -80.29 -55.08 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.657 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.411 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 8.8 ptm180 -54.59 -31.82 57.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 110.405 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.35 -21.93 55.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.796 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.72 -15.41 15.76 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.606 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -82.44 90.52 6.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.712 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.74 -30.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.429 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.602 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.0 -9.48 57.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.164 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.88 23.83 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 114.81 0.684 . . . . 0.0 114.81 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 32.2 p30 -113.79 -5.55 13.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.227 0.513 . . . . 0.0 111.303 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 6.66 44.39 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.213 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.58 -174.82 4.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.834 0.35 . . . . 0.0 110.661 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.4 t -127.33 120.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -98.71 -169.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.608 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.463 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.5 t80 -60.12 -73.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.609 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.66 -43.59 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.286 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.712 ' HA ' HG12 ' A' ' 130' ' ' ILE . 3.2 mt-10 -56.26 -34.72 66.66 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -79.45 -48.7 13.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 111.22 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.66 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.9 m -58.71 -40.41 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.321 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -71.19 -36.04 71.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.615 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.431 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.1 4.92 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.451 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 1.1 mtt -112.04 -31.62 6.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.028 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.464 -179.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.791 0.329 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.15 -68.23 1.76 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.58 -52.72 46.79 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.589 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.37 -62.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.509 0.195 . . . . 0.0 110.871 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.428 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.81 -35.2 43.38 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.39 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.2 OUTLIER -56.6 -53.27 59.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.589 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.69 -42.28 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.238 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.516 HG21 ' O ' ' B' ' 68' ' ' PHE . 97.1 t -50.43 -52.86 14.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.415 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.0 mpt_? -69.92 -45.57 67.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.543 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 40.7 mt -55.79 -52.61 63.38 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.656 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.5 p -61.84 -47.62 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.24 -28.89 59.38 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.205 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 79.8 t -76.78 -56.15 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.533 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.42 -43.75 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.533 ' N ' HD11 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.03 -34.64 70.28 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.22 0.533 . . . . 0.0 109.783 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.19 -37.25 82.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.293 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.523 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 2.7 t90 -95.25 -11.1 28.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.744 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' B' ' 78' ' ' ILE . . . -76.29 -36.21 58.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.523 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -177.02 -178.92 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.81 165.11 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -71.37 177.28 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.132 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 13.0 pt-20 -58.36 -38.98 78.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.9 -56.77 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.044 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -43.36 89.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.738 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.0 tt -69.04 -26.44 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.062 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.42 -43.37 61.97 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -33.47 74.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.63 -49.74 65.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -44.85 92.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.264 0.554 . . . . 0.0 110.047 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -64.45 -48.5 75.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.576 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.39 -41.7 63.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.316 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -38.28 71.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.05 -15.67 61.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.62 -38.6 16.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.199 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.607 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.38 -65.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.44 132.64 49.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.707 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -37.14 75.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.3 -12.27 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.96 77.7 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.636 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 1.72 44.64 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.048 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.0 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.678 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.607 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.9 mt -108.18 121.53 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 t -97.88 167.5 10.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.0 p -54.34 -35.53 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -56.77 -50.43 72.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.158 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.83 -37.91 47.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 110.768 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.55 -43.31 71.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.909 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.36 -27.5 72.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.202 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -72.34 -49.75 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.32 -33.54 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.0 mtp -60.41 -45.71 92.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.958 0.409 . . . . 0.0 110.677 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -25.92 44.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -58.05 -37.11 73.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.51 -30.75 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.79 41.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -142.61 163.22 33.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.51 61.84 12.08 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.73 -170.93 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.567 2.178 . . . . 0.0 112.277 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -122.11 167.01 13.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.82 -31.98 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.67 59.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.341 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -43.33 94.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.208 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.3 mt -55.15 -50.67 68.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -52.31 58.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.432 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.67 -51.15 70.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.249 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.526 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.69 -47.76 83.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.754 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.512 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -60.98 -45.11 99.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.27 -26.48 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.599 0.714 . . . . 0.0 110.143 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.8 mt-10 -82.75 -2.06 53.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.496 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.61 -33.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 52.9 t0 -72.25 148.57 45.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.317 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.37 -53.57 6.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.15 -8.66 58.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.3 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.55 48.42 81.26 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.968 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -97.31 -0.88 45.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.543 0.211 . . . . 0.0 111.421 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.33 15.51 21.12 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.939 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -149.73 139.79 22.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.591 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.12 149.39 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.301 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.26 175.92 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -58.65 -61.64 7.28 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.157 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.2 Cg_endo -63.98 -33.83 61.48 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.374 2.049 . . . . 0.0 111.756 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -68.71 -36.46 78.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.391 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -75.33 -40.15 58.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.349 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 4.6 tp -76.78 -53.08 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.586 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -51.46 -49.98 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.487 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 tpp -53.47 -48.05 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.9 mmt -88.64 10.44 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.52 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.21 -36.39 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -57.13 -40.12 76.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.24 167.58 22.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -153.69 152.52 30.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.777 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -25.49 23.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -74.58 -38.13 62.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.23 -31.27 70.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.644 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.34 -39.38 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.291 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -70.93 -49.35 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.338 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -61.05 -46.19 91.68 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.61 -49.44 67.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.149 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.03 -38.55 52.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.917 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -76.65 -30.53 56.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.866 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.23 -36.94 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 110.898 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.5 m-85 -72.41 -62.91 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.5 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.62 119.35 24.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -62.34 -52.61 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.52 -9.65 59.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.461 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.63 0.47 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.08 14.44 17.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.663 0.268 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.76 66.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.4 m-85 -161.55 116.68 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.92 124.66 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.47 . . . . 0.0 111.656 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.8 t -104.28 161.15 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.579 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.89 -43.94 29.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.268 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.07 -58.93 6.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.931 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.36 -37.61 67.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.671 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.508 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.36 -50.86 71.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.844 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.3 tpt85 -55.74 -43.61 76.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.117 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -58.1 -38.88 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.382 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 92' ' ' PHE . 39.1 t -68.25 -54.92 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.4 mmt -49.41 -54.06 19.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.5 t -67.7 -25.17 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.581 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -68.53 -30.36 69.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.26 -28.73 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.013 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.41 43.46 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.584 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -152.79 110.77 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -83.73 115.8 22.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -105.81 163.31 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 158.76 15.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.59 -40.81 93.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.92 -35.56 74.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.568 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.96 -54.88 23.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.709 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.38 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.71 -40.06 93.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.11 0.481 . . . . 0.0 110.171 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 14.2 mt-10 -72.9 -30.15 63.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.289 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 46.1 ttm -71.01 -35.79 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.879 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.2 mm -80.4 -54.91 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.579 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -53.44 -31.79 46.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.996 0.427 . . . . 0.0 110.46 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.96 -21.58 50.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.942 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.95 -8.56 17.55 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ILE . 35.9 t0 -88.54 110.27 20.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.645 . . . . 0.0 111.312 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.22 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.765 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.86 -9.09 44.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.562 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.9 57.94 9.18 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -114.23 -4.19 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.033 0.416 . . . . 0.0 111.505 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 7.59 42.45 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.13 -174.96 4.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 110.458 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.14 126.62 66.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.94 -167.54 1.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.592 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.1 t80 -58.52 -73.94 0.07 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.588 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.47 -45.74 47.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.617 . . . . 0.0 110.32 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.44 -36.4 68.95 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.62 -49.59 11.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.965 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -55.28 -40.53 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -34.28 70.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.713 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 8.9 13.82 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.649 0.261 . . . . 0.0 111.328 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.466 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.0 mtt -118.18 -38.9 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.767 0.317 . . . . 0.0 111.034 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.9 mpp_? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.68 -68.39 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.49 -49.75 75.17 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.608 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.64 -66.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.477 0.179 . . . . 0.0 110.87 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -51.79 -38.96 57.74 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.329 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -54.58 -49.52 70.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.608 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.58 -41.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.18 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.488 HG21 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.46 -53.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.556 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -46.46 68.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.42 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 20.6 mt -55.72 -53.57 54.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.736 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.8 p -60.32 -47.2 93.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.434 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.422 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.33 -30.3 61.28 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.112 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 93.6 t -75.26 -55.39 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.606 0.241 . . . . 0.0 111.446 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.54 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.06 -43.98 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.54 ' N ' HD11 ' B' ' 78' ' ' ILE . 21.3 mmm180 -58.2 -35.3 71.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 109.728 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -61.14 -37.12 81.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.252 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.508 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.4 t90 -95.32 -10.09 31.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.854 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' B' ' 78' ' ' ILE . . . -76.62 -36.1 57.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.297 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.112 -179.583 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.927 0.394 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -176.93 169.63 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.69 165.25 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -70.09 177.33 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.96 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 23.1 pt-20 -59.8 -37.12 78.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -56.94 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.116 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -41.48 83.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.423 . . . . 0.0 110.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.8 tt -71.93 -26.44 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.092 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.49 -43.4 62.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.478 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.35 -33.11 72.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.14 -49.67 66.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.436 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -45.0 90.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 110.168 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -64.88 -48.44 74.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.37 -41.64 63.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.447 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -33.98 65.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.022 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -87.72 -39.08 15.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.927 0.394 . . . . 0.0 110.045 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -67.36 -65.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.374 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.43 132.47 48.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.874 0.368 . . . . 0.0 110.705 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -37.25 74.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.02 -12.16 29.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.39 36.93 79.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.632 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -74.89 -4.45 38.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.446 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.01 44.09 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.125 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -149.46 132.53 16.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.876 0.338 . . . . 0.0 110.899 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.589 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mp -106.22 127.27 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 t -101.97 167.7 9.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.8 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -54.26 -31.51 53.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -62.67 -50.43 71.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.338 . . . . 0.0 111.222 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.15 -35.8 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.589 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.34 -58.17 8.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.752 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.44 68.8 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.685 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.8 m -70.18 -54.21 13.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.49 -31.1 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.1 ttt -61.02 -44.78 96.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -25.68 44.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.941 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -56.75 -36.43 69.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.99 -31.47 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -142.61 160.88 39.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.4 62.22 22.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.88 -170.11 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -121.34 167.23 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.76 -32.14 71.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.132 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.6 60.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.384 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -43.3 94.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.1 mt -55.27 -50.75 68.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -64.72 -52.32 57.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.42 -51.12 70.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.263 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.539 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.88 -48.08 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -60.73 -44.37 97.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.279 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -57.07 -26.45 60.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.556 0.693 . . . . 0.0 110.033 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.92 -2.06 53.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.71 -32.99 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.22 149.28 44.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.343 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.06 -53.55 6.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.49 -8.72 58.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.59 48.91 77.96 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.93 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -97.5 -0.77 45.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.627 0.251 . . . . 0.0 111.496 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.21 15.53 21.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.885 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -149.88 139.77 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.01 149.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.412 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.88 172.91 6.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -56.39 -61.58 6.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.1 Cg_endo -63.94 -33.04 64.91 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.046 . . . . 0.0 111.862 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -69.62 -35.73 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.8 t80 -75.28 -40.6 58.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.262 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 6.5 tp -76.78 -53.99 7.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.587 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.4 m -51.37 -45.2 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.526 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -52.62 60.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.9 mtt -80.02 -10.35 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.533 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.66 -33.33 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.899 0.38 . . . . 0.0 110.845 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -57.88 -43.81 86.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.963 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.38 -178.31 4.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.2 m -162.15 161.92 28.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.63 -27.38 39.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.23 -42.46 75.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.973 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 mt-10 -59.25 -33.09 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.658 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.36 -37.99 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.244 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -49.41 41.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.04 -46.41 89.27 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.652 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.58 -48.09 69.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.781 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -50.85 -43.15 59.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -71.1 -32.17 68.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.72 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 m -75.0 -36.62 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.733 0.301 . . . . 0.0 111.002 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.546 ' N ' HG23 ' A' ' 91' ' ' VAL . 3.1 m-85 -74.65 -62.92 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.496 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -84.68 132.23 34.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -76.62 -52.59 9.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.54 -9.61 59.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.46 70.21 0.66 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.902 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -94.24 15.32 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.44 69.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.696 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -160.39 117.04 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -112.17 123.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.229 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.0 t -103.96 157.72 16.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.308 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.55 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.68 -41.52 22.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.12 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -58.77 6.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.78 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -55.13 -39.08 69.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.707 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.515 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.52 -50.9 72.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.92 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 5.6 tpt85 -56.43 -42.31 77.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.146 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -36.22 77.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.32 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.58 -54.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.762 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.1 mmt -49.54 -54.03 20.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.657 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 t -66.94 -25.46 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.65 -30.01 68.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.64 -28.77 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.24 43.89 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -149.59 114.88 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -91.6 101.5 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.83 163.56 13.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.821 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -59.38 -42.07 90.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.741 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -69.73 -35.85 75.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.15 -54.86 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.74 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.407 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 2.3 m -63.6 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -61.49 -41.42 97.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.082 0.467 . . . . 0.0 110.313 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 34.8 mt-10 -72.42 -30.15 64.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.266 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -34.41 71.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.647 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.55 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.5 mm -80.27 -55.17 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.708 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm180 -54.38 -31.8 55.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 0.0 110.415 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -21.6 57.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.892 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -18.09 14.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.66 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.05 90.59 4.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.94 -30.91 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.6 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.28 -9.46 57.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.123 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 51.06 53.61 26.4 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.7 p30 -113.78 -5.55 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.232 0.516 . . . . 0.0 111.271 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 6.24 44.64 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.219 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.06 -174.88 4.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.669 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 141' ' ' PHE . 47.0 t -127.36 120.59 55.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.006 0.432 . . . . 0.0 111.274 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -98.98 -169.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.64 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.465 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.2 t80 -59.53 -73.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.618 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.62 -43.62 46.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.405 0.622 . . . . 0.0 110.331 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.714 ' HA ' HG12 ' A' ' 130' ' ' ILE . 3.1 mt-10 -56.3 -34.75 66.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.928 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.537 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -79.41 -48.45 13.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.293 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.658 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.9 m -58.8 -39.79 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.07 71.45 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.567 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.418 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -84.77 11.1 9.75 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.449 ' HE2' ' CZ ' ' A' ' 141' ' ' PHE . 1.4 mtt -119.26 -39.56 2.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.479 -179.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 65' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.843 0.354 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.97 -71.46 1.14 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.586 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.29 -48.2 65.1 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.59 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.719 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.151 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.416 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.07 -31.7 61.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.009 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -53.78 -53.56 50.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.409 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.719 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.34 -38.55 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.56 HG21 ' O ' ' B' ' 68' ' ' PHE . 99.4 t -50.61 -43.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.742 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.413 ' CD ' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -74.94 -46.45 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.051 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.85 -48.28 75.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.373 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.1 p -65.07 -48.24 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.431 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.58 -29.63 57.95 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.017 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 81.7 t -76.88 -54.62 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.611 0.243 . . . . 0.0 111.58 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.528 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -61.58 -43.91 97.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.528 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.0 mmm180 -57.68 -34.44 69.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.239 0.542 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -37.42 83.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.22 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.515 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.0 t90 -95.3 -10.48 30.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.852 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.09 58.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.059 -179.484 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.85 0.357 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -177.26 179.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.87 165.32 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -69.11 177.33 2.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 14.6 pt-20 -60.48 -36.34 78.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.298 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -56.95 4.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -41.95 83.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.006 0.432 . . . . 0.0 110.686 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.2 tt -71.36 -26.43 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.48 -43.53 62.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.14 -32.82 70.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.53 -49.68 68.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.456 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -45.1 89.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.193 0.521 . . . . 0.0 110.23 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -64.67 -48.81 73.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.691 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.36 -41.39 63.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.471 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.81 -38.68 70.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.999 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -74.14 -13.92 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.933 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.69 -39.74 14.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.954 0.406 . . . . 0.0 110.151 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.565 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.45 -65.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.356 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.39 132.88 50.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -37.62 74.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.24 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.73 -12.26 29.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.7 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.64 37.21 82.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -74.77 -4.55 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.244 -0.183 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.15 44.16 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.116 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -149.55 132.5 16.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.796 0.331 . . . . 0.0 110.892 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.586 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mt -105.52 127.38 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 t -102.41 168.44 9.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 p -54.78 -34.35 62.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.48 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -50.49 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.248 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -77.19 -36.53 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.158 0.504 . . . . 0.0 110.826 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.586 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.3 -58.21 8.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.823 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.52 64.23 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.793 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -72.04 -59.97 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 111.172 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG12 ' CE1' ' A' ' 19' ' ' PHE . 9.1 p -64.33 -30.56 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.174 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 mtp -60.93 -56.43 21.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -25.63 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.95 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.4 t -57.77 -38.66 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.64 -35.65 68.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.72 43.59 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -142.6 163.39 32.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.43 61.17 27.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.09 -170.17 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 0.0 112.248 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -122.11 166.92 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.83 -31.96 71.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.084 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.45 59.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.436 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.53 -41.9 92.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -56.63 -50.95 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -57.04 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.407 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -51.06 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.147 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.537 ' O ' HG21 ' A' ' 55' ' ' VAL . 19.2 mtt -58.19 -46.84 85.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.502 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -60.83 -45.82 97.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.029 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -56.13 -26.53 50.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.538 0.685 . . . . 0.0 110.042 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.7 mt-10 -82.15 -2.19 51.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.467 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.25 -32.99 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.0 111.934 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -72.74 152.72 41.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.33 -53.55 6.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.54 -8.74 57.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.316 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.91 49.93 70.31 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.853 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -97.27 -0.2 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.424 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.5 24.11 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.825 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -149.84 139.86 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.591 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.58 149.43 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -103.87 174.78 5.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -58.06 -61.58 7.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -63.62 -33.82 65.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.055 . . . . 0.0 111.81 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -69.15 -36.25 77.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.427 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.29 -40.11 58.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.28 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 6.4 tp -76.7 -54.7 6.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.536 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -51.61 -43.3 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.427 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -55.18 33.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtt -79.08 -11.47 59.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.516 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.08 -38.25 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -63.13 -30.46 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.64 179.05 7.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -160.85 154.44 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -25.52 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -39.7 65.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -59.95 -30.45 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.644 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.89 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -49.4 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.438 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -61.59 -45.81 92.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.66 -48.89 69.01 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.966 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.04 -38.74 53.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -30.5 57.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.28 -36.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.536 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.8 m-85 -73.29 -62.91 1.31 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.511 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -83.48 119.1 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -62.7 -52.62 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.8 -9.72 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.471 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.0 71.3 0.49 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.956 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -93.48 14.55 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.279 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.18 67.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.582 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.421 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 6.6 m-85 -162.37 116.89 1.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.21 124.38 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.069 0.461 . . . . 0.0 111.539 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -104.11 160.08 15.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.954 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.579 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -43.54 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.83 6.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.019 0.437 . . . . 0.0 110.84 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -55.22 -37.34 67.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.671 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.507 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.68 -50.78 72.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.795 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.4 tpt85 -55.91 -43.14 77.04 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -37.41 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.382 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.65 -53.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.626 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -51.16 -54.16 27.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.0 t -66.52 -25.72 66.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.24 -30.04 69.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.79 -28.79 14.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -152.37 109.77 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -86.48 110.55 19.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.36 166.06 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.0 m -98.35 158.73 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.41 -40.51 91.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.39 -55.04 23.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.3 m -62.94 -40.97 90.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.35 -39.03 89.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.1 0.476 . . . . 0.0 110.123 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.7 mt-10 -73.4 -30.15 63.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.3 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.16 -35.5 71.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.3 mm -80.31 -55.02 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.589 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.8 ptm180 -53.95 -31.81 51.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.016 0.436 . . . . 0.0 110.386 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -79.24 -21.31 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.15 -2.33 21.03 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.331 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.9 t0 -94.61 104.92 16.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.448 0.642 . . . . 0.0 111.135 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.723 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -79.04 -31.66 14.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.092 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.1 -9.1 46.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.55 -178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.15 57.1 10.57 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -114.23 -4.04 13.11 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.104 0.452 . . . . 0.0 111.408 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 6.93 43.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.087 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.421 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.08 -174.74 4.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.613 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.3 t -128.13 125.28 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.931 0.396 . . . . 0.0 111.212 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.7 t30 -105.12 -165.24 1.11 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.939 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.571 ' O ' HG13 ' A' ' 142' ' ' VAL . 13.2 t80 -60.09 -73.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.612 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.6 -44.82 47.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 110.383 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.723 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -57.39 -35.66 70.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.558 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.44 -48.61 13.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.994 0.426 . . . . 0.0 111.673 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -56.81 -38.65 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.55 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -71.2 -35.1 71.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.627 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.403 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -86.36 12.85 9.2 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.726 0.298 . . . . 0.0 111.088 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 1.9 mtt -120.73 -38.47 2.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.313 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.418 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.58 -75.0 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.692 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.99 -50.48 27.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.668 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.725 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.28 -65.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.089 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.437 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -54.1 -31.81 53.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.44 . . . . 0.0 110.045 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.6 tpp85 -54.07 -53.61 50.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.725 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.73 -37.78 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.552 HG21 ' O ' ' B' ' 68' ' ' PHE . 97.3 t -50.47 -45.65 25.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.366 0.603 . . . . 0.0 110.861 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.437 ' HD3' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -75.48 -45.66 37.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.338 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 29.8 mt -55.97 -46.68 78.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.979 0.419 . . . . 0.0 110.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.9 p -66.42 -48.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.499 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.434 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.93 -28.11 57.5 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.866 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 95.9 t -76.83 -54.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 111.419 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.525 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -62.86 -44.08 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.525 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.5 mmm180 -58.0 -35.36 71.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -37.3 79.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.507 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.7 t90 -95.38 -11.25 28.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.831 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.04 -35.57 59.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.342 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 -179.56 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -158.14 179.55 9.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.22 165.29 21.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -70.07 177.31 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 pt-20 -59.93 -36.85 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.339 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.33 -56.93 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -57.59 -41.16 80.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.0 tt -72.33 -26.24 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.32 -44.41 61.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.788 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 6.4 pm0 -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.18 -49.71 68.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.417 -179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -45.12 88.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.85 -48.65 73.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.715 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.32 -41.42 62.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.486 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -38.84 69.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.066 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -74.2 -13.76 60.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.75 -39.8 14.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.151 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.574 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.95 -65.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.392 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.34 133.16 50.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.844 0.354 . . . . 0.0 110.736 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.61 -37.62 73.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.19 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.64 -12.25 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 37.28 82.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.688 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -74.69 -4.58 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.211 -0.195 . . . . 0.0 111.389 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.25 0.21 44.09 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.064 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.9 p -149.58 132.53 16.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.851 0.358 . . . . 0.0 110.879 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.589 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.0 mt -105.33 126.92 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.9 t -101.87 168.1 9.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 p -53.81 -37.21 63.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.644 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -57.27 -50.52 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.357 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.96 -36.67 56.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.144 0.497 . . . . 0.0 110.821 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.589 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.42 -58.11 8.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.859 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.49 64.94 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.833 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -71.32 -60.29 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.336 . . . . 0.0 111.197 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG12 ' CE1' ' A' ' 19' ' ' PHE . 9.1 p -63.84 -30.49 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.9 mtp -61.03 -56.49 20.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.59 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -25.6 66.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.8 t -57.22 -38.13 73.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.57 -30.94 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.0 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.583 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -142.63 166.16 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -120.34 60.99 7.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.43 165.22 33.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.6 p -102.87 165.33 11.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.05 -29.35 67.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 110.274 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.68 -50.86 53.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.638 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.45 -37.6 87.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 19.6 mt -57.51 -51.01 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.771 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -56.67 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.33 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -54.91 -51.02 67.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.163 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.538 ' O ' HG21 ' A' ' 55' ' ' VAL . 59.4 mtt -59.03 -46.11 89.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.499 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -60.64 -45.91 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.953 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -55.96 -26.56 48.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.555 0.693 . . . . 0.0 110.03 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.4 mt-10 -82.12 -2.11 50.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.442 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.36 -32.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.905 0.383 . . . . 0.0 111.99 -177.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.82 152.17 41.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.87 -53.54 6.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.679 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.52 -8.6 57.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.282 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.84 49.79 71.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.891 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -97.34 -0.25 46.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.536 0.208 . . . . 0.0 111.444 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.64 23.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.881 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -149.85 139.86 22.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.82 149.32 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.458 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.68 174.83 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.952 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.418 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -57.94 -61.67 6.95 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -63.74 -33.75 64.57 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.392 2.062 . . . . 0.0 111.812 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -69.06 -36.12 77.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.438 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.27 -40.04 59.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.295 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 7.0 tp -76.72 -54.93 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.451 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -51.67 -43.42 62.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.519 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -55.5 30.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtt -76.95 -17.3 58.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.442 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.58 -31.63 32.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -30.61 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 -178.48 6.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.52 157.68 30.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -54.61 -26.43 32.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -59.54 -31.82 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.654 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.28 -39.28 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.257 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -49.35 46.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.468 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.39 -46.21 91.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.375 0.607 . . . . 0.0 109.404 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.53 -48.95 68.6 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.07 -38.58 52.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.023 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -76.56 -30.53 57.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.82 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.35 -36.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.675 0.274 . . . . 0.0 111.077 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.526 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.5 m-85 -73.34 -62.97 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.352 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -83.94 129.98 34.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -74.83 -52.66 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.63 -9.7 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.01 70.54 0.6 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.94 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -93.87 15.04 17.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.698 0.285 . . . . 0.0 111.217 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.58 69.02 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.2 m-85 -163.96 116.92 1.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.688 0.28 . . . . 0.0 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 mt -111.27 126.55 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.7 t -104.0 156.85 17.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.521 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -40.91 21.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.92 6.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 110.801 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -55.87 -38.13 69.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.706 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.03 -50.74 72.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.845 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.0 tpt85 -55.72 -44.17 77.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -37.21 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.289 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.41 -53.58 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.732 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.2 mmt -50.3 -54.08 23.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -67.14 -25.62 66.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -29.95 68.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.73 -28.78 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.87 43.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -149.36 116.78 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -91.75 102.84 15.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.983 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.54 163.71 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 m -98.29 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.01 -42.2 93.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.643 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.89 -54.87 20.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 m -64.52 -40.0 87.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.973 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -62.26 -41.41 98.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 110.34 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.7 mt-10 -72.91 -30.17 63.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.415 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -71.45 -34.3 70.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.534 HD13 HD13 ' A' ' 105' ' ' LEU . 3.2 mm -80.33 -54.91 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.631 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.0 ptm180 -54.51 -31.77 56.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.043 0.449 . . . . 0.0 110.347 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.99 -21.7 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.36 16.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.435 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 125' ' ' ILE . 49.0 t0 -84.07 89.65 7.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.449 0.642 . . . . 0.0 110.965 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.723 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -62.93 -30.8 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.419 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.595 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.8 -9.48 56.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.163 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.47 54.17 21.72 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.802 0.681 . . . . 0.0 114.802 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.9 p30 -113.84 -5.38 13.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.207 0.504 . . . . 0.0 111.307 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 6.29 44.54 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.316 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.83 -174.82 4.45 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.937 0.368 . . . . 0.0 110.712 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.5 t -128.6 123.56 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.424 . . . . 0.0 111.304 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.74 -164.95 1.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.535 ' O ' HG13 ' A' ' 142' ' ' VAL . 16.2 t80 -62.44 -74.06 0.1 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.68 -44.29 47.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 110.329 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.723 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.48 -35.82 68.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.006 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.558 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.17 -48.34 14.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 111.418 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.654 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.8 m -59.15 -40.31 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.437 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.41 -34.78 70.65 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.577 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.402 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -83.54 9.53 11.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.642 0.258 . . . . 0.0 111.279 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.423 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 3.5 mtt -119.21 -39.16 2.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.477 -179.804 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.945 0.403 . . . . 0.0 110.989 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.81 -71.88 1.0 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.532 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.7 -49.47 46.94 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.459 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.712 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.0 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.008 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.42 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.7 OUTLIER -56.32 -31.76 64.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -52.84 -53.55 47.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.331 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.712 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.93 -38.7 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.57 HG21 ' O ' ' B' ' 68' ' ' PHE . 98.9 t -50.62 -44.5 25.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.316 0.579 . . . . 0.0 110.884 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.42 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 5.1 mpt_? -75.24 -47.22 29.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 33.1 mt -55.81 -46.57 78.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 15.0 p -65.99 -48.72 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.38 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.75 -28.26 56.74 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.855 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 99.3 t -76.85 -55.44 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.65 0.262 . . . . 0.0 111.525 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.523 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -61.91 -44.13 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.523 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.7 mmm180 -57.77 -35.14 70.37 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 109.767 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -36.48 81.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.517 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.8 t90 -95.31 -10.46 30.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.785 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.89 -36.22 56.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.028 -179.56 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.844 0.354 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -176.22 172.78 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -120.3 165.4 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 8' ' ' GLN . 12.6 t -71.81 177.36 4.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.783 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 16.1 pt-20 -58.32 -41.99 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.292 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.14 -57.11 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.7 tp60 -58.08 -44.68 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.018 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.445 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.6 tt -69.64 -26.59 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.251 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.6 -43.47 62.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.453 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 2.2 pt-20 -70.75 -32.81 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -66.07 -49.61 67.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -45.05 90.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.211 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -64.75 -48.82 73.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.7 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.43 -41.12 62.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.399 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.499 ' CE1' HD13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -54.08 -40.51 67.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.401 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 t -75.9 -12.94 60.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.13 -40.34 14.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 110.425 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -63.76 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.222 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.69 133.21 48.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.837 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.9 88.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.347 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.03 -12.13 36.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.28 38.7 91.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.69 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -73.51 -5.78 42.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.435 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 6.32 42.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.215 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -149.83 133.19 16.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.801 0.3 . . . . 0.0 110.74 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.614 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.3 mp -100.04 117.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -89.18 159.07 17.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.725 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.8 p -54.72 -34.33 62.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.36 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.51 -50.42 73.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 111.046 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -76.08 -36.69 58.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.85 -44.43 73.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.095 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.85 -27.4 73.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.321 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -71.92 -49.68 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.6 p -72.43 -35.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.3 ttm -58.94 -45.22 90.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -25.59 44.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.8 t -54.64 -38.09 66.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.77 -30.15 65.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.986 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.87 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -142.62 161.75 37.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -119.66 62.79 7.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.69 176.38 8.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.207 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -109.38 168.27 9.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -32.15 71.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.079 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.92 60.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.451 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.313 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.64 -50.66 72.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.05 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.78 -43.44 93.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.335 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.31 -51.14 62.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.155 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.564 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.64 -52.13 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -58.11 -42.28 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.015 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.66 -26.43 65.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.513 0.673 . . . . 0.0 109.893 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.9 mt-10 -83.03 -2.21 54.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.719 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.35 -33.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.078 -177.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -70.54 154.62 41.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.399 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.62 -53.75 5.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.802 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -89.14 -8.65 53.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.362 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.2 51.67 57.79 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.848 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -100.06 1.13 42.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.574 0.226 . . . . 0.0 111.437 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.35 15.02 22.56 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.975 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -150.02 139.72 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.604 0.24 . . . . 0.0 110.88 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.599 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.0 mm -96.54 149.89 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.94 172.85 6.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.2 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -53.55 -61.55 4.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.775 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 -26.3 37.42 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.673 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 15.6 mm-40 -73.71 -38.31 64.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.41 -43.32 50.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 110.37 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 7.4 tp -70.08 -57.06 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.811 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.3 m -51.44 -53.78 33.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.649 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.9 tpp -54.26 -38.72 66.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.8 mmt -97.91 14.53 26.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.244 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . . . -111.22 -36.01 5.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -55.49 -55.76 28.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.265 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.59 -175.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -168.4 -166.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -67.36 -29.15 68.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.51 -26.57 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB3' HG23 ' B' ' 77' ' ' VAL . 8.1 mt-10 -71.1 -45.16 64.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.472 . . . . 0.0 110.83 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -74.6 -33.64 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.593 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -49.37 52.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.368 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -62.41 -48.47 79.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.415 0.626 . . . . 0.0 109.698 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.38 -44.54 68.72 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.953 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.47 57.8 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.928 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.56 -32.35 58.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.946 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -73.9 -36.65 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 120.678 0.275 . . . . 0.0 111.024 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.537 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -72.94 -63.08 1.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.487 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -86.23 128.57 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -52.72 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.982 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.86 -9.75 58.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.413 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.52 69.74 0.63 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.006 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -93.27 14.35 18.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.284 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 17.3 66.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.604 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.8 m-85 -158.45 116.94 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.694 0.283 . . . . 0.0 110.972 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.458 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.7 mt -110.36 124.31 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -103.91 157.45 17.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.255 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.559 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.77 -42.94 26.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.25 -58.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -55.0 -39.23 68.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.629 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.518 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.17 -50.71 72.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.888 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -41.01 80.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.674 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.63 -39.03 86.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.513 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.8 -55.34 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.5 mmt -49.03 -54.0 17.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 t -65.41 -25.42 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -30.98 68.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.53 -28.83 15.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.35 42.31 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -144.0 109.77 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -88.88 94.14 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.63 147.11 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -85.88 163.37 18.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.72 -31.03 69.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.64 -45.97 73.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.12 -54.87 39.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.41 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 1.6 m -62.23 -38.3 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -61.44 -43.59 98.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 110.345 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 71.5 mt-10 -71.77 -30.2 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.401 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtp -70.71 -34.0 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.731 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.1 mm -80.31 -54.94 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.585 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 11.5 ptt180 -55.14 -31.93 61.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 110.385 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.3 -21.12 54.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.56 -14.51 15.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.95 93.73 7.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.395 0.616 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.1 pt -66.43 -31.27 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.51 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.618 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -85.83 -9.37 57.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.123 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.22 54.76 18.31 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.697 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.7 p30 -113.98 -5.18 13.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.194 0.497 . . . . 0.0 111.367 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.069 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.91 -174.77 4.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.35 . . . . 0.0 110.547 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 141' ' ' PHE . 42.3 t -127.3 120.51 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 7.3 t30 -96.07 -167.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.354 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.444 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.2 t80 -62.36 -73.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.596 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.74 -43.3 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.303 0.573 . . . . 0.0 110.414 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.69 ' HA ' HG12 ' A' ' 130' ' ' ILE . 3.2 mt-10 -55.9 -33.49 64.68 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.489 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -79.07 -45.45 20.07 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.104 0.478 . . . . 0.0 111.683 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.701 ' HA ' HG23 ' A' ' 85' ' ' ILE . 2.8 m -65.52 -38.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.158 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.496 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -70.43 -36.07 73.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.57 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.548 ' HE1' ' CG ' ' B' ' 81' ' ' TRP . 6.1 ptm -73.35 -21.42 60.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.429 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 1.2 tpp -88.63 -49.48 6.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.288 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.498 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.88 3.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.673 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.86 -49.34 55.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.391 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.599 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -53.22 -68.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.533 0.206 . . . . 0.0 110.887 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.8 -38.84 57.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.771 0.319 . . . . 0.0 110.455 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -56.06 -48.28 76.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.56 -40.28 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.262 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.537 ' O ' HG12 ' B' ' 75' ' ' VAL . 94.1 t -53.44 -53.46 24.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.816 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -71.95 -49.08 40.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.354 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.96 -44.15 78.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 72' ' ' VAL . 12.5 p -67.6 -48.97 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.752 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.44 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -55.96 -31.26 58.4 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.079 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 84' ' ' GLU . 49.1 t -76.79 -54.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.696 0.284 . . . . 0.0 111.731 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.535 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -62.1 -43.85 98.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.535 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.5 mmm180 -57.96 -31.71 67.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.997 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -37.12 85.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.548 ' CG ' ' HE1' ' A' ' 144' ' ' MET . 2.5 t90 -95.26 -15.72 22.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.888 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.2 -31.6 16.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.31 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.339 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.863 0.363 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -158.81 178.7 9.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.85 165.34 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 8' ' ' GLN . 14.2 t -72.43 177.4 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 pt-20 -57.36 -42.85 82.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.418 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -56.97 8.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.185 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 5' ' ' THR . 2.2 tp60 -59.16 -49.05 79.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 10' ' ' ALA . 10.9 tt -63.61 -26.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.3 -44.17 61.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.742 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 1.8 pt-20 -69.11 -33.18 73.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.32 -49.74 65.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.354 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -44.75 88.3 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.194 0.521 . . . . 0.0 110.122 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -64.9 -49.17 71.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.703 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.33 -41.13 62.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -58.5 -33.94 70.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.085 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.63 -16.3 57.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.937 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.07 -36.92 17.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.583 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -69.26 -65.94 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 12.5 t70 -66.16 130.31 42.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.905 0.383 . . . . 0.0 110.832 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -39.28 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.34 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.19 -12.15 30.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.54 36.12 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.677 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -74.94 -4.99 41.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.487 0.184 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.16 4.27 44.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.177 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.9 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 19' ' ' PHE . 2.4 mt -109.87 127.93 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.185 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 t -101.68 169.85 8.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.97 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 p -55.88 -32.31 63.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.409 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -62.05 -50.49 71.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -75.64 -36.94 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.128 0.489 . . . . 0.0 110.834 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.577 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.32 -58.21 8.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.558 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.58 -27.43 69.71 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.776 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.4 m -67.45 -55.17 14.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.69 -31.59 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -46.8 88.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -26.18 44.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.959 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -58.15 -35.96 72.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.05 -31.25 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.71 42.63 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -142.65 165.04 28.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -121.28 63.25 12.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 -173.63 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.311 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 p -122.08 161.8 22.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 46' ' ' ALA . 24.7 pm0 -69.02 -28.49 66.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.18 0.514 . . . . 0.0 110.3 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 45' ' ' GLU . . . -50.81 -49.53 58.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.595 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.4 -37.35 86.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.0 mt -57.39 -50.79 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -67.35 -48.0 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.272 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.99 -51.02 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.96 -49.73 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.398 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.523 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.1 mt -57.81 -41.86 80.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.5 -26.42 65.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.677 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.1 mt-10 -83.67 -2.19 55.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.89 -33.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 112.084 -177.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 56.1 t0 -71.04 144.97 50.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.77 -53.55 7.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.595 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.54 -8.69 59.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.217 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.79 47.71 83.74 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.963 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -97.69 -1.3 43.87 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.663 0.231 . . . . 0.0 111.495 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.3 15.86 20.13 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.889 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -149.97 139.83 21.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.21 149.34 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.23 170.09 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -53.74 -61.66 4.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -63.55 -37.62 46.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.37 2.047 . . . . 0.0 111.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -60.97 -48.42 81.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.503 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.39 -58.01 9.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.177 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 7.5 tp -58.28 -55.54 33.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.822 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -51.58 -44.36 62.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.737 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -53.28 58.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.9 mmt -78.31 -16.82 57.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -30.38 28.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.165 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.37 -27.14 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -155.8 163.96 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.44 157.06 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -26.19 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.11 -33.4 59.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.722 HG23 ' HA ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -74.55 -34.3 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.318 0.58 . . . . 0.0 109.737 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -49.35 53.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.471 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.11 -46.9 85.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.402 0.62 . . . . 0.0 109.653 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.59 -45.6 70.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.95 -38.67 51.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -33.11 58.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -73.66 -36.46 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.673 0.273 . . . . 0.0 111.02 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.507 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -70.67 -62.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.549 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.42 117.18 24.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -52.67 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.78 -9.66 59.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.1 70.47 0.56 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -93.54 14.88 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.646 0.26 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.45 68.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.635 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.4 m-85 -160.12 116.92 2.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.928 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mt -114.59 125.49 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -104.09 159.58 15.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.981 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.571 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.7 -40.25 19.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.396 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 -59.0 6.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.984 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.56 -37.29 70.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.721 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.04 -50.7 72.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.903 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -56.2 -42.8 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -39.19 83.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.642 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.17 -55.35 13.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.118 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.4 mmt -49.04 -54.01 17.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -66.05 -25.42 67.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.09 -30.28 66.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -28.81 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.9 43.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.58 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -150.65 110.54 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.792 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -86.41 101.9 13.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.57 148.79 26.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.6 t -86.75 163.33 17.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -58.09 -34.17 69.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.61 -39.33 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -64.36 -54.87 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 m -62.76 -40.59 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.66 -41.49 97.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.0 110.129 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 40.9 mt-10 -72.66 -30.12 64.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.315 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.2 mtp -70.3 -36.25 74.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.857 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.571 HG13 ' N ' ' A' ' 102' ' ' ALA . 3.7 mm -80.21 -54.86 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.639 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.36 -31.76 55.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.005 0.431 . . . . 0.0 110.417 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.18 -21.77 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.888 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.21 -9.13 17.9 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.4 t0 -86.97 100.67 12.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.504 0.668 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.706 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -75.11 -31.64 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.042 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.99 -9.1 47.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.521 -178.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.47 57.07 11.02 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -114.31 -3.62 13.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.217 0.508 . . . . 0.0 111.47 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.49 5.85 45.06 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.078 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.416 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.11 -174.72 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.469 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.55 HG11 ' CD1' ' A' ' 141' ' ' PHE . 46.3 t -128.87 124.83 61.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 111.281 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.571 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.6 t30 -102.95 -162.6 0.93 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.564 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.7 t80 -60.75 -74.45 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.525 ' O ' HG21 ' A' ' 142' ' ' VAL . 2.1 tt0 -49.95 -45.45 51.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.302 0.572 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.706 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.6 mt-10 -56.21 -34.52 66.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.728 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -78.99 -47.06 16.98 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.111 0.481 . . . . 0.0 111.608 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.722 ' HA ' HG23 ' A' ' 85' ' ' ILE . 2.5 m -64.48 -34.46 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.812 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 144' ' ' MET . 1.6 pp0? -71.05 -36.29 72.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.39 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.464 ' HE1' ' CE ' ' A' ' 145' ' ' MET . 1.3 ptt? -83.83 -4.09 58.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.779 0.323 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.464 ' CE ' ' HE1' ' A' ' 144' ' ' MET . 0.1 OUTLIER -96.68 -35.75 10.92 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.671 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.378 -179.822 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.7 mpp_? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.825 0.345 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 -67.51 2.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.822 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.9 -50.22 69.9 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.592 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.0 -65.28 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.539 0.209 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.407 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.8 -36.68 48.67 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.465 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -56.14 -48.76 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.592 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -63.42 -41.79 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.096 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.494 HG21 ' O ' ' B' ' 68' ' ' PHE . 96.3 t -50.63 -51.14 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.57 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.407 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 2.9 mpt_? -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.507 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 mt -56.05 -47.47 77.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.71 0.29 . . . . 0.0 110.795 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.474 HG12 ' O ' ' B' ' 72' ' ' VAL . 14.5 p -67.0 -47.51 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.422 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.62 -30.18 62.02 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.075 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.453 ' CG1' ' HE1' ' A' ' 145' ' ' MET . 96.6 t -76.79 -55.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.726 0.298 . . . . 0.0 111.096 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.548 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.6 pp -60.22 -43.73 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.581 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.548 ' HG2' HD11 ' B' ' 78' ' ' ILE . 9.3 mmp_? -55.65 -35.54 66.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.267 0.556 . . . . 0.0 109.562 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.76 -37.49 73.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.512 ' CZ3' ' HE1' ' A' ' 141' ' ' PHE . 3.5 t90 -95.05 -17.23 22.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.318 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.09 -37.54 46.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.891 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.646 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -165.69 174.77 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.4 165.39 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -69.08 176.88 2.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 28.2 mt-10 -60.0 -39.04 84.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -69.79 -56.84 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -44.84 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.972 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.8 tt -69.02 -26.82 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.201 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.438 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.86 -43.04 63.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.412 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 3.8 mp0 -71.62 -25.78 62.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.364 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.73 -49.36 25.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.332 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -44.56 85.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.148 0.499 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.99 -49.11 68.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.886 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.26 -41.28 62.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.74 -34.42 67.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.027 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t -78.59 -14.59 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.99 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.74 -39.26 15.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.147 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.699 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.17 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.234 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.5 t0 -63.65 126.28 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.681 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -37.83 83.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -92.09 -12.4 33.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.23 32.75 63.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.811 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' OD1' ' OD2' ' A' ' 20' ' ' ASP . 9.7 p30 -77.07 1.91 16.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.845 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.78 43.37 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.084 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -149.6 132.59 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.52 0.66 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.1 mp -105.11 118.61 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 31' ' ' GLU . 8.4 t -98.01 163.99 12.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.763 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.0 p -51.73 -25.47 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.891 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -68.11 -50.69 53.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 28' ' ' THR . 9.1 mm-40 -77.86 -37.82 47.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.248 0.547 . . . . 0.0 110.574 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.556 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.16 -44.78 71.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.619 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.89 73.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.235 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.0 m -73.53 -59.92 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.7 -30.5 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.475 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.2 ttt -61.51 -56.45 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.86 -25.46 66.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -51.4 -47.03 63.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.71 -60.19 2.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.913 0.387 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.19 40.16 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -142.71 170.32 15.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -138.16 59.54 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -178.93 3.93 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.622 2.214 . . . . 0.0 112.495 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 174.24 6.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.45 -29.93 68.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.89 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.12 59.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.147 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -40.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.089 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.41 -50.53 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.98 -39.17 93.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.173 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -68.98 -51.19 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.334 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -54.0 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 110.454 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.488 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -59.0 -45.71 92.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.367 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -51.98 -25.96 9.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.271 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.3 mt-10 -82.37 -3.24 55.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.691 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.35 -32.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.57 135.69 57.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.105 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.89 -53.32 21.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.557 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -95.81 3.71 53.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.665 -179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.09 59.13 9.87 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.88 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -109.21 -2.5 17.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.852 0.326 . . . . 0.0 111.354 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.25 17.37 15.93 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.863 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.2 p -149.51 139.94 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.072 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.503 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.4 mm -104.55 149.44 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.785 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -107.6 171.06 7.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.9 m-85 -55.77 -61.5 6.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.524 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.6 Cg_endo -66.98 -20.25 51.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.436 2.091 . . . . 0.0 112.567 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.466 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.24 -37.64 37.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.085 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' HA ' HG11 ' A' ' 55' ' ' VAL . 4.7 t80 -75.24 -33.95 61.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.294 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 11.3 tp -76.75 -58.29 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -51.89 -45.67 64.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.142 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.76 -31.26 69.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 41.6 mtt -108.21 15.34 24.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.221 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.81 -40.47 4.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.91 0.386 . . . . 0.0 111.024 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -59.9 -45.12 93.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 111.0 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.836 0.35 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.81 -179.41 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -148.3 156.28 42.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.788 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -50.89 -25.98 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.373 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -73.65 -39.46 64.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.179 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.21 -38.93 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.32 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -71.13 -49.36 45.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -61.2 -46.29 91.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.39 0.614 . . . . 0.0 109.447 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.6 -49.22 68.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.059 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.08 -38.52 52.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.996 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -30.38 56.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.49 -37.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.55 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.5 m-85 -71.42 -62.92 1.23 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.865 0.364 . . . . 0.0 110.483 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.93 120.61 25.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -63.35 -52.56 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.193 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.43 -9.61 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.492 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.96 71.76 0.47 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.884 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.47 14.53 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.679 0.276 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 13.65 61.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.685 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -158.33 116.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -113.45 124.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.137 0.494 . . . . 0.0 111.714 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -104.27 161.69 13.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.131 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -45.56 30.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.528 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.84 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 111.093 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.92 -36.47 65.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.543 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.52 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.61 -50.0 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.675 178.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.65 -41.44 77.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.412 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -60.57 -39.16 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 92' ' ' PHE . 49.1 t -67.61 -54.45 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.0 mmt -50.33 -54.11 23.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.21 -24.51 65.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.559 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -69.89 -30.9 68.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.5 -28.7 16.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.15 42.78 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.548 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -153.23 110.28 3.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -91.85 101.44 14.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.59 166.98 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 t -94.63 163.79 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -59.75 -41.83 91.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.35 -35.87 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -65.48 -54.9 21.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.409 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.8 m -64.89 -40.02 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.182 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -62.6 -41.95 99.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.3 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.411 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.5 mt-10 -72.63 -30.14 64.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.3 mtt -70.91 -35.98 72.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.2 mm -80.25 -54.87 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.699 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.411 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.3 ptm180 -54.05 -31.85 52.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 110.377 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.25 -20.96 46.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.798 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.45 -2.6 20.32 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.471 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.9 t0 -94.87 109.71 21.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.394 0.616 . . . . 0.0 111.204 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.693 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.27 7.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.803 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.91 -9.12 44.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.579 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.56 58.23 8.49 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 114.515 0.566 . . . . 0.0 114.515 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -114.24 -4.58 13.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.072 0.436 . . . . 0.0 111.513 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 7.78 42.32 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.955 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.15 -174.88 4.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.673 0.273 . . . . 0.0 110.38 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.584 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.7 t -128.18 126.5 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 111.245 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -104.83 -167.81 1.4 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.95 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.585 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.2 t80 -58.79 -73.92 0.07 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.584 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.57 -45.41 47.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 110.286 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.693 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.54 -36.39 69.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.102 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.584 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.66 -49.56 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.94 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.643 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -55.44 -40.63 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.715 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -34.35 70.6 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.652 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.401 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.22 8.36 13.54 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.68 0.276 . . . . 0.0 111.246 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.463 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.4 mtt -118.39 -38.28 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.429 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 121.03 0.443 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.26 -75.69 0.23 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.905 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.02 -46.76 61.04 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -58.75 -70.85 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.279 . . . . 0.0 110.54 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.459 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.11 -34.92 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.842 0.354 . . . . 0.0 110.38 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 4.9 tpp85 -57.1 -53.26 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.634 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.63 -41.65 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.125 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.507 ' O ' HG12 ' B' ' 75' ' ' VAL . 84.2 t -52.2 -53.02 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.283 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.416 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.6 mpt_? -71.91 -44.08 64.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 19.7 mt -56.2 -49.24 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 15' ' ' ALA . 13.9 p -65.48 -47.66 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.435 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -59.69 -29.39 67.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.302 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 70.1 t -76.82 -53.46 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.666 0.27 . . . . 0.0 111.246 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -65.65 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.364 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.617 ' HG2' HD11 ' B' ' 78' ' ' ILE . 3.7 mmp_? -57.03 -34.45 68.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 109.67 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -37.29 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.52 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.0 t90 -95.47 -10.19 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.03 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -94.67 -28.09 15.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.277 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.501 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.8 171.83 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -128.85 165.33 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -68.47 169.25 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.682 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 23.6 mt-10 -55.05 -36.51 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.3 -56.85 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.371 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -45.05 89.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 0.0 110.845 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.433 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.9 tt -67.54 -26.78 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.79 -43.47 63.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.475 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 3.5 mp0 -70.96 -25.8 62.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.86 -49.41 25.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.263 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -57.43 -44.66 84.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.19 0.519 . . . . 0.0 110.207 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.34 -49.85 67.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.28 -40.76 62.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.45 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -55.97 -38.94 71.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.207 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.76 -38.37 15.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.97 0.414 . . . . 0.0 110.388 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.669 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.375 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.6 t70 -63.62 129.02 38.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.862 0.363 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -37.3 83.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.215 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.61 -12.31 29.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.7 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.3 37.86 83.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.649 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -77.02 -1.85 30.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.478 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 -2.57 43.67 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.217 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.6 p -149.47 132.5 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.986 0.393 . . . . 0.0 110.959 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.3 mp -104.0 120.07 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.028 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.83 164.59 12.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.818 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.0 p -52.53 -25.47 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -70.49 -50.53 36.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.356 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.77 -36.58 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.467 . . . . 0.0 111.005 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.576 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -54.25 -47.92 71.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.028 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.53 -27.39 73.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.391 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.9 m -72.05 -51.65 20.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.331 . . . . 0.0 111.218 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 19' ' ' PHE . 6.9 p -70.61 -34.96 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.414 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -52.59 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.71 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.56 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -52.13 -37.72 55.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.71 -65.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.56 38.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.7 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -140.5 58.34 10.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 -170.25 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.412 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p -102.15 171.83 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.74 -29.44 67.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.44 56.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.41 -39.75 94.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.727 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.7 mt -58.33 -50.59 73.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.77 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -64.63 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.09 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.088 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -53.77 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.493 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -59.06 -44.73 92.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.415 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.71 -25.92 12.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.1 mt-10 -82.66 -3.32 56.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.697 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.44 -32.31 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.46 135.31 56.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.067 0.461 . . . . 0.0 111.027 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.43 -53.5 28.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.07 4.23 52.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.744 -179.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 59.43 9.39 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.895 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.97 -2.49 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.75 0.275 . . . . 0.0 111.342 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 17.47 15.75 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.893 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.8 p -149.46 139.92 22.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.09 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.478 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.3 mm -105.34 149.61 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.52 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.56 171.03 7.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.634 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.8 m-85 -55.03 -61.52 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.659 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.4 Cg_endo -67.22 -20.28 49.61 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.434 2.089 . . . . 0.0 112.595 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -79.26 -38.08 36.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.168 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.5 t80 -75.1 -33.49 61.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 11.6 tp -75.25 -58.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.295 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -51.56 -43.19 62.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -54.15 -43.33 70.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.438 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 36.9 mtt -101.12 14.5 31.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -107.15 -36.7 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -73.62 -26.9 61.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -87.45 -178.49 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 85' ' ' ILE . 68.2 m -142.66 159.56 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -50.83 -25.97 5.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.387 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -75.85 -37.45 58.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -26.76 68.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.639 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.03 -38.47 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.099 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -71.37 -49.36 42.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.31 -46.29 90.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.378 0.609 . . . . 0.0 109.442 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.46 -49.02 68.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.022 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.12 -39.01 55.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.919 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -30.37 58.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.43 -37.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.55 ' N ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -70.66 -63.02 1.18 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.895 0.379 . . . . 0.0 110.44 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.55 120.79 26.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -52.58 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.279 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.49 -9.62 59.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.52 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.82 71.76 0.46 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.814 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -92.98 14.5 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.61 16.59 65.75 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.619 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -161.15 116.76 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.303 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -113.05 124.28 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.119 0.485 . . . . 0.0 111.65 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -104.26 161.52 13.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.206 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.577 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.86 -44.42 29.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.472 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 -58.84 6.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 111.015 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.02 -38.0 67.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.653 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.514 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.61 -49.48 77.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.744 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -41.72 80.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.334 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.64 -39.36 84.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 92' ' ' PHE . 70.2 t -67.15 -55.71 16.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.668 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 mmt -49.07 -54.09 17.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -67.62 -24.22 65.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -70.57 -30.2 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.07 -28.85 14.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.95 43.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.9 109.77 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -89.59 101.97 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -99.27 165.31 11.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -98.28 171.15 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.0 -32.46 72.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 -47.63 69.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.54 -54.85 40.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.434 HG21 ' HB1' ' A' ' 102' ' ' ALA . 5.3 m -57.7 -50.93 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.391 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -57.47 -39.27 76.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 52.1 mt-10 -72.59 -30.19 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.47 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -36.07 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.577 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.5 mm -80.18 -54.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.646 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.9 ptm180 -53.56 -31.74 47.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 0.0 110.516 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -21.1 53.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.44 -10.86 15.64 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.624 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -84.87 110.02 18.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.385 0.612 . . . . 0.0 111.302 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.89 -31.15 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.791 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.32 -9.07 43.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.6 -178.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.06 57.78 9.55 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -114.27 -4.19 13.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.039 0.42 . . . . 0.0 111.515 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 7.51 42.59 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.006 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.88 4.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.419 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.0 t -129.02 126.25 64.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 111.157 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.48 -167.53 1.34 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.062 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.609 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.3 t80 -57.71 -73.89 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.555 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.56 -45.86 48.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.564 . . . . 0.0 110.306 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.688 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.57 -36.48 69.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.157 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.74 -49.73 11.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.881 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.0 m -56.32 -36.82 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -34.79 71.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.63 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -87.1 15.36 6.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.701 0.286 . . . . 0.0 110.858 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.458 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 5.1 mtt -126.99 -49.5 1.46 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.328 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.002 0.429 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.28 -75.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.64 -45.56 59.92 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.697 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.22 -71.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.699 -0.251 . . . . 0.0 110.586 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.26 -32.96 39.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.611 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 5.1 tpp85 -58.47 -53.2 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.602 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.55 -41.14 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.969 178.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.534 ' O ' HG12 ' B' ' 75' ' ' VAL . 86.4 t -53.14 -50.95 43.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.333 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -47.06 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.431 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.426 ' CD1' HG11 ' A' ' 91' ' ' VAL . 33.2 mt -56.67 -45.78 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.808 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.8 p -66.77 -47.43 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.804 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -60.18 -29.83 69.37 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.294 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 79.7 t -76.8 -51.88 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 111.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.621 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -67.42 -42.03 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.537 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.621 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.0 mmp_? -57.37 -34.66 69.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.216 0.532 . . . . 0.0 109.763 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -36.81 84.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.514 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.0 t90 -95.38 -14.19 24.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -91.24 -26.92 18.77 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.95 176.56 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.53 165.32 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 8' ' ' GLN . 7.3 t -70.4 171.79 9.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.893 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.6 mm-40 -55.62 -38.03 68.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.242 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -56.75 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.108 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER -58.11 -45.2 87.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.851 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 10' ' ' ALA . 5.9 tt -67.14 -26.78 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.98 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.71 -42.87 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.5 -25.78 63.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.91 -49.41 24.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.499 0.19 . . . . 0.0 111.262 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.65 -44.64 85.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.196 0.522 . . . . 0.0 110.117 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.12 -49.08 71.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.746 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.29 -41.33 62.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.44 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.49 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -56.33 -36.7 69.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.129 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.87 -13.85 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.7 -38.29 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.273 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.25 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.319 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.3 t70 -64.97 127.41 31.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.639 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -38.52 91.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.65 -12.26 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 0.0 110.794 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.08 37.94 82.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.641 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -76.88 -1.91 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 -2.33 43.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.173 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 p -149.42 132.42 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.924 0.362 . . . . 0.0 110.745 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.659 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.4 mp -104.44 120.33 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.095 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 t -97.78 159.83 14.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.496 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -50.17 -25.45 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -67.69 -50.95 55.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -78.13 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.428 0.633 . . . . 0.0 110.424 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.21 -50.51 66.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.41 -27.47 71.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.31 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.0 m -69.5 -54.95 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.51 -31.72 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.416 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -47.08 87.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 110.413 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -25.57 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 t -55.13 -50.57 68.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -47.78 -58.03 4.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.576 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -142.56 179.73 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.825 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -159.73 58.74 1.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.34 -170.57 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.676 2.25 . . . . 0.0 112.509 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 p -93.9 171.11 9.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 11.7 pt-20 -68.48 -31.44 70.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.291 0.567 . . . . 0.0 110.05 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.03 65.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.892 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.16 -53.33 56.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.657 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -53.15 -50.79 63.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.351 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -57.98 -40.35 80.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.63 -45.12 94.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.264 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.416 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -60.8 -52.66 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.203 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.48 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -57.15 -45.86 84.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.126 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.06 -25.99 9.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.351 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -83.02 -3.29 57.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.012 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.37 -32.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 46.2 t0 -63.0 136.93 58.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.037 0.446 . . . . 0.0 111.155 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.35 -53.74 26.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.481 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -96.95 4.16 51.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.701 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.68 59.66 8.92 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.735 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.37 -1.17 17.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.726 0.263 . . . . 0.0 111.409 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.24 17.37 15.98 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.877 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -149.53 139.96 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.186 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.6 mm -104.47 149.78 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.459 . . . . 0.0 111.705 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.44 168.76 9.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.63 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.2 m-85 -52.53 -61.21 4.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -68.16 -19.81 44.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.11 . . . . 0.0 112.669 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.9 mm-40 -79.27 -37.47 37.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.106 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.7 t80 -75.23 -32.46 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.01 0.433 . . . . 0.0 110.311 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 11.1 tp -76.19 -58.07 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m -51.61 -43.1 62.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.4 tmm? -54.14 -44.72 71.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 33.8 mtt -100.66 15.35 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.537 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -109.99 -31.68 7.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.877 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -61.93 -39.32 91.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.245 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 111.317 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.786 0.326 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -90.9 -175.21 4.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.462 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -143.99 161.72 38.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -50.7 -25.42 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.525 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.7 -46.18 47.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.43 -26.71 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -73.65 -38.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.188 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -49.49 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.544 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.18 -46.12 91.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.404 0.621 . . . . 0.0 109.442 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.6 -49.3 68.11 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.984 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.05 -38.19 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.968 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -30.49 57.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.831 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.78 -36.77 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.659 0.266 . . . . 0.0 111.006 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.525 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.8 m-85 -72.23 -62.93 1.26 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.492 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.82 114.07 20.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.827 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -60.96 -50.08 74.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.06 -9.66 59.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.74 72.37 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.839 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -94.33 13.76 22.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.69 0.281 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.48 69.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 4.5 m-85 -166.19 116.77 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.2 mt -112.24 124.34 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 0.0 111.863 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -104.43 161.96 13.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.085 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.565 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.8 -44.79 28.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.475 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.79 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.031 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -54.88 -36.29 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.6 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.93 -50.7 71.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.713 178.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.77 -41.47 74.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.385 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -61.05 -39.32 89.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.281 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.97 -53.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.5 -54.04 25.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.28 -25.03 65.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.18 -32.05 72.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.44 -28.78 16.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.36 42.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -140.31 109.81 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -85.28 80.61 9.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.26 161.54 17.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.3 t -96.76 162.86 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -30.3 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.2 -42.31 88.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.21 -51.78 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 5.1 m -61.56 -41.5 90.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.225 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.23 -43.28 99.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.3 mt-10 -72.4 -30.13 64.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.44 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.9 ttm -70.73 -35.4 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.565 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.3 mm -80.3 -54.94 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.556 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.8 ptm180 -54.02 -31.72 52.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.365 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -21.01 50.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.904 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 -7.65 16.42 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.1 t0 -88.68 109.89 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.383 0.611 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.695 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.6 pt -84.88 -31.1 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.77 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.39 -9.08 43.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.612 -178.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.68 58.11 8.76 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -114.3 -4.41 13.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 117.036 0.418 . . . . 0.0 111.428 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.59 42.65 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.011 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.1 -174.88 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.417 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.8 t -127.84 127.28 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 111.224 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -106.17 -168.27 1.41 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.1 t80 -57.98 -73.95 0.07 Allowed 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -49.57 -45.6 47.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 0.0 110.262 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.695 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.7 mt-10 -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.109 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.588 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.6 -49.62 11.9 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.02 0.438 . . . . 0.0 111.797 -178.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.631 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.1 m -56.47 -36.55 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.615 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' NE2' ' CG2' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -70.96 -33.96 70.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.8 OUTLIER -88.58 16.58 6.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.804 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.449 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 5.0 mtt -128.36 -51.38 1.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.215 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.749 -179.69 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.17 -75.77 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.859 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.16 -46.11 56.82 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.238 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.698 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -59.83 -71.55 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.667 0.27 . . . . 0.0 110.589 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.409 ' NE2' ' CD ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.96 -33.38 37.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.473 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.401 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.0 tpp180 -57.27 -51.92 67.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -60.88 -42.62 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.806 178.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.479 HG21 ' O ' ' B' ' 68' ' ' PHE . 97.7 t -50.62 -47.68 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.428 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.409 ' CD ' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -72.13 -48.24 45.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.438 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.416 ' CD1' HG11 ' A' ' 91' ' ' VAL . 37.4 mt -56.12 -46.45 79.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 15.0 p -66.05 -48.84 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.01 -29.61 59.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.099 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 88.1 t -76.71 -56.5 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.686 0.279 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.529 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -61.49 -43.83 97.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.529 ' N ' HD11 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.0 -33.58 69.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 109.864 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.32 -36.42 83.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.517 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.6 t90 -95.37 -15.98 22.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.39 -25.06 20.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.632 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.79 170.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.31 165.3 17.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -69.31 177.35 2.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 35.9 mt-10 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -56.99 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.263 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.86 -44.72 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.446 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.1 tt -69.29 -26.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.033 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.78 -42.94 62.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 15.2 mp0 -71.75 -27.04 62.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.196 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.38 -49.56 40.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.279 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.08 -44.81 83.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.167 0.508 . . . . 0.0 110.228 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.532 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 39.9 mm-40 -65.15 -50.67 65.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -51.33 -40.36 58.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.844 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.09 -45.66 79.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.475 -179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 m -70.77 -14.86 62.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.428 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 mt -87.83 -37.4 16.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 0.0 110.619 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.578 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.0 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.053 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.9 132.5 49.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.869 0.366 . . . . 0.0 110.553 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -38.84 81.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.319 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.8 -12.3 31.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.802 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.57 84.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.633 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -74.25 -4.56 36.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.181 -0.207 . . . . 0.0 111.437 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 0.27 43.99 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.061 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -149.58 132.5 16.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 110.733 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -105.07 127.42 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.5 t -102.02 168.77 9.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -53.55 -40.37 65.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.772 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -55.68 -50.45 70.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.57 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -76.25 -36.37 58.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.926 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.22 -58.4 7.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.573 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -31.99 78.79 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.42 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -61.47 -57.79 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.972 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 36' ' ' MET . 7.1 p -67.78 -30.48 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.319 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.4 ' N ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -61.31 -51.99 66.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 110.44 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.66 61.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.786 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -60.87 -45.18 95.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.2 mt -49.35 -60.69 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.073 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.25 41.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.546 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -142.6 171.99 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.848 0.356 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.71 59.33 19.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.5 -170.36 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.551 2.167 . . . . 0.0 112.357 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.3 p -115.88 170.15 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.7 -30.56 69.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 0.0 110.098 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.65 -44.35 57.43 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.035 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -42.33 99.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.043 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.35 -50.56 73.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.07 -48.16 81.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.465 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.35 -51.04 65.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.515 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.25 -50.75 70.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.499 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.2 mt -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -55.74 -26.45 45.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.515 0.674 . . . . 0.0 110.236 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 51' ' ' MET . 4.0 mt-10 -83.46 -2.03 54.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.535 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.8 -33.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 0.0 112.121 -177.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 53.6 t0 -69.97 139.59 52.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -71.98 -53.57 12.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.478 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -93.39 -3.16 53.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.621 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.9 55.86 27.4 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.911 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.1 m120 -105.63 15.6 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.857 0.328 . . . . 0.0 111.11 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 83.41 16.95 67.58 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.908 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -149.9 139.8 21.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.718 0.294 . . . . 0.0 110.804 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.538 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.7 mm -97.59 149.47 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 111.414 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.67 -178.92 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 8.6 m-85 -62.82 -61.67 7.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.395 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 25.6 Cg_endo -62.19 -34.4 78.83 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.416 2.077 . . . . 0.0 111.942 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -67.78 -47.42 69.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.457 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -61.66 -44.58 96.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.327 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 9.8 tp -72.66 -58.11 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.9 m -51.71 -45.59 63.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.4 mmt -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.7 mmt -108.47 14.97 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.17 -44.48 3.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -57.08 -45.86 82.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.023 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.4 -177.37 6.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.911 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -147.59 159.23 43.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.77 -26.57 5.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.338 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.47 -41.27 61.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.69 -26.78 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.639 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.1 mm -74.11 -37.63 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.921 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -71.71 -49.41 39.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.24 -46.43 90.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 109.395 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.4 -49.17 67.83 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.97 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.27 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.946 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -30.61 62.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.852 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.52 -37.08 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.98 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.558 ' N ' HG23 ' A' ' 91' ' ' VAL . 2.0 m-85 -71.84 -62.86 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.883 0.373 . . . . 0.0 110.484 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.9 t0 -82.79 115.14 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -59.04 -52.58 65.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.1 -9.58 59.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.42 0.49 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.831 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -93.46 14.43 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.675 0.274 . . . . 0.0 111.203 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.5 16.83 65.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.588 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.3 m-85 -162.38 116.75 1.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.717 0.294 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 93' ' ' ASP . 5.0 mt -113.31 124.84 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.147 0.498 . . . . 0.0 111.751 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.0 t -104.28 161.53 13.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.171 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.58 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.84 -44.87 29.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.434 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.85 -58.82 6.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -55.0 -36.75 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.62 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.519 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.7 -49.91 74.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.723 178.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -41.79 76.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.38 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.71 -38.68 85.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.235 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.55 -54.29 24.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.752 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.92 -53.97 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.08 -24.65 65.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.53 -31.05 69.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.59 -28.73 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.02 43.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.564 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -147.55 109.82 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -88.2 100.52 13.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.18 163.21 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 t -98.25 171.67 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.08 -32.75 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.58 -47.91 68.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.35 -54.84 40.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.416 HG21 ' HB1' ' A' ' 102' ' ' ALA . 5.4 m -57.55 -51.02 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.54 -38.84 75.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.982 0.42 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.407 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 32.6 mt-10 -72.86 -30.09 63.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.476 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -36.33 72.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.58 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.7 mm -80.32 -54.9 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.692 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.407 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.1 ptm180 -53.75 -31.83 49.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.76 -20.93 48.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.957 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -7.27 16.86 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.476 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.3 t0 -89.05 110.05 20.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.359 0.6 . . . . 0.0 111.272 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.689 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.94 -31.12 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.819 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.37 -9.14 42.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.605 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.94 57.85 9.34 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.566 0.587 . . . . 0.0 114.566 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -114.3 -4.45 13.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.992 0.396 . . . . 0.0 111.437 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.75 42.06 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.12 -174.92 4.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.475 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.583 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.88 126.56 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.571 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.98 -167.57 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.605 ' O ' HG13 ' A' ' 142' ' ' VAL . 54.1 t80 -57.67 -73.89 0.06 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.584 ' O ' HG21 ' A' ' 142' ' ' VAL . 1.7 tt0 -49.5 -45.99 47.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.689 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.6 -36.27 69.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.069 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.52 -49.68 11.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -55.88 -37.08 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.685 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' NE2' ' CG2' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -70.98 -34.32 71.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.657 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -88.12 15.89 6.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.883 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.454 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.7 mtt -126.85 -51.13 1.46 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.705 -179.781 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.79 0.328 . . . . 0.0 111.059 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.12 -66.01 3.0 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.793 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.13 -50.66 26.94 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.588 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.44 -63.5 1.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.476 0.179 . . . . 0.0 110.891 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.441 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.68 -36.42 46.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.46 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.9 tpt180 -56.16 -53.2 59.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.46 -42.48 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.276 178.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.529 ' O ' HG12 ' B' ' 75' ' ' VAL . 94.0 t -50.83 -53.44 13.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.441 ' HD3' ' NE2' ' B' ' 69' ' ' GLN . 0.4 OUTLIER -73.32 -44.27 59.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.662 -178.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 19.4 mt -55.91 -48.46 75.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.168 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.529 HG12 ' O ' ' B' ' 72' ' ' VAL . 14.6 p -63.97 -47.97 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.271 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.03 -28.53 58.36 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 87.8 t -76.77 -56.18 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.452 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.527 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.97 -43.5 96.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.527 ' N ' HD11 ' B' ' 78' ' ' ILE . 24.8 mmm180 -58.04 -34.16 69.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.232 0.539 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -36.82 84.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.426 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.519 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.5 t90 -95.43 -15.33 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.988 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.49 -26.47 19.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.429 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -160.29 171.96 18.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -118.37 165.47 13.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 t -68.55 177.06 2.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 36.7 mt-10 -61.01 -37.75 83.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.39 -56.74 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.86 -44.1 86.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.913 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.4 tt -68.9 -26.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.96 -43.12 63.39 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -71.28 -25.75 62.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -74.11 -49.39 24.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.565 0.221 . . . . 0.0 111.226 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -44.49 85.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.225 0.536 . . . . 0.0 110.175 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.76 -49.13 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.3 -41.01 62.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.492 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.25 -38.81 69.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.174 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 t -76.8 -14.23 59.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.75 -37.9 16.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.833 0.349 . . . . 0.0 110.455 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.643 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.75 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.262 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.0 t70 -64.57 127.01 29.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.637 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -38.66 91.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.35 -12.31 32.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 110.781 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.04 37.64 80.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -76.49 -2.17 30.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 -1.82 43.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.2 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -149.45 132.49 16.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.643 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.6 mt -104.53 120.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.93 161.99 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.568 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -52.26 -25.57 9.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.809 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -67.27 -50.83 58.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.016 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.95 -36.77 48.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.331 0.586 . . . . 0.0 110.572 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.2 -41.55 68.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.683 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.58 -27.46 69.38 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.195 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -69.07 -51.39 39.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.697 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.45 -33.16 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.7 ttt -57.74 -44.16 85.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.384 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -25.54 44.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 t -56.53 -44.88 81.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 mt -46.04 -30.12 1.73 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.59 35.18 0.32 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.751 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -142.82 173.6 11.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 28.3 m120 -140.93 63.65 19.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 2.7 Cg_exo -75.85 -171.63 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 112.185 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -100.07 170.94 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.55 -31.36 70.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.22 -44.04 64.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -53.23 57.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.685 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.27 -50.72 64.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.365 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -60.23 -39.15 85.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.529 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.42 -44.65 90.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -52.94 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.217 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.502 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -57.96 -46.25 87.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.299 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -51.58 -26.03 7.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.372 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.4 mt-10 -83.64 -3.32 57.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.36 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -62.9 134.44 56.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.083 0.468 . . . . 0.0 111.101 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -65.5 -53.32 44.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.717 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -97.45 4.37 50.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.817 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.52 60.11 8.7 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.928 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.41 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -110.37 -2.57 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.768 0.284 . . . . 0.0 111.38 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 17.38 15.95 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 p -149.53 139.94 22.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 111.224 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.46 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.3 mm -105.45 149.6 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.234 0.54 . . . . 0.0 111.802 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.98 172.05 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.487 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.467 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.8 m-85 -56.1 -61.49 6.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 41.9 Cg_endo -67.42 -20.34 48.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.469 2.112 . . . . 0.0 112.864 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.23 -37.97 36.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.489 ' HA ' HG11 ' A' ' 55' ' ' VAL . 3.7 t80 -75.24 -34.59 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.0 tp -74.97 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.093 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.0 -46.44 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 mmt -61.66 -30.8 70.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.697 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.8 mmt -105.13 13.91 29.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.287 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . . . -114.46 -36.67 4.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -56.48 21.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.829 0.347 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.26 179.34 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.47 155.87 40.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.8 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -25.31 8.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.322 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.11 -35.79 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.223 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.78 -26.64 67.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.215 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.25 -37.82 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.0 110.155 179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.71 -49.4 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.585 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.4 -44.45 96.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.352 0.596 . . . . 0.0 109.42 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.77 -50.06 66.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.819 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.92 -37.75 45.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.868 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -30.57 57.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.714 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.5 m -76.63 -36.76 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.665 0.269 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' HG23 ' A' ' 91' ' ' VAL . 2.1 m-85 -73.56 -62.82 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.545 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.4 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.5 t0 -81.9 116.63 21.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -63.24 -52.43 62.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -77.68 -9.63 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.25 70.71 0.58 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -94.62 14.02 22.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 0.0 111.22 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 18.2 67.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.0 m-85 -163.54 116.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 93' ' ' ASP . 4.9 mt -113.52 124.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 0.0 111.678 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -104.22 162.06 13.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.197 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -46.56 31.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.37 -58.8 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 111.104 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -54.88 -36.42 65.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.583 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.519 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.46 -50.64 71.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.647 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -41.53 75.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.384 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.62 -39.03 86.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.333 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.66 -54.64 19.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.785 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.4 mmt -50.06 -54.05 22.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.697 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -66.37 -24.62 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.567 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -31.32 69.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.35 -28.8 15.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.65 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.05 109.78 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -91.9 93.74 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.83 158.1 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -88.34 163.56 15.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -58.93 -39.89 82.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -36.14 83.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.73 -54.83 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.408 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.5 m -64.27 -39.77 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.3 -42.0 98.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.9 mt-10 -72.6 -30.22 64.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.359 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.1 mtt -70.78 -35.88 72.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.4 mm -80.31 -54.89 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.67 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.415 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.01 -31.81 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.446 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.12 -21.06 47.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.821 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.05 -4.35 19.04 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.441 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.0 t0 -93.06 109.76 21.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.04 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.814 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.36 -9.08 43.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.563 -178.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.59 58.1 8.67 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -114.31 -4.42 13.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.963 0.382 . . . . 0.0 111.484 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 7.81 42.05 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.06 -174.91 4.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.48 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.82 126.39 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.359 . . . . 0.0 111.198 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.82 -167.59 1.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.595 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.9 t80 -58.15 -73.88 0.07 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' HG21 ' A' ' 142' ' ' VAL . 2.8 tt0 -49.46 -45.71 47.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.375 0.607 . . . . 0.0 110.333 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.56 -36.55 69.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.129 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.7 -49.77 11.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.93 0.395 . . . . 0.0 111.983 -179.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.633 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -54.82 -40.74 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.69 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -34.47 70.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.719 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.401 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.18 8.29 13.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.465 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.4 mtt -118.39 -37.78 3.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.073 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.458 -179.83 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.001 0.429 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.11 -76.21 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.888 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.76 -46.33 59.95 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.11 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.698 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -58.85 -71.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.245 . . . . 0.0 110.588 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.37 -36.87 54.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.377 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 ttm-85 -57.31 -48.17 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.634 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -59.55 -40.47 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.132 178.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.556 ' O ' HG12 ' B' ' 75' ' ' VAL . 92.2 t -54.71 -53.59 30.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.521 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.414 ' O ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.71 -46.4 53.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.336 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 16.4 mt -56.04 -46.31 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.618 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.6 p -65.78 -46.6 88.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.391 . . . . 0.0 110.443 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -60.2 -30.33 70.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.367 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 42.3 t -75.77 -52.45 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.692 0.282 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.627 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -67.03 -42.67 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.563 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.627 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.3 mmp_? -57.33 -34.75 69.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -62.4 -37.22 84.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.523 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.519 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 2.6 t90 -95.54 -14.84 23.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.013 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.16 -27.11 19.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.479 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.594 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.36 176.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.406 ' CB ' ' HB3' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -127.4 165.13 20.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 8' ' ' GLN . 12.6 t -73.47 170.13 15.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.3 pt-20 -50.85 -42.21 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.426 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -56.91 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.204 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.0 OUTLIER -60.67 -54.69 42.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.404 HG21 ' N ' ' A' ' 10' ' ' ALA . 10.8 tt -56.1 -26.18 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.224 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.24 -42.67 61.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.334 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -66.45 -35.18 79.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.03 -49.53 60.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.432 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 1.2 mtpp -58.74 -46.49 87.31 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.22 0.533 . . . . 0.0 109.996 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.83 -50.42 72.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.589 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.39 -40.75 62.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.296 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.08 -35.83 67.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -75.0 -16.94 60.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -86.91 -38.78 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.421 . . . . 0.0 110.201 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.633 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.77 -65.69 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.246 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' N ' HG12 ' A' ' 27' ' ' ILE . 9.0 t70 -65.98 131.04 45.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.883 0.373 . . . . 0.0 110.712 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -36.39 77.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.139 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.92 -12.3 27.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.783 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.28 37.85 83.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.646 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -77.68 -1.9 33.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.12 43.86 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.131 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.6 p -147.48 132.47 18.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.869 0.335 . . . . 0.0 110.795 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.633 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.2 mp -107.28 119.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -98.35 168.41 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.1 p -54.45 -29.34 49.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.641 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -67.22 -50.43 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.279 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.15 -36.18 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.38 -42.83 70.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.847 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.51 -27.32 72.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.052 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.0 m -73.58 -45.24 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.67 -34.9 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.084 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -49.45 77.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.755 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -65.33 -30.19 71.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -58.86 -21.14 56.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.897 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.47 -60.76 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.79 -39.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.504 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.3 mt-30 -140.15 147.88 40.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.991 0.396 . . . . 0.0 111.103 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -99.11 99.42 8.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.93 -168.95 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.302 2.002 . . . . 0.0 111.994 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 169.39 13.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.73 -30.37 68.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.031 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.94 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.126 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.4 -43.22 99.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.79 -50.31 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.26 -39.11 93.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -66.14 -51.14 60.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -54.18 49.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.119 0.485 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -59.7 -43.89 92.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.683 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -52.53 -25.99 11.92 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.561 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.497 ' O ' ' CE ' ' A' ' 71' ' ' MET . 2.2 mt-10 -83.39 -4.82 58.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.679 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -126.2 -32.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.074 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -64.91 133.54 52.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.13 -53.66 16.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.952 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.74 58.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.24 49.21 81.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.924 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -104.47 -1.37 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.703 0.252 . . . . 0.0 111.482 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.26 17.62 15.31 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.254 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -149.06 139.78 22.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.3 mm -103.77 149.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.157 0.503 . . . . 0.0 111.691 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.47 173.78 6.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.503 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -57.65 -61.46 7.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.323 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 48.7 Cg_endo -68.41 -26.86 34.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.48 2.12 . . . . 0.0 112.468 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -67.63 -43.5 80.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.089 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 63' ' ' ILE . 1.9 t80 -75.19 -38.44 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.055 0.455 . . . . 0.0 110.293 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 9.5 tp -66.0 -58.06 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.071 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 m -51.9 -41.47 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.497 ' CE ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tpt -60.14 -32.83 71.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.424 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.422 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -108.27 15.32 24.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.148 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.24 -33.12 5.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -58.48 -41.08 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.619 0.247 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 58.41 171.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.431 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -169.69 149.26 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -26.46 5.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.648 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.09 -25.72 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.734 0.302 . . . . 0.0 111.096 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' B' ' 77' ' ' VAL . 5.0 mt-10 -74.15 -28.92 61.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.923 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -74.29 -32.73 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -49.33 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.413 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.99 -47.99 80.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.28 -44.09 67.99 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.729 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.84 -39.91 54.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.909 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -33.03 58.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.782 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.5 m -73.28 -36.97 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.515 ' N ' HG23 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -72.89 -63.07 1.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.59 125.29 33.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -52.61 9.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.0 -9.66 58.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.69 68.91 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.875 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -95.07 12.87 27.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 111.341 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.54 16.61 65.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.7 m-85 -157.94 116.95 3.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.644 0.259 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.452 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.4 mt -109.41 124.29 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.014 0.435 . . . . 0.0 111.262 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -103.89 157.15 17.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.272 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.562 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.75 -43.34 27.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.446 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.72 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.97 -39.63 69.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.692 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.523 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.05 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.864 179.026 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.61 -41.45 81.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -61.06 -38.07 84.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.466 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 81.7 t -72.77 -56.01 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 5.9 mmt -48.99 -54.03 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.508 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -65.53 -25.25 67.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.376 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.53 -30.31 65.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.837 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.2 -28.82 17.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.58 43.02 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.594 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.53 109.76 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.16 100.34 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.17 160.65 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 t -89.57 161.97 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -57.64 -40.72 79.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.12 -36.09 82.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.71 -54.77 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.441 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.5 m -64.99 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.277 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.15 -44.05 97.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 45.1 mt-10 -71.74 -30.2 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.414 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.5 mmm -70.67 -34.55 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.685 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.0 mm -80.23 -54.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.762 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.413 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.1 ptt85 -54.91 -31.8 60.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 110.363 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.77 -20.85 52.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.76 -11.34 16.31 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.488 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 125' ' ' ILE . 50.6 t0 -85.51 90.95 8.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.426 0.632 . . . . 0.0 110.785 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.711 HD12 ' HG2' ' A' ' 140' ' ' GLU . 1.2 pt -63.43 -30.74 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.592 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.61 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -86.94 -9.41 55.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.208 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.19 54.57 18.91 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.2 p30 -113.93 -5.14 13.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.243 0.521 . . . . 0.0 111.365 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.48 5.8 45.16 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.99 -174.69 4.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.907 0.385 . . . . 0.0 110.595 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.516 HG11 ' CD1' ' A' ' 141' ' ' PHE . 41.3 t -127.24 120.66 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.6 t30 -97.37 -167.72 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.7 t80 -61.63 -74.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.3 OUTLIER -49.89 -43.06 49.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.315 0.579 . . . . 0.0 110.337 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.711 ' HG2' HD12 ' A' ' 130' ' ' ILE . 3.3 mt-10 -56.06 -33.69 65.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.617 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -78.97 -47.19 16.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.233 0.539 . . . . 0.0 111.631 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.701 ' HA ' HG23 ' A' ' 85' ' ' ILE . 2.6 m -64.8 -36.47 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.023 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -70.53 -36.71 73.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.657 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.565 ' HE1' ' CD2' ' B' ' 81' ' ' TRP . 1.4 ptt? -74.95 -15.2 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.479 ' CE ' ' CE ' ' A' ' 144' ' ' MET . 3.9 tpp -95.2 -50.22 5.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.374 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.545 179.862 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 2.0 mpp_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 121.047 0.451 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.01 -76.01 0.21 Allowed Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.928 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.23 -45.81 57.41 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.156 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.679 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.27 -70.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.516 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.28 -32.0 35.32 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.396 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -58.65 -52.85 63.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.621 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.31 -42.43 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.684 178.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.481 ' O ' HG12 ' B' ' 75' ' ' VAL . 88.4 t -52.67 -50.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.105 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -49.27 49.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.453 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.413 ' CD1' HG11 ' A' ' 91' ' ' VAL . 29.4 mt -56.04 -46.3 78.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.149 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.4 p -67.01 -47.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.431 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -59.8 -30.57 69.66 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.348 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 88' ' ' ALA . 86.7 t -76.75 -52.64 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -65.54 -41.7 91.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.581 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.577 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.2 mmp_? -56.02 -34.25 65.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -38.04 86.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.698 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.565 ' CD2' ' HE1' ' A' ' 144' ' ' MET . 5.7 t90 -95.15 -14.74 23.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.901 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' NH2' ' B' ' 79' ' ' ARG . . . -90.53 -31.93 16.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.409 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -176.51 169.06 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.75 165.27 17.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.408 HG23 ' HB2' ' A' ' 8' ' ' GLN . 14.4 t -71.93 177.09 4.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 pt-20 -57.3 -43.38 83.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.78 -56.95 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.6 tp60 -59.69 -52.96 63.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 10' ' ' ALA . 11.2 tt -59.1 -26.55 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.262 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.46 -42.9 61.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.405 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 6.3 pt-20 -65.7 -36.76 84.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.216 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.11 -49.67 64.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.576 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -59.04 -46.05 89.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.506 . . . . 0.0 110.025 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.81 -49.52 72.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.48 -41.09 63.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.361 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -55.81 -37.31 68.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.061 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -76.12 -15.82 60.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.78 -40.23 14.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.316 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.2 -63.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.238 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.9 t0 -65.7 126.61 28.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.37 79.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.313 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -92.16 -12.47 32.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.974 0.416 . . . . 0.0 110.313 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 56.96 32.82 62.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.805 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' OD2' ' A' ' 20' ' ' ASP . 9.1 p30 -76.62 1.27 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.845 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.3 43.31 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.028 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -149.55 132.62 16.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.351 0.576 . . . . 0.0 111.205 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.672 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.3 mp -105.53 118.4 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.422 HG22 ' HG2' ' A' ' 31' ' ' GLU . 7.8 t -97.4 166.0 11.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.615 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.3 p -52.17 -31.16 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.836 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -63.95 -50.45 68.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 111.321 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG2' HG22 ' A' ' 28' ' ' THR . 7.9 mm-40 -77.7 -36.07 51.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.011 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.24 -45.67 72.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.013 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.33 -27.39 73.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.279 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 85.0 m -72.21 -47.14 52.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 19' ' ' PHE . 6.5 p -74.71 -34.97 35.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -49.77 76.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -64.41 -30.36 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 t -58.31 -21.29 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.59 -60.26 2.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.312 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.92 -39.0 0.02 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.542 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.8 mt-30 -140.93 147.86 39.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.111 0.455 . . . . 0.0 111.162 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -99.64 99.65 9.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.258 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.44 -168.8 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.356 2.037 . . . . 0.0 111.971 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -85.1 169.82 13.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.65 -30.49 69.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 0.0 110.066 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -44.25 59.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.141 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.03 -41.1 97.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.861 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.24 -39.59 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -66.27 -51.09 60.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.413 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.66 -53.42 58.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.381 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -60.26 -45.35 96.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.497 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.07 -26.12 10.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.446 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 2.2 mt-10 -82.96 -3.3 56.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.38 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -64.59 133.22 51.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.053 0.454 . . . . 0.0 111.344 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.11 -53.58 16.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.897 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.66 58.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.07 49.22 80.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.933 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -104.26 -1.47 27.02 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.771 -0.253 . . . . 0.0 111.439 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.3 17.72 15.01 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.252 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.2 p -149.23 139.82 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.3 mm -103.44 149.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 111.985 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.75 170.8 7.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.415 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.4 m-85 -56.03 -61.55 6.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.533 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -68.24 -18.59 44.9 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.508 2.138 . . . . 0.0 112.68 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.409 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HA ' HG11 ' A' ' 55' ' ' VAL . 3.4 t80 -75.28 -38.48 60.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 12.1 tp -64.45 -55.61 19.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -51.67 -37.26 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.22 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.405 ' HG2' HG12 ' A' ' 55' ' ' VAL . 2.8 tpt -64.08 -32.74 74.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.4 mmt -108.27 15.52 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.35 -36.69 3.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.803 0.335 . . . . 0.0 111.291 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -53.31 -54.33 37.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.826 0.346 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 58.56 161.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.367 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 t -166.2 -167.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -73.55 -26.04 60.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.03 -33.79 59.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' B' ' 73' ' ' ARG . 4.4 mt-10 -61.24 -45.4 94.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.67 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -72.34 -39.14 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.761 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -71.54 -49.47 40.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.799 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.36 -45.56 93.89 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 109.313 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.685 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.54 -50.51 65.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.894 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.21 -40.8 59.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.833 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -31.76 68.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.443 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.57 -36.85 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.554 ' N ' HG23 ' A' ' 91' ' ' VAL . 6.5 m-85 -75.63 -43.28 48.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -112.57 109.29 18.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -42.03 80.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -74.19 -9.71 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.06 68.51 0.77 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.172 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.46 8.82 40.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.47 16.38 65.14 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.296 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 3.6 m-85 -163.86 116.68 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.731 0.3 . . . . 0.0 111.066 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.28 127.38 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 111.788 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.5 m -104.21 158.59 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.059 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.536 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -48.0 -41.98 26.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.732 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 111.126 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.67 -37.77 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.591 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.542 HD13 HD13 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -60.82 -47.71 85.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.882 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.405 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.39 -44.47 88.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.559 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 1.3 t60 -58.73 -38.33 78.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.38 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.31 -55.64 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.0 mmt -49.05 -53.44 20.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.617 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 t -68.0 -24.34 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 24.4 t30 -74.54 -31.39 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.664 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.7 -28.72 20.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.18 44.11 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.576 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.85 109.72 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -90.72 99.66 12.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.27 172.51 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 t -96.59 166.58 11.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.829 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.32 -34.07 77.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -35.51 78.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -65.64 -50.02 66.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.411 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 4.2 m -66.77 -39.56 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.13 -42.37 99.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 110.216 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.0 mt-10 -72.74 -30.13 63.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.339 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -36.19 72.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.542 HD13 HD13 ' A' ' 105' ' ' LEU . 2.8 mm -80.36 -54.5 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 15.7 ptt180 -53.73 -31.92 50.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.431 . . . . 0.0 110.303 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.65 -21.72 44.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.734 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.68 -0.3 23.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.34 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 46.1 t0 -96.24 102.82 14.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.368 0.604 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.692 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -76.93 -32.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.157 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.3 -9.05 49.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.88 0.371 . . . . 0.0 111.491 -178.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.54 56.98 11.28 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -114.33 -3.71 13.07 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.145 0.472 . . . . 0.0 111.49 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.5 44.34 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.099 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.76 -174.79 4.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.646 0.26 . . . . 0.0 110.349 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.2 t -129.22 126.99 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.8 t30 -104.61 -167.68 1.38 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.942 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.588 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.5 t80 -56.7 -73.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.588 ' O ' HG21 ' A' ' 142' ' ' VAL . 1.9 tt0 -49.65 -47.13 50.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.23 0.538 . . . . 0.0 110.445 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.692 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -56.29 -33.72 65.8 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.759 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -79.23 -48.93 13.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.063 0.458 . . . . 0.0 111.686 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.67 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.0 m -60.29 -41.86 88.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.217 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.5 OUTLIER -70.85 -35.63 72.5 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.584 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 2.7 ptm -70.6 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 17.8 mtt -105.11 -44.2 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.666 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.434 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.007 0.432 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.61 -76.26 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.9 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.4 -41.46 55.39 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -64.93 -70.31 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.702 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -52.25 -38.82 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.492 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.4 OUTLIER -55.42 -49.88 71.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.654 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.55 -41.58 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.147 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.508 ' O ' HG12 ' B' ' 75' ' ' VAL . 89.4 t -53.6 -53.47 25.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.31 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.423 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.0 mpt_? -71.33 -44.26 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.405 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 17.7 mt -56.23 -50.43 71.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.596 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.508 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.8 p -64.09 -47.02 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.43 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.59 -32.98 65.76 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.526 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 47.4 t -76.75 -53.02 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.649 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -63.29 -43.08 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.524 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.2 mmp_? -57.92 -35.07 70.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 109.687 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -36.04 80.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.337 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.506 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.1 t90 -95.37 -13.86 24.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -92.03 -31.4 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -176.55 175.23 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.27 165.4 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -69.64 170.31 11.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.88 -37.29 66.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.321 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.04 -56.8 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.134 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -57.91 -44.38 86.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.1 tt -68.04 -26.78 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.8 -43.17 62.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -71.45 -27.5 63.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.234 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.55 -49.41 41.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.239 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.06 -45.09 83.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 110.222 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.1 mm-40 -64.38 -51.66 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -51.21 -40.18 58.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.841 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -56.01 -47.34 77.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -13.62 62.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.3 mt -88.0 -38.3 15.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 110.503 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.668 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -63.12 -64.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.07 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.4 t70 -61.99 128.1 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -38.54 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.279 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.19 -12.25 30.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.824 0.345 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.33 38.44 86.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -77.66 -1.15 29.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.26 -2.53 43.58 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.213 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.1 p -149.42 132.47 16.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 0.0 110.756 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.668 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.2 mp -104.73 119.21 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 t -99.15 165.88 11.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.697 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 p -52.33 -32.56 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.885 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -62.13 -50.56 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.329 . . . . 0.0 111.374 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.78 -37.59 48.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 110.974 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.517 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.23 -40.39 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.585 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.2 -30.86 69.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.914 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.6 m -67.58 -53.25 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.401 HG12 ' CE1' ' A' ' 19' ' ' PHE . 10.1 p -69.76 -30.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.246 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 mtp -60.14 -46.62 89.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.321 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -25.52 44.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -53.64 -50.67 65.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -46.97 -57.88 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.589 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -142.72 178.76 7.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -147.69 58.58 4.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.91 -178.5 3.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.559 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.1 p -98.66 173.76 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.49 -30.2 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.29 60.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.15 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.71 -42.01 96.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.062 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.35 -50.53 73.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -62.77 -38.63 91.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.89 -51.23 42.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.352 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -54.1 50.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.491 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -59.28 -45.26 93.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.477 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -52.36 -25.9 10.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.8 mt-10 -82.35 -3.33 55.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.98 -32.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -63.92 134.82 55.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 111.079 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -66.52 -53.35 35.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.728 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.77 4.2 51.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.813 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.16 59.71 9.11 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.213 -0.517 . . . . 0.0 113.933 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -109.35 -2.72 17.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.771 0.286 . . . . 0.0 111.323 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.22 17.3 16.18 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.927 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -149.49 139.96 22.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.337 . . . . 0.0 111.02 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.3 mm -104.64 149.56 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.209 0.528 . . . . 0.0 111.725 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 171.72 7.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.495 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -55.9 -61.59 6.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.712 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.1 Cg_endo -67.97 -19.48 45.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.753 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.439 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.18 -39.07 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.367 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.461 ' HA ' HG11 ' A' ' 55' ' ' VAL . 4.2 t80 -75.27 -35.74 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.662 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.7 tp -71.99 -58.43 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.085 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.13 -46.69 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mmt -59.71 -30.69 68.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.417 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.26 14.97 24.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.08 -43.0 3.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -48.7 76.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.795 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.772 0.32 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -85.85 -179.95 6.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -150.2 156.21 41.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.84 -38.54 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.261 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 45.4 mt-10 -63.92 -27.86 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.178 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.641 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.18 -39.22 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -70.88 -49.32 47.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.29 -46.44 90.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.34 0.59 . . . . 0.0 109.476 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.58 -48.85 68.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.068 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.06 -38.86 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.994 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -30.42 57.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.955 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.53 -37.02 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 91' ' ' VAL . 2.0 m-85 -71.86 -62.89 1.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.494 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.82 121.17 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.33 -52.62 57.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.234 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.04 -9.61 59.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.496 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.13 71.13 0.52 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.864 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.39 14.58 18.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.633 0.254 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.28 66.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.608 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.2 m-85 -161.84 116.75 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.755 0.312 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.28 124.45 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.115 0.483 . . . . 0.0 111.645 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -104.26 161.63 13.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.16 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -44.52 29.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.442 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.09 -58.87 6.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.03 -36.62 65.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.636 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.99 -49.49 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.729 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -41.49 78.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.333 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -60.55 -39.87 89.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.306 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.72 -51.8 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.749 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.28 -54.05 29.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.802 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 t -66.99 -25.08 66.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -70.69 -31.29 68.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.62 -28.8 16.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.51 43.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -152.11 109.78 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.66 95.63 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.018 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -94.07 157.14 16.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 t -88.01 164.02 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.55 -42.69 83.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -62.46 -35.35 79.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -65.31 -54.85 23.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.021 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.412 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.5 m -64.94 -39.78 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -62.53 -41.88 99.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 110.276 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 5.6 mt-10 -72.66 -30.14 64.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.317 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.3 tpp -70.75 -36.09 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.6 mm -80.24 -54.91 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.567 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -53.65 -31.75 48.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.01 0.433 . . . . 0.0 110.456 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -20.79 52.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.968 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.06 -10.96 15.76 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.55 0.214 . . . . 0.0 111.523 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -85.51 109.67 18.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.429 0.633 . . . . 0.0 111.307 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.689 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.13 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.755 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.05 -9.14 43.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.523 -178.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.31 57.62 10.05 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -114.25 -4.33 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.05 0.425 . . . . 0.0 111.456 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.69 42.45 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.991 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.05 -174.87 4.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.53 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 141' ' ' PHE . 54.0 t -128.34 126.82 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -106.55 -167.36 1.28 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.6 t80 -58.09 -73.98 0.07 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.573 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -49.56 -45.64 47.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.375 0.607 . . . . 0.0 110.336 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.689 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.55 -36.61 69.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.569 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.64 -49.51 12.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.913 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.641 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -55.85 -40.21 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -34.44 70.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.757 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.82 8.93 13.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 111.283 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.457 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.8 mtt -118.81 -36.32 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -179.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.438 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.036 0 CA-C-O 120.971 0.415 . . . . 0.0 110.774 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.03 -75.81 0.22 Allowed Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.95 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.35 -46.69 63.67 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -58.71 -70.26 0.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.27 . . . . 0.0 110.552 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.461 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.29 -34.09 45.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.205 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.432 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 6.6 tpt180 -58.14 -52.18 66.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.632 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.38 -41.8 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.053 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.483 ' O ' HG12 ' B' ' 75' ' ' VAL . 90.4 t -53.03 -53.3 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.446 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -71.02 -45.01 64.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.436 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 21.2 mt -55.99 -49.73 72.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.557 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 14.6 p -64.62 -48.62 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.96 -29.67 59.39 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.151 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 98.8 t -76.8 -55.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.604 0.24 . . . . 0.0 111.562 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.531 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.73 -43.91 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.531 ' N ' HD11 ' B' ' 78' ' ' ILE . 23.6 mmm180 -58.16 -34.26 70.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.229 0.538 . . . . 0.0 109.855 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -62.27 -37.03 83.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.517 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.8 t90 -95.34 -15.38 23.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.73 -26.26 19.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.501 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.645 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.57 170.82 2.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -124.13 165.36 17.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -67.93 166.33 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 41.2 mt-10 -54.34 -26.48 30.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.36 -56.89 3.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.126 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -46.57 84.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.0 tt -65.52 -26.65 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.55 -44.04 62.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.294 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 2.0 mp0 -72.5 -25.71 61.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -71.42 -49.39 42.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.298 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.35 -44.93 80.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.307 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.4 mm-40 -65.35 -51.44 60.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -51.18 -40.06 57.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.922 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -57.07 -45.98 82.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -70.94 -13.76 62.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.2 mt -87.99 -38.38 15.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.906 0.384 . . . . 0.0 110.57 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -63.31 -64.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.3 t70 -62.52 127.34 30.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.801 0.334 . . . . 0.0 110.432 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -38.69 92.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.9 -12.31 31.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.26 38.38 86.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -77.65 -1.06 29.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.79 43.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.195 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.7 p -149.37 132.49 16.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.939 0.37 . . . . 0.0 110.764 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.672 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.2 mp -104.38 119.35 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 t -98.75 165.11 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.696 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 p -52.76 -30.45 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.83 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -63.24 -50.61 69.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -77.85 -37.87 47.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.14 -41.39 68.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 -29.42 72.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.9 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.6 m -69.51 -52.05 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.542 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.452 ' CG1' ' CE1' ' A' ' 19' ' ' PHE . 7.7 p -69.01 -31.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.415 ' N ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -60.07 -47.16 87.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -25.47 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.758 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 t -54.69 -50.72 67.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.51 -58.72 3.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 111.085 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.6 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -142.71 -178.02 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -150.99 58.16 2.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 -177.18 2.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.65 2.233 . . . . 0.0 112.504 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.2 p -99.71 173.6 6.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -68.54 -30.14 68.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.918 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.12 59.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.32 -42.51 98.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.076 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.5 -50.53 72.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -63.28 -39.43 94.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.214 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.61 -51.25 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.325 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -53.84 53.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 110.347 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.484 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -59.31 -45.27 93.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.437 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -52.38 -25.92 11.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.2 mt-10 -82.39 -3.26 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.669 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.12 -32.36 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 45.0 t0 -63.31 136.51 57.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 111.195 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.46 -53.9 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.562 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -95.6 4.24 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.62 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.31 58.74 10.16 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.8 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -109.72 -1.76 17.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.788 0.294 . . . . 0.0 111.301 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.26 17.44 15.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.953 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 p -149.32 139.85 22.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.137 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.483 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.4 mm -103.95 149.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.082 0.468 . . . . 0.0 111.708 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.38 169.28 8.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.624 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.2 m-85 -53.44 -61.12 5.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.393 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 51.9 Cg_endo -69.11 -18.44 40.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.486 2.124 . . . . 0.0 112.636 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mm-40 -79.24 -38.85 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.479 ' HA ' HG11 ' A' ' 55' ' ' VAL . 4.0 t80 -75.26 -34.09 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.622 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.9 tp -73.74 -58.43 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -52.08 -47.81 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.55 -28.58 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.22 13.23 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . . . -110.64 -43.69 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -55.58 -44.26 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 110.859 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.783 0.325 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 -178.84 7.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.039 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.92 155.96 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.51 -24.97 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.362 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.1 -37.25 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.202 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 55.3 mt-10 -64.9 -28.07 69.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.165 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.64 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.2 -39.27 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.287 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -70.83 -49.28 47.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.04 -47.0 88.43 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.592 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.43 -48.85 68.4 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.241 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.14 -38.86 54.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.984 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -30.46 56.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.949 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.44 -37.07 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 111.026 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.4 m-85 -71.62 -62.95 1.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.8 117.95 23.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -60.66 -52.63 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.47 -9.64 59.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.501 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.7 71.65 0.47 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.879 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.38 14.42 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.57 13.72 61.32 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.673 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.9 m-85 -158.07 116.69 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -113.76 125.1 70.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 161.86 13.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.237 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.575 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.91 -46.98 32.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.555 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.31 -58.87 5.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.14 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.88 -36.55 65.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.606 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.2 -50.52 72.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.648 178.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -41.85 77.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -60.12 -39.35 85.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.397 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.21 -55.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.694 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.6 mmt -49.94 -54.07 22.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.39 -24.92 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.12 -31.41 70.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.73 -28.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.03 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.27 43.17 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -150.17 109.82 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -90.21 98.82 12.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.37 171.22 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 m -98.29 158.96 15.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -56.76 -48.9 76.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -64.18 -31.66 72.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.64 -54.91 32.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.6 m -65.37 -40.46 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.47 -40.99 98.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.094 0.473 . . . . 0.0 110.283 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.41 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 9.8 mt-10 -73.02 -30.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.405 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.0 mtp -71.04 -35.74 72.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.575 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.0 mm -80.35 -54.94 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.623 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.41 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 ptm180 -53.89 -31.86 51.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 0.0 110.38 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.96 -21.01 47.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.786 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.97 -5.05 18.43 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 121.114 -0.235 . . . . 0.0 111.445 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.4 t0 -92.38 109.7 21.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.41 0.624 . . . . 0.0 111.325 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.691 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.74 -31.18 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.793 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.92 -9.12 44.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.554 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.55 58.21 8.51 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -114.25 -4.53 13.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.04 0.42 . . . . 0.0 111.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.38 7.83 42.13 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.967 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.436 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.11 -174.81 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.04 126.67 66.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.261 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -105.29 -168.28 1.44 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.587 ' O ' HG13 ' A' ' 142' ' ' VAL . 59.7 t80 -58.51 -73.98 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.581 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.52 -45.52 47.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.348 0.594 . . . . 0.0 110.265 -179.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.691 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.51 -36.38 69.11 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.108 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.71 -49.83 11.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.901 0.381 . . . . 0.0 111.92 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.64 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -55.12 -40.49 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -34.45 70.9 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.705 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.43 8.6 13.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.647 0.261 . . . . 0.0 111.305 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.7 mtt -118.51 -37.66 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.396 -179.799 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' ARG . . . . . 0.436 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 121.014 0.435 . . . . 0.0 110.822 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.14 -75.74 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.935 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.48 63.24 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.058 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . 0.669 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -59.1 -70.29 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.653 -0.273 . . . . 0.0 110.501 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.08 -34.0 41.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.179 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.8 tpp180 -58.27 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ILE . . . . . 0.624 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.14 -41.81 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.963 178.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' VAL . . . . . 0.503 ' O ' HG12 ' B' ' 75' ' ' VAL . 88.6 t -52.95 -52.62 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.468 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -45.78 63.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.331 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 22.7 mt -55.87 -49.26 73.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 110.545 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 72' ' ' VAL . 15.0 p -63.97 -48.2 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.56 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' GLY . . . . . 0.426 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.76 -29.82 58.86 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.14 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 88.2 t -76.77 -56.06 9.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.596 0.236 . . . . 0.0 111.63 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.534 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -60.74 -43.56 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . 0.534 ' N ' HD11 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.05 -33.29 68.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 109.901 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -37.79 88.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.469 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' TRP . . . . . 0.522 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.2 t90 -95.52 -11.37 27.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.153 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -93.29 -31.23 14.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.419 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.562 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.792 0.33 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -157.06 85.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.54 -179.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.55 165.27 25.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -70.09 169.4 13.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.075 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' HA ' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -54.87 -30.29 57.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.518 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -56.88 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.31 -45.32 91.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.481 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.425 HG22 ' HA ' ' A' ' 6' ' ' GLU . 13.0 tt -65.17 -26.65 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.955 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.68 -44.04 62.96 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.442 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -69.21 -32.71 72.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.257 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -67.6 -49.7 61.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.328 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -44.74 92.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.254 0.55 . . . . 0.0 110.043 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.42 -47.88 74.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.704 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.4 -41.97 63.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.438 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -56.76 -35.12 68.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.043 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -77.86 -14.64 59.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.927 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.66 -38.5 15.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.554 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.26 -65.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.01 132.33 48.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.741 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -37.89 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.01 -12.15 29.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.51 36.76 79.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.654 179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -74.67 -5.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.523 0.201 . . . . 0.0 111.501 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.18 2.29 44.9 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.1 p -149.43 132.53 16.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -108.97 126.56 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 t -101.03 167.82 10.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 p -54.01 -30.44 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.48 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -62.79 -50.39 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.204 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -77.73 -36.28 51.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.798 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.37 -58.35 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.703 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.25 -27.49 69.27 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.555 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -70.99 -60.99 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.12 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 19' ' ' PHE . 7.1 p -64.71 -30.76 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.7 ttt -60.22 -55.22 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -25.63 64.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 t -56.04 -38.37 70.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.92 -62.3 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.65 41.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -142.56 167.8 21.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -134.97 59.66 35.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.71 -169.98 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.588 2.192 . . . . 0.0 112.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 p -116.46 167.57 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.78 -32.05 71.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.8 -45.62 59.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.405 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.17 -43.4 95.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.302 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -55.25 -50.58 69.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.09 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -64.56 -57.03 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -51.19 67.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.182 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.511 ' O ' HG21 ' A' ' 55' ' ' VAL . 15.7 mtt -57.64 -47.06 83.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.507 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -61.58 -45.68 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.159 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -56.36 -26.53 53.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.529 0.68 . . . . 0.0 110.113 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 51' ' ' MET . 6.6 mt-10 -81.53 -2.14 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.351 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.523 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -127.0 -33.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 112.04 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.49 148.5 45.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.251 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.5 -53.57 7.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.54 -8.63 58.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.34 48.55 79.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.931 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -96.6 -0.22 48.95 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.643 0.222 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.25 15.13 22.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.922 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -149.88 139.89 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.56 0.18 . . . . 0.0 110.565 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.567 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.71 147.34 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.497 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.52 179.08 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.882 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -60.93 -61.69 7.48 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.0 Cg_endo -66.93 -30.94 39.0 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.435 2.09 . . . . 0.0 112.197 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mt-10 -65.74 -40.61 92.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.454 ' HB2' HG23 ' A' ' 63' ' ' ILE . 2.1 t80 -75.14 -41.95 57.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -71.17 -53.1 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.482 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 90.4 m -51.58 -46.34 63.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.182 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.8 tpp -56.65 -48.33 77.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.932 0.396 . . . . 0.0 110.936 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.9 mmt -85.95 0.15 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.66 -38.89 11.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.93 0.395 . . . . 0.0 111.076 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -55.04 -30.48 59.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 149.2 31.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.84 89.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -103.6 -49.7 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -135.54 114.1 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.4 t -176.74 170.09 2.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -151.75 174.44 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -152.17 155.46 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -54.64 -24.29 20.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 -38.68 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 53.5 mt-10 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.026 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.648 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.29 -38.88 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -49.35 33.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -61.06 -45.49 94.55 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.47 -53.33 53.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.997 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.36 -38.88 55.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.833 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -31.46 68.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.25 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.39 -36.68 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.558 ' N ' HG23 ' A' ' 91' ' ' VAL . 5.9 m-85 -71.93 -62.9 1.26 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -85.25 129.93 34.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -75.67 -52.6 10.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.37 -9.6 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.481 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.21 70.44 0.62 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.898 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -93.43 15.32 16.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.3 68.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.2 m-85 -166.35 116.34 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.66 129.11 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.787 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -104.08 156.5 17.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.197 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.93 -38.88 17.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.385 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.85 -59.01 6.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.057 0.456 . . . . 0.0 110.864 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -36.87 72.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.689 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.57 HD13 HD13 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.56 -49.31 77.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -56.75 -44.49 81.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.205 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -58.76 -37.52 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.17 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 38.5 t -68.87 -53.77 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.674 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.0 mmt -50.35 -54.12 23.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.815 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 t -67.29 -24.87 65.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.38 -29.99 67.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.61 -28.84 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.75 43.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.96 125.75 18.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -92.31 95.6 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.79 150.84 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 16.9 m -98.24 159.05 15.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.08 -44.38 87.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -34.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -65.52 -54.87 22.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.7 m -64.66 -38.82 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.038 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.68 -42.04 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.39 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.42 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.1 mt-10 -73.03 -30.11 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.444 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 1.5 mmt -71.18 -35.07 71.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.57 HD13 HD13 ' A' ' 105' ' ' LEU . 2.4 mm -80.35 -54.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.42 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.3 ptm180 -54.04 -31.86 52.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.302 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.19 -22.87 57.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.743 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.46 -11.17 18.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -96.35 97.79 9.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.484 0.659 . . . . 0.0 111.214 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.68 -30.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 6.6 p30 -95.74 -9.51 31.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.972 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 45.98 62.43 3.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.505 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -113.68 3.2 15.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.584 0.23 . . . . 0.0 111.447 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.34 2.96 47.79 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.09 -177.33 5.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.094 0.447 . . . . 0.0 110.966 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.545 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.2 t -130.78 128.58 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.145 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -99.52 -175.07 2.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.736 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.545 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.7 t80 -56.82 -72.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.018 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.601 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.37 -43.26 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.152 0.501 . . . . 0.0 110.91 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.55 -36.17 71.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.38 -49.67 12.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.134 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.648 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.6 m -53.97 -42.41 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.438 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.6 pt20 -70.93 -48.6 52.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.231 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.438 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.74 -15.76 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.459 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 1.2 mtt -89.83 -42.96 10.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t -135.77 -51.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.83 53.69 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 111.599 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.909 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.681 0.277 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.02 -176.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.578 2.186 . . . . 0.0 112.328 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -102.8 -47.13 4.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -150.34 30.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.01 -135.52 5.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -109.6 114.62 28.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.55 -71.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.603 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.57 -50.29 49.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.601 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -58.3 -67.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.606 0.241 . . . . 0.0 110.514 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.438 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.99 -35.99 48.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.298 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 19.5 tpp85 -56.38 -49.86 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.601 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.35 -42.19 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.006 178.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.473 HG21 ' O ' ' B' ' 68' ' ' PHE . 98.5 t -50.72 -50.31 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.558 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -45.88 63.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 19.5 mt -55.87 -50.61 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 13.3 p -63.02 -47.8 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 110.414 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.418 ' N ' HG11 ' B' ' 75' ' ' VAL . . . -56.95 -29.6 59.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.165 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 92.5 t -76.76 -56.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.629 0.252 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.515 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -59.9 -43.69 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.515 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.9 mmm180 -57.81 -35.09 70.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.236 0.541 . . . . 0.0 109.673 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.86 -35.77 81.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.109 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.51 ' CH2' HD13 ' A' ' 105' ' ' LEU . 2.4 t90 -95.19 -9.97 31.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.774 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.77 -36.94 50.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.281 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -148.23 -65.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.018 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.9 66.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 -66.6 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' B' ' 86' ' ' PHE . 67.9 t80 -106.29 33.96 3.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.879 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.832 0.349 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -66.43 77.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.39 -175.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.04 165.17 26.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -69.78 171.4 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 11.9 pt-20 -54.97 -35.81 64.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.444 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 -56.88 4.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -41.26 84.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.699 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.5 tt -71.4 -26.38 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.029 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.39 -43.22 61.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.514 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.34 -33.44 73.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -65.96 -49.65 67.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.467 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.56 -44.82 89.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.202 0.525 . . . . 0.0 110.215 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.03 -48.86 72.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.703 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.548 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.34 -41.45 63.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.497 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -57.51 -31.73 66.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.957 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -79.7 -15.08 58.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.64 -38.79 15.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -67.04 -65.84 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.35 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -66.57 132.69 48.74 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 110.702 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -37.3 74.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.92 -12.28 29.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.49 37.08 80.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.64 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -75.21 -4.2 37.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.505 0.193 . . . . 0.0 111.473 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 -0.23 44.01 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.059 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.3 p -149.54 132.59 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.803 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.592 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mp -107.54 128.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -103.28 165.13 11.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.737 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 p -52.78 -26.65 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.688 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -67.53 -50.5 58.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 15.3 mm-40 -77.46 -35.41 53.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.752 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.592 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.27 -58.36 7.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.773 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.0 -27.3 66.89 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.919 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -69.89 -56.52 6.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 111.52 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.81 -33.78 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.484 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.417 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -59.05 -53.1 62.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.713 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -25.77 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.984 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -60.41 -36.71 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.7 mt -58.31 -30.65 66.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.23 42.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.524 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -142.6 161.59 37.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.23 62.75 8.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.73 -174.13 1.21 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.571 2.181 . . . . 0.0 112.355 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -122.12 167.29 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.79 -32.26 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.183 0.516 . . . . 0.0 110.084 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.487 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -41.92 95.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.394 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.41 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -56.34 -50.79 70.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -65.46 -50.03 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.54 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.08 71.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.578 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.6 -49.89 75.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.698 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.526 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -58.88 -42.32 85.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.261 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -59.18 -26.34 64.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.56 0.695 . . . . 0.0 110.06 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -83.79 -2.16 55.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.86 -33.06 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -71.15 148.02 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.5 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.85 -53.45 6.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.646 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.36 -8.76 58.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.49 48.75 78.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -96.96 -1.42 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 111.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.21 15.24 22.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.86 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -149.88 139.81 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.547 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.3 mm -95.33 147.21 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.473 . . . . 0.0 111.663 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.49 176.92 5.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.929 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 3.3 m-85 -60.21 -61.62 7.56 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 33.4 Cg_endo -64.48 -30.94 61.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.411 2.074 . . . . 0.0 111.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 1.9 mt-10 -69.03 -37.09 78.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.336 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.3 t80 -75.12 -39.97 60.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 6.6 tp -76.79 -54.57 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.604 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.1 m -51.58 -44.02 62.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.613 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -54.17 47.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.864 0.364 . . . . 0.0 111.011 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.402 ' HE1' ' CZ ' ' A' ' 68' ' ' PHE . 22.9 mtt -80.31 -8.06 59.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.604 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.82 -42.68 12.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.842 0.353 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -59.5 -29.88 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.921 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 138.28 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.4 mpp? 60.71 93.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -93.83 -59.77 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -130.87 132.07 44.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -169.32 169.68 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.03 163.29 37.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 157.55 43.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -57.44 -27.78 62.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.2 -34.43 61.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 19.2 mt-10 -61.48 -33.84 74.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.637 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.41 -39.02 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.298 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -49.32 33.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -60.9 -44.94 96.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.66 -52.87 58.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.883 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.28 -38.85 55.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.865 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -71.49 -31.44 67.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.43 -36.68 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.545 ' N ' HG23 ' A' ' 91' ' ' VAL . 7.8 m-85 -73.51 -62.81 1.35 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.934 0.397 . . . . 0.0 110.394 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -84.81 118.14 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -64.8 -52.64 55.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.27 -9.63 59.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.541 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.81 70.97 0.56 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.21 15.14 16.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.45 66.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.617 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.9 m-85 -165.67 116.36 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.7 mt -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 111.866 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -104.04 156.39 17.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.929 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.463 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.97 -36.63 12.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.446 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -59.06 5.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.105 0.479 . . . . 0.0 110.978 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -58.75 -38.92 79.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.749 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.17 -48.36 82.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.842 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -56.91 -45.53 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.14 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.9 -36.63 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.148 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.43 -54.44 23.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.66 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.1 mmt -50.36 -54.01 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.727 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.6 t -67.63 -25.57 65.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.606 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.5 -31.23 71.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.82 -28.79 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.035 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.18 42.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.552 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -146.72 110.68 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.838 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -88.0 86.01 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.13 175.64 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.6 m -98.41 158.68 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.706 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.95 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.111 0.481 . . . . 0.0 110.209 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -71.76 -32.98 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.196 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.18 -52.98 56.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.54 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 m -66.95 -39.18 82.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.48 -45.15 88.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.046 0.45 . . . . 0.0 110.373 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 24.3 mt-10 -72.97 -30.16 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.622 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -34.46 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.755 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.573 HD13 HD13 ' A' ' 105' ' ' LEU . 2.0 mm -80.27 -54.73 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.463 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.2 ptm180 -53.91 -31.88 51.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 110.284 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.33 -23.48 57.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.688 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.03 -4.99 25.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.442 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -101.45 96.45 7.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.469 0.652 . . . . 0.0 111.273 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -30.84 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.611 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 5.0 p30 -95.82 -9.37 31.75 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 46.7 62.66 3.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.6 p30 -113.7 1.99 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.568 0.223 . . . . 0.0 111.434 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.28 4.57 47.09 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -149.98 -177.59 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 0.0 111.064 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.4 t -130.78 128.69 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.2 t30 -101.13 -174.03 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.549 ' O ' HG13 ' A' ' 142' ' ' VAL . 24.4 t80 -57.06 -73.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.575 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.38 -42.73 42.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.43 -37.24 72.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.326 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.556 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -79.43 -49.74 11.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.189 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.637 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.5 m -53.68 -42.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.3 pt20 -70.94 -48.18 54.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.267 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.441 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.66 -15.56 52.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.473 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.463 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 1.6 mtt -90.59 -42.62 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.751 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t -135.46 -51.17 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -84.97 53.32 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.577 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.876 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.709 0.29 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.12 173.89 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -60.18 -43.47 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -176.83 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.84 -83.27 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.518 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.406 ' CZ ' ' HB2' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -145.23 120.09 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.938 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.67 -70.46 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -57.9 -46.86 91.94 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.606 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.728 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.2 OUTLIER -52.23 -64.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.295 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.421 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.03 -31.57 61.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 0.0 110.005 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -54.0 -53.57 51.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.728 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -38.62 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.554 HG21 ' O ' ' B' ' 68' ' ' PHE . 98.0 t -50.85 -43.11 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.351 0.596 . . . . 0.0 110.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.413 ' CD ' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -74.67 -48.16 27.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.121 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 62.6 mt -55.75 -46.77 77.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.548 HG13 ' HB3' ' A' ' 15' ' ' ALA . 14.8 p -66.28 -46.72 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.593 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -58.16 -30.7 64.4 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.156 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 69.0 t -76.77 -55.05 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.645 0.26 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -61.39 -43.03 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.501 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.608 ' HG2' HD11 ' B' ' 78' ' ' ILE . 9.8 mmp_? -56.58 -37.4 70.56 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.381 0.61 . . . . 0.0 109.518 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -35.74 79.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.374 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.545 ' CH2' HD13 ' A' ' 105' ' ' LEU . 2.1 t90 -95.03 -9.92 32.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.685 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.53 -36.55 52.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.385 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -65.87 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.62 65.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.1 OUTLIER -84.81 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.847 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' B' ' 86' ' ' PHE . 24.1 t80 -137.28 35.31 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.97 78.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -176.98 -178.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.68 165.32 23.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.7 t -70.6 177.05 3.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.103 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 20.6 pt-20 -59.0 -37.99 78.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.48 -56.82 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.942 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.71 -40.72 80.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.422 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.1 tt -72.28 -26.57 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.981 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.64 -43.74 62.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.525 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.11 -33.05 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.15 -49.69 63.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.229 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -59.69 -44.93 93.44 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.218 0.532 . . . . 0.0 109.906 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -63.68 -48.21 78.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.409 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.465 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.43 -41.83 63.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.285 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.56 -38.61 69.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -74.0 -15.66 61.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -87.07 -38.3 16.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.556 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.36 -65.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.276 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -66.1 134.02 51.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -37.91 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.256 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.24 -12.14 28.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.824 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.57 79.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.724 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.58 -5.51 43.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.523 0.201 . . . . 0.0 111.45 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 3.72 44.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.044 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -149.45 132.59 16.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -110.64 126.93 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.3 t -100.42 168.27 9.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -54.32 -30.34 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.44 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -64.12 -50.41 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.185 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.79 -35.29 57.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.477 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.58 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.41 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.805 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -64.08 -27.46 71.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.803 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.5 m -66.89 -60.24 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.194 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.03 -30.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.1 ttt -62.02 -47.2 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.66 -25.72 44.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.998 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -57.7 -36.33 71.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.15 -61.52 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -142.63 161.89 36.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -130.05 60.06 49.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.0 -170.07 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.8 p -117.52 167.45 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.78 -32.11 71.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.69 59.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.338 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -44.85 92.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.262 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.9 mt -53.57 -50.59 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.86 -53.04 52.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -56.85 -51.13 70.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.566 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.06 -48.31 82.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.679 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -59.52 -43.65 91.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.79 -26.38 64.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.559 0.695 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -82.83 -2.24 54.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.663 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.78 -33.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -70.2 153.92 42.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.17 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.68 -53.5 6.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.855 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.58 -8.54 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.56 52.02 55.6 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.859 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.43 0.11 44.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.577 0.227 . . . . 0.0 111.45 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.39 24.38 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.8 p -149.98 139.9 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.542 0.21 . . . . 0.0 110.633 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.588 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.66 149.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.039 0.447 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 178.26 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.722 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.6 m-85 -60.79 -61.59 7.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.521 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.5 Cg_endo -67.22 -32.68 32.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.48 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -65.04 -38.76 91.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.6 t80 -75.35 -41.17 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.438 . . . . 0.0 110.036 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 8.3 tp -68.4 -56.28 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.4 m -51.72 -46.11 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.514 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.0 tpp -55.89 -49.6 72.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 111.087 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.0 mmt -81.14 -13.39 58.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 -35.17 20.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 110.978 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -38.65 90.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 134.7 45.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mpp? 57.71 76.44 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -74.1 -61.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -133.35 134.95 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -177.38 156.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.28 159.5 35.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -150.25 154.0 37.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -55.17 -26.64 40.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.6 -34.05 67.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.77 -32.39 73.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.659 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.25 -38.92 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.2 -49.41 43.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.388 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.5 -45.84 92.52 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.65 -49.32 68.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.978 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.498 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.1 -38.42 51.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.97 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -30.47 57.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.822 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.14 -37.05 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.551 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.6 m-85 -73.74 -62.95 1.32 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.855 0.36 . . . . 0.0 110.483 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -84.42 128.48 34.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.787 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -73.17 -52.63 13.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.254 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -78.57 -9.62 59.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.528 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.72 70.61 0.57 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.956 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -93.67 14.87 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 111.219 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.73 68.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.6 m-85 -162.99 116.94 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 mt -111.77 126.67 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.499 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -103.96 156.94 17.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.133 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.62 -41.54 22.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.334 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -58.91 6.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.056 0.455 . . . . 0.0 110.863 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.71 -38.46 69.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.754 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.545 HD13 HD13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.71 -50.76 72.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.834 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.3 tpt85 -55.74 -44.15 77.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.06 -37.51 74.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.333 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.78 -53.88 22.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.1 mmt -49.74 -54.11 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.6 t -66.45 -25.42 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.4 -29.87 68.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.41 -28.76 13.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.22 43.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.536 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -149.66 114.15 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.06 103.08 15.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.32 163.6 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.768 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -98.28 158.82 15.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.5 -42.34 91.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.81 -35.42 74.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.32 -54.83 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 m -64.06 -39.9 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.85 -41.69 98.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.2 mt-10 -72.57 -30.1 64.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.356 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.421 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 53.9 ttm -70.85 -34.88 72.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.678 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 105' ' ' LEU . 3.2 mm -80.38 -54.93 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.659 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm85 -54.26 -31.78 54.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.41 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.13 -22.02 55.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.897 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.72 15.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.576 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -83.88 90.82 7.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.472 0.654 . . . . 0.0 111.06 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.728 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -64.1 -30.74 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.411 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.601 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.74 -9.46 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.17 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.3 54.49 19.67 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.9 p30 -113.86 -5.33 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.206 0.503 . . . . 0.0 111.371 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.5 6.49 44.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.185 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.417 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.38 -174.89 4.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.895 0.348 . . . . 0.0 110.566 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.561 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.3 t -128.94 123.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.409 . . . . 0.0 111.326 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.2 -164.73 1.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.855 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.537 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 t80 -63.12 -73.9 0.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.587 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.6 -44.27 47.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.346 0.593 . . . . 0.0 110.302 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.728 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.43 -36.06 68.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.007 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.561 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -48.66 13.56 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.906 0.384 . . . . 0.0 111.496 -179.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.659 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.9 m -57.85 -41.2 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.363 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.34 -35.3 71.13 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.578 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.41 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -81.66 6.31 15.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.337 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.452 ' HE2' ' CZ ' ' A' ' 141' ' ' PHE . 2.9 mtt -115.75 -31.97 5.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.287 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t -141.64 -48.83 0.39 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.604 0.24 . . . . 0.0 111.628 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.41 79.66 8.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 111.452 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.001 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 -174.61 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.546 2.164 . . . . 0.0 112.288 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -96.56 -31.34 12.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -155.2 39.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.6 -135.68 4.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.466 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? -111.93 123.67 50.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.06 -67.94 1.95 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.851 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.31 70.1 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.598 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.588 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -56.69 -66.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.493 0.187 . . . . 0.0 111.004 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.41 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.74 -36.78 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.507 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.5 tpt180 -55.88 -50.27 71.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.579 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.12 -41.75 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.138 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.512 HG21 ' O ' ' B' ' 68' ' ' PHE . 96.8 t -50.45 -52.4 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.581 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.41 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.1 mpt_? -70.69 -44.38 67.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.423 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 15.2 mt -56.03 -51.34 68.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.8 p -63.66 -48.09 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.419 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.24 -28.87 59.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.042 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 78.6 t -76.84 -54.6 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.625 0.25 . . . . 0.0 111.398 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.538 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.9 -44.09 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.538 ' N ' HD11 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.23 -35.37 71.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.224 0.535 . . . . 0.0 109.793 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.66 -36.99 80.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.194 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.513 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 2.9 t90 -95.28 -11.14 28.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.798 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' B' ' 78' ' ' ILE . . . -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.368 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -148.51 -65.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.88 66.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -66.65 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' B' ' 86' ' ' PHE . 67.0 t80 -109.53 35.54 3.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.203 -0.904 . . . . 0.0 110.842 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.834 0.35 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.77 69.27 8.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -173.82 -178.59 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.3 165.37 24.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.5 t -70.21 176.85 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.138 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -59.06 -38.01 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.322 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.51 -56.79 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.996 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -57.65 -40.75 80.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.4 tt -72.27 -26.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.62 -43.86 62.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.516 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -67.79 -33.48 74.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.205 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.02 -49.61 64.74 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.239 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.74 -44.86 93.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 109.887 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.1 -49.06 75.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.41 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.35 -41.43 63.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.83 -38.0 69.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -75.05 -15.47 60.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.33 -37.7 16.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 110.31 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.567 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.92 -65.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.249 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.01 133.42 50.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.66 77.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.36 -12.2 28.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.55 36.69 79.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.694 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -74.8 -5.26 42.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.406 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.18 44.81 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.069 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -149.48 132.62 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.68 126.63 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.269 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -99.5 167.3 10.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.821 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.3 p -53.5 -32.14 49.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -62.67 -50.51 70.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.336 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -75.82 -36.37 59.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.731 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.38 -58.23 8.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.699 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.41 -30.88 77.6 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.665 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.6 m -63.84 -60.95 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.361 . . . . 0.0 111.086 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.68 -30.55 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.5 mtp -59.68 -52.14 66.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.626 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.35 -25.66 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -55.85 -38.97 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 mt -58.06 -63.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.14 40.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -141.09 168.37 19.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.05 59.48 34.1 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.43 -169.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.277 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.9 p -118.1 167.47 11.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.82 -32.07 71.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.191 0.519 . . . . 0.0 110.064 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.76 -45.74 59.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -44.55 93.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.279 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -54.03 -50.54 66.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.234 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -64.86 -52.7 55.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.534 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.17 -51.03 70.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.275 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.559 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.21 -48.38 81.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.508 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -59.35 -43.61 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.112 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.71 -26.34 63.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.532 0.682 . . . . 0.0 109.991 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 51' ' ' MET . 5.9 mt-10 -82.61 -2.26 53.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.591 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.6 -33.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -70.95 152.83 43.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.03 -53.46 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.861 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.09 -8.67 53.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.4 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.37 51.64 57.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.909 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.28 0.24 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.581 0.229 . . . . 0.0 111.402 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.51 24.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.866 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.9 p -150.0 139.88 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.536 0.208 . . . . 0.0 110.644 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.583 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.5 149.34 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 111.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.26 178.2 4.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.762 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -61.17 -61.59 7.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.5 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.8 Cg_endo -67.1 -31.22 37.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.481 2.12 . . . . 0.0 112.468 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -66.58 -38.78 87.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.977 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 63' ' ' ILE . 1.8 t80 -75.27 -41.01 58.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 110.038 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 8.9 tp -68.81 -56.23 8.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.485 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 m -51.65 -44.57 63.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.525 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.6 tpp -57.21 -49.92 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 mmt -79.21 -18.23 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.43 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 69' ' ' LEU . . . -82.87 -32.75 27.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -45.16 89.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.95 142.77 42.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.7 ttm 59.92 73.78 0.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -76.91 -62.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.84 126.54 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -177.23 146.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -127.43 177.8 6.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.981 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -161.29 154.15 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.84 -26.95 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.59 -37.1 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -61.7 -30.38 70.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.642 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.31 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.252 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -49.36 41.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.425 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.45 -45.83 92.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.412 0.625 . . . . 0.0 109.445 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.59 -49.43 67.79 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.956 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.98 -38.68 52.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.018 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.16 -30.48 58.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.31 -37.12 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.552 ' N ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -72.55 -63.01 1.24 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.864 0.364 . . . . 0.0 110.465 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.07 113.71 20.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.11 -52.56 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 -9.6 59.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.3 71.79 0.47 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.83 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -94.85 13.46 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 111.213 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.08 68.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -162.65 116.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.5 mt -113.5 123.22 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 111.531 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -104.2 161.4 14.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.979 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.584 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.71 -43.92 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.189 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -58.81 6.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.068 0.461 . . . . 0.0 110.908 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -55.11 -37.59 67.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.733 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.503 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.66 -50.88 71.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.835 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.2 tpt85 -56.02 -42.8 77.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -59.09 -37.88 78.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.8 t -68.92 -54.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -49.08 -54.03 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 t -67.21 -25.2 66.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.493 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.33 -30.26 69.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.731 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.38 -28.8 14.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.7 43.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.98 117.05 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -89.92 107.01 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.41 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.6 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.929 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.93 -41.16 91.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.686 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.535 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.4 -54.93 25.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.1 m -62.89 -41.24 91.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.19 -39.48 90.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 110.191 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 11.2 mt-10 -73.1 -30.22 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.329 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -35.4 71.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.584 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.7 mm -80.28 -54.89 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.5 ptm180 -53.74 -31.73 49.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 0.0 110.389 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -21.18 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.965 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.94 -9.12 16.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.417 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.5 t0 -87.37 110.22 20.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.418 0.627 . . . . 0.0 111.203 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.696 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.86 -31.18 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.781 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.1 -9.12 43.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.614 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.08 57.69 9.69 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 114.57 0.588 . . . . 0.0 114.57 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.9 p30 -114.27 -4.27 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.053 0.427 . . . . 0.0 111.505 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.7 42.17 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.968 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.94 4.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 110.552 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.577 HG11 ' CD1' ' A' ' 141' ' ' PHE . 52.2 t -128.31 125.42 64.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.935 0.397 . . . . 0.0 111.156 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.7 t-20 -105.31 -166.32 1.21 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.597 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.2 t80 -59.09 -73.9 0.08 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.588 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.57 -45.04 47.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.351 0.595 . . . . 0.0 110.33 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.696 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.7 mt-10 -57.22 -36.65 71.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.176 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.577 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -49.08 12.85 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 111.877 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.642 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -55.83 -38.88 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -34.25 70.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.743 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.37 12.45 10.1 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 111.165 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.456 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 2.3 mtt -121.24 -38.98 2.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.984 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 t -147.84 -51.57 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.315 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.06 74.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 111.376 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.958 179.866 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -168.01 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.192 . . . . 0.0 112.309 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -106.38 -33.8 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 mmt-85 -155.52 38.24 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 -135.6 4.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.45 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.921 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -66.58 2.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.71 -49.37 77.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.583 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -56.84 -67.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.546 0.212 . . . . 0.0 110.89 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -51.7 -37.02 48.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.522 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.3 tpp85 -55.9 -51.0 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.573 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.06 -41.61 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.517 HG21 ' O ' ' B' ' 68' ' ' PHE . 95.6 t -50.46 -53.4 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.623 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.418 ' HD3' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -70.52 -43.71 69.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 16.3 mt -56.22 -53.21 59.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 110.573 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.474 HG12 ' O ' ' B' ' 72' ' ' VAL . 14.5 p -61.6 -46.52 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.719 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -60.38 -28.32 67.02 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.245 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.453 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 77.7 t -75.92 -53.27 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.62 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -66.35 -40.99 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.2 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.62 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.1 mmp_? -57.19 -37.59 72.38 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.363 0.601 . . . . 0.0 109.551 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.53 79.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.503 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.6 t90 -95.12 -9.86 32.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.814 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.65 -36.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.287 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -148.5 -64.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.025 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.2 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.57 -66.77 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -131.66 35.49 3.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.865 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.829 0.347 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -96.34 103.55 15.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.85 -179.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.85 165.32 25.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -70.09 176.42 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.142 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 12.9 pt-20 -58.38 -37.89 76.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.369 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.12 -56.84 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.26 -42.23 85.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.713 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.413 HG21 ' N ' ' A' ' 10' ' ' ALA . 12.2 tt -70.43 -26.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.79 -44.12 63.32 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.498 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.13 -32.83 71.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.428 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -66.88 -49.76 64.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -44.87 90.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.244 0.545 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -65.48 -47.48 75.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.39 -42.15 63.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -57.21 -34.5 68.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.119 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mt -87.24 -38.3 16.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.949 0.404 . . . . 0.0 110.245 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -67.97 -65.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.39 132.35 48.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.808 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -38.11 80.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.22 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.89 -12.25 29.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.84 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.686 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -74.73 -5.16 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.421 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 2.44 44.73 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 p -149.47 132.62 16.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.577 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.21 127.05 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.5 t -100.62 167.59 10.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.963 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 p -54.4 -28.75 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -64.53 -50.47 67.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -77.15 -36.21 55.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.577 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.35 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.572 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.54 70.57 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.732 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -67.04 -53.28 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.4 p -72.45 -31.57 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.351 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -45.13 93.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.669 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -29.47 45.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.1 t -61.82 -35.11 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.05 -31.09 66.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.57 42.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -141.55 172.56 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.08 59.96 41.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.43 -170.23 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.591 2.194 . . . . 0.0 112.253 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -122.12 165.04 16.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.75 -31.15 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 0.0 110.141 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.67 60.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -45.25 88.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.7 mt -53.28 -50.64 64.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -64.98 -53.88 39.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.606 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.33 -51.14 69.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.303 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.563 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -59.28 -47.72 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.669 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -59.74 -44.32 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.89 -26.37 62.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.529 0.681 . . . . 0.0 109.978 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.65 -2.2 53.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.634 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.62 -33.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 112.043 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.07 148.27 45.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.267 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.36 -53.54 7.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.684 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.67 -8.66 58.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.326 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.3 48.69 78.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.967 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -96.81 -0.19 48.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.589 0.233 . . . . 0.0 111.535 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.3 15.08 22.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.895 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -149.92 139.88 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.559 0.218 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.576 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.94 147.44 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.08 0.467 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.15 178.33 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.786 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.45 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -60.28 -61.7 7.41 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.452 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -67.11 -31.51 36.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.219 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 mt-10 -64.7 -39.84 94.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' HB2' HG23 ' A' ' 63' ' ' ILE . 1.9 t80 -75.17 -45.03 43.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 110.29 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 0.2 OUTLIER -67.92 -52.6 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.279 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.6 m -51.6 -49.58 61.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.161 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpp -54.53 -49.5 70.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.0 2.04 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.569 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.57 -42.13 9.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.899 0.38 . . . . 0.0 110.999 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -53.69 -33.27 54.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.158 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.36 150.49 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 34.3 mtt 61.45 95.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.31 -30.86 7.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -153.34 126.35 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -177.55 159.13 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -141.52 163.62 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 152.22 32.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -26.77 19.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.157 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.66 -35.7 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.33 -30.97 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.66 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.34 -37.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.119 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -49.46 35.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.519 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.88 -46.01 91.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.359 178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.62 -48.64 69.13 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.839 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -50.86 -43.08 59.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.031 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -70.8 -31.59 68.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.701 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 m -75.54 -37.15 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 111.064 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.547 ' N ' HG23 ' A' ' 91' ' ' VAL . 3.5 m-85 -76.6 -62.93 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.871 0.367 . . . . 0.0 110.509 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -83.44 121.9 27.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.782 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -71.24 -52.63 17.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.45 -9.58 59.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.5 68.65 0.86 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.936 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -94.41 15.84 16.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.641 0.257 . . . . 0.0 111.272 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.5 69.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.633 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.5 m-85 -162.47 116.97 1.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -110.63 123.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.979 0.419 . . . . 0.0 111.278 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -103.96 157.05 17.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.248 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -41.45 22.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.79 6.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -55.1 -39.31 69.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.677 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.18 -50.9 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.922 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 5.6 tpt85 -56.55 -42.81 79.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.286 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -36.42 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.404 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.1 t -72.73 -54.79 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.3 mmt -49.11 -54.02 18.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.645 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.9 t -66.9 -25.18 66.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.96 -29.97 68.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.63 -28.78 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.68 43.75 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -149.88 112.95 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -90.85 102.23 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.47 164.48 12.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.794 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.6 m -98.32 158.81 15.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -59.32 -42.17 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.31 -54.87 22.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.756 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.406 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 2.2 m -63.52 -40.66 89.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.65 -41.03 96.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.433 . . . . 0.0 110.275 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.411 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 26.8 mt-10 -72.63 -30.12 64.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.373 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -33.94 69.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.611 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.55 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.3 mm -80.29 -55.08 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.657 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.411 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 8.8 ptm180 -54.59 -31.82 57.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 110.405 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.35 -21.93 55.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.796 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.72 -15.41 15.76 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.606 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -82.44 90.52 6.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.712 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.74 -30.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.429 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.0 -9.48 57.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.164 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.88 23.83 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 114.81 0.684 . . . . 0.0 114.81 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 32.2 p30 -113.79 -5.55 13.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.227 0.513 . . . . 0.0 111.303 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 6.66 44.39 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.213 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.447 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.58 -174.82 4.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.834 0.35 . . . . 0.0 110.661 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.528 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.4 t -127.33 120.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -98.71 -169.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.608 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.463 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.5 t80 -60.12 -73.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.609 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.66 -43.59 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.286 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.712 ' HA ' HG12 ' A' ' 130' ' ' ILE . 3.2 mt-10 -56.26 -34.72 66.66 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -79.45 -48.7 13.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 111.22 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.66 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.9 m -58.71 -40.41 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.321 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.416 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 2.4 pp0? -71.19 -36.04 71.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.615 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.431 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.1 4.92 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.451 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 1.1 mtt -112.04 -31.62 6.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.028 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t -146.55 -50.01 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.464 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 143' ' ' GLN . . . -82.73 80.41 8.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.412 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.0 mttp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.035 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.714 0.292 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.575 2.184 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -98.92 -39.83 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -155.21 37.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.77 -135.43 4.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? -110.5 123.37 49.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.787 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.15 -68.23 1.76 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.58 -52.72 46.79 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.589 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.37 -62.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.509 0.195 . . . . 0.0 110.871 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.428 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.81 -35.2 43.38 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.39 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.2 OUTLIER -56.6 -53.27 59.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.589 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.69 -42.28 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.238 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.516 HG21 ' O ' ' B' ' 68' ' ' PHE . 97.1 t -50.43 -52.86 14.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.415 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.0 mpt_? -69.92 -45.57 67.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.543 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 40.7 mt -55.79 -52.61 63.38 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.656 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.5 p -61.84 -47.62 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.24 -28.89 59.38 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.205 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.486 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 79.8 t -76.78 -56.15 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.533 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.42 -43.75 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.533 ' N ' HD11 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.03 -34.64 70.28 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.22 0.533 . . . . 0.0 109.783 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.19 -37.25 82.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.293 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.523 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 2.7 t90 -95.25 -11.1 28.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.744 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' B' ' 78' ' ' ILE . . . -76.29 -36.21 58.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -149.28 -65.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.74 67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.058 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.23 -66.55 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.776 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' B' ' 86' ' ' PHE . 67.6 t80 -101.72 31.38 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.815 0.341 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -175.06 79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -177.02 -178.92 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.81 165.11 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.861 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -71.37 177.28 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.132 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 13.0 pt-20 -58.36 -38.98 78.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -71.9 -56.77 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.044 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -43.36 89.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.738 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.0 tt -69.04 -26.44 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.062 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.42 -43.37 61.97 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.22 -33.47 74.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.63 -49.74 65.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -44.85 92.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.264 0.554 . . . . 0.0 110.047 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -64.45 -48.5 75.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.576 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.433 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.39 -41.7 63.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.316 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -38.28 71.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.05 -15.67 61.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.62 -38.6 16.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.199 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.607 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.38 -65.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.44 132.64 49.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.707 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -37.14 75.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.3 -12.27 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.19 36.96 77.7 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.636 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 1.72 44.64 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.048 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.0 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.678 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.607 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.9 mt -108.18 121.53 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 t -97.88 167.5 10.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.0 p -54.34 -35.53 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -56.77 -50.43 72.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.158 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.83 -37.91 47.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 110.768 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.55 -43.31 71.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.909 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.36 -27.5 72.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.202 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -72.34 -49.75 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.32 -33.54 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.0 mtp -60.41 -45.71 92.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.958 0.409 . . . . 0.0 110.677 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -25.92 44.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -58.05 -37.11 73.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.51 -30.75 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.79 41.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -142.61 163.22 33.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.51 61.84 12.08 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.73 -170.93 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.567 2.178 . . . . 0.0 112.277 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -122.11 167.01 13.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.82 -31.98 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.67 59.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.341 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -43.33 94.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.208 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.3 mt -55.15 -50.67 68.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -52.31 58.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.432 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.67 -51.15 70.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.249 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.526 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.69 -47.76 83.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.754 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.512 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -60.98 -45.11 99.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.27 -26.48 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.599 0.714 . . . . 0.0 110.143 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.8 mt-10 -82.75 -2.06 53.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.496 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.61 -33.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 52.9 t0 -72.25 148.57 45.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.317 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.37 -53.57 6.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.15 -8.66 58.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.3 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.55 48.42 81.26 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.968 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -97.31 -0.88 45.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.543 0.211 . . . . 0.0 111.421 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.33 15.51 21.12 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.939 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.8 p -149.73 139.79 22.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.591 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.12 149.39 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.301 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.26 175.92 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.419 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -58.65 -61.64 7.28 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.157 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.2 Cg_endo -63.98 -33.83 61.48 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.374 2.049 . . . . 0.0 111.756 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -68.71 -36.46 78.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.391 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -75.33 -40.15 58.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.349 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 12' ' ' PHE . 4.6 tp -76.78 -53.08 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.586 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -51.46 -49.98 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.487 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 tpp -53.47 -48.05 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.9 mmt -88.64 10.44 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.52 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.21 -36.39 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -57.13 -40.12 76.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.44 149.71 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.8 mtm 60.81 91.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.6 -31.57 9.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.05 124.94 6.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -176.59 164.81 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.24 167.58 22.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -153.69 152.52 30.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.777 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -25.49 23.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -74.58 -38.13 62.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.23 -31.27 70.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.644 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.34 -39.38 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.291 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -70.93 -49.35 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.338 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -61.05 -46.19 91.68 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.61 -49.44 67.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.149 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.03 -38.55 52.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.917 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -76.65 -30.53 56.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.866 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.23 -36.94 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 110.898 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.5 m-85 -72.41 -62.91 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.5 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.62 119.35 24.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -62.34 -52.61 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.52 -9.65 59.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.461 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.63 0.47 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.08 14.44 17.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.663 0.268 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.76 66.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.4 m-85 -161.55 116.68 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.7 mt -113.92 124.66 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.47 . . . . 0.0 111.656 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.8 t -104.28 161.15 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.579 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.89 -43.94 29.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.268 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.07 -58.93 6.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.931 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.36 -37.61 67.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.671 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.508 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.36 -50.86 71.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.844 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.3 tpt85 -55.74 -43.61 76.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.117 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -58.1 -38.88 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.382 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 92' ' ' PHE . 39.1 t -68.25 -54.92 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.4 mmt -49.41 -54.06 19.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.869 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.5 t -67.7 -25.17 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.581 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -68.53 -30.36 69.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.26 -28.73 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.013 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.41 43.46 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.584 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -152.79 110.77 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -83.73 115.8 22.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -105.81 163.31 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 m -98.27 158.76 15.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.59 -40.81 93.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.92 -35.56 74.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.568 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.96 -54.88 23.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.709 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 m -63.38 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.71 -40.06 93.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.11 0.481 . . . . 0.0 110.171 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 14.2 mt-10 -72.9 -30.15 63.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.289 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 46.1 ttm -71.01 -35.79 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.879 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.2 mm -80.4 -54.91 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.579 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -53.44 -31.79 46.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.996 0.427 . . . . 0.0 110.46 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.96 -21.58 50.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.942 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.95 -8.56 17.55 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ILE . 35.9 t0 -88.54 110.27 20.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.645 . . . . 0.0 111.312 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.22 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.765 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.86 -9.09 44.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.562 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.9 57.94 9.18 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.4 p30 -114.23 -4.19 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.033 0.416 . . . . 0.0 111.505 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 7.59 42.45 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.13 -174.96 4.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 110.458 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.14 126.62 66.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.94 -167.54 1.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.592 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.1 t80 -58.52 -73.94 0.07 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.588 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.47 -45.74 47.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.617 . . . . 0.0 110.32 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.44 -36.4 68.95 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.62 -49.59 11.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.965 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -55.28 -40.53 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -34.28 70.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.713 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.02 8.9 13.82 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.649 0.261 . . . . 0.0 111.328 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.466 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.0 mtt -118.18 -38.9 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.767 0.317 . . . . 0.0 111.034 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -139.88 -51.66 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.45 58.41 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 111.248 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.907 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.734 0.302 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.19 172.14 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.312 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.48 -41.79 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -148.9 31.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -117.16 -135.17 5.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.9 mpp_? -115.46 122.97 47.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.321 . . . . 0.0 110.767 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.68 -68.39 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.49 -49.75 75.17 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.608 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.64 -66.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.477 0.179 . . . . 0.0 110.87 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.44 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -51.79 -38.96 57.74 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.329 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.418 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -54.58 -49.52 70.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.608 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.58 -41.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.18 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.488 HG21 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.46 -53.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.556 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -46.46 68.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.42 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 20.6 mt -55.72 -53.57 54.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.736 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.492 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.8 p -60.32 -47.2 93.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.434 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.422 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.33 -30.3 61.28 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.112 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 93.6 t -75.26 -55.39 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.606 0.241 . . . . 0.0 111.446 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.54 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.06 -43.98 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.54 ' N ' HD11 ' B' ' 78' ' ' ILE . 21.3 mmm180 -58.2 -35.3 71.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 109.728 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -61.14 -37.12 81.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.252 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.508 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.4 t90 -95.32 -10.09 31.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.854 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.411 ' HB2' ' O ' ' B' ' 78' ' ' ILE . . . -76.62 -36.1 57.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.297 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -148.54 -64.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.112 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.32 65.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.86 -70.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -106.22 32.0 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.832 0.348 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -157.31 66.15 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -176.93 169.63 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.69 165.25 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 110.839 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -70.09 177.33 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.96 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 23.1 pt-20 -59.8 -37.12 78.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.85 -56.94 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.116 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -41.48 83.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.423 . . . . 0.0 110.758 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.8 tt -71.93 -26.44 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.092 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.49 -43.4 62.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.478 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.35 -33.11 72.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.14 -49.67 66.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.436 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -45.0 90.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 110.168 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -64.88 -48.44 74.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.37 -41.64 63.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.447 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -33.98 65.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.022 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.7 mt -87.72 -39.08 15.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.927 0.394 . . . . 0.0 110.045 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -67.36 -65.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.374 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -66.43 132.47 48.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.874 0.368 . . . . 0.0 110.705 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -37.25 74.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.02 -12.16 29.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.39 36.93 79.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.632 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -74.89 -4.45 38.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.446 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.01 44.09 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.125 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -149.46 132.53 16.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.876 0.338 . . . . 0.0 110.899 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.589 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mp -106.22 127.27 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 t -101.97 167.7 9.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.8 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -54.26 -31.51 53.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -62.67 -50.43 71.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.338 . . . . 0.0 111.222 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -77.15 -35.8 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.855 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.589 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.34 -58.17 8.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.752 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.44 68.8 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.685 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.8 m -70.18 -54.21 13.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.49 -31.1 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.1 ttt -61.02 -44.78 96.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -25.68 44.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.941 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -56.75 -36.43 69.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.99 -31.47 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -142.61 160.88 39.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.4 62.22 22.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.88 -170.11 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -121.34 167.23 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.76 -32.14 71.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.132 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.6 60.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.384 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -43.3 94.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.1 mt -55.27 -50.75 68.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -64.72 -52.32 57.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.42 -51.12 70.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.263 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.539 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -58.88 -48.08 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.0 OUTLIER -60.73 -44.37 97.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.279 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -57.07 -26.45 60.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.556 0.693 . . . . 0.0 110.033 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.92 -2.06 53.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.71 -32.99 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -72.22 149.28 44.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.343 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.06 -53.55 6.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.49 -8.72 58.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.59 48.91 77.96 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.93 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -97.5 -0.77 45.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.627 0.251 . . . . 0.0 111.496 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.21 15.53 21.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.885 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 p -149.88 139.77 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.01 149.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.412 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.88 172.91 6.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -56.39 -61.58 6.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.1 Cg_endo -63.94 -33.04 64.91 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.046 . . . . 0.0 111.862 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -69.62 -35.73 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.8 t80 -75.28 -40.6 58.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.262 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 6.5 tp -76.78 -53.99 7.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.587 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 62.4 m -51.37 -45.2 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.526 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -52.62 60.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.9 mtt -80.02 -10.35 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.533 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.66 -33.33 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.899 0.38 . . . . 0.0 110.845 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -57.88 -43.81 86.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.963 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 150.98 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.0 92.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -106.72 -34.87 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.35 111.57 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -176.79 142.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.38 -178.31 4.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.2 m -162.15 161.92 28.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.63 -27.38 39.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.23 -42.46 75.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.973 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 mt-10 -59.25 -33.09 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.658 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.36 -37.99 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.244 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -49.41 41.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -62.04 -46.41 89.27 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.652 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.58 -48.09 69.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.781 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.537 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -50.85 -43.15 59.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -71.1 -32.17 68.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.72 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.3 m -75.0 -36.62 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.733 0.301 . . . . 0.0 111.002 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.546 ' N ' HG23 ' A' ' 91' ' ' VAL . 3.1 m-85 -74.65 -62.92 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.496 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -84.68 132.23 34.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -76.62 -52.59 9.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.54 -9.61 59.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.46 70.21 0.66 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.902 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -94.24 15.32 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.44 69.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.696 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.439 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -160.39 117.04 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.43 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -112.17 123.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.229 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.0 t -103.96 157.72 16.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.308 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.55 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.68 -41.52 22.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.12 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -58.77 6.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.78 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -55.13 -39.08 69.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.707 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.515 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.52 -50.9 72.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.92 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 5.6 tpt85 -56.43 -42.31 77.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.146 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -36.22 77.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.32 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 67.5 t -72.58 -54.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.762 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.1 mmt -49.54 -54.03 20.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.657 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 t -66.94 -25.46 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.65 -30.01 68.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.64 -28.77 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.24 43.89 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -149.59 114.88 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -91.6 101.5 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.83 163.56 13.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.821 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -59.38 -42.07 90.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.741 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -69.73 -35.85 75.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.15 -54.86 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.74 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.407 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 2.3 m -63.6 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -61.49 -41.42 97.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.082 0.467 . . . . 0.0 110.313 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 34.8 mt-10 -72.42 -30.15 64.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.266 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.72 -34.41 71.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.647 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.55 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.5 mm -80.27 -55.17 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.708 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm180 -54.38 -31.8 55.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 0.0 110.415 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -21.6 57.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.892 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -18.09 14.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.66 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.05 90.59 4.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.714 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.94 -30.91 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.6 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.28 -9.46 57.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.123 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 51.06 53.61 26.4 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.7 p30 -113.78 -5.55 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.232 0.516 . . . . 0.0 111.271 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 6.24 44.64 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.219 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.06 -174.88 4.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.669 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.519 HG11 ' CD1' ' A' ' 141' ' ' PHE . 47.0 t -127.36 120.59 55.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.006 0.432 . . . . 0.0 111.274 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -98.98 -169.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.64 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.465 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.2 t80 -59.53 -73.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.618 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.62 -43.62 46.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.405 0.622 . . . . 0.0 110.331 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.714 ' HA ' HG12 ' A' ' 130' ' ' ILE . 3.1 mt-10 -56.3 -34.75 66.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.928 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.537 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.1 OUTLIER -79.41 -48.45 13.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.293 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.658 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.9 m -58.8 -39.79 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.07 71.45 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.567 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.418 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -84.77 11.1 9.75 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.449 ' HE2' ' CZ ' ' A' ' 141' ' ' PHE . 1.4 mtt -119.26 -39.56 2.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 t -148.88 -48.54 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.479 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.59 75.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 111.406 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.74 0.305 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 164.11 35.96 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.61 2.206 . . . . 0.0 112.317 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.57 -65.16 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.48 -96.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.539 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -139.3 116.82 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.992 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.97 -71.46 1.14 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.586 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.29 -48.2 65.1 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.59 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.719 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.151 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.416 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.07 -31.7 61.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.009 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -53.78 -53.56 50.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.409 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.719 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.34 -38.55 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.56 HG21 ' O ' ' B' ' 68' ' ' PHE . 99.4 t -50.61 -43.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.742 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.413 ' CD ' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -74.94 -46.45 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.051 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 32.8 mt -55.85 -48.28 75.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.373 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.1 p -65.07 -48.24 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.431 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.58 -29.63 57.95 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.017 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 81.7 t -76.88 -54.62 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.611 0.243 . . . . 0.0 111.58 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.528 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -61.58 -43.91 97.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.528 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.0 mmm180 -57.68 -34.44 69.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.239 0.542 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -37.42 83.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.22 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.515 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.0 t90 -95.3 -10.48 30.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.852 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.31 -36.09 58.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -148.79 -64.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.059 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.31 65.61 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.93 -66.72 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -107.23 34.46 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -172.55 96.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -177.26 179.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.87 165.32 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.901 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 t -69.11 177.33 2.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 14.6 pt-20 -60.48 -36.34 78.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.298 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -56.95 4.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -41.95 83.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.006 0.432 . . . . 0.0 110.686 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.426 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.2 tt -71.36 -26.43 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.48 -43.53 62.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.14 -32.82 70.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.53 -49.68 68.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.456 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -45.1 89.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.193 0.521 . . . . 0.0 110.23 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -64.67 -48.81 73.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.691 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.36 -41.39 63.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.471 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.81 -38.68 70.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.999 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -74.14 -13.92 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.933 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.69 -39.74 14.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.954 0.406 . . . . 0.0 110.151 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.565 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.45 -65.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.356 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -65.39 132.88 50.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -37.62 74.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.24 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.73 -12.26 29.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.7 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.64 37.21 82.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -74.77 -4.55 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.244 -0.183 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.15 44.16 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.116 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -149.55 132.5 16.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.796 0.331 . . . . 0.0 110.892 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.586 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mt -105.52 127.38 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.8 t -102.41 168.44 9.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 p -54.78 -34.35 62.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.48 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -50.49 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.248 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -77.19 -36.53 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.158 0.504 . . . . 0.0 110.826 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.586 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.3 -58.21 8.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.823 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.52 64.23 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.793 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -72.04 -59.97 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 111.172 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG12 ' CE1' ' A' ' 19' ' ' PHE . 9.1 p -64.33 -30.56 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.174 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 mtp -60.93 -56.43 21.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -25.63 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.95 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.4 t -57.77 -38.66 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.64 -35.65 68.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.72 43.59 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -142.6 163.39 32.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.43 61.17 27.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.09 -170.17 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 0.0 112.248 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -122.11 166.92 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.83 -31.96 71.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.084 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.45 59.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.436 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.53 -41.9 92.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.364 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -56.63 -50.95 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -57.04 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.407 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -51.06 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.147 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.537 ' O ' HG21 ' A' ' 55' ' ' VAL . 19.2 mtt -58.19 -46.84 85.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.502 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -60.83 -45.82 97.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.029 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -56.13 -26.53 50.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.538 0.685 . . . . 0.0 110.042 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.7 mt-10 -82.15 -2.19 51.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.467 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.25 -32.99 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.0 111.934 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -72.74 152.72 41.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.33 -53.55 6.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.54 -8.74 57.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.316 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.91 49.93 70.31 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.853 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -97.27 -0.2 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.424 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.5 24.11 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.825 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 p -149.84 139.86 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.591 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.58 149.43 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -103.87 174.78 5.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -58.06 -61.58 7.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -63.62 -33.82 65.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.055 . . . . 0.0 111.81 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -69.15 -36.25 77.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.427 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.29 -40.11 58.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.28 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 6.4 tp -76.7 -54.7 6.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.536 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -51.61 -43.3 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.427 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -55.18 33.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mtt -79.08 -11.47 59.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.516 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.08 -38.25 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -63.13 -30.46 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.61 29.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.4 mtm 60.23 78.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -85.42 -61.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.868 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.5 118.08 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -171.68 161.32 6.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.64 179.05 7.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -160.85 154.44 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -25.52 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -39.7 65.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -59.95 -30.45 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.644 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.89 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -49.4 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.438 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -61.59 -45.81 92.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.66 -48.89 69.01 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.966 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.04 -38.74 53.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -30.5 57.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.28 -36.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.536 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.8 m-85 -73.29 -62.91 1.31 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.511 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -83.48 119.1 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -62.7 -52.62 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.8 -9.72 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.471 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.0 71.3 0.49 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.956 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -93.48 14.55 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.279 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.18 67.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.582 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.421 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 6.6 m-85 -162.37 116.89 1.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.21 124.38 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.069 0.461 . . . . 0.0 111.539 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -104.11 160.08 15.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.954 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.579 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -43.54 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.83 6.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.019 0.437 . . . . 0.0 110.84 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -55.22 -37.34 67.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.671 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.507 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.68 -50.78 72.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.795 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.4 tpt85 -55.91 -43.14 77.04 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -37.41 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.382 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.65 -53.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.626 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -51.16 -54.16 27.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.0 t -66.52 -25.72 66.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.24 -30.04 69.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.79 -28.79 14.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -152.37 109.77 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -86.48 110.55 19.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -101.36 166.06 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.0 m -98.35 158.73 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.41 -40.51 91.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.39 -55.04 23.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.725 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.3 m -62.94 -40.97 90.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.35 -39.03 89.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.1 0.476 . . . . 0.0 110.123 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.7 mt-10 -73.4 -30.15 63.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.3 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.16 -35.5 71.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.579 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.3 mm -80.31 -55.02 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.589 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.8 ptm180 -53.95 -31.81 51.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.016 0.436 . . . . 0.0 110.386 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -79.24 -21.31 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.15 -2.33 21.03 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.331 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.9 t0 -94.61 104.92 16.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.448 0.642 . . . . 0.0 111.135 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.723 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -79.04 -31.66 14.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.092 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.1 -9.1 46.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.55 -178.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.15 57.1 10.57 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -114.23 -4.04 13.11 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.104 0.452 . . . . 0.0 111.408 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 6.93 43.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.087 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.421 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.08 -174.74 4.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.613 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.3 t -128.13 125.28 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.931 0.396 . . . . 0.0 111.212 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.7 t30 -105.12 -165.24 1.11 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.939 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.571 ' O ' HG13 ' A' ' 142' ' ' VAL . 13.2 t80 -60.09 -73.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.612 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.6 -44.82 47.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 110.383 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.723 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -57.39 -35.66 70.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.558 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.44 -48.61 13.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.994 0.426 . . . . 0.0 111.673 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.644 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -56.81 -38.65 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.55 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -71.2 -35.1 71.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.627 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.403 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -86.36 12.85 9.2 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.726 0.298 . . . . 0.0 111.088 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.453 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 1.9 mtt -120.73 -38.47 2.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t -149.19 -48.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.313 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.07 75.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.435 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.968 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.704 0.288 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.17 156.78 7.22 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.597 2.198 . . . . 0.0 112.309 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -75.05 -40.99 59.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.76 83.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.02 -91.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.418 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.3 OUTLIER -142.2 105.42 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.58 -75.0 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.692 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.99 -50.48 27.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.668 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.725 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.28 -65.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.089 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.437 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -54.1 -31.81 53.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.44 . . . . 0.0 110.045 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.6 tpp85 -54.07 -53.61 50.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.725 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.73 -37.78 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.552 HG21 ' O ' ' B' ' 68' ' ' PHE . 97.3 t -50.47 -45.65 25.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.366 0.603 . . . . 0.0 110.861 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.437 ' HD3' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -75.48 -45.66 37.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.338 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 29.8 mt -55.97 -46.68 78.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.979 0.419 . . . . 0.0 110.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 14.9 p -66.42 -48.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.499 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.434 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.93 -28.11 57.5 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.866 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 95.9 t -76.83 -54.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 111.419 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.525 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -62.86 -44.08 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.525 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.5 mmm180 -58.0 -35.36 71.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -37.3 79.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.507 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.7 t90 -95.38 -11.25 28.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.831 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.04 -35.57 59.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.342 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -148.45 -65.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.15 65.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -75.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.68 31.69 5.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.918 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.772 0.32 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -146.39 36.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -158.14 179.55 9.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.22 165.29 21.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 t -70.07 177.31 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 pt-20 -59.93 -36.85 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.339 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.33 -56.93 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' O ' ' HG2' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -57.59 -41.16 80.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.0 tt -72.33 -26.24 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.32 -44.41 61.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.788 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 6.4 pm0 -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.18 -49.71 68.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.417 -179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.38 -45.12 88.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.85 -48.65 73.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.715 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.32 -41.42 62.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.486 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -38.84 69.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.066 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -74.2 -13.76 60.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.75 -39.8 14.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.151 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.574 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.95 -65.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.392 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.34 133.16 50.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.844 0.354 . . . . 0.0 110.736 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.61 -37.62 73.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.19 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.64 -12.25 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 37.28 82.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.688 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -74.69 -4.58 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.211 -0.195 . . . . 0.0 111.389 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.25 0.21 44.09 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.064 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.9 p -149.58 132.53 16.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.851 0.358 . . . . 0.0 110.879 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.589 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.0 mt -105.33 126.92 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.9 t -101.87 168.1 9.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.819 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 p -53.81 -37.21 63.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.644 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -57.27 -50.52 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.357 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.96 -36.67 56.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.144 0.497 . . . . 0.0 110.821 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.589 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.42 -58.11 8.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.859 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.49 64.94 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.833 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -71.32 -60.29 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.336 . . . . 0.0 111.197 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG12 ' CE1' ' A' ' 19' ' ' PHE . 9.1 p -63.84 -30.49 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.9 mtp -61.03 -56.49 20.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.59 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -25.6 66.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.8 t -57.22 -38.13 73.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.57 -30.94 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.0 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.583 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -142.63 166.16 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -120.34 60.99 7.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.43 165.22 33.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.6 p -102.87 165.33 11.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.05 -29.35 67.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 110.274 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.68 -50.86 53.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.638 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.45 -37.6 87.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 19.6 mt -57.51 -51.01 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.771 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -56.67 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.33 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -54.91 -51.02 67.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.163 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.538 ' O ' HG21 ' A' ' 55' ' ' VAL . 59.4 mtt -59.03 -46.11 89.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.499 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -60.64 -45.91 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.953 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -55.96 -26.56 48.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.555 0.693 . . . . 0.0 110.03 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.4 mt-10 -82.12 -2.11 50.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.442 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.36 -32.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.905 0.383 . . . . 0.0 111.99 -177.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -72.82 152.17 41.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.87 -53.54 6.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.679 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.52 -8.6 57.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.282 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.84 49.79 71.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.891 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -97.34 -0.25 46.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.536 0.208 . . . . 0.0 111.444 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 14.64 23.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.881 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -149.85 139.86 22.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.582 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.82 149.32 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.458 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.68 174.83 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.952 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.418 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -57.94 -61.67 6.95 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -63.74 -33.75 64.57 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.392 2.062 . . . . 0.0 111.812 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -69.06 -36.12 77.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.438 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.27 -40.04 59.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.295 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 7.0 tp -76.72 -54.93 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.451 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -51.67 -43.42 62.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.519 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -55.5 30.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.6 mtt -76.95 -17.3 58.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.442 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.58 -31.63 32.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -30.61 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.28 146.17 27.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 mtt 61.67 85.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -64.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -129.57 124.51 34.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -176.56 172.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 -178.48 6.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.52 157.68 30.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -54.61 -26.43 32.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -59.54 -31.82 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.654 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.28 -39.28 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.257 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -49.35 46.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.468 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.39 -46.21 91.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.375 0.607 . . . . 0.0 109.404 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.53 -48.95 68.6 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.07 -38.58 52.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.023 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -76.56 -30.53 57.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.82 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.35 -36.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.675 0.274 . . . . 0.0 111.077 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.526 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.5 m-85 -73.34 -62.97 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.352 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -83.94 129.98 34.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -74.83 -52.66 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.63 -9.7 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.01 70.54 0.6 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.94 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -93.87 15.04 17.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.698 0.285 . . . . 0.0 111.217 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.58 69.02 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.2 m-85 -163.96 116.92 1.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.688 0.28 . . . . 0.0 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.1 mt -111.27 126.55 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.547 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.7 t -104.0 156.85 17.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.521 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -40.91 21.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.92 6.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 110.801 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -55.87 -38.13 69.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.706 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.03 -50.74 72.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.845 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 106' ' ' ARG . 8.0 tpt85 -55.72 -44.17 77.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -37.21 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.289 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.41 -53.58 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.732 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.2 mmt -50.3 -54.08 23.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -67.14 -25.62 66.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -29.95 68.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.73 -28.78 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.87 43.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -149.36 116.78 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -91.75 102.84 15.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.983 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -95.54 163.71 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.4 m -98.29 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.01 -42.2 93.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.643 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.89 -54.87 20.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.4 m -64.52 -40.0 87.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.973 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -62.26 -41.41 98.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 110.34 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.7 mt-10 -72.91 -30.17 63.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.415 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -71.45 -34.3 70.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.534 HD13 HD13 ' A' ' 105' ' ' LEU . 3.2 mm -80.33 -54.91 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.631 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.0 ptm180 -54.51 -31.77 56.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.043 0.449 . . . . 0.0 110.347 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.99 -21.7 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.36 16.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.435 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 125' ' ' ILE . 49.0 t0 -84.07 89.65 7.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.449 0.642 . . . . 0.0 110.965 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.723 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -62.93 -30.8 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.419 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.595 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.8 -9.48 56.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.163 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.47 54.17 21.72 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.802 0.681 . . . . 0.0 114.802 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.9 p30 -113.84 -5.38 13.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.207 0.504 . . . . 0.0 111.307 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 6.29 44.54 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.316 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.83 -174.82 4.45 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.937 0.368 . . . . 0.0 110.712 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.5 t -128.6 123.56 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.424 . . . . 0.0 111.304 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.74 -164.95 1.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.535 ' O ' HG13 ' A' ' 142' ' ' VAL . 16.2 t80 -62.44 -74.06 0.1 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.582 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.68 -44.29 47.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 110.329 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.723 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.48 -35.82 68.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.006 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.558 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.17 -48.34 14.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 111.418 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.654 ' N ' HG23 ' A' ' 85' ' ' ILE . 2.8 m -59.15 -40.31 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.437 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.401 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -71.41 -34.78 70.65 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.577 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.402 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -83.54 9.53 11.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.642 0.258 . . . . 0.0 111.279 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.423 ' HE3' ' CZ ' ' A' ' 141' ' ' PHE . 3.5 mtt -119.21 -39.16 2.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 t -148.55 -48.56 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.477 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' A' ' 143' ' ' GLN . . . -71.56 74.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.374 . . . . 0.0 111.403 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.2 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.943 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.18 -176.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.591 2.194 . . . . 0.0 112.32 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -97.08 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.74 31.41 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.89 -108.41 3.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.71 117.39 21.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.403 . . . . 0.0 110.989 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.81 -71.88 1.0 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.532 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.7 -49.47 46.94 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.459 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.712 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.0 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.008 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.42 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.7 OUTLIER -56.32 -31.76 64.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -52.84 -53.55 47.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.331 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.712 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.93 -38.7 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.57 HG21 ' O ' ' B' ' 68' ' ' PHE . 98.9 t -50.62 -44.5 25.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.316 0.579 . . . . 0.0 110.884 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.42 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 5.1 mpt_? -75.24 -47.22 29.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 33.1 mt -55.81 -46.57 78.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.47 ' O ' ' HG2' ' B' ' 79' ' ' ARG . 15.0 p -65.99 -48.72 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.38 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.75 -28.26 56.74 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.855 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 99.3 t -76.85 -55.44 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.65 0.262 . . . . 0.0 111.525 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.523 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -61.91 -44.13 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.523 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.7 mmm180 -57.77 -35.14 70.37 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 109.767 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -36.48 81.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.517 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.8 t90 -95.31 -10.46 30.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.785 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.89 -36.22 56.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -148.23 -64.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.028 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 65.68 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -74.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.76 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -106.69 34.16 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.872 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.826 0.346 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -132.0 80.86 1.94 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -176.22 172.78 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -120.3 165.4 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 8' ' ' GLN . 12.6 t -71.81 177.36 4.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.783 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 16.1 pt-20 -58.32 -41.99 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.292 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -67.14 -57.11 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.7 tp60 -58.08 -44.68 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.018 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.445 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.6 tt -69.64 -26.59 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.251 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.6 -43.47 62.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.453 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 2.2 pt-20 -70.75 -32.81 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -66.07 -49.61 67.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -45.05 90.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.211 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -64.75 -48.82 73.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.7 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.43 -41.12 62.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.399 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.499 ' CE1' HD13 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -54.08 -40.51 67.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.401 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 t -75.9 -12.94 60.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.13 -40.34 14.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 110.425 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.614 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -63.76 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.222 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.69 133.21 48.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.837 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.9 88.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.347 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.03 -12.13 36.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.28 38.7 91.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.69 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -73.51 -5.78 42.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.435 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 6.32 42.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.215 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -149.83 133.19 16.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.801 0.3 . . . . 0.0 110.74 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.614 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.3 mp -100.04 117.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -89.18 159.07 17.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.725 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.8 p -54.72 -34.33 62.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.36 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.51 -50.42 73.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 111.046 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -76.08 -36.69 58.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.485 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.85 -44.43 73.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.095 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.85 -27.4 73.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.321 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -71.92 -49.68 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.6 p -72.43 -35.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.3 ttm -58.94 -45.22 90.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -25.59 44.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.8 t -54.64 -38.09 66.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.77 -30.15 65.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.986 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.87 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -142.62 161.75 37.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -119.66 62.79 7.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.69 176.38 8.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.207 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -109.38 168.27 9.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -32.15 71.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.079 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.92 60.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.451 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.313 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.3 mt -59.64 -50.66 72.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.05 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.78 -43.44 93.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.335 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.31 -51.14 62.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.155 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.564 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -57.64 -52.13 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -58.11 -42.28 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.015 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.66 -26.43 65.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.513 0.673 . . . . 0.0 109.893 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.9 mt-10 -83.03 -2.21 54.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.719 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.35 -33.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.078 -177.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -70.54 154.62 41.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.399 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.498 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.62 -53.75 5.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.802 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -89.14 -8.65 53.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.362 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.2 51.67 57.79 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.848 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -100.06 1.13 42.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.574 0.226 . . . . 0.0 111.437 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.35 15.02 22.56 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.975 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.6 p -150.02 139.72 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.604 0.24 . . . . 0.0 110.88 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.599 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.0 mm -96.54 149.89 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.94 172.85 6.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.2 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -53.55 -61.55 4.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.775 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 -26.3 37.42 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.673 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.498 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 15.6 mm-40 -73.71 -38.31 64.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.41 -43.32 50.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 110.37 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 7.4 tp -70.08 -57.06 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.811 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.3 m -51.44 -53.78 33.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.649 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.9 tpp -54.26 -38.72 66.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.8 mmt -97.91 14.53 26.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.244 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . . . -111.22 -36.01 5.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -55.49 -55.76 28.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.265 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.31 42.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.22 29.46 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.107 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -82.71 -67.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.64 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 49.9 -175.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -132.41 38.72 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.59 -175.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -168.4 -166.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -67.36 -29.15 68.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.51 -26.57 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB3' HG23 ' B' ' 77' ' ' VAL . 8.1 mt-10 -71.1 -45.16 64.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.472 . . . . 0.0 110.83 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -74.6 -33.64 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.593 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -49.37 52.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.368 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -62.41 -48.47 79.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.415 0.626 . . . . 0.0 109.698 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.603 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.38 -44.54 68.72 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.953 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.47 57.8 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.928 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.56 -32.35 58.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.946 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -73.9 -36.65 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 120.678 0.275 . . . . 0.0 111.024 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.537 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -72.94 -63.08 1.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.487 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -86.23 128.57 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -52.72 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.982 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.86 -9.75 58.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.413 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.52 69.74 0.63 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.006 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -93.27 14.35 18.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.284 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 17.3 66.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.604 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.457 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.8 m-85 -158.45 116.94 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.694 0.283 . . . . 0.0 110.972 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.458 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.7 mt -110.36 124.31 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -103.91 157.45 17.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.255 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.559 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.77 -42.94 26.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.25 -58.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -55.0 -39.23 68.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.629 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.518 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.17 -50.71 72.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.888 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -41.01 80.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.674 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.63 -39.03 86.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.513 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.7 t -72.8 -55.34 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.5 mmt -49.03 -54.0 17.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 t -65.41 -25.42 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -30.98 68.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.53 -28.83 15.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.35 42.31 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -144.0 109.77 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -88.88 94.14 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.63 147.11 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -85.88 163.37 18.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.72 -31.03 69.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.64 -45.97 73.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -61.12 -54.87 39.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.41 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 1.6 m -62.23 -38.3 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -61.44 -43.59 98.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 110.345 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 71.5 mt-10 -71.77 -30.2 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.401 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtp -70.71 -34.0 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.731 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.559 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.1 mm -80.31 -54.94 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.585 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 11.5 ptt180 -55.14 -31.93 61.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 110.385 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.3 -21.12 54.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.56 -14.51 15.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.433 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.95 93.73 7.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.395 0.616 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.69 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.1 pt -66.43 -31.27 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.51 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.618 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -85.83 -9.37 57.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.123 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.22 54.76 18.31 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.697 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.7 p30 -113.98 -5.18 13.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.194 0.497 . . . . 0.0 111.367 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.069 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.91 -174.77 4.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.35 . . . . 0.0 110.547 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG11 ' CD1' ' A' ' 141' ' ' PHE . 42.3 t -127.3 120.51 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 7.3 t30 -96.07 -167.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.354 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.444 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.2 t80 -62.36 -73.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.596 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.74 -43.3 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.303 0.573 . . . . 0.0 110.414 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.69 ' HA ' HG12 ' A' ' 130' ' ' ILE . 3.2 mt-10 -55.9 -33.49 64.68 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.489 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -79.07 -45.45 20.07 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.104 0.478 . . . . 0.0 111.683 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.701 ' HA ' HG23 ' A' ' 85' ' ' ILE . 2.8 m -65.52 -38.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.158 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.496 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -70.43 -36.07 73.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.57 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.548 ' HE1' ' CG ' ' B' ' 81' ' ' TRP . 6.1 ptm -73.35 -21.42 60.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.429 ' CE ' ' HE2' ' A' ' 144' ' ' MET . 1.2 tpp -88.63 -49.48 6.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.288 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t 179.56 -38.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.498 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . 54.35 51.59 14.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.907 0.385 . . . . 0.0 111.291 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.885 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.742 0.306 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 146.97 62.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.562 2.175 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -60.25 -31.58 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -176.38 76.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 -132.82 2.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -110.74 132.73 53.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.88 3.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.673 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.86 -49.34 55.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.391 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.599 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -53.22 -68.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.533 0.206 . . . . 0.0 110.887 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.8 -38.84 57.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.771 0.319 . . . . 0.0 110.455 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -56.06 -48.28 76.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.56 -40.28 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.262 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.537 ' O ' HG12 ' B' ' 75' ' ' VAL . 94.1 t -53.44 -53.46 24.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.816 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.443 ' HD2' ' N ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -71.95 -49.08 40.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.354 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.96 -44.15 78.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 72' ' ' VAL . 12.5 p -67.6 -48.97 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.752 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.44 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -55.96 -31.26 58.4 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.079 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 84' ' ' GLU . 49.1 t -76.79 -54.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.696 0.284 . . . . 0.0 111.731 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.535 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -62.1 -43.85 98.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.535 ' N ' HD11 ' B' ' 78' ' ' ILE . 22.5 mmm180 -57.96 -31.71 67.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.997 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -37.12 85.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.548 ' CG ' ' HE1' ' A' ' 144' ' ' MET . 2.5 t90 -95.26 -15.72 22.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.888 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.2 -31.6 16.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.31 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.29 -74.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.339 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -69.17 67.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 -69.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.19 -33.87 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.915 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.94 43.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -158.81 178.7 9.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.85 165.34 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 8' ' ' GLN . 14.2 t -72.43 177.4 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.2 pt-20 -57.36 -42.85 82.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.418 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -56.97 8.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.185 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 5' ' ' THR . 2.2 tp60 -59.16 -49.05 79.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 10' ' ' ALA . 10.9 tt -63.61 -26.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.3 -44.17 61.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.742 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 1.8 pt-20 -69.11 -33.18 73.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.32 -49.74 65.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.354 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.21 -44.75 88.3 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.194 0.521 . . . . 0.0 110.122 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -64.9 -49.17 71.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.703 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.33 -41.13 62.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -58.5 -33.94 70.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.085 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.63 -16.3 57.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.937 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.07 -36.92 17.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.583 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -69.26 -65.94 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 12.5 t70 -66.16 130.31 42.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.905 0.383 . . . . 0.0 110.832 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -39.28 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.34 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.19 -12.15 30.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.54 36.12 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.677 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -74.94 -4.99 41.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.487 0.184 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.16 4.27 44.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.177 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.9 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.583 HG12 ' HB3' ' A' ' 19' ' ' PHE . 2.4 mt -109.87 127.93 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.185 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 t -101.68 169.85 8.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.97 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 p -55.88 -32.31 63.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.409 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -62.05 -50.49 71.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -75.64 -36.94 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.128 0.489 . . . . 0.0 110.834 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.577 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.32 -58.21 8.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.558 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.58 -27.43 69.71 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.776 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.4 m -67.45 -55.17 14.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.8 p -69.69 -31.59 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -46.8 88.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -26.18 44.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.959 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -58.15 -35.96 72.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.05 -31.25 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.71 42.63 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -142.65 165.04 28.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -121.28 63.25 12.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 -173.63 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.311 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 p -122.08 161.8 22.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 46' ' ' ALA . 24.7 pm0 -69.02 -28.49 66.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.18 0.514 . . . . 0.0 110.3 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' N ' ' HG2' ' A' ' 45' ' ' GLU . . . -50.81 -49.53 58.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.595 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.4 -37.35 86.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.0 mt -57.39 -50.79 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -67.35 -48.0 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.272 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.99 -51.02 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.571 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -60.96 -49.73 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.398 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.523 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.1 mt -57.81 -41.86 80.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.5 -26.42 65.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.677 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.1 mt-10 -83.67 -2.19 55.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.89 -33.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 112.084 -177.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 56.1 t0 -71.04 144.97 50.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.77 -53.55 7.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.595 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.54 -8.69 59.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.217 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.79 47.71 83.74 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.963 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -97.69 -1.3 43.87 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.663 0.231 . . . . 0.0 111.495 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.3 15.86 20.13 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.889 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.4 p -149.97 139.83 21.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.577 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.21 149.34 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.23 170.09 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -53.74 -61.66 4.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -63.55 -37.62 46.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.37 2.047 . . . . 0.0 111.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -60.97 -48.42 81.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.503 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.39 -58.01 9.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.177 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 7.5 tp -58.28 -55.54 33.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.822 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -51.58 -44.36 62.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.737 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -53.28 58.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.03 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.9 mmt -78.31 -16.82 57.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.76 -30.38 28.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.165 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.37 -27.14 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.79 160.3 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.9 ttp 64.11 78.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -114.11 124.55 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.648 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.2 t0 64.61 106.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 t -166.26 166.64 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -155.8 163.96 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.44 157.06 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -26.19 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.11 -33.4 59.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.722 HG23 ' HA ' ' A' ' 142' ' ' VAL . 0.1 OUTLIER -74.55 -34.3 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.318 0.58 . . . . 0.0 109.737 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -49.35 53.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.471 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -63.11 -46.9 85.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.402 0.62 . . . . 0.0 109.653 179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.605 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.59 -45.6 70.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.95 -38.67 51.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -33.11 58.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -73.66 -36.46 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.673 0.273 . . . . 0.0 111.02 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.507 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.9 m-85 -70.67 -62.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.549 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.42 117.18 24.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -52.67 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.78 -9.66 59.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.1 70.47 0.56 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -93.54 14.88 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.646 0.26 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.45 68.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.635 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.416 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.4 m-85 -160.12 116.92 2.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.928 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.9 mt -114.59 125.49 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -104.09 159.58 15.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.981 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.571 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.7 -40.25 19.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.396 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 -59.0 6.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.984 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.56 -37.29 70.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.721 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.04 -50.7 72.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.903 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -56.2 -42.8 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -39.19 83.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.642 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.17 -55.35 13.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.118 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.4 mmt -49.04 -54.01 17.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.1 t -66.05 -25.42 67.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.09 -30.28 66.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -28.81 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.9 43.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.58 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -150.65 110.54 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.792 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -86.41 101.9 13.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.57 148.79 26.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.6 t -86.75 163.33 17.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -58.09 -34.17 69.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.61 -39.33 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -64.36 -54.87 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.5 m -62.76 -40.59 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.66 -41.49 97.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.0 110.129 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 40.9 mt-10 -72.66 -30.12 64.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.315 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.2 mtp -70.3 -36.25 74.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.857 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.571 HG13 ' N ' ' A' ' 102' ' ' ALA . 3.7 mm -80.21 -54.86 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.639 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.36 -31.76 55.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.005 0.431 . . . . 0.0 110.417 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.18 -21.77 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.888 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.21 -9.13 17.9 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.248 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.4 t0 -86.97 100.67 12.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.504 0.668 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.706 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -75.11 -31.64 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.042 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.99 -9.1 47.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.521 -178.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.47 57.07 11.02 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 p30 -114.31 -3.62 13.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.217 0.508 . . . . 0.0 111.47 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.49 5.85 45.06 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.078 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.416 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.11 -174.72 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.469 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.55 HG11 ' CD1' ' A' ' 141' ' ' PHE . 46.3 t -128.87 124.83 61.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 111.281 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.571 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.6 t30 -102.95 -162.6 0.93 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.564 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.7 t80 -60.75 -74.45 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.525 ' O ' HG21 ' A' ' 142' ' ' VAL . 2.1 tt0 -49.95 -45.45 51.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.302 0.572 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.706 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.6 mt-10 -56.21 -34.52 66.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.728 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.571 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -78.99 -47.06 16.98 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.111 0.481 . . . . 0.0 111.608 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.722 ' HA ' HG23 ' A' ' 85' ' ' ILE . 2.5 m -64.48 -34.46 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.812 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.424 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 1.6 pp0? -71.05 -36.29 72.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.39 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.464 ' HE1' ' CE ' ' A' ' 145' ' ' MET . 1.3 ptt? -83.83 -4.09 58.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.779 0.323 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.464 ' CE ' ' HE1' ' A' ' 144' ' ' MET . 0.1 OUTLIER -96.68 -35.75 10.92 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.671 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.6 t -159.94 -46.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.378 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' A' ' 143' ' ' GLN . . . -68.19 74.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 111.376 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.939 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -174.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -48.4 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -150.08 40.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.86 -135.89 4.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.423 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.7 mpp_? -112.75 125.26 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.76 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 -67.51 2.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.822 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.9 -50.22 69.9 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.592 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.0 -65.28 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.539 0.209 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.407 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.8 -36.68 48.67 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.465 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -56.14 -48.76 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.592 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -63.42 -41.79 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.096 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.494 HG21 ' O ' ' B' ' 68' ' ' PHE . 96.3 t -50.63 -51.14 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.57 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.407 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 2.9 mpt_? -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.507 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 14.2 mt -56.05 -47.47 77.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.71 0.29 . . . . 0.0 110.795 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.474 HG12 ' O ' ' B' ' 72' ' ' VAL . 14.5 p -67.0 -47.51 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.422 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.62 -30.18 62.02 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.075 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.453 ' CG1' ' HE1' ' A' ' 145' ' ' MET . 96.6 t -76.79 -55.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.726 0.298 . . . . 0.0 111.096 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.548 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.6 pp -60.22 -43.73 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.581 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.548 ' HG2' HD11 ' B' ' 78' ' ' ILE . 9.3 mmp_? -55.65 -35.54 66.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.267 0.556 . . . . 0.0 109.562 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.76 -37.49 73.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.512 ' CZ3' ' HE1' ' A' ' 141' ' ' PHE . 3.5 t90 -95.05 -17.23 22.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.318 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.09 -37.54 46.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.891 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -69.42 0.83 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.646 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 9.9 mmpt? -43.52 -79.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.493 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.3 OUTLIER 69.74 -63.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.337 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.28 35.99 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.172 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -104.81 42.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -165.69 174.77 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.4 165.39 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.8 t -69.08 176.88 2.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 28.2 mt-10 -60.0 -39.04 84.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -69.79 -56.84 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -44.84 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.972 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.8 tt -69.02 -26.82 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.201 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.438 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.86 -43.04 63.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.412 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 3.8 mp0 -71.62 -25.78 62.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.364 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.73 -49.36 25.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.332 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -44.56 85.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.148 0.499 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.99 -49.11 68.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.886 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.508 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.26 -41.28 62.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.74 -34.42 67.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.027 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t -78.59 -14.59 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.99 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.74 -39.26 15.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.147 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.699 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.17 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.234 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 6.5 t0 -63.65 126.28 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.681 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -37.83 83.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -92.09 -12.4 33.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.23 32.75 63.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.811 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -77.07 1.91 16.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.845 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.78 43.37 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.084 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -149.6 132.59 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.52 0.66 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.699 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.1 mp -105.11 118.61 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 31' ' ' GLU . 8.4 t -98.01 163.99 12.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.763 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.0 p -51.73 -25.47 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.891 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -68.11 -50.69 53.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 28' ' ' THR . 9.1 mm-40 -77.86 -37.82 47.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.248 0.547 . . . . 0.0 110.574 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.16 -44.78 71.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.619 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.0 -28.89 73.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.235 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.0 m -73.53 -59.92 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -62.7 -30.5 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.475 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.2 ttt -61.51 -56.45 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.86 -25.46 66.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -51.4 -47.03 63.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.71 -60.19 2.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.913 0.387 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.19 40.16 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -142.71 170.32 15.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -138.16 59.54 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -178.93 3.93 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.622 2.214 . . . . 0.0 112.495 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 174.24 6.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.45 -29.93 68.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.89 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.12 59.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.147 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.31 -40.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.089 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -59.41 -50.53 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.933 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -62.98 -39.17 93.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.173 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -68.98 -51.19 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.334 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -54.0 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 110.454 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.488 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -59.0 -45.71 92.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.367 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -51.98 -25.96 9.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.271 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.3 mt-10 -82.37 -3.24 55.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.691 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.35 -32.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.248 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -63.57 135.69 57.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.105 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.89 -53.32 21.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.557 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -95.81 3.71 53.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.665 -179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.09 59.13 9.87 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.88 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.21 -2.5 17.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.852 0.326 . . . . 0.0 111.354 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.25 17.37 15.93 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.863 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.2 p -149.51 139.94 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.072 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.503 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.4 mm -104.55 149.44 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.785 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -107.6 171.06 7.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.479 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.9 m-85 -55.77 -61.5 6.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.524 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.6 Cg_endo -66.98 -20.25 51.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.436 2.091 . . . . 0.0 112.567 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.466 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.24 -37.64 37.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.085 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' HA ' HG11 ' A' ' 55' ' ' VAL . 4.7 t80 -75.24 -33.95 61.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.294 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 11.3 tp -76.75 -58.29 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -51.89 -45.67 64.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.142 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.76 -31.26 69.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 41.6 mtt -108.21 15.34 24.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.221 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.81 -40.47 4.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.91 0.386 . . . . 0.0 111.024 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -59.9 -45.12 93.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 59.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 111.0 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -163.5 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -122.39 69.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.91 -175.2 2.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p -89.51 -167.54 1.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.81 -179.41 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -148.3 156.28 42.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.788 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -50.89 -25.98 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.373 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -73.65 -39.46 64.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.179 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.643 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.21 -38.93 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.32 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -71.13 -49.36 45.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -61.2 -46.29 91.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.39 0.614 . . . . 0.0 109.447 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.608 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.6 -49.22 68.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.059 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.08 -38.52 52.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.996 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -30.38 56.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.49 -37.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.55 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.5 m-85 -71.42 -62.92 1.23 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.865 0.364 . . . . 0.0 110.483 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.93 120.61 25.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -63.35 -52.56 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.193 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.43 -9.61 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.492 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.96 71.76 0.47 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.884 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.47 14.53 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.679 0.276 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 13.65 61.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.685 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -158.33 116.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -113.45 124.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.137 0.494 . . . . 0.0 111.714 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -104.27 161.69 13.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.131 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -45.56 30.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.528 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.84 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 111.093 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.92 -36.47 65.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.543 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.52 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.61 -50.0 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.675 178.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.65 -41.44 77.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.412 178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -60.57 -39.16 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 92' ' ' PHE . 49.1 t -67.61 -54.45 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.0 mmt -50.33 -54.11 23.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.21 -24.51 65.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.559 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -69.89 -30.9 68.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.5 -28.7 16.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.15 42.78 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.548 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -153.23 110.28 3.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -91.85 101.44 14.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.59 166.98 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.8 t -94.63 163.79 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -59.75 -41.83 91.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.35 -35.87 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -65.48 -54.9 21.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.409 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.8 m -64.89 -40.02 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.182 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -62.6 -41.95 99.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.3 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.411 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.5 mt-10 -72.63 -30.14 64.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.3 mtt -70.91 -35.98 72.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.567 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.2 mm -80.25 -54.87 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.699 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.411 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.3 ptm180 -54.05 -31.85 52.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 110.377 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.25 -20.96 46.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.798 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.45 -2.6 20.32 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.471 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.9 t0 -94.87 109.71 21.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.394 0.616 . . . . 0.0 111.204 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.693 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.27 7.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.803 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.91 -9.12 44.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.579 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.56 58.23 8.49 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 114.515 0.566 . . . . 0.0 114.515 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -114.24 -4.58 13.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.072 0.436 . . . . 0.0 111.513 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 7.78 42.32 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.955 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.15 -174.88 4.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.673 0.273 . . . . 0.0 110.38 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.584 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.7 t -128.18 126.5 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 111.245 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -104.83 -167.81 1.4 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.95 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.585 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.2 t80 -58.79 -73.92 0.07 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.584 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.57 -45.41 47.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 110.286 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.693 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.54 -36.39 69.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.102 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.584 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.66 -49.56 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.94 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.643 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -55.44 -40.63 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.715 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -34.35 70.6 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.652 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.401 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.22 8.36 13.54 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.68 0.276 . . . . 0.0 111.246 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.463 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.4 mtt -118.39 -38.28 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -148.96 -52.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.429 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.58 74.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 111.394 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.938 179.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.67 0.271 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.04 155.22 65.52 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.519 2.146 . . . . 0.0 112.29 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -61.95 -53.55 54.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.8 mmt-85 -144.82 81.92 1.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.37 -123.61 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -115.41 103.72 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 0.0 110.85 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.26 -75.69 0.23 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.905 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.02 -46.76 61.04 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -58.75 -70.85 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.279 . . . . 0.0 110.54 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.459 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.11 -34.92 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.842 0.354 . . . . 0.0 110.38 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 4.9 tpp85 -57.1 -53.26 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.634 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.63 -41.65 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.125 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.507 ' O ' HG12 ' B' ' 75' ' ' VAL . 84.2 t -52.2 -53.02 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.283 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.416 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.6 mpt_? -71.91 -44.08 64.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 19.7 mt -56.2 -49.24 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 15' ' ' ALA . 13.9 p -65.48 -47.66 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.435 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -59.69 -29.39 67.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.302 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 70.1 t -76.82 -53.46 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.666 0.27 . . . . 0.0 111.246 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -65.65 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.364 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.617 ' HG2' HD11 ' B' ' 78' ' ' ILE . 3.7 mmp_? -57.03 -34.45 68.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 109.67 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -37.29 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.52 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.0 t90 -95.47 -10.19 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.03 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -94.67 -28.09 15.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.277 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.98 -70.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.501 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 0.0 OUTLIER -51.35 -77.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.4 OUTLIER 70.45 -62.6 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.249 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -103.67 32.89 3.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.413 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 1.2 ptm180 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.109 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -102.12 75.66 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.8 171.83 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -128.85 165.33 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -68.47 169.25 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.682 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 23.6 mt-10 -55.05 -36.51 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -71.3 -56.85 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.371 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -45.05 89.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 0.0 110.845 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.433 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.9 tt -67.54 -26.78 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.79 -43.47 63.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.475 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 3.5 mp0 -70.96 -25.8 62.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.86 -49.41 25.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.263 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -57.43 -44.66 84.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.19 0.519 . . . . 0.0 110.207 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.34 -49.85 67.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.28 -40.76 62.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.45 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -55.97 -38.94 71.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.207 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.76 -38.37 15.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.97 0.414 . . . . 0.0 110.388 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.669 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.375 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.6 t70 -63.62 129.02 38.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.862 0.363 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -37.3 83.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.215 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.61 -12.31 29.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.7 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.3 37.86 83.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.649 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -77.02 -1.85 30.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.478 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 -2.57 43.67 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.217 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.6 p -149.47 132.5 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.986 0.393 . . . . 0.0 110.959 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.3 mp -104.0 120.07 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.028 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.83 164.59 12.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.818 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.0 p -52.53 -25.47 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -70.49 -50.53 36.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.356 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.77 -36.58 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.467 . . . . 0.0 111.005 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.576 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -54.25 -47.92 71.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.028 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.53 -27.39 73.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.391 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.9 m -72.05 -51.65 20.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.331 . . . . 0.0 111.218 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG12 ' CD1' ' A' ' 19' ' ' PHE . 6.9 p -70.61 -34.96 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.414 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -52.59 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.71 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.56 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -52.13 -37.72 55.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.71 -65.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.56 38.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.7 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -140.5 58.34 10.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 -170.25 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.412 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p -102.15 171.83 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.74 -29.44 67.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.44 56.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.41 -39.75 94.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.727 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.7 mt -58.33 -50.59 73.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.77 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -64.63 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.09 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.088 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -53.77 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.493 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -59.06 -44.73 92.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.415 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -52.71 -25.92 12.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.1 mt-10 -82.66 -3.32 56.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.697 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.44 -32.31 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -63.46 135.31 56.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.067 0.461 . . . . 0.0 111.027 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.476 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.43 -53.5 28.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.07 4.23 52.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.744 -179.184 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 59.43 9.39 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.895 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.97 -2.49 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.75 0.275 . . . . 0.0 111.342 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 17.47 15.75 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.893 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.8 p -149.46 139.92 22.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.09 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.478 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.3 mm -105.34 149.61 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.52 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.56 171.03 7.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.634 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.8 m-85 -55.03 -61.52 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.659 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.4 Cg_endo -67.22 -20.28 49.61 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.434 2.089 . . . . 0.0 112.595 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -79.26 -38.08 36.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.168 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.5 t80 -75.1 -33.49 61.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 11.6 tp -75.25 -58.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.295 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.2 m -51.56 -43.19 62.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -54.15 -43.33 70.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.438 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 36.9 mtt -101.12 14.5 31.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -107.15 -36.7 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -73.62 -26.9 61.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 62.72 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 tpp -180.0 61.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.024 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -136.15 78.79 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -132.73 -169.14 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p -91.3 -168.25 2.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -87.45 -178.49 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 85' ' ' ILE . 68.2 m -142.66 159.56 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -50.83 -25.97 5.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.387 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -75.85 -37.45 58.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -65.4 -26.76 68.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.639 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.03 -38.47 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.099 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -71.37 -49.36 42.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -61.31 -46.29 90.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.378 0.609 . . . . 0.0 109.442 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.46 -49.02 68.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.022 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.558 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.12 -39.01 55.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.919 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -30.37 58.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.43 -37.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.55 ' N ' HG23 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -70.66 -63.02 1.18 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.895 0.379 . . . . 0.0 110.44 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.55 120.79 26.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -52.58 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.279 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.49 -9.62 59.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.52 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.82 71.76 0.46 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.814 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -92.98 14.5 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.61 16.59 65.75 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.619 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -161.15 116.76 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.303 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -113.05 124.28 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.119 0.485 . . . . 0.0 111.65 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -104.26 161.52 13.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.206 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.577 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.86 -44.42 29.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.472 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 -58.84 6.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 111.015 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.02 -38.0 67.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.653 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.514 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -60.61 -49.48 77.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.744 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -41.72 80.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.334 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.64 -39.36 84.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 92' ' ' PHE . 70.2 t -67.15 -55.71 16.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.668 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 mmt -49.07 -54.09 17.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.2 t -67.62 -24.22 65.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -70.57 -30.2 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.07 -28.85 14.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.95 43.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.9 109.77 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -89.59 101.97 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -99.27 165.31 11.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.0 t -98.28 171.15 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.828 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.0 -32.46 72.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 -47.63 69.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.54 -54.85 40.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.434 HG21 ' HB1' ' A' ' 102' ' ' ALA . 5.3 m -57.7 -50.93 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.391 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -57.47 -39.27 76.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 52.1 mt-10 -72.59 -30.19 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.47 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.03 -36.07 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.82 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.577 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.5 mm -80.18 -54.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.646 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.9 ptm180 -53.56 -31.74 47.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 0.0 110.516 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.32 -21.1 53.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.44 -10.86 15.64 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.624 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -84.87 110.02 18.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.385 0.612 . . . . 0.0 111.302 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.688 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.89 -31.15 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.791 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.32 -9.07 43.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.6 -178.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.06 57.78 9.55 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -114.27 -4.19 13.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.039 0.42 . . . . 0.0 111.515 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 7.51 42.59 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.006 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.88 4.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.419 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.0 t -129.02 126.25 64.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 111.157 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.48 -167.53 1.34 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.062 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.609 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.3 t80 -57.71 -73.89 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.555 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.56 -45.86 48.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.564 . . . . 0.0 110.306 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.688 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.57 -36.48 69.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.157 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.74 -49.73 11.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.881 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.0 m -56.32 -36.82 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.492 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -71.08 -34.79 71.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.63 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.7 OUTLIER -87.1 15.36 6.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.701 0.286 . . . . 0.0 110.858 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.458 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 5.1 mtt -126.99 -49.5 1.46 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.328 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 t -163.2 30.77 0.09 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.492 ' HB1' ' HA ' ' A' ' 143' ' ' GLN . . . -144.87 55.29 1.24 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.006 0.431 . . . . 0.0 111.264 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.994 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -175.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.456 2.104 . . . . 0.0 112.346 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -103.16 -45.86 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -154.0 31.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.25 -134.92 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -101.51 103.41 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 110.794 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.28 -75.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.64 -45.56 59.92 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.697 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.22 -71.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.699 -0.251 . . . . 0.0 110.586 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.26 -32.96 39.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.611 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 5.1 tpp85 -58.47 -53.2 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.602 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.55 -41.14 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.969 178.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.534 ' O ' HG12 ' B' ' 75' ' ' VAL . 86.4 t -53.14 -50.95 43.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.333 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -47.06 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.431 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.426 ' CD1' HG11 ' A' ' 91' ' ' VAL . 33.2 mt -56.67 -45.78 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.808 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.534 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.8 p -66.77 -47.43 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.804 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -60.18 -29.83 69.37 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.294 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 79.7 t -76.8 -51.88 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 111.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.621 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -67.42 -42.03 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.537 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.621 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.0 mmp_? -57.37 -34.66 69.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.216 0.532 . . . . 0.0 109.763 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -36.81 84.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.514 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.0 t90 -95.38 -14.19 24.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -91.24 -26.92 18.77 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 -71.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -50.85 -74.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' B' ' 85' ' ' ASN . 0.5 OUTLIER 70.63 -61.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.43 29.57 3.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.112 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.068 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.843 0.354 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -167.22 35.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.95 176.56 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.53 165.32 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 8' ' ' GLN . 7.3 t -70.4 171.79 9.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.893 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.6 mm-40 -55.62 -38.03 68.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.242 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -56.75 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.108 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER -58.11 -45.2 87.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.851 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.429 HG21 ' N ' ' A' ' 10' ' ' ALA . 5.9 tt -67.14 -26.78 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.98 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.71 -42.87 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.5 -25.78 63.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.91 -49.41 24.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.499 0.19 . . . . 0.0 111.262 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.65 -44.64 85.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.196 0.522 . . . . 0.0 110.117 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.12 -49.08 71.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.746 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.29 -41.33 62.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.44 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.49 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -56.33 -36.7 69.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.129 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.87 -13.85 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.7 -38.29 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.273 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.659 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.25 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.319 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.3 t70 -64.97 127.41 31.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.639 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -38.52 91.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.65 -12.26 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 0.0 110.794 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.08 37.94 82.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.641 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -76.88 -1.91 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 -2.33 43.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.173 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 p -149.42 132.42 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.924 0.362 . . . . 0.0 110.745 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.659 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.4 mp -104.44 120.33 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.095 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 t -97.78 159.83 14.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.496 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.2 p -50.17 -25.45 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -67.69 -50.95 55.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -78.13 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.428 0.633 . . . . 0.0 110.424 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.21 -50.51 66.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.41 -27.47 71.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.31 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.0 m -69.5 -54.95 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.51 -31.72 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.416 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -47.08 87.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 110.413 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -25.57 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 t -55.13 -50.57 68.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -47.78 -58.03 4.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.576 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -142.56 179.73 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.825 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -159.73 58.74 1.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.34 -170.57 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.676 2.25 . . . . 0.0 112.509 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 p -93.9 171.11 9.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.403 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 11.7 pt-20 -68.48 -31.44 70.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.291 0.567 . . . . 0.0 110.05 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.03 65.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.892 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.16 -53.33 56.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.657 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -53.15 -50.79 63.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.351 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -57.98 -40.35 80.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.63 -45.12 94.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.264 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.416 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -60.8 -52.66 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.203 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.48 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.6 OUTLIER -57.15 -45.86 84.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.126 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.06 -25.99 9.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.351 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -83.02 -3.29 57.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.012 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.37 -32.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 46.2 t0 -63.0 136.93 58.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.037 0.446 . . . . 0.0 111.155 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.47 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.35 -53.74 26.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.481 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -96.95 4.16 51.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.701 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.68 59.66 8.92 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.735 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.37 -1.17 17.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.726 0.263 . . . . 0.0 111.409 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.24 17.37 15.98 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.877 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.5 p -149.53 139.96 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.186 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.6 mm -104.47 149.78 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.459 . . . . 0.0 111.705 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.44 168.76 9.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.63 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.49 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.2 m-85 -52.53 -61.21 4.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -68.16 -19.81 44.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.11 . . . . 0.0 112.669 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.9 mm-40 -79.27 -37.47 37.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.106 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.7 t80 -75.23 -32.46 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.01 0.433 . . . . 0.0 110.311 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 11.1 tp -76.19 -58.07 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m -51.61 -43.1 62.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.4 tmm? -54.14 -44.72 71.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.946 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 33.8 mtt -100.66 15.35 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.537 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 69' ' ' LEU . . . -109.99 -31.68 7.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.877 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -61.93 -39.32 91.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.245 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 46.6 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 111.317 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtt -149.04 73.61 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.983 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.53 40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.08 -169.44 1.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.0 p -99.68 -165.82 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -90.9 -175.21 4.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.462 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -143.99 161.72 38.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -50.7 -25.42 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.525 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.7 -46.18 47.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -57.43 -26.71 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.209 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.631 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -73.65 -38.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.188 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -49.49 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.544 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -61.18 -46.12 91.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.404 0.621 . . . . 0.0 109.442 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.614 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.6 -49.3 68.11 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.984 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.05 -38.19 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.968 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -30.49 57.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.831 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.78 -36.77 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.659 0.266 . . . . 0.0 111.006 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.525 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.8 m-85 -72.23 -62.93 1.26 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.492 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.82 114.07 20.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.827 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -60.96 -50.08 74.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.06 -9.66 59.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.74 72.37 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.839 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -94.33 13.76 22.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.69 0.281 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.48 69.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 4.5 m-85 -166.19 116.77 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 6.2 mt -112.24 124.34 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 0.0 111.863 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -104.43 161.96 13.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.085 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.565 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.8 -44.79 28.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.475 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.79 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.031 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -54.88 -36.29 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.6 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.93 -50.7 71.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.713 178.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.77 -41.47 74.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.385 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -61.05 -39.32 89.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.281 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.97 -53.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.5 -54.04 25.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.28 -25.03 65.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.18 -32.05 72.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.44 -28.78 16.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.36 42.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -140.31 109.81 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -85.28 80.61 9.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.26 161.54 17.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.3 t -96.76 162.86 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -30.3 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.2 -42.31 88.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -63.21 -51.78 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 5.1 m -61.56 -41.5 90.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.225 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.23 -43.28 99.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.3 mt-10 -72.4 -30.13 64.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.44 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 4.9 ttm -70.73 -35.4 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.565 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.3 mm -80.3 -54.94 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.556 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.8 ptm180 -54.02 -31.72 52.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.365 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.3 -21.01 50.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.904 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 -7.65 16.42 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.1 t0 -88.68 109.89 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.383 0.611 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.695 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.6 pt -84.88 -31.1 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.77 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.39 -9.08 43.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.612 -178.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.68 58.11 8.76 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -114.3 -4.41 13.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 117.036 0.418 . . . . 0.0 111.428 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.59 42.65 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.011 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.1 -174.88 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.417 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.8 t -127.84 127.28 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 111.224 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -106.17 -168.27 1.41 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.1 t80 -57.98 -73.95 0.07 Allowed 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -49.57 -45.6 47.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 0.0 110.262 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.695 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.7 mt-10 -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.109 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.588 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.6 -49.62 11.9 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.02 0.438 . . . . 0.0 111.797 -178.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.631 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.1 m -56.47 -36.55 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.615 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.412 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -70.96 -33.96 70.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.8 OUTLIER -88.58 16.58 6.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.804 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.449 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 5.0 mtt -128.36 -51.38 1.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.215 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 27.88 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.749 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 143' ' ' GLN . . . -144.05 54.46 1.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.357 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.968 179.864 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.39 173.65 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.542 2.161 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -95.03 -47.52 6.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -151.28 31.08 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -134.83 6.63 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -103.77 103.82 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.17 -75.77 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.859 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.16 -46.11 56.82 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.238 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.698 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -59.83 -71.55 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.667 0.27 . . . . 0.0 110.589 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.409 ' NE2' ' CD ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.96 -33.38 37.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.473 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.401 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.0 tpp180 -57.27 -51.92 67.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -60.88 -42.62 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.806 178.415 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.479 HG21 ' O ' ' B' ' 68' ' ' PHE . 97.7 t -50.62 -47.68 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.428 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.409 ' CD ' ' NE2' ' B' ' 69' ' ' GLN . 0.0 OUTLIER -72.13 -48.24 45.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.438 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.416 ' CD1' HG11 ' A' ' 91' ' ' VAL . 37.4 mt -56.12 -46.45 79.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 15.0 p -66.05 -48.84 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.01 -29.61 59.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.099 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 88.1 t -76.71 -56.5 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.686 0.279 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.529 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -61.49 -43.83 97.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.529 ' N ' HD11 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.0 -33.58 69.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 109.864 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.32 -36.42 83.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.517 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.6 t90 -95.37 -15.98 22.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.39 -25.06 20.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.72 -71.41 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -68.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 111.194 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.47 -61.76 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.08 29.65 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.148 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.813 0.34 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -102.13 74.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.79 170.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.31 165.3 17.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.7 t -69.31 177.35 2.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 35.9 mt-10 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.92 -56.99 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.263 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.86 -44.72 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.446 HG21 ' N ' ' A' ' 10' ' ' ALA . 6.1 tt -69.29 -26.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.033 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.78 -42.94 62.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 15.2 mp0 -71.75 -27.04 62.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.196 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.38 -49.56 40.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.279 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.08 -44.81 83.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.167 0.508 . . . . 0.0 110.228 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.532 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 39.9 mm-40 -65.15 -50.67 65.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -51.33 -40.36 58.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.844 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.09 -45.66 79.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.475 -179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 m -70.77 -14.86 62.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.428 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 mt -87.83 -37.4 16.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 0.0 110.619 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.578 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.0 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.053 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -64.9 132.5 49.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.869 0.366 . . . . 0.0 110.553 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -38.84 81.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.319 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.8 -12.3 31.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.802 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.57 84.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.633 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -74.25 -4.56 36.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.181 -0.207 . . . . 0.0 111.437 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 0.27 43.99 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.061 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -149.58 132.5 16.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 110.733 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.579 ' CG2' HD12 ' A' ' 32' ' ' LEU . 2.1 mt -105.07 127.42 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.5 t -102.02 168.77 9.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -53.55 -40.37 65.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.772 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -55.68 -50.45 70.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.57 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -76.25 -36.37 58.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.926 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.579 HD12 ' CG2' ' A' ' 27' ' ' ILE . 0.1 OUTLIER -54.22 -58.4 7.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.573 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -31.99 78.79 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.42 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -61.47 -57.79 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.972 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 36' ' ' MET . 7.1 p -67.78 -30.48 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.319 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.4 ' N ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -61.31 -51.99 66.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 110.44 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.66 61.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.786 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -60.87 -45.18 95.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.2 mt -49.35 -60.69 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.073 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.25 41.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.546 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -142.6 171.99 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.848 0.356 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.71 59.33 19.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.5 -170.36 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.551 2.167 . . . . 0.0 112.357 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.3 p -115.88 170.15 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.7 -30.56 69.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 0.0 110.098 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.65 -44.35 57.43 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.035 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -42.33 99.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.043 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -59.35 -50.56 73.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.042 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.07 -48.16 81.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.465 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.35 -51.04 65.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.515 ' O ' HG21 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.25 -50.75 70.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.499 HG23 ' C ' ' A' ' 61' ' ' GLY . 1.2 mt -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -55.74 -26.45 45.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.515 0.674 . . . . 0.0 110.236 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 51' ' ' MET . 4.0 mt-10 -83.46 -2.03 54.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.535 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -126.8 -33.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 0.0 112.121 -177.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 53.6 t0 -69.97 139.59 52.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -71.98 -53.57 12.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.478 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -93.39 -3.16 53.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.621 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.9 55.86 27.4 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.911 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.63 15.6 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.857 0.328 . . . . 0.0 111.11 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 83.41 16.95 67.58 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.908 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 p -149.9 139.8 21.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.718 0.294 . . . . 0.0 110.804 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.538 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.7 mm -97.59 149.47 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 111.414 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.67 -178.92 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 8.6 m-85 -62.82 -61.67 7.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.395 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 25.6 Cg_endo -62.19 -34.4 78.83 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.416 2.077 . . . . 0.0 111.942 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -67.78 -47.42 69.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.457 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -61.66 -44.58 96.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.327 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 9.8 tp -72.66 -58.11 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.9 m -51.71 -45.59 63.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.4 mmt -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.7 mmt -108.47 14.97 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.17 -44.48 3.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -57.08 -45.86 82.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.023 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 68.65 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.26 35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -105.91 43.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.47 -175.7 3.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 p -96.29 -167.31 1.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.973 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.4 -177.37 6.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.911 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -147.59 159.23 43.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.77 -26.57 5.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.338 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.47 -41.27 61.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.69 -26.78 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.639 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.1 mm -74.11 -37.63 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.921 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -71.71 -49.41 39.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.24 -46.43 90.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 109.395 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.619 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.4 -49.17 67.83 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.97 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.27 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.946 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -30.61 62.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.852 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.52 -37.08 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.98 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.558 ' N ' HG23 ' A' ' 91' ' ' VAL . 2.0 m-85 -71.84 -62.86 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.883 0.373 . . . . 0.0 110.484 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.9 t0 -82.79 115.14 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -59.04 -52.58 65.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.1 -9.58 59.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.42 0.49 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.831 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -93.46 14.43 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.675 0.274 . . . . 0.0 111.203 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.5 16.83 65.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.588 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.3 m-85 -162.38 116.75 1.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.717 0.294 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 93' ' ' ASP . 5.0 mt -113.31 124.84 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.147 0.498 . . . . 0.0 111.751 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.0 t -104.28 161.53 13.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.171 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.58 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.84 -44.87 29.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.434 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.85 -58.82 6.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -55.0 -36.75 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.62 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.519 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.7 -49.91 74.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.723 178.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -41.79 76.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.38 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.71 -38.68 85.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.235 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.55 -54.29 24.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.752 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.92 -53.97 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.695 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.08 -24.65 65.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.53 -31.05 69.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.59 -28.73 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.02 43.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.564 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -147.55 109.82 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -88.2 100.52 13.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.18 163.21 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 t -98.25 171.67 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.08 -32.75 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.58 -47.91 68.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.35 -54.84 40.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.416 HG21 ' HB1' ' A' ' 102' ' ' ALA . 5.4 m -57.55 -51.02 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -57.54 -38.84 75.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.982 0.42 . . . . 0.0 110.566 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.407 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 32.6 mt-10 -72.86 -30.09 63.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.476 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.0 -36.33 72.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.845 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.58 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.7 mm -80.32 -54.9 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.692 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.407 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.1 ptm180 -53.75 -31.83 49.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.76 -20.93 48.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.957 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -7.27 16.86 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.476 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.3 t0 -89.05 110.05 20.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.359 0.6 . . . . 0.0 111.272 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.689 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.94 -31.12 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.819 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.37 -9.14 42.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.605 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.94 57.85 9.34 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.566 0.587 . . . . 0.0 114.566 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -114.3 -4.45 13.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.992 0.396 . . . . 0.0 111.437 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.75 42.06 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.12 -174.92 4.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.475 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.583 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.88 126.56 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.571 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.98 -167.57 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.605 ' O ' HG13 ' A' ' 142' ' ' VAL . 54.1 t80 -57.67 -73.89 0.06 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.584 ' O ' HG21 ' A' ' 142' ' ' VAL . 1.7 tt0 -49.5 -45.99 47.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.689 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.6 -36.27 69.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.069 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.52 -49.68 11.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.639 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -55.88 -37.08 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.685 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.412 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -70.98 -34.32 71.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.657 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -88.12 15.89 6.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.883 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.454 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.7 mtt -126.85 -51.13 1.46 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 t -158.38 28.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.705 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 143' ' ' GLN . . . -144.29 54.56 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.656 0.265 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -51.07 98.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.553 2.168 . . . . 0.0 112.401 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -59.94 -31.22 69.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.68 30.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.09 -135.28 4.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.478 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.95 128.3 46.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.059 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.12 -66.01 3.0 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.793 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.13 -50.66 26.94 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.588 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.44 -63.5 1.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.476 0.179 . . . . 0.0 110.891 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.441 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.68 -36.42 46.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.46 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.9 tpt180 -56.16 -53.2 59.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.588 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.46 -42.48 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.276 178.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.529 ' O ' HG12 ' B' ' 75' ' ' VAL . 94.0 t -50.83 -53.44 13.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.441 ' HD3' ' NE2' ' B' ' 69' ' ' GLN . 0.4 OUTLIER -73.32 -44.27 59.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.662 -178.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 19.4 mt -55.91 -48.46 75.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.168 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.529 HG12 ' O ' ' B' ' 72' ' ' VAL . 14.6 p -63.97 -47.97 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.271 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.03 -28.53 58.36 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 87.8 t -76.77 -56.18 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.452 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.527 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.97 -43.5 96.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.527 ' N ' HD11 ' B' ' 78' ' ' ILE . 24.8 mmm180 -58.04 -34.16 69.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.232 0.539 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -36.82 84.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.426 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.519 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.5 t90 -95.43 -15.33 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.988 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.49 -26.47 19.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.429 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.48 -71.77 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -51.06 -74.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.315 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.411 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.5 OUTLIER 70.98 -61.63 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.247 179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.53 29.66 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.137 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.85 48.02 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -160.29 171.96 18.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -118.37 165.47 13.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 t -68.55 177.06 2.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.834 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 36.7 mt-10 -61.01 -37.75 83.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.39 -56.74 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -57.86 -44.1 86.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.913 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.4 tt -68.9 -26.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.96 -43.12 63.39 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.7 OUTLIER -71.28 -25.75 62.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -74.11 -49.39 24.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.565 0.221 . . . . 0.0 111.226 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -44.49 85.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.225 0.536 . . . . 0.0 110.175 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.76 -49.13 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.3 -41.01 62.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.492 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.25 -38.81 69.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.174 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 t -76.8 -14.23 59.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.75 -37.9 16.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.833 0.349 . . . . 0.0 110.455 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.643 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.75 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.262 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.0 t70 -64.57 127.01 29.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.637 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -38.66 91.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.35 -12.31 32.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 110.781 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.04 37.64 80.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -76.49 -2.17 30.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 -1.82 43.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.2 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -149.45 132.49 16.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.643 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.6 mt -104.53 120.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.93 161.99 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.568 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -52.26 -25.57 9.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.809 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -67.27 -50.83 58.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.016 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.95 -36.77 48.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.331 0.586 . . . . 0.0 110.572 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD12 HG22 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -54.2 -41.55 68.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.683 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.58 -27.46 69.38 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.195 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -69.07 -51.39 39.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.697 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.6 p -74.45 -33.16 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.7 ttt -57.74 -44.16 85.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.384 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -25.54 44.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 t -56.53 -44.88 81.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 mt -46.04 -30.12 1.73 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.59 35.18 0.32 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.751 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -142.82 173.6 11.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 28.3 m120 -140.93 63.65 19.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 2.7 Cg_exo -75.85 -171.63 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 112.185 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -100.07 170.94 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.55 -31.36 70.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.22 -44.04 64.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -53.23 57.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.685 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.27 -50.72 64.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.365 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -60.23 -39.15 85.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.529 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.42 -44.65 90.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -52.94 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.217 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.502 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -57.96 -46.25 87.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.299 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -51.58 -26.03 7.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.372 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.415 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.4 mt-10 -83.64 -3.32 57.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.36 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -62.9 134.44 56.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.083 0.468 . . . . 0.0 111.101 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -65.5 -53.32 44.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.717 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -97.45 4.37 50.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.817 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.52 60.11 8.7 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.928 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -110.37 -2.57 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.768 0.284 . . . . 0.0 111.38 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.23 17.38 15.95 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.6 p -149.53 139.94 22.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 111.224 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.46 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.3 mm -105.45 149.6 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.234 0.54 . . . . 0.0 111.802 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.98 172.05 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.487 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.467 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.8 m-85 -56.1 -61.49 6.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 41.9 Cg_endo -67.42 -20.34 48.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.469 2.112 . . . . 0.0 112.864 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.23 -37.97 36.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.489 ' HA ' HG11 ' A' ' 55' ' ' VAL . 3.7 t80 -75.24 -34.59 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.0 tp -74.97 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.093 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.0 -46.44 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 mmt -61.66 -30.8 70.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.697 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 6.8 mmt -105.13 13.91 29.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.287 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . . . -114.46 -36.67 4.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -56.48 21.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 43.98 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.4 mmt -150.21 66.85 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -133.08 39.06 3.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.5 -168.49 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.006 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.53 -174.88 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.26 179.34 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.47 155.87 40.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.8 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -25.31 8.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.322 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.11 -35.79 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.223 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -66.78 -26.64 67.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.215 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.633 HG23 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.25 -37.82 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.0 110.155 179.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.71 -49.4 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.585 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.4 -44.45 96.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.352 0.596 . . . . 0.0 109.42 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.77 -50.06 66.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.819 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.92 -37.75 45.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.868 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -30.57 57.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.714 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.5 m -76.63 -36.76 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.665 0.269 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.544 ' N ' HG23 ' A' ' 91' ' ' VAL . 2.1 m-85 -73.56 -62.82 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.545 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.4 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.5 t0 -81.9 116.63 21.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -63.24 -52.43 62.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -77.68 -9.63 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.25 70.71 0.58 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -94.62 14.02 22.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 0.0 111.22 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 18.2 67.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.0 m-85 -163.54 116.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 93' ' ' ASP . 4.9 mt -113.52 124.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 0.0 111.678 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -104.22 162.06 13.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.197 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -46.56 31.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.37 -58.8 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 111.104 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -54.88 -36.42 65.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.583 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.519 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.46 -50.64 71.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.647 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -41.53 75.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.384 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.62 -39.03 86.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.333 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.66 -54.64 19.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.785 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.4 mmt -50.06 -54.05 22.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.697 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 t -66.37 -24.62 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.567 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -31.32 69.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.35 -28.8 15.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.65 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.05 109.78 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -91.9 93.74 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.83 158.1 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.1 t -88.34 163.56 15.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.809 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -58.93 -39.89 82.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -36.14 83.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.73 -54.83 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.5 m -64.27 -39.77 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.3 -42.0 98.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.415 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.9 mt-10 -72.6 -30.22 64.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.359 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.1 mtt -70.78 -35.88 72.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.4 mm -80.31 -54.89 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.67 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.415 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.01 -31.81 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.446 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.12 -21.06 47.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.821 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.05 -4.35 19.04 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.441 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.0 t0 -93.06 109.76 21.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.04 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.814 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.36 -9.08 43.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.563 -178.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.59 58.1 8.67 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.3 p30 -114.31 -4.42 13.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.963 0.382 . . . . 0.0 111.484 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 7.81 42.05 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.06 -174.91 4.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.48 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.82 126.39 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.359 . . . . 0.0 111.198 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.82 -167.59 1.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.595 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.9 t80 -58.15 -73.88 0.07 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.586 ' O ' HG21 ' A' ' 142' ' ' VAL . 2.8 tt0 -49.46 -45.71 47.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.375 0.607 . . . . 0.0 110.333 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.56 -36.55 69.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.129 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.7 -49.77 11.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.93 0.395 . . . . 0.0 111.983 -179.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.633 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -54.82 -40.74 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.69 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -34.47 70.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.719 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.401 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.18 8.29 13.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.465 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.4 mtt -118.39 -37.78 3.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.073 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t -148.8 -52.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.458 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.01 74.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 111.415 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.971 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.91 -168.11 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.556 2.171 . . . . 0.0 112.334 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -100.99 -64.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.38 31.32 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.78 -134.35 7.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.432 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -97.28 102.46 14.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.824 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.11 -76.21 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.888 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.76 -46.33 59.95 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.11 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.698 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -58.85 -71.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.245 . . . . 0.0 110.588 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.45 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.37 -36.87 54.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.377 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 ttm-85 -57.31 -48.17 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.634 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -59.55 -40.47 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.132 178.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.556 ' O ' HG12 ' B' ' 75' ' ' VAL . 92.2 t -54.71 -53.59 30.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.521 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.414 ' O ' HG21 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.71 -46.4 53.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.336 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 16.4 mt -56.04 -46.31 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.618 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.556 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.6 p -65.78 -46.6 88.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.391 . . . . 0.0 110.443 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -60.2 -30.33 70.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.367 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 42.3 t -75.77 -52.45 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.692 0.282 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.627 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -67.03 -42.67 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.563 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.627 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.3 mmp_? -57.33 -34.75 69.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -62.4 -37.22 84.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.523 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.519 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 2.6 t90 -95.54 -14.84 23.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.013 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.16 -27.11 19.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.479 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -71.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.594 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -49.56 -69.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.236 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.23 -61.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.38 29.72 3.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.025 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.095 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.774 0.321 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -105.7 80.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.36 176.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.406 ' CB ' ' HB3' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -127.4 165.13 20.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' HB2' ' A' ' 8' ' ' GLN . 12.6 t -73.47 170.13 15.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.3 pt-20 -50.85 -42.21 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.426 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -56.91 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.204 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.0 OUTLIER -60.67 -54.69 42.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.404 HG21 ' N ' ' A' ' 10' ' ' ALA . 10.8 tt -56.1 -26.18 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.224 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.24 -42.67 61.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.334 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -66.45 -35.18 79.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.03 -49.53 60.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.432 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 1.2 mtpp -58.74 -46.49 87.31 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.22 0.533 . . . . 0.0 109.996 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.83 -50.42 72.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.589 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -52.39 -40.75 62.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.296 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.08 -35.83 67.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -75.0 -16.94 60.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -86.91 -38.78 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.421 . . . . 0.0 110.201 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.633 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.77 -65.69 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.246 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' N ' HG12 ' A' ' 27' ' ' ILE . 9.0 t70 -65.98 131.04 45.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.883 0.373 . . . . 0.0 110.712 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -36.39 77.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.139 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.92 -12.3 27.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.783 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.28 37.85 83.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.646 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -77.68 -1.9 33.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.12 43.86 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.131 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.6 p -147.48 132.47 18.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.869 0.335 . . . . 0.0 110.795 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.633 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.2 mp -107.28 119.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.7 t -98.35 168.41 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.1 p -54.45 -29.34 49.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.641 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -67.22 -50.43 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.279 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.15 -36.18 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.531 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.38 -42.83 70.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.847 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.51 -27.32 72.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.052 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.0 m -73.58 -45.24 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.67 -34.9 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.084 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -49.45 77.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.755 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -65.33 -30.19 71.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -58.86 -21.14 56.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.897 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.9 mt -72.47 -60.76 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.79 -39.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.504 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.3 mt-30 -140.15 147.88 40.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.991 0.396 . . . . 0.0 111.103 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -99.11 99.42 8.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.93 -168.95 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.302 2.002 . . . . 0.0 111.994 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 169.39 13.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.73 -30.37 68.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.031 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.94 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.126 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.4 -43.22 99.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.244 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.79 -50.31 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -64.26 -39.11 93.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.141 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -66.14 -51.14 60.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -54.18 49.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.119 0.485 . . . . 0.0 110.348 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -59.7 -43.89 92.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.683 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -52.53 -25.99 11.92 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.561 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.497 ' O ' ' CE ' ' A' ' 71' ' ' MET . 2.2 mt-10 -83.39 -4.82 58.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -126.2 -32.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.074 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -64.91 133.54 52.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 111.342 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.13 -53.66 16.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.952 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.74 58.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.24 49.21 81.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.924 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -104.47 -1.37 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.703 0.252 . . . . 0.0 111.482 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.26 17.62 15.31 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.254 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.2 p -149.06 139.78 22.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.3 mm -103.77 149.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.157 0.503 . . . . 0.0 111.691 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.47 173.78 6.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.503 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -57.65 -61.46 7.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.323 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 48.7 Cg_endo -68.41 -26.86 34.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.48 2.12 . . . . 0.0 112.468 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -67.63 -43.5 80.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.089 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 63' ' ' ILE . 1.9 t80 -75.19 -38.44 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.055 0.455 . . . . 0.0 110.293 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 9.5 tp -66.0 -58.06 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.071 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 m -51.9 -41.47 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.497 ' CE ' ' O ' ' A' ' 54' ' ' GLU . 1.8 tpt -60.14 -32.83 71.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.424 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.422 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -108.27 15.32 24.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.148 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.24 -33.12 5.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -58.48 -41.08 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 40.96 1.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.78 138.78 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -148.8 31.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.858 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 62.42 100.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -117.84 -7.41 10.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 58.41 171.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.431 ' O ' HD11 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -169.69 149.26 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -26.46 5.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.648 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -78.09 -25.72 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.734 0.302 . . . . 0.0 111.096 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' B' ' 77' ' ' VAL . 5.0 mt-10 -74.15 -28.92 61.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.923 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.701 HG23 ' HA ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -74.29 -32.73 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -49.33 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.413 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -62.99 -47.99 80.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.28 -44.09 67.99 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.729 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.84 -39.91 54.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.909 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -33.03 58.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.782 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.5 m -73.28 -36.97 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.515 ' N ' HG23 ' A' ' 91' ' ' VAL . 0.7 OUTLIER -72.89 -63.07 1.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.59 125.29 33.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -52.61 9.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.0 -9.66 58.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.69 68.91 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.875 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -95.07 12.87 27.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 111.341 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.54 16.61 65.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.7 m-85 -157.94 116.95 3.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.644 0.259 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.452 HD13 ' CD1' ' A' ' 89' ' ' PHE . 2.4 mt -109.41 124.29 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.014 0.435 . . . . 0.0 111.262 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -103.89 157.15 17.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.272 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.562 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.75 -43.34 27.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.446 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.72 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.97 -39.63 69.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.692 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.523 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -59.05 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.864 179.026 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.61 -41.45 81.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -61.06 -38.07 84.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.466 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 81.7 t -72.77 -56.01 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.063 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 5.9 mmt -48.99 -54.03 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.508 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.0 t -65.53 -25.25 67.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.376 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.53 -30.31 65.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.837 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.2 -28.82 17.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.58 43.02 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.594 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.53 109.76 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.16 100.34 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.17 160.65 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.4 t -89.57 161.97 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -57.64 -40.72 79.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.12 -36.09 82.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -65.71 -54.77 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.441 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.5 m -64.99 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.277 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.15 -44.05 97.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 45.1 mt-10 -71.74 -30.2 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.414 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.5 mmm -70.67 -34.55 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.685 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.562 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.0 mm -80.23 -54.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.762 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.413 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.1 ptt85 -54.91 -31.8 60.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 110.363 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.77 -20.85 52.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.76 -11.34 16.31 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.488 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 125' ' ' ILE . 50.6 t0 -85.51 90.95 8.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.426 0.632 . . . . 0.0 110.785 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.711 HD12 ' HG2' ' A' ' 140' ' ' GLU . 1.2 pt -63.43 -30.74 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.592 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.61 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -86.94 -9.41 55.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.208 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.19 54.57 18.91 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.2 p30 -113.93 -5.14 13.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.243 0.521 . . . . 0.0 111.365 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.48 5.8 45.16 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.461 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.99 -174.69 4.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.907 0.385 . . . . 0.0 110.595 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.516 HG11 ' CD1' ' A' ' 141' ' ' PHE . 41.3 t -127.24 120.66 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.6 t30 -97.37 -167.72 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.7 t80 -61.63 -74.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.3 OUTLIER -49.89 -43.06 49.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.315 0.579 . . . . 0.0 110.337 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.711 ' HG2' HD12 ' A' ' 130' ' ' ILE . 3.3 mt-10 -56.06 -33.69 65.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.617 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.559 ' CB ' ' CE2' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -78.97 -47.19 16.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.233 0.539 . . . . 0.0 111.631 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.701 ' HA ' HG23 ' A' ' 85' ' ' ILE . 2.6 m -64.8 -36.47 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.023 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.478 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -70.53 -36.71 73.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.657 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.565 ' HE1' ' CD2' ' B' ' 81' ' ' TRP . 1.4 ptt? -74.95 -15.2 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.479 ' CE ' ' CE ' ' A' ' 144' ' ' MET . 3.9 tpp -95.2 -50.22 5.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.374 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.8 t -177.47 -39.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.545 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . 54.06 53.06 11.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.964 0.411 . . . . 0.0 111.252 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.883 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.689 0.281 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.94 165.12 32.23 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.526 2.151 . . . . 0.0 112.31 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 19.7 mtt-85 -60.57 -37.31 80.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 80.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 -93.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.425 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 2.0 mpp_? -140.81 103.03 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.047 0.451 . . . . 0.0 110.77 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.01 -76.01 0.21 Allowed Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.928 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.23 -45.81 57.41 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.156 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.679 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.27 -70.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.516 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.28 -32.0 35.32 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.396 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -58.65 -52.85 63.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.621 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.31 -42.43 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.684 178.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.481 ' O ' HG12 ' B' ' 75' ' ' VAL . 88.4 t -52.67 -50.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.105 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 -49.27 49.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.453 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.413 ' CD1' HG11 ' A' ' 91' ' ' VAL . 29.4 mt -56.04 -46.3 78.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.149 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.481 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.4 p -67.01 -47.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.431 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -59.8 -30.57 69.66 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.348 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.446 HG12 ' CB ' ' A' ' 88' ' ' ALA . 86.7 t -76.75 -52.64 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.577 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -65.54 -41.7 91.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.581 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.577 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.2 mmp_? -56.02 -34.25 65.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -38.04 86.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.698 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.565 ' CD2' ' HE1' ' A' ' 144' ' ' MET . 5.7 t90 -95.15 -14.74 23.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.901 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.401 ' HB3' ' NH2' ' B' ' 79' ' ' ARG . . . -90.53 -31.93 16.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -73.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.409 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -67.79 69.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.2 OUTLIER -86.93 -63.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -89.63 -32.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.863 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -93.37 79.05 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -176.51 169.06 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.75 165.27 17.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.408 HG23 ' HB2' ' A' ' 8' ' ' GLN . 14.4 t -71.93 177.09 4.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 pt-20 -57.3 -43.38 83.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.78 -56.95 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.167 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.6 tp60 -59.69 -52.96 63.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 10' ' ' ALA . 11.2 tt -59.1 -26.55 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.262 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 6' ' ' GLU . . . -51.46 -42.9 61.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.405 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 6.3 pt-20 -65.7 -36.76 84.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.216 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.11 -49.67 64.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.576 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -59.04 -46.05 89.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.506 . . . . 0.0 110.025 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.81 -49.52 72.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB3' HG13 ' B' ' 75' ' ' VAL . . . -52.48 -41.09 63.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.361 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.475 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -55.81 -37.31 68.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.061 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -76.12 -15.82 60.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.78 -40.23 14.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.316 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.2 -63.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.238 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 5.9 t0 -65.7 126.61 28.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.37 79.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.313 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -92.16 -12.47 32.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.974 0.416 . . . . 0.0 110.313 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 56.96 32.82 62.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.805 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -76.62 1.27 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.845 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.3 43.31 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.028 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -149.55 132.62 16.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.351 0.576 . . . . 0.0 111.205 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.672 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.3 mp -105.53 118.4 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.422 HG22 ' HG2' ' A' ' 31' ' ' GLU . 7.8 t -97.4 166.0 11.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.615 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.3 p -52.17 -31.16 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.836 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -63.95 -50.45 68.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 111.321 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' HG2' HG22 ' A' ' 28' ' ' THR . 7.9 mm-40 -77.7 -36.07 51.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.011 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.24 -45.67 72.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.013 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.33 -27.39 73.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.279 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 85.0 m -72.21 -47.14 52.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG12 ' CD1' ' A' ' 19' ' ' PHE . 6.5 p -74.71 -34.97 35.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.08 -49.77 76.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -64.41 -30.36 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 t -58.31 -21.29 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -71.59 -60.26 2.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.312 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.92 -39.0 0.02 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.542 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.8 mt-30 -140.93 147.86 39.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.111 0.455 . . . . 0.0 111.162 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -99.64 99.65 9.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.258 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.44 -168.8 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.356 2.037 . . . . 0.0 111.971 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -85.1 169.82 13.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.65 -30.49 69.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 0.0 110.066 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -44.25 59.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.141 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.03 -41.1 97.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.266 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.9 mt -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.861 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -64.24 -39.59 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.99 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -66.27 -51.09 60.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.413 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.66 -53.42 58.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.381 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.9 OUTLIER -60.26 -45.35 96.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.497 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -52.07 -26.12 10.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.446 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 2.2 mt-10 -82.96 -3.3 56.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.38 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -64.59 133.22 51.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.053 0.454 . . . . 0.0 111.344 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.11 -53.58 16.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.897 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.66 58.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.07 49.22 80.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.933 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -104.26 -1.47 27.02 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.771 -0.253 . . . . 0.0 111.439 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.3 17.72 15.01 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.252 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.2 p -149.23 139.82 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.3 mm -103.44 149.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 111.985 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.75 170.8 7.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.415 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.475 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.4 m-85 -56.03 -61.55 6.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.533 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -68.24 -18.59 44.9 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.508 2.138 . . . . 0.0 112.68 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.409 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.478 ' HA ' HG11 ' A' ' 55' ' ' VAL . 3.4 t80 -75.28 -38.48 60.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 12.1 tp -64.45 -55.61 19.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -51.67 -37.26 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.22 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.405 ' HG2' HG12 ' A' ' 55' ' ' VAL . 2.8 tpt -64.08 -32.74 74.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.4 mmt -108.27 15.52 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.35 -36.69 3.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.803 0.335 . . . . 0.0 111.291 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -53.31 -54.33 37.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 39.31 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 tpt -160.52 137.51 9.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.035 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -148.22 30.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.17 101.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -110.99 -14.02 14.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 58.56 161.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.367 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 t -166.2 -167.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -73.55 -26.04 60.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.03 -33.79 59.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' CG ' ' HG3' ' B' ' 73' ' ' ARG . 4.4 mt-10 -61.24 -45.4 94.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.67 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -72.34 -39.14 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.761 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -71.54 -49.47 40.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.799 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -61.36 -45.56 93.89 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 109.313 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.685 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.54 -50.51 65.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.894 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.21 -40.8 59.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.833 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -31.76 68.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.443 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.57 -36.85 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.554 ' N ' HG23 ' A' ' 91' ' ' VAL . 6.5 m-85 -75.63 -43.28 48.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -112.57 109.29 18.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -42.03 80.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -74.19 -9.71 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.06 68.51 0.77 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.172 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.46 8.82 40.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.47 16.38 65.14 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.296 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 3.6 m-85 -163.86 116.68 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.731 0.3 . . . . 0.0 111.066 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 8.9 mt -111.28 127.38 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 111.788 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.5 m -104.21 158.59 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.059 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.536 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -48.0 -41.98 26.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.732 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 111.126 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.67 -37.77 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.591 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.542 HD13 HD13 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -60.82 -47.71 85.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.882 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.405 ' N ' HG13 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.39 -44.47 88.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.559 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 1.3 t60 -58.73 -38.33 78.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.38 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.31 -55.64 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.0 mmt -49.05 -53.44 20.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.617 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.3 t -68.0 -24.34 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 24.4 t30 -74.54 -31.39 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.664 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.7 -28.72 20.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.18 44.11 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.576 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.85 109.72 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -90.72 99.66 12.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.27 172.51 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.806 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.3 t -96.59 166.58 11.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.829 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.32 -34.07 77.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -35.51 78.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -65.64 -50.02 66.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.411 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 4.2 m -66.77 -39.56 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.13 -42.37 99.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 110.216 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.0 mt-10 -72.74 -30.13 63.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.339 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -36.19 72.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.542 HD13 HD13 ' A' ' 105' ' ' LEU . 2.8 mm -80.36 -54.5 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 15.7 ptt180 -53.73 -31.92 50.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.431 . . . . 0.0 110.303 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.65 -21.72 44.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.734 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.68 -0.3 23.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.34 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 46.1 t0 -96.24 102.82 14.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.368 0.604 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.692 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -76.93 -32.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.157 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.3 -9.05 49.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.88 0.371 . . . . 0.0 111.491 -178.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.54 56.98 11.28 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -114.33 -3.71 13.07 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.145 0.472 . . . . 0.0 111.49 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.5 44.34 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.099 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.76 -174.79 4.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.646 0.26 . . . . 0.0 110.349 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.571 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.2 t -129.22 126.99 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.8 t30 -104.61 -167.68 1.38 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.942 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.588 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.5 t80 -56.7 -73.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.588 ' O ' HG21 ' A' ' 142' ' ' VAL . 1.9 tt0 -49.65 -47.13 50.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.23 0.538 . . . . 0.0 110.445 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.692 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -56.29 -33.72 65.8 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.759 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.592 ' HB2' ' O ' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -79.23 -48.93 13.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.063 0.458 . . . . 0.0 111.686 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.67 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.0 m -60.29 -41.86 88.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.217 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.5 OUTLIER -70.85 -35.63 72.5 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.584 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 2.7 ptm -70.6 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 17.8 mtt -105.11 -44.2 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t 177.37 -37.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 142' ' ' VAL . . . 54.71 41.89 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.842 0.353 . . . . 0.0 111.321 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.915 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.764 0.316 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 163.89 36.78 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.561 2.174 . . . . 0.0 112.31 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -84.24 -40.05 18.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -151.91 79.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.43 -129.45 1.03 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.434 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -106.52 103.18 12.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.759 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.61 -76.26 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.9 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.4 -41.46 55.39 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -64.93 -70.31 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.702 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -52.25 -38.82 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.492 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.4 OUTLIER -55.42 -49.88 71.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.654 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.55 -41.58 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.147 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.508 ' O ' HG12 ' B' ' 75' ' ' VAL . 89.4 t -53.6 -53.47 25.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.31 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.423 ' NE ' ' NE2' ' B' ' 69' ' ' GLN . 3.0 mpt_? -71.33 -44.26 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.405 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 17.7 mt -56.23 -50.43 71.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.596 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.508 HG12 ' O ' ' B' ' 72' ' ' VAL . 13.8 p -64.09 -47.02 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.43 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -57.59 -32.98 65.76 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.526 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.45 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 47.4 t -76.75 -53.02 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.649 HD11 ' HG2' ' B' ' 79' ' ' ARG . 2.7 pp -63.29 -43.08 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.524 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' HG2' HD11 ' B' ' 78' ' ' ILE . 4.2 mmp_? -57.92 -35.07 70.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 109.687 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -36.04 80.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.337 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.506 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.1 t90 -95.37 -13.86 24.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -92.03 -31.4 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -74.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -67.82 70.19 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.76 -65.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.93 -34.01 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.894 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -105.46 72.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -176.55 175.23 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.27 165.4 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.7 t -69.64 170.31 11.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.88 -37.29 66.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.321 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.04 -56.8 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.134 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -57.91 -44.38 86.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.1 tt -68.04 -26.78 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.8 -43.17 62.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.9 OUTLIER -71.45 -27.5 63.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.234 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.55 -49.41 41.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.239 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.06 -45.09 83.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 110.222 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.545 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.1 mm-40 -64.38 -51.66 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -51.21 -40.18 58.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.841 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.495 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -56.01 -47.34 77.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -13.62 62.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.3 mt -88.0 -38.3 15.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 110.503 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.668 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -63.12 -64.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.07 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.4 t70 -61.99 128.1 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -38.54 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.279 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.19 -12.25 30.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.824 0.345 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.33 38.44 86.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -77.66 -1.15 29.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.26 -2.53 43.58 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.213 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.1 p -149.42 132.47 16.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 0.0 110.756 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.668 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.2 mp -104.73 119.21 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.0 t -99.15 165.88 11.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.697 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 p -52.33 -32.56 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.885 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -62.13 -50.56 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.329 . . . . 0.0 111.374 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.78 -37.59 48.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 110.974 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.23 -40.39 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.585 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.2 -30.86 69.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.914 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.6 m -67.58 -53.25 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.401 HG12 ' CE1' ' A' ' 19' ' ' PHE . 10.1 p -69.76 -30.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.246 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.9 mtp -60.14 -46.62 89.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.321 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -25.52 44.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -53.64 -50.67 65.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -46.97 -57.88 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.589 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -142.72 178.76 7.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -147.69 58.58 4.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.91 -178.5 3.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.559 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.1 p -98.66 173.76 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.49 -30.2 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.29 60.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.15 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.71 -42.01 96.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.062 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.0 mt -58.35 -50.53 73.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.868 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -62.77 -38.63 91.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.89 -51.23 42.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.352 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -54.1 50.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.491 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.7 OUTLIER -59.28 -45.26 93.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.477 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -52.36 -25.9 10.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.8 mt-10 -82.35 -3.33 55.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.67 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.98 -32.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -63.92 134.82 55.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 111.079 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -66.52 -53.35 35.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.728 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.77 4.2 51.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.813 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.16 59.71 9.11 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.213 -0.517 . . . . 0.0 113.933 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.35 -2.72 17.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.771 0.286 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.22 17.3 16.18 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.927 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 p -149.49 139.96 22.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.337 . . . . 0.0 111.02 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.3 mm -104.64 149.56 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.209 0.528 . . . . 0.0 111.725 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 171.72 7.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.495 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -55.9 -61.59 6.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.712 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.1 Cg_endo -67.97 -19.48 45.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.753 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.439 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.18 -39.07 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.367 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' HA ' HG11 ' A' ' 55' ' ' VAL . 4.2 t80 -75.27 -35.74 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.662 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.7 tp -71.99 -58.43 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.085 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.13 -46.69 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mmt -59.71 -30.69 68.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.417 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.26 14.97 24.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.08 -43.0 3.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -48.7 76.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 64.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.795 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.51 31.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -104.12 46.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.757 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.31 -175.12 4.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 p -97.28 -166.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.946 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -85.85 -179.95 6.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -150.2 156.21 41.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.84 -38.54 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.261 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 45.4 mt-10 -63.92 -27.86 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.178 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.641 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.18 -39.22 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -70.88 -49.32 47.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -61.29 -46.44 90.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.34 0.59 . . . . 0.0 109.476 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.595 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.58 -48.85 68.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.068 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.536 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.06 -38.86 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.994 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -30.42 57.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.955 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.53 -37.02 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 91' ' ' VAL . 2.0 m-85 -71.86 -62.89 1.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.494 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.82 121.17 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.33 -52.62 57.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.234 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.04 -9.61 59.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.496 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.13 71.13 0.52 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.864 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.39 14.58 18.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.633 0.254 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.28 66.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.608 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.2 m-85 -161.84 116.75 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.755 0.312 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.6 mt -113.28 124.45 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.115 0.483 . . . . 0.0 111.645 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -104.26 161.63 13.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.16 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -44.52 29.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.442 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.09 -58.87 6.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.03 -36.62 65.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.636 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.99 -49.49 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.729 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -41.49 78.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.333 178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -60.55 -39.87 89.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.306 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -68.72 -51.8 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.749 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.28 -54.05 29.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.802 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 t -66.99 -25.08 66.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -70.69 -31.29 68.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.62 -28.8 16.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.51 43.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -152.11 109.78 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.66 95.63 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.018 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -94.07 157.14 16.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.6 t -88.01 164.02 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.822 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.55 -42.69 83.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -62.46 -35.35 79.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -65.31 -54.85 23.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.021 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.412 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.5 m -64.94 -39.78 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -62.53 -41.88 99.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 110.276 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 5.6 mt-10 -72.66 -30.14 64.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.317 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.3 tpp -70.75 -36.09 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.882 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.57 HG13 ' N ' ' A' ' 102' ' ' ALA . 4.6 mm -80.24 -54.91 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.567 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -53.65 -31.75 48.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.01 0.433 . . . . 0.0 110.456 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -20.79 52.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.968 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.06 -10.96 15.76 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.55 0.214 . . . . 0.0 111.523 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -85.51 109.67 18.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.429 0.633 . . . . 0.0 111.307 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.689 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.13 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.755 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.05 -9.14 43.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.523 -178.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.31 57.62 10.05 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -114.25 -4.33 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.05 0.425 . . . . 0.0 111.456 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.69 42.45 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.991 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.05 -174.87 4.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.53 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 141' ' ' PHE . 54.0 t -128.34 126.82 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.559 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -106.55 -167.36 1.28 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.6 t80 -58.09 -73.98 0.07 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.573 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -49.56 -45.64 47.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.375 0.607 . . . . 0.0 110.336 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.689 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.55 -36.61 69.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.569 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.64 -49.51 12.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.913 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.641 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.2 m -55.85 -40.21 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -34.44 70.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.757 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.82 8.93 13.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 111.283 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.457 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.8 mtt -118.81 -36.32 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -150.4 -52.61 0.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.43 75.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.936 179.877 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.698 0.285 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.11 -172.57 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.501 2.134 . . . . 0.0 112.304 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -99.91 -56.51 2.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -141.75 35.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.79 -134.82 6.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.438 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -94.54 103.21 15.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.774 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.03 -75.81 0.22 Allowed Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.95 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.35 -46.69 63.67 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -58.71 -70.26 0.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.27 . . . . 0.0 110.552 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.461 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.29 -34.09 45.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.205 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.432 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 6.6 tpt180 -58.14 -52.18 66.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.632 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.38 -41.8 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.053 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.483 ' O ' HG12 ' B' ' 75' ' ' VAL . 90.4 t -53.03 -53.3 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.446 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' B' ' 73' ' ' ARG . 0.0 OUTLIER -71.02 -45.01 64.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.436 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 21.2 mt -55.99 -49.73 72.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.557 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 15' ' ' ALA . 14.6 p -64.62 -48.62 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.96 -29.67 59.39 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.151 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 98.8 t -76.8 -55.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.604 0.24 . . . . 0.0 111.562 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.531 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.73 -43.91 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.531 ' N ' HD11 ' B' ' 78' ' ' ILE . 23.6 mmm180 -58.16 -34.26 70.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.229 0.538 . . . . 0.0 109.855 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -62.27 -37.03 83.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.517 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.8 t90 -95.34 -15.38 23.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.73 -26.26 19.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.501 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.42 -72.07 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.645 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -49.61 -69.58 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.262 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.27 -62.36 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.258 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.27 30.47 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.015 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.176 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.73 69.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -176.57 170.82 2.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -124.13 165.36 17.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -67.93 166.33 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 41.2 mt-10 -54.34 -26.48 30.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.36 -56.89 3.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.126 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -46.57 84.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 10' ' ' ALA . 7.0 tt -65.52 -26.65 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' N ' HG21 ' A' ' 9' ' ' ILE . . . -51.55 -44.04 62.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.294 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 2.0 mp0 -72.5 -25.71 61.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -71.42 -49.39 42.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.298 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.35 -44.93 80.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.307 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.555 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.4 mm-40 -65.35 -51.44 60.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' HB3' ' CG2' ' B' ' 75' ' ' VAL . . . -51.18 -40.06 57.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.922 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.511 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -57.07 -45.98 82.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -70.94 -13.76 62.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.2 mt -87.99 -38.38 15.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.906 0.384 . . . . 0.0 110.57 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.672 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -63.31 -64.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.3 t70 -62.52 127.34 30.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.801 0.334 . . . . 0.0 110.432 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -38.69 92.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.9 -12.31 31.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.26 38.38 86.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -77.65 -1.06 29.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.79 43.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.195 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.7 p -149.37 132.49 16.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.939 0.37 . . . . 0.0 110.764 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.672 HG12 ' HB3' ' A' ' 19' ' ' PHE . 1.2 mp -104.38 119.35 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.9 t -98.75 165.11 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.696 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 p -52.76 -30.45 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.83 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -63.24 -50.61 69.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -77.85 -37.87 47.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.525 ' HG ' ' CE1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -54.14 -41.39 68.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 -29.42 72.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.9 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.6 m -69.51 -52.05 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.542 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.452 ' CG1' ' CE1' ' A' ' 19' ' ' PHE . 7.7 p -69.01 -31.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.415 ' N ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -60.07 -47.16 87.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -25.47 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.758 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 t -54.69 -50.72 67.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.51 -58.72 3.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 111.085 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.6 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -142.71 -178.02 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -150.99 58.16 2.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 -177.18 2.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.65 2.233 . . . . 0.0 112.504 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.2 p -99.71 173.6 6.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -68.54 -30.14 68.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.918 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.12 59.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.32 -42.51 98.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.076 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.5 -50.53 72.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -63.28 -39.43 94.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.214 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.61 -51.25 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.325 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -53.84 53.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 110.347 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.484 HG23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -59.31 -45.27 93.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.437 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -52.38 -25.92 11.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.257 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.2 mt-10 -82.39 -3.26 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG22 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.12 -32.36 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 57' ' ' ALA . 45.0 t0 -63.31 136.51 57.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 111.195 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.46 -53.9 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.562 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -95.6 4.24 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.62 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.31 58.74 10.16 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.8 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -109.72 -1.76 17.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.788 0.294 . . . . 0.0 111.301 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' HG23 ' A' ' 52' ' ' ILE . . . 104.26 17.44 15.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.953 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.9 p -149.32 139.85 22.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.137 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.483 HG21 ' HB ' ' A' ' 55' ' ' VAL . 2.4 mm -103.95 149.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.082 0.468 . . . . 0.0 111.708 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.38 169.28 8.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.624 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.2 m-85 -53.44 -61.12 5.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.393 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 51.9 Cg_endo -69.11 -18.44 40.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.486 2.124 . . . . 0.0 112.636 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mm-40 -79.24 -38.85 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.479 ' HA ' HG11 ' A' ' 55' ' ' VAL . 4.0 t80 -75.26 -34.09 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.622 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.9 tp -73.74 -58.43 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -52.08 -47.81 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.55 -28.58 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.22 13.23 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.407 ' HA ' ' CD2' ' A' ' 4' ' ' LEU . . . -110.64 -43.69 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -55.58 -44.26 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.29 65.13 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 31.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -102.31 41.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.79 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -175.45 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.5 p -100.86 -166.72 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 -178.84 7.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.039 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.92 155.96 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.51 -24.97 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.362 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.1 -37.25 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.202 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 55.3 mt-10 -64.9 -28.07 69.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.165 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.64 HG23 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.2 -39.27 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.287 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -70.83 -49.28 47.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.04 -47.0 88.43 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.592 ' O ' HG23 ' A' ' 91' ' ' VAL . . . -53.43 -48.85 68.4 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.241 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.519 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.14 -38.86 54.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.984 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -30.46 56.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.949 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 88' ' ' ALA . 1.4 m -76.44 -37.07 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 111.026 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 91' ' ' VAL . 1.4 m-85 -71.62 -62.95 1.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.8 117.95 23.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -60.66 -52.63 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.47 -9.64 59.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.501 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.7 71.65 0.47 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.879 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.38 14.42 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.57 13.72 61.32 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.673 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.9 m-85 -158.07 116.69 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -113.76 125.1 70.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 161.86 13.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.237 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.575 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.91 -46.98 32.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.555 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.31 -58.87 5.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.14 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.88 -36.55 65.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.606 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.522 ' CD1' ' CH2' ' B' ' 81' ' ' TRP . 0.2 OUTLIER -61.2 -50.52 72.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.648 178.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -41.85 77.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -60.12 -39.35 85.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.397 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.21 -55.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.694 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.6 mmt -49.94 -54.07 22.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -67.39 -24.92 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.12 -31.41 70.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.73 -28.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.03 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.27 43.17 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -150.17 109.82 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -90.21 98.82 12.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.37 171.22 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 m -98.29 158.96 15.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -56.76 -48.9 76.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -64.18 -31.66 72.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.64 -54.91 32.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.407 ' CG2' ' HB1' ' A' ' 102' ' ' ALA . 3.6 m -65.37 -40.46 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.47 -40.99 98.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.094 0.473 . . . . 0.0 110.283 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.41 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 9.8 mt-10 -73.02 -30.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.405 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.0 mtp -71.04 -35.74 72.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.575 HG13 ' N ' ' A' ' 102' ' ' ALA . 5.0 mm -80.35 -54.94 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.623 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.41 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 ptm180 -53.89 -31.86 51.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 0.0 110.38 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.96 -21.01 47.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.786 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.97 -5.05 18.43 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 121.114 -0.235 . . . . 0.0 111.445 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.4 t0 -92.38 109.7 21.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.41 0.624 . . . . 0.0 111.325 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.691 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.5 pt -84.74 -31.18 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.793 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.92 -9.12 44.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.554 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.55 58.21 8.51 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -114.25 -4.53 13.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.04 0.42 . . . . 0.0 111.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.38 7.83 42.13 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.967 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.436 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.11 -174.81 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.591 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.04 126.67 66.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.261 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.552 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -105.29 -168.28 1.44 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.587 ' O ' HG13 ' A' ' 142' ' ' VAL . 59.7 t80 -58.51 -73.98 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.581 ' O ' HG21 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.52 -45.52 47.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.348 0.594 . . . . 0.0 110.265 -179.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.691 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.51 -36.38 69.11 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.108 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.591 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.71 -49.83 11.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.901 0.381 . . . . 0.0 111.92 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.64 ' N ' HG23 ' A' ' 85' ' ' ILE . 3.3 m -55.12 -40.49 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -34.45 70.9 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.705 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.43 8.6 13.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.647 0.261 . . . . 0.0 111.305 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.462 ' CE ' ' CE2' ' A' ' 141' ' ' PHE . 3.7 mtt -118.51 -37.66 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t -149.34 -52.48 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.396 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.86 74.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 111.356 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 31.1 mttp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.923 179.842 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.735 0.303 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.33 149.15 62.84 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.592 2.195 . . . . 0.0 112.287 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mtm-85 -60.29 -51.03 71.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.17 73.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.13 -132.88 2.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.522 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.436 ' HG3' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -97.29 103.67 15.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.014 0.435 . . . . 0.0 110.822 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.14 -75.74 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.935 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.48 63.24 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.058 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.669 ' CE2' HG22 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -59.1 -70.29 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.653 -0.273 . . . . 0.0 110.501 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.08 -34.0 41.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.179 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.8 tpp180 -58.27 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ILE . . . . . 0.624 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.14 -41.81 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.963 178.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.503 ' O ' HG12 ' B' ' 75' ' ' VAL . 88.6 t -52.95 -52.62 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.468 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -45.78 63.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.331 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 70' ' ' ARG . 22.7 mt -55.87 -49.26 73.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 110.545 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 72' ' ' VAL . 15.0 p -63.97 -48.2 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.56 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . 0.426 ' N ' ' CG1' ' B' ' 75' ' ' VAL . . . -56.76 -29.82 58.86 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.14 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 88' ' ' ALA . 88.2 t -76.77 -56.06 9.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.596 0.236 . . . . 0.0 111.63 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.534 HD11 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -60.74 -43.56 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . 0.534 ' N ' HD11 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.05 -33.29 68.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 109.901 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -37.79 88.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.469 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' TRP . . . . . 0.522 ' CH2' ' CD1' ' A' ' 105' ' ' LEU . 3.2 t90 -95.52 -11.37 27.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.153 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -93.29 -31.23 14.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.419 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.32 -71.33 0.74 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.562 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' LYS . . . . . 0.408 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 0.0 OUTLIER -47.27 -80.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.245 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.3 OUTLIER 68.78 -67.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -117.86 40.39 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 14.1 ptt85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 70' ' ' THR . 32.9 p-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.437 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -177.54 -179.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.633 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -133.55 165.27 25.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 169.4 13.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.075 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -30.29 57.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.518 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -78.45 -56.88 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.633 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -59.31 -45.32 91.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.481 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 5' ' ' THR . 13.0 tt -65.17 -26.65 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.955 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.68 -44.04 62.96 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.442 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -32.71 72.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.257 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -67.6 -49.7 61.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.328 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -44.74 92.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.254 0.55 . . . . 0.0 110.043 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.42 -47.88 74.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.704 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.4 -41.97 63.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -56.76 -35.12 68.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.043 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -77.86 -14.64 59.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.927 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.66 -38.5 15.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.26 -65.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.8 t70 -66.01 132.33 48.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -37.89 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.01 -12.15 29.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.51 36.76 79.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.654 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -74.67 -5.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.523 0.201 . . . . 0.0 111.501 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.18 2.29 44.9 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.1 p -149.43 132.53 16.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -108.97 126.56 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.03 167.82 10.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 p -54.01 -30.44 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.48 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -62.79 -50.39 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.204 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.5 mm-40 -77.73 -36.28 51.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.798 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.37 -58.35 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.703 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.25 -27.49 69.27 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.555 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -70.99 -60.99 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.12 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -64.71 -30.76 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.7 ttt -60.22 -55.22 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.77 -25.63 64.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.967 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 t -56.04 -38.37 70.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.92 -62.3 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.65 41.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -142.56 167.8 21.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -134.97 59.66 35.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.71 -169.98 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.588 2.192 . . . . 0.0 112.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 p -116.46 167.57 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.78 -32.05 71.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.8 -45.62 59.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.405 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.0 OUTLIER -64.17 -43.4 95.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.302 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -55.25 -50.58 69.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.09 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -64.56 -57.03 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -51.19 67.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.182 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.519 ' HE2' ' H ' ' B' ' 66' ' ' GLY . 15.7 mtt -57.64 -47.06 83.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -61.58 -45.68 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.159 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -56.36 -26.53 53.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.529 0.68 . . . . 0.0 110.113 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' MET . 6.6 mt-10 -81.53 -2.14 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.351 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.629 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -127.0 -33.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 112.04 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.484 ' N ' HD12 ' A' ' 63' ' ' ILE . 54.1 t0 -72.49 148.5 45.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.251 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.5 -53.57 7.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.54 -8.63 58.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.34 48.55 79.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.931 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -96.6 -0.22 48.95 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.643 0.222 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 15.13 22.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.922 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.4 p -149.88 139.89 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.56 0.18 . . . . 0.0 110.565 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.71 147.34 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.497 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.52 179.08 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.882 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -60.93 -61.69 7.48 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.0 Cg_endo -66.93 -30.94 39.0 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.435 2.09 . . . . 0.0 112.197 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mt-10 -65.74 -40.61 92.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.14 -41.95 57.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -71.17 -53.1 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.482 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.556 ' N ' HD23 ' A' ' 69' ' ' LEU . 90.4 m -51.58 -46.34 63.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.182 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.404 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 tpp -56.65 -48.33 77.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.932 0.396 . . . . 0.0 110.936 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.9 mmt -85.95 0.15 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.559 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.66 -38.89 11.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.93 0.395 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -55.04 -30.48 59.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.746 HG23 HH22 ' B' ' 73' ' ' ARG . 1.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -151.75 174.44 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -152.17 155.46 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -54.64 -24.29 20.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 -38.68 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 53.5 mt-10 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.026 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.29 -38.88 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -49.35 33.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.7 mt-10 -61.06 -45.49 94.55 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.87 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.47 -53.33 53.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.997 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.636 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.36 -38.88 55.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.833 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -31.46 68.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.25 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.937 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.39 -36.68 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' HG21 ' A' ' 108' ' ' VAL . 5.9 m-85 -71.93 -62.9 1.26 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -85.25 129.93 34.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -75.67 -52.6 10.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.37 -9.6 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.481 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.21 70.44 0.62 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.898 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -93.43 15.32 16.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.3 68.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.2 m-85 -166.35 116.34 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.2 mt -111.66 129.11 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.787 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -104.08 156.5 17.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.197 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.488 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.93 -38.88 17.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.385 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.85 -59.01 6.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.057 0.456 . . . . 0.0 110.864 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -36.87 72.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.689 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.845 HD12 HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.56 -49.31 77.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 110' ' ' THR . 2.0 tpt180 -56.75 -44.49 81.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.205 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -58.76 -37.52 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.17 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 92' ' ' PHE . 38.5 t -68.87 -53.77 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.674 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.528 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.0 mmt -50.35 -54.12 23.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.3 t -67.29 -24.87 65.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.38 -29.99 67.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.61 -28.84 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.75 43.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.96 125.75 18.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -92.31 95.6 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.8 mm? -97.79 150.84 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.813 ' O ' HG22 ' A' ' 121' ' ' VAL . 16.9 m -98.24 159.05 15.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.08 -44.38 87.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -34.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -65.52 -54.87 22.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 117' ' ' THR . 2.7 m -64.66 -38.82 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.038 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.68 -42.04 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.39 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.1 mt-10 -73.03 -30.11 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.444 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 1.5 mmt -71.18 -35.07 71.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 105' ' ' LEU . 2.4 mm -80.35 -54.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.3 ptm180 -54.04 -31.86 52.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.302 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.19 -22.87 57.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.743 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.46 -11.17 18.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -96.35 97.79 9.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.484 0.659 . . . . 0.0 111.214 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.405 HG21 ' OE1' ' A' ' 143' ' ' GLN . 0.8 OUTLIER -57.68 -30.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 6.6 p30 -95.74 -9.51 31.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.972 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 45.98 62.43 3.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.505 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -113.68 3.2 15.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.584 0.23 . . . . 0.0 111.447 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.34 2.96 47.79 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.09 -177.33 5.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.094 0.447 . . . . 0.0 110.966 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.636 HG12 ' HZ ' ' A' ' 89' ' ' PHE . 82.2 t -130.78 128.58 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.145 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.3 t30 -99.52 -175.07 2.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.736 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.7 t80 -56.82 -72.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.018 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.37 -43.26 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.152 0.501 . . . . 0.0 110.91 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.55 -36.17 71.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.38 -49.67 12.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.134 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.6 m -53.97 -42.41 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.6 pt20 -70.93 -48.6 52.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.231 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.74 -15.76 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.2 mtt -89.83 -42.96 10.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.332 -0.195 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.502 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.519 ' H ' ' HE2' ' A' ' 51' ' ' MET . . . -58.55 -71.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.603 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.57 -50.29 49.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.629 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -58.3 -67.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.606 0.241 . . . . 0.0 110.514 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.2 OUTLIER -51.99 -35.99 48.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.298 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 19.5 tpp85 -56.38 -49.86 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.615 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.35 -42.19 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.006 178.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.5 t -50.72 -50.31 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.558 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.854 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.82 -45.88 63.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.937 HD22 HG11 ' A' ' 91' ' ' VAL . 19.5 mt -55.87 -50.61 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.3 p -63.02 -47.8 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 110.414 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.95 -29.6 59.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.165 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.855 HG11 ' CB ' ' A' ' 88' ' ' ALA . 92.5 t -76.76 -56.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.629 0.252 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.644 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -59.9 -43.69 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.644 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.9 mmm180 -57.81 -35.09 70.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.236 0.541 . . . . 0.0 109.673 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.86 -35.77 81.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.109 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.763 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.4 t90 -95.19 -9.97 31.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.774 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.77 -36.94 50.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.281 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.018 -179.551 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.0 p30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.823 0.344 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.633 ' CG ' HD21 ' A' ' 69' ' ' LEU . 2.5 tt0 -177.39 -175.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.64 HD13 ' CD ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -137.04 165.17 26.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.594 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.6 t -69.78 171.4 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.97 -35.81 64.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.444 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -74.27 -56.88 4.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.64 ' CD ' HD13 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -58.38 -41.26 84.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.699 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 5' ' ' THR . 7.5 tt -71.4 -26.38 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.029 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.39 -43.22 61.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.514 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.34 -33.44 73.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -65.96 -49.65 67.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.467 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.56 -44.82 89.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.202 0.525 . . . . 0.0 110.215 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.03 -48.86 72.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.703 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.897 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.34 -41.45 63.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.497 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -57.51 -31.73 66.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.957 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -79.7 -15.08 58.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.64 -38.79 15.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.591 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.04 -65.84 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.35 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -66.57 132.69 48.74 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 110.702 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -37.3 74.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.92 -12.28 29.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.49 37.08 80.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.64 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -75.21 -4.2 37.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.505 0.193 . . . . 0.0 111.473 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 -0.23 44.01 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.059 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.3 p -149.54 132.59 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.803 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mp -107.54 128.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.7 t -103.28 165.13 11.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 p -52.78 -26.65 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.688 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -67.53 -50.5 58.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 15.3 mm-40 -77.46 -35.41 53.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.752 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.012 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.27 -58.36 7.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.773 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -61.0 -27.3 66.89 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.919 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -69.89 -56.52 6.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 111.52 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.7 p -67.81 -33.78 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.484 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.455 ' HE2' ' HA3' ' B' ' 67' ' ' GLY . 0.0 OUTLIER -59.05 -53.1 62.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.713 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.9 -25.77 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.984 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -60.41 -36.71 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.7 mt -58.31 -30.65 66.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.23 42.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.524 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -142.6 161.59 37.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.23 62.75 8.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.73 -174.13 1.21 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.571 2.181 . . . . 0.0 112.355 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -122.12 167.29 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.79 -32.26 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.183 0.516 . . . . 0.0 110.084 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.487 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -41.92 95.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.394 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -56.34 -50.79 70.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -65.46 -50.03 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.54 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.08 71.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.6 -49.89 75.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.698 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -58.88 -42.32 85.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.261 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -59.18 -26.34 64.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.56 0.695 . . . . 0.0 110.06 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -83.79 -2.16 55.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.86 -33.06 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.3 t0 -71.15 148.02 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.85 -53.45 6.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.646 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.36 -8.76 58.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.49 48.75 78.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -96.96 -1.42 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 111.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.24 22.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.86 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.81 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' ILE . 3.3 mm -95.33 147.21 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.473 . . . . 0.0 111.663 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.49 176.92 5.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.929 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 3.3 m-85 -60.21 -61.62 7.56 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 33.4 Cg_endo -64.48 -30.94 61.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.411 2.074 . . . . 0.0 111.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 1.9 mt-10 -69.03 -37.09 78.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.336 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.3 t80 -75.12 -39.97 60.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.633 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.6 tp -76.79 -54.57 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.604 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.1 m -51.58 -44.02 62.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.613 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -54.17 47.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.864 0.364 . . . . 0.0 111.011 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.47 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 22.9 mtt -80.31 -8.06 59.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.604 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -87.82 -42.68 12.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.842 0.353 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -59.5 -29.88 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.921 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.03 163.29 37.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 157.55 43.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -57.44 -27.78 62.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.2 -34.43 61.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.2 mt-10 -61.48 -33.84 74.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.811 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.41 -39.02 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.298 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -49.32 33.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.5 mm-40 -60.9 -44.94 96.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.66 -52.87 58.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.883 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.608 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.28 -38.85 55.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.865 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -71.49 -31.44 67.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.43 -36.68 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.656 ' CE2' HG22 ' B' ' 78' ' ' ILE . 7.8 m-85 -73.51 -62.81 1.35 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.934 0.397 . . . . 0.0 110.394 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -84.81 118.14 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -64.8 -52.64 55.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.27 -9.63 59.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.541 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.81 70.97 0.56 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.21 15.14 16.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.45 66.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.617 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.9 m-85 -165.67 116.36 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.576 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.7 mt -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -104.04 156.39 17.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.929 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.97 -36.63 12.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.446 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -59.06 5.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.105 0.479 . . . . 0.0 110.978 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.4 mm-40 -58.75 -38.92 79.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.799 HD12 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.17 -48.36 82.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.842 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 110' ' ' THR . 5.0 tpt85 -56.91 -45.53 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.14 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.9 -36.63 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.148 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 92' ' ' PHE . 52.6 t -67.43 -54.44 23.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.66 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.703 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.1 mmt -50.36 -54.01 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.6 t -67.63 -25.57 65.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.606 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.5 -31.23 71.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.82 -28.79 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.035 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.18 42.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.552 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.576 ' OE2' HD21 ' A' ' 116' ' ' LEU . 6.2 tt0 -146.72 110.68 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -88.0 86.01 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -80.13 175.64 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' VAL . 3.6 m -98.41 158.68 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.706 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.95 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.111 0.481 . . . . 0.0 110.209 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -71.76 -32.98 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.196 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.18 -52.98 56.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.54 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 117' ' ' THR . 2.9 m -66.95 -39.18 82.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.48 -45.15 88.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.046 0.45 . . . . 0.0 110.373 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 24.3 mt-10 -72.97 -30.16 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.622 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -34.46 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.755 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.799 HD11 HD12 ' A' ' 105' ' ' LEU . 2.0 mm -80.27 -54.73 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.463 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.2 ptm180 -53.91 -31.88 51.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 110.284 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.33 -23.48 57.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.688 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.03 -4.99 25.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.442 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -101.45 96.45 7.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.469 0.652 . . . . 0.0 111.273 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -30.84 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.611 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 5.0 p30 -95.82 -9.37 31.75 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 46.7 62.66 3.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.6 p30 -113.7 1.99 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.568 0.223 . . . . 0.0 111.434 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.28 4.57 47.09 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.98 -177.59 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 0.0 111.064 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.692 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.4 t -130.78 128.69 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.2 t30 -101.13 -174.03 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 142' ' ' VAL . 24.4 t80 -57.06 -73.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.514 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.38 -42.73 42.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.43 -37.24 72.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.326 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.692 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -79.43 -49.74 11.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.189 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.811 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.5 m -53.68 -42.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.3 pt20 -70.94 -48.18 54.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.267 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.457 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.66 -15.56 52.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.473 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.589 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.6 mtt -90.59 -42.62 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.751 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.422 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.544 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.873 0.368 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.67 -70.46 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 36' ' ' MET . . . -57.9 -46.86 91.94 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.606 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.75 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.2 OUTLIER -52.23 -64.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.295 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.1 OUTLIER -55.03 -31.57 61.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 0.0 110.005 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -54.0 -53.57 51.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.75 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -38.62 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.0 t -50.85 -43.11 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.351 0.596 . . . . 0.0 110.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.516 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.67 -48.16 27.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.121 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.749 HD22 HG11 ' A' ' 91' ' ' VAL . 62.6 mt -55.75 -46.77 77.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.897 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -66.28 -46.72 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.593 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -58.16 -30.7 64.4 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.156 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 88' ' ' ALA . 69.0 t -76.77 -55.05 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.645 0.26 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.656 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -61.39 -43.03 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.501 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.635 ' N ' HD12 ' B' ' 78' ' ' ILE . 9.8 mmp_? -56.58 -37.4 70.56 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.381 0.61 . . . . 0.0 109.518 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -35.74 79.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.374 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.769 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.1 t90 -95.03 -9.92 32.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.685 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.53 -36.55 52.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.385 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.613 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -176.98 -178.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.553 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -131.68 165.32 23.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.87 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.7 t -70.6 177.05 3.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.103 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -59.0 -37.99 78.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.264 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -73.48 -56.82 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.942 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.591 ' H ' HG23 ' A' ' 5' ' ' THR . 2.3 tt0 -57.71 -40.72 80.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.1 tt -72.28 -26.57 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.981 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.64 -43.74 62.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.525 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.11 -33.05 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.15 -49.69 63.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.229 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -59.69 -44.93 93.44 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.218 0.532 . . . . 0.0 109.906 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -63.68 -48.21 78.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.409 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.83 63.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.285 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.56 -38.61 69.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -74.0 -15.66 61.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -87.07 -38.3 16.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.36 -65.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.276 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -66.1 134.02 51.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -37.91 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.256 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.24 -12.14 28.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.824 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.57 79.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.724 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.58 -5.51 43.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.523 0.201 . . . . 0.0 111.45 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 3.72 44.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.044 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -149.45 132.59 16.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.874 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -110.64 126.93 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.3 t -100.42 168.27 9.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -54.32 -30.34 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.44 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -64.12 -50.41 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.185 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HG12 ' A' ' 35' ' ' VAL . 22.3 mm-40 -76.79 -35.29 57.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.477 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.017 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.41 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.805 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -64.08 -27.46 71.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.803 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.5 m -66.89 -60.24 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.194 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -70.03 -30.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.1 ttt -62.02 -47.2 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.66 -25.72 44.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.998 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -57.7 -36.33 71.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.15 -61.52 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -142.63 161.89 36.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -130.05 60.06 49.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.0 -170.07 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.8 p -117.52 167.45 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.78 -32.11 71.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.69 59.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.338 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -44.85 92.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.262 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.9 mt -53.57 -50.59 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.86 -53.04 52.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -56.85 -51.13 70.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.06 -48.31 82.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.679 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.017 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.52 -43.65 91.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.79 -26.38 64.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.559 0.695 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -82.83 -2.24 54.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.663 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.78 -33.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.0 t0 -70.2 153.92 42.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.17 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.68 -53.5 6.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.855 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.58 -8.54 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.56 52.02 55.6 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.859 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.43 0.11 44.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.577 0.227 . . . . 0.0 111.45 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.39 24.38 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.8 p -149.98 139.9 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.542 0.21 . . . . 0.0 110.633 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.66 149.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.039 0.447 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 178.26 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.722 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.6 m-85 -60.79 -61.59 7.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.521 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.5 Cg_endo -67.22 -32.68 32.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.48 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -65.04 -38.76 91.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.6 t80 -75.35 -41.17 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.438 . . . . 0.0 110.036 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.613 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.3 tp -68.4 -56.28 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.4 m -51.72 -46.11 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.514 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.0 tpp -55.89 -49.6 72.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 111.087 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.0 mmt -81.14 -13.39 58.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -86.24 -35.17 20.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 110.978 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -38.65 90.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.28 159.5 35.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -150.25 154.0 37.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -55.17 -26.64 40.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.6 -34.05 67.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.2 mt-10 -66.77 -32.39 73.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.823 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.25 -38.92 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.2 -49.41 43.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.388 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.878 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.4 mm-40 -61.5 -45.84 92.52 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.766 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.65 -49.32 68.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.978 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.1 -38.42 51.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.97 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -30.47 57.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.822 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.14 -37.05 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.6 m-85 -73.74 -62.95 1.32 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.855 0.36 . . . . 0.0 110.483 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -84.42 128.48 34.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.787 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -73.17 -52.63 13.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.254 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -78.57 -9.62 59.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.528 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.72 70.61 0.57 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.956 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -93.67 14.87 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 111.219 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.73 68.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.6 m-85 -162.99 116.94 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.77 126.67 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.499 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -103.96 156.94 17.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.133 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.62 -41.54 22.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.334 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -58.91 6.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.056 0.455 . . . . 0.0 110.863 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.71 -38.46 69.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.754 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.886 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.71 -50.76 72.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.834 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -44.15 77.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.06 -37.51 74.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.333 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.78 -53.88 22.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.74 -54.11 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.6 t -66.45 -25.42 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -68.4 -29.87 68.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.41 -28.76 13.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.22 43.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.536 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -149.66 114.15 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.06 103.08 15.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.32 163.6 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.768 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.835 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.1 m -98.28 158.82 15.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.5 -42.34 91.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.81 -35.42 74.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.32 -54.83 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -64.06 -39.9 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.85 -41.69 98.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.2 mt-10 -72.57 -30.1 64.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.356 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.437 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 53.9 ttm -70.85 -34.88 72.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.678 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.886 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.38 -54.93 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.659 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm85 -54.26 -31.78 54.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.41 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -76.13 -22.02 55.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.897 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.72 15.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.576 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -83.88 90.82 7.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.472 0.654 . . . . 0.0 111.06 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.736 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -64.1 -30.74 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.411 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.601 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.74 -9.46 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.17 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.3 54.49 19.67 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.9 p30 -113.86 -5.33 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.206 0.503 . . . . 0.0 111.371 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.5 6.49 44.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.185 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.38 -174.89 4.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.895 0.348 . . . . 0.0 110.566 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.3 t -128.94 123.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.409 . . . . 0.0 111.326 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.2 -164.73 1.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.855 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.575 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 t80 -63.12 -73.9 0.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.6 -44.27 47.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.346 0.593 . . . . 0.0 110.302 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.736 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.43 -36.06 68.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.007 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.77 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -48.66 13.56 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.906 0.384 . . . . 0.0 111.496 -179.246 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.823 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -57.85 -41.2 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.363 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -35.3 71.13 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.578 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.41 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -81.66 6.31 15.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.337 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.58 ' SD ' HG13 ' B' ' 77' ' ' VAL . 2.9 mtt -115.75 -31.97 5.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.287 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.604 0.24 . . . . 0.0 111.628 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.827 0.346 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.06 -67.94 1.95 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.851 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.31 70.1 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.598 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.69 -66.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.493 0.187 . . . . 0.0 111.004 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.408 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.2 OUTLIER -51.74 -36.78 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.507 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.5 tpt180 -55.88 -50.27 71.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.12 -41.75 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.138 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.8 t -50.45 -52.4 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.581 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.828 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.1 mpt_? -70.69 -44.38 67.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.423 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 91' ' ' VAL . 15.2 mt -56.03 -51.34 68.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -63.66 -48.09 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.87 59.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.042 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.828 HG23 ' O ' ' B' ' 73' ' ' ARG . 78.6 t -76.84 -54.6 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.625 0.25 . . . . 0.0 111.398 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.655 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.9 -44.09 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.655 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.23 -35.37 71.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.224 0.535 . . . . 0.0 109.793 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.66 -36.99 80.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.194 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.834 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.9 t90 -95.28 -11.14 28.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.798 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.368 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.112 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.885 0.374 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.617 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.2 tt0 -173.82 -178.59 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.3 165.37 24.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.5 t -70.21 176.85 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.138 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -59.06 -38.01 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.322 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -73.51 -56.79 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.996 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 5' ' ' THR . 2.0 tt0 -57.65 -40.75 80.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.4 tt -72.27 -26.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.62 -43.86 62.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.516 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -67.79 -33.48 74.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.205 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.02 -49.61 64.74 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.239 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.74 -44.86 93.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 109.887 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.1 -49.06 75.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.41 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.35 -41.43 63.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.83 -38.0 69.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -75.05 -15.47 60.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.33 -37.7 16.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 110.31 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.92 -65.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.249 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.01 133.42 50.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.66 77.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.36 -12.2 28.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.55 36.69 79.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.694 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -74.8 -5.26 42.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.406 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.18 44.81 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.069 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -149.48 132.62 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.876 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.68 126.63 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.269 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.0 t -99.5 167.3 10.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.3 p -53.5 -32.14 49.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -62.67 -50.51 70.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.336 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.3 mm-40 -75.82 -36.37 59.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.731 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.0 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.38 -58.23 8.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.699 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.41 -30.88 77.6 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.665 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.6 m -63.84 -60.95 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.361 . . . . 0.0 111.086 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.2 p -65.68 -30.55 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.5 mtp -59.68 -52.14 66.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.626 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.35 -25.66 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -55.85 -38.97 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 mt -58.06 -63.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.14 40.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -141.09 168.37 19.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.05 59.48 34.1 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.43 -169.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.277 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.9 p -118.1 167.47 11.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.82 -32.07 71.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.191 0.519 . . . . 0.0 110.064 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.76 -45.74 59.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -44.55 93.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.279 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -54.03 -50.54 66.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.234 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -64.86 -52.7 55.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.534 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.17 -51.03 70.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.275 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.21 -48.38 81.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.0 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.35 -43.61 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.112 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.71 -26.34 63.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.532 0.682 . . . . 0.0 109.991 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 51' ' ' MET . 5.9 mt-10 -82.61 -2.26 53.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.591 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.628 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.6 -33.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.4 t0 -70.95 152.83 43.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.03 -53.46 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.861 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.09 -8.67 53.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.4 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.37 51.64 57.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.909 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.28 0.24 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.581 0.229 . . . . 0.0 111.402 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.51 24.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.866 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -150.0 139.88 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.536 0.208 . . . . 0.0 110.644 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.5 149.34 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 111.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.26 178.2 4.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.762 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -61.17 -61.59 7.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.5 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.8 Cg_endo -67.1 -31.22 37.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.481 2.12 . . . . 0.0 112.468 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -66.58 -38.78 87.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.977 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.8 t80 -75.27 -41.01 58.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 110.038 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.9 tp -68.81 -56.23 8.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.485 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 m -51.65 -44.57 63.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.525 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tpp -57.21 -49.92 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 mmt -79.21 -18.23 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.43 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.87 -32.75 27.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -45.16 89.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -127.43 177.8 6.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.981 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -161.29 154.15 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.84 -26.95 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.59 -37.1 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.3 mt-10 -61.7 -30.38 70.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.31 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.252 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -49.36 41.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.425 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.872 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.8 mm-40 -61.45 -45.83 92.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.412 0.625 . . . . 0.0 109.445 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -49.43 67.79 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.956 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.98 -38.68 52.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.018 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.16 -30.48 58.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.31 -37.12 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.594 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -72.55 -63.01 1.24 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.864 0.364 . . . . 0.0 110.465 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.07 113.71 20.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.11 -52.56 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 -9.6 59.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.3 71.79 0.47 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.83 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -94.85 13.46 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 111.213 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.08 68.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -162.65 116.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -113.5 123.22 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 111.531 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -104.2 161.4 14.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.979 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.588 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.71 -43.92 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.189 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -58.81 6.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.068 0.461 . . . . 0.0 110.908 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 32.2 mm-40 -55.11 -37.59 67.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.733 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.66 -50.88 71.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.835 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 110' ' ' THR . 8.2 tpt85 -56.02 -42.8 77.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -59.09 -37.88 78.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 66.8 t -68.92 -54.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.536 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.8 mmt -49.08 -54.03 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.1 t -67.21 -25.2 66.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.493 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.33 -30.26 69.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.731 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.38 -28.8 14.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.7 43.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.98 117.05 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -89.92 107.01 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.1 mm? -99.41 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.827 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.6 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.93 -41.16 91.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.686 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.535 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.4 -54.93 25.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 117' ' ' THR . 2.1 m -62.89 -41.24 91.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.19 -39.48 90.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 110.191 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 11.2 mt-10 -73.1 -30.22 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.329 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.21 -35.4 71.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.28 -54.89 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.5 ptm180 -53.74 -31.73 49.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 0.0 110.389 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.92 -21.18 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.965 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.94 -9.12 16.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.417 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.5 t0 -87.37 110.22 20.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.418 0.627 . . . . 0.0 111.203 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.725 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.86 -31.18 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.781 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.1 -9.12 43.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.614 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.08 57.69 9.69 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 114.57 0.588 . . . . 0.0 114.57 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.9 p30 -114.27 -4.27 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.053 0.427 . . . . 0.0 111.505 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.7 42.17 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.968 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.94 4.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 110.552 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 141' ' ' PHE . 52.2 t -128.31 125.42 64.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.935 0.397 . . . . 0.0 111.156 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -105.31 -166.32 1.21 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.051 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.2 t80 -59.09 -73.9 0.08 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.57 -45.04 47.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.351 0.595 . . . . 0.0 110.33 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.725 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -57.22 -36.65 71.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.176 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -49.08 12.85 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 111.877 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.83 -38.88 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -34.25 70.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.743 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -86.37 12.45 10.1 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 111.165 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.586 ' SD ' HG23 ' A' ' 85' ' ' ILE . 2.3 mtt -121.24 -38.98 2.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.984 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.315 -179.837 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.783 0.325 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -66.58 2.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.71 -49.37 77.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.84 -67.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.546 0.212 . . . . 0.0 110.89 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.439 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 1.0 OUTLIER -51.7 -37.02 48.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.522 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.3 tpp85 -55.9 -51.0 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.596 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.06 -41.61 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.563 HG12 ' NH1' ' B' ' 73' ' ' ARG . 95.6 t -50.46 -53.4 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.623 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.52 -43.71 69.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 91' ' ' VAL . 16.3 mt -56.22 -53.21 59.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 110.573 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.948 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.6 -46.52 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.719 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.38 -28.32 67.02 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.245 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 73' ' ' ARG . 77.7 t -75.92 -53.27 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.653 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -66.35 -40.99 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.2 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.1 mmp_? -57.19 -37.59 72.38 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.363 0.601 . . . . 0.0 109.551 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.53 79.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.919 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.12 -9.86 32.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.814 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.65 -36.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.287 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.025 -179.553 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.737 ' CG ' HG23 ' A' ' 70' ' ' THR . 3.2 p30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.807 0.337 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -177.85 -179.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.625 HD13 ' CD ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -135.85 165.32 25.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.09 176.42 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.142 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -37.89 76.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.369 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -73.12 -56.84 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.625 ' CD ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -58.26 -42.23 85.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.713 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 5' ' ' THR . 12.2 tt -70.43 -26.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -44.12 63.32 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.498 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.13 -32.83 71.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -66.88 -49.76 64.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -44.87 90.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.244 0.545 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -65.48 -47.48 75.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.947 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -42.15 63.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -57.21 -34.5 68.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.119 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mt -87.24 -38.3 16.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.949 0.404 . . . . 0.0 110.245 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.97 -65.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.9 t70 -66.39 132.35 48.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.808 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -38.11 80.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.22 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.89 -12.25 29.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 36.84 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.686 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -74.73 -5.16 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.421 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 2.44 44.73 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 p -149.47 132.62 16.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.21 127.05 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 62' ' ' THR . 4.5 t -100.62 167.59 10.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 p -54.4 -28.75 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -64.53 -50.47 67.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -77.15 -36.21 55.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.35 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.572 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.54 70.57 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.732 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -67.04 -53.28 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 19' ' ' PHE . 14.4 p -72.45 -31.57 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.351 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -45.13 93.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.669 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -29.47 45.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.1 t -61.82 -35.11 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.05 -31.09 66.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.57 42.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -141.55 172.56 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.08 59.96 41.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.43 -170.23 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.591 2.194 . . . . 0.0 112.253 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -122.12 165.04 16.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.75 -31.15 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 0.0 110.141 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.67 60.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -45.25 88.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.7 mt -53.28 -50.64 64.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -64.98 -53.88 39.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.606 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.33 -51.14 69.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.303 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.28 -47.72 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.669 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -59.74 -44.32 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.89 -26.37 62.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.529 0.681 . . . . 0.0 109.978 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.65 -2.2 53.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.634 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.62 -33.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 112.043 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.8 t0 -72.07 148.27 45.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.267 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.36 -53.54 7.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.684 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.67 -8.66 58.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.326 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.3 48.69 78.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.967 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -96.81 -0.19 48.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.589 0.233 . . . . 0.0 111.535 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.08 22.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.895 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.92 139.88 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.559 0.218 . . . . 0.0 110.486 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.94 147.44 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.08 0.467 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.15 178.33 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.786 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -60.28 -61.7 7.41 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.452 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -67.11 -31.51 36.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.219 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 mt-10 -64.7 -39.84 94.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.17 -45.03 43.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 110.29 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -67.92 -52.6 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.279 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 2' ' ' ASP . 76.6 m -51.6 -49.58 61.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpp -54.53 -49.5 70.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.0 2.04 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.569 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.57 -42.13 9.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.899 0.38 . . . . 0.0 110.999 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -53.69 -33.27 54.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.158 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -141.52 163.62 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 152.22 32.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -26.77 19.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.157 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.66 -35.7 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.3 mt-10 -64.33 -30.97 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.813 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.34 -37.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.119 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -49.46 35.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.519 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.9 mm-40 -61.88 -46.01 91.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.359 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.827 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.62 -48.64 69.13 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.839 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.86 -43.08 59.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.031 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -70.8 -31.59 68.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.701 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.3 m -75.54 -37.15 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 111.064 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.5 m-85 -76.6 -62.93 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.871 0.367 . . . . 0.0 110.509 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -83.44 121.9 27.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.782 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -71.24 -52.63 17.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.45 -9.58 59.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.5 68.65 0.86 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.936 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -94.41 15.84 16.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.641 0.257 . . . . 0.0 111.272 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.5 69.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.633 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.5 m-85 -162.47 116.97 1.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.585 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -110.63 123.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.979 0.419 . . . . 0.0 111.278 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -103.96 157.05 17.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.248 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -41.45 22.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.79 6.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.6 mm-40 -55.1 -39.31 69.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.677 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.18 -50.9 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.922 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.704 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.55 -42.81 79.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.286 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -36.42 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.404 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.1 t -72.73 -54.79 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.518 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.3 mmt -49.11 -54.02 18.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.645 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' ARG . 10.9 t -66.9 -25.18 66.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.96 -29.97 68.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.63 -28.78 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.68 43.75 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -149.88 112.95 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -90.85 102.23 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -94.47 164.48 12.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.794 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.847 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.6 m -98.32 158.81 15.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -59.32 -42.17 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.31 -54.87 22.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.756 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 117' ' ' THR . 2.2 m -63.52 -40.66 89.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.65 -41.03 96.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.433 . . . . 0.0 110.275 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 26.8 mt-10 -72.63 -30.12 64.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.373 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -33.94 69.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.611 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.29 -55.08 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.657 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 8.8 ptm180 -54.59 -31.82 57.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 110.405 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.35 -21.93 55.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.796 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.72 -15.41 15.76 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.606 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -82.44 90.52 6.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.74 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.74 -30.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.429 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.602 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.0 -9.48 57.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.164 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.88 23.83 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 114.81 0.684 . . . . 0.0 114.81 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 32.2 p30 -113.79 -5.55 13.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.227 0.513 . . . . 0.0 111.303 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 6.66 44.39 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.213 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.58 -174.82 4.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.834 0.35 . . . . 0.0 110.661 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.4 t -127.33 120.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -98.71 -169.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.608 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.5 t80 -60.12 -73.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.536 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.66 -43.59 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.286 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.74 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -56.26 -34.72 66.66 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.45 -48.7 13.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 111.22 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.813 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.71 -40.41 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.321 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -36.04 71.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.615 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.475 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.1 4.92 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.556 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.1 mtt -112.04 -31.62 6.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.028 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.464 -179.818 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.791 0.329 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.15 -68.23 1.76 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.58 -52.72 46.79 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.37 -62.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.509 0.195 . . . . 0.0 110.871 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.1 OUTLIER -51.81 -35.2 43.38 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.39 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.563 ' HE ' HD11 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -56.6 -53.27 59.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.69 -42.28 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.238 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.1 t -50.43 -52.86 14.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -69.92 -45.57 67.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.543 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.78 HD22 HG11 ' A' ' 91' ' ' VAL . 40.7 mt -55.79 -52.61 63.38 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.656 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.947 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.84 -47.62 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.575 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.89 59.38 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.205 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.82 HG11 ' CB ' ' A' ' 88' ' ' ALA . 79.8 t -76.78 -56.15 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.689 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.42 -43.75 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.662 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.03 -34.64 70.28 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.22 0.533 . . . . 0.0 109.783 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.19 -37.25 82.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.293 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.906 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.7 t90 -95.25 -11.1 28.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.744 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.29 -36.21 58.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.523 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 70' ' ' THR . 6.5 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.6 tt0 -177.02 -178.92 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.749 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -134.81 165.11 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.861 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.2 t -71.37 177.28 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.132 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.36 -38.98 78.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 tt0 -71.9 -56.77 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.044 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.749 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -58.63 -43.36 89.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.738 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 5' ' ' THR . 7.0 tt -69.04 -26.44 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.062 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.42 -43.37 61.97 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -68.22 -33.47 74.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.63 -49.74 65.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.17 -44.85 92.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.264 0.554 . . . . 0.0 110.047 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -64.45 -48.5 75.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.576 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -41.7 63.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.316 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -38.28 71.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.05 -15.67 61.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.62 -38.6 16.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.199 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.38 -65.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.2 t70 -65.44 132.64 49.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.707 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -37.14 75.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.3 -12.27 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.19 36.96 77.7 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.636 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 1.72 44.64 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.048 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.0 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.678 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.844 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mt -108.18 121.53 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.5 t -97.88 167.5 10.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.0 p -54.34 -35.53 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -56.77 -50.43 72.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.158 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.83 -37.91 47.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 110.768 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.55 -43.31 71.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.909 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.36 -27.5 72.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.202 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -72.34 -49.75 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.2 p -72.32 -33.54 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.0 mtp -60.41 -45.71 92.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.958 0.409 . . . . 0.0 110.677 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -25.92 44.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -58.05 -37.11 73.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.51 -30.75 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.79 41.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -142.61 163.22 33.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.51 61.84 12.08 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.73 -170.93 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.567 2.178 . . . . 0.0 112.277 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -122.11 167.01 13.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.82 -31.98 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.67 59.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.341 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -43.33 94.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.208 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.3 mt -55.15 -50.67 68.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -52.31 58.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.432 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.67 -51.15 70.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.249 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.69 -47.76 83.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.754 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.98 -45.11 99.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.27 -26.48 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.599 0.714 . . . . 0.0 110.143 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.8 mt-10 -82.75 -2.06 53.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.496 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.64 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.61 -33.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.505 ' N ' HD12 ' A' ' 63' ' ' ILE . 52.9 t0 -72.25 148.57 45.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.317 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.37 -53.57 6.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.15 -8.66 58.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.3 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.55 48.42 81.26 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.968 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -97.31 -0.88 45.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.543 0.211 . . . . 0.0 111.421 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.485 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.33 15.51 21.12 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.939 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 28' ' ' THR . 2.8 p -149.73 139.79 22.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.12 149.39 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.301 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.26 175.92 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -58.65 -61.64 7.28 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.157 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.2 Cg_endo -63.98 -33.83 61.48 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.374 2.049 . . . . 0.0 111.756 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -68.71 -36.46 78.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.391 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -75.33 -40.15 58.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.349 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD21 ' CG ' ' A' ' 3' ' ' GLN . 4.6 tp -76.78 -53.08 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.586 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 2' ' ' ASP . 98.7 m -51.46 -49.98 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.487 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 2.1 tpp -53.47 -48.05 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.9 mmt -88.64 10.44 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.52 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -105.21 -36.39 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -57.13 -40.12 76.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.24 167.58 22.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -153.69 152.52 30.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.777 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -25.49 23.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -74.58 -38.13 62.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 47.3 mt-10 -60.23 -31.27 70.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.814 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.34 -39.38 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.291 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -70.93 -49.35 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.338 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.2 mt-10 -61.05 -46.19 91.68 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.61 -49.44 67.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.149 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.03 -38.55 52.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.917 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -76.65 -30.53 56.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.866 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.23 -36.94 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 110.898 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -72.41 -62.91 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.5 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.62 119.35 24.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -62.34 -52.61 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.52 -9.65 59.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.461 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.63 0.47 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.08 14.44 17.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.663 0.268 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.76 66.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.4 m-85 -161.55 116.68 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.512 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.7 mt -113.92 124.66 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.47 . . . . 0.0 111.656 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.8 t -104.28 161.15 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.89 -43.94 29.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.268 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.07 -58.93 6.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.931 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.36 -37.61 67.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.671 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.36 -50.86 71.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.844 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -43.61 76.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.117 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -58.1 -38.88 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.382 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.25 -54.92 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.617 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.4 mmt -49.41 -54.06 19.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.869 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.5 t -67.7 -25.17 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.581 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -68.53 -30.36 69.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.26 -28.73 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.013 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.41 43.46 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.584 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -152.79 110.77 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -83.73 115.8 22.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -105.81 163.31 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.792 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.6 m -98.27 158.76 15.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.59 -40.81 93.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.92 -35.56 74.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.568 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.96 -54.88 23.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.709 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -63.38 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.71 -40.06 93.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.11 0.481 . . . . 0.0 110.171 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 14.2 mt-10 -72.9 -30.15 63.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.289 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.459 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 46.1 ttm -71.01 -35.79 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.879 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 105' ' ' LEU . 4.2 mm -80.4 -54.91 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.579 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -53.44 -31.79 46.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.996 0.427 . . . . 0.0 110.46 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.96 -21.58 50.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.942 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.95 -8.56 17.55 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ILE . 35.9 t0 -88.54 110.27 20.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.645 . . . . 0.0 111.312 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.724 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.22 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.765 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.86 -9.09 44.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.562 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.9 57.94 9.18 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.4 p30 -114.23 -4.19 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.033 0.416 . . . . 0.0 111.505 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 7.59 42.45 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.13 -174.96 4.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 110.458 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.14 126.62 66.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.94 -167.54 1.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.638 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.1 t80 -58.52 -73.94 0.07 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.516 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.47 -45.74 47.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.617 . . . . 0.0 110.32 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.724 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.44 -36.4 68.95 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.62 -49.59 11.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.965 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.814 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.28 -40.53 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -34.28 70.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.713 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.02 8.9 13.82 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.649 0.261 . . . . 0.0 111.328 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.0 mtt -118.18 -38.9 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.767 0.317 . . . . 0.0 111.034 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.9 mpp_? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.68 -68.39 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.49 -49.75 75.17 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.64 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.64 -66.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.477 0.179 . . . . 0.0 110.87 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.437 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.2 OUTLIER -51.79 -38.96 57.74 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.329 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.432 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -54.58 -49.52 70.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.58 -41.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.18 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.46 -53.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.556 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.869 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -68.9 -46.46 68.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.42 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.95 HD22 HG11 ' A' ' 91' ' ' VAL . 20.6 mt -55.72 -53.57 54.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.736 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -60.32 -47.2 93.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.434 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.565 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.33 -30.3 61.28 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.112 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.869 HG23 ' O ' ' B' ' 73' ' ' ARG . 93.6 t -75.26 -55.39 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.606 0.241 . . . . 0.0 111.446 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.06 -43.98 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.3 mmm180 -58.2 -35.3 71.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 109.728 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -61.14 -37.12 81.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.252 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.884 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.4 t90 -95.32 -10.09 31.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.854 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.62 -36.1 57.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.297 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.112 -179.583 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.0 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.927 0.394 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.496 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 1.4 tt0 -176.93 169.63 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.587 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -127.69 165.25 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 110.839 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 177.33 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.96 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.8 -37.12 78.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.85 -56.94 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.116 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.587 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.99 -41.48 83.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.423 . . . . 0.0 110.758 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' THR . 6.8 tt -71.93 -26.44 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.092 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.49 -43.4 62.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.478 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.35 -33.11 72.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.14 -49.67 66.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.436 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -45.0 90.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 110.168 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -64.88 -48.44 74.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.37 -41.64 63.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.447 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -33.98 65.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.022 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.7 mt -87.72 -39.08 15.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.927 0.394 . . . . 0.0 110.045 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.631 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.36 -65.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.374 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -66.43 132.47 48.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.874 0.368 . . . . 0.0 110.705 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -37.25 74.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.02 -12.16 29.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.39 36.93 79.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.632 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -74.89 -4.45 38.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.446 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.01 44.09 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.125 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -149.46 132.53 16.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.876 0.338 . . . . 0.0 110.899 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -106.22 127.27 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.6 t -101.97 167.7 9.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.8 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -54.26 -31.51 53.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -62.67 -50.43 71.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.338 . . . . 0.0 111.222 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' O ' HG12 ' A' ' 35' ' ' VAL . 15.6 mm-40 -77.15 -35.8 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.34 -58.17 8.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.752 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.44 68.8 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.685 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.8 m -70.18 -54.21 13.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -74.49 -31.1 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.1 ttt -61.02 -44.78 96.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -25.68 44.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.941 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -56.75 -36.43 69.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.99 -31.47 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -142.61 160.88 39.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.4 62.22 22.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.88 -170.11 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -121.34 167.23 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.76 -32.14 71.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.132 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.6 60.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.384 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -43.3 94.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.1 mt -55.27 -50.75 68.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -64.72 -52.32 57.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.42 -51.12 70.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.263 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.88 -48.08 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.73 -44.37 97.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.279 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -57.07 -26.45 60.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.556 0.693 . . . . 0.0 110.033 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.92 -2.06 53.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.71 -32.99 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.9 t0 -72.22 149.28 44.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.343 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.06 -53.55 6.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.49 -8.72 58.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.59 48.91 77.96 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.93 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -97.5 -0.77 45.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.627 0.251 . . . . 0.0 111.496 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.53 21.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.885 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.77 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.608 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.01 149.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.412 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.88 172.91 6.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -56.39 -61.58 6.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.1 Cg_endo -63.94 -33.04 64.91 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.046 . . . . 0.0 111.862 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -69.62 -35.73 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.8 t80 -75.28 -40.6 58.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.262 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.515 HD11 ' HG ' ' A' ' 4' ' ' LEU . 6.5 tp -76.78 -53.99 7.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.587 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 2' ' ' ASP . 62.4 m -51.37 -45.2 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.526 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.439 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -54.32 -52.62 60.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.488 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 21.9 mtt -80.02 -10.35 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.533 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -84.66 -33.33 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.899 0.38 . . . . 0.0 110.845 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -57.88 -43.81 86.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.963 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.38 -178.31 4.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.2 m -162.15 161.92 28.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.63 -27.38 39.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.23 -42.46 75.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.973 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 mt-10 -59.25 -33.09 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.36 -37.99 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.244 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -49.41 41.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 57.9 mt-10 -62.04 -46.41 89.27 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.58 -48.09 69.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.781 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.85 -43.15 59.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -71.1 -32.17 68.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.72 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.003 HG11 HD22 ' B' ' 74' ' ' LEU . 1.3 m -75.0 -36.62 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.733 0.301 . . . . 0.0 111.002 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.722 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.1 m-85 -74.65 -62.92 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.496 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -84.68 132.23 34.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -76.62 -52.59 9.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.54 -9.61 59.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.46 70.21 0.66 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.902 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -94.24 15.32 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.44 69.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.696 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -160.39 117.04 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.549 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -112.17 123.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.229 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.0 t -103.96 157.72 16.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.308 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.554 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.68 -41.52 22.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.12 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -58.77 6.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.78 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.9 mm-40 -55.13 -39.08 69.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.991 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.52 -50.9 72.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.92 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.657 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.43 -42.31 77.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.146 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -36.22 77.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.32 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 67.5 t -72.58 -54.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.762 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.516 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.54 -54.03 20.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.657 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.4 t -66.94 -25.46 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.65 -30.01 68.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.64 -28.77 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.24 43.89 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -149.59 114.88 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -91.6 101.5 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -93.83 163.56 13.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.839 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.3 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -59.38 -42.07 90.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.741 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -69.73 -35.85 75.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.15 -54.86 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.74 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -63.6 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -61.49 -41.42 97.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.082 0.467 . . . . 0.0 110.313 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 34.8 mt-10 -72.42 -30.15 64.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.266 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -70.72 -34.41 71.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.647 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.991 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.27 -55.17 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.708 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm180 -54.38 -31.8 55.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 0.0 110.415 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.47 -21.6 57.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.892 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -18.09 14.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.66 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.05 90.59 4.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.94 -30.91 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.6 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.28 -9.46 57.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.123 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 51.06 53.61 26.4 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.7 p30 -113.78 -5.55 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.232 0.516 . . . . 0.0 111.271 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 6.24 44.64 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.219 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.06 -174.88 4.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.669 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 47.0 t -127.36 120.59 55.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.006 0.432 . . . . 0.0 111.274 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB3' ' HG3' ' A' ' 140' ' ' GLU . 5.5 t30 -98.98 -169.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.64 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.2 t80 -59.53 -73.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.62 -43.62 46.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.405 0.622 . . . . 0.0 110.331 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.746 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.1 mt-10 -56.3 -34.75 66.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.928 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.41 -48.45 13.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.293 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.8 -39.79 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.07 71.45 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.567 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.478 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -84.77 11.1 9.75 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.543 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.4 mtt -119.26 -39.56 2.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.479 -179.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.579 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.843 0.354 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.97 -71.46 1.14 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.586 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.29 -48.2 65.1 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.59 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.151 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.1 OUTLIER -55.07 -31.7 61.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.009 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -53.78 -53.56 50.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.409 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.739 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.34 -38.55 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 68' ' ' PHE . 99.4 t -50.61 -43.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.742 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.94 -46.45 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.051 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 91' ' ' VAL . 32.8 mt -55.85 -48.28 75.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.373 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.1 p -65.07 -48.24 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.584 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.58 -29.63 57.95 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.017 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 88' ' ' ALA . 81.7 t -76.88 -54.62 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.611 0.243 . . . . 0.0 111.58 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.58 -43.91 97.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.0 mmm180 -57.68 -34.44 69.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.239 0.542 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -37.42 83.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.22 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.932 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.3 -10.48 30.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.852 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.31 -36.09 58.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.059 -179.484 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.85 0.357 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.681 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -177.26 179.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.62 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -130.87 165.32 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.901 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 8' ' ' GLN . 8.7 t -69.11 177.33 2.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -60.48 -36.34 78.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -73.22 -56.95 4.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.62 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.89 -41.95 83.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.006 0.432 . . . . 0.0 110.686 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 5' ' ' THR . 7.2 tt -71.36 -26.43 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.48 -43.53 62.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.14 -32.82 70.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.53 -49.68 68.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.456 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -45.1 89.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.193 0.521 . . . . 0.0 110.23 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -64.67 -48.81 73.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.691 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.36 -41.39 63.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.471 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.81 -38.68 70.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.999 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -74.14 -13.92 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.933 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.69 -39.74 14.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.954 0.406 . . . . 0.0 110.151 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.45 -65.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.356 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -65.39 132.88 50.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -37.62 74.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.24 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.73 -12.26 29.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.7 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.64 37.21 82.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -74.77 -4.55 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.244 -0.183 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.15 44.16 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.116 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -149.55 132.5 16.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.796 0.331 . . . . 0.0 110.892 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mt -105.52 127.38 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.8 t -102.41 168.44 9.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 p -54.78 -34.35 62.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.48 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -50.49 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.248 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -77.19 -36.53 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.158 0.504 . . . . 0.0 110.826 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.3 -58.21 8.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.823 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.52 64.23 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.793 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -72.04 -59.97 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 111.172 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -64.33 -30.56 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.174 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 mtp -60.93 -56.43 21.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -25.63 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.95 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.4 t -57.77 -38.66 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.64 -35.65 68.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.72 43.59 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -142.6 163.39 32.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.43 61.17 27.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.09 -170.17 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 0.0 112.248 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -122.11 166.92 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.83 -31.96 71.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.084 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.45 59.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.436 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.53 -41.9 92.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.364 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -56.63 -50.95 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.59 -57.04 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.407 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -51.06 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.147 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 19.2 mtt -58.19 -46.84 85.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.959 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.83 -45.82 97.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.029 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -56.13 -26.53 50.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.538 0.685 . . . . 0.0 110.042 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.7 mt-10 -82.15 -2.19 51.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.467 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.25 -32.99 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.0 111.934 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.8 t0 -72.74 152.72 41.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.183 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.33 -53.55 6.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.54 -8.74 57.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.316 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.91 49.93 70.31 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.853 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -97.27 -0.2 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.424 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.5 24.11 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.825 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.84 139.86 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.58 149.43 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -103.87 174.78 5.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -58.06 -61.58 7.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -63.62 -33.82 65.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.055 . . . . 0.0 111.81 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -69.15 -36.25 77.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.427 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.29 -40.11 58.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.28 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.4 tp -76.7 -54.7 6.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.536 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -51.61 -43.3 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.427 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -55.18 33.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 11.6 mtt -79.08 -11.47 59.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.516 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -85.08 -38.25 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -63.13 -30.46 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.64 179.05 7.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -160.85 154.44 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -25.52 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -39.7 65.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 60.2 mt-10 -59.95 -30.45 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.89 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -49.4 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.438 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 50.7 mt-10 -61.59 -45.81 92.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.783 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.66 -48.89 69.01 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.966 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.04 -38.74 53.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -30.5 57.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.995 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.28 -36.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.715 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -73.29 -62.91 1.31 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.511 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -83.48 119.1 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -62.7 -52.62 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.8 -9.72 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.471 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.0 71.3 0.49 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.956 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -93.48 14.55 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.279 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.18 67.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.582 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 6.6 m-85 -162.37 116.89 1.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -113.21 124.38 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.069 0.461 . . . . 0.0 111.539 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -104.11 160.08 15.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.954 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.583 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -43.54 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.83 6.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.019 0.437 . . . . 0.0 110.84 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -55.22 -37.34 67.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.671 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.958 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.68 -50.78 72.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.795 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 110' ' ' THR . 8.4 tpt85 -55.91 -43.14 77.04 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -37.41 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.382 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.65 -53.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.626 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -51.16 -54.16 27.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.0 t -66.52 -25.72 66.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.24 -30.04 69.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.79 -28.79 14.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -152.37 109.77 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -86.48 110.55 19.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.489 HD12 ' CG ' ' A' ' 120' ' ' GLU . 3.8 mm? -101.36 166.06 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.0 m -98.35 158.73 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.41 -40.51 91.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' CG ' HD12 ' A' ' 116' ' ' LEU . 5.3 tp10 -64.39 -55.04 23.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.725 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -62.94 -40.97 90.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.35 -39.03 89.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.1 0.476 . . . . 0.0 110.123 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.7 mt-10 -73.4 -30.15 63.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.3 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.16 -35.5 71.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.958 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.31 -55.02 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.589 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.8 ptm180 -53.95 -31.81 51.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.016 0.436 . . . . 0.0 110.386 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -79.24 -21.31 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.15 -2.33 21.03 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.331 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.9 t0 -94.61 104.92 16.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.448 0.642 . . . . 0.0 111.135 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -79.04 -31.66 14.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.092 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.1 -9.1 46.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.55 -178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.15 57.1 10.57 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.7 p30 -114.23 -4.04 13.11 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.104 0.452 . . . . 0.0 111.408 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 6.93 43.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.087 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.08 -174.74 4.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.613 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.3 t -128.13 125.28 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.931 0.396 . . . . 0.0 111.212 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.7 t30 -105.12 -165.24 1.11 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.939 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.61 ' O ' HG13 ' A' ' 142' ' ' VAL . 13.2 t80 -60.09 -73.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.6 -44.82 47.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 110.383 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.73 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -57.39 -35.66 70.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.731 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.44 -48.61 13.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.994 0.426 . . . . 0.0 111.673 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -56.81 -38.65 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.55 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -71.2 -35.1 71.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.627 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.421 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -86.36 12.85 9.2 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.726 0.298 . . . . 0.0 111.088 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.6 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.9 mtt -120.73 -38.47 2.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.313 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.58 -75.0 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.692 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.99 -50.48 27.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.668 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.28 -65.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.089 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.454 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -54.1 -31.81 53.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.44 . . . . 0.0 110.045 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.6 tpp85 -54.07 -53.61 50.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.734 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.73 -37.78 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.612 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.3 t -50.47 -45.65 25.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.366 0.603 . . . . 0.0 110.861 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.833 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -75.48 -45.66 37.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.338 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.995 HD22 HG11 ' A' ' 91' ' ' VAL . 29.8 mt -55.97 -46.68 78.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.979 0.419 . . . . 0.0 110.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.9 p -66.42 -48.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.499 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.585 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.93 -28.11 57.5 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.866 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.833 HG23 ' O ' ' B' ' 73' ' ' ARG . 95.9 t -76.83 -54.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 111.419 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.715 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -62.86 -44.08 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -58.0 -35.36 71.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -37.3 79.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.913 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.7 t90 -95.38 -11.25 28.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.831 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.04 -35.57 59.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.342 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 -179.56 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.676 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.9 tt0 -158.14 179.55 9.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.806 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -129.22 165.29 21.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.07 177.31 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -59.93 -36.85 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.339 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -73.33 -56.93 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.806 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.59 -41.16 80.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' THR . 6.0 tt -72.33 -26.24 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.32 -44.41 61.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.788 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 6.4 pm0 -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.18 -49.71 68.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.417 -179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -58.38 -45.12 88.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.85 -48.65 73.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.715 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.32 -41.42 62.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.486 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.5 -38.84 69.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.066 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -74.2 -13.76 60.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.4 mt -87.75 -39.8 14.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.95 -65.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.392 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 6.8 t70 -65.34 133.16 50.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.844 0.354 . . . . 0.0 110.736 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.61 -37.62 73.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.19 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.64 -12.25 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 37.28 82.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.688 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -74.69 -4.58 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.211 -0.195 . . . . 0.0 111.389 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.25 0.21 44.09 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.064 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.9 p -149.58 132.53 16.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.851 0.358 . . . . 0.0 110.879 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 32' ' ' LEU . 2.0 mt -105.33 126.92 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 6.9 t -101.87 168.1 9.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 p -53.81 -37.21 63.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.644 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -57.27 -50.52 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.357 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.96 -36.67 56.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.144 0.497 . . . . 0.0 110.821 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.956 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.42 -58.11 8.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.859 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.49 64.94 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.833 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -71.32 -60.29 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.336 . . . . 0.0 111.197 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -63.84 -30.49 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.9 mtp -61.03 -56.49 20.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.59 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -25.6 66.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.8 t -57.22 -38.13 73.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.57 -30.94 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.0 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.583 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -142.63 166.16 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -120.34 60.99 7.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.43 165.22 33.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.6 p -102.87 165.33 11.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.05 -29.35 67.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 110.274 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.68 -50.86 53.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.638 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.45 -37.6 87.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 19.6 mt -57.51 -51.01 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.771 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -56.67 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.33 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -54.91 -51.02 67.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.163 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.507 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 59.4 mtt -59.03 -46.11 89.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.956 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.64 -45.91 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.953 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -55.96 -26.56 48.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.555 0.693 . . . . 0.0 110.03 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.4 mt-10 -82.12 -2.11 50.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.442 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.36 -32.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.905 0.383 . . . . 0.0 111.99 -177.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.9 t0 -72.82 152.17 41.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.87 -53.54 6.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.679 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.52 -8.6 57.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.282 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.84 49.79 71.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.891 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -97.34 -0.25 46.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.536 0.208 . . . . 0.0 111.444 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.64 23.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.881 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -149.85 139.86 22.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.82 149.32 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.458 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.68 174.83 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.952 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -57.94 -61.67 6.95 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -63.74 -33.75 64.57 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.392 2.062 . . . . 0.0 111.812 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -69.06 -36.12 77.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.438 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.27 -40.04 59.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.295 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.676 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.0 tp -76.72 -54.93 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.451 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -51.67 -43.42 62.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.519 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -55.5 30.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.491 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 17.6 mtt -76.95 -17.3 58.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.442 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -81.58 -31.63 32.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -30.61 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 -178.48 6.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.52 157.68 30.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -54.61 -26.43 32.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 66.6 mt-10 -59.54 -31.82 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.828 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.28 -39.28 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.257 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -49.35 46.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.468 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.3 mm-40 -61.39 -46.21 91.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.375 0.607 . . . . 0.0 109.404 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.53 -48.95 68.6 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.07 -38.58 52.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.023 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -76.56 -30.53 57.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.82 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.013 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.35 -36.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.675 0.274 . . . . 0.0 111.077 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -73.34 -62.97 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.352 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -83.94 129.98 34.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -74.83 -52.66 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.63 -9.7 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.01 70.54 0.6 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.94 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -93.87 15.04 17.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.698 0.285 . . . . 0.0 111.217 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.58 69.02 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.2 m-85 -163.96 116.92 1.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.688 0.28 . . . . 0.0 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.27 126.55 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.547 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.7 t -104.0 156.85 17.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -40.91 21.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.92 6.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 110.801 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -55.87 -38.13 69.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.706 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.906 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.03 -50.74 72.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.845 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 110' ' ' THR . 8.0 tpt85 -55.72 -44.17 77.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -37.21 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.289 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.41 -53.58 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.732 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.546 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.2 mmt -50.3 -54.08 23.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.4 t -67.14 -25.62 66.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -29.95 68.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.73 -28.78 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.87 43.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -149.36 116.78 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -91.75 102.84 15.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.983 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.54 163.71 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.4 m -98.29 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.01 -42.2 93.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.643 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.89 -54.87 20.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -64.52 -40.0 87.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -62.26 -41.41 98.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 110.34 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.7 mt-10 -72.91 -30.17 63.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.415 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -71.45 -34.3 70.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.906 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.33 -54.91 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.631 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.0 ptm180 -54.51 -31.77 56.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.043 0.449 . . . . 0.0 110.347 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.99 -21.7 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.36 16.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.435 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 125' ' ' ILE . 49.0 t0 -84.07 89.65 7.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.449 0.642 . . . . 0.0 110.965 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -62.93 -30.8 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.419 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.595 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.8 -9.48 56.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.163 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.47 54.17 21.72 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.802 0.681 . . . . 0.0 114.802 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.9 p30 -113.84 -5.38 13.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.207 0.504 . . . . 0.0 111.307 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 6.29 44.54 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.316 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.83 -174.82 4.45 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.937 0.368 . . . . 0.0 110.712 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.5 t -128.6 123.56 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.424 . . . . 0.0 111.304 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.74 -164.95 1.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' O ' HG13 ' A' ' 142' ' ' VAL . 16.2 t80 -62.44 -74.06 0.1 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.68 -44.29 47.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 110.329 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.741 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.48 -35.82 68.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.006 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.17 -48.34 14.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 111.418 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.828 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -59.15 -40.31 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.437 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.41 -34.78 70.65 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.577 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -83.54 9.53 11.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.642 0.258 . . . . 0.0 111.279 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.583 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.5 mtt -119.21 -39.16 2.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.477 -179.804 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.945 0.403 . . . . 0.0 110.989 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 70' ' ' ARG . . . -71.81 -71.88 1.0 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.532 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.7 -49.47 46.94 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.459 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.729 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.0 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.008 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.404 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.0 OUTLIER -56.32 -31.76 64.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -52.84 -53.55 47.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.331 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.729 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.93 -38.7 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.9 t -50.62 -44.5 25.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.316 0.579 . . . . 0.0 110.884 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.82 ' O ' HG23 ' B' ' 77' ' ' VAL . 5.1 mpt_? -75.24 -47.22 29.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.013 HD22 HG11 ' A' ' 91' ' ' VAL . 33.1 mt -55.81 -46.57 78.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -65.99 -48.72 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.38 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.588 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.75 -28.26 56.74 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.855 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.82 HG23 ' O ' ' B' ' 73' ' ' ARG . 99.3 t -76.85 -55.44 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.65 0.262 . . . . 0.0 111.525 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.91 -44.13 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.7 mmm180 -57.77 -35.14 70.37 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 109.767 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -36.48 81.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.855 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.31 -10.46 30.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.785 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.89 -36.22 56.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.028 -179.56 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.844 0.354 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.705 ' CG ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -176.22 172.78 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -120.3 165.4 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -71.81 177.36 4.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.783 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 9' ' ' ILE . 16.1 pt-20 -58.32 -41.99 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.292 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.9 tt0 -67.14 -57.11 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.08 -44.68 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.018 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.438 HG13 HD13 ' A' ' 69' ' ' LEU . 7.6 tt -69.64 -26.59 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.251 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.6 -43.47 62.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.453 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.75 -32.81 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -66.07 -49.61 67.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -45.05 90.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.211 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -64.75 -48.82 73.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.7 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.12 62.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.399 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -54.08 -40.51 67.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.401 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 t -75.9 -12.94 60.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.13 -40.34 14.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 110.425 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.716 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.76 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.222 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.69 133.21 48.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.837 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.9 88.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.347 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.03 -12.13 36.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.28 38.7 91.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.69 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -73.51 -5.78 42.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.435 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 6.32 42.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.215 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -149.83 133.19 16.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.801 0.3 . . . . 0.0 110.74 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -100.04 117.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HA ' HG22 ' A' ' 62' ' ' THR . 8.9 t -89.18 159.07 17.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.725 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.8 p -54.72 -34.33 62.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.36 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.51 -50.42 73.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 111.046 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -76.08 -36.69 58.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.029 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.85 -44.43 73.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.095 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.85 -27.4 73.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.321 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -71.92 -49.68 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.6 p -72.43 -35.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.3 ttm -58.94 -45.22 90.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -25.59 44.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.8 t -54.64 -38.09 66.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.77 -30.15 65.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.986 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.87 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -142.62 161.75 37.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -119.66 62.79 7.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.69 176.38 8.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.207 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -109.38 168.27 9.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -32.15 71.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.079 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.92 60.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.451 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.313 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.434 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.3 mt -59.64 -50.66 72.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.78 -43.44 93.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.335 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.31 -51.14 62.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.155 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -57.64 -52.13 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.029 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -58.11 -42.28 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.015 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.66 -26.43 65.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.513 0.673 . . . . 0.0 109.893 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.9 mt-10 -83.03 -2.21 54.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.719 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.35 -33.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.078 -177.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' HD12 ' A' ' 63' ' ' ILE . 49.7 t0 -70.54 154.62 41.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.399 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.62 -53.75 5.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.802 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -89.14 -8.65 53.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.362 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.2 51.67 57.79 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.848 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -100.06 1.13 42.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.574 0.226 . . . . 0.0 111.437 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.35 15.02 22.56 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.975 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.6 p -150.02 139.72 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.604 0.24 . . . . 0.0 110.88 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.626 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.0 mm -96.54 149.89 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.94 172.85 6.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.2 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -53.55 -61.55 4.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.775 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 -26.3 37.42 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.673 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 15.6 mm-40 -73.71 -38.31 64.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.41 -43.32 50.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 110.37 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.705 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.4 tp -70.08 -57.06 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.811 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.3 m -51.44 -53.78 33.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.649 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.9 tpp -54.26 -38.72 66.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.8 mmt -97.91 14.53 26.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.244 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.22 -36.01 5.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -55.49 -55.76 28.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.265 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.59 -175.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -168.4 -166.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -67.36 -29.15 68.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.51 -26.57 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -71.1 -45.16 64.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.472 . . . . 0.0 110.83 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.6 -33.64 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.593 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -49.37 52.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.368 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.757 ' O ' HG13 ' A' ' 91' ' ' VAL . 46.3 mm-40 -62.41 -48.47 79.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.415 0.626 . . . . 0.0 109.698 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.774 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.38 -44.54 68.72 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.953 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.47 57.8 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.928 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.56 -32.35 58.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.946 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.91 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.9 -36.65 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 120.678 0.275 . . . . 0.0 111.024 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.585 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -72.94 -63.08 1.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.487 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -86.23 128.57 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -52.72 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.982 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.86 -9.75 58.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.413 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.52 69.74 0.63 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.006 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -93.27 14.35 18.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.284 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 17.3 66.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.604 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.8 m-85 -158.45 116.94 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.694 0.283 . . . . 0.0 110.972 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 125' ' ' ILE . 2.7 mt -110.36 124.31 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -103.91 157.45 17.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.255 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.566 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.77 -42.94 26.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.25 -58.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.7 mm-40 -55.0 -39.23 68.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.629 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.971 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.17 -50.71 72.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.888 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 110' ' ' THR . 0.0 OUTLIER -57.64 -41.01 80.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.674 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.63 -39.03 86.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.513 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.7 t -72.8 -55.34 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.5 mmt -49.03 -54.0 17.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.3 t -65.41 -25.42 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -30.98 68.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.53 -28.83 15.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.35 42.31 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -144.0 109.77 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -88.88 94.14 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.63 147.11 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 121' ' ' VAL . 12.5 t -85.88 163.37 18.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.72 -31.03 69.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.64 -45.97 73.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.599 ' H ' HG23 ' A' ' 117' ' ' THR . 49.2 mm-40 -61.12 -54.87 39.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 117' ' ' THR . 1.6 m -62.23 -38.3 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -61.44 -43.59 98.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 110.345 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 71.5 mt-10 -71.77 -30.2 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.401 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtp -70.71 -34.0 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.731 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 105' ' ' LEU . 4.1 mm -80.31 -54.94 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.585 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 11.5 ptt180 -55.14 -31.93 61.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 110.385 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.3 -21.12 54.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.632 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -104.56 -14.51 15.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.433 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.95 93.73 7.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.395 0.616 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.1 pt -66.43 -31.27 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.51 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.618 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -85.83 -9.37 57.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.123 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.22 54.76 18.31 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.697 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.7 p30 -113.98 -5.18 13.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.194 0.497 . . . . 0.0 111.367 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.069 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.91 -174.77 4.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.35 . . . . 0.0 110.547 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 141' ' ' PHE . 42.3 t -127.3 120.51 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 7.3 t30 -96.07 -167.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.354 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.2 t80 -62.36 -73.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.58 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.74 -43.3 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.303 0.573 . . . . 0.0 110.414 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.748 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -55.9 -33.49 64.68 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.489 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -79.07 -45.45 20.07 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.104 0.478 . . . . 0.0 111.683 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -65.52 -38.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.158 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.493 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -70.43 -36.07 73.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.57 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.797 ' HE3' ' CG ' ' B' ' 81' ' ' TRP . 6.1 ptm -73.35 -21.42 60.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.447 ' O ' ' HB ' ' A' ' 146' ' ' THR . 1.2 tpp -88.63 -49.48 6.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.288 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 145' ' ' MET . 11.3 t . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.498 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.88 3.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.673 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.86 -49.34 55.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.391 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -53.22 -68.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.533 0.206 . . . . 0.0 110.887 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.8 -38.84 57.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.771 0.319 . . . . 0.0 110.455 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.7 tpt180 -56.06 -48.28 76.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.671 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -61.56 -40.28 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.262 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.1 t -53.44 -53.46 24.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.816 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.873 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.95 -49.08 40.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.354 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.91 HD22 HG11 ' A' ' 91' ' ' VAL . 18.9 mt -55.96 -44.15 78.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 12.5 p -67.6 -48.97 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.752 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.578 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -55.96 -31.26 58.4 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.079 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' B' ' 73' ' ' ARG . 49.1 t -76.79 -54.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.696 0.284 . . . . 0.0 111.731 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -62.1 -43.85 98.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -57.96 -31.71 67.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.997 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -37.12 85.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.935 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.5 t90 -95.26 -15.72 22.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.888 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.2 -31.6 16.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.31 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.339 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.863 0.363 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.651 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.1 tt0 -158.81 178.7 9.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -127.85 165.34 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.2 t -72.43 177.4 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 9' ' ' ILE . 17.2 pt-20 -57.36 -42.85 82.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.418 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -66.3 -56.97 8.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.185 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 2.2 tp60 -59.16 -49.05 79.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 5' ' ' THR . 10.9 tt -63.61 -26.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.3 -44.17 61.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.742 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 1.8 pt-20 -69.11 -33.18 73.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.32 -49.74 65.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.354 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.21 -44.75 88.3 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.194 0.521 . . . . 0.0 110.122 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -64.9 -49.17 71.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.703 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.33 -41.13 62.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -58.5 -33.94 70.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.085 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.63 -16.3 57.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.937 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.07 -36.92 17.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.26 -65.94 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 12.5 t70 -66.16 130.31 42.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.905 0.383 . . . . 0.0 110.832 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -39.28 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.34 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.19 -12.15 30.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.54 36.12 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.677 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -74.94 -4.99 41.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.487 0.184 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.16 4.27 44.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.177 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.9 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.4 mt -109.87 127.93 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.185 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.68 169.85 8.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.97 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 p -55.88 -32.31 63.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.409 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -62.05 -50.49 71.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -75.64 -36.94 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.128 0.489 . . . . 0.0 110.834 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.32 -58.21 8.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.558 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.58 -27.43 69.71 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.776 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.4 m -67.45 -55.17 14.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 13.8 p -69.69 -31.59 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -46.8 88.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -26.18 44.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.959 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -58.15 -35.96 72.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.05 -31.25 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.71 42.63 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -142.65 165.04 28.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -121.28 63.25 12.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 -173.63 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.311 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 p -122.08 161.8 22.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 24.7 pm0 -69.02 -28.49 66.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.18 0.514 . . . . 0.0 110.3 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.81 -49.53 58.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.595 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.4 -37.35 86.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD11 ' HA3' ' A' ' 33' ' ' GLY . 21.0 mt -57.39 -50.79 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -67.35 -48.0 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.272 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.99 -51.02 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.494 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.96 -49.73 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.398 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 32' ' ' LEU . 1.1 mt -57.81 -41.86 80.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.5 -26.42 65.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.677 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.1 mt-10 -83.67 -2.19 55.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.89 -33.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 112.084 -177.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 63' ' ' ILE . 56.1 t0 -71.04 144.97 50.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.77 -53.55 7.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.595 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.54 -8.69 59.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.217 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.79 47.71 83.74 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.963 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -97.69 -1.3 43.87 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.663 0.231 . . . . 0.0 111.495 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.86 20.13 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.889 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.4 p -149.97 139.83 21.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.606 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.21 149.34 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.23 170.09 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -53.74 -61.66 4.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -63.55 -37.62 46.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.37 2.047 . . . . 0.0 111.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -60.97 -48.42 81.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.503 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.39 -58.01 9.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.177 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.5 tp -58.28 -55.54 33.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.822 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -51.58 -44.36 62.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.737 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.427 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -55.26 -53.28 58.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.03 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.9 mmt -78.31 -16.82 57.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.76 -30.38 28.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.165 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.37 -27.14 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -155.8 163.96 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.44 157.06 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -26.19 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.11 -33.4 59.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -74.55 -34.3 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.318 0.58 . . . . 0.0 109.737 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -49.35 53.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.471 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.747 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.2 mm-40 -63.11 -46.9 85.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.402 0.62 . . . . 0.0 109.653 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.778 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -45.6 70.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.95 -38.67 51.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -33.11 58.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.809 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.66 -36.46 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.673 0.273 . . . . 0.0 111.02 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -70.67 -62.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.549 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.42 117.18 24.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -52.67 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.78 -9.66 59.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.1 70.47 0.56 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -93.54 14.88 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.646 0.26 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.45 68.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.635 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.4 m-85 -160.12 116.92 2.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.928 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.491 ' O ' HD12 ' A' ' 125' ' ' ILE . 3.9 mt -114.59 125.49 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.626 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -104.09 159.58 15.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.981 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.577 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.7 -40.25 19.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.396 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 -59.0 6.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.984 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.56 -37.29 70.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.721 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.04 -50.7 72.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.903 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.769 ' O ' HG22 ' A' ' 110' ' ' THR . 1.1 tpt180 -56.2 -42.8 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -39.19 83.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.642 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 92' ' ' PHE . 44.9 t -72.17 -55.35 13.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.118 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.588 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.4 mmt -49.04 -54.01 17.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.1 t -66.05 -25.42 67.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.09 -30.28 66.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -28.81 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.9 43.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.58 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -150.65 110.54 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.792 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -86.41 101.9 13.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.656 HD12 ' HG2' ' A' ' 120' ' ' GLU . 3.5 mm? -105.57 148.79 26.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.6 t -86.75 163.33 17.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -58.09 -34.17 69.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.61 -39.33 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 7.6 tp10 -64.36 -54.87 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -62.76 -40.59 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.66 -41.49 97.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.0 110.129 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 40.9 mt-10 -72.66 -30.12 64.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.315 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.2 mtp -70.3 -36.25 74.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.857 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 105' ' ' LEU . 3.7 mm -80.21 -54.86 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.639 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.36 -31.76 55.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.005 0.431 . . . . 0.0 110.417 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.18 -21.77 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.888 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.541 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.21 -9.13 17.9 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.248 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.4 t0 -86.97 100.67 12.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.504 0.668 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -75.11 -31.64 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.042 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.99 -9.1 47.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.521 -178.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.47 57.07 11.02 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.5 p30 -114.31 -3.62 13.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.217 0.508 . . . . 0.0 111.47 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.49 5.85 45.06 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.078 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.11 -174.72 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.469 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 141' ' ' PHE . 46.3 t -128.87 124.83 61.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 111.281 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.6 t30 -102.95 -162.6 0.93 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.7 t80 -60.75 -74.45 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 142' ' ' VAL . 2.1 tt0 -49.95 -45.45 51.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.302 0.572 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.6 mt-10 -56.21 -34.52 66.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.728 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -78.99 -47.06 16.98 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.111 0.481 . . . . 0.0 111.608 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.632 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.5 m -64.48 -34.46 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.812 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 144' ' ' MET . 1.6 pp0? -71.05 -36.29 72.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.39 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.541 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 1.3 ptt? -83.83 -4.09 58.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.779 0.323 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.609 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -96.68 -35.75 10.92 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.671 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.378 -179.822 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.7 mpp_? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.825 0.345 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 -67.51 2.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.822 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.9 -50.22 69.9 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.0 -65.28 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.539 0.209 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.8 -36.68 48.67 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.465 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 13.8 tpp180 -56.14 -48.76 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -63.42 -41.79 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.096 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.3 t -50.63 -51.14 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.57 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.85 ' O ' HG23 ' B' ' 77' ' ' VAL . 2.9 mpt_? -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.507 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.809 HD22 HG11 ' A' ' 91' ' ' VAL . 14.2 mt -56.05 -47.47 77.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.71 0.29 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -67.0 -47.51 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.62 -30.18 62.02 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.075 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 73' ' ' ARG . 96.6 t -76.79 -55.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.726 0.298 . . . . 0.0 111.096 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.711 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.22 -43.73 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.581 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.654 ' HA ' ' HB3' ' B' ' 82' ' ' ALA . 9.3 mmp_? -55.65 -35.54 66.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.267 0.556 . . . . 0.0 109.562 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.76 -37.49 73.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.857 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.05 -17.23 22.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.318 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -78.09 -37.54 46.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.646 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.578 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -165.69 174.77 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.848 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.4 165.39 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.8 t -69.08 176.88 2.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.0 -39.04 84.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.8 tt0 -69.79 -56.84 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.848 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -57.82 -44.84 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.972 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.447 HG13 HD13 ' A' ' 69' ' ' LEU . 6.8 tt -69.02 -26.82 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.201 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.86 -43.04 63.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.412 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.62 -25.78 62.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.364 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.73 -49.36 25.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.332 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -44.56 85.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.148 0.499 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.99 -49.11 68.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.886 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.26 -41.28 62.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.74 -34.42 67.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.027 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t -78.59 -14.59 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.99 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.74 -39.26 15.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.147 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.17 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.234 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.5 t0 -63.65 126.28 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.681 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -37.83 83.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -92.09 -12.4 33.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.23 32.75 63.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.811 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' OD1' ' OD2' ' A' ' 20' ' ' ASP . 9.7 p30 -77.07 1.91 16.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.845 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.78 43.37 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.084 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -149.6 132.59 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.52 0.66 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.934 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.1 mp -105.11 118.61 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.437 ' CB ' HG22 ' A' ' 62' ' ' THR . 8.4 t -98.01 163.99 12.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.763 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.0 p -51.73 -25.47 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.891 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -68.11 -50.69 53.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -77.86 -37.82 47.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.248 0.547 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.015 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.16 -44.78 71.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.619 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.0 -28.89 73.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.235 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.0 m -73.53 -59.92 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.4 p -62.7 -30.5 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.2 ttt -61.51 -56.45 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.86 -25.46 66.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -51.4 -47.03 63.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.71 -60.19 2.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.913 0.387 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.19 40.16 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -142.71 170.32 15.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -138.16 59.54 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -178.93 3.93 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.622 2.214 . . . . 0.0 112.495 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 174.24 6.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.45 -29.93 68.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.89 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.12 59.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.147 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.9 OUTLIER -61.31 -40.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.089 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.1 mt -59.41 -50.53 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.933 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 8.2 tt0 -62.98 -39.17 93.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -68.98 -51.19 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.334 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.04 -54.0 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 110.454 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.0 -45.71 92.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.367 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 15.8 t-20 -51.98 -25.96 9.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.271 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.3 mt-10 -82.37 -3.24 55.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.35 -32.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.248 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.566 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.4 t0 -63.57 135.69 57.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.105 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.89 -53.32 21.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.557 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -95.81 3.71 53.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.665 -179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.09 59.13 9.87 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.88 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -109.21 -2.5 17.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.852 0.326 . . . . 0.0 111.354 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 17.37 15.93 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.863 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.612 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.51 139.94 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.072 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -104.55 149.44 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.785 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -107.6 171.06 7.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.9 m-85 -55.77 -61.5 6.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.524 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.6 Cg_endo -66.98 -20.25 51.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.436 2.091 . . . . 0.0 112.567 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.24 -37.64 37.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.085 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 4.7 t80 -75.24 -33.95 61.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.294 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.3 tp -76.75 -58.29 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -51.89 -45.67 64.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.142 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.76 -31.26 69.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 41.6 mtt -108.21 15.34 24.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.221 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.81 -40.47 4.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.91 0.386 . . . . 0.0 111.024 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -59.9 -45.12 93.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 111.0 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.836 0.35 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.81 -179.41 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -148.3 156.28 42.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.788 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -50.89 -25.98 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.373 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -73.65 -39.46 64.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' B' ' 77' ' ' VAL . 43.8 mt-10 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.179 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.81 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.21 -38.93 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.32 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -71.13 -49.36 45.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.7 mm-40 -61.2 -46.29 91.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.39 0.614 . . . . 0.0 109.447 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.742 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.6 -49.22 68.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.059 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.08 -38.52 52.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.996 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -30.38 56.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.008 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.49 -37.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -71.42 -62.92 1.23 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.865 0.364 . . . . 0.0 110.483 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.93 120.61 25.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -63.35 -52.56 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.193 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.43 -9.61 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.492 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.96 71.76 0.47 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.884 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.47 14.53 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.679 0.276 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 13.65 61.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.685 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -158.33 116.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.52 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.45 124.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.137 0.494 . . . . 0.0 111.714 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -104.27 161.69 13.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.131 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.572 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -45.56 30.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.528 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.84 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 111.093 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.92 -36.47 65.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.543 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.61 -50.0 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.675 178.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.542 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -56.65 -41.44 77.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.412 178.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -60.57 -39.16 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.61 -54.45 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.817 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 116' ' ' LEU . 10.0 mmt -50.33 -54.11 23.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.21 -24.51 65.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.559 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -69.89 -30.9 68.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.5 -28.7 16.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.15 42.78 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.548 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -153.23 110.28 3.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -91.85 101.44 14.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.0 mm? -96.59 166.98 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 120' ' ' GLU . 12.8 t -94.63 163.79 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -59.75 -41.83 91.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.35 -35.87 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.653 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -65.48 -54.9 21.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.8 m -64.89 -40.02 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.182 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -62.6 -41.95 99.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.3 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.5 mt-10 -72.63 -30.14 64.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.3 mtt -70.91 -35.98 72.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 105' ' ' LEU . 5.2 mm -80.25 -54.87 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.699 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.3 ptm180 -54.05 -31.85 52.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 110.377 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.25 -20.96 46.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.798 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.45 -2.6 20.32 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.471 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.9 t0 -94.87 109.71 21.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.394 0.616 . . . . 0.0 111.204 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.27 7.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.803 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.91 -9.12 44.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.579 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.56 58.23 8.49 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 114.515 0.566 . . . . 0.0 114.515 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.7 p30 -114.24 -4.58 13.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.072 0.436 . . . . 0.0 111.513 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 7.78 42.32 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.955 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.15 -174.88 4.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.673 0.273 . . . . 0.0 110.38 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.7 t -128.18 126.5 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 111.245 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.4 t30 -104.83 -167.81 1.4 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.95 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.2 t80 -58.79 -73.92 0.07 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.57 -45.41 47.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 110.286 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.54 -36.39 69.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.102 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.66 -49.56 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.94 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.81 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.44 -40.63 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.715 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -34.35 70.6 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.652 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.22 8.36 13.54 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.68 0.276 . . . . 0.0 111.246 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.568 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -38.28 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.429 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 121.03 0.443 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.26 -75.69 0.23 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.905 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.02 -46.76 61.04 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -58.75 -70.85 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.279 . . . . 0.0 110.54 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.1 OUTLIER -52.11 -34.92 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.842 0.354 . . . . 0.0 110.38 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 4.9 tpp85 -57.1 -53.26 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.635 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.63 -41.65 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.125 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 68' ' ' PHE . 84.2 t -52.2 -53.02 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.283 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.785 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.6 mpt_? -71.91 -44.08 64.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.008 HD22 HG11 ' A' ' 91' ' ' VAL . 19.7 mt -56.2 -49.24 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.9 p -65.48 -47.66 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.583 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.69 -29.39 67.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.302 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' B' ' 73' ' ' ARG . 70.1 t -76.82 -53.46 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.666 0.27 . . . . 0.0 111.246 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.708 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.65 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.364 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.646 ' N ' HD12 ' B' ' 78' ' ' ILE . 3.7 mmp_? -57.03 -34.45 68.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 109.67 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -37.29 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.929 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.47 -10.19 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.03 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -94.67 -28.09 15.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.277 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.501 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.481 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -176.8 171.83 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.608 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -128.85 165.33 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.4 t -68.47 169.25 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -55.05 -36.51 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.6 tt0 -71.3 -56.85 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.371 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.606 ' H ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -58.54 -45.05 89.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 0.0 110.845 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG13 HD13 ' A' ' 69' ' ' LEU . 6.9 tt -67.54 -26.78 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -43.47 63.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.475 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.96 -25.8 62.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.86 -49.41 25.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.263 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -57.43 -44.66 84.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.19 0.519 . . . . 0.0 110.207 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.34 -49.85 67.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.877 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.28 -40.76 62.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.45 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -55.97 -38.94 71.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.207 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.76 -38.37 15.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.97 0.414 . . . . 0.0 110.388 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.666 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.375 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.6 t70 -63.62 129.02 38.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.862 0.363 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -37.3 83.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.215 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.61 -12.31 29.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.7 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.3 37.86 83.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.649 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -77.02 -1.85 30.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.478 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 -2.57 43.67 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.217 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.6 p -149.47 132.5 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.986 0.393 . . . . 0.0 110.959 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -104.0 120.07 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.028 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.83 164.59 12.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.818 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.0 p -52.53 -25.47 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -70.49 -50.53 36.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.356 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.77 -36.58 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.467 . . . . 0.0 111.005 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -54.25 -47.92 71.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.028 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.53 -27.39 73.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.391 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.9 m -72.05 -51.65 20.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.331 . . . . 0.0 111.218 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.9 p -70.61 -34.96 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.414 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -52.59 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.71 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.56 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -52.13 -37.72 55.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.71 -65.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.56 38.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.7 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -140.5 58.34 10.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 -170.25 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.412 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p -102.15 171.83 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.74 -29.44 67.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.44 56.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.41 -39.75 94.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.727 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.481 HD11 ' HA3' ' A' ' 33' ' ' GLY . 31.7 mt -58.33 -50.59 73.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.77 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 tp60 -64.63 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.09 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.088 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -58.44 -53.77 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.06 -44.73 92.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.415 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 32.4 t30 -52.71 -25.92 12.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.1 mt-10 -82.66 -3.32 56.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.928 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.44 -32.31 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.3 t0 -63.46 135.31 56.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.067 0.461 . . . . 0.0 111.027 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.43 -53.5 28.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.07 4.23 52.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.744 -179.184 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 59.43 9.39 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.895 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.97 -2.49 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.75 0.275 . . . . 0.0 111.342 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.47 15.75 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.893 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.624 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.8 p -149.46 139.92 22.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.09 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.34 149.61 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.52 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.56 171.03 7.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.634 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.8 m-85 -55.03 -61.52 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.659 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.4 Cg_endo -67.22 -20.28 49.61 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.434 2.089 . . . . 0.0 112.595 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -79.26 -38.08 36.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.168 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.5 t80 -75.1 -33.49 61.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 4' ' ' LEU . 11.6 tp -75.25 -58.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.295 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 53.2 m -51.56 -43.19 62.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -54.15 -43.33 70.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.438 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 36.9 mtt -101.12 14.5 31.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -107.15 -36.7 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -73.62 -26.9 61.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.765 ' OD2' HG22 ' B' ' 77' ' ' VAL . 12.4 m-20 -87.45 -178.49 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.2 m -142.66 159.56 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -50.83 -25.97 5.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.387 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -75.85 -37.45 58.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.523 ' HB3' HG21 ' B' ' 77' ' ' VAL . 42.3 mt-10 -65.4 -26.76 68.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.809 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.03 -38.47 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.099 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -71.37 -49.36 42.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.9 mt-10 -61.31 -46.29 90.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.378 0.609 . . . . 0.0 109.442 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.743 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.46 -49.02 68.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.022 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.12 -39.01 55.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.919 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -30.37 58.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.014 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.43 -37.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -70.66 -63.02 1.18 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.895 0.379 . . . . 0.0 110.44 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.55 120.79 26.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -52.58 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.279 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.49 -9.62 59.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.52 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.82 71.76 0.46 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.814 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -92.98 14.5 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.61 16.59 65.75 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.619 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -161.15 116.76 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.303 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.537 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.05 124.28 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.119 0.485 . . . . 0.0 111.65 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -104.26 161.52 13.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.206 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.86 -44.42 29.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.472 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 -58.84 6.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 111.015 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.9 mm-40 -55.02 -38.0 67.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.653 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.899 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.61 -49.48 77.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.744 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.884 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -57.24 -41.72 80.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.334 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.64 -39.36 84.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.2 t -67.15 -55.71 16.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.668 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 mmt -49.07 -54.09 17.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.2 t -67.62 -24.22 65.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -70.57 -30.2 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.07 -28.85 14.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.95 43.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.9 109.77 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -89.59 101.97 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -99.27 165.31 11.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.0 t -98.28 171.15 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.0 -32.46 72.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 -47.63 69.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -60.54 -54.85 40.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.884 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.3 m -57.7 -50.93 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.391 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 121' ' ' VAL . 36.6 t70 -57.47 -39.27 76.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 52.1 mt-10 -72.59 -30.19 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.47 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.03 -36.07 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.82 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.18 -54.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.646 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.9 ptm180 -53.56 -31.74 47.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 0.0 110.516 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.32 -21.1 53.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.44 -10.86 15.64 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.624 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -84.87 110.02 18.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.385 0.612 . . . . 0.0 111.302 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.89 -31.15 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.791 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.32 -9.07 43.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.6 -178.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.06 57.78 9.55 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -114.27 -4.19 13.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.039 0.42 . . . . 0.0 111.515 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 7.51 42.59 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.006 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.88 4.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.419 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.0 t -129.02 126.25 64.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 111.157 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.48 -167.53 1.34 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.062 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.3 t80 -57.71 -73.89 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.56 -45.86 48.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.564 . . . . 0.0 110.306 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.57 -36.48 69.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.157 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.734 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.74 -49.73 11.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.881 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.809 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -56.32 -36.82 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -34.79 71.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.63 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.444 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.7 OUTLIER -87.1 15.36 6.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.701 0.286 . . . . 0.0 110.858 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.1 mtt -126.99 -49.5 1.46 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.328 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.002 0.429 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.28 -75.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.64 -45.56 59.92 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.928 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.22 -71.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.699 -0.251 . . . . 0.0 110.586 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.26 -32.96 39.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.611 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.43 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 5.1 tpp85 -58.47 -53.2 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.55 -41.14 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.969 178.44 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 68' ' ' PHE . 86.4 t -53.14 -50.95 43.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.333 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.725 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.92 -47.06 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.431 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.014 HD22 HG11 ' A' ' 91' ' ' VAL . 33.2 mt -56.67 -45.78 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.808 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -66.77 -47.43 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.804 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.18 -29.83 69.37 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.294 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.765 HG22 ' OD2' ' A' ' 80' ' ' ASP . 79.7 t -76.8 -51.88 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 111.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -67.42 -42.03 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.537 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.642 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.0 mmp_? -57.37 -34.66 69.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.216 0.532 . . . . 0.0 109.763 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -36.81 84.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.877 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.38 -14.19 24.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -91.24 -26.92 18.77 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.545 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -169.95 176.56 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -126.53 165.32 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.3 t -70.4 171.79 9.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.893 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.62 -38.03 68.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.242 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -71.47 -56.75 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.108 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.623 ' H ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -58.11 -45.2 87.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.851 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.494 HG13 HD13 ' A' ' 69' ' ' LEU . 5.9 tt -67.14 -26.78 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.98 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.71 -42.87 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.5 -25.78 63.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.91 -49.41 24.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.499 0.19 . . . . 0.0 111.262 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.65 -44.64 85.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.196 0.522 . . . . 0.0 110.117 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.12 -49.08 71.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.746 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.943 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.29 -41.33 62.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.44 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -56.33 -36.7 69.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.129 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.87 -13.85 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.7 -38.29 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.273 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.25 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.319 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.3 t70 -64.97 127.41 31.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.639 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -38.52 91.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.65 -12.26 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 0.0 110.794 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.08 37.94 82.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.641 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -76.88 -1.91 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 -2.33 43.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.173 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 p -149.42 132.42 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.924 0.362 . . . . 0.0 110.745 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.4 mp -104.44 120.33 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.095 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 t -97.78 159.83 14.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.496 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.415 HG21 ' NE2' ' A' ' 49' ' ' GLN . 19.2 p -50.17 -25.45 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -67.69 -50.95 55.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -78.13 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.428 0.633 . . . . 0.0 110.424 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.097 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.21 -50.51 66.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.796 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -64.41 -27.47 71.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.31 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.0 m -69.5 -54.95 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.51 -31.72 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -47.08 87.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 110.413 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -25.57 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 t -55.13 -50.57 68.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -47.78 -58.03 4.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.576 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -142.56 179.73 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.825 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -159.73 58.74 1.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.34 -170.57 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.676 2.25 . . . . 0.0 112.509 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 p -93.9 171.11 9.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 11.7 pt-20 -68.48 -31.44 70.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.291 0.567 . . . . 0.0 110.05 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.03 65.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.892 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 1.4 mt-10 -62.16 -53.33 56.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.657 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.15 -50.79 63.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.351 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 29' ' ' THR . 2.3 tp-100 -57.98 -40.35 80.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.63 -45.12 94.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.264 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -60.8 -52.66 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.203 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.097 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -57.15 -45.86 84.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.126 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.06 -25.99 9.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.351 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -83.02 -3.29 57.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.012 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.37 -32.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.2 t0 -63.0 136.93 58.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.037 0.446 . . . . 0.0 111.155 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.35 -53.74 26.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.481 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -96.95 4.16 51.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.701 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.68 59.66 8.92 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.735 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.37 -1.17 17.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.726 0.263 . . . . 0.0 111.409 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.24 17.37 15.98 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.877 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.579 ' C ' HD13 ' A' ' 63' ' ' ILE . 10.5 p -149.53 139.96 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.186 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 62' ' ' THR . 2.6 mm -104.47 149.78 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.459 . . . . 0.0 111.705 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.44 168.76 9.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.63 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.2 m-85 -52.53 -61.21 4.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -68.16 -19.81 44.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.11 . . . . 0.0 112.669 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.9 mm-40 -79.27 -37.47 37.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.106 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.7 t80 -75.23 -32.46 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.01 0.433 . . . . 0.0 110.311 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.545 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.1 tp -76.19 -58.07 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 52.5 m -51.61 -43.1 62.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.503 ' HE2' ' HD3' ' B' ' 65' ' ' ARG . 4.4 tmm? -54.14 -44.72 71.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.946 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 33.8 mtt -100.66 15.35 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.537 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -109.99 -31.68 7.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.877 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -61.93 -39.32 91.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.245 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 111.317 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.786 0.326 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -90.9 -175.21 4.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.99 161.72 38.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -50.7 -25.42 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.525 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.7 -46.18 47.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.9 mt-10 -57.43 -26.71 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -73.65 -38.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.188 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -49.49 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.544 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.1 mt-10 -61.18 -46.12 91.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.404 0.621 . . . . 0.0 109.442 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.773 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.6 -49.3 68.11 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.984 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.05 -38.19 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.968 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -30.49 57.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.831 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.051 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.78 -36.77 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.659 0.266 . . . . 0.0 111.006 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -72.23 -62.93 1.26 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.492 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.82 114.07 20.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.827 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -60.96 -50.08 74.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.06 -9.66 59.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.74 72.37 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.839 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -94.33 13.76 22.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.69 0.281 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.48 69.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 4.5 m-85 -166.19 116.77 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.505 HD11 ' HD1' ' A' ' 89' ' ' PHE . 6.2 mt -112.24 124.34 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 0.0 111.863 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -104.43 161.96 13.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.085 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.574 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.8 -44.79 28.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.475 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.79 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.031 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -54.88 -36.29 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.6 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.93 -50.7 71.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.713 178.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.536 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -55.77 -41.47 74.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.385 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -61.05 -39.32 89.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.281 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.97 -53.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.5 -54.04 25.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.28 -25.03 65.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.18 -32.05 72.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.44 -28.78 16.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.36 42.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -140.31 109.81 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -85.28 80.61 9.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.26 161.54 17.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 120' ' ' GLU . 14.3 t -96.76 162.86 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -30.3 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.2 -42.31 88.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 117' ' ' THR . 17.2 mm-40 -63.21 -51.78 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.1 m -61.56 -41.5 90.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.225 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.23 -43.28 99.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.3 mt-10 -72.4 -30.13 64.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.44 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.9 ttm -70.73 -35.4 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 105' ' ' LEU . 5.3 mm -80.3 -54.94 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.556 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.8 ptm180 -54.02 -31.72 52.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.365 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -78.3 -21.01 50.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.904 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 -7.65 16.42 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.1 t0 -88.68 109.89 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.383 0.611 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.6 pt -84.88 -31.1 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.77 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.39 -9.08 43.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.612 -178.555 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.68 58.11 8.76 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.3 -4.41 13.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 117.036 0.418 . . . . 0.0 111.428 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.59 42.65 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.011 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.1 -174.88 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.417 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.749 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.8 t -127.84 127.28 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 111.224 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 4.7 t30 -106.17 -168.27 1.41 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.1 t80 -57.98 -73.95 0.07 Allowed 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -49.57 -45.6 47.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 0.0 110.262 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.727 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.109 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.749 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.6 -49.62 11.9 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.02 0.438 . . . . 0.0 111.797 -178.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.1 m -56.47 -36.55 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.615 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -33.96 70.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.471 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.8 OUTLIER -88.58 16.58 6.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.804 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.616 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.0 mtt -128.36 -51.38 1.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.215 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.749 -179.69 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.17 -75.77 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.859 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.16 -46.11 56.82 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.238 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.919 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -59.83 -71.55 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.667 0.27 . . . . 0.0 110.589 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.1 OUTLIER -51.96 -33.38 37.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.473 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.0 tpp180 -57.27 -51.92 67.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.619 HG21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -60.88 -42.62 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.806 178.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.7 t -50.62 -47.68 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.428 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.843 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.13 -48.24 45.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.438 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.051 HD22 HG11 ' A' ' 91' ' ' VAL . 37.4 mt -56.12 -46.45 79.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -66.05 -48.84 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.01 -29.61 59.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.099 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.843 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.1 t -76.71 -56.5 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.686 0.279 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.691 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.49 -43.83 97.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.658 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.0 -33.58 69.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 109.864 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.32 -36.42 83.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.37 -15.98 22.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.39 -25.06 20.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.632 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -177.79 170.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.594 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.31 165.3 17.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -69.31 177.35 2.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -70.92 -56.99 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.263 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.594 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -56.86 -44.72 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 69' ' ' LEU . 6.1 tt -69.29 -26.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.033 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.78 -42.94 62.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -71.75 -27.04 62.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.38 -49.56 40.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.279 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -57.08 -44.81 83.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.167 0.508 . . . . 0.0 110.228 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 39.9 mm-40 -65.15 -50.67 65.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 1.038 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.33 -40.36 58.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.844 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.09 -45.66 79.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.475 -179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 m -70.77 -14.86 62.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.428 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 mt -87.83 -37.4 16.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 0.0 110.619 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.56 -65.0 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.053 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.2 t70 -64.9 132.5 49.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.869 0.366 . . . . 0.0 110.553 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -38.84 81.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.319 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.8 -12.3 31.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.802 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.83 37.57 84.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.633 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -74.25 -4.56 36.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.181 -0.207 . . . . 0.0 111.437 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 0.27 43.99 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.061 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -149.58 132.5 16.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 110.733 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -105.07 127.42 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.5 t -102.02 168.77 9.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -53.55 -40.37 65.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.772 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -55.68 -50.45 70.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.57 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -76.25 -36.37 58.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.926 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.22 -58.4 7.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.573 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -31.99 78.79 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.42 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -61.47 -57.79 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.972 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.78 -30.48 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.319 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -51.99 66.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 110.44 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.66 61.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.786 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -60.87 -45.18 95.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.2 mt -49.35 -60.69 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.073 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.25 41.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.546 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -142.6 171.99 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.848 0.356 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.71 59.33 19.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.5 -170.36 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.551 2.167 . . . . 0.0 112.357 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.3 p -115.88 170.15 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.7 -30.56 69.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 0.0 110.098 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.65 -44.35 57.43 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.035 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -42.33 99.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.043 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 13.3 mt -59.35 -50.56 73.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.07 -48.16 81.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.465 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.35 -51.04 65.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -56.25 -50.75 70.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 32' ' ' LEU . 1.2 mt -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -55.74 -26.45 45.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.515 0.674 . . . . 0.0 110.236 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 51' ' ' MET . 4.0 mt-10 -83.46 -2.03 54.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.535 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.8 -33.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 0.0 112.121 -177.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.539 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.6 t0 -69.97 139.59 52.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -71.98 -53.57 12.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.478 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -93.39 -3.16 53.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.621 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.9 55.86 27.4 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.911 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.1 m120 -105.63 15.6 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.857 0.328 . . . . 0.0 111.11 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 83.41 16.95 67.58 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.908 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.447 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.8 p -149.9 139.8 21.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.718 0.294 . . . . 0.0 110.804 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.7 mm -97.59 149.47 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 111.414 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.67 -178.92 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 8.6 m-85 -62.82 -61.67 7.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.395 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 25.6 Cg_endo -62.19 -34.4 78.83 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.416 2.077 . . . . 0.0 111.942 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -67.78 -47.42 69.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.457 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -61.66 -44.58 96.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.327 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.8 tp -72.66 -58.11 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.9 m -51.71 -45.59 63.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.4 mmt -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.7 mmt -108.47 14.97 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.17 -44.48 3.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -57.08 -45.86 82.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.023 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' B' ' 77' ' ' VAL . 0.8 OUTLIER -86.4 -177.37 6.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.911 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 159.23 43.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.77 -26.57 5.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.338 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.47 -41.27 61.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 22.8 mt-10 -59.69 -26.78 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.817 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.1 mm -74.11 -37.63 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.921 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -71.71 -49.41 39.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.88 ' O ' HG13 ' A' ' 91' ' ' VAL . 37.5 mt-10 -61.24 -46.43 90.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 109.395 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.4 -49.17 67.83 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.97 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.27 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.946 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -30.61 62.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.852 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.928 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.52 -37.08 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.98 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.635 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.84 -62.86 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.883 0.373 . . . . 0.0 110.484 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.9 t0 -82.79 115.14 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -59.04 -52.58 65.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.1 -9.58 59.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.42 0.49 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.831 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -93.46 14.43 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.675 0.274 . . . . 0.0 111.203 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.5 16.83 65.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.588 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.3 m-85 -162.38 116.75 1.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.717 0.294 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.528 HD11 ' HD1' ' A' ' 89' ' ' PHE . 5.0 mt -113.31 124.84 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.147 0.498 . . . . 0.0 111.751 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.0 t -104.28 161.53 13.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.171 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.84 -44.87 29.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.434 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.85 -58.82 6.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -55.0 -36.75 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.62 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.7 -49.91 74.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.723 178.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.36 -41.79 76.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.38 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.71 -38.68 85.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.235 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.55 -54.29 24.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.752 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.8 mmt -50.92 -53.97 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.08 -24.65 65.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.53 -31.05 69.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.59 -28.73 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.02 43.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.564 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -147.55 109.82 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -88.2 100.52 13.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -99.18 163.21 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.4 t -98.25 171.67 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.08 -32.75 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.58 -47.91 68.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.691 ' H ' HG23 ' A' ' 117' ' ' THR . 74.7 mm-40 -60.35 -54.84 40.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.85 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.4 m -57.55 -51.02 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 121' ' ' VAL . 20.7 t70 -57.54 -38.84 75.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.982 0.42 . . . . 0.0 110.566 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 32.6 mt-10 -72.86 -30.09 63.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.476 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -71.0 -36.33 72.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.845 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.943 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.32 -54.9 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.692 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.1 ptm180 -53.75 -31.83 49.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.9 pt-20 -78.76 -20.93 48.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.957 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -7.27 16.86 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.476 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.3 t0 -89.05 110.05 20.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.359 0.6 . . . . 0.0 111.272 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.735 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.94 -31.12 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.819 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.37 -9.14 42.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.605 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.94 57.85 9.34 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.566 0.587 . . . . 0.0 114.566 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.1 p30 -114.3 -4.45 13.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.992 0.396 . . . . 0.0 111.437 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.75 42.06 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.12 -174.92 4.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.475 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.727 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.88 126.56 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.98 -167.57 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.649 ' O ' HG13 ' A' ' 142' ' ' VAL . 54.1 t80 -57.67 -73.89 0.06 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.508 ' O ' HG22 ' A' ' 142' ' ' VAL . 1.7 tt0 -49.5 -45.99 47.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.735 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.6 -36.27 69.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.069 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.727 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.52 -49.68 11.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.817 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.88 -37.08 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.685 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' NE2' ' CG2' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -70.98 -34.32 71.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.657 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.442 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -88.12 15.89 6.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.883 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.611 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -126.85 -51.13 1.46 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.705 -179.781 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.79 0.328 . . . . 0.0 111.059 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.12 -66.01 3.0 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.793 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.13 -50.66 26.94 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.44 -63.5 1.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.476 0.179 . . . . 0.0 110.891 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.68 -36.42 46.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.46 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.9 tpt180 -56.16 -53.2 59.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.613 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -58.46 -42.48 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.276 178.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.568 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.83 -53.44 13.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -73.32 -44.27 59.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.662 -178.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 91' ' ' VAL . 19.4 mt -55.91 -48.46 75.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.168 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.038 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -63.97 -47.97 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.271 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.03 -28.53 58.36 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 73' ' ' ARG . 87.8 t -76.77 -56.18 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.452 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.649 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.97 -43.5 96.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 24.8 mmm180 -58.04 -34.16 69.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.232 0.539 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -36.82 84.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.426 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.905 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.43 -15.33 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.988 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.49 -26.47 19.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.429 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.698 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.6 tt0 -160.29 171.96 18.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -118.37 165.47 13.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.6 t -68.55 177.06 2.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.01 -37.75 83.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.8 tt0 -71.39 -56.74 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.637 ' H ' HG23 ' A' ' 5' ' ' THR . 1.1 tt0 -57.86 -44.1 86.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.913 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 69' ' ' LEU . 7.4 tt -68.9 -26.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.96 -43.12 63.39 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -25.75 62.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -74.11 -49.39 24.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.565 0.221 . . . . 0.0 111.226 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -57.62 -44.49 85.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.225 0.536 . . . . 0.0 110.175 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.76 -49.13 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.3 -41.01 62.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.492 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.25 -38.81 69.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.174 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 t -76.8 -14.23 59.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.75 -37.9 16.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.833 0.349 . . . . 0.0 110.455 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.75 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.262 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.0 t70 -64.57 127.01 29.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.637 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -38.66 91.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.35 -12.31 32.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 110.781 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.04 37.64 80.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -76.49 -2.17 30.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 -1.82 43.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.2 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -149.45 132.49 16.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.922 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mt -104.53 120.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.93 161.99 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.568 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -52.26 -25.57 9.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.809 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -67.27 -50.83 58.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.016 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.95 -36.77 48.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.331 0.586 . . . . 0.0 110.572 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.092 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.2 -41.55 68.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.683 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.805 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -72.58 -27.46 69.38 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.195 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -69.07 -51.39 39.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.697 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.6 p -74.45 -33.16 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.7 ttt -57.74 -44.16 85.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.384 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -25.54 44.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 t -56.53 -44.88 81.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD13 ' CD ' ' B' ' 70' ' ' ARG . 3.6 mt -46.04 -30.12 1.73 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.59 35.18 0.32 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.751 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -142.82 173.6 11.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 28.3 m120 -140.93 63.65 19.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 2.7 Cg_exo -75.85 -171.63 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 112.185 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -100.07 170.94 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.55 -31.36 70.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.22 -44.04 64.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -53.23 57.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.685 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.805 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.27 -50.72 64.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.365 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -60.23 -39.15 85.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.529 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.42 -44.65 90.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -60.27 -52.94 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.217 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.96 -46.25 87.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.299 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -51.58 -26.03 7.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.372 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.4 mt-10 -83.64 -3.32 57.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.36 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -62.9 134.44 56.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.083 0.468 . . . . 0.0 111.101 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -65.5 -53.32 44.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.717 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -97.45 4.37 50.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.817 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.52 60.11 8.7 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.928 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.41 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -110.37 -2.57 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.768 0.284 . . . . 0.0 111.38 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.38 15.95 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.6 p -149.53 139.94 22.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 111.224 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.45 149.6 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.234 0.54 . . . . 0.0 111.802 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.98 172.05 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.487 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.8 m-85 -56.1 -61.49 6.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 41.9 Cg_endo -67.42 -20.34 48.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.469 2.112 . . . . 0.0 112.864 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.23 -37.97 36.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.7 t80 -75.24 -34.59 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.0 tp -74.97 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.093 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.0 -46.44 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 mmt -61.66 -30.8 70.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.697 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.407 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 6.8 mmt -105.13 13.91 29.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.46 -36.67 4.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -56.48 21.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.829 0.347 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.26 179.34 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.47 155.87 40.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.8 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -25.31 8.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.322 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.11 -35.79 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.223 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' B' ' 77' ' ' VAL . 36.8 mt-10 -66.78 -26.64 67.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.215 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.801 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.25 -37.82 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.0 110.155 179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.71 -49.4 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.585 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.87 ' O ' HG13 ' A' ' 91' ' ' VAL . 44.9 mt-10 -62.4 -44.45 96.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.352 0.596 . . . . 0.0 109.42 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.775 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.77 -50.06 66.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.819 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.92 -37.75 45.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.868 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -30.57 57.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.714 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.5 m -76.63 -36.76 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.665 0.269 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.697 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.1 m-85 -73.56 -62.82 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.545 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.5 t0 -81.9 116.63 21.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -63.24 -52.43 62.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -77.68 -9.63 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.25 70.71 0.58 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -94.62 14.02 22.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 0.0 111.22 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 18.2 67.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.0 m-85 -163.54 116.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.515 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.52 124.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 0.0 111.678 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -104.22 162.06 13.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.197 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -46.56 31.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.37 -58.8 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 111.104 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -54.88 -36.42 65.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.583 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.46 -50.64 71.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.647 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.16 -41.53 75.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.384 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.62 -39.03 86.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.333 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.66 -54.64 19.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.785 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.4 mmt -50.06 -54.05 22.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.697 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.8 t -66.37 -24.62 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.567 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -69.8 -31.32 69.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.35 -28.8 15.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.65 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.05 109.78 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -91.9 93.74 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.83 158.1 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.1 t -88.34 163.56 15.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -58.93 -39.89 82.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -36.14 83.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.661 ' H ' HG23 ' A' ' 117' ' ' THR . 29.1 mm-40 -64.73 -54.83 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.27 -39.77 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.3 -42.0 98.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.9 mt-10 -72.6 -30.22 64.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.359 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.1 mtt -70.78 -35.88 72.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.96 HD11 HD12 ' A' ' 105' ' ' LEU . 5.4 mm -80.31 -54.89 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.67 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.01 -31.81 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.446 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.12 -21.06 47.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.821 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.05 -4.35 19.04 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.441 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.0 t0 -93.06 109.76 21.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.726 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.04 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.814 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.36 -9.08 43.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.563 -178.479 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.59 58.1 8.67 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.31 -4.42 13.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.963 0.382 . . . . 0.0 111.484 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 7.81 42.05 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.06 -174.91 4.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.48 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.82 126.39 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.359 . . . . 0.0 111.198 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.82 -167.59 1.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.636 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.9 t80 -58.15 -73.88 0.07 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 142' ' ' VAL . 2.8 tt0 -49.46 -45.71 47.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.375 0.607 . . . . 0.0 110.333 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.726 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.56 -36.55 69.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.129 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.7 -49.77 11.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.93 0.395 . . . . 0.0 111.983 -179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.801 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -54.82 -40.74 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.69 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -34.47 70.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.719 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.42 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.18 8.29 13.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.607 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -37.78 3.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.073 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.458 -179.83 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.001 0.429 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.11 -76.21 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.888 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.76 -46.33 59.95 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.11 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -58.85 -71.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.245 . . . . 0.0 110.588 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.448 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.37 -36.87 54.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.377 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 ttm-85 -57.31 -48.17 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.641 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -59.55 -40.47 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.132 178.541 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 68' ' ' PHE . 92.2 t -54.71 -53.59 30.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.521 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.71 -46.4 53.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.336 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 91' ' ' VAL . 16.4 mt -56.04 -46.31 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.618 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.6 p -65.78 -46.6 88.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.391 . . . . 0.0 110.443 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.567 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.2 -30.33 70.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.367 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.723 HG11 ' CB ' ' A' ' 88' ' ' ALA . 42.3 t -75.77 -52.45 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.692 0.282 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.697 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -67.03 -42.67 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.563 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.3 mmp_? -57.33 -34.75 69.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -62.4 -37.22 84.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.523 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.6 t90 -95.54 -14.84 23.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.013 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.16 -27.11 19.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.479 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.594 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.746 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -176.36 176.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -127.4 165.13 20.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.546 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -73.47 170.13 15.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -50.85 -42.21 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.426 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -65.59 -56.91 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.204 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB3' ' CB ' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -60.67 -54.69 42.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' HD12 ' A' ' 4' ' ' LEU . 10.8 tt -56.1 -26.18 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.224 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.24 -42.67 61.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.334 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -35.18 79.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.03 -49.53 60.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.432 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 1.2 mtpp -58.74 -46.49 87.31 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.22 0.533 . . . . 0.0 109.996 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.83 -50.42 72.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.589 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -40.75 62.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.296 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.08 -35.83 67.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -75.0 -16.94 60.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -86.91 -38.78 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.421 . . . . 0.0 110.201 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.77 -65.69 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.246 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 27' ' ' ILE . 9.0 t70 -65.98 131.04 45.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.883 0.373 . . . . 0.0 110.712 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -36.39 77.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.139 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.92 -12.3 27.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.783 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.28 37.85 83.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.646 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -77.68 -1.9 33.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.12 43.86 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.131 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.6 p -147.48 132.47 18.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.869 0.335 . . . . 0.0 110.795 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.906 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -107.28 119.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.449 ' CB ' HG22 ' A' ' 62' ' ' THR . 4.7 t -98.35 168.41 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.1 p -54.45 -29.34 49.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.641 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -67.22 -50.43 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.279 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.15 -36.18 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.38 -42.83 70.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.847 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.51 -27.32 72.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.052 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.0 m -73.58 -45.24 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.0 p -74.67 -34.9 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.084 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -60.84 -49.45 77.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.755 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -65.33 -30.19 71.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -58.86 -21.14 56.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.897 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' B' ' 74' ' ' LEU . 15.9 mt -72.47 -60.76 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.79 -39.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.504 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.3 mt-30 -140.15 147.88 40.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.991 0.396 . . . . 0.0 111.103 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -99.11 99.42 8.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.93 -168.95 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.302 2.002 . . . . 0.0 111.994 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 169.39 13.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.73 -30.37 68.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.031 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.94 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.126 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.1 mt-10 -62.4 -43.22 99.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.244 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.8 mt -56.79 -50.31 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.5 tt0 -64.26 -39.11 93.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.141 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -66.14 -51.14 60.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.452 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.03 -54.18 49.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.119 0.485 . . . . 0.0 110.348 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.7 -43.89 92.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.683 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 18.8 t-20 -52.53 -25.99 11.92 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.561 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.497 ' O ' ' CE ' ' A' ' 71' ' ' MET . 2.2 mt-10 -83.39 -4.82 58.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.915 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -126.2 -32.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.074 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.7 t0 -64.91 133.54 52.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 111.342 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.13 -53.66 16.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.952 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.74 58.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.24 49.21 81.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.924 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -104.47 -1.37 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.703 0.252 . . . . 0.0 111.482 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.62 15.31 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.254 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 3.2 p -149.06 139.78 22.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 111.085 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.77 149.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.157 0.503 . . . . 0.0 111.691 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.47 173.78 6.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.503 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -57.65 -61.46 7.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.323 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 48.7 Cg_endo -68.41 -26.86 34.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.48 2.12 . . . . 0.0 112.468 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -67.63 -43.5 80.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.089 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 1.9 t80 -75.19 -38.44 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.055 0.455 . . . . 0.0 110.293 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.5 tp -66.0 -58.06 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.071 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 m -51.9 -41.47 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 55' ' ' VAL . 1.8 tpt -60.14 -32.83 71.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.424 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.425 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -108.27 15.32 24.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.148 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.24 -33.12 5.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -58.48 -41.08 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.619 0.247 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 58.41 171.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -169.69 149.26 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -26.46 5.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.648 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 81' ' ' SER . 13.7 pt-20 -78.09 -25.72 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.734 0.302 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' B' ' 77' ' ' VAL . 5.0 mt-10 -74.15 -28.92 61.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.923 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.29 -32.73 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -49.33 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.413 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.707 ' O ' HG13 ' A' ' 91' ' ' VAL . 10.8 mt-10 -62.99 -47.99 80.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.739 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.28 -44.09 67.99 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.729 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.84 -39.91 54.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.909 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -33.03 58.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.782 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG11 HD22 ' B' ' 74' ' ' LEU . 1.5 m -73.28 -36.97 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.7 OUTLIER -72.89 -63.07 1.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.59 125.29 33.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -52.61 9.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.0 -9.66 58.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.69 68.91 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.875 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -95.07 12.87 27.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 111.341 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.54 16.61 65.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.7 m-85 -157.94 116.95 3.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.644 0.259 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.4 mt -109.41 124.29 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.014 0.435 . . . . 0.0 111.262 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -103.89 157.15 17.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.272 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.75 -43.34 27.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.446 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.72 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 mm-40 -54.97 -39.63 69.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.692 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.05 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.864 179.026 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.79 ' O ' HG22 ' A' ' 110' ' ' THR . 0.3 OUTLIER -57.61 -41.45 81.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.721 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -61.06 -38.07 84.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.466 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' GLU . 81.7 t -72.77 -56.01 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.063 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 5.9 mmt -48.99 -54.03 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.508 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.79 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.0 t -65.53 -25.25 67.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.376 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.53 -30.31 65.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.837 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.2 -28.82 17.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.58 43.02 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.594 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.53 109.76 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.16 100.34 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -98.17 160.65 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 120' ' ' GLU . 15.4 t -89.57 161.97 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -57.64 -40.72 79.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.12 -36.09 82.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.644 ' H ' HG23 ' A' ' 117' ' ' THR . 13.9 mm-40 -65.71 -54.77 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.99 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.277 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.15 -44.05 97.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 45.1 mt-10 -71.74 -30.2 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.414 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.5 mmm -70.67 -34.55 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.685 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.952 HD11 HD12 ' A' ' 105' ' ' LEU . 4.0 mm -80.23 -54.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.762 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.1 ptt85 -54.91 -31.8 60.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 110.363 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.77 -20.85 52.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.76 -11.34 16.31 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.488 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 125' ' ' ILE . 50.6 t0 -85.51 90.95 8.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.426 0.632 . . . . 0.0 110.785 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.2 pt -63.43 -30.74 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.592 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.61 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -86.94 -9.41 55.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.208 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.19 54.57 18.91 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.2 p30 -113.93 -5.14 13.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.243 0.521 . . . . 0.0 111.365 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.48 5.8 45.16 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.99 -174.69 4.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.907 0.385 . . . . 0.0 110.595 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.697 HG11 ' CD1' ' A' ' 141' ' ' PHE . 41.3 t -127.24 120.66 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.6 t30 -97.37 -167.72 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.7 t80 -61.63 -74.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.3 OUTLIER -49.89 -43.06 49.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.315 0.579 . . . . 0.0 110.337 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.77 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.3 mt-10 -56.06 -33.69 65.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.617 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.697 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -78.97 -47.19 16.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.233 0.539 . . . . 0.0 111.631 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.6 m -64.8 -36.47 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.023 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.4 OUTLIER -70.53 -36.71 73.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.657 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.535 ' HE1' ' CD2' ' B' ' 81' ' ' TRP . 1.4 ptt? -74.95 -15.2 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.57 ' HG2' HD12 ' A' ' 85' ' ' ILE . 3.9 tpp -95.2 -50.22 5.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.374 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 145' ' ' MET . 13.8 t . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.545 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 2.0 mpp_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 121.047 0.451 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.01 -76.01 0.21 Allowed Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.928 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.23 -45.81 57.41 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.156 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.915 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.27 -70.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.516 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.1 OUTLIER -52.28 -32.0 35.32 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.396 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.8 tpt180 -58.65 -52.85 63.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.653 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.31 -42.43 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.684 178.338 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.4 t -52.67 -50.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.105 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.816 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.58 -49.27 49.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.453 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.032 HD22 HG11 ' A' ' 91' ' ' VAL . 29.4 mt -56.04 -46.3 78.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.149 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.4 p -67.01 -47.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.586 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.8 -30.57 69.66 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.348 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.816 HG23 ' O ' ' B' ' 73' ' ' ARG . 86.7 t -76.75 -52.64 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.657 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.54 -41.7 91.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.581 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.619 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -56.02 -34.25 65.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -38.04 86.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.698 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.931 ' CH2' HD11 ' A' ' 105' ' ' LEU . 5.7 t90 -95.15 -14.74 23.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.901 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.53 -31.93 16.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.409 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -176.51 169.06 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.59 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -123.75 165.27 17.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.4 t -71.93 177.09 4.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 17.1 pt-20 -57.3 -43.38 83.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.1 tt0 -64.78 -56.95 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -59.69 -52.96 63.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' THR . 11.2 tt -59.1 -26.55 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.262 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.46 -42.9 61.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.405 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.7 -36.76 84.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.216 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.11 -49.67 64.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.576 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -59.04 -46.05 89.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.506 . . . . 0.0 110.025 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.81 -49.52 72.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.891 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.48 -41.09 63.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.361 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -55.81 -37.31 68.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.061 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -76.12 -15.82 60.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.78 -40.23 14.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.316 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.721 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.2 -63.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.238 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.9 t0 -65.7 126.61 28.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.37 79.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.313 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -92.16 -12.47 32.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.974 0.416 . . . . 0.0 110.313 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 56.96 32.82 62.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.805 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' OD2' ' A' ' 20' ' ' ASP . 9.1 p30 -76.62 1.27 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.845 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.3 43.31 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.028 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -149.55 132.62 16.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.351 0.576 . . . . 0.0 111.205 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.915 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -105.53 118.4 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.439 ' CB ' HG22 ' A' ' 62' ' ' THR . 7.8 t -97.4 166.0 11.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.615 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.3 p -52.17 -31.16 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.836 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -63.95 -50.45 68.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 111.321 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.7 -36.07 51.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.24 -45.67 72.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.013 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.33 -27.39 73.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.279 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 85.0 m -72.21 -47.14 52.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.721 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.5 p -74.71 -34.97 35.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -60.08 -49.77 76.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -64.41 -30.36 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 t -58.31 -21.29 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' B' ' 74' ' ' LEU . 11.4 mt -71.59 -60.26 2.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.92 -39.0 0.02 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.542 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.8 mt-30 -140.93 147.86 39.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.111 0.455 . . . . 0.0 111.162 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -99.64 99.65 9.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.258 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.44 -168.8 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.356 2.037 . . . . 0.0 111.971 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -85.1 169.82 13.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.65 -30.49 69.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 0.0 110.066 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -44.25 59.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.141 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 51' ' ' MET . 1.3 mt-10 -62.03 -41.1 97.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.266 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.9 mt -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.861 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.4 tt0 -64.24 -39.59 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -66.27 -51.09 60.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.66 -53.42 58.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.381 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.027 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -60.26 -45.35 96.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.497 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 26.7 t-20 -52.07 -26.12 10.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.446 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 2.2 mt-10 -82.96 -3.3 56.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.38 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -64.59 133.22 51.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.053 0.454 . . . . 0.0 111.344 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.11 -53.58 16.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.897 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.66 58.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.07 49.22 80.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.933 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -104.26 -1.47 27.02 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.771 -0.253 . . . . 0.0 111.439 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 17.72 15.01 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.252 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.23 139.82 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.44 149.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 111.985 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.75 170.8 7.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.415 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.4 m-85 -56.03 -61.55 6.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.533 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -68.24 -18.59 44.9 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.508 2.138 . . . . 0.0 112.68 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.409 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.475 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.4 t80 -75.28 -38.48 60.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 3' ' ' GLN . 12.1 tp -64.45 -55.61 19.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -51.67 -37.26 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.22 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.425 ' HG2' HG13 ' A' ' 55' ' ' VAL . 2.8 tpt -64.08 -32.74 74.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.4 mmt -108.27 15.52 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -119.35 -36.69 3.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.803 0.335 . . . . 0.0 111.291 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -53.31 -54.33 37.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.826 0.346 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.536 ' CB ' HG21 ' A' ' 146' ' ' THR . 11.5 m-20 58.56 161.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.367 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 t -166.2 -167.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -73.55 -26.04 60.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.03 -33.79 59.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' OE1' HG22 ' B' ' 77' ' ' VAL . 4.4 mt-10 -61.24 -45.4 94.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -72.34 -39.14 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.761 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -71.54 -49.47 40.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.799 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 91' ' ' VAL . 58.4 mt-10 -61.36 -45.56 93.89 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 109.313 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.54 -50.51 65.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.894 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.21 -40.8 59.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.833 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -31.76 68.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.443 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.061 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.57 -36.85 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.828 ' CE2' HG22 ' B' ' 78' ' ' ILE . 6.5 m-85 -75.63 -43.28 48.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -112.57 109.29 18.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -42.03 80.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -74.19 -9.71 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.06 68.51 0.77 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.172 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.46 8.82 40.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.47 16.38 65.14 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.296 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 3.6 m-85 -163.86 116.68 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.731 0.3 . . . . 0.0 111.066 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.605 HD11 ' HD1' ' A' ' 89' ' ' PHE . 8.9 mt -111.28 127.38 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 111.788 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.5 m -104.21 158.59 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.059 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -48.0 -41.98 26.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.732 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 111.126 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt-10 -56.67 -37.77 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.591 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -60.82 -47.71 85.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.882 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.746 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.39 -44.47 88.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.559 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 1.3 t60 -58.73 -38.33 78.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.38 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 92' ' ' PHE . 77.6 t -67.31 -55.64 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.0 mmt -49.05 -53.44 20.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.617 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.3 t -68.0 -24.34 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 19.3 t-20 -74.54 -31.39 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.664 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.7 -28.72 20.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.18 44.11 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.576 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.85 109.72 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -90.72 99.66 12.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 116' ' ' LEU . 4.4 mm? -101.27 172.51 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.806 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.3 t -96.59 166.58 11.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.829 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.32 -34.07 77.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -35.51 78.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.707 ' H ' HG23 ' A' ' 117' ' ' THR . 52.0 mm-40 -65.64 -50.02 66.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 106' ' ' ARG . 4.2 m -66.77 -39.56 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.13 -42.37 99.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 110.216 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.0 mt-10 -72.74 -30.13 63.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.339 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -36.19 72.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 105' ' ' LEU . 2.8 mm -80.36 -54.5 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 15.7 ptt180 -53.73 -31.92 50.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.431 . . . . 0.0 110.303 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.65 -21.72 44.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.734 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.673 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -106.68 -0.3 23.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.34 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 46.1 t0 -96.24 102.82 14.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.368 0.604 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -76.93 -32.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.157 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.3 -9.05 49.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.88 0.371 . . . . 0.0 111.491 -178.731 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.54 56.98 11.28 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -114.33 -3.71 13.07 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.145 0.472 . . . . 0.0 111.49 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.5 44.34 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.099 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.76 -174.79 4.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.646 0.26 . . . . 0.0 110.349 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.2 t -129.22 126.99 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.8 t30 -104.61 -167.68 1.38 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.942 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.629 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.5 t80 -56.7 -73.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 142' ' ' VAL . 1.9 tt0 -49.65 -47.13 50.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.23 0.538 . . . . 0.0 110.445 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.5 mt-10 -56.29 -33.72 65.8 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.759 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.67 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.23 -48.93 13.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.063 0.458 . . . . 0.0 111.686 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.844 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -60.29 -41.86 88.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.217 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.48 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.5 OUTLIER -70.85 -35.63 72.5 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.673 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 2.7 ptm -70.6 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 85' ' ' ILE . 17.8 mtt -105.11 -44.2 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.536 HG21 ' CB ' ' A' ' 80' ' ' ASP . 1.8 t . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HA ' ' HG3' ' A' ' 51' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.007 0.432 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.61 -76.26 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.9 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.4 -41.46 55.39 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -64.93 -70.31 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.702 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.2 OUTLIER -52.25 -38.82 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.51 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.4 OUTLIER -55.42 -49.88 71.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.67 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.55 -41.58 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.147 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' B' ' 69' ' ' GLN . 89.4 t -53.6 -53.47 25.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.31 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.878 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -71.33 -44.26 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.405 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.061 HD22 HG11 ' A' ' 91' ' ' VAL . 17.7 mt -56.23 -50.43 71.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.596 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -64.09 -47.02 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.59 -32.98 65.76 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.526 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 73' ' ' ARG . 47.4 t -76.75 -53.02 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.828 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -63.29 -43.08 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.524 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.637 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -57.92 -35.07 70.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 109.687 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -36.04 80.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.337 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.697 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 3.1 t90 -95.37 -13.86 24.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -92.03 -31.4 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.659 ' HG3' HD21 ' A' ' 69' ' ' LEU . 3.2 tt0 -176.55 175.23 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -122.27 165.4 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.631 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.7 t -69.64 170.31 11.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.88 -37.29 66.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.321 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.04 -56.8 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.134 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.631 ' H ' HG23 ' A' ' 5' ' ' THR . 1.2 tt0 -57.91 -44.38 86.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.868 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.437 HG13 HD13 ' A' ' 69' ' ' LEU . 7.1 tt -68.04 -26.78 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.8 -43.17 62.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -27.5 63.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.55 -49.41 41.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.239 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -57.06 -45.09 83.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 110.222 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.1 mm-40 -64.38 -51.66 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.21 -40.18 58.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.841 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -56.01 -47.34 77.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -13.62 62.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.3 mt -88.0 -38.3 15.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 110.503 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.12 -64.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.07 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.4 t70 -61.99 128.1 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -38.54 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.279 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.19 -12.25 30.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.824 0.345 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.33 38.44 86.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -77.66 -1.15 29.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.26 -2.53 43.58 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.213 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.1 p -149.42 132.47 16.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 0.0 110.756 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.925 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.73 119.21 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.423 ' CB ' HG22 ' A' ' 62' ' ' THR . 2.0 t -99.15 165.88 11.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.697 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 p -52.33 -32.56 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.885 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -62.13 -50.56 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.329 . . . . 0.0 111.374 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.78 -37.59 48.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 110.974 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.047 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.23 -40.39 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.585 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.2 -30.86 69.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.914 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.6 m -67.58 -53.25 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.1 p -69.76 -30.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.246 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.418 ' HE2' ' HG3' ' A' ' 43' ' ' PRO . 1.9 mtp -60.14 -46.62 89.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.321 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -25.52 44.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -53.64 -50.67 65.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -46.97 -57.88 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.589 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -142.72 178.76 7.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -147.69 58.58 4.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HG3' ' HE2' ' A' ' 36' ' ' MET . 65.9 Cg_endo -73.91 -178.5 3.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.559 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.1 p -98.66 173.76 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.49 -30.2 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.29 60.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.15 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.2 mt-10 -60.71 -42.01 96.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.062 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.0 mt -58.35 -50.53 73.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.6 tp-100 -62.77 -38.63 91.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.89 -51.23 42.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.352 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.467 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.39 -54.1 50.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.047 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.28 -45.26 93.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.477 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 27.7 t30 -52.36 -25.9 10.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.242 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.8 mt-10 -82.35 -3.33 55.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.98 -32.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.18 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.5 t0 -63.92 134.82 55.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -66.52 -53.35 35.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.728 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.77 4.2 51.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.813 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.16 59.71 9.11 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.213 -0.517 . . . . 0.0 113.933 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -109.35 -2.72 17.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.771 0.286 . . . . 0.0 111.323 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.22 17.3 16.18 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.927 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.5 p -149.49 139.96 22.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.337 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -104.64 149.56 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.209 0.528 . . . . 0.0 111.725 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 171.72 7.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -55.9 -61.59 6.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.712 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.1 Cg_endo -67.97 -19.48 45.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.753 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.18 -39.07 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.367 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.2 t80 -75.27 -35.74 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.662 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.7 tp -71.99 -58.43 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.085 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.13 -46.69 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mmt -59.71 -30.69 68.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.426 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.26 14.97 24.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.08 -43.0 3.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -48.7 76.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.795 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.772 0.32 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -85.85 -179.95 6.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -150.2 156.21 41.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.84 -38.54 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.261 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 45.4 mt-10 -63.92 -27.86 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.178 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.18 -39.22 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -70.88 -49.32 47.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.4 mt-10 -61.29 -46.44 90.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.34 0.59 . . . . 0.0 109.476 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.748 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.58 -48.85 68.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.068 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.06 -38.86 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.994 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -30.42 57.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.955 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.01 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.53 -37.02 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.705 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.86 -62.89 1.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.494 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.82 121.17 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.33 -52.62 57.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.234 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.04 -9.61 59.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.496 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.13 71.13 0.52 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.864 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.39 14.58 18.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.633 0.254 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.28 66.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.608 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.2 m-85 -161.84 116.75 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.755 0.312 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.6 mt -113.28 124.45 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.115 0.483 . . . . 0.0 111.645 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -104.26 161.63 13.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.16 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -44.52 29.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.442 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.09 -58.87 6.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.03 -36.62 65.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.636 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.934 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.99 -49.49 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.729 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.85 -41.49 78.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 2.4 t60 -60.55 -39.87 89.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.306 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 92' ' ' PHE . 28.1 t -68.72 -51.8 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.749 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.427 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.7 mmt -51.28 -54.05 29.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.802 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.1 t -66.99 -25.08 66.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 15.8 t-20 -70.69 -31.29 68.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.62 -28.8 16.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.51 43.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -152.11 109.78 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.66 95.63 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.018 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.4 mm? -94.07 157.14 16.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 120' ' ' GLU . 11.6 t -88.01 164.02 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.55 -42.69 83.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -62.46 -35.35 79.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 117' ' ' THR . 20.2 mt-10 -65.31 -54.85 23.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.021 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.94 -39.78 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -62.53 -41.88 99.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 110.276 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 5.6 mt-10 -72.66 -30.14 64.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.317 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 2.3 tpp -70.75 -36.09 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.934 HD11 HD12 ' A' ' 105' ' ' LEU . 4.6 mm -80.24 -54.91 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.567 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.43 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -53.65 -31.75 48.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.01 0.433 . . . . 0.0 110.456 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.77 -20.79 52.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.968 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.06 -10.96 15.76 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.55 0.214 . . . . 0.0 111.523 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -85.51 109.67 18.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.429 0.633 . . . . 0.0 111.307 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.13 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.755 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.05 -9.14 43.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.523 -178.565 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.31 57.62 10.05 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.8 p30 -114.25 -4.33 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.05 0.425 . . . . 0.0 111.456 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.69 42.45 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.991 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.05 -174.87 4.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.53 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 141' ' ' PHE . 54.0 t -128.34 126.82 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -106.55 -167.36 1.28 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.6 t80 -58.09 -73.98 0.07 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -49.56 -45.64 47.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.375 0.607 . . . . 0.0 110.336 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.55 -36.61 69.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.74 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.64 -49.51 12.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.913 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.85 -40.21 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -34.44 70.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.757 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.424 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.82 8.93 13.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 111.283 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.8 mtt -118.81 -36.32 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -179.851 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.036 0 CA-C-O 120.971 0.415 . . . . 0.0 110.774 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.03 -75.81 0.22 Allowed Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.95 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.35 -46.69 63.67 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -58.71 -70.26 0.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.27 . . . . 0.0 110.552 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.46 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.29 -34.09 45.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.205 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 6.6 tpt180 -58.14 -52.18 66.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.38 -41.8 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.053 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 68' ' ' PHE . 90.4 t -53.03 -53.3 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.446 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.826 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.02 -45.01 64.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.436 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.01 HD22 HG11 ' A' ' 91' ' ' VAL . 21.2 mt -55.99 -49.73 72.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.557 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -64.62 -48.62 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.574 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.96 -29.67 59.39 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.151 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.826 HG23 ' O ' ' B' ' 73' ' ' ARG . 98.8 t -76.8 -55.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.604 0.24 . . . . 0.0 111.562 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.705 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.5 pp -61.73 -43.91 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.664 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.6 mmm180 -58.16 -34.26 70.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.229 0.538 . . . . 0.0 109.855 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -62.27 -37.03 83.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.901 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.34 -15.38 23.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.73 -26.26 19.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.501 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.645 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -176.57 170.82 2.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.836 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -124.13 165.36 17.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 8' ' ' GLN . 10.1 t -67.93 166.33 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -54.34 -26.48 30.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -80.36 -56.89 3.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.126 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.836 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.84 -46.57 84.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 69' ' ' LEU . 7.0 tt -65.52 -26.65 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.55 -44.04 62.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.294 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 -25.71 61.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -71.42 -49.39 42.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.298 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -56.35 -44.93 80.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.307 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.4 mm-40 -65.35 -51.44 60.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 1.046 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.18 -40.06 57.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.922 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -57.07 -45.98 82.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -70.94 -13.76 62.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.2 mt -87.99 -38.38 15.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.906 0.384 . . . . 0.0 110.57 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.788 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.31 -64.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.3 t70 -62.52 127.34 30.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.801 0.334 . . . . 0.0 110.432 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -38.69 92.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.9 -12.31 31.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.26 38.38 86.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -77.65 -1.06 29.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.79 43.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.195 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.7 p -149.37 132.49 16.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.939 0.37 . . . . 0.0 110.764 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.38 119.35 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.404 ' HA ' HG22 ' A' ' 62' ' ' THR . 2.9 t -98.75 165.11 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.696 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 p -52.76 -30.45 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.83 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -63.24 -50.61 69.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -77.85 -37.87 47.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.14 -41.39 68.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 -29.42 72.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.9 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.6 m -69.51 -52.05 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.542 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.7 p -69.01 -31.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -47.16 87.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -25.47 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.758 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 t -54.69 -50.72 67.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.51 -58.72 3.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 111.085 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.6 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -142.71 -178.02 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -150.99 58.16 2.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 -177.18 2.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.65 2.233 . . . . 0.0 112.504 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.2 p -99.71 173.6 6.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -68.54 -30.14 68.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.918 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.12 59.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.8 OUTLIER -61.32 -42.51 98.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.076 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.5 -50.53 72.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 28.2 tp60 -63.28 -39.43 94.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.214 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.61 -51.25 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.325 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.79 -53.84 53.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 110.347 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.043 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.31 -45.27 93.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.437 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 10.0 t30 -52.38 -25.92 11.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.257 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.2 mt-10 -82.39 -3.26 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.12 -32.36 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.183 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -63.31 136.51 57.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 111.195 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.46 -53.9 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.562 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -95.6 4.24 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.62 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.31 58.74 10.16 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.8 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -109.72 -1.76 17.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.788 0.294 . . . . 0.0 111.301 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.44 15.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.953 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.586 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.9 p -149.32 139.85 22.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.137 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.59 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -103.95 149.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.082 0.468 . . . . 0.0 111.708 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.38 169.28 8.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.624 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.2 m-85 -53.44 -61.12 5.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.393 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_endo -69.11 -18.44 40.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.486 2.124 . . . . 0.0 112.636 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mm-40 -79.24 -38.85 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.0 t80 -75.26 -34.09 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.622 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.9 tp -73.74 -58.43 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -52.08 -47.81 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.491 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 4.4 mmt -59.55 -28.58 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.43 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.22 13.23 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -110.64 -43.69 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -55.58 -44.26 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 110.859 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.783 0.325 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 -178.84 7.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.039 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.92 155.96 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.51 -24.97 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.362 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.1 -37.25 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.202 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 55.3 mt-10 -64.9 -28.07 69.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.165 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.2 -39.27 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.287 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -70.83 -49.28 47.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 36.1 mt-10 -61.04 -47.0 88.43 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.795 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.43 -48.85 68.4 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.241 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.14 -38.86 54.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.984 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -30.46 56.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.949 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.044 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.44 -37.07 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 111.026 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.4 m-85 -71.62 -62.95 1.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.8 117.95 23.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -60.66 -52.63 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.47 -9.64 59.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.501 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.7 71.65 0.47 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.879 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.38 14.42 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.57 13.72 61.32 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.673 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.9 m-85 -158.07 116.69 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.76 125.1 70.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.792 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 161.86 13.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.237 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.581 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.91 -46.98 32.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.555 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.31 -58.87 5.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.14 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.88 -36.55 65.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.606 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.2 -50.52 72.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.648 178.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.559 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -56.4 -41.85 77.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -60.12 -39.35 85.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.397 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.21 -55.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.694 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.6 mmt -49.94 -54.07 22.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.39 -24.92 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.12 -31.41 70.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.73 -28.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.03 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.27 43.17 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -150.17 109.82 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -90.21 98.82 12.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.3 mm? -88.37 171.22 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 m -98.29 158.96 15.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -56.76 -48.9 76.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -64.18 -31.66 72.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.64 -54.91 32.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.6 m -65.37 -40.46 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.47 -40.99 98.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.094 0.473 . . . . 0.0 110.283 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 9.8 mt-10 -73.02 -30.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.405 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.0 mtp -71.04 -35.74 72.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 105' ' ' LEU . 5.0 mm -80.35 -54.94 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.623 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 ptm180 -53.89 -31.86 51.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 0.0 110.38 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.96 -21.01 47.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.786 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.97 -5.05 18.43 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 121.114 -0.235 . . . . 0.0 111.445 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.4 t0 -92.38 109.7 21.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.41 0.624 . . . . 0.0 111.325 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.74 -31.18 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.793 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.92 -9.12 44.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.554 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.55 58.21 8.51 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.8 p30 -114.25 -4.53 13.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.04 0.42 . . . . 0.0 111.463 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.38 7.83 42.13 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.967 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.11 -174.81 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.766 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.04 126.67 66.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.261 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.3 t30 -105.29 -168.28 1.44 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.628 ' O ' HG13 ' A' ' 142' ' ' VAL . 59.7 t80 -58.51 -73.98 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.52 -45.52 47.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.348 0.594 . . . . 0.0 110.265 -179.536 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.51 -36.38 69.11 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.108 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.766 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.71 -49.83 11.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.901 0.381 . . . . 0.0 111.92 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.12 -40.49 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -34.45 70.9 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.705 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.41 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.43 8.6 13.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.647 0.261 . . . . 0.0 111.305 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.574 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -118.51 -37.66 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.396 -179.799 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 65' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 121.014 0.435 . . . . 0.0 110.822 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.14 -75.74 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.935 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.48 63.24 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.058 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -59.1 -70.29 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.653 -0.273 . . . . 0.0 110.501 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.08 -34.0 41.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.179 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.8 tpp180 -58.27 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ILE . . . . . 0.621 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.14 -41.81 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.963 178.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 72' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.6 t -52.95 -52.62 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.468 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ARG . . . . . 0.863 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.04 -45.78 63.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.331 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 1.044 HD22 HG11 ' A' ' 91' ' ' VAL . 22.7 mt -55.87 -49.26 73.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 110.545 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' VAL . . . . . 1.046 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -63.97 -48.2 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.56 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' GLY . . . . . 0.569 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.76 -29.82 58.86 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.14 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' VAL . . . . . 0.863 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.2 t -76.77 -56.06 9.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.596 0.236 . . . . 0.0 111.63 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.66 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -60.74 -43.56 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ARG . . . . . 0.66 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.05 -33.29 68.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 109.901 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -37.79 88.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.469 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' TRP . . . . . 0.933 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.2 t90 -95.52 -11.37 27.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.153 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -93.29 -31.23 14.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.419 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.562 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.792 0.33 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 70' ' ' THR . 32.9 p-10 -157.06 85.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -177.54 -179.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -133.55 165.27 25.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 169.4 13.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.075 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -30.29 57.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.518 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -78.45 -56.88 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.633 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -59.31 -45.32 91.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.481 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 5' ' ' THR . 13.0 tt -65.17 -26.65 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.955 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.68 -44.04 62.96 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.442 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -32.71 72.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.257 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -67.6 -49.7 61.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.328 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -44.74 92.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.254 0.55 . . . . 0.0 110.043 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.42 -47.88 74.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.704 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.4 -41.97 63.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -56.76 -35.12 68.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.043 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -77.86 -14.64 59.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.927 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.66 -38.5 15.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.631 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.26 -65.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.8 t70 -66.01 132.33 48.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -37.89 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.01 -12.15 29.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.51 36.76 79.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.654 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -74.67 -5.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.523 0.201 . . . . 0.0 111.501 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.18 2.29 44.9 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.1 p -149.43 132.53 16.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -108.97 126.56 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.03 167.82 10.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 p -54.01 -30.44 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.48 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -62.79 -50.39 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.204 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.5 mm-40 -77.73 -36.28 51.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.798 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.37 -58.35 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.703 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.25 -27.49 69.27 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.555 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -70.99 -60.99 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.12 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -64.71 -30.76 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.7 ttt -60.22 -55.22 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.77 -25.63 64.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.967 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 t -56.04 -38.37 70.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.92 -62.3 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.65 41.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -142.56 167.8 21.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -134.97 59.66 35.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.71 -169.98 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.588 2.192 . . . . 0.0 112.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 p -116.46 167.57 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.78 -32.05 71.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.8 -45.62 59.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.405 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.0 OUTLIER -64.17 -43.4 95.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.302 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -55.25 -50.58 69.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.09 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -64.56 -57.03 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -51.19 67.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.182 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.519 ' HE2' ' H ' ' B' ' 66' ' ' GLY . 15.7 mtt -57.64 -47.06 83.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -61.58 -45.68 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.159 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -56.36 -26.53 53.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.529 0.68 . . . . 0.0 110.113 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' MET . 6.6 mt-10 -81.53 -2.14 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.351 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.629 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -127.0 -33.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 112.04 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.484 ' N ' HD12 ' A' ' 63' ' ' ILE . 54.1 t0 -72.49 148.5 45.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.251 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.5 -53.57 7.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.54 -8.63 58.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.34 48.55 79.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.931 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -96.6 -0.22 48.95 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.643 0.222 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 15.13 22.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.922 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.4 p -149.88 139.89 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.56 0.18 . . . . 0.0 110.565 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.71 147.34 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.497 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.52 179.08 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.882 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -60.93 -61.69 7.48 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.0 Cg_endo -66.93 -30.94 39.0 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.435 2.09 . . . . 0.0 112.197 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mt-10 -65.74 -40.61 92.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.14 -41.95 57.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -71.17 -53.1 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.482 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.556 ' N ' HD23 ' A' ' 69' ' ' LEU . 90.4 m -51.58 -46.34 63.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.182 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.404 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 tpp -56.65 -48.33 77.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.932 0.396 . . . . 0.0 110.936 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.9 mmt -85.95 0.15 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.559 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.66 -38.89 11.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.93 0.395 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -55.04 -30.48 59.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 149.2 31.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.84 89.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -103.6 -49.7 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -135.54 114.1 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.746 HG23 HH22 ' B' ' 73' ' ' ARG . 1.4 t -176.74 170.09 2.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -151.75 174.44 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -152.17 155.46 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -54.64 -24.29 20.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 -38.68 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 53.5 mt-10 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.026 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.29 -38.88 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -49.35 33.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.7 mt-10 -61.06 -45.49 94.55 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.87 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.47 -53.33 53.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.997 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.636 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.36 -38.88 55.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.833 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -31.46 68.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.25 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.937 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.39 -36.68 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' HG21 ' A' ' 108' ' ' VAL . 5.9 m-85 -71.93 -62.9 1.26 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -85.25 129.93 34.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -75.67 -52.6 10.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.37 -9.6 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.481 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.21 70.44 0.62 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.898 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -93.43 15.32 16.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.3 68.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.2 m-85 -166.35 116.34 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.2 mt -111.66 129.11 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.787 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -104.08 156.5 17.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.197 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.488 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.93 -38.88 17.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.385 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.85 -59.01 6.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.057 0.456 . . . . 0.0 110.864 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -36.87 72.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.689 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.845 HD12 HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.56 -49.31 77.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 110' ' ' THR . 2.0 tpt180 -56.75 -44.49 81.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.205 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -58.76 -37.52 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.17 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 92' ' ' PHE . 38.5 t -68.87 -53.77 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.674 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.528 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.0 mmt -50.35 -54.12 23.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.3 t -67.29 -24.87 65.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.38 -29.99 67.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.61 -28.84 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.75 43.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.96 125.75 18.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -92.31 95.6 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.8 mm? -97.79 150.84 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.813 ' O ' HG22 ' A' ' 121' ' ' VAL . 16.9 m -98.24 159.05 15.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.08 -44.38 87.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -34.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -65.52 -54.87 22.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 117' ' ' THR . 2.7 m -64.66 -38.82 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.038 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.68 -42.04 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.39 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.1 mt-10 -73.03 -30.11 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.444 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 1.5 mmt -71.18 -35.07 71.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 105' ' ' LEU . 2.4 mm -80.35 -54.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.3 ptm180 -54.04 -31.86 52.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.302 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.19 -22.87 57.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.743 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.46 -11.17 18.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -96.35 97.79 9.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.484 0.659 . . . . 0.0 111.214 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.405 HG21 ' OE1' ' A' ' 143' ' ' GLN . 0.8 OUTLIER -57.68 -30.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 6.6 p30 -95.74 -9.51 31.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.972 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 45.98 62.43 3.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.505 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -113.68 3.2 15.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.584 0.23 . . . . 0.0 111.447 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.34 2.96 47.79 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.09 -177.33 5.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.094 0.447 . . . . 0.0 110.966 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.636 HG12 ' HZ ' ' A' ' 89' ' ' PHE . 82.2 t -130.78 128.58 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.145 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.3 t30 -99.52 -175.07 2.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.736 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.7 t80 -56.82 -72.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.018 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.37 -43.26 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.152 0.501 . . . . 0.0 110.91 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.55 -36.17 71.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.38 -49.67 12.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.134 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.6 m -53.97 -42.41 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 12.6 pt20 -70.93 -48.6 52.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.231 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.74 -15.76 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.2 mtt -89.83 -42.96 10.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 147' ' ' ALA . 4.5 t -135.77 -51.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -84.83 53.69 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 111.599 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.909 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.681 0.277 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.02 -176.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.578 2.186 . . . . 0.0 112.328 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -102.8 -47.13 4.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -150.34 30.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.01 -135.52 5.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -109.6 114.62 28.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.519 ' H ' ' HE2' ' A' ' 51' ' ' MET . . . -58.55 -71.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.603 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.57 -50.29 49.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.629 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -58.3 -67.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.606 0.241 . . . . 0.0 110.514 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.99 -35.99 48.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.298 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 19.5 tpp85 -56.38 -49.86 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.615 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.35 -42.19 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.006 178.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.5 t -50.72 -50.31 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.558 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.854 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.82 -45.88 63.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.937 HD22 HG11 ' A' ' 91' ' ' VAL . 19.5 mt -55.87 -50.61 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.3 p -63.02 -47.8 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 110.414 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.95 -29.6 59.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.165 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.855 HG11 ' CB ' ' A' ' 88' ' ' ALA . 92.5 t -76.76 -56.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.629 0.252 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.644 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -59.9 -43.69 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.644 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.9 mmm180 -57.81 -35.09 70.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.236 0.541 . . . . 0.0 109.673 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.86 -35.77 81.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.109 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.763 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.4 t90 -95.19 -9.97 31.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.774 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.77 -36.94 50.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.281 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -148.23 -65.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.018 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.9 66.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 -66.6 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' B' ' 86' ' ' PHE . 67.9 t80 -106.29 33.96 3.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.879 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.832 0.349 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -66.43 77.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.633 ' CG ' HD21 ' A' ' 69' ' ' LEU . 2.5 tt0 -177.39 -175.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.64 HD13 ' CD ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -137.04 165.17 26.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.594 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.6 t -69.78 171.4 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.97 -35.81 64.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.444 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -74.27 -56.88 4.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.64 ' CD ' HD13 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -58.38 -41.26 84.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.699 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 5' ' ' THR . 7.5 tt -71.4 -26.38 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.029 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.39 -43.22 61.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.514 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.34 -33.44 73.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -65.96 -49.65 67.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.467 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.56 -44.82 89.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.202 0.525 . . . . 0.0 110.215 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.03 -48.86 72.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.703 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.897 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.34 -41.45 63.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.497 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -57.51 -31.73 66.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.957 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -79.7 -15.08 58.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.64 -38.79 15.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.591 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.04 -65.84 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.35 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -66.57 132.69 48.74 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 110.702 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -37.3 74.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.92 -12.28 29.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.49 37.08 80.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.64 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -75.21 -4.2 37.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.505 0.193 . . . . 0.0 111.473 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 -0.23 44.01 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.059 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.3 p -149.54 132.59 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.803 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mp -107.54 128.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.7 t -103.28 165.13 11.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 p -52.78 -26.65 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.688 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -67.53 -50.5 58.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 15.3 mm-40 -77.46 -35.41 53.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.752 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.012 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.27 -58.36 7.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.773 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -61.0 -27.3 66.89 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.919 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -69.89 -56.52 6.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 111.52 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.7 p -67.81 -33.78 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.484 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.455 ' HE2' ' HA3' ' B' ' 67' ' ' GLY . 0.0 OUTLIER -59.05 -53.1 62.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.713 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.9 -25.77 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.984 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -60.41 -36.71 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.7 mt -58.31 -30.65 66.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.23 42.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.524 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -142.6 161.59 37.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.23 62.75 8.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.73 -174.13 1.21 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.571 2.181 . . . . 0.0 112.355 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -122.12 167.29 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.79 -32.26 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.183 0.516 . . . . 0.0 110.084 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.487 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -41.92 95.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.394 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -56.34 -50.79 70.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -65.46 -50.03 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.54 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.08 71.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.6 -49.89 75.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.698 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -58.88 -42.32 85.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.261 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -59.18 -26.34 64.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.56 0.695 . . . . 0.0 110.06 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -83.79 -2.16 55.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.86 -33.06 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.3 t0 -71.15 148.02 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.85 -53.45 6.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.646 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.36 -8.76 58.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.49 48.75 78.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -96.96 -1.42 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 111.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.24 22.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.86 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.81 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' ILE . 3.3 mm -95.33 147.21 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.473 . . . . 0.0 111.663 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.49 176.92 5.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.929 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 3.3 m-85 -60.21 -61.62 7.56 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 33.4 Cg_endo -64.48 -30.94 61.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.411 2.074 . . . . 0.0 111.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 1.9 mt-10 -69.03 -37.09 78.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.336 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.3 t80 -75.12 -39.97 60.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.633 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.6 tp -76.79 -54.57 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.604 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.1 m -51.58 -44.02 62.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.613 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -54.17 47.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.864 0.364 . . . . 0.0 111.011 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.47 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 22.9 mtt -80.31 -8.06 59.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.604 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -87.82 -42.68 12.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.842 0.353 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -59.5 -29.88 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.921 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 138.28 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.4 mpp? 60.71 93.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -93.83 -59.77 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 79' ' ' THR . 25.8 t0 -130.87 132.07 44.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -169.32 169.68 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.03 163.29 37.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 157.55 43.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -57.44 -27.78 62.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.2 -34.43 61.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.2 mt-10 -61.48 -33.84 74.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.811 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.41 -39.02 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.298 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -49.32 33.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.5 mm-40 -60.9 -44.94 96.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.66 -52.87 58.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.883 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.608 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.28 -38.85 55.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.865 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -71.49 -31.44 67.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.43 -36.68 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.656 ' CE2' HG22 ' B' ' 78' ' ' ILE . 7.8 m-85 -73.51 -62.81 1.35 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.934 0.397 . . . . 0.0 110.394 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -84.81 118.14 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -64.8 -52.64 55.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.27 -9.63 59.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.541 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.81 70.97 0.56 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.21 15.14 16.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.45 66.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.617 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.9 m-85 -165.67 116.36 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.576 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.7 mt -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -104.04 156.39 17.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.929 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.97 -36.63 12.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.446 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -59.06 5.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.105 0.479 . . . . 0.0 110.978 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.4 mm-40 -58.75 -38.92 79.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.799 HD12 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.17 -48.36 82.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.842 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 110' ' ' THR . 5.0 tpt85 -56.91 -45.53 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.14 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.9 -36.63 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.148 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 92' ' ' PHE . 52.6 t -67.43 -54.44 23.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.66 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.703 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.1 mmt -50.36 -54.01 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.6 t -67.63 -25.57 65.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.606 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.5 -31.23 71.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.82 -28.79 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.035 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.18 42.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.552 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.576 ' OE2' HD21 ' A' ' 116' ' ' LEU . 6.2 tt0 -146.72 110.68 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -88.0 86.01 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -80.13 175.64 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' VAL . 3.6 m -98.41 158.68 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.706 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.95 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.111 0.481 . . . . 0.0 110.209 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -71.76 -32.98 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.196 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.18 -52.98 56.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.54 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 117' ' ' THR . 2.9 m -66.95 -39.18 82.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.48 -45.15 88.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.046 0.45 . . . . 0.0 110.373 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 24.3 mt-10 -72.97 -30.16 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.622 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -34.46 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.755 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.799 HD11 HD12 ' A' ' 105' ' ' LEU . 2.0 mm -80.27 -54.73 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.463 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.2 ptm180 -53.91 -31.88 51.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 110.284 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.33 -23.48 57.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.688 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.03 -4.99 25.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.442 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -101.45 96.45 7.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.469 0.652 . . . . 0.0 111.273 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -30.84 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.611 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 5.0 p30 -95.82 -9.37 31.75 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 46.7 62.66 3.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.6 p30 -113.7 1.99 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.568 0.223 . . . . 0.0 111.434 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.28 4.57 47.09 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -149.98 -177.59 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 0.0 111.064 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.692 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.4 t -130.78 128.69 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.2 t30 -101.13 -174.03 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 142' ' ' VAL . 24.4 t80 -57.06 -73.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.514 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.38 -42.73 42.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.43 -37.24 72.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.326 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.692 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -79.43 -49.74 11.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.189 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.811 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.5 m -53.68 -42.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 12.3 pt20 -70.94 -48.18 54.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.267 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.457 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.66 -15.56 52.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.473 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.589 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.6 mtt -90.59 -42.62 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.751 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 147' ' ' ALA . 4.5 t -135.46 -51.17 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -84.97 53.32 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.577 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.876 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' THR . . . . . 0.728 HG23 ' NH2' ' B' ' 70' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.709 0.29 . . . . 0.0 111.162 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.12 173.89 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -60.18 -43.47 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -176.83 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.84 -83.27 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.518 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.544 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -145.23 120.09 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.938 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.67 -70.46 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 36' ' ' MET . . . -57.9 -46.86 91.94 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.606 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.75 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.2 OUTLIER -52.23 -64.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.295 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.03 -31.57 61.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 0.0 110.005 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.728 ' NH2' HG23 ' B' ' 60' ' ' THR . 10.3 tpp180 -54.0 -53.57 51.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.75 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -38.62 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.0 t -50.85 -43.11 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.351 0.596 . . . . 0.0 110.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.516 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.67 -48.16 27.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.121 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.749 HD22 HG11 ' A' ' 91' ' ' VAL . 62.6 mt -55.75 -46.77 77.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.897 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -66.28 -46.72 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.593 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -58.16 -30.7 64.4 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.156 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 88' ' ' ALA . 69.0 t -76.77 -55.05 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.645 0.26 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.656 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -61.39 -43.03 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.501 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.635 ' N ' HD12 ' B' ' 78' ' ' ILE . 9.8 mmp_? -56.58 -37.4 70.56 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.381 0.61 . . . . 0.0 109.518 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -35.74 79.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.374 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.769 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.1 t90 -95.03 -9.92 32.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.685 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.53 -36.55 52.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.385 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -65.87 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.62 65.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.81 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.847 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' B' ' 86' ' ' PHE . 24.1 t80 -137.28 35.31 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.97 78.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.613 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -176.98 -178.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.553 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -131.68 165.32 23.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.87 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.7 t -70.6 177.05 3.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.103 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -59.0 -37.99 78.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.264 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -73.48 -56.82 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.942 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.591 ' H ' HG23 ' A' ' 5' ' ' THR . 2.3 tt0 -57.71 -40.72 80.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.1 tt -72.28 -26.57 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.981 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.64 -43.74 62.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.525 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.11 -33.05 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.15 -49.69 63.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.229 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -59.69 -44.93 93.44 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.218 0.532 . . . . 0.0 109.906 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -63.68 -48.21 78.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.409 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.83 63.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.285 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.56 -38.61 69.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -74.0 -15.66 61.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -87.07 -38.3 16.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.36 -65.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.276 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -66.1 134.02 51.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -37.91 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.256 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.24 -12.14 28.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.824 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.57 79.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.724 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.58 -5.51 43.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.523 0.201 . . . . 0.0 111.45 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 3.72 44.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.044 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -149.45 132.59 16.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.874 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -110.64 126.93 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.3 t -100.42 168.27 9.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -54.32 -30.34 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.44 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -64.12 -50.41 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.185 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HG12 ' A' ' 35' ' ' VAL . 22.3 mm-40 -76.79 -35.29 57.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.477 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.017 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.41 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.805 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -64.08 -27.46 71.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.803 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.5 m -66.89 -60.24 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.194 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -70.03 -30.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.1 ttt -62.02 -47.2 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.66 -25.72 44.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.998 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -57.7 -36.33 71.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.15 -61.52 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -142.63 161.89 36.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -130.05 60.06 49.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.0 -170.07 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.8 p -117.52 167.45 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.78 -32.11 71.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.69 59.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.338 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -44.85 92.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.262 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.9 mt -53.57 -50.59 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.86 -53.04 52.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -56.85 -51.13 70.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.06 -48.31 82.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.679 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.017 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.52 -43.65 91.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.79 -26.38 64.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.559 0.695 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -82.83 -2.24 54.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.663 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.78 -33.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.0 t0 -70.2 153.92 42.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.17 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.68 -53.5 6.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.855 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.58 -8.54 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.56 52.02 55.6 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.859 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.43 0.11 44.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.577 0.227 . . . . 0.0 111.45 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.39 24.38 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.8 p -149.98 139.9 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.542 0.21 . . . . 0.0 110.633 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.66 149.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.039 0.447 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 178.26 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.722 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.6 m-85 -60.79 -61.59 7.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.521 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.5 Cg_endo -67.22 -32.68 32.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.48 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -65.04 -38.76 91.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.6 t80 -75.35 -41.17 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.438 . . . . 0.0 110.036 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.613 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.3 tp -68.4 -56.28 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.4 m -51.72 -46.11 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.514 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.0 tpp -55.89 -49.6 72.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 111.087 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.0 mmt -81.14 -13.39 58.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -86.24 -35.17 20.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 110.978 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -38.65 90.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 134.7 45.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mpp? 57.71 76.44 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -74.1 -61.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -133.35 134.95 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -177.38 156.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.28 159.5 35.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -150.25 154.0 37.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -55.17 -26.64 40.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.6 -34.05 67.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.2 mt-10 -66.77 -32.39 73.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.823 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.25 -38.92 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.2 -49.41 43.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.388 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.878 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.4 mm-40 -61.5 -45.84 92.52 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.766 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.65 -49.32 68.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.978 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.1 -38.42 51.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.97 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -30.47 57.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.822 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.14 -37.05 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.6 m-85 -73.74 -62.95 1.32 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.855 0.36 . . . . 0.0 110.483 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -84.42 128.48 34.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.787 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -73.17 -52.63 13.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.254 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -78.57 -9.62 59.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.528 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.72 70.61 0.57 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.956 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -93.67 14.87 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 111.219 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.73 68.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.6 m-85 -162.99 116.94 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.77 126.67 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.499 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -103.96 156.94 17.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.133 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.62 -41.54 22.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.334 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -58.91 6.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.056 0.455 . . . . 0.0 110.863 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.71 -38.46 69.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.754 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.886 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.71 -50.76 72.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.834 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -44.15 77.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.06 -37.51 74.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.333 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.78 -53.88 22.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.74 -54.11 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.6 t -66.45 -25.42 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -68.4 -29.87 68.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.41 -28.76 13.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.22 43.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.536 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -149.66 114.15 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.06 103.08 15.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.32 163.6 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.768 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.835 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.1 m -98.28 158.82 15.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.5 -42.34 91.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.81 -35.42 74.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.32 -54.83 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -64.06 -39.9 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.85 -41.69 98.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.2 mt-10 -72.57 -30.1 64.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.356 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.437 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 53.9 ttm -70.85 -34.88 72.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.678 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.886 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.38 -54.93 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.659 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm85 -54.26 -31.78 54.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.41 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -76.13 -22.02 55.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.897 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.72 15.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.576 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -83.88 90.82 7.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.472 0.654 . . . . 0.0 111.06 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.736 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -64.1 -30.74 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.411 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.601 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.74 -9.46 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.17 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.3 54.49 19.67 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.9 p30 -113.86 -5.33 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.206 0.503 . . . . 0.0 111.371 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.5 6.49 44.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.185 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.38 -174.89 4.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.895 0.348 . . . . 0.0 110.566 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.3 t -128.94 123.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.409 . . . . 0.0 111.326 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.2 -164.73 1.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.855 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.575 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 t80 -63.12 -73.9 0.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.6 -44.27 47.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.346 0.593 . . . . 0.0 110.302 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.736 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.43 -36.06 68.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.007 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.77 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -48.66 13.56 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.906 0.384 . . . . 0.0 111.496 -179.246 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.823 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -57.85 -41.2 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.363 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 2.5 pp0? -71.34 -35.3 71.13 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.578 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.41 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -81.66 6.31 15.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.337 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.58 ' SD ' HG13 ' B' ' 77' ' ' VAL . 2.9 mtt -115.75 -31.97 5.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.287 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 147' ' ' ALA . 12.1 t -141.64 -48.83 0.39 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.604 0.24 . . . . 0.0 111.628 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -87.41 79.66 8.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 111.452 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.001 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 -174.61 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.546 2.164 . . . . 0.0 112.288 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -96.56 -31.34 12.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -155.2 39.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.6 -135.68 4.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.466 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? -111.93 123.67 50.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.06 -67.94 1.95 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.851 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.31 70.1 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.598 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.69 -66.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.493 0.187 . . . . 0.0 111.004 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.41 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.74 -36.78 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.507 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.5 tpt180 -55.88 -50.27 71.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.12 -41.75 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.138 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.8 t -50.45 -52.4 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.581 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.828 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.1 mpt_? -70.69 -44.38 67.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.423 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 91' ' ' VAL . 15.2 mt -56.03 -51.34 68.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -63.66 -48.09 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.87 59.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.042 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.828 HG23 ' O ' ' B' ' 73' ' ' ARG . 78.6 t -76.84 -54.6 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.625 0.25 . . . . 0.0 111.398 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.655 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.9 -44.09 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.655 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.23 -35.37 71.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.224 0.535 . . . . 0.0 109.793 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.66 -36.99 80.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.194 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.834 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.9 t90 -95.28 -11.14 28.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.798 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.368 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -148.51 -65.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.88 66.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.59 -66.65 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' B' ' 86' ' ' PHE . 67.0 t80 -109.53 35.54 3.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.203 -0.904 . . . . 0.0 110.842 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.834 0.35 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.77 69.27 8.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.617 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.2 tt0 -173.82 -178.59 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.3 165.37 24.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.5 t -70.21 176.85 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.138 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -59.06 -38.01 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.322 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -73.51 -56.79 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.996 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 5' ' ' THR . 2.0 tt0 -57.65 -40.75 80.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.4 tt -72.27 -26.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.62 -43.86 62.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.516 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -67.79 -33.48 74.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.205 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.02 -49.61 64.74 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.239 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.74 -44.86 93.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 109.887 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.1 -49.06 75.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.41 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.35 -41.43 63.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.83 -38.0 69.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -75.05 -15.47 60.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.33 -37.7 16.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 110.31 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.92 -65.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.249 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.01 133.42 50.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.66 77.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.36 -12.2 28.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.55 36.69 79.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.694 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -74.8 -5.26 42.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.406 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.18 44.81 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.069 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -149.48 132.62 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.876 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.68 126.63 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.269 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.0 t -99.5 167.3 10.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.3 p -53.5 -32.14 49.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -62.67 -50.51 70.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.336 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.3 mm-40 -75.82 -36.37 59.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.731 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.0 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.38 -58.23 8.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.699 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.41 -30.88 77.6 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.665 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.6 m -63.84 -60.95 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.361 . . . . 0.0 111.086 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.2 p -65.68 -30.55 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.5 mtp -59.68 -52.14 66.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.626 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.35 -25.66 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -55.85 -38.97 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 mt -58.06 -63.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.14 40.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -141.09 168.37 19.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.05 59.48 34.1 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.43 -169.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.277 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.9 p -118.1 167.47 11.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.82 -32.07 71.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.191 0.519 . . . . 0.0 110.064 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.76 -45.74 59.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -44.55 93.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.279 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -54.03 -50.54 66.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.234 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -64.86 -52.7 55.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.534 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.17 -51.03 70.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.275 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.21 -48.38 81.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.0 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.35 -43.61 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.112 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.71 -26.34 63.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.532 0.682 . . . . 0.0 109.991 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 51' ' ' MET . 5.9 mt-10 -82.61 -2.26 53.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.591 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.628 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.6 -33.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.4 t0 -70.95 152.83 43.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.03 -53.46 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.861 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.09 -8.67 53.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.4 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.37 51.64 57.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.909 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.28 0.24 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.581 0.229 . . . . 0.0 111.402 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.51 24.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.866 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -150.0 139.88 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.536 0.208 . . . . 0.0 110.644 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.5 149.34 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 111.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.26 178.2 4.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.762 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -61.17 -61.59 7.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.5 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.8 Cg_endo -67.1 -31.22 37.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.481 2.12 . . . . 0.0 112.468 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -66.58 -38.78 87.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.977 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.8 t80 -75.27 -41.01 58.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 110.038 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.9 tp -68.81 -56.23 8.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.485 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 m -51.65 -44.57 63.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.525 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tpp -57.21 -49.92 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 mmt -79.21 -18.23 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.43 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.87 -32.75 27.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -45.16 89.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.95 142.77 42.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.7 ttm 59.92 73.78 0.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -76.91 -62.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.84 126.54 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -177.23 146.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -127.43 177.8 6.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.981 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -161.29 154.15 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.84 -26.95 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.59 -37.1 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.3 mt-10 -61.7 -30.38 70.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.31 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.252 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -49.36 41.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.425 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.872 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.8 mm-40 -61.45 -45.83 92.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.412 0.625 . . . . 0.0 109.445 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -49.43 67.79 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.956 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.98 -38.68 52.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.018 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.16 -30.48 58.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.31 -37.12 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.594 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -72.55 -63.01 1.24 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.864 0.364 . . . . 0.0 110.465 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.07 113.71 20.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.11 -52.56 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 -9.6 59.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.3 71.79 0.47 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.83 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -94.85 13.46 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 111.213 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.08 68.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -162.65 116.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -113.5 123.22 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 111.531 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -104.2 161.4 14.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.979 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.588 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.71 -43.92 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.189 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -58.81 6.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.068 0.461 . . . . 0.0 110.908 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 32.2 mm-40 -55.11 -37.59 67.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.733 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.66 -50.88 71.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.835 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 110' ' ' THR . 8.2 tpt85 -56.02 -42.8 77.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -59.09 -37.88 78.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 66.8 t -68.92 -54.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.536 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.8 mmt -49.08 -54.03 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.1 t -67.21 -25.2 66.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.493 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.33 -30.26 69.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.731 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.38 -28.8 14.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.7 43.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.98 117.05 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -89.92 107.01 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.1 mm? -99.41 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.827 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.6 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.93 -41.16 91.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.686 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.535 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.4 -54.93 25.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 117' ' ' THR . 2.1 m -62.89 -41.24 91.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.19 -39.48 90.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 110.191 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 11.2 mt-10 -73.1 -30.22 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.329 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.21 -35.4 71.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.28 -54.89 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.5 ptm180 -53.74 -31.73 49.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 0.0 110.389 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.92 -21.18 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.965 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.94 -9.12 16.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.417 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.5 t0 -87.37 110.22 20.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.418 0.627 . . . . 0.0 111.203 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.725 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.86 -31.18 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.781 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.1 -9.12 43.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.614 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.08 57.69 9.69 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 114.57 0.588 . . . . 0.0 114.57 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.9 p30 -114.27 -4.27 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.053 0.427 . . . . 0.0 111.505 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.7 42.17 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.968 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.94 4.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 110.552 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 141' ' ' PHE . 52.2 t -128.31 125.42 64.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.935 0.397 . . . . 0.0 111.156 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -105.31 -166.32 1.21 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.051 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.2 t80 -59.09 -73.9 0.08 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.57 -45.04 47.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.351 0.595 . . . . 0.0 110.33 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.725 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -57.22 -36.65 71.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.176 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -49.08 12.85 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 111.877 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.83 -38.88 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.612 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -71.21 -34.25 70.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.743 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -86.37 12.45 10.1 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 111.165 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.586 ' SD ' HG23 ' A' ' 85' ' ' ILE . 2.3 mtt -121.24 -38.98 2.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.984 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 147' ' ' ALA . 2.6 t -147.84 -51.57 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.315 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -69.06 74.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 111.376 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.958 179.866 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -168.01 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.192 . . . . 0.0 112.309 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -106.38 -33.8 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 mmt-85 -155.52 38.24 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 -135.6 4.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.45 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.921 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -66.58 2.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.71 -49.37 77.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.84 -67.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.546 0.212 . . . . 0.0 110.89 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.439 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 1.0 OUTLIER -51.7 -37.02 48.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.522 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.3 tpp85 -55.9 -51.0 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.596 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.06 -41.61 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.563 HG12 ' NH1' ' B' ' 73' ' ' ARG . 95.6 t -50.46 -53.4 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.623 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.52 -43.71 69.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 91' ' ' VAL . 16.3 mt -56.22 -53.21 59.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 110.573 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.948 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.6 -46.52 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.719 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.38 -28.32 67.02 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.245 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 73' ' ' ARG . 77.7 t -75.92 -53.27 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.653 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -66.35 -40.99 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.2 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.1 mmp_? -57.19 -37.59 72.38 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.363 0.601 . . . . 0.0 109.551 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.53 79.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.919 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.12 -9.86 32.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.814 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.65 -36.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.287 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -148.5 -64.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.025 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.2 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.57 -66.77 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -131.66 35.49 3.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.865 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.829 0.347 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.737 ' CG ' HG23 ' A' ' 70' ' ' THR . 3.2 p30 -96.34 103.55 15.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -177.85 -179.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.625 HD13 ' CD ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -135.85 165.32 25.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.09 176.42 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.142 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -37.89 76.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.369 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -73.12 -56.84 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.625 ' CD ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -58.26 -42.23 85.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.713 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 5' ' ' THR . 12.2 tt -70.43 -26.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -44.12 63.32 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.498 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.13 -32.83 71.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -66.88 -49.76 64.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -44.87 90.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.244 0.545 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -65.48 -47.48 75.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.947 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -42.15 63.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -57.21 -34.5 68.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.119 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mt -87.24 -38.3 16.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.949 0.404 . . . . 0.0 110.245 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.97 -65.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.9 t70 -66.39 132.35 48.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.808 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -38.11 80.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.22 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.89 -12.25 29.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 36.84 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.686 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -74.73 -5.16 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.421 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 2.44 44.73 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 p -149.47 132.62 16.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.21 127.05 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 62' ' ' THR . 4.5 t -100.62 167.59 10.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 p -54.4 -28.75 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -64.53 -50.47 67.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -77.15 -36.21 55.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.35 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.572 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.54 70.57 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.732 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -67.04 -53.28 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 19' ' ' PHE . 14.4 p -72.45 -31.57 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.351 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -45.13 93.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.669 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -29.47 45.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.1 t -61.82 -35.11 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.05 -31.09 66.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.57 42.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -141.55 172.56 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.08 59.96 41.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.43 -170.23 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.591 2.194 . . . . 0.0 112.253 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -122.12 165.04 16.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.75 -31.15 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 0.0 110.141 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.67 60.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -45.25 88.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.7 mt -53.28 -50.64 64.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -64.98 -53.88 39.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.606 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.33 -51.14 69.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.303 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.28 -47.72 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.669 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -59.74 -44.32 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.89 -26.37 62.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.529 0.681 . . . . 0.0 109.978 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.65 -2.2 53.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.634 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.62 -33.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 112.043 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.8 t0 -72.07 148.27 45.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.267 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.36 -53.54 7.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.684 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.67 -8.66 58.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.326 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.3 48.69 78.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.967 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -96.81 -0.19 48.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.589 0.233 . . . . 0.0 111.535 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.08 22.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.895 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.92 139.88 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.559 0.218 . . . . 0.0 110.486 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.94 147.44 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.08 0.467 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.15 178.33 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.786 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -60.28 -61.7 7.41 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.452 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -67.11 -31.51 36.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.219 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 mt-10 -64.7 -39.84 94.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.17 -45.03 43.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 110.29 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -67.92 -52.6 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.279 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 2' ' ' ASP . 76.6 m -51.6 -49.58 61.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpp -54.53 -49.5 70.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.0 2.04 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.569 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.57 -42.13 9.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.899 0.38 . . . . 0.0 110.999 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -53.69 -33.27 54.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.158 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.36 150.49 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 34.3 mtt 61.45 95.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.31 -30.86 7.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -153.34 126.35 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -177.55 159.13 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -141.52 163.62 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 152.22 32.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -26.77 19.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.157 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.66 -35.7 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.3 mt-10 -64.33 -30.97 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.813 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.34 -37.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.119 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -49.46 35.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.519 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.9 mm-40 -61.88 -46.01 91.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.359 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.827 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.62 -48.64 69.13 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.839 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.86 -43.08 59.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.031 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -70.8 -31.59 68.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.701 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.3 m -75.54 -37.15 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 111.064 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.5 m-85 -76.6 -62.93 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.871 0.367 . . . . 0.0 110.509 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -83.44 121.9 27.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.782 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -71.24 -52.63 17.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.45 -9.58 59.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.5 68.65 0.86 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.936 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -94.41 15.84 16.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.641 0.257 . . . . 0.0 111.272 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.5 69.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.633 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.5 m-85 -162.47 116.97 1.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.585 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -110.63 123.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.979 0.419 . . . . 0.0 111.278 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -103.96 157.05 17.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.248 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -41.45 22.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.79 6.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.6 mm-40 -55.1 -39.31 69.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.677 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.18 -50.9 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.922 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.704 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.55 -42.81 79.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.286 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -36.42 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.404 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.1 t -72.73 -54.79 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.518 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.3 mmt -49.11 -54.02 18.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.645 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' ARG . 10.9 t -66.9 -25.18 66.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.96 -29.97 68.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.63 -28.78 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.68 43.75 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -149.88 112.95 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -90.85 102.23 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -94.47 164.48 12.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.794 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.847 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.6 m -98.32 158.81 15.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -59.32 -42.17 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.31 -54.87 22.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.756 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 117' ' ' THR . 2.2 m -63.52 -40.66 89.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.65 -41.03 96.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.433 . . . . 0.0 110.275 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 26.8 mt-10 -72.63 -30.12 64.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.373 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -33.94 69.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.611 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.29 -55.08 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.657 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 8.8 ptm180 -54.59 -31.82 57.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 110.405 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.35 -21.93 55.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.796 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.72 -15.41 15.76 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.606 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -82.44 90.52 6.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.74 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.74 -30.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.429 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.0 -9.48 57.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.164 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.88 23.83 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 114.81 0.684 . . . . 0.0 114.81 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 32.2 p30 -113.79 -5.55 13.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.227 0.513 . . . . 0.0 111.303 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 6.66 44.39 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.213 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.58 -174.82 4.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.834 0.35 . . . . 0.0 110.661 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.4 t -127.33 120.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -98.71 -169.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.608 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.5 t80 -60.12 -73.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.536 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.66 -43.59 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.286 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.74 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -56.26 -34.72 66.66 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.45 -48.7 13.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 111.22 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.813 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.71 -40.41 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.321 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 2.4 pp0? -71.19 -36.04 71.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.615 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.463 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.1 4.92 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.556 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.1 mtt -112.04 -31.62 6.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.028 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 147' ' ' ALA . 5.1 t -146.55 -50.01 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.464 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -82.73 80.41 8.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.412 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.0 mttp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.035 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.714 0.292 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.575 2.184 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -98.92 -39.83 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -155.21 37.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.77 -135.43 4.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? -110.5 123.37 49.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.787 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.15 -68.23 1.76 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.58 -52.72 46.79 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.37 -62.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.509 0.195 . . . . 0.0 110.871 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.81 -35.2 43.38 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.39 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.563 ' HE ' HD11 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -56.6 -53.27 59.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.69 -42.28 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.238 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.1 t -50.43 -52.86 14.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -69.92 -45.57 67.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.543 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.78 HD22 HG11 ' A' ' 91' ' ' VAL . 40.7 mt -55.79 -52.61 63.38 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.656 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.947 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.84 -47.62 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.575 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.89 59.38 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.205 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.82 HG11 ' CB ' ' A' ' 88' ' ' ALA . 79.8 t -76.78 -56.15 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.689 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.42 -43.75 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.662 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.03 -34.64 70.28 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.22 0.533 . . . . 0.0 109.783 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.19 -37.25 82.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.293 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.906 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.7 t90 -95.25 -11.1 28.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.744 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.29 -36.21 58.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -149.28 -65.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.74 67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.058 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.23 -66.55 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.776 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' B' ' 86' ' ' PHE . 67.6 t80 -101.72 31.38 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.815 0.341 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 70' ' ' THR . 6.5 p-10 -175.06 79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.6 tt0 -177.02 -178.92 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.749 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -134.81 165.11 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.861 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.2 t -71.37 177.28 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.132 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.36 -38.98 78.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 tt0 -71.9 -56.77 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.044 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.749 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -58.63 -43.36 89.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.738 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 5' ' ' THR . 7.0 tt -69.04 -26.44 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.062 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.42 -43.37 61.97 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -68.22 -33.47 74.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.63 -49.74 65.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.17 -44.85 92.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.264 0.554 . . . . 0.0 110.047 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -64.45 -48.5 75.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.576 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -41.7 63.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.316 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -38.28 71.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.05 -15.67 61.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.62 -38.6 16.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.199 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.38 -65.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.2 t70 -65.44 132.64 49.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.707 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -37.14 75.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.3 -12.27 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.19 36.96 77.7 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.636 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 1.72 44.64 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.048 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.0 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.678 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.844 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mt -108.18 121.53 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.5 t -97.88 167.5 10.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.0 p -54.34 -35.53 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -56.77 -50.43 72.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.158 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.83 -37.91 47.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 110.768 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.55 -43.31 71.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.909 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.36 -27.5 72.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.202 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -72.34 -49.75 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.2 p -72.32 -33.54 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.0 mtp -60.41 -45.71 92.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.958 0.409 . . . . 0.0 110.677 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -25.92 44.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -58.05 -37.11 73.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.51 -30.75 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.79 41.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -142.61 163.22 33.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.51 61.84 12.08 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.73 -170.93 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.567 2.178 . . . . 0.0 112.277 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -122.11 167.01 13.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.82 -31.98 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.67 59.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.341 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -43.33 94.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.208 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.3 mt -55.15 -50.67 68.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.39 -52.31 58.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.432 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.67 -51.15 70.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.249 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.69 -47.76 83.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.754 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.98 -45.11 99.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.27 -26.48 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.599 0.714 . . . . 0.0 110.143 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.8 mt-10 -82.75 -2.06 53.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.496 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.64 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.61 -33.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' N ' HD12 ' A' ' 63' ' ' ILE . 52.9 t0 -72.25 148.57 45.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.317 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.37 -53.57 6.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.15 -8.66 58.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.3 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.55 48.42 81.26 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.968 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -97.31 -0.88 45.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.543 0.211 . . . . 0.0 111.421 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.485 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.33 15.51 21.12 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.939 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 28' ' ' THR . 2.8 p -149.73 139.79 22.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.12 149.39 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.301 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.26 175.92 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -58.65 -61.64 7.28 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.157 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.2 Cg_endo -63.98 -33.83 61.48 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.374 2.049 . . . . 0.0 111.756 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -68.71 -36.46 78.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.391 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -75.33 -40.15 58.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.349 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD21 ' CG ' ' A' ' 3' ' ' GLN . 4.6 tp -76.78 -53.08 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.586 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 2' ' ' ASP . 98.7 m -51.46 -49.98 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.487 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 2.1 tpp -53.47 -48.05 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.9 mmt -88.64 10.44 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.52 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -105.21 -36.39 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -57.13 -40.12 76.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.44 149.71 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.8 mtm 60.81 91.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.6 -31.57 9.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.05 124.94 6.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -176.59 164.81 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.24 167.58 22.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -153.69 152.52 30.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.777 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -25.49 23.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -74.58 -38.13 62.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 47.3 mt-10 -60.23 -31.27 70.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.814 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.34 -39.38 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.291 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -70.93 -49.35 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.338 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.2 mt-10 -61.05 -46.19 91.68 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.61 -49.44 67.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.149 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.03 -38.55 52.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.917 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -76.65 -30.53 56.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.866 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.23 -36.94 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 110.898 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -72.41 -62.91 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.5 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.62 119.35 24.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -62.34 -52.61 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.52 -9.65 59.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.461 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.63 0.47 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.08 14.44 17.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.663 0.268 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.76 66.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.4 m-85 -161.55 116.68 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.512 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.7 mt -113.92 124.66 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.47 . . . . 0.0 111.656 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.8 t -104.28 161.15 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.89 -43.94 29.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.268 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.07 -58.93 6.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.931 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.36 -37.61 67.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.671 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.36 -50.86 71.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.844 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -43.61 76.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.117 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -58.1 -38.88 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.382 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.25 -54.92 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.617 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.4 mmt -49.41 -54.06 19.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.869 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.5 t -67.7 -25.17 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.581 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -68.53 -30.36 69.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.26 -28.73 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.013 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.41 43.46 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.584 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -152.79 110.77 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -83.73 115.8 22.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -105.81 163.31 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.792 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.6 m -98.27 158.76 15.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.59 -40.81 93.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.92 -35.56 74.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.568 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.96 -54.88 23.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.709 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -63.38 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.71 -40.06 93.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.11 0.481 . . . . 0.0 110.171 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 14.2 mt-10 -72.9 -30.15 63.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.289 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.459 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 46.1 ttm -71.01 -35.79 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.879 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 105' ' ' LEU . 4.2 mm -80.4 -54.91 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.579 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -53.44 -31.79 46.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.996 0.427 . . . . 0.0 110.46 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.452 ' OE2' ' ND2' ' B' ' 85' ' ' ASN . 17.4 pt-20 -77.96 -21.58 50.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.942 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.95 -8.56 17.55 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ILE . 35.9 t0 -88.54 110.27 20.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.645 . . . . 0.0 111.312 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.724 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.22 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.765 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.86 -9.09 44.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.562 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.9 57.94 9.18 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.4 p30 -114.23 -4.19 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.033 0.416 . . . . 0.0 111.505 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 7.59 42.45 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.13 -174.96 4.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 110.458 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.14 126.62 66.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.94 -167.54 1.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.638 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.1 t80 -58.52 -73.94 0.07 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.516 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.47 -45.74 47.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.617 . . . . 0.0 110.32 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.724 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.44 -36.4 68.95 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.62 -49.59 11.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.965 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.814 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.28 -40.53 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.29 -34.28 70.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.713 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.02 8.9 13.82 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.649 0.261 . . . . 0.0 111.328 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.0 mtt -118.18 -38.9 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.767 0.317 . . . . 0.0 111.034 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -139.88 -51.66 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -82.45 58.41 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 111.248 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.907 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.734 0.302 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.19 172.14 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.312 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.48 -41.79 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -148.9 31.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -117.16 -135.17 5.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.9 mpp_? -115.46 122.97 47.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.321 . . . . 0.0 110.767 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.68 -68.39 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.49 -49.75 75.17 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.64 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.64 -66.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.477 0.179 . . . . 0.0 110.87 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.437 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -51.79 -38.96 57.74 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.329 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.432 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -54.58 -49.52 70.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.58 -41.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.18 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.46 -53.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.556 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.869 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -68.9 -46.46 68.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.42 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.95 HD22 HG11 ' A' ' 91' ' ' VAL . 20.6 mt -55.72 -53.57 54.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.736 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -60.32 -47.2 93.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.434 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.565 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.33 -30.3 61.28 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.112 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.869 HG23 ' O ' ' B' ' 73' ' ' ARG . 93.6 t -75.26 -55.39 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.606 0.241 . . . . 0.0 111.446 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.06 -43.98 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.3 mmm180 -58.2 -35.3 71.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 109.728 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -61.14 -37.12 81.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.252 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.884 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.4 t90 -95.32 -10.09 31.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.854 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.62 -36.1 57.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.297 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -148.54 -64.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.112 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.32 65.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.452 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -112.86 -70.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -106.22 32.0 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.832 0.348 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.0 p-10 -157.31 66.15 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 1.4 tt0 -176.93 169.63 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.587 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -127.69 165.25 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 110.839 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 177.33 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.96 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.8 -37.12 78.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.85 -56.94 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.116 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.587 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.99 -41.48 83.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.423 . . . . 0.0 110.758 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' THR . 6.8 tt -71.93 -26.44 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.092 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.49 -43.4 62.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.478 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.35 -33.11 72.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.14 -49.67 66.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.436 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -45.0 90.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 110.168 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -64.88 -48.44 74.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.37 -41.64 63.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.447 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -33.98 65.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.022 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.7 mt -87.72 -39.08 15.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.927 0.394 . . . . 0.0 110.045 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.631 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.36 -65.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.374 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -66.43 132.47 48.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.874 0.368 . . . . 0.0 110.705 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -37.25 74.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.02 -12.16 29.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.39 36.93 79.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.632 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -74.89 -4.45 38.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.446 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.01 44.09 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.125 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -149.46 132.53 16.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.876 0.338 . . . . 0.0 110.899 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -106.22 127.27 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.6 t -101.97 167.7 9.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.8 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -54.26 -31.51 53.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -62.67 -50.43 71.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.338 . . . . 0.0 111.222 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' O ' HG12 ' A' ' 35' ' ' VAL . 15.6 mm-40 -77.15 -35.8 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.34 -58.17 8.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.752 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.44 68.8 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.685 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.8 m -70.18 -54.21 13.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -74.49 -31.1 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.1 ttt -61.02 -44.78 96.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -25.68 44.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.941 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -56.75 -36.43 69.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.99 -31.47 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -142.61 160.88 39.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.4 62.22 22.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.88 -170.11 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -121.34 167.23 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.76 -32.14 71.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.132 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.6 60.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.384 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -43.3 94.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.1 mt -55.27 -50.75 68.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -64.72 -52.32 57.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.42 -51.12 70.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.263 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.88 -48.08 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.73 -44.37 97.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.279 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -57.07 -26.45 60.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.556 0.693 . . . . 0.0 110.033 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.92 -2.06 53.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.71 -32.99 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.9 t0 -72.22 149.28 44.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.343 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.06 -53.55 6.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.49 -8.72 58.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.59 48.91 77.96 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.93 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -97.5 -0.77 45.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.627 0.251 . . . . 0.0 111.496 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.53 21.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.885 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.77 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.608 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.01 149.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.412 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.88 172.91 6.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -56.39 -61.58 6.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.1 Cg_endo -63.94 -33.04 64.91 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.046 . . . . 0.0 111.862 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -69.62 -35.73 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.8 t80 -75.28 -40.6 58.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.262 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.515 HD11 ' HG ' ' A' ' 4' ' ' LEU . 6.5 tp -76.78 -53.99 7.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.587 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 2' ' ' ASP . 62.4 m -51.37 -45.2 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.526 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.439 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -54.32 -52.62 60.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.488 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 21.9 mtt -80.02 -10.35 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.533 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -84.66 -33.33 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.899 0.38 . . . . 0.0 110.845 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -57.88 -43.81 86.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.963 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 150.98 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.0 92.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -106.72 -34.87 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.35 111.57 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -176.79 142.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.38 -178.31 4.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.2 m -162.15 161.92 28.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.63 -27.38 39.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.23 -42.46 75.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.973 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 mt-10 -59.25 -33.09 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.36 -37.99 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.244 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -49.41 41.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 57.9 mt-10 -62.04 -46.41 89.27 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.58 -48.09 69.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.781 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.85 -43.15 59.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -71.1 -32.17 68.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.72 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.003 HG11 HD22 ' B' ' 74' ' ' LEU . 1.3 m -75.0 -36.62 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.733 0.301 . . . . 0.0 111.002 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.722 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.1 m-85 -74.65 -62.92 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.496 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -84.68 132.23 34.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -76.62 -52.59 9.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.54 -9.61 59.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.46 70.21 0.66 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.902 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -94.24 15.32 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.44 69.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.696 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -160.39 117.04 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.549 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -112.17 123.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.229 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.0 t -103.96 157.72 16.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.308 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.68 -41.52 22.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.12 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -58.77 6.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.78 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.9 mm-40 -55.13 -39.08 69.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.991 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.52 -50.9 72.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.92 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.657 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.43 -42.31 77.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.146 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -36.22 77.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.32 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 67.5 t -72.58 -54.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.762 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.516 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.54 -54.03 20.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.657 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.4 t -66.94 -25.46 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.65 -30.01 68.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.64 -28.77 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.24 43.89 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -149.59 114.88 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -91.6 101.5 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -93.83 163.56 13.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.839 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.3 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -59.38 -42.07 90.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.741 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -69.73 -35.85 75.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.15 -54.86 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.74 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -63.6 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -61.49 -41.42 97.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.082 0.467 . . . . 0.0 110.313 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 34.8 mt-10 -72.42 -30.15 64.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.266 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -70.72 -34.41 71.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.647 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.991 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.27 -55.17 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.708 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm180 -54.38 -31.8 55.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 0.0 110.415 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.47 -21.6 57.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.892 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -18.09 14.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.66 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.05 90.59 4.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.94 -30.91 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.6 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.28 -9.46 57.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.123 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 51.06 53.61 26.4 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.7 p30 -113.78 -5.55 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.232 0.516 . . . . 0.0 111.271 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 6.24 44.64 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.219 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.06 -174.88 4.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.669 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 47.0 t -127.36 120.59 55.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.006 0.432 . . . . 0.0 111.274 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB3' ' HG3' ' A' ' 140' ' ' GLU . 5.5 t30 -98.98 -169.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.64 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.2 t80 -59.53 -73.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.62 -43.62 46.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.405 0.622 . . . . 0.0 110.331 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.746 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.1 mt-10 -56.3 -34.75 66.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.928 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.41 -48.45 13.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.293 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.8 -39.79 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -71.19 -35.07 71.45 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.567 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.478 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -84.77 11.1 9.75 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.543 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.4 mtt -119.26 -39.56 2.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 147' ' ' ALA . 12.0 t -148.88 -48.54 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.479 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -71.59 75.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 111.406 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.74 0.305 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 164.11 35.96 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.61 2.206 . . . . 0.0 112.317 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.57 -65.16 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.48 -96.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.539 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.579 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -139.3 116.82 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.992 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.97 -71.46 1.14 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.586 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.29 -48.2 65.1 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.59 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.151 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.07 -31.7 61.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.009 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -53.78 -53.56 50.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.409 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.739 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.34 -38.55 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 68' ' ' PHE . 99.4 t -50.61 -43.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.742 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.94 -46.45 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.051 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 91' ' ' VAL . 32.8 mt -55.85 -48.28 75.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.373 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.1 p -65.07 -48.24 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.584 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.58 -29.63 57.95 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.017 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 88' ' ' ALA . 81.7 t -76.88 -54.62 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.611 0.243 . . . . 0.0 111.58 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.58 -43.91 97.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.0 mmm180 -57.68 -34.44 69.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.239 0.542 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -37.42 83.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.22 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.932 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.3 -10.48 30.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.852 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.31 -36.09 58.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -148.79 -64.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.059 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.31 65.61 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.93 -66.72 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -107.23 34.46 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -172.55 96.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.681 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -177.26 179.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.62 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -130.87 165.32 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.901 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 8' ' ' GLN . 8.7 t -69.11 177.33 2.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -60.48 -36.34 78.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -73.22 -56.95 4.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.62 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.89 -41.95 83.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.006 0.432 . . . . 0.0 110.686 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 5' ' ' THR . 7.2 tt -71.36 -26.43 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.48 -43.53 62.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.14 -32.82 70.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.53 -49.68 68.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.456 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -45.1 89.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.193 0.521 . . . . 0.0 110.23 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -64.67 -48.81 73.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.691 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.36 -41.39 63.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.471 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.81 -38.68 70.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.999 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -74.14 -13.92 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.933 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.69 -39.74 14.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.954 0.406 . . . . 0.0 110.151 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.45 -65.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.356 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -65.39 132.88 50.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -37.62 74.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.24 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.73 -12.26 29.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.7 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.64 37.21 82.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -74.77 -4.55 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.244 -0.183 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.15 44.16 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.116 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -149.55 132.5 16.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.796 0.331 . . . . 0.0 110.892 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mt -105.52 127.38 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.8 t -102.41 168.44 9.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.5 p -54.78 -34.35 62.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.48 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -50.49 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.248 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -77.19 -36.53 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.158 0.504 . . . . 0.0 110.826 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.3 -58.21 8.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.823 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.52 64.23 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.793 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -72.04 -59.97 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 111.172 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -64.33 -30.56 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.174 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 mtp -60.93 -56.43 21.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -25.63 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.95 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.4 t -57.77 -38.66 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.64 -35.65 68.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.72 43.59 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -142.6 163.39 32.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.43 61.17 27.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.09 -170.17 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 0.0 112.248 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -122.11 166.92 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.83 -31.96 71.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.084 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.45 59.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.436 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.53 -41.9 92.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.364 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -56.63 -50.95 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.59 -57.04 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.407 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -51.06 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.147 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 19.2 mtt -58.19 -46.84 85.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.959 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.83 -45.82 97.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.029 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -56.13 -26.53 50.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.538 0.685 . . . . 0.0 110.042 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.7 mt-10 -82.15 -2.19 51.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.467 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.25 -32.99 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.0 111.934 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.8 t0 -72.74 152.72 41.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.183 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.33 -53.55 6.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.54 -8.74 57.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.316 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.91 49.93 70.31 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.853 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -97.27 -0.2 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.424 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.5 24.11 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.825 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.84 139.86 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.58 149.43 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -103.87 174.78 5.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -58.06 -61.58 7.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -63.62 -33.82 65.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.055 . . . . 0.0 111.81 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -69.15 -36.25 77.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.427 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.29 -40.11 58.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.28 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.4 tp -76.7 -54.7 6.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.536 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -51.61 -43.3 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.427 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -55.18 33.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 11.6 mtt -79.08 -11.47 59.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.516 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -85.08 -38.25 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -63.13 -30.46 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.61 29.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.4 mtm 60.23 78.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -85.42 -61.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.868 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.5 118.08 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -171.68 161.32 6.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.64 179.05 7.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -160.85 154.44 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -25.52 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -39.7 65.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 60.2 mt-10 -59.95 -30.45 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.89 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -49.4 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.438 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 50.7 mt-10 -61.59 -45.81 92.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.783 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.66 -48.89 69.01 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.966 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.04 -38.74 53.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -30.5 57.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.995 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.28 -36.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.715 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -73.29 -62.91 1.31 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.511 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -83.48 119.1 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -62.7 -52.62 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.8 -9.72 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.471 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.0 71.3 0.49 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.956 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -93.48 14.55 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.279 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.18 67.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.582 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 6.6 m-85 -162.37 116.89 1.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -113.21 124.38 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.069 0.461 . . . . 0.0 111.539 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -104.11 160.08 15.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.954 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.583 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -43.54 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.83 6.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.019 0.437 . . . . 0.0 110.84 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -55.22 -37.34 67.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.671 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.958 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.68 -50.78 72.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.795 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 110' ' ' THR . 8.4 tpt85 -55.91 -43.14 77.04 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -37.41 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.382 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.65 -53.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.626 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -51.16 -54.16 27.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.0 t -66.52 -25.72 66.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.24 -30.04 69.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.79 -28.79 14.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -152.37 109.77 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -86.48 110.55 19.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.489 HD12 ' CG ' ' A' ' 120' ' ' GLU . 3.8 mm? -101.36 166.06 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.0 m -98.35 158.73 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.41 -40.51 91.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' CG ' HD12 ' A' ' 116' ' ' LEU . 5.3 tp10 -64.39 -55.04 23.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.725 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -62.94 -40.97 90.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.35 -39.03 89.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.1 0.476 . . . . 0.0 110.123 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.7 mt-10 -73.4 -30.15 63.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.3 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.16 -35.5 71.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.958 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.31 -55.02 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.589 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.8 ptm180 -53.95 -31.81 51.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.016 0.436 . . . . 0.0 110.386 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.422 ' OE2' ' ND2' ' B' ' 85' ' ' ASN . 18.6 pt-20 -79.24 -21.31 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.15 -2.33 21.03 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.331 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.9 t0 -94.61 104.92 16.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.448 0.642 . . . . 0.0 111.135 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -79.04 -31.66 14.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.092 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.1 -9.1 46.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.55 -178.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.15 57.1 10.57 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.7 p30 -114.23 -4.04 13.11 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.104 0.452 . . . . 0.0 111.408 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 6.93 43.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.087 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.08 -174.74 4.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.613 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.3 t -128.13 125.28 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.931 0.396 . . . . 0.0 111.212 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.7 t30 -105.12 -165.24 1.11 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.939 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.61 ' O ' HG13 ' A' ' 142' ' ' VAL . 13.2 t80 -60.09 -73.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.6 -44.82 47.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 110.383 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.73 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -57.39 -35.66 70.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.731 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.44 -48.61 13.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.994 0.426 . . . . 0.0 111.673 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -56.81 -38.65 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.55 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.628 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 2.3 pp0? -71.2 -35.1 71.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.421 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -86.36 12.85 9.2 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.726 0.298 . . . . 0.0 111.088 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.6 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.9 mtt -120.73 -38.47 2.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 147' ' ' ALA . 10.2 t -149.19 -48.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.313 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -72.07 75.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.435 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.968 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.704 0.288 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.17 156.78 7.22 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.597 2.198 . . . . 0.0 112.309 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -75.05 -40.99 59.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.76 83.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.02 -91.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -142.2 105.42 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.58 -75.0 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.692 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.99 -50.48 27.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.668 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.28 -65.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.089 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.454 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -54.1 -31.81 53.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.44 . . . . 0.0 110.045 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.6 tpp85 -54.07 -53.61 50.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.734 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.73 -37.78 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.612 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.3 t -50.47 -45.65 25.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.366 0.603 . . . . 0.0 110.861 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.833 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -75.48 -45.66 37.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.338 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.995 HD22 HG11 ' A' ' 91' ' ' VAL . 29.8 mt -55.97 -46.68 78.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.979 0.419 . . . . 0.0 110.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.9 p -66.42 -48.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.499 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.585 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.93 -28.11 57.5 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.866 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.833 HG23 ' O ' ' B' ' 73' ' ' ARG . 95.9 t -76.83 -54.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 111.419 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.715 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -62.86 -44.08 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -58.0 -35.36 71.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -37.3 79.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.913 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.7 t90 -95.38 -11.25 28.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.831 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.04 -35.57 59.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.342 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -148.45 -65.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.15 65.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.422 ' ND2' ' OE2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -112.53 -75.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.78 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.68 31.69 5.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.918 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.772 0.32 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -146.39 36.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.676 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.9 tt0 -158.14 179.55 9.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.806 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -129.22 165.29 21.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.07 177.31 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -59.93 -36.85 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.339 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -73.33 -56.93 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.806 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.59 -41.16 80.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' THR . 6.0 tt -72.33 -26.24 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.32 -44.41 61.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.788 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 6.4 pm0 -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.18 -49.71 68.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.417 -179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -58.38 -45.12 88.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.85 -48.65 73.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.715 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.32 -41.42 62.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.486 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.5 -38.84 69.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.066 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -74.2 -13.76 60.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.4 mt -87.75 -39.8 14.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.95 -65.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.392 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 6.8 t70 -65.34 133.16 50.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.844 0.354 . . . . 0.0 110.736 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.61 -37.62 73.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.19 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.64 -12.25 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 37.28 82.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.688 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -74.69 -4.58 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.211 -0.195 . . . . 0.0 111.389 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.25 0.21 44.09 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.064 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.9 p -149.58 132.53 16.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.851 0.358 . . . . 0.0 110.879 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 32' ' ' LEU . 2.0 mt -105.33 126.92 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 6.9 t -101.87 168.1 9.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 p -53.81 -37.21 63.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.644 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -57.27 -50.52 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.357 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.96 -36.67 56.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.144 0.497 . . . . 0.0 110.821 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.956 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.42 -58.11 8.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.859 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.49 64.94 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.833 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -71.32 -60.29 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.336 . . . . 0.0 111.197 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -63.84 -30.49 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.9 mtp -61.03 -56.49 20.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.59 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -25.6 66.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.8 t -57.22 -38.13 73.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.57 -30.94 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.0 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.583 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -142.63 166.16 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -120.34 60.99 7.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.43 165.22 33.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.6 p -102.87 165.33 11.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.05 -29.35 67.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 110.274 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.68 -50.86 53.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.638 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.45 -37.6 87.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 19.6 mt -57.51 -51.01 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.771 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -56.67 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.33 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -54.91 -51.02 67.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.163 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.507 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 59.4 mtt -59.03 -46.11 89.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.956 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.64 -45.91 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.953 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -55.96 -26.56 48.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.555 0.693 . . . . 0.0 110.03 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.4 mt-10 -82.12 -2.11 50.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.442 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.36 -32.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.905 0.383 . . . . 0.0 111.99 -177.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.9 t0 -72.82 152.17 41.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.87 -53.54 6.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.679 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.52 -8.6 57.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.282 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.84 49.79 71.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.891 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -97.34 -0.25 46.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.536 0.208 . . . . 0.0 111.444 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.64 23.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.881 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -149.85 139.86 22.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.82 149.32 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.458 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.68 174.83 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.952 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -57.94 -61.67 6.95 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -63.74 -33.75 64.57 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.392 2.062 . . . . 0.0 111.812 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -69.06 -36.12 77.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.438 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.27 -40.04 59.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.295 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.676 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.0 tp -76.72 -54.93 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.451 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -51.67 -43.42 62.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.519 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -55.5 30.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.491 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 17.6 mtt -76.95 -17.3 58.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.442 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -81.58 -31.63 32.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -30.61 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.28 146.17 27.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 mtt 61.67 85.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -64.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -129.57 124.51 34.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -176.56 172.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 -178.48 6.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.52 157.68 30.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -54.61 -26.43 32.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 66.6 mt-10 -59.54 -31.82 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.828 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.28 -39.28 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.257 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -49.35 46.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.468 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.3 mm-40 -61.39 -46.21 91.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.375 0.607 . . . . 0.0 109.404 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.53 -48.95 68.6 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.07 -38.58 52.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.023 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -76.56 -30.53 57.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.82 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.013 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.35 -36.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.675 0.274 . . . . 0.0 111.077 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -73.34 -62.97 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.352 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -83.94 129.98 34.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -74.83 -52.66 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.63 -9.7 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.01 70.54 0.6 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.94 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -93.87 15.04 17.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.698 0.285 . . . . 0.0 111.217 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.58 69.02 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.2 m-85 -163.96 116.92 1.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.688 0.28 . . . . 0.0 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.27 126.55 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.547 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.7 t -104.0 156.85 17.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -40.91 21.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.92 6.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 110.801 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -55.87 -38.13 69.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.706 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.906 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.03 -50.74 72.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.845 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 110' ' ' THR . 8.0 tpt85 -55.72 -44.17 77.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -37.21 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.289 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.41 -53.58 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.732 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.546 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.2 mmt -50.3 -54.08 23.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.4 t -67.14 -25.62 66.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -29.95 68.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.73 -28.78 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.87 43.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -149.36 116.78 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -91.75 102.84 15.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.983 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.54 163.71 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.4 m -98.29 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.01 -42.2 93.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.643 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.89 -54.87 20.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -64.52 -40.0 87.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -62.26 -41.41 98.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 110.34 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.7 mt-10 -72.91 -30.17 63.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.415 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -71.45 -34.3 70.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.906 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.33 -54.91 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.631 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.0 ptm180 -54.51 -31.77 56.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.043 0.449 . . . . 0.0 110.347 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.99 -21.7 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.36 16.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.435 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 125' ' ' ILE . 49.0 t0 -84.07 89.65 7.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.449 0.642 . . . . 0.0 110.965 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -62.93 -30.8 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.419 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.595 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.8 -9.48 56.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.163 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.47 54.17 21.72 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.802 0.681 . . . . 0.0 114.802 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.9 p30 -113.84 -5.38 13.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.207 0.504 . . . . 0.0 111.307 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 6.29 44.54 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.316 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.83 -174.82 4.45 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.937 0.368 . . . . 0.0 110.712 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.5 t -128.6 123.56 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.424 . . . . 0.0 111.304 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.74 -164.95 1.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' O ' HG13 ' A' ' 142' ' ' VAL . 16.2 t80 -62.44 -74.06 0.1 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.68 -44.29 47.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 110.329 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.741 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.48 -35.82 68.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.006 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.17 -48.34 14.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 111.418 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.828 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -59.15 -40.31 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.437 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -71.41 -34.78 70.65 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.577 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -83.54 9.53 11.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.642 0.258 . . . . 0.0 111.279 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.583 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.5 mtt -119.21 -39.16 2.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.457 HG23 ' N ' ' A' ' 147' ' ' ALA . 11.8 t -148.55 -48.56 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.477 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -71.56 74.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.374 . . . . 0.0 111.403 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.2 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.943 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.18 -176.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.591 2.194 . . . . 0.0 112.32 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -97.08 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.74 31.41 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.89 -108.41 3.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.71 117.39 21.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.403 . . . . 0.0 110.989 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 70' ' ' ARG . . . -71.81 -71.88 1.0 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.532 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.7 -49.47 46.94 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.459 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.729 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.0 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.008 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.42 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.7 OUTLIER -56.32 -31.76 64.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -52.84 -53.55 47.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.331 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.729 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.93 -38.7 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.9 t -50.62 -44.5 25.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.316 0.579 . . . . 0.0 110.884 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.82 ' O ' HG23 ' B' ' 77' ' ' VAL . 5.1 mpt_? -75.24 -47.22 29.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.013 HD22 HG11 ' A' ' 91' ' ' VAL . 33.1 mt -55.81 -46.57 78.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -65.99 -48.72 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.38 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.588 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.75 -28.26 56.74 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.855 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.82 HG23 ' O ' ' B' ' 73' ' ' ARG . 99.3 t -76.85 -55.44 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.65 0.262 . . . . 0.0 111.525 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.91 -44.13 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.7 mmm180 -57.77 -35.14 70.37 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 109.767 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -36.48 81.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.855 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.31 -10.46 30.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.785 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.89 -36.22 56.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -148.23 -64.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.028 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 65.68 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.0 -74.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.76 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -106.69 34.16 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.872 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.826 0.346 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -132.0 80.86 1.94 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.705 ' CG ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -176.22 172.78 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -120.3 165.4 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -71.81 177.36 4.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.783 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 9' ' ' ILE . 16.1 pt-20 -58.32 -41.99 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.292 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.9 tt0 -67.14 -57.11 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.08 -44.68 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.018 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG13 HD13 ' A' ' 69' ' ' LEU . 7.6 tt -69.64 -26.59 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.251 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.6 -43.47 62.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.453 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.75 -32.81 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -66.07 -49.61 67.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -45.05 90.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.211 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -64.75 -48.82 73.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.7 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.12 62.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.399 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -54.08 -40.51 67.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.401 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 t -75.9 -12.94 60.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.13 -40.34 14.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 110.425 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.716 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.76 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.222 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.69 133.21 48.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.837 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.9 88.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.347 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.03 -12.13 36.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.28 38.7 91.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.69 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -73.51 -5.78 42.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.435 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 6.32 42.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.215 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -149.83 133.19 16.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.801 0.3 . . . . 0.0 110.74 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -100.04 117.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HA ' HG22 ' A' ' 62' ' ' THR . 8.9 t -89.18 159.07 17.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.725 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.8 p -54.72 -34.33 62.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.36 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.51 -50.42 73.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 111.046 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -76.08 -36.69 58.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.029 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.85 -44.43 73.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.095 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.85 -27.4 73.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.321 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -71.92 -49.68 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.6 p -72.43 -35.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.3 ttm -58.94 -45.22 90.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -25.59 44.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.8 t -54.64 -38.09 66.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.77 -30.15 65.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.986 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.87 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -142.62 161.75 37.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -119.66 62.79 7.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.69 176.38 8.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.207 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -109.38 168.27 9.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -32.15 71.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.079 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.92 60.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.451 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.313 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.434 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.3 mt -59.64 -50.66 72.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.78 -43.44 93.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.335 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.31 -51.14 62.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.155 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -57.64 -52.13 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.029 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -58.11 -42.28 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.015 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.66 -26.43 65.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.513 0.673 . . . . 0.0 109.893 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.9 mt-10 -83.03 -2.21 54.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.719 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.35 -33.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.078 -177.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' HD12 ' A' ' 63' ' ' ILE . 49.7 t0 -70.54 154.62 41.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.399 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.62 -53.75 5.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.802 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -89.14 -8.65 53.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.362 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.2 51.67 57.79 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.848 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -100.06 1.13 42.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.574 0.226 . . . . 0.0 111.437 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.35 15.02 22.56 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.975 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.6 p -150.02 139.72 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.604 0.24 . . . . 0.0 110.88 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.626 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.0 mm -96.54 149.89 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.94 172.85 6.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.2 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -53.55 -61.55 4.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.775 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 -26.3 37.42 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.673 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 15.6 mm-40 -73.71 -38.31 64.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.41 -43.32 50.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 110.37 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.705 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.4 tp -70.08 -57.06 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.811 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.3 m -51.44 -53.78 33.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.649 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.9 tpp -54.26 -38.72 66.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.8 mmt -97.91 14.53 26.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.244 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.22 -36.01 5.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -55.49 -55.76 28.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.265 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.31 42.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.22 29.46 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.107 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -82.71 -67.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.64 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 49.9 -175.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -132.41 38.72 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.59 -175.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -168.4 -166.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -67.36 -29.15 68.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.51 -26.57 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -71.1 -45.16 64.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.472 . . . . 0.0 110.83 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.6 -33.64 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.593 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -49.37 52.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.368 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.757 ' O ' HG13 ' A' ' 91' ' ' VAL . 46.3 mm-40 -62.41 -48.47 79.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.415 0.626 . . . . 0.0 109.698 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.774 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.38 -44.54 68.72 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.953 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.47 57.8 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.928 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.56 -32.35 58.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.946 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.91 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.9 -36.65 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 120.678 0.275 . . . . 0.0 111.024 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.585 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -72.94 -63.08 1.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.487 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -86.23 128.57 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -52.72 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.982 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.86 -9.75 58.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.413 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.52 69.74 0.63 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.006 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -93.27 14.35 18.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.284 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 17.3 66.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.604 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.8 m-85 -158.45 116.94 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.694 0.283 . . . . 0.0 110.972 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 125' ' ' ILE . 2.7 mt -110.36 124.31 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -103.91 157.45 17.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.255 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.566 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.77 -42.94 26.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.25 -58.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.7 mm-40 -55.0 -39.23 68.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.629 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.971 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.17 -50.71 72.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.888 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 110' ' ' THR . 0.0 OUTLIER -57.64 -41.01 80.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.674 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.63 -39.03 86.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.513 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.7 t -72.8 -55.34 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.5 mmt -49.03 -54.0 17.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.3 t -65.41 -25.42 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -30.98 68.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.53 -28.83 15.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.35 42.31 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -144.0 109.77 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -88.88 94.14 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.63 147.11 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 121' ' ' VAL . 12.5 t -85.88 163.37 18.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.72 -31.03 69.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.64 -45.97 73.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.599 ' H ' HG23 ' A' ' 117' ' ' THR . 49.2 mm-40 -61.12 -54.87 39.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 117' ' ' THR . 1.6 m -62.23 -38.3 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -61.44 -43.59 98.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 110.345 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 71.5 mt-10 -71.77 -30.2 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.401 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtp -70.71 -34.0 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.731 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 105' ' ' LEU . 4.1 mm -80.31 -54.94 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.585 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 11.5 ptt180 -55.14 -31.93 61.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 110.385 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.3 -21.12 54.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.632 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -104.56 -14.51 15.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.433 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.95 93.73 7.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.395 0.616 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.1 pt -66.43 -31.27 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.51 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.618 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -85.83 -9.37 57.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.123 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.22 54.76 18.31 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.697 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.7 p30 -113.98 -5.18 13.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.194 0.497 . . . . 0.0 111.367 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.069 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.91 -174.77 4.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.35 . . . . 0.0 110.547 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 141' ' ' PHE . 42.3 t -127.3 120.51 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 7.3 t30 -96.07 -167.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.354 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.2 t80 -62.36 -73.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.58 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.74 -43.3 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.303 0.573 . . . . 0.0 110.414 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.748 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -55.9 -33.49 64.68 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.489 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -79.07 -45.45 20.07 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.104 0.478 . . . . 0.0 111.683 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -65.52 -38.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.158 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.704 ' HA ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -70.43 -36.07 73.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.57 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.797 ' HE3' ' CG ' ' B' ' 81' ' ' TRP . 6.1 ptm -73.35 -21.42 60.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.447 ' O ' ' HB ' ' A' ' 146' ' ' THR . 1.2 tpp -88.63 -49.48 6.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.288 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 145' ' ' MET . 11.3 t 179.56 -38.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.498 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.704 ' HB2' ' HA ' ' A' ' 143' ' ' GLN . . . 54.35 51.59 14.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.907 0.385 . . . . 0.0 111.291 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.885 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.742 0.306 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 146.97 62.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.562 2.175 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -60.25 -31.58 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -176.38 76.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 -132.82 2.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -110.74 132.73 53.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.88 3.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.673 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.86 -49.34 55.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.391 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -53.22 -68.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.533 0.206 . . . . 0.0 110.887 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.8 -38.84 57.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.771 0.319 . . . . 0.0 110.455 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.7 tpt180 -56.06 -48.28 76.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.671 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -61.56 -40.28 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.262 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.1 t -53.44 -53.46 24.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.816 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.873 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.95 -49.08 40.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.354 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.91 HD22 HG11 ' A' ' 91' ' ' VAL . 18.9 mt -55.96 -44.15 78.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 12.5 p -67.6 -48.97 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.752 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.578 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -55.96 -31.26 58.4 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.079 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' B' ' 73' ' ' ARG . 49.1 t -76.79 -54.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.696 0.284 . . . . 0.0 111.731 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -62.1 -43.85 98.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -57.96 -31.71 67.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.997 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -37.12 85.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.935 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.5 t90 -95.26 -15.72 22.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.888 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.2 -31.6 16.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.31 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.29 -74.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.339 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -69.17 67.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' B' ' 86' ' ' PHE . 0.2 OUTLIER -116.95 -69.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.406 ' H ' ' ND2' ' B' ' 85' ' ' ASN . 4.2 t80 -62.19 -33.87 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.915 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.94 43.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.651 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.1 tt0 -158.81 178.7 9.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -127.85 165.34 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.2 t -72.43 177.4 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 9' ' ' ILE . 17.2 pt-20 -57.36 -42.85 82.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.418 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -66.3 -56.97 8.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.185 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 2.2 tp60 -59.16 -49.05 79.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 5' ' ' THR . 10.9 tt -63.61 -26.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.3 -44.17 61.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.742 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 1.8 pt-20 -69.11 -33.18 73.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.32 -49.74 65.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.354 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.21 -44.75 88.3 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.194 0.521 . . . . 0.0 110.122 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -64.9 -49.17 71.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.703 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.33 -41.13 62.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -58.5 -33.94 70.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.085 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.63 -16.3 57.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.937 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.07 -36.92 17.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.26 -65.94 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 12.5 t70 -66.16 130.31 42.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.905 0.383 . . . . 0.0 110.832 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -39.28 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.34 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.19 -12.15 30.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.54 36.12 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.677 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -74.94 -4.99 41.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.487 0.184 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.16 4.27 44.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.177 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.9 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.4 mt -109.87 127.93 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.185 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.68 169.85 8.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.97 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 p -55.88 -32.31 63.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.409 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -62.05 -50.49 71.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -75.64 -36.94 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.128 0.489 . . . . 0.0 110.834 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.32 -58.21 8.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.558 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.58 -27.43 69.71 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.776 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.4 m -67.45 -55.17 14.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 13.8 p -69.69 -31.59 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -46.8 88.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -26.18 44.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.959 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -58.15 -35.96 72.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.05 -31.25 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.71 42.63 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -142.65 165.04 28.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -121.28 63.25 12.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 -173.63 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.311 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 p -122.08 161.8 22.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 24.7 pm0 -69.02 -28.49 66.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.18 0.514 . . . . 0.0 110.3 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.81 -49.53 58.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.595 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.4 -37.35 86.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD11 ' HA3' ' A' ' 33' ' ' GLY . 21.0 mt -57.39 -50.79 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -67.35 -48.0 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.272 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.99 -51.02 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.494 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.96 -49.73 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.398 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 32' ' ' LEU . 1.1 mt -57.81 -41.86 80.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.5 -26.42 65.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.677 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.1 mt-10 -83.67 -2.19 55.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.89 -33.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 112.084 -177.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 63' ' ' ILE . 56.1 t0 -71.04 144.97 50.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.77 -53.55 7.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.595 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.54 -8.69 59.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.217 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.79 47.71 83.74 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.963 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -97.69 -1.3 43.87 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.663 0.231 . . . . 0.0 111.495 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.86 20.13 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.889 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.4 p -149.97 139.83 21.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.606 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.21 149.34 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.23 170.09 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -53.74 -61.66 4.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -63.55 -37.62 46.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.37 2.047 . . . . 0.0 111.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -60.97 -48.42 81.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.503 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.39 -58.01 9.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.177 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.5 tp -58.28 -55.54 33.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.822 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -51.58 -44.36 62.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.737 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.427 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -55.26 -53.28 58.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.03 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.9 mmt -78.31 -16.82 57.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.76 -30.38 28.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.165 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.37 -27.14 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.79 160.3 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.9 ttp 64.11 78.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -114.11 124.55 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.648 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.2 t0 64.61 106.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 t -166.26 166.64 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -155.8 163.96 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.44 157.06 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -26.19 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.11 -33.4 59.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -74.55 -34.3 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.318 0.58 . . . . 0.0 109.737 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -49.35 53.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.471 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.747 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.2 mm-40 -63.11 -46.9 85.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.402 0.62 . . . . 0.0 109.653 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.778 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -45.6 70.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.95 -38.67 51.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -33.11 58.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.809 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.66 -36.46 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.673 0.273 . . . . 0.0 111.02 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -70.67 -62.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.549 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.42 117.18 24.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -52.67 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.78 -9.66 59.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.1 70.47 0.56 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -93.54 14.88 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.646 0.26 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.45 68.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.635 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.4 m-85 -160.12 116.92 2.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.928 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.491 ' O ' HD12 ' A' ' 125' ' ' ILE . 3.9 mt -114.59 125.49 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.626 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -104.09 159.58 15.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.981 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.577 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.7 -40.25 19.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.396 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 -59.0 6.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.984 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.56 -37.29 70.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.721 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.04 -50.7 72.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.903 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.769 ' O ' HG22 ' A' ' 110' ' ' THR . 1.1 tpt180 -56.2 -42.8 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -39.19 83.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.642 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 92' ' ' PHE . 44.9 t -72.17 -55.35 13.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.118 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.588 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.4 mmt -49.04 -54.01 17.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.1 t -66.05 -25.42 67.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.09 -30.28 66.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -28.81 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.9 43.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.58 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -150.65 110.54 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.792 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -86.41 101.9 13.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.656 HD12 ' HG2' ' A' ' 120' ' ' GLU . 3.5 mm? -105.57 148.79 26.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.6 t -86.75 163.33 17.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -58.09 -34.17 69.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.61 -39.33 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 7.6 tp10 -64.36 -54.87 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -62.76 -40.59 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.66 -41.49 97.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.0 110.129 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 40.9 mt-10 -72.66 -30.12 64.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.315 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.2 mtp -70.3 -36.25 74.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.857 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 105' ' ' LEU . 3.7 mm -80.21 -54.86 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.639 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.36 -31.76 55.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.005 0.431 . . . . 0.0 110.417 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.18 -21.77 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.888 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.541 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.21 -9.13 17.9 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.248 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.4 t0 -86.97 100.67 12.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.504 0.668 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -75.11 -31.64 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.042 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.99 -9.1 47.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.521 -178.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.47 57.07 11.02 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.5 p30 -114.31 -3.62 13.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.217 0.508 . . . . 0.0 111.47 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.49 5.85 45.06 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.078 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.11 -174.72 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.469 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 141' ' ' PHE . 46.3 t -128.87 124.83 61.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 111.281 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.6 t30 -102.95 -162.6 0.93 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.7 t80 -60.75 -74.45 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 142' ' ' VAL . 2.1 tt0 -49.95 -45.45 51.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.302 0.572 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.6 mt-10 -56.21 -34.52 66.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.728 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -78.99 -47.06 16.98 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.111 0.481 . . . . 0.0 111.608 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.632 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.5 m -64.48 -34.46 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.812 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.702 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.6 pp0? -71.05 -36.29 72.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.39 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.541 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 1.3 ptt? -83.83 -4.09 58.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.779 0.323 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.609 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -96.68 -35.75 10.92 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.671 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 147' ' ' ALA . 10.6 t -159.94 -46.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.378 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -68.19 74.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 111.376 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.939 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -174.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -48.4 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -150.08 40.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.86 -135.89 4.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.423 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.7 mpp_? -112.75 125.26 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.76 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 -67.51 2.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.822 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.9 -50.22 69.9 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.0 -65.28 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.539 0.209 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.407 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.8 -36.68 48.67 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.465 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 13.8 tpp180 -56.14 -48.76 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -63.42 -41.79 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.096 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.3 t -50.63 -51.14 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.57 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.85 ' O ' HG23 ' B' ' 77' ' ' VAL . 2.9 mpt_? -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.507 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.809 HD22 HG11 ' A' ' 91' ' ' VAL . 14.2 mt -56.05 -47.47 77.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.71 0.29 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -67.0 -47.51 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.62 -30.18 62.02 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.075 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 73' ' ' ARG . 96.6 t -76.79 -55.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.726 0.298 . . . . 0.0 111.096 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.711 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.22 -43.73 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.581 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.654 ' HA ' ' HB3' ' B' ' 82' ' ' ALA . 9.3 mmp_? -55.65 -35.54 66.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.267 0.556 . . . . 0.0 109.562 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.76 -37.49 73.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.857 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.05 -17.23 22.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.318 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -78.09 -37.54 46.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' B' ' 85' ' ' ASN . 0.8 OUTLIER -122.82 -69.42 0.83 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.646 -179.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 9.9 mmpt? -43.52 -79.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.493 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 83' ' ' ASN . 0.2 OUTLIER 69.74 -63.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.337 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.28 35.99 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.172 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -104.81 42.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -165.69 174.77 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.698 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.4 165.39 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.8 t -69.08 176.88 2.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.0 -39.04 84.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.8 tt0 -69.79 -56.84 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.698 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.82 -44.84 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.972 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.447 HG13 HD13 ' A' ' 69' ' ' LEU . 6.8 tt -69.02 -26.82 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.201 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.86 -43.04 63.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.412 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.62 -25.78 62.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.364 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.73 -49.36 25.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.332 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -44.56 85.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.148 0.499 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.99 -49.11 68.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.886 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.26 -41.28 62.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.74 -34.42 67.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.027 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t -78.59 -14.59 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.99 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.74 -39.26 15.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.147 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.17 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.234 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 6.5 t0 -63.65 126.28 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.681 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -37.83 83.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -92.09 -12.4 33.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.23 32.75 63.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.811 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -77.07 1.91 16.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.845 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.78 43.37 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.084 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -149.6 132.59 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.52 0.66 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.934 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.1 mp -105.11 118.61 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.437 ' CB ' HG22 ' A' ' 62' ' ' THR . 8.4 t -98.01 163.99 12.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.763 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.0 p -51.73 -25.47 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.891 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -68.11 -50.69 53.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -77.86 -37.82 47.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.248 0.547 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.015 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.16 -44.78 71.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.619 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.0 -28.89 73.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.235 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.0 m -73.53 -59.92 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.4 p -62.7 -30.5 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.2 ttt -61.51 -56.45 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.86 -25.46 66.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -51.4 -47.03 63.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.71 -60.19 2.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.913 0.387 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.19 40.16 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -142.71 170.32 15.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -138.16 59.54 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -178.93 3.93 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.622 2.214 . . . . 0.0 112.495 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 174.24 6.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.45 -29.93 68.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.89 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.12 59.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.147 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.9 OUTLIER -61.31 -40.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.089 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.1 mt -59.41 -50.53 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.933 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 8.2 tt0 -62.98 -39.17 93.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -68.98 -51.19 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.334 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.04 -54.0 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 110.454 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.0 -45.71 92.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.367 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 15.8 t-20 -51.98 -25.96 9.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.271 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.3 mt-10 -82.37 -3.24 55.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.35 -32.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.248 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.566 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.4 t0 -63.57 135.69 57.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.105 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.89 -53.32 21.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.557 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -95.81 3.71 53.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.665 -179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.09 59.13 9.87 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.88 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.21 -2.5 17.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.852 0.326 . . . . 0.0 111.354 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 17.37 15.93 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.863 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.612 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.51 139.94 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.072 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -104.55 149.44 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.785 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -107.6 171.06 7.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.9 m-85 -55.77 -61.5 6.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.524 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.6 Cg_endo -66.98 -20.25 51.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.436 2.091 . . . . 0.0 112.567 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.24 -37.64 37.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.085 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 4.7 t80 -75.24 -33.95 61.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.294 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.3 tp -76.75 -58.29 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -51.89 -45.67 64.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.142 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.76 -31.26 69.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 41.6 mtt -108.21 15.34 24.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.221 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.81 -40.47 4.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.91 0.386 . . . . 0.0 111.024 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -59.9 -45.12 93.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 59.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 111.0 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -163.5 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -122.39 69.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.91 -175.2 2.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p -89.51 -167.54 1.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.81 -179.41 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -148.3 156.28 42.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.788 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -50.89 -25.98 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.373 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -73.65 -39.46 64.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' B' ' 77' ' ' VAL . 43.8 mt-10 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.179 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.81 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.21 -38.93 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.32 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -71.13 -49.36 45.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.7 mm-40 -61.2 -46.29 91.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.39 0.614 . . . . 0.0 109.447 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.742 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.6 -49.22 68.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.059 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.08 -38.52 52.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.996 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -30.38 56.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.008 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.49 -37.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -71.42 -62.92 1.23 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.865 0.364 . . . . 0.0 110.483 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.93 120.61 25.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -63.35 -52.56 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.193 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.43 -9.61 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.492 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.96 71.76 0.47 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.884 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.47 14.53 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.679 0.276 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 13.65 61.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.685 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -158.33 116.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.52 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.45 124.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.137 0.494 . . . . 0.0 111.714 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -104.27 161.69 13.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.131 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.572 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -45.56 30.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.528 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.84 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 111.093 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.92 -36.47 65.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.543 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.61 -50.0 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.675 178.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.542 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -56.65 -41.44 77.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.412 178.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -60.57 -39.16 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.61 -54.45 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.817 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 116' ' ' LEU . 10.0 mmt -50.33 -54.11 23.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.21 -24.51 65.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.559 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -69.89 -30.9 68.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.5 -28.7 16.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.15 42.78 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.548 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -153.23 110.28 3.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -91.85 101.44 14.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.0 mm? -96.59 166.98 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 120' ' ' GLU . 12.8 t -94.63 163.79 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -59.75 -41.83 91.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.35 -35.87 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.653 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -65.48 -54.9 21.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.8 m -64.89 -40.02 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.182 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -62.6 -41.95 99.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.3 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.5 mt-10 -72.63 -30.14 64.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.3 mtt -70.91 -35.98 72.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 105' ' ' LEU . 5.2 mm -80.25 -54.87 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.699 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.3 ptm180 -54.05 -31.85 52.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 110.377 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.25 -20.96 46.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.798 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.45 -2.6 20.32 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.471 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.9 t0 -94.87 109.71 21.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.394 0.616 . . . . 0.0 111.204 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.27 7.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.803 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.91 -9.12 44.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.579 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.56 58.23 8.49 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 114.515 0.566 . . . . 0.0 114.515 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.7 p30 -114.24 -4.58 13.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.072 0.436 . . . . 0.0 111.513 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 7.78 42.32 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.955 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.15 -174.88 4.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.673 0.273 . . . . 0.0 110.38 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.7 t -128.18 126.5 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 111.245 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.4 t30 -104.83 -167.81 1.4 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.95 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.2 t80 -58.79 -73.92 0.07 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.57 -45.41 47.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 110.286 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.54 -36.39 69.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.102 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.66 -49.56 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.94 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.81 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.44 -40.63 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.715 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.28 -34.35 70.6 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.652 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.22 8.36 13.54 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.68 0.276 . . . . 0.0 111.246 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.568 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -38.28 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -148.96 -52.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.429 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.611 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -67.58 74.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 111.394 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.938 179.86 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.67 0.271 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.04 155.22 65.52 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.519 2.146 . . . . 0.0 112.29 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -61.95 -53.55 54.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.8 mmt-85 -144.82 81.92 1.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.37 -123.61 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -115.41 103.72 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 0.0 110.85 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.26 -75.69 0.23 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.905 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.02 -46.76 61.04 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -58.75 -70.85 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.279 . . . . 0.0 110.54 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.11 -34.92 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.842 0.354 . . . . 0.0 110.38 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 4.9 tpp85 -57.1 -53.26 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.635 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.63 -41.65 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.125 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 68' ' ' PHE . 84.2 t -52.2 -53.02 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.283 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.785 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.6 mpt_? -71.91 -44.08 64.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.008 HD22 HG11 ' A' ' 91' ' ' VAL . 19.7 mt -56.2 -49.24 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.9 p -65.48 -47.66 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.583 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.69 -29.39 67.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.302 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' B' ' 73' ' ' ARG . 70.1 t -76.82 -53.46 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.666 0.27 . . . . 0.0 111.246 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.708 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.65 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.364 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.646 ' N ' HD12 ' B' ' 78' ' ' ILE . 3.7 mmp_? -57.03 -34.45 68.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 109.67 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -37.29 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.929 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.47 -10.19 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.03 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -94.67 -28.09 15.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.277 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.98 -70.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.501 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 0.0 OUTLIER -51.35 -77.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 70.45 -62.6 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.249 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -103.67 32.89 3.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 1.2 ptm180 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.109 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -102.12 75.66 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.481 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -176.8 171.83 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.608 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -128.85 165.33 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.4 t -68.47 169.25 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -55.05 -36.51 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.6 tt0 -71.3 -56.85 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.371 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.606 ' H ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -58.54 -45.05 89.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 0.0 110.845 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG13 HD13 ' A' ' 69' ' ' LEU . 6.9 tt -67.54 -26.78 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -43.47 63.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.475 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.96 -25.8 62.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.86 -49.41 25.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.263 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -57.43 -44.66 84.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.19 0.519 . . . . 0.0 110.207 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.34 -49.85 67.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.877 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.28 -40.76 62.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.45 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -55.97 -38.94 71.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.207 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.76 -38.37 15.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.97 0.414 . . . . 0.0 110.388 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.666 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.375 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.6 t70 -63.62 129.02 38.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.862 0.363 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -37.3 83.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.215 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.61 -12.31 29.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.7 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.3 37.86 83.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.649 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -77.02 -1.85 30.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.478 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 -2.57 43.67 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.217 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.6 p -149.47 132.5 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.986 0.393 . . . . 0.0 110.959 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -104.0 120.07 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.028 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.83 164.59 12.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.818 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.0 p -52.53 -25.47 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -70.49 -50.53 36.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.356 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.77 -36.58 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.467 . . . . 0.0 111.005 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -54.25 -47.92 71.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.028 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.53 -27.39 73.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.391 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.9 m -72.05 -51.65 20.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.331 . . . . 0.0 111.218 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.9 p -70.61 -34.96 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.414 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -52.59 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.71 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.56 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -52.13 -37.72 55.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.71 -65.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.56 38.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.7 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -140.5 58.34 10.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 -170.25 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.412 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p -102.15 171.83 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.74 -29.44 67.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.44 56.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.41 -39.75 94.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.727 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.481 HD11 ' HA3' ' A' ' 33' ' ' GLY . 31.7 mt -58.33 -50.59 73.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.77 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 tp60 -64.63 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.09 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.088 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -58.44 -53.77 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.06 -44.73 92.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.415 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 32.4 t30 -52.71 -25.92 12.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.1 mt-10 -82.66 -3.32 56.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.928 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.44 -32.31 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.3 t0 -63.46 135.31 56.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.067 0.461 . . . . 0.0 111.027 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.43 -53.5 28.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.07 4.23 52.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.744 -179.184 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 59.43 9.39 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.895 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.97 -2.49 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.75 0.275 . . . . 0.0 111.342 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.47 15.75 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.893 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.624 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.8 p -149.46 139.92 22.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.09 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.34 149.61 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.52 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.56 171.03 7.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.634 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.8 m-85 -55.03 -61.52 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.659 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.4 Cg_endo -67.22 -20.28 49.61 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.434 2.089 . . . . 0.0 112.595 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -79.26 -38.08 36.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.168 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.5 t80 -75.1 -33.49 61.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 4' ' ' LEU . 11.6 tp -75.25 -58.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.295 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 53.2 m -51.56 -43.19 62.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -54.15 -43.33 70.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.438 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 36.9 mtt -101.12 14.5 31.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -107.15 -36.7 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -73.62 -26.9 61.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 62.72 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 tpp -180.0 61.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.024 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -136.15 78.79 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -132.73 -169.14 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p -91.3 -168.25 2.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.765 ' OD2' HG22 ' B' ' 77' ' ' VAL . 12.4 m-20 -87.45 -178.49 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.2 m -142.66 159.56 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -50.83 -25.97 5.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.387 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -75.85 -37.45 58.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.523 ' HB3' HG21 ' B' ' 77' ' ' VAL . 42.3 mt-10 -65.4 -26.76 68.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.809 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.03 -38.47 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.099 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -71.37 -49.36 42.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.9 mt-10 -61.31 -46.29 90.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.378 0.609 . . . . 0.0 109.442 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.743 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.46 -49.02 68.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.022 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.12 -39.01 55.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.919 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -30.37 58.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.014 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.43 -37.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -70.66 -63.02 1.18 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.895 0.379 . . . . 0.0 110.44 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.55 120.79 26.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -52.58 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.279 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.49 -9.62 59.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.52 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.82 71.76 0.46 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.814 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -92.98 14.5 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.61 16.59 65.75 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.619 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -161.15 116.76 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.303 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.537 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.05 124.28 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.119 0.485 . . . . 0.0 111.65 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -104.26 161.52 13.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.206 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.86 -44.42 29.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.472 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 -58.84 6.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 111.015 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.9 mm-40 -55.02 -38.0 67.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.653 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.899 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.61 -49.48 77.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.744 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.884 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -57.24 -41.72 80.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.334 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.64 -39.36 84.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.2 t -67.15 -55.71 16.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.668 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 mmt -49.07 -54.09 17.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.2 t -67.62 -24.22 65.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -70.57 -30.2 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.07 -28.85 14.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.95 43.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.9 109.77 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -89.59 101.97 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -99.27 165.31 11.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.0 t -98.28 171.15 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.0 -32.46 72.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 -47.63 69.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -60.54 -54.85 40.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.884 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.3 m -57.7 -50.93 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.391 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 121' ' ' VAL . 36.6 t70 -57.47 -39.27 76.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 52.1 mt-10 -72.59 -30.19 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.47 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.03 -36.07 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.82 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.18 -54.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.646 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.9 ptm180 -53.56 -31.74 47.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 0.0 110.516 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.32 -21.1 53.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.44 -10.86 15.64 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.624 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -84.87 110.02 18.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.385 0.612 . . . . 0.0 111.302 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.89 -31.15 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.791 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.32 -9.07 43.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.6 -178.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.06 57.78 9.55 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -114.27 -4.19 13.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.039 0.42 . . . . 0.0 111.515 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 7.51 42.59 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.006 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.88 4.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.419 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.0 t -129.02 126.25 64.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 111.157 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.48 -167.53 1.34 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.062 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.3 t80 -57.71 -73.89 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.56 -45.86 48.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.564 . . . . 0.0 110.306 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.57 -36.48 69.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.157 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.734 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.74 -49.73 11.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.881 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.809 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -56.32 -36.82 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -71.08 -34.79 71.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.63 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.444 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.7 OUTLIER -87.1 15.36 6.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.701 0.286 . . . . 0.0 110.858 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.1 mtt -126.99 -49.5 1.46 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.328 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 t -163.2 30.77 0.09 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -144.87 55.29 1.24 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.006 0.431 . . . . 0.0 111.264 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.994 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 60' ' ' THR . . . . . 0.427 HG23 ' HD2' ' B' ' 61' ' ' PRO . 87.7 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' B' ' 60' ' ' THR . 52.4 Cg_exo -52.71 -175.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.456 2.104 . . . . 0.0 112.346 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -103.16 -45.86 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -154.0 31.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.25 -134.92 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -101.51 103.41 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 110.794 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.28 -75.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.64 -45.56 59.92 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.928 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.22 -71.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.699 -0.251 . . . . 0.0 110.586 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.26 -32.96 39.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.611 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.43 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 5.1 tpp85 -58.47 -53.2 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.55 -41.14 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.969 178.44 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 68' ' ' PHE . 86.4 t -53.14 -50.95 43.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.333 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.725 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.92 -47.06 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.431 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.014 HD22 HG11 ' A' ' 91' ' ' VAL . 33.2 mt -56.67 -45.78 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.808 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -66.77 -47.43 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.804 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.18 -29.83 69.37 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.294 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.765 HG22 ' OD2' ' A' ' 80' ' ' ASP . 79.7 t -76.8 -51.88 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 111.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -67.42 -42.03 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.537 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.642 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.0 mmp_? -57.37 -34.66 69.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.216 0.532 . . . . 0.0 109.763 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -36.81 84.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.877 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.38 -14.19 24.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -91.24 -26.92 18.77 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 -71.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -50.85 -74.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.63 -61.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.43 29.57 3.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.112 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.068 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.843 0.354 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -167.22 35.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.545 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -169.95 176.56 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -126.53 165.32 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.3 t -70.4 171.79 9.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.893 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.62 -38.03 68.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.242 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -71.47 -56.75 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.108 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.623 ' H ' HG23 ' A' ' 5' ' ' THR . 0.0 OUTLIER -58.11 -45.2 87.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.851 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.494 HG13 HD13 ' A' ' 69' ' ' LEU . 5.9 tt -67.14 -26.78 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.98 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.71 -42.87 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.5 -25.78 63.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.91 -49.41 24.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.499 0.19 . . . . 0.0 111.262 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.65 -44.64 85.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.196 0.522 . . . . 0.0 110.117 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.12 -49.08 71.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.746 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.943 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.29 -41.33 62.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.44 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -56.33 -36.7 69.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.129 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.87 -13.85 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.7 -38.29 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.273 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.25 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.319 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.3 t70 -64.97 127.41 31.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.639 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -38.52 91.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.65 -12.26 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 0.0 110.794 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.08 37.94 82.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.641 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -76.88 -1.91 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 -2.33 43.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.173 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 p -149.42 132.42 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.924 0.362 . . . . 0.0 110.745 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.4 mp -104.44 120.33 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.095 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 t -97.78 159.83 14.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.496 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.415 HG21 ' NE2' ' A' ' 49' ' ' GLN . 19.2 p -50.17 -25.45 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -67.69 -50.95 55.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -78.13 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.428 0.633 . . . . 0.0 110.424 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.097 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.21 -50.51 66.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.796 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -64.41 -27.47 71.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.31 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.0 m -69.5 -54.95 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.51 -31.72 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -47.08 87.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 110.413 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -25.57 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 t -55.13 -50.57 68.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -47.78 -58.03 4.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.576 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -142.56 179.73 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.825 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -159.73 58.74 1.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.34 -170.57 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.676 2.25 . . . . 0.0 112.509 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 p -93.9 171.11 9.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 11.7 pt-20 -68.48 -31.44 70.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.291 0.567 . . . . 0.0 110.05 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.03 65.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.892 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 1.4 mt-10 -62.16 -53.33 56.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.657 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.15 -50.79 63.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.351 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 29' ' ' THR . 2.3 tp-100 -57.98 -40.35 80.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.63 -45.12 94.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.264 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -60.8 -52.66 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.203 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.097 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -57.15 -45.86 84.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.126 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.06 -25.99 9.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.351 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -83.02 -3.29 57.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.012 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.37 -32.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.2 t0 -63.0 136.93 58.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.037 0.446 . . . . 0.0 111.155 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.35 -53.74 26.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.481 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -96.95 4.16 51.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.701 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.68 59.66 8.92 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.735 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.37 -1.17 17.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.726 0.263 . . . . 0.0 111.409 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.24 17.37 15.98 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.877 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.579 ' C ' HD13 ' A' ' 63' ' ' ILE . 10.5 p -149.53 139.96 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.186 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 62' ' ' THR . 2.6 mm -104.47 149.78 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.459 . . . . 0.0 111.705 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.44 168.76 9.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.63 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.2 m-85 -52.53 -61.21 4.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -68.16 -19.81 44.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.11 . . . . 0.0 112.669 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.9 mm-40 -79.27 -37.47 37.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.106 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.7 t80 -75.23 -32.46 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.01 0.433 . . . . 0.0 110.311 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.545 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.1 tp -76.19 -58.07 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 52.5 m -51.61 -43.1 62.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.503 ' HE2' ' HD3' ' B' ' 65' ' ' ARG . 4.4 tmm? -54.14 -44.72 71.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.946 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 33.8 mtt -100.66 15.35 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.537 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -109.99 -31.68 7.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.877 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -61.93 -39.32 91.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.245 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 46.6 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 111.317 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtt -149.04 73.61 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.983 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.53 40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.08 -169.44 1.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.0 p -99.68 -165.82 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -90.9 -175.21 4.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.99 161.72 38.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -50.7 -25.42 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.525 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.7 -46.18 47.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.9 mt-10 -57.43 -26.71 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -73.65 -38.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.188 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -49.49 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.544 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.1 mt-10 -61.18 -46.12 91.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.404 0.621 . . . . 0.0 109.442 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.773 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.6 -49.3 68.11 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.984 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.05 -38.19 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.968 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -30.49 57.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.831 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.051 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.78 -36.77 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.659 0.266 . . . . 0.0 111.006 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -72.23 -62.93 1.26 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.492 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.82 114.07 20.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.827 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -60.96 -50.08 74.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.06 -9.66 59.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.74 72.37 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.839 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -94.33 13.76 22.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.69 0.281 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.48 69.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 4.5 m-85 -166.19 116.77 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.505 HD11 ' HD1' ' A' ' 89' ' ' PHE . 6.2 mt -112.24 124.34 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 0.0 111.863 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -104.43 161.96 13.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.085 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.574 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.8 -44.79 28.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.475 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.79 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.031 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -54.88 -36.29 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.6 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.93 -50.7 71.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.713 178.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.536 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -55.77 -41.47 74.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.385 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -61.05 -39.32 89.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.281 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.97 -53.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.5 -54.04 25.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.28 -25.03 65.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.18 -32.05 72.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.44 -28.78 16.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.36 42.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -140.31 109.81 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -85.28 80.61 9.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.26 161.54 17.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 120' ' ' GLU . 14.3 t -96.76 162.86 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -30.3 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.2 -42.31 88.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 117' ' ' THR . 17.2 mm-40 -63.21 -51.78 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.1 m -61.56 -41.5 90.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.225 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.23 -43.28 99.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.3 mt-10 -72.4 -30.13 64.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.44 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.9 ttm -70.73 -35.4 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 105' ' ' LEU . 5.3 mm -80.3 -54.94 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.556 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.8 ptm180 -54.02 -31.72 52.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.365 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -78.3 -21.01 50.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.904 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 -7.65 16.42 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.1 t0 -88.68 109.89 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.383 0.611 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.6 pt -84.88 -31.1 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.77 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.39 -9.08 43.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.612 -178.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.68 58.11 8.76 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.3 -4.41 13.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 117.036 0.418 . . . . 0.0 111.428 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.59 42.65 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.011 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.1 -174.88 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.417 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.749 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.8 t -127.84 127.28 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 111.224 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 4.7 t30 -106.17 -168.27 1.41 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.1 t80 -57.98 -73.95 0.07 Allowed 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -49.57 -45.6 47.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 0.0 110.262 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.727 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.109 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.749 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.6 -49.62 11.9 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.02 0.438 . . . . 0.0 111.797 -178.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.1 m -56.47 -36.55 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.615 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -70.96 -33.96 70.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.471 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.8 OUTLIER -88.58 16.58 6.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.804 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.616 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.0 mtt -128.36 -51.38 1.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.215 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 27.88 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.749 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -144.05 54.46 1.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.357 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.968 179.864 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.39 173.65 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.542 2.161 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -95.03 -47.52 6.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -151.28 31.08 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -134.83 6.63 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -103.77 103.82 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.17 -75.77 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.859 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.16 -46.11 56.82 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.238 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.919 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -59.83 -71.55 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.667 0.27 . . . . 0.0 110.589 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.409 ' NE2' ' CD ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.96 -33.38 37.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.473 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.0 tpp180 -57.27 -51.92 67.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.619 HG21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -60.88 -42.62 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.806 178.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.7 t -50.62 -47.68 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.428 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.843 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.13 -48.24 45.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.438 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.051 HD22 HG11 ' A' ' 91' ' ' VAL . 37.4 mt -56.12 -46.45 79.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -66.05 -48.84 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.01 -29.61 59.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.099 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.843 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.1 t -76.71 -56.5 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.686 0.279 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.691 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.49 -43.83 97.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.658 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.0 -33.58 69.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 109.864 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.32 -36.42 83.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.37 -15.98 22.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.39 -25.06 20.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.72 -71.41 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -68.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 111.194 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.47 -61.76 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.08 29.65 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.148 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.813 0.34 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -102.13 74.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -177.79 170.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.594 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.31 165.3 17.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -69.31 177.35 2.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -70.92 -56.99 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.263 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.594 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -56.86 -44.72 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 69' ' ' LEU . 6.1 tt -69.29 -26.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.033 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.78 -42.94 62.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -71.75 -27.04 62.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.38 -49.56 40.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.279 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -57.08 -44.81 83.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.167 0.508 . . . . 0.0 110.228 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 39.9 mm-40 -65.15 -50.67 65.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 1.038 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.33 -40.36 58.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.844 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.09 -45.66 79.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.475 -179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 m -70.77 -14.86 62.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.428 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 mt -87.83 -37.4 16.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 0.0 110.619 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.56 -65.0 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.053 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.2 t70 -64.9 132.5 49.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.869 0.366 . . . . 0.0 110.553 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -38.84 81.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.319 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.8 -12.3 31.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.802 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.83 37.57 84.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.633 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -74.25 -4.56 36.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.181 -0.207 . . . . 0.0 111.437 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 0.27 43.99 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.061 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -149.58 132.5 16.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 110.733 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -105.07 127.42 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.5 t -102.02 168.77 9.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -53.55 -40.37 65.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.772 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -55.68 -50.45 70.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.57 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -76.25 -36.37 58.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.926 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.22 -58.4 7.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.573 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -31.99 78.79 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.42 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -61.47 -57.79 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.972 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.78 -30.48 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.319 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -51.99 66.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 110.44 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.66 61.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.786 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -60.87 -45.18 95.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.2 mt -49.35 -60.69 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.073 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.25 41.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.546 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -142.6 171.99 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.848 0.356 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.71 59.33 19.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.5 -170.36 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.551 2.167 . . . . 0.0 112.357 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.3 p -115.88 170.15 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.7 -30.56 69.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 0.0 110.098 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.65 -44.35 57.43 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.035 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -42.33 99.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.043 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 13.3 mt -59.35 -50.56 73.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.07 -48.16 81.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.465 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.35 -51.04 65.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -56.25 -50.75 70.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 32' ' ' LEU . 1.2 mt -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -55.74 -26.45 45.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.515 0.674 . . . . 0.0 110.236 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 51' ' ' MET . 4.0 mt-10 -83.46 -2.03 54.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.535 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.8 -33.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 0.0 112.121 -177.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.539 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.6 t0 -69.97 139.59 52.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -71.98 -53.57 12.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.478 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -93.39 -3.16 53.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.621 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.9 55.86 27.4 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.911 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.63 15.6 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.857 0.328 . . . . 0.0 111.11 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 83.41 16.95 67.58 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.908 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.447 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.8 p -149.9 139.8 21.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.718 0.294 . . . . 0.0 110.804 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.7 mm -97.59 149.47 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 111.414 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.67 -178.92 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 8.6 m-85 -62.82 -61.67 7.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.395 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 25.6 Cg_endo -62.19 -34.4 78.83 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.416 2.077 . . . . 0.0 111.942 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -67.78 -47.42 69.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.457 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -61.66 -44.58 96.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.327 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.8 tp -72.66 -58.11 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.9 m -51.71 -45.59 63.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.4 mmt -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.7 mmt -108.47 14.97 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.17 -44.48 3.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -57.08 -45.86 82.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.023 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 68.65 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.26 35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -105.91 43.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.47 -175.7 3.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 p -96.29 -167.31 1.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.973 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' B' ' 77' ' ' VAL . 0.8 OUTLIER -86.4 -177.37 6.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.911 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 159.23 43.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.77 -26.57 5.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.338 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.47 -41.27 61.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 22.8 mt-10 -59.69 -26.78 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.817 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.1 mm -74.11 -37.63 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.921 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -71.71 -49.41 39.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.88 ' O ' HG13 ' A' ' 91' ' ' VAL . 37.5 mt-10 -61.24 -46.43 90.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 109.395 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.4 -49.17 67.83 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.97 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.27 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.946 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -30.61 62.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.852 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.928 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.52 -37.08 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.98 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.635 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.84 -62.86 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.883 0.373 . . . . 0.0 110.484 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.9 t0 -82.79 115.14 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -59.04 -52.58 65.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.1 -9.58 59.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.42 0.49 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.831 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -93.46 14.43 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.675 0.274 . . . . 0.0 111.203 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.5 16.83 65.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.588 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.3 m-85 -162.38 116.75 1.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.717 0.294 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.528 HD11 ' HD1' ' A' ' 89' ' ' PHE . 5.0 mt -113.31 124.84 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.147 0.498 . . . . 0.0 111.751 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.0 t -104.28 161.53 13.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.171 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.84 -44.87 29.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.434 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.85 -58.82 6.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -55.0 -36.75 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.62 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.7 -49.91 74.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.723 178.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.36 -41.79 76.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.38 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.71 -38.68 85.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.235 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.55 -54.29 24.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.752 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.8 mmt -50.92 -53.97 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.08 -24.65 65.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.53 -31.05 69.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.59 -28.73 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.02 43.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.564 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -147.55 109.82 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -88.2 100.52 13.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -99.18 163.21 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.4 t -98.25 171.67 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.08 -32.75 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.58 -47.91 68.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.691 ' H ' HG23 ' A' ' 117' ' ' THR . 74.7 mm-40 -60.35 -54.84 40.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.85 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.4 m -57.55 -51.02 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 121' ' ' VAL . 20.7 t70 -57.54 -38.84 75.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.982 0.42 . . . . 0.0 110.566 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 32.6 mt-10 -72.86 -30.09 63.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.476 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -71.0 -36.33 72.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.845 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.943 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.32 -54.9 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.692 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.1 ptm180 -53.75 -31.83 49.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.9 pt-20 -78.76 -20.93 48.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.957 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -7.27 16.86 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.476 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.3 t0 -89.05 110.05 20.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.359 0.6 . . . . 0.0 111.272 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.735 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.94 -31.12 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.819 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.37 -9.14 42.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.605 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.94 57.85 9.34 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.566 0.587 . . . . 0.0 114.566 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.1 p30 -114.3 -4.45 13.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.992 0.396 . . . . 0.0 111.437 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.75 42.06 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.12 -174.92 4.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.475 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.727 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.88 126.56 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.98 -167.57 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.649 ' O ' HG13 ' A' ' 142' ' ' VAL . 54.1 t80 -57.67 -73.89 0.06 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.508 ' O ' HG22 ' A' ' 142' ' ' VAL . 1.7 tt0 -49.5 -45.99 47.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.735 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.6 -36.27 69.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.069 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.727 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.52 -49.68 11.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.817 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.88 -37.08 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.685 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.664 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -70.98 -34.32 71.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.657 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.442 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -88.12 15.89 6.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.883 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.611 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -126.85 -51.13 1.46 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 t -158.38 28.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.705 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.664 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -144.29 54.56 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' THR . . . . . 0.713 HG22 ' HD2' ' B' ' 61' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.656 0.265 . . . . 0.0 111.149 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.713 ' HD2' HG22 ' B' ' 60' ' ' THR . 65.4 Cg_exo -51.07 98.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.553 2.168 . . . . 0.0 112.401 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -59.94 -31.22 69.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.68 30.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.09 -135.28 4.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.478 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.95 128.3 46.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.059 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.12 -66.01 3.0 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.793 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.13 -50.66 26.94 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.44 -63.5 1.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.476 0.179 . . . . 0.0 110.891 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.68 -36.42 46.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.46 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.9 tpt180 -56.16 -53.2 59.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.613 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -58.46 -42.48 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.276 178.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.568 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.83 -53.44 13.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -73.32 -44.27 59.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.662 -178.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 91' ' ' VAL . 19.4 mt -55.91 -48.46 75.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.168 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.038 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -63.97 -47.97 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.271 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.03 -28.53 58.36 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 73' ' ' ARG . 87.8 t -76.77 -56.18 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.452 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.649 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.97 -43.5 96.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 24.8 mmm180 -58.04 -34.16 69.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.232 0.539 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -36.82 84.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.426 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.905 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.43 -15.33 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.988 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.49 -26.47 19.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.429 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.48 -71.77 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -51.06 -74.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.315 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.98 -61.63 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.247 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.53 29.66 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.137 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.85 48.02 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.698 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.6 tt0 -160.29 171.96 18.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -118.37 165.47 13.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.6 t -68.55 177.06 2.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.01 -37.75 83.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.8 tt0 -71.39 -56.74 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.637 ' H ' HG23 ' A' ' 5' ' ' THR . 1.1 tt0 -57.86 -44.1 86.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.913 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 69' ' ' LEU . 7.4 tt -68.9 -26.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.96 -43.12 63.39 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -25.75 62.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -74.11 -49.39 24.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.565 0.221 . . . . 0.0 111.226 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -57.62 -44.49 85.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.225 0.536 . . . . 0.0 110.175 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.76 -49.13 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.3 -41.01 62.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.492 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.25 -38.81 69.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.174 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 t -76.8 -14.23 59.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.75 -37.9 16.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.833 0.349 . . . . 0.0 110.455 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.75 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.262 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.0 t70 -64.57 127.01 29.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.637 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -38.66 91.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.35 -12.31 32.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 110.781 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.04 37.64 80.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -76.49 -2.17 30.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 -1.82 43.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.2 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -149.45 132.49 16.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.922 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mt -104.53 120.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.93 161.99 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.568 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -52.26 -25.57 9.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.809 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -67.27 -50.83 58.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.016 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.95 -36.77 48.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.331 0.586 . . . . 0.0 110.572 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.092 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.2 -41.55 68.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.683 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.805 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -72.58 -27.46 69.38 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.195 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -69.07 -51.39 39.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.697 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.6 p -74.45 -33.16 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.7 ttt -57.74 -44.16 85.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.384 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -25.54 44.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 t -56.53 -44.88 81.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD13 ' CD ' ' B' ' 70' ' ' ARG . 3.6 mt -46.04 -30.12 1.73 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.59 35.18 0.32 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.751 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -142.82 173.6 11.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 28.3 m120 -140.93 63.65 19.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 2.7 Cg_exo -75.85 -171.63 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 112.185 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -100.07 170.94 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.55 -31.36 70.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.22 -44.04 64.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -53.23 57.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.685 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.805 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.27 -50.72 64.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.365 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -60.23 -39.15 85.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.529 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.42 -44.65 90.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -60.27 -52.94 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.217 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.96 -46.25 87.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.299 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -51.58 -26.03 7.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.372 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.4 mt-10 -83.64 -3.32 57.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.36 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -62.9 134.44 56.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.083 0.468 . . . . 0.0 111.101 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -65.5 -53.32 44.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.717 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -97.45 4.37 50.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.817 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.52 60.11 8.7 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.928 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -110.37 -2.57 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.768 0.284 . . . . 0.0 111.38 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.38 15.95 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.6 p -149.53 139.94 22.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 111.224 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.45 149.6 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.234 0.54 . . . . 0.0 111.802 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.98 172.05 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.487 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.8 m-85 -56.1 -61.49 6.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 41.9 Cg_endo -67.42 -20.34 48.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.469 2.112 . . . . 0.0 112.864 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.23 -37.97 36.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.7 t80 -75.24 -34.59 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.0 tp -74.97 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.093 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.0 -46.44 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 mmt -61.66 -30.8 70.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.697 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.407 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 6.8 mmt -105.13 13.91 29.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.46 -36.67 4.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -56.48 21.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 43.98 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.4 mmt -150.21 66.85 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -133.08 39.06 3.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.5 -168.49 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.006 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.53 -174.88 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.26 179.34 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.47 155.87 40.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.8 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -25.31 8.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.322 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.11 -35.79 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.223 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' B' ' 77' ' ' VAL . 36.8 mt-10 -66.78 -26.64 67.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.215 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.801 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.25 -37.82 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.0 110.155 179.59 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.71 -49.4 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.585 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.87 ' O ' HG13 ' A' ' 91' ' ' VAL . 44.9 mt-10 -62.4 -44.45 96.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.352 0.596 . . . . 0.0 109.42 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.775 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.77 -50.06 66.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.819 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.92 -37.75 45.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.868 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -30.57 57.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.714 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.5 m -76.63 -36.76 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.665 0.269 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.697 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.1 m-85 -73.56 -62.82 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.545 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.5 t0 -81.9 116.63 21.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -63.24 -52.43 62.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -77.68 -9.63 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.25 70.71 0.58 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -94.62 14.02 22.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 0.0 111.22 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 18.2 67.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.0 m-85 -163.54 116.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.515 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.52 124.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 0.0 111.678 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -104.22 162.06 13.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.197 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -46.56 31.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.37 -58.8 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 111.104 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -54.88 -36.42 65.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.583 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.46 -50.64 71.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.647 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.16 -41.53 75.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.384 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.62 -39.03 86.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.333 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.66 -54.64 19.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.785 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.4 mmt -50.06 -54.05 22.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.697 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.8 t -66.37 -24.62 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.567 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -69.8 -31.32 69.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.35 -28.8 15.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.65 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.05 109.78 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -91.9 93.74 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.83 158.1 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.1 t -88.34 163.56 15.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -58.93 -39.89 82.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -36.14 83.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.661 ' H ' HG23 ' A' ' 117' ' ' THR . 29.1 mm-40 -64.73 -54.83 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.27 -39.77 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.3 -42.0 98.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.9 mt-10 -72.6 -30.22 64.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.359 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.1 mtt -70.78 -35.88 72.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.96 HD11 HD12 ' A' ' 105' ' ' LEU . 5.4 mm -80.31 -54.89 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.67 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.01 -31.81 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.446 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.12 -21.06 47.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.821 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.05 -4.35 19.04 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.441 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.0 t0 -93.06 109.76 21.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.726 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.04 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.814 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.499 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.36 -9.08 43.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.563 -178.479 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.59 58.1 8.67 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.31 -4.42 13.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.963 0.382 . . . . 0.0 111.484 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 7.81 42.05 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.06 -174.91 4.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.48 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.82 126.39 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.359 . . . . 0.0 111.198 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.82 -167.59 1.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.636 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.9 t80 -58.15 -73.88 0.07 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 142' ' ' VAL . 2.8 tt0 -49.46 -45.71 47.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.375 0.607 . . . . 0.0 110.333 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.726 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.56 -36.55 69.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.129 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.7 -49.77 11.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.93 0.395 . . . . 0.0 111.983 -179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.801 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -54.82 -40.74 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.69 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.609 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.24 -34.47 70.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.719 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.42 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.18 8.29 13.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.607 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -37.78 3.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.073 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t -148.8 -52.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.458 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -68.01 74.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 111.415 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.971 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' THR . . . . . 0.595 HG23 ' OE1' ' A' ' 87' ' ' GLU . 6.1 p . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.91 -168.11 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.556 2.171 . . . . 0.0 112.334 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -100.99 -64.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.38 31.32 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.78 -134.35 7.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -97.28 102.46 14.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.824 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.11 -76.21 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.888 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.76 -46.33 59.95 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.11 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -58.85 -71.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.245 . . . . 0.0 110.588 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.448 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.37 -36.87 54.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.377 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 ttm-85 -57.31 -48.17 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.641 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -59.55 -40.47 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.132 178.541 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 68' ' ' PHE . 92.2 t -54.71 -53.59 30.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.521 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.71 -46.4 53.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.336 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 91' ' ' VAL . 16.4 mt -56.04 -46.31 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.618 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.6 p -65.78 -46.6 88.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.391 . . . . 0.0 110.443 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.567 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.2 -30.33 70.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.367 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.723 HG11 ' CB ' ' A' ' 88' ' ' ALA . 42.3 t -75.77 -52.45 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.692 0.282 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.697 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -67.03 -42.67 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.563 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.3 mmp_? -57.33 -34.75 69.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -62.4 -37.22 84.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.523 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.6 t90 -95.54 -14.84 23.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.013 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.16 -27.11 19.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.479 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -71.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.594 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -49.56 -69.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.236 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.23 -61.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.38 29.72 3.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.025 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.095 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.774 0.321 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -105.7 80.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.746 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -176.36 176.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -127.4 165.13 20.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.546 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -73.47 170.13 15.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -50.85 -42.21 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.426 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -65.59 -56.91 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.204 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB3' ' CB ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -60.67 -54.69 42.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' HD12 ' A' ' 4' ' ' LEU . 10.8 tt -56.1 -26.18 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.224 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.24 -42.67 61.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.334 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -35.18 79.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.03 -49.53 60.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.432 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 1.2 mtpp -58.74 -46.49 87.31 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.22 0.533 . . . . 0.0 109.996 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.83 -50.42 72.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.589 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -40.75 62.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.296 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.08 -35.83 67.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -75.0 -16.94 60.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -86.91 -38.78 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.421 . . . . 0.0 110.201 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.77 -65.69 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.246 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 27' ' ' ILE . 9.0 t70 -65.98 131.04 45.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.883 0.373 . . . . 0.0 110.712 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -36.39 77.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.139 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.92 -12.3 27.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.783 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.28 37.85 83.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.646 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -77.68 -1.9 33.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.12 43.86 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.131 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.6 p -147.48 132.47 18.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.869 0.335 . . . . 0.0 110.795 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.906 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -107.28 119.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.449 ' CB ' HG22 ' A' ' 62' ' ' THR . 4.7 t -98.35 168.41 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.1 p -54.45 -29.34 49.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.641 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -67.22 -50.43 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.279 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.15 -36.18 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.38 -42.83 70.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.847 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.51 -27.32 72.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.052 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.0 m -73.58 -45.24 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.0 p -74.67 -34.9 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.084 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -60.84 -49.45 77.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.755 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -65.33 -30.19 71.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -58.86 -21.14 56.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.897 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' B' ' 74' ' ' LEU . 15.9 mt -72.47 -60.76 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.79 -39.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.504 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.3 mt-30 -140.15 147.88 40.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.991 0.396 . . . . 0.0 111.103 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -99.11 99.42 8.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.93 -168.95 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.302 2.002 . . . . 0.0 111.994 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 169.39 13.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.73 -30.37 68.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.031 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.94 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.126 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.1 mt-10 -62.4 -43.22 99.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.244 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.8 mt -56.79 -50.31 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.5 tt0 -64.26 -39.11 93.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.141 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -66.14 -51.14 60.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.452 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.03 -54.18 49.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.119 0.485 . . . . 0.0 110.348 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.7 -43.89 92.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.683 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 18.8 t-20 -52.53 -25.99 11.92 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.561 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.497 ' O ' ' CE ' ' A' ' 71' ' ' MET . 2.2 mt-10 -83.39 -4.82 58.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.915 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -126.2 -32.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.074 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.7 t0 -64.91 133.54 52.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 111.342 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.13 -53.66 16.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.952 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.74 58.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.24 49.21 81.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.924 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -104.47 -1.37 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.703 0.252 . . . . 0.0 111.482 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.62 15.31 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.254 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 3.2 p -149.06 139.78 22.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 111.085 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.77 149.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.157 0.503 . . . . 0.0 111.691 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.47 173.78 6.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.503 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -57.65 -61.46 7.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.323 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 48.7 Cg_endo -68.41 -26.86 34.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.48 2.12 . . . . 0.0 112.468 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -67.63 -43.5 80.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.089 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 1.9 t80 -75.19 -38.44 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.055 0.455 . . . . 0.0 110.293 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.5 tp -66.0 -58.06 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.071 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 m -51.9 -41.47 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 55' ' ' VAL . 1.8 tpt -60.14 -32.83 71.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.424 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.425 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -108.27 15.32 24.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.148 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.24 -33.12 5.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -58.48 -41.08 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 40.96 1.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.78 138.78 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -148.8 31.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.858 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 62.42 100.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -117.84 -7.41 10.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 58.41 171.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -169.69 149.26 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -26.46 5.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.648 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 81' ' ' SER . 13.7 pt-20 -78.09 -25.72 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.734 0.302 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' B' ' 77' ' ' VAL . 5.0 mt-10 -74.15 -28.92 61.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.923 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.29 -32.73 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -49.33 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.413 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.707 ' O ' HG13 ' A' ' 91' ' ' VAL . 10.8 mt-10 -62.99 -47.99 80.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.739 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.28 -44.09 67.99 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.729 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.84 -39.91 54.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.909 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -33.03 58.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.782 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG11 HD22 ' B' ' 74' ' ' LEU . 1.5 m -73.28 -36.97 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.7 OUTLIER -72.89 -63.07 1.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.59 125.29 33.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -52.61 9.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.0 -9.66 58.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.69 68.91 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.875 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -95.07 12.87 27.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 111.341 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.54 16.61 65.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.7 m-85 -157.94 116.95 3.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.644 0.259 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.4 mt -109.41 124.29 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.014 0.435 . . . . 0.0 111.262 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -103.89 157.15 17.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.272 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.75 -43.34 27.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.446 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.72 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 mm-40 -54.97 -39.63 69.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.692 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.05 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.864 179.026 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.79 ' O ' HG22 ' A' ' 110' ' ' THR . 0.3 OUTLIER -57.61 -41.45 81.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.721 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -61.06 -38.07 84.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.466 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' GLU . 81.7 t -72.77 -56.01 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.063 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 5.9 mmt -48.99 -54.03 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.508 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.79 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.0 t -65.53 -25.25 67.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.376 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.53 -30.31 65.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.837 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.2 -28.82 17.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.58 43.02 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.594 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.53 109.76 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.16 100.34 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -98.17 160.65 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 120' ' ' GLU . 15.4 t -89.57 161.97 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -57.64 -40.72 79.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.12 -36.09 82.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.644 ' H ' HG23 ' A' ' 117' ' ' THR . 13.9 mm-40 -65.71 -54.77 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.99 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.277 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.15 -44.05 97.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 45.1 mt-10 -71.74 -30.2 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.414 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.5 mmm -70.67 -34.55 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.685 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.952 HD11 HD12 ' A' ' 105' ' ' LEU . 4.0 mm -80.23 -54.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.762 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.1 ptt85 -54.91 -31.8 60.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 110.363 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.77 -20.85 52.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.76 -11.34 16.31 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.488 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 125' ' ' ILE . 50.6 t0 -85.51 90.95 8.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.426 0.632 . . . . 0.0 110.785 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.2 pt -63.43 -30.74 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.592 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.61 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -86.94 -9.41 55.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.208 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.19 54.57 18.91 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.2 p30 -113.93 -5.14 13.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.243 0.521 . . . . 0.0 111.365 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.48 5.8 45.16 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.99 -174.69 4.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.907 0.385 . . . . 0.0 110.595 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.697 HG11 ' CD1' ' A' ' 141' ' ' PHE . 41.3 t -127.24 120.66 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.6 t30 -97.37 -167.72 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.7 t80 -61.63 -74.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.3 OUTLIER -49.89 -43.06 49.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.315 0.579 . . . . 0.0 110.337 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.77 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.3 mt-10 -56.06 -33.69 65.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.617 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.697 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -78.97 -47.19 16.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.233 0.539 . . . . 0.0 111.631 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.6 m -64.8 -36.47 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.023 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.696 ' HA ' ' HB2' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -70.53 -36.71 73.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.657 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.535 ' HE1' ' CD2' ' B' ' 81' ' ' TRP . 1.4 ptt? -74.95 -15.2 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.57 ' HG2' HD12 ' A' ' 85' ' ' ILE . 3.9 tpp -95.2 -50.22 5.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.374 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 145' ' ' MET . 13.8 t -177.47 -39.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.545 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 143' ' ' GLN . . . 54.06 53.06 11.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.964 0.411 . . . . 0.0 111.252 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.883 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.689 0.281 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.94 165.12 32.23 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.526 2.151 . . . . 0.0 112.31 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 19.7 mtt-85 -60.57 -37.31 80.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 80.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 -93.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 2.0 mpp_? -140.81 103.03 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.047 0.451 . . . . 0.0 110.77 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.01 -76.01 0.21 Allowed Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.928 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.23 -45.81 57.41 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.156 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.915 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.27 -70.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.516 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.28 -32.0 35.32 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.396 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.8 tpt180 -58.65 -52.85 63.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.653 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.31 -42.43 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.684 178.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.4 t -52.67 -50.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.105 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.816 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.58 -49.27 49.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.453 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.032 HD22 HG11 ' A' ' 91' ' ' VAL . 29.4 mt -56.04 -46.3 78.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.149 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.4 p -67.01 -47.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.586 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.8 -30.57 69.66 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.348 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.816 HG23 ' O ' ' B' ' 73' ' ' ARG . 86.7 t -76.75 -52.64 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.657 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.54 -41.7 91.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.581 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.619 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -56.02 -34.25 65.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -38.04 86.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.698 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.931 ' CH2' HD11 ' A' ' 105' ' ' LEU . 5.7 t90 -95.15 -14.74 23.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.901 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.53 -31.93 16.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -73.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.409 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -67.79 69.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -63.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -89.63 -32.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.863 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -93.37 79.05 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -176.51 169.06 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.59 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -123.75 165.27 17.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.4 t -71.93 177.09 4.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 17.1 pt-20 -57.3 -43.38 83.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.1 tt0 -64.78 -56.95 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.69 -52.96 63.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' THR . 11.2 tt -59.1 -26.55 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.262 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.46 -42.9 61.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.405 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.7 -36.76 84.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.216 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.11 -49.67 64.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.576 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -59.04 -46.05 89.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.506 . . . . 0.0 110.025 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.81 -49.52 72.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.891 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.48 -41.09 63.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.361 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -55.81 -37.31 68.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.061 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -76.12 -15.82 60.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.78 -40.23 14.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.316 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.721 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.2 -63.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.238 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 5.9 t0 -65.7 126.61 28.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.37 79.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.313 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -92.16 -12.47 32.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.974 0.416 . . . . 0.0 110.313 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 56.96 32.82 62.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.805 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -76.62 1.27 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.845 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.3 43.31 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.028 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -149.55 132.62 16.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.351 0.576 . . . . 0.0 111.205 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.915 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -105.53 118.4 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.439 ' CB ' HG22 ' A' ' 62' ' ' THR . 7.8 t -97.4 166.0 11.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.615 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.3 p -52.17 -31.16 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.836 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -63.95 -50.45 68.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 111.321 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.7 -36.07 51.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.24 -45.67 72.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.013 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.33 -27.39 73.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.279 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 85.0 m -72.21 -47.14 52.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.721 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.5 p -74.71 -34.97 35.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -60.08 -49.77 76.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -64.41 -30.36 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 t -58.31 -21.29 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' B' ' 74' ' ' LEU . 11.4 mt -71.59 -60.26 2.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.92 -39.0 0.02 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.542 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.8 mt-30 -140.93 147.86 39.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.111 0.455 . . . . 0.0 111.162 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -99.64 99.65 9.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.258 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.44 -168.8 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.356 2.037 . . . . 0.0 111.971 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -85.1 169.82 13.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.65 -30.49 69.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 0.0 110.066 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -44.25 59.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.141 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 51' ' ' MET . 1.3 mt-10 -62.03 -41.1 97.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.266 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.9 mt -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.861 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.4 tt0 -64.24 -39.59 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -66.27 -51.09 60.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.66 -53.42 58.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.381 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.027 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -60.26 -45.35 96.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.497 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 26.7 t-20 -52.07 -26.12 10.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.446 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 2.2 mt-10 -82.96 -3.3 56.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.38 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -64.59 133.22 51.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.053 0.454 . . . . 0.0 111.344 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.11 -53.58 16.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.897 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.66 58.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.07 49.22 80.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.933 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -104.26 -1.47 27.02 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.771 -0.253 . . . . 0.0 111.439 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 17.72 15.01 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.252 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.23 139.82 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.44 149.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 111.985 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.75 170.8 7.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.415 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.4 m-85 -56.03 -61.55 6.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.533 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -68.24 -18.59 44.9 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.508 2.138 . . . . 0.0 112.68 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.409 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.4 t80 -75.28 -38.48 60.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 3' ' ' GLN . 12.1 tp -64.45 -55.61 19.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -51.67 -37.26 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.22 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.425 ' HG2' HG13 ' A' ' 55' ' ' VAL . 2.8 tpt -64.08 -32.74 74.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.4 mmt -108.27 15.52 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -119.35 -36.69 3.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.803 0.335 . . . . 0.0 111.291 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -53.31 -54.33 37.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 39.31 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 tpt -160.52 137.51 9.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.035 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -148.22 30.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.17 101.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -110.99 -14.02 14.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.536 ' CB ' HG21 ' A' ' 146' ' ' THR . 11.5 m-20 58.56 161.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.367 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 t -166.2 -167.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -73.55 -26.04 60.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.03 -33.79 59.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' OE1' HG22 ' B' ' 77' ' ' VAL . 4.4 mt-10 -61.24 -45.4 94.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -72.34 -39.14 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.761 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -71.54 -49.47 40.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.799 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 91' ' ' VAL . 58.4 mt-10 -61.36 -45.56 93.89 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 109.313 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.54 -50.51 65.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.894 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.21 -40.8 59.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.833 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -31.76 68.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.443 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.061 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.57 -36.85 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.828 ' CE2' HG22 ' B' ' 78' ' ' ILE . 6.5 m-85 -75.63 -43.28 48.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -112.57 109.29 18.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -42.03 80.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -74.19 -9.71 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.06 68.51 0.77 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.172 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.46 8.82 40.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.47 16.38 65.14 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.296 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 3.6 m-85 -163.86 116.68 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.731 0.3 . . . . 0.0 111.066 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.605 HD11 ' HD1' ' A' ' 89' ' ' PHE . 8.9 mt -111.28 127.38 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 111.788 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.5 m -104.21 158.59 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.059 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -48.0 -41.98 26.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.732 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 111.126 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt-10 -56.67 -37.77 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.591 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -60.82 -47.71 85.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.882 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.746 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.39 -44.47 88.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.559 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 1.3 t60 -58.73 -38.33 78.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.38 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 92' ' ' PHE . 77.6 t -67.31 -55.64 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.0 mmt -49.05 -53.44 20.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.617 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.3 t -68.0 -24.34 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 19.3 t-20 -74.54 -31.39 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.664 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.7 -28.72 20.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.18 44.11 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.576 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.85 109.72 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -90.72 99.66 12.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 116' ' ' LEU . 4.4 mm? -101.27 172.51 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.806 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.3 t -96.59 166.58 11.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.829 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.32 -34.07 77.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -35.51 78.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.707 ' H ' HG23 ' A' ' 117' ' ' THR . 52.0 mm-40 -65.64 -50.02 66.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 106' ' ' ARG . 4.2 m -66.77 -39.56 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.13 -42.37 99.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 110.216 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.0 mt-10 -72.74 -30.13 63.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.339 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -36.19 72.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 105' ' ' LEU . 2.8 mm -80.36 -54.5 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 15.7 ptt180 -53.73 -31.92 50.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.431 . . . . 0.0 110.303 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.65 -21.72 44.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.734 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.673 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -106.68 -0.3 23.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.34 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 46.1 t0 -96.24 102.82 14.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.368 0.604 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -76.93 -32.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.157 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.3 -9.05 49.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.88 0.371 . . . . 0.0 111.491 -178.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.54 56.98 11.28 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -114.33 -3.71 13.07 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.145 0.472 . . . . 0.0 111.49 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.5 44.34 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.099 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.76 -174.79 4.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.646 0.26 . . . . 0.0 110.349 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.2 t -129.22 126.99 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.8 t30 -104.61 -167.68 1.38 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.942 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.629 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.5 t80 -56.7 -73.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 142' ' ' VAL . 1.9 tt0 -49.65 -47.13 50.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.23 0.538 . . . . 0.0 110.445 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.5 mt-10 -56.29 -33.72 65.8 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.759 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.67 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.23 -48.93 13.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.063 0.458 . . . . 0.0 111.686 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.844 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -60.29 -41.86 88.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.217 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -70.85 -35.63 72.5 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.673 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 2.7 ptm -70.6 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 85' ' ' ILE . 17.8 mtt -105.11 -44.2 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.536 HG21 ' CB ' ' A' ' 80' ' ' ASP . 1.8 t 177.37 -37.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 143' ' ' GLN . . . 54.71 41.89 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.842 0.353 . . . . 0.0 111.321 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.915 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.764 0.316 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 163.89 36.78 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.561 2.174 . . . . 0.0 112.31 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -84.24 -40.05 18.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -151.91 79.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.43 -129.45 1.03 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HA ' ' HG3' ' A' ' 51' ' ' MET . 0.0 OUTLIER -106.52 103.18 12.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.759 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.61 -76.26 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.9 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.4 -41.46 55.39 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -64.93 -70.31 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.702 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -52.25 -38.82 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.51 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.4 OUTLIER -55.42 -49.88 71.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.67 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.55 -41.58 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.147 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' B' ' 69' ' ' GLN . 89.4 t -53.6 -53.47 25.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.31 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.878 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -71.33 -44.26 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.405 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.061 HD22 HG11 ' A' ' 91' ' ' VAL . 17.7 mt -56.23 -50.43 71.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.596 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -64.09 -47.02 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.59 -32.98 65.76 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.526 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 73' ' ' ARG . 47.4 t -76.75 -53.02 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.828 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -63.29 -43.08 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.524 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.637 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -57.92 -35.07 70.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 109.687 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -36.04 80.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.337 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.697 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 3.1 t90 -95.37 -13.86 24.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -92.03 -31.4 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -74.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -67.82 70.19 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.76 -65.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.93 -34.01 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.894 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -105.46 72.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.659 ' HG3' HD21 ' A' ' 69' ' ' LEU . 3.2 tt0 -176.55 175.23 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -122.27 165.4 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.631 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.7 t -69.64 170.31 11.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.88 -37.29 66.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.321 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.04 -56.8 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.134 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.631 ' H ' HG23 ' A' ' 5' ' ' THR . 1.2 tt0 -57.91 -44.38 86.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.868 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.437 HG13 HD13 ' A' ' 69' ' ' LEU . 7.1 tt -68.04 -26.78 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.8 -43.17 62.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -27.5 63.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.55 -49.41 41.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.239 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -57.06 -45.09 83.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 110.222 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.1 mm-40 -64.38 -51.66 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.21 -40.18 58.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.841 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -56.01 -47.34 77.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -13.62 62.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.3 mt -88.0 -38.3 15.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 110.503 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.12 -64.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.07 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.4 t70 -61.99 128.1 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -38.54 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.279 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.19 -12.25 30.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.824 0.345 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.33 38.44 86.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -77.66 -1.15 29.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.26 -2.53 43.58 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.213 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.1 p -149.42 132.47 16.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 0.0 110.756 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.925 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.73 119.21 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.423 ' CB ' HG22 ' A' ' 62' ' ' THR . 2.0 t -99.15 165.88 11.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.697 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 p -52.33 -32.56 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.885 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -62.13 -50.56 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.329 . . . . 0.0 111.374 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.78 -37.59 48.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 110.974 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.047 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.23 -40.39 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.585 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.2 -30.86 69.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.914 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.6 m -67.58 -53.25 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.1 p -69.76 -30.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.246 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.418 ' HE2' ' HG3' ' A' ' 43' ' ' PRO . 1.9 mtp -60.14 -46.62 89.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.321 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -25.52 44.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -53.64 -50.67 65.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -46.97 -57.88 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.589 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -142.72 178.76 7.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -147.69 58.58 4.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HG3' ' HE2' ' A' ' 36' ' ' MET . 65.9 Cg_endo -73.91 -178.5 3.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.559 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.1 p -98.66 173.76 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.49 -30.2 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.29 60.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.15 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.2 mt-10 -60.71 -42.01 96.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.062 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.0 mt -58.35 -50.53 73.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.6 tp-100 -62.77 -38.63 91.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.89 -51.23 42.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.352 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.467 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.39 -54.1 50.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.047 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.28 -45.26 93.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.477 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 27.7 t30 -52.36 -25.9 10.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.242 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.8 mt-10 -82.35 -3.33 55.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.98 -32.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.18 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.5 t0 -63.92 134.82 55.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -66.52 -53.35 35.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.728 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.77 4.2 51.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.813 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.16 59.71 9.11 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.213 -0.517 . . . . 0.0 113.933 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.35 -2.72 17.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.771 0.286 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.22 17.3 16.18 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.927 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.5 p -149.49 139.96 22.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.337 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -104.64 149.56 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.209 0.528 . . . . 0.0 111.725 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 171.72 7.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -55.9 -61.59 6.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.712 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.1 Cg_endo -67.97 -19.48 45.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.753 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.18 -39.07 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.367 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.2 t80 -75.27 -35.74 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.662 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.7 tp -71.99 -58.43 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.085 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.13 -46.69 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mmt -59.71 -30.69 68.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.426 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.26 14.97 24.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.08 -43.0 3.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -48.7 76.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 64.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.795 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.51 31.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -104.12 46.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.757 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.31 -175.12 4.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 p -97.28 -166.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.946 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -85.85 -179.95 6.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -150.2 156.21 41.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.84 -38.54 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.261 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 45.4 mt-10 -63.92 -27.86 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.178 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.18 -39.22 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -70.88 -49.32 47.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.4 mt-10 -61.29 -46.44 90.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.34 0.59 . . . . 0.0 109.476 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.748 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.58 -48.85 68.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.068 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.06 -38.86 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.994 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -30.42 57.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.955 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.01 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.53 -37.02 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.705 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.86 -62.89 1.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.494 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.82 121.17 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.33 -52.62 57.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.234 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.04 -9.61 59.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.496 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.13 71.13 0.52 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.864 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.39 14.58 18.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.633 0.254 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.28 66.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.608 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.2 m-85 -161.84 116.75 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.755 0.312 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.6 mt -113.28 124.45 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.115 0.483 . . . . 0.0 111.645 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -104.26 161.63 13.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.16 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -44.52 29.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.442 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.09 -58.87 6.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.03 -36.62 65.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.636 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.934 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.99 -49.49 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.729 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.85 -41.49 78.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 2.4 t60 -60.55 -39.87 89.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.306 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 92' ' ' PHE . 28.1 t -68.72 -51.8 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.749 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.427 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.7 mmt -51.28 -54.05 29.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.802 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.1 t -66.99 -25.08 66.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 15.8 t-20 -70.69 -31.29 68.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.62 -28.8 16.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.51 43.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -152.11 109.78 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.66 95.63 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.018 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.4 mm? -94.07 157.14 16.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 120' ' ' GLU . 11.6 t -88.01 164.02 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.55 -42.69 83.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -62.46 -35.35 79.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 117' ' ' THR . 20.2 mt-10 -65.31 -54.85 23.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.021 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.94 -39.78 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -62.53 -41.88 99.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 110.276 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 5.6 mt-10 -72.66 -30.14 64.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.317 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 2.3 tpp -70.75 -36.09 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.934 HD11 HD12 ' A' ' 105' ' ' LEU . 4.6 mm -80.24 -54.91 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.567 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -53.65 -31.75 48.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.01 0.433 . . . . 0.0 110.456 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.77 -20.79 52.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.968 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.06 -10.96 15.76 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.55 0.214 . . . . 0.0 111.523 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -85.51 109.67 18.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.429 0.633 . . . . 0.0 111.307 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.13 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.755 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.496 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.05 -9.14 43.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.523 -178.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.31 57.62 10.05 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.8 p30 -114.25 -4.33 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.05 0.425 . . . . 0.0 111.456 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.69 42.45 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.991 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.05 -174.87 4.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.53 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 141' ' ' PHE . 54.0 t -128.34 126.82 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -106.55 -167.36 1.28 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.6 t80 -58.09 -73.98 0.07 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -49.56 -45.64 47.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.375 0.607 . . . . 0.0 110.336 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.55 -36.61 69.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.74 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.64 -49.51 12.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.913 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.85 -40.21 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.3 -34.44 70.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.757 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.413 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -83.82 8.93 13.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 111.283 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.8 mtt -118.81 -36.32 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -150.4 -52.61 0.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -68.43 75.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.936 179.877 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.698 0.285 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.11 -172.57 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.501 2.134 . . . . 0.0 112.304 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -99.91 -56.51 2.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -141.75 35.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.79 -134.82 6.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -94.54 103.21 15.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.774 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.03 -75.81 0.22 Allowed Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.95 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.35 -46.69 63.67 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -58.71 -70.26 0.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.27 . . . . 0.0 110.552 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.46 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.29 -34.09 45.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.205 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 6.6 tpt180 -58.14 -52.18 66.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.38 -41.8 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.053 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 68' ' ' PHE . 90.4 t -53.03 -53.3 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.446 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.826 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.02 -45.01 64.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.436 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.01 HD22 HG11 ' A' ' 91' ' ' VAL . 21.2 mt -55.99 -49.73 72.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.557 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -64.62 -48.62 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.574 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.96 -29.67 59.39 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.151 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.826 HG23 ' O ' ' B' ' 73' ' ' ARG . 98.8 t -76.8 -55.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.604 0.24 . . . . 0.0 111.562 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.705 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.5 pp -61.73 -43.91 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.664 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.6 mmm180 -58.16 -34.26 70.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.229 0.538 . . . . 0.0 109.855 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -62.27 -37.03 83.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.901 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.34 -15.38 23.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.73 -26.26 19.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.501 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.42 -72.07 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.645 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 3.0 mmpt? -49.61 -69.58 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.27 -62.36 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.258 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.27 30.47 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.015 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.176 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.73 69.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -176.57 170.82 2.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.836 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -124.13 165.36 17.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 8' ' ' GLN . 10.1 t -67.93 166.33 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -54.34 -26.48 30.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -80.36 -56.89 3.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.126 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.836 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.84 -46.57 84.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 69' ' ' LEU . 7.0 tt -65.52 -26.65 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.55 -44.04 62.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.294 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 -25.71 61.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -71.42 -49.39 42.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.298 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -56.35 -44.93 80.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.307 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.4 mm-40 -65.35 -51.44 60.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 1.046 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.18 -40.06 57.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.922 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -57.07 -45.98 82.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -70.94 -13.76 62.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.2 mt -87.99 -38.38 15.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.906 0.384 . . . . 0.0 110.57 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.788 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.31 -64.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.3 t70 -62.52 127.34 30.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.801 0.334 . . . . 0.0 110.432 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -38.69 92.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.9 -12.31 31.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.26 38.38 86.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -77.65 -1.06 29.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.79 43.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.195 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.7 p -149.37 132.49 16.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.939 0.37 . . . . 0.0 110.764 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.38 119.35 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.404 ' HA ' HG22 ' A' ' 62' ' ' THR . 2.9 t -98.75 165.11 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.696 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 p -52.76 -30.45 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.83 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -63.24 -50.61 69.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -77.85 -37.87 47.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.14 -41.39 68.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 -29.42 72.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.9 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.6 m -69.51 -52.05 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.542 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.7 p -69.01 -31.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -47.16 87.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -25.47 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.758 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 t -54.69 -50.72 67.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.51 -58.72 3.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 111.085 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.6 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -142.71 -178.02 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -150.99 58.16 2.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 -177.18 2.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.65 2.233 . . . . 0.0 112.504 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.2 p -99.71 173.6 6.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -68.54 -30.14 68.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.918 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.12 59.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.8 OUTLIER -61.32 -42.51 98.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.076 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.5 -50.53 72.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 28.2 tp60 -63.28 -39.43 94.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.214 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.61 -51.25 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.325 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.79 -53.84 53.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 110.347 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.043 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.31 -45.27 93.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.437 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 10.0 t30 -52.38 -25.92 11.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.257 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.2 mt-10 -82.39 -3.26 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.12 -32.36 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -63.31 136.51 57.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 111.195 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.46 -53.9 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.562 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -95.6 4.24 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.62 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.31 58.74 10.16 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.8 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -109.72 -1.76 17.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.788 0.294 . . . . 0.0 111.301 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.44 15.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.953 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.586 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.9 p -149.32 139.85 22.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.137 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.59 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -103.95 149.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.082 0.468 . . . . 0.0 111.708 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.38 169.28 8.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.624 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.2 m-85 -53.44 -61.12 5.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.393 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_endo -69.11 -18.44 40.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.486 2.124 . . . . 0.0 112.636 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mm-40 -79.24 -38.85 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.0 t80 -75.26 -34.09 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.622 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.9 tp -73.74 -58.43 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -52.08 -47.81 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.491 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 4.4 mmt -59.55 -28.58 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.43 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.22 13.23 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -110.64 -43.69 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -55.58 -44.26 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.29 65.13 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 31.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -102.31 41.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.79 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -175.45 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.5 p -100.86 -166.72 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 -178.84 7.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.039 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.92 155.96 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.51 -24.97 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.362 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.1 -37.25 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.202 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 55.3 mt-10 -64.9 -28.07 69.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.165 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.2 -39.27 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.287 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -70.83 -49.28 47.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 36.1 mt-10 -61.04 -47.0 88.43 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.795 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.43 -48.85 68.4 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.241 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.14 -38.86 54.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.984 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -30.46 56.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.949 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.044 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.44 -37.07 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 111.026 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.4 m-85 -71.62 -62.95 1.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.8 117.95 23.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -60.66 -52.63 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.47 -9.64 59.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.501 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.7 71.65 0.47 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.879 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.38 14.42 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.57 13.72 61.32 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.673 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.9 m-85 -158.07 116.69 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.76 125.1 70.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.792 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 161.86 13.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.237 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.581 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.91 -46.98 32.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.555 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.31 -58.87 5.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.14 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.88 -36.55 65.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.606 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.2 -50.52 72.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.648 178.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.559 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -56.4 -41.85 77.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -60.12 -39.35 85.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.397 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.21 -55.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.694 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.6 mmt -49.94 -54.07 22.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.39 -24.92 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.12 -31.41 70.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.73 -28.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.03 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.27 43.17 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -150.17 109.82 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -90.21 98.82 12.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.3 mm? -88.37 171.22 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 m -98.29 158.96 15.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -56.76 -48.9 76.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -64.18 -31.66 72.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.64 -54.91 32.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.6 m -65.37 -40.46 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.47 -40.99 98.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.094 0.473 . . . . 0.0 110.283 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 9.8 mt-10 -73.02 -30.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.405 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.0 mtp -71.04 -35.74 72.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 105' ' ' LEU . 5.0 mm -80.35 -54.94 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.623 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 ptm180 -53.89 -31.86 51.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 0.0 110.38 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.96 -21.01 47.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.786 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.97 -5.05 18.43 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 121.114 -0.235 . . . . 0.0 111.445 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.4 t0 -92.38 109.7 21.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.41 0.624 . . . . 0.0 111.325 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.74 -31.18 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.793 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' C ' ' OD1' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.92 -9.12 44.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.554 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.55 58.21 8.51 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.8 p30 -114.25 -4.53 13.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.04 0.42 . . . . 0.0 111.463 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.38 7.83 42.13 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.967 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.11 -174.81 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.766 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.04 126.67 66.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.261 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.3 t30 -105.29 -168.28 1.44 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.628 ' O ' HG13 ' A' ' 142' ' ' VAL . 59.7 t80 -58.51 -73.98 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.52 -45.52 47.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.348 0.594 . . . . 0.0 110.265 -179.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.51 -36.38 69.11 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.108 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.766 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.71 -49.83 11.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.901 0.381 . . . . 0.0 111.92 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.12 -40.49 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.19 -34.45 70.9 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.705 179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.41 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.43 8.6 13.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.647 0.261 . . . . 0.0 111.305 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.574 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -118.51 -37.66 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t -149.34 -52.48 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.396 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -67.86 74.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 31.1 mttp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.923 179.842 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.735 0.303 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.33 149.15 62.84 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.592 2.195 . . . . 0.0 112.287 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mtm-85 -60.29 -51.03 71.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.17 73.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.13 -132.88 2.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.522 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -97.29 103.67 15.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.014 0.435 . . . . 0.0 110.822 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.14 -75.74 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.935 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.48 63.24 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.058 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -59.1 -70.29 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.653 -0.273 . . . . 0.0 110.501 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.08 -34.0 41.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.179 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.8 tpp180 -58.27 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ILE . . . . . 0.621 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.14 -41.81 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.963 178.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.6 t -52.95 -52.62 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.468 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ARG . . . . . 0.863 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.04 -45.78 63.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.331 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 1.044 HD22 HG11 ' A' ' 91' ' ' VAL . 22.7 mt -55.87 -49.26 73.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 110.545 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' VAL . . . . . 1.046 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -63.97 -48.2 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.56 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' GLY . . . . . 0.569 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.76 -29.82 58.86 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.14 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' VAL . . . . . 0.863 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.2 t -76.77 -56.06 9.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.596 0.236 . . . . 0.0 111.63 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.66 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -60.74 -43.56 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ARG . . . . . 0.66 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.05 -33.29 68.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 109.901 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -37.79 88.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.469 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' TRP . . . . . 0.933 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.2 t90 -95.52 -11.37 27.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.153 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -93.29 -31.23 14.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.419 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.32 -71.33 0.74 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.562 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 0.0 OUTLIER -47.27 -80.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.245 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 68.78 -67.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -117.86 40.39 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 14.1 ptt85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 70' ' ' THR . 32.9 p-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.795 0.331 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.437 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -177.54 -179.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.783 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -133.55 165.27 25.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 169.4 13.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.075 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -30.29 57.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.518 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -78.45 -56.88 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.783 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -59.31 -45.32 91.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.481 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 5' ' ' THR . 13.0 tt -65.17 -26.65 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.955 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.68 -44.04 62.96 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.442 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -32.71 72.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.257 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -67.6 -49.7 61.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.328 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -44.74 92.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.254 0.55 . . . . 0.0 110.043 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.42 -47.88 74.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.704 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.4 -41.97 63.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -56.76 -35.12 68.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.043 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -77.86 -14.64 59.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.927 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.66 -38.5 15.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.631 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.26 -65.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.8 t70 -66.01 132.33 48.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -37.89 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.01 -12.15 29.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.51 36.76 79.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.654 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -74.67 -5.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.523 0.201 . . . . 0.0 111.501 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.18 2.29 44.9 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.1 p -149.43 132.53 16.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -108.97 126.56 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.03 167.82 10.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 p -54.01 -30.44 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.48 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -62.79 -50.39 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.204 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.5 mm-40 -77.73 -36.28 51.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.798 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.37 -58.35 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.703 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.25 -27.49 69.27 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.555 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -70.99 -60.99 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.12 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -64.71 -30.76 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.7 ttt -60.22 -55.22 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.77 -25.63 64.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.967 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 t -56.04 -38.37 70.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.92 -62.3 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.65 41.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -142.56 167.8 21.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -134.97 59.66 35.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.71 -169.98 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.588 2.192 . . . . 0.0 112.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 p -116.46 167.57 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.78 -32.05 71.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.8 -45.62 59.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.405 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.0 OUTLIER -64.17 -43.4 95.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.302 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -55.25 -50.58 69.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.09 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -64.56 -57.03 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -51.19 67.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.182 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.519 ' HE2' ' H ' ' B' ' 66' ' ' GLY . 15.7 mtt -57.64 -47.06 83.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -61.58 -45.68 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.159 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -56.36 -26.53 53.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.529 0.68 . . . . 0.0 110.113 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' MET . 6.6 mt-10 -81.53 -2.14 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.351 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.629 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -127.0 -33.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 112.04 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.484 ' N ' HD12 ' A' ' 63' ' ' ILE . 54.1 t0 -72.49 148.5 45.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.251 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.5 -53.57 7.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.54 -8.63 58.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.34 48.55 79.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.931 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -96.6 -0.22 48.95 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.643 0.222 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 15.13 22.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.922 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.4 p -149.88 139.89 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.56 0.18 . . . . 0.0 110.565 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.71 147.34 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.497 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.52 179.08 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.882 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -60.93 -61.69 7.48 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.0 Cg_endo -66.93 -30.94 39.0 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.435 2.09 . . . . 0.0 112.197 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mt-10 -65.74 -40.61 92.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.14 -41.95 57.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -71.17 -53.1 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.482 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.556 ' N ' HD23 ' A' ' 69' ' ' LEU . 90.4 m -51.58 -46.34 63.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.182 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.404 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 tpp -56.65 -48.33 77.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.932 0.396 . . . . 0.0 110.936 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.9 mmt -85.95 0.15 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.559 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.66 -38.89 11.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.93 0.395 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -55.04 -30.48 59.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.746 HG23 HH22 ' B' ' 73' ' ' ARG . 1.4 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.862 0.363 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -151.75 174.44 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -152.17 155.46 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -54.64 -24.29 20.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 -38.68 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 53.5 mt-10 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.026 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.29 -38.88 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -49.35 33.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.7 mt-10 -61.06 -45.49 94.55 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.87 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.47 -53.33 53.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.997 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.636 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.36 -38.88 55.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.833 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -31.46 68.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.25 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.937 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.39 -36.68 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' HG21 ' A' ' 108' ' ' VAL . 5.9 m-85 -71.93 -62.9 1.26 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -85.25 129.93 34.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -75.67 -52.6 10.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.37 -9.6 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.481 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.21 70.44 0.62 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.898 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -93.43 15.32 16.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.3 68.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.2 m-85 -166.35 116.34 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.2 mt -111.66 129.11 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.787 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -104.08 156.5 17.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.197 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.488 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.93 -38.88 17.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.385 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.85 -59.01 6.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.057 0.456 . . . . 0.0 110.864 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -36.87 72.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.689 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.845 HD12 HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.56 -49.31 77.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 110' ' ' THR . 2.0 tpt180 -56.75 -44.49 81.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.205 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -58.76 -37.52 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.17 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 92' ' ' PHE . 38.5 t -68.87 -53.77 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.674 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.528 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.0 mmt -50.35 -54.12 23.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.3 t -67.29 -24.87 65.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.38 -29.99 67.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.61 -28.84 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.75 43.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.96 125.75 18.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -92.31 95.6 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.8 mm? -97.79 150.84 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.813 ' O ' HG22 ' A' ' 121' ' ' VAL . 16.9 m -98.24 159.05 15.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.08 -44.38 87.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -34.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -65.52 -54.87 22.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 117' ' ' THR . 2.7 m -64.66 -38.82 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.038 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.68 -42.04 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.39 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.1 mt-10 -73.03 -30.11 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.444 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 1.5 mmt -71.18 -35.07 71.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 105' ' ' LEU . 2.4 mm -80.35 -54.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.3 ptm180 -54.04 -31.86 52.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.302 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.19 -22.87 57.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.743 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.46 -11.17 18.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -96.35 97.79 9.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.484 0.659 . . . . 0.0 111.214 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.405 HG21 ' OE1' ' A' ' 143' ' ' GLN . 0.8 OUTLIER -57.68 -30.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.461 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 6.6 p30 -95.74 -9.51 31.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.972 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 45.98 62.43 3.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.505 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -113.68 3.2 15.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.584 0.23 . . . . 0.0 111.447 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.34 2.96 47.79 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.09 -177.33 5.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.094 0.447 . . . . 0.0 110.966 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.636 HG12 ' HZ ' ' A' ' 89' ' ' PHE . 82.2 t -130.78 128.58 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.145 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -99.52 -175.07 2.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.736 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.7 t80 -56.82 -72.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.018 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.37 -43.26 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.152 0.501 . . . . 0.0 110.91 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.55 -36.17 71.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.38 -49.67 12.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.134 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.6 m -53.97 -42.41 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.6 pt20 -70.93 -48.6 52.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.231 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.74 -15.76 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.2 mtt -89.83 -42.96 10.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.332 -0.195 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.502 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.519 ' H ' ' HE2' ' A' ' 51' ' ' MET . . . -58.55 -71.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.603 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.57 -50.29 49.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.629 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -58.3 -67.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.606 0.241 . . . . 0.0 110.514 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.99 -35.99 48.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.298 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 19.5 tpp85 -56.38 -49.86 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.615 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.35 -42.19 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.006 178.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.5 t -50.72 -50.31 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.558 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.854 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.82 -45.88 63.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.937 HD22 HG11 ' A' ' 91' ' ' VAL . 19.5 mt -55.87 -50.61 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.3 p -63.02 -47.8 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 110.414 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.95 -29.6 59.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.165 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.855 HG11 ' CB ' ' A' ' 88' ' ' ALA . 92.5 t -76.76 -56.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.629 0.252 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.644 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -59.9 -43.69 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.644 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.9 mmm180 -57.81 -35.09 70.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.236 0.541 . . . . 0.0 109.673 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.86 -35.77 81.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.109 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.763 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.4 t90 -95.19 -9.97 31.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.774 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.77 -36.94 50.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.281 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.018 -179.551 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.0 p30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.823 0.344 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.633 ' CG ' HD21 ' A' ' 69' ' ' LEU . 2.5 tt0 -177.39 -175.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -137.04 165.17 26.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.594 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.6 t -69.78 171.4 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.97 -35.81 64.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.444 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -74.27 -56.88 4.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.707 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -58.38 -41.26 84.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.699 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 5' ' ' THR . 7.5 tt -71.4 -26.38 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.029 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.39 -43.22 61.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.514 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.34 -33.44 73.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -65.96 -49.65 67.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.467 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.56 -44.82 89.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.202 0.525 . . . . 0.0 110.215 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.03 -48.86 72.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.703 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.897 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.34 -41.45 63.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.497 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -57.51 -31.73 66.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.957 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -79.7 -15.08 58.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.64 -38.79 15.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.591 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.04 -65.84 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.35 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -66.57 132.69 48.74 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 110.702 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -37.3 74.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.92 -12.28 29.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.49 37.08 80.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.64 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -75.21 -4.2 37.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.505 0.193 . . . . 0.0 111.473 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 -0.23 44.01 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.059 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.3 p -149.54 132.59 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.803 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mp -107.54 128.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.7 t -103.28 165.13 11.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 p -52.78 -26.65 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.688 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -67.53 -50.5 58.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 15.3 mm-40 -77.46 -35.41 53.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.752 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.012 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.27 -58.36 7.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.773 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -61.0 -27.3 66.89 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.919 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -69.89 -56.52 6.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 111.52 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.7 p -67.81 -33.78 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.484 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.455 ' HE2' ' HA3' ' B' ' 67' ' ' GLY . 0.0 OUTLIER -59.05 -53.1 62.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.713 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.9 -25.77 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.984 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -60.41 -36.71 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.7 mt -58.31 -30.65 66.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.23 42.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.524 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -142.6 161.59 37.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.23 62.75 8.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.73 -174.13 1.21 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.571 2.181 . . . . 0.0 112.355 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -122.12 167.29 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.79 -32.26 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.183 0.516 . . . . 0.0 110.084 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.487 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -41.92 95.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.394 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -56.34 -50.79 70.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -65.46 -50.03 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.54 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.08 71.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.6 -49.89 75.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.698 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -58.88 -42.32 85.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.261 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -59.18 -26.34 64.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.56 0.695 . . . . 0.0 110.06 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -83.79 -2.16 55.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.86 -33.06 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.3 t0 -71.15 148.02 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.85 -53.45 6.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.646 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.36 -8.76 58.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.49 48.75 78.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -96.96 -1.42 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 111.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.24 22.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.86 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.81 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' ILE . 3.3 mm -95.33 147.21 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.473 . . . . 0.0 111.663 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.49 176.92 5.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.929 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 3.3 m-85 -60.21 -61.62 7.56 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 33.4 Cg_endo -64.48 -30.94 61.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.411 2.074 . . . . 0.0 111.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 1.9 mt-10 -69.03 -37.09 78.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.336 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.3 t80 -75.12 -39.97 60.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.633 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.6 tp -76.79 -54.57 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.604 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.1 m -51.58 -44.02 62.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.613 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -54.17 47.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.864 0.364 . . . . 0.0 111.011 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.47 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 22.9 mtt -80.31 -8.06 59.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.604 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -87.82 -42.68 12.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.842 0.353 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -59.5 -29.88 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.921 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.03 163.29 37.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 157.55 43.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -57.44 -27.78 62.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.2 -34.43 61.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.2 mt-10 -61.48 -33.84 74.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.811 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.41 -39.02 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.298 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -49.32 33.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.5 mm-40 -60.9 -44.94 96.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.66 -52.87 58.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.883 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.608 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.28 -38.85 55.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.865 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -71.49 -31.44 67.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.43 -36.68 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.656 ' CE2' HG22 ' B' ' 78' ' ' ILE . 7.8 m-85 -73.51 -62.81 1.35 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.934 0.397 . . . . 0.0 110.394 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -84.81 118.14 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -64.8 -52.64 55.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.27 -9.63 59.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.541 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.81 70.97 0.56 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.21 15.14 16.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.45 66.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.617 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.9 m-85 -165.67 116.36 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.576 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.7 mt -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -104.04 156.39 17.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.929 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.478 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.97 -36.63 12.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.446 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -59.06 5.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.105 0.479 . . . . 0.0 110.978 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.4 mm-40 -58.75 -38.92 79.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.799 HD12 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.17 -48.36 82.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.842 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 110' ' ' THR . 5.0 tpt85 -56.91 -45.53 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.14 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.9 -36.63 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.148 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 92' ' ' PHE . 52.6 t -67.43 -54.44 23.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.66 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.703 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.1 mmt -50.36 -54.01 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.6 t -67.63 -25.57 65.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.606 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.5 -31.23 71.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.82 -28.79 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.035 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.18 42.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.552 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.576 ' OE2' HD21 ' A' ' 116' ' ' LEU . 6.2 tt0 -146.72 110.68 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -88.0 86.01 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -80.13 175.64 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' VAL . 3.6 m -98.41 158.68 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.706 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.95 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.111 0.481 . . . . 0.0 110.209 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -71.76 -32.98 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.196 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.18 -52.98 56.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.54 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 117' ' ' THR . 2.9 m -66.95 -39.18 82.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.48 -45.15 88.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.046 0.45 . . . . 0.0 110.373 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 24.3 mt-10 -72.97 -30.16 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.622 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -34.46 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.755 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.799 HD11 HD12 ' A' ' 105' ' ' LEU . 2.0 mm -80.27 -54.73 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.463 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.2 ptm180 -53.91 -31.88 51.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 110.284 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.33 -23.48 57.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.688 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.03 -4.99 25.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.442 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -101.45 96.45 7.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.469 0.652 . . . . 0.0 111.273 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -30.84 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.611 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 5.0 p30 -95.82 -9.37 31.75 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 46.7 62.66 3.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.6 p30 -113.7 1.99 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.568 0.223 . . . . 0.0 111.434 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.28 4.57 47.09 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -149.98 -177.59 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 0.0 111.064 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.692 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.4 t -130.78 128.69 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.2 t30 -101.13 -174.03 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 142' ' ' VAL . 24.4 t80 -57.06 -73.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.514 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.38 -42.73 42.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.43 -37.24 72.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.326 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.692 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -79.43 -49.74 11.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.189 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.811 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.5 m -53.68 -42.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 144' ' ' MET . 12.3 pt20 -70.94 -48.18 54.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.267 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.457 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.66 -15.56 52.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.473 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.589 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.6 mtt -90.59 -42.62 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.751 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 C--N 1.33 -0.244 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.422 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.544 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.873 0.368 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.67 -70.46 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 36' ' ' MET . . . -57.9 -46.86 91.94 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.606 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.75 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.2 OUTLIER -52.23 -64.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.295 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.03 -31.57 61.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 0.0 110.005 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -54.0 -53.57 51.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.75 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -38.62 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.0 t -50.85 -43.11 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.351 0.596 . . . . 0.0 110.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.516 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.67 -48.16 27.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.121 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.749 HD22 HG11 ' A' ' 91' ' ' VAL . 62.6 mt -55.75 -46.77 77.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.897 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -66.28 -46.72 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.593 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -58.16 -30.7 64.4 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.156 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 88' ' ' ALA . 69.0 t -76.77 -55.05 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.645 0.26 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.656 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -61.39 -43.03 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.501 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.635 ' N ' HD12 ' B' ' 78' ' ' ILE . 9.8 mmp_? -56.58 -37.4 70.56 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.381 0.61 . . . . 0.0 109.518 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -35.74 79.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.374 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.769 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.1 t90 -95.03 -9.92 32.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.685 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.53 -36.55 52.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.385 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.613 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -176.98 -178.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.553 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -131.68 165.32 23.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.87 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.7 t -70.6 177.05 3.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.103 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -59.0 -37.99 78.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.264 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -73.48 -56.82 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.942 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.591 ' H ' HG23 ' A' ' 5' ' ' THR . 2.3 tt0 -57.71 -40.72 80.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.1 tt -72.28 -26.57 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.981 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.64 -43.74 62.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.525 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.11 -33.05 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.15 -49.69 63.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.229 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -59.69 -44.93 93.44 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.218 0.532 . . . . 0.0 109.906 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -63.68 -48.21 78.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.409 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.83 63.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.285 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.56 -38.61 69.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -74.0 -15.66 61.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -87.07 -38.3 16.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.36 -65.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.276 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -66.1 134.02 51.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -37.91 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.256 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.24 -12.14 28.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.824 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.57 79.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.724 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.58 -5.51 43.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.523 0.201 . . . . 0.0 111.45 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 3.72 44.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.044 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -149.45 132.59 16.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.874 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -110.64 126.93 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.3 t -100.42 168.27 9.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -54.32 -30.34 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.44 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -64.12 -50.41 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.185 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HG12 ' A' ' 35' ' ' VAL . 22.3 mm-40 -76.79 -35.29 57.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.477 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.017 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.41 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.805 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -64.08 -27.46 71.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.803 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.5 m -66.89 -60.24 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.194 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -70.03 -30.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.1 ttt -62.02 -47.2 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.66 -25.72 44.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.998 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -57.7 -36.33 71.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.15 -61.52 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -142.63 161.89 36.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -130.05 60.06 49.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.0 -170.07 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.8 p -117.52 167.45 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.78 -32.11 71.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.69 59.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.338 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -44.85 92.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.262 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.9 mt -53.57 -50.59 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.86 -53.04 52.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -56.85 -51.13 70.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.06 -48.31 82.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.679 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.017 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.52 -43.65 91.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.79 -26.38 64.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.559 0.695 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -82.83 -2.24 54.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.663 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.78 -33.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.0 t0 -70.2 153.92 42.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.17 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.68 -53.5 6.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.855 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.58 -8.54 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.56 52.02 55.6 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.859 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.43 0.11 44.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.577 0.227 . . . . 0.0 111.45 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.39 24.38 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.8 p -149.98 139.9 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.542 0.21 . . . . 0.0 110.633 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.66 149.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.039 0.447 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 178.26 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.722 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.6 m-85 -60.79 -61.59 7.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.521 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.5 Cg_endo -67.22 -32.68 32.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.48 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -65.04 -38.76 91.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.6 t80 -75.35 -41.17 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.438 . . . . 0.0 110.036 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.613 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.3 tp -68.4 -56.28 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.4 m -51.72 -46.11 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.514 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.0 tpp -55.89 -49.6 72.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 111.087 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.0 mmt -81.14 -13.39 58.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -86.24 -35.17 20.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 110.978 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -38.65 90.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.28 159.5 35.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -150.25 154.0 37.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -55.17 -26.64 40.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.6 -34.05 67.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.2 mt-10 -66.77 -32.39 73.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.823 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.25 -38.92 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.2 -49.41 43.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.388 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.878 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.4 mm-40 -61.5 -45.84 92.52 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.766 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.65 -49.32 68.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.978 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.1 -38.42 51.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.97 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -30.47 57.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.822 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.14 -37.05 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.6 m-85 -73.74 -62.95 1.32 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.855 0.36 . . . . 0.0 110.483 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -84.42 128.48 34.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.787 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -73.17 -52.63 13.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.254 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -78.57 -9.62 59.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.528 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.72 70.61 0.57 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.956 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -93.67 14.87 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 111.219 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.73 68.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.6 m-85 -162.99 116.94 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.77 126.67 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.499 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -103.96 156.94 17.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.133 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.62 -41.54 22.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.334 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -58.91 6.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.056 0.455 . . . . 0.0 110.863 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.71 -38.46 69.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.754 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.886 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.71 -50.76 72.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.834 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.518 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -44.15 77.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.06 -37.51 74.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.333 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.78 -53.88 22.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.74 -54.11 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.6 t -66.45 -25.42 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.4 -29.87 68.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.41 -28.76 13.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.22 43.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.536 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -149.66 114.15 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.06 103.08 15.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.32 163.6 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.768 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.835 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.1 m -98.28 158.82 15.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.5 -42.34 91.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.81 -35.42 74.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.32 -54.83 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -64.06 -39.9 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.85 -41.69 98.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.2 mt-10 -72.57 -30.1 64.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.356 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.437 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 53.9 ttm -70.85 -34.88 72.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.678 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.886 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.38 -54.93 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.659 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm85 -54.26 -31.78 54.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.41 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -76.13 -22.02 55.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.897 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.72 15.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.576 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -83.88 90.82 7.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.472 0.654 . . . . 0.0 111.06 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.736 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -64.1 -30.74 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.411 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.601 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.74 -9.46 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.17 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.3 54.49 19.67 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.9 p30 -113.86 -5.33 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.206 0.503 . . . . 0.0 111.371 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.5 6.49 44.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.185 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.38 -174.89 4.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.895 0.348 . . . . 0.0 110.566 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.3 t -128.94 123.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.409 . . . . 0.0 111.326 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.544 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.2 -164.73 1.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.855 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.575 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 t80 -63.12 -73.9 0.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.6 -44.27 47.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.346 0.593 . . . . 0.0 110.302 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.736 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.43 -36.06 68.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.007 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.77 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -48.66 13.56 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.906 0.384 . . . . 0.0 111.496 -179.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.823 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -57.85 -41.2 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.363 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.34 -35.3 71.13 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.578 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.41 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -81.66 6.31 15.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.337 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.58 ' SD ' HG13 ' B' ' 77' ' ' VAL . 2.9 mtt -115.75 -31.97 5.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.287 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.604 0.24 . . . . 0.0 111.628 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.827 0.346 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.06 -67.94 1.95 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.851 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.31 70.1 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.598 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.69 -66.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.493 0.187 . . . . 0.0 111.004 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.41 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.74 -36.78 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.507 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.5 tpt180 -55.88 -50.27 71.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.12 -41.75 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.138 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.8 t -50.45 -52.4 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.581 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.828 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.1 mpt_? -70.69 -44.38 67.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.423 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 91' ' ' VAL . 15.2 mt -56.03 -51.34 68.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -63.66 -48.09 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.87 59.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.042 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.828 HG23 ' O ' ' B' ' 73' ' ' ARG . 78.6 t -76.84 -54.6 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.625 0.25 . . . . 0.0 111.398 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.655 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.9 -44.09 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.655 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.23 -35.37 71.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.224 0.535 . . . . 0.0 109.793 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.66 -36.99 80.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.194 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.834 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.9 t90 -95.28 -11.14 28.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.798 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.368 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.112 -179.542 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.885 0.374 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.617 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.2 tt0 -173.82 -178.59 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.3 165.37 24.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.5 t -70.21 176.85 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.138 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -59.06 -38.01 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.322 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -73.51 -56.79 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.996 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 5' ' ' THR . 2.0 tt0 -57.65 -40.75 80.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.4 tt -72.27 -26.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.62 -43.86 62.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.516 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -67.79 -33.48 74.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.205 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.02 -49.61 64.74 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.239 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.74 -44.86 93.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 109.887 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.1 -49.06 75.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.41 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.35 -41.43 63.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.83 -38.0 69.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -75.05 -15.47 60.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.33 -37.7 16.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 110.31 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.92 -65.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.249 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.01 133.42 50.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.66 77.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.36 -12.2 28.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.55 36.69 79.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.694 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -74.8 -5.26 42.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.406 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.18 44.81 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.069 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -149.48 132.62 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.876 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.68 126.63 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.269 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.0 t -99.5 167.3 10.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.3 p -53.5 -32.14 49.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -62.67 -50.51 70.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.336 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.3 mm-40 -75.82 -36.37 59.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.731 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.0 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.38 -58.23 8.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.699 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.41 -30.88 77.6 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.665 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.6 m -63.84 -60.95 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.361 . . . . 0.0 111.086 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.2 p -65.68 -30.55 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.5 mtp -59.68 -52.14 66.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.626 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.35 -25.66 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -55.85 -38.97 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 mt -58.06 -63.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.14 40.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -141.09 168.37 19.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.05 59.48 34.1 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.43 -169.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.277 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.9 p -118.1 167.47 11.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.82 -32.07 71.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.191 0.519 . . . . 0.0 110.064 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.76 -45.74 59.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -44.55 93.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.279 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -54.03 -50.54 66.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.234 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -64.86 -52.7 55.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.534 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.17 -51.03 70.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.275 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.21 -48.38 81.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.0 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.35 -43.61 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.112 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.71 -26.34 63.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.532 0.682 . . . . 0.0 109.991 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 51' ' ' MET . 5.9 mt-10 -82.61 -2.26 53.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.591 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.628 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.6 -33.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.4 t0 -70.95 152.83 43.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.03 -53.46 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.861 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.09 -8.67 53.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.4 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.37 51.64 57.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.909 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.28 0.24 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.581 0.229 . . . . 0.0 111.402 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.51 24.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.866 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -150.0 139.88 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.536 0.208 . . . . 0.0 110.644 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.5 149.34 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 111.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.26 178.2 4.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.762 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -61.17 -61.59 7.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.5 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.8 Cg_endo -67.1 -31.22 37.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.481 2.12 . . . . 0.0 112.468 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -66.58 -38.78 87.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.977 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.8 t80 -75.27 -41.01 58.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 110.038 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.9 tp -68.81 -56.23 8.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.485 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 m -51.65 -44.57 63.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.525 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tpp -57.21 -49.92 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 mmt -79.21 -18.23 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.43 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.87 -32.75 27.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -45.16 89.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.773 0.32 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -127.43 177.8 6.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.981 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -161.29 154.15 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.84 -26.95 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.59 -37.1 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.3 mt-10 -61.7 -30.38 70.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.31 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.252 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -49.36 41.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.425 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.872 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.8 mm-40 -61.45 -45.83 92.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.412 0.625 . . . . 0.0 109.445 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -49.43 67.79 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.956 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.98 -38.68 52.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.018 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.16 -30.48 58.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.31 -37.12 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.594 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -72.55 -63.01 1.24 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.864 0.364 . . . . 0.0 110.465 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.07 113.71 20.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.11 -52.56 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 -9.6 59.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.3 71.79 0.47 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.83 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -94.85 13.46 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 111.213 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.08 68.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -162.65 116.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -113.5 123.22 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 111.531 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -104.2 161.4 14.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.979 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.588 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.71 -43.92 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.189 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -58.81 6.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.068 0.461 . . . . 0.0 110.908 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 32.2 mm-40 -55.11 -37.59 67.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.733 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.66 -50.88 71.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.835 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 110' ' ' THR . 8.2 tpt85 -56.02 -42.8 77.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -59.09 -37.88 78.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 66.8 t -68.92 -54.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.536 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.8 mmt -49.08 -54.03 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.1 t -67.21 -25.2 66.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.493 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.33 -30.26 69.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.731 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.38 -28.8 14.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.7 43.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.98 117.05 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -89.92 107.01 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.1 mm? -99.41 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.827 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.6 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.93 -41.16 91.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.686 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.535 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.4 -54.93 25.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 117' ' ' THR . 2.1 m -62.89 -41.24 91.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.19 -39.48 90.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 110.191 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 11.2 mt-10 -73.1 -30.22 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.329 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.21 -35.4 71.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.28 -54.89 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.5 ptm180 -53.74 -31.73 49.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 0.0 110.389 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.92 -21.18 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.965 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.94 -9.12 16.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.417 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.5 t0 -87.37 110.22 20.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.418 0.627 . . . . 0.0 111.203 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.725 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.86 -31.18 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.781 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.1 -9.12 43.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.614 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.08 57.69 9.69 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 114.57 0.588 . . . . 0.0 114.57 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.9 p30 -114.27 -4.27 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.053 0.427 . . . . 0.0 111.505 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.7 42.17 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.968 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.94 4.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 110.552 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 141' ' ' PHE . 52.2 t -128.31 125.42 64.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.935 0.397 . . . . 0.0 111.156 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.7 t-20 -105.31 -166.32 1.21 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.2 t80 -59.09 -73.9 0.08 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.57 -45.04 47.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.351 0.595 . . . . 0.0 110.33 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.725 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -57.22 -36.65 71.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.176 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -49.08 12.85 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 111.877 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.83 -38.88 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.21 -34.25 70.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.743 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -86.37 12.45 10.1 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 111.165 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.586 ' SD ' HG23 ' A' ' 85' ' ' ILE . 2.3 mtt -121.24 -38.98 2.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.984 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.315 -179.837 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.783 0.325 . . . . 0.0 110.921 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -66.58 2.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.71 -49.37 77.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.84 -67.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.546 0.212 . . . . 0.0 110.89 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.439 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 1.0 OUTLIER -51.7 -37.02 48.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.522 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.3 tpp85 -55.9 -51.0 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.596 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.06 -41.61 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.563 HG12 ' NH1' ' B' ' 73' ' ' ARG . 95.6 t -50.46 -53.4 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.623 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.52 -43.71 69.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 91' ' ' VAL . 16.3 mt -56.22 -53.21 59.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 110.573 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.948 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.6 -46.52 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.719 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.38 -28.32 67.02 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.245 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 73' ' ' ARG . 77.7 t -75.92 -53.27 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.653 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -66.35 -40.99 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.2 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.1 mmp_? -57.19 -37.59 72.38 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.363 0.601 . . . . 0.0 109.551 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.53 79.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.919 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.12 -9.86 32.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.814 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.65 -36.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.287 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.025 -179.553 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.737 ' CG ' HG23 ' A' ' 70' ' ' THR . 3.2 p30 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.807 0.337 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -177.85 -179.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.703 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -135.85 165.32 25.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.09 176.42 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.142 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -37.89 76.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.369 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -73.12 -56.84 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.703 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -58.26 -42.23 85.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.713 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 5' ' ' THR . 12.2 tt -70.43 -26.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -44.12 63.32 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.498 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.13 -32.83 71.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -66.88 -49.76 64.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -44.87 90.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.244 0.545 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -65.48 -47.48 75.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.947 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -42.15 63.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -57.21 -34.5 68.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.119 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mt -87.24 -38.3 16.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.949 0.404 . . . . 0.0 110.245 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.97 -65.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.9 t70 -66.39 132.35 48.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.808 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -38.11 80.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.22 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.89 -12.25 29.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 36.84 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.686 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -74.73 -5.16 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.421 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 2.44 44.73 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 p -149.47 132.62 16.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.21 127.05 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 62' ' ' THR . 4.5 t -100.62 167.59 10.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 p -54.4 -28.75 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -64.53 -50.47 67.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -77.15 -36.21 55.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.35 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.572 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.54 70.57 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.732 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -67.04 -53.28 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 19' ' ' PHE . 14.4 p -72.45 -31.57 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.351 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -45.13 93.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.669 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -29.47 45.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.1 t -61.82 -35.11 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.05 -31.09 66.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.57 42.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -141.55 172.56 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.08 59.96 41.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.43 -170.23 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.591 2.194 . . . . 0.0 112.253 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -122.12 165.04 16.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.75 -31.15 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 0.0 110.141 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.67 60.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -45.25 88.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.7 mt -53.28 -50.64 64.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -64.98 -53.88 39.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.606 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.33 -51.14 69.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.303 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.28 -47.72 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.669 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -59.74 -44.32 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.89 -26.37 62.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.529 0.681 . . . . 0.0 109.978 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.65 -2.2 53.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.634 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.62 -33.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 112.043 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.477 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.8 t0 -72.07 148.27 45.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.267 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.36 -53.54 7.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.684 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.67 -8.66 58.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.326 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.3 48.69 78.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.967 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -96.81 -0.19 48.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.589 0.233 . . . . 0.0 111.535 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.476 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.08 22.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.895 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.92 139.88 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.559 0.218 . . . . 0.0 110.486 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.94 147.44 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.08 0.467 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.15 178.33 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.786 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -60.28 -61.7 7.41 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.452 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -67.11 -31.51 36.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.219 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 mt-10 -64.7 -39.84 94.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.17 -45.03 43.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 110.29 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -67.92 -52.6 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.279 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 2' ' ' ASP . 76.6 m -51.6 -49.58 61.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpp -54.53 -49.5 70.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.0 2.04 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.569 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.57 -42.13 9.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.899 0.38 . . . . 0.0 110.999 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -53.69 -33.27 54.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.158 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -141.52 163.62 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 152.22 32.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -26.77 19.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.157 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.66 -35.7 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.3 mt-10 -64.33 -30.97 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.813 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.34 -37.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.119 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -49.46 35.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.519 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.9 mm-40 -61.88 -46.01 91.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.359 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.827 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.62 -48.64 69.13 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.839 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.86 -43.08 59.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.031 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -70.8 -31.59 68.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.701 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.3 m -75.54 -37.15 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 111.064 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.5 m-85 -76.6 -62.93 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.871 0.367 . . . . 0.0 110.509 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -83.44 121.9 27.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.782 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -71.24 -52.63 17.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.45 -9.58 59.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.5 68.65 0.86 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.936 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -94.41 15.84 16.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.641 0.257 . . . . 0.0 111.272 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.5 69.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.633 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.5 m-85 -162.47 116.97 1.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.585 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -110.63 123.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.979 0.419 . . . . 0.0 111.278 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -103.96 157.05 17.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.248 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -41.45 22.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.79 6.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.6 mm-40 -55.1 -39.31 69.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.677 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.18 -50.9 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.922 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.704 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.55 -42.81 79.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.286 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -36.42 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.404 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.1 t -72.73 -54.79 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.518 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.3 mmt -49.11 -54.02 18.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.645 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' ARG . 10.9 t -66.9 -25.18 66.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.96 -29.97 68.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.63 -28.78 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.68 43.75 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -149.88 112.95 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -90.85 102.23 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -94.47 164.48 12.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.794 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.847 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.6 m -98.32 158.81 15.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -59.32 -42.17 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.31 -54.87 22.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.756 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 117' ' ' THR . 2.2 m -63.52 -40.66 89.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.65 -41.03 96.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.433 . . . . 0.0 110.275 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 26.8 mt-10 -72.63 -30.12 64.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.373 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -33.94 69.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.611 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.29 -55.08 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.657 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 8.8 ptm180 -54.59 -31.82 57.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 110.405 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.35 -21.93 55.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.796 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.72 -15.41 15.76 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.606 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -82.44 90.52 6.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.74 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.74 -30.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.429 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.602 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.0 -9.48 57.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.164 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.88 23.83 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 114.81 0.684 . . . . 0.0 114.81 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.423 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 32.2 p30 -113.79 -5.55 13.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.227 0.513 . . . . 0.0 111.303 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 6.66 44.39 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.213 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.58 -174.82 4.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.834 0.35 . . . . 0.0 110.661 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.4 t -127.33 120.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -98.71 -169.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.608 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.5 t80 -60.12 -73.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.536 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.66 -43.59 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.286 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.74 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -56.26 -34.72 66.66 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.45 -48.7 13.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 111.22 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.813 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.71 -40.41 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.321 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -71.19 -36.04 71.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.615 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.475 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.1 4.92 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.556 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.1 mtt -112.04 -31.62 6.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.028 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.464 -179.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.791 0.329 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.15 -68.23 1.76 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.58 -52.72 46.79 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.37 -62.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.509 0.195 . . . . 0.0 110.871 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.81 -35.2 43.38 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.39 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.563 ' HE ' HD11 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -56.6 -53.27 59.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.69 -42.28 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.238 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.1 t -50.43 -52.86 14.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -69.92 -45.57 67.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.543 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.78 HD22 HG11 ' A' ' 91' ' ' VAL . 40.7 mt -55.79 -52.61 63.38 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.656 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.947 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.84 -47.62 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.575 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.89 59.38 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.205 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.82 HG11 ' CB ' ' A' ' 88' ' ' ALA . 79.8 t -76.78 -56.15 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.689 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.42 -43.75 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.662 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.03 -34.64 70.28 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.22 0.533 . . . . 0.0 109.783 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.19 -37.25 82.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.293 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.906 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.7 t90 -95.25 -11.1 28.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.744 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.29 -36.21 58.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.523 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 70' ' ' THR . 6.5 p-10 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.821 0.343 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.6 tt0 -177.02 -178.92 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.735 HD22 ' NE2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -134.81 165.11 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.861 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.2 t -71.37 177.28 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.132 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.36 -38.98 78.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 tt0 -71.9 -56.77 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.044 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.735 ' NE2' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -58.63 -43.36 89.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.738 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 5' ' ' THR . 7.0 tt -69.04 -26.44 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.062 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.42 -43.37 61.97 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -68.22 -33.47 74.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.63 -49.74 65.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.17 -44.85 92.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.264 0.554 . . . . 0.0 110.047 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -64.45 -48.5 75.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.576 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -41.7 63.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.316 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -38.28 71.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.05 -15.67 61.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.62 -38.6 16.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.199 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.38 -65.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.2 t70 -65.44 132.64 49.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.707 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -37.14 75.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.3 -12.27 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.19 36.96 77.7 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.636 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 1.72 44.64 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.048 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.0 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.678 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.844 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mt -108.18 121.53 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.5 t -97.88 167.5 10.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.0 p -54.34 -35.53 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -56.77 -50.43 72.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.158 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.83 -37.91 47.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 110.768 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.55 -43.31 71.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.909 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.4 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.36 -27.5 72.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.202 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -72.34 -49.75 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.2 p -72.32 -33.54 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.0 mtp -60.41 -45.71 92.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.958 0.409 . . . . 0.0 110.677 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -25.92 44.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -58.05 -37.11 73.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.51 -30.75 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.79 41.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -142.61 163.22 33.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.51 61.84 12.08 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.73 -170.93 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.567 2.178 . . . . 0.0 112.277 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -122.11 167.01 13.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.82 -31.98 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.67 59.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.341 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -43.33 94.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.208 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.3 mt -55.15 -50.67 68.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -52.31 58.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.432 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.67 -51.15 70.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.249 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.69 -47.76 83.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.754 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.98 -45.11 99.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.27 -26.48 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.599 0.714 . . . . 0.0 110.143 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.8 mt-10 -82.75 -2.06 53.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.496 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.64 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.61 -33.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.505 ' N ' HD12 ' A' ' 63' ' ' ILE . 52.9 t0 -72.25 148.57 45.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.317 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.37 -53.57 6.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.15 -8.66 58.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.3 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.55 48.42 81.26 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.968 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -97.31 -0.88 45.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.543 0.211 . . . . 0.0 111.421 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.485 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.33 15.51 21.12 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.939 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 28' ' ' THR . 2.8 p -149.73 139.79 22.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.12 149.39 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.301 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.26 175.92 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -58.65 -61.64 7.28 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.157 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.2 Cg_endo -63.98 -33.83 61.48 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.374 2.049 . . . . 0.0 111.756 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -68.71 -36.46 78.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.391 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -75.33 -40.15 58.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.349 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD21 ' CG ' ' A' ' 3' ' ' GLN . 4.6 tp -76.78 -53.08 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.586 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 2' ' ' ASP . 98.7 m -51.46 -49.98 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.487 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 2.1 tpp -53.47 -48.05 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.9 mmt -88.64 10.44 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.52 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -105.21 -36.39 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -57.13 -40.12 76.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.814 0.34 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.24 167.58 22.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -153.69 152.52 30.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.777 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -25.49 23.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -74.58 -38.13 62.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 47.3 mt-10 -60.23 -31.27 70.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.814 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.34 -39.38 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.291 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -70.93 -49.35 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.338 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.2 mt-10 -61.05 -46.19 91.68 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.61 -49.44 67.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.149 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.03 -38.55 52.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.917 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -76.65 -30.53 56.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.866 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.23 -36.94 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 110.898 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -72.41 -62.91 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.5 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.62 119.35 24.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -62.34 -52.61 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.52 -9.65 59.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.461 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.63 0.47 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.08 14.44 17.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.663 0.268 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.76 66.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.4 m-85 -161.55 116.68 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.512 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.7 mt -113.92 124.66 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.47 . . . . 0.0 111.656 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.8 t -104.28 161.15 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.89 -43.94 29.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.268 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.07 -58.93 6.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.931 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.36 -37.61 67.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.671 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.36 -50.86 71.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.844 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -43.61 76.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.117 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -58.1 -38.88 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.382 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.25 -54.92 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.617 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.4 mmt -49.41 -54.06 19.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.869 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.5 t -67.7 -25.17 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.581 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -68.53 -30.36 69.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.26 -28.73 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.013 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.41 43.46 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.584 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -152.79 110.77 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -83.73 115.8 22.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -105.81 163.31 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.792 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.6 m -98.27 158.76 15.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.59 -40.81 93.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.92 -35.56 74.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.568 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.96 -54.88 23.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.709 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -63.38 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.71 -40.06 93.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.11 0.481 . . . . 0.0 110.171 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 14.2 mt-10 -72.9 -30.15 63.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.289 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.459 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 46.1 ttm -71.01 -35.79 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.879 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 105' ' ' LEU . 4.2 mm -80.4 -54.91 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.579 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -53.44 -31.79 46.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.996 0.427 . . . . 0.0 110.46 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.96 -21.58 50.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.942 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.95 -8.56 17.55 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ILE . 35.9 t0 -88.54 110.27 20.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.645 . . . . 0.0 111.312 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.724 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.22 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.765 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.86 -9.09 44.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.562 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.9 57.94 9.18 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.4 p30 -114.23 -4.19 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.033 0.416 . . . . 0.0 111.505 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 7.59 42.45 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.13 -174.96 4.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 110.458 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.14 126.62 66.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.94 -167.54 1.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.638 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.1 t80 -58.52 -73.94 0.07 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.516 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.47 -45.74 47.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.617 . . . . 0.0 110.32 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.724 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.44 -36.4 68.95 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.62 -49.59 11.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.965 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.814 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.28 -40.53 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -34.28 70.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.713 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.02 8.9 13.82 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.649 0.261 . . . . 0.0 111.328 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.0 mtt -118.18 -38.9 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.767 0.317 . . . . 0.0 111.034 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.9 mpp_? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.775 0.321 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.68 -68.39 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.49 -49.75 75.17 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.64 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.64 -66.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.477 0.179 . . . . 0.0 110.87 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.437 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -51.79 -38.96 57.74 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.329 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.432 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -54.58 -49.52 70.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.58 -41.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.18 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.46 -53.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.556 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.869 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -68.9 -46.46 68.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.42 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.95 HD22 HG11 ' A' ' 91' ' ' VAL . 20.6 mt -55.72 -53.57 54.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.736 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -60.32 -47.2 93.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.434 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.565 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.33 -30.3 61.28 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.112 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.869 HG23 ' O ' ' B' ' 73' ' ' ARG . 93.6 t -75.26 -55.39 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.606 0.241 . . . . 0.0 111.446 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.06 -43.98 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.3 mmm180 -58.2 -35.3 71.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 109.728 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -61.14 -37.12 81.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.252 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.884 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.4 t90 -95.32 -10.09 31.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.854 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.62 -36.1 57.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.297 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.112 -179.583 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.0 p-10 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.927 0.394 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.496 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 1.4 tt0 -176.93 169.63 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.737 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -127.69 165.25 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 110.839 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 177.33 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.96 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.8 -37.12 78.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.85 -56.94 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.116 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.737 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -57.99 -41.48 83.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.423 . . . . 0.0 110.758 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' THR . 6.8 tt -71.93 -26.44 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.092 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.49 -43.4 62.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.478 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.35 -33.11 72.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.14 -49.67 66.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.436 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -45.0 90.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 110.168 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -64.88 -48.44 74.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.37 -41.64 63.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.447 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -33.98 65.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.022 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.7 mt -87.72 -39.08 15.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.927 0.394 . . . . 0.0 110.045 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.631 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.36 -65.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.374 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -66.43 132.47 48.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.874 0.368 . . . . 0.0 110.705 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -37.25 74.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.02 -12.16 29.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.39 36.93 79.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.632 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -74.89 -4.45 38.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.446 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.01 44.09 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.125 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -149.46 132.53 16.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.876 0.338 . . . . 0.0 110.899 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -106.22 127.27 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.6 t -101.97 167.7 9.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.8 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -54.26 -31.51 53.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -62.67 -50.43 71.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.338 . . . . 0.0 111.222 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' O ' HG12 ' A' ' 35' ' ' VAL . 15.6 mm-40 -77.15 -35.8 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.34 -58.17 8.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.752 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.44 68.8 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.685 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.8 m -70.18 -54.21 13.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -74.49 -31.1 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.1 ttt -61.02 -44.78 96.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -25.68 44.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.941 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -56.75 -36.43 69.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.99 -31.47 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -142.61 160.88 39.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.4 62.22 22.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.88 -170.11 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -121.34 167.23 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.76 -32.14 71.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.132 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.6 60.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.384 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -43.3 94.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.1 mt -55.27 -50.75 68.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -64.72 -52.32 57.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.42 -51.12 70.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.263 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.88 -48.08 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.73 -44.37 97.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.279 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -57.07 -26.45 60.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.556 0.693 . . . . 0.0 110.033 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.92 -2.06 53.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.71 -32.99 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.5 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.9 t0 -72.22 149.28 44.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.343 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.06 -53.55 6.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.49 -8.72 58.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.59 48.91 77.96 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.93 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -97.5 -0.77 45.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.627 0.251 . . . . 0.0 111.496 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.53 21.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.885 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.77 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.608 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.01 149.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.412 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.88 172.91 6.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -56.39 -61.58 6.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.1 Cg_endo -63.94 -33.04 64.91 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.046 . . . . 0.0 111.862 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -69.62 -35.73 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.8 t80 -75.28 -40.6 58.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.262 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.515 HD11 ' HG ' ' A' ' 4' ' ' LEU . 6.5 tp -76.78 -53.99 7.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.587 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 2' ' ' ASP . 62.4 m -51.37 -45.2 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.526 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.439 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -54.32 -52.62 60.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.488 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 21.9 mtt -80.02 -10.35 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.533 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -84.66 -33.33 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.899 0.38 . . . . 0.0 110.845 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -57.88 -43.81 86.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.963 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.38 -178.31 4.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.2 m -162.15 161.92 28.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.63 -27.38 39.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.23 -42.46 75.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.973 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 mt-10 -59.25 -33.09 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.36 -37.99 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.244 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -49.41 41.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 57.9 mt-10 -62.04 -46.41 89.27 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.58 -48.09 69.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.781 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.85 -43.15 59.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -71.1 -32.17 68.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.72 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.003 HG11 HD22 ' B' ' 74' ' ' LEU . 1.3 m -75.0 -36.62 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.733 0.301 . . . . 0.0 111.002 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.722 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.1 m-85 -74.65 -62.92 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.496 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -84.68 132.23 34.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -76.62 -52.59 9.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.54 -9.61 59.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.46 70.21 0.66 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.902 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -94.24 15.32 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.44 69.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.696 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -160.39 117.04 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.549 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -112.17 123.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.229 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.0 t -103.96 157.72 16.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.308 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.554 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.68 -41.52 22.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.12 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -58.77 6.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.78 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.9 mm-40 -55.13 -39.08 69.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.991 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.52 -50.9 72.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.92 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.657 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.43 -42.31 77.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.146 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -36.22 77.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.32 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 67.5 t -72.58 -54.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.762 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.516 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.54 -54.03 20.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.657 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.4 t -66.94 -25.46 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.65 -30.01 68.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.64 -28.77 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.24 43.89 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -149.59 114.88 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -91.6 101.5 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -93.83 163.56 13.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.839 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.3 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -59.38 -42.07 90.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.741 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -69.73 -35.85 75.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.15 -54.86 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.74 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -63.6 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -61.49 -41.42 97.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.082 0.467 . . . . 0.0 110.313 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 34.8 mt-10 -72.42 -30.15 64.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.266 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -70.72 -34.41 71.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.647 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.991 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.27 -55.17 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.708 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm180 -54.38 -31.8 55.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 0.0 110.415 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.47 -21.6 57.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.892 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -18.09 14.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.66 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.05 90.59 4.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.94 -30.91 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.6 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.28 -9.46 57.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.123 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 51.06 53.61 26.4 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.7 p30 -113.78 -5.55 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.232 0.516 . . . . 0.0 111.271 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 6.24 44.64 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.219 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.06 -174.88 4.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.669 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 47.0 t -127.36 120.59 55.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.006 0.432 . . . . 0.0 111.274 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB3' ' HG3' ' A' ' 140' ' ' GLU . 5.5 t30 -98.98 -169.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.64 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.513 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.2 t80 -59.53 -73.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.62 -43.62 46.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.405 0.622 . . . . 0.0 110.331 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.746 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.1 mt-10 -56.3 -34.75 66.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.928 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.41 -48.45 13.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.293 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.8 -39.79 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.19 -35.07 71.45 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.567 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.478 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -84.77 11.1 9.75 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.543 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.4 mtt -119.26 -39.56 2.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.479 -179.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.579 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.843 0.354 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.97 -71.46 1.14 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.586 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.29 -48.2 65.1 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.59 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.151 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.07 -31.7 61.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.009 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -53.78 -53.56 50.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.409 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.739 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.34 -38.55 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 68' ' ' PHE . 99.4 t -50.61 -43.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.742 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.94 -46.45 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.051 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 91' ' ' VAL . 32.8 mt -55.85 -48.28 75.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.373 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.1 p -65.07 -48.24 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.584 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.58 -29.63 57.95 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.017 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 88' ' ' ALA . 81.7 t -76.88 -54.62 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.611 0.243 . . . . 0.0 111.58 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.58 -43.91 97.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.0 mmm180 -57.68 -34.44 69.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.239 0.542 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -37.42 83.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.22 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.932 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.3 -10.48 30.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.852 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.31 -36.09 58.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.059 -179.484 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.85 0.357 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.681 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -177.26 179.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.77 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -130.87 165.32 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.901 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 8' ' ' GLN . 8.7 t -69.11 177.33 2.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -60.48 -36.34 78.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -73.22 -56.95 4.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.77 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -57.89 -41.95 83.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.006 0.432 . . . . 0.0 110.686 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 5' ' ' THR . 7.2 tt -71.36 -26.43 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.48 -43.53 62.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.14 -32.82 70.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.53 -49.68 68.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.456 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -45.1 89.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.193 0.521 . . . . 0.0 110.23 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -64.67 -48.81 73.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.691 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.36 -41.39 63.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.471 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.81 -38.68 70.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.999 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -74.14 -13.92 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.933 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.69 -39.74 14.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.954 0.406 . . . . 0.0 110.151 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.45 -65.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.356 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -65.39 132.88 50.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -37.62 74.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.24 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.73 -12.26 29.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.7 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.64 37.21 82.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -74.77 -4.55 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.244 -0.183 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.15 44.16 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.116 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -149.55 132.5 16.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.796 0.331 . . . . 0.0 110.892 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mt -105.52 127.38 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.8 t -102.41 168.44 9.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.405 HG21 ' NE2' ' A' ' 49' ' ' GLN . 28.5 p -54.78 -34.35 62.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.48 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -50.49 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.248 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -77.19 -36.53 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.158 0.504 . . . . 0.0 110.826 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.3 -58.21 8.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.823 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.52 64.23 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.793 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -72.04 -59.97 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 111.172 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -64.33 -30.56 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.174 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 mtp -60.93 -56.43 21.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -25.63 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.95 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.4 t -57.77 -38.66 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.64 -35.65 68.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.72 43.59 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -142.6 163.39 32.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.43 61.17 27.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.09 -170.17 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 0.0 112.248 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -122.11 166.92 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.83 -31.96 71.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.084 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.45 59.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.436 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.53 -41.9 92.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.364 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -56.63 -50.95 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' NE2' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -65.59 -57.04 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.407 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -51.06 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.147 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 19.2 mtt -58.19 -46.84 85.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.959 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.83 -45.82 97.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.029 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -56.13 -26.53 50.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.538 0.685 . . . . 0.0 110.042 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.7 mt-10 -82.15 -2.19 51.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.467 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.25 -32.99 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.0 111.934 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.8 t0 -72.74 152.72 41.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.183 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.33 -53.55 6.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.54 -8.74 57.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.316 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.91 49.93 70.31 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.853 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -97.27 -0.2 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.424 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.5 24.11 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.825 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.84 139.86 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.58 149.43 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -103.87 174.78 5.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -58.06 -61.58 7.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -63.62 -33.82 65.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.055 . . . . 0.0 111.81 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.518 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -69.15 -36.25 77.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.427 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.29 -40.11 58.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.28 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.4 tp -76.7 -54.7 6.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.536 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -51.61 -43.3 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.427 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -55.18 33.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 11.6 mtt -79.08 -11.47 59.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.516 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -85.08 -38.25 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -63.13 -30.46 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.64 179.05 7.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -160.85 154.44 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -25.52 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -39.7 65.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 60.2 mt-10 -59.95 -30.45 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.89 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -49.4 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.438 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 50.7 mt-10 -61.59 -45.81 92.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.783 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.66 -48.89 69.01 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.966 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.04 -38.74 53.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -30.5 57.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.995 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.28 -36.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.715 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -73.29 -62.91 1.31 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.511 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -83.48 119.1 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -62.7 -52.62 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.8 -9.72 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.471 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.0 71.3 0.49 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.956 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -93.48 14.55 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.279 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.18 67.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.582 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 6.6 m-85 -162.37 116.89 1.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -113.21 124.38 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.069 0.461 . . . . 0.0 111.539 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -104.11 160.08 15.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.954 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.583 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -43.54 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.83 6.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.019 0.437 . . . . 0.0 110.84 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -55.22 -37.34 67.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.671 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.958 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.68 -50.78 72.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.795 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 110' ' ' THR . 8.4 tpt85 -55.91 -43.14 77.04 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -37.41 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.382 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.65 -53.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.626 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -51.16 -54.16 27.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.0 t -66.52 -25.72 66.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.24 -30.04 69.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.79 -28.79 14.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -152.37 109.77 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -86.48 110.55 19.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.489 HD12 ' CG ' ' A' ' 120' ' ' GLU . 3.8 mm? -101.36 166.06 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.0 m -98.35 158.73 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.41 -40.51 91.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' CG ' HD12 ' A' ' 116' ' ' LEU . 5.3 tp10 -64.39 -55.04 23.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.725 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -62.94 -40.97 90.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.35 -39.03 89.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.1 0.476 . . . . 0.0 110.123 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.7 mt-10 -73.4 -30.15 63.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.3 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.16 -35.5 71.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.958 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.31 -55.02 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.589 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.8 ptm180 -53.95 -31.81 51.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.016 0.436 . . . . 0.0 110.386 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -79.24 -21.31 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.15 -2.33 21.03 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.331 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.9 t0 -94.61 104.92 16.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.448 0.642 . . . . 0.0 111.135 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -79.04 -31.66 14.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.092 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.1 -9.1 46.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.55 -178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.15 57.1 10.57 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.7 p30 -114.23 -4.04 13.11 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.104 0.452 . . . . 0.0 111.408 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 6.93 43.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.087 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.08 -174.74 4.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.613 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.3 t -128.13 125.28 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.931 0.396 . . . . 0.0 111.212 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.7 t30 -105.12 -165.24 1.11 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.939 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.61 ' O ' HG13 ' A' ' 142' ' ' VAL . 13.2 t80 -60.09 -73.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.6 -44.82 47.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 110.383 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.73 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -57.39 -35.66 70.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.731 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.44 -48.61 13.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.994 0.426 . . . . 0.0 111.673 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -56.81 -38.65 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.55 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -71.2 -35.1 71.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.627 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.421 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -86.36 12.85 9.2 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.726 0.298 . . . . 0.0 111.088 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.6 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.9 mtt -120.73 -38.47 2.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.313 -179.893 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.58 -75.0 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.692 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.99 -50.48 27.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.668 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.28 -65.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.089 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.454 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -54.1 -31.81 53.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.44 . . . . 0.0 110.045 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.6 tpp85 -54.07 -53.61 50.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.734 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.73 -37.78 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.612 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.3 t -50.47 -45.65 25.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.366 0.603 . . . . 0.0 110.861 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.833 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -75.48 -45.66 37.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.338 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.995 HD22 HG11 ' A' ' 91' ' ' VAL . 29.8 mt -55.97 -46.68 78.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.979 0.419 . . . . 0.0 110.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.9 p -66.42 -48.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.499 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.585 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.93 -28.11 57.5 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.866 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.833 HG23 ' O ' ' B' ' 73' ' ' ARG . 95.9 t -76.83 -54.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 111.419 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.715 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -62.86 -44.08 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -58.0 -35.36 71.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -37.3 79.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.913 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.7 t90 -95.38 -11.25 28.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.831 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.04 -35.57 59.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.342 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 -179.56 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.772 0.32 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.676 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.9 tt0 -158.14 179.55 9.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.806 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -129.22 165.29 21.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.07 177.31 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -59.93 -36.85 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.339 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -73.33 -56.93 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.806 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.59 -41.16 80.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' THR . 6.0 tt -72.33 -26.24 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.32 -44.41 61.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.788 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 6.4 pm0 -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.18 -49.71 68.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.417 -179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -58.38 -45.12 88.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.85 -48.65 73.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.715 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.32 -41.42 62.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.486 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.5 -38.84 69.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.066 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -74.2 -13.76 60.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.4 mt -87.75 -39.8 14.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.95 -65.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.392 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 6.8 t70 -65.34 133.16 50.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.844 0.354 . . . . 0.0 110.736 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.61 -37.62 73.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.19 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.64 -12.25 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 37.28 82.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.688 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -74.69 -4.58 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.211 -0.195 . . . . 0.0 111.389 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.25 0.21 44.09 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.064 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.9 p -149.58 132.53 16.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.851 0.358 . . . . 0.0 110.879 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 32' ' ' LEU . 2.0 mt -105.33 126.92 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 6.9 t -101.87 168.1 9.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 p -53.81 -37.21 63.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.644 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -57.27 -50.52 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.357 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.96 -36.67 56.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.144 0.497 . . . . 0.0 110.821 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.956 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.42 -58.11 8.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.859 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.49 64.94 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.833 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -71.32 -60.29 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.336 . . . . 0.0 111.197 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -63.84 -30.49 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.9 mtp -61.03 -56.49 20.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.59 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -25.6 66.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.8 t -57.22 -38.13 73.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.57 -30.94 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.0 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.583 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -142.63 166.16 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -120.34 60.99 7.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.43 165.22 33.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.6 p -102.87 165.33 11.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.05 -29.35 67.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 110.274 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.68 -50.86 53.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.638 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.45 -37.6 87.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 19.6 mt -57.51 -51.01 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.771 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -56.67 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.33 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -54.91 -51.02 67.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.163 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.507 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 59.4 mtt -59.03 -46.11 89.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.956 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.64 -45.91 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.953 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -55.96 -26.56 48.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.555 0.693 . . . . 0.0 110.03 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.4 mt-10 -82.12 -2.11 50.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.442 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.36 -32.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.905 0.383 . . . . 0.0 111.99 -177.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.9 t0 -72.82 152.17 41.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.87 -53.54 6.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.679 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.52 -8.6 57.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.282 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.84 49.79 71.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.891 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -97.34 -0.25 46.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.536 0.208 . . . . 0.0 111.444 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.64 23.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.881 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -149.85 139.86 22.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.82 149.32 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.458 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.68 174.83 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.952 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -57.94 -61.67 6.95 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -63.74 -33.75 64.57 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.392 2.062 . . . . 0.0 111.812 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -69.06 -36.12 77.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.438 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.27 -40.04 59.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.295 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.676 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.0 tp -76.72 -54.93 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.451 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -51.67 -43.42 62.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.519 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -55.5 30.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.491 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 17.6 mtt -76.95 -17.3 58.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.442 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -81.58 -31.63 32.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -30.61 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 -178.48 6.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.52 157.68 30.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -54.61 -26.43 32.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 66.6 mt-10 -59.54 -31.82 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.828 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.28 -39.28 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.257 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -49.35 46.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.468 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.3 mm-40 -61.39 -46.21 91.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.375 0.607 . . . . 0.0 109.404 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.53 -48.95 68.6 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.07 -38.58 52.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.023 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -76.56 -30.53 57.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.82 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.013 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.35 -36.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.675 0.274 . . . . 0.0 111.077 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -73.34 -62.97 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.352 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -83.94 129.98 34.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -74.83 -52.66 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.63 -9.7 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.01 70.54 0.6 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.94 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -93.87 15.04 17.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.698 0.285 . . . . 0.0 111.217 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.58 69.02 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.2 m-85 -163.96 116.92 1.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.688 0.28 . . . . 0.0 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.27 126.55 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.547 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.7 t -104.0 156.85 17.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -40.91 21.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.92 6.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 110.801 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -55.87 -38.13 69.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.706 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.906 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.03 -50.74 72.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.845 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 110' ' ' THR . 8.0 tpt85 -55.72 -44.17 77.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -37.21 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.289 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.41 -53.58 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.732 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.546 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.2 mmt -50.3 -54.08 23.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.4 t -67.14 -25.62 66.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -29.95 68.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.73 -28.78 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.87 43.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -149.36 116.78 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -91.75 102.84 15.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.983 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.54 163.71 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.4 m -98.29 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.01 -42.2 93.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.643 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.89 -54.87 20.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -64.52 -40.0 87.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -62.26 -41.41 98.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 110.34 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.7 mt-10 -72.91 -30.17 63.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.415 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -71.45 -34.3 70.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.906 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.33 -54.91 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.631 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.0 ptm180 -54.51 -31.77 56.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.043 0.449 . . . . 0.0 110.347 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.99 -21.7 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.36 16.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.435 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 125' ' ' ILE . 49.0 t0 -84.07 89.65 7.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.449 0.642 . . . . 0.0 110.965 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -62.93 -30.8 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.419 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.595 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.8 -9.48 56.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.163 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.47 54.17 21.72 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.802 0.681 . . . . 0.0 114.802 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.9 p30 -113.84 -5.38 13.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.207 0.504 . . . . 0.0 111.307 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 6.29 44.54 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.316 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.83 -174.82 4.45 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.937 0.368 . . . . 0.0 110.712 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.5 t -128.6 123.56 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.424 . . . . 0.0 111.304 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.74 -164.95 1.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' O ' HG13 ' A' ' 142' ' ' VAL . 16.2 t80 -62.44 -74.06 0.1 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.68 -44.29 47.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 110.329 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.741 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.48 -35.82 68.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.006 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.17 -48.34 14.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 111.418 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.828 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -59.15 -40.31 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.437 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.41 -34.78 70.65 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.577 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -83.54 9.53 11.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.642 0.258 . . . . 0.0 111.279 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.583 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.5 mtt -119.21 -39.16 2.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.477 -179.804 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.945 0.403 . . . . 0.0 110.989 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 70' ' ' ARG . . . -71.81 -71.88 1.0 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.532 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.7 -49.47 46.94 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.459 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.729 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.0 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.008 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.42 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.7 OUTLIER -56.32 -31.76 64.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -52.84 -53.55 47.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.331 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.729 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.93 -38.7 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.9 t -50.62 -44.5 25.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.316 0.579 . . . . 0.0 110.884 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.82 ' O ' HG23 ' B' ' 77' ' ' VAL . 5.1 mpt_? -75.24 -47.22 29.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.013 HD22 HG11 ' A' ' 91' ' ' VAL . 33.1 mt -55.81 -46.57 78.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -65.99 -48.72 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.38 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.588 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.75 -28.26 56.74 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.855 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.82 HG23 ' O ' ' B' ' 73' ' ' ARG . 99.3 t -76.85 -55.44 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.65 0.262 . . . . 0.0 111.525 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.91 -44.13 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.7 mmm180 -57.77 -35.14 70.37 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 109.767 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -36.48 81.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.855 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.31 -10.46 30.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.785 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.89 -36.22 56.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.028 -179.56 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.844 0.354 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.705 ' CG ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -176.22 172.78 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -120.3 165.4 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -71.81 177.36 4.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.783 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 9' ' ' ILE . 16.1 pt-20 -58.32 -41.99 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.292 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.9 tt0 -67.14 -57.11 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.08 -44.68 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.018 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.438 HG13 HD13 ' A' ' 69' ' ' LEU . 7.6 tt -69.64 -26.59 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.251 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.6 -43.47 62.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.453 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.75 -32.81 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -66.07 -49.61 67.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -45.05 90.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.211 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -64.75 -48.82 73.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.7 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.12 62.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.399 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -54.08 -40.51 67.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.401 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 t -75.9 -12.94 60.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.13 -40.34 14.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 110.425 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.716 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.76 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.222 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.69 133.21 48.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.837 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.9 88.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.347 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.03 -12.13 36.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.28 38.7 91.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.69 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -73.51 -5.78 42.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.435 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 6.32 42.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.215 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -149.83 133.19 16.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.801 0.3 . . . . 0.0 110.74 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -100.04 117.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HA ' HG22 ' A' ' 62' ' ' THR . 8.9 t -89.18 159.07 17.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.725 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.8 p -54.72 -34.33 62.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.36 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.51 -50.42 73.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 111.046 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -76.08 -36.69 58.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.029 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.85 -44.43 73.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.095 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.434 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.85 -27.4 73.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.321 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -71.92 -49.68 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.6 p -72.43 -35.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.3 ttm -58.94 -45.22 90.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -25.59 44.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.8 t -54.64 -38.09 66.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.77 -30.15 65.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.986 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.87 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -142.62 161.75 37.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -119.66 62.79 7.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.69 176.38 8.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.207 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -109.38 168.27 9.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -32.15 71.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.079 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.92 60.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.451 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.313 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.434 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.3 mt -59.64 -50.66 72.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.78 -43.44 93.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.335 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.31 -51.14 62.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.155 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -57.64 -52.13 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.029 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -58.11 -42.28 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.015 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.66 -26.43 65.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.513 0.673 . . . . 0.0 109.893 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.9 mt-10 -83.03 -2.21 54.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.719 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.35 -33.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.078 -177.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' HD12 ' A' ' 63' ' ' ILE . 49.7 t0 -70.54 154.62 41.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.399 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.62 -53.75 5.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.802 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -89.14 -8.65 53.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.362 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.2 51.67 57.79 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.848 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -100.06 1.13 42.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.574 0.226 . . . . 0.0 111.437 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.35 15.02 22.56 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.975 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.6 p -150.02 139.72 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.604 0.24 . . . . 0.0 110.88 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.626 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.0 mm -96.54 149.89 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.94 172.85 6.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.2 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -53.55 -61.55 4.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.775 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 -26.3 37.42 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.673 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 15.6 mm-40 -73.71 -38.31 64.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.41 -43.32 50.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 110.37 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.705 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.4 tp -70.08 -57.06 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.811 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.3 m -51.44 -53.78 33.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.649 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.9 tpp -54.26 -38.72 66.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.8 mmt -97.91 14.53 26.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.244 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.22 -36.01 5.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -55.49 -55.76 28.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.265 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.884 0.373 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.59 -175.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -168.4 -166.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -67.36 -29.15 68.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.51 -26.57 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -71.1 -45.16 64.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.472 . . . . 0.0 110.83 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.6 -33.64 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.593 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -49.37 52.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.368 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.757 ' O ' HG13 ' A' ' 91' ' ' VAL . 46.3 mm-40 -62.41 -48.47 79.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.415 0.626 . . . . 0.0 109.698 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.774 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.38 -44.54 68.72 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.953 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.47 57.8 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.928 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.56 -32.35 58.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.946 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.91 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.9 -36.65 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 120.678 0.275 . . . . 0.0 111.024 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.585 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -72.94 -63.08 1.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.487 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -86.23 128.57 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -52.72 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.982 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.86 -9.75 58.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.413 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.52 69.74 0.63 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.006 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -93.27 14.35 18.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.284 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 17.3 66.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.604 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.8 m-85 -158.45 116.94 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.694 0.283 . . . . 0.0 110.972 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 125' ' ' ILE . 2.7 mt -110.36 124.31 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -103.91 157.45 17.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.255 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.566 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.77 -42.94 26.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.25 -58.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.7 mm-40 -55.0 -39.23 68.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.629 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.971 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.17 -50.71 72.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.888 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 110' ' ' THR . 0.0 OUTLIER -57.64 -41.01 80.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.674 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.63 -39.03 86.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.513 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.7 t -72.8 -55.34 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.5 mmt -49.03 -54.0 17.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.3 t -65.41 -25.42 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -30.98 68.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.53 -28.83 15.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.35 42.31 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -144.0 109.77 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -88.88 94.14 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.63 147.11 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 121' ' ' VAL . 12.5 t -85.88 163.37 18.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.72 -31.03 69.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.64 -45.97 73.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.599 ' H ' HG23 ' A' ' 117' ' ' THR . 49.2 mm-40 -61.12 -54.87 39.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 117' ' ' THR . 1.6 m -62.23 -38.3 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -61.44 -43.59 98.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 110.345 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 71.5 mt-10 -71.77 -30.2 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.401 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtp -70.71 -34.0 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.731 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 105' ' ' LEU . 4.1 mm -80.31 -54.94 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.585 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 11.5 ptt180 -55.14 -31.93 61.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 110.385 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.3 -21.12 54.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.632 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -104.56 -14.51 15.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.433 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.95 93.73 7.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.395 0.616 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.1 pt -66.43 -31.27 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.51 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.618 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -85.83 -9.37 57.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.123 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.22 54.76 18.31 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.697 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.7 p30 -113.98 -5.18 13.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.194 0.497 . . . . 0.0 111.367 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.069 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.91 -174.77 4.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.35 . . . . 0.0 110.547 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 141' ' ' PHE . 42.3 t -127.3 120.51 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 7.3 t30 -96.07 -167.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.354 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.2 t80 -62.36 -73.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.58 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.74 -43.3 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.303 0.573 . . . . 0.0 110.414 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.748 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -55.9 -33.49 64.68 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.489 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -79.07 -45.45 20.07 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.104 0.478 . . . . 0.0 111.683 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -65.52 -38.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.158 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.493 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -70.43 -36.07 73.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.57 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.797 ' HE3' ' CG ' ' B' ' 81' ' ' TRP . 6.1 ptm -73.35 -21.42 60.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.447 ' O ' ' HB ' ' A' ' 146' ' ' THR . 1.2 tpp -88.63 -49.48 6.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.288 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 145' ' ' MET . 11.3 t . . . . . 0 CA--C 1.529 0.162 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.498 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.88 3.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.673 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.86 -49.34 55.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.391 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -53.22 -68.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.533 0.206 . . . . 0.0 110.887 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.8 -38.84 57.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.771 0.319 . . . . 0.0 110.455 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.7 tpt180 -56.06 -48.28 76.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.671 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -61.56 -40.28 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.262 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.1 t -53.44 -53.46 24.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.816 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.873 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.95 -49.08 40.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.354 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.91 HD22 HG11 ' A' ' 91' ' ' VAL . 18.9 mt -55.96 -44.15 78.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 12.5 p -67.6 -48.97 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.752 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.578 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -55.96 -31.26 58.4 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.079 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' B' ' 73' ' ' ARG . 49.1 t -76.79 -54.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.696 0.284 . . . . 0.0 111.731 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -62.1 -43.85 98.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -57.96 -31.71 67.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.997 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -37.12 85.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.935 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.5 t90 -95.26 -15.72 22.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.888 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.2 -31.6 16.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.31 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.339 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.863 0.363 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.651 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.1 tt0 -158.81 178.7 9.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -127.85 165.34 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.2 t -72.43 177.4 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 9' ' ' ILE . 17.2 pt-20 -57.36 -42.85 82.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.418 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -66.3 -56.97 8.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.185 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 2.2 tp60 -59.16 -49.05 79.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 5' ' ' THR . 10.9 tt -63.61 -26.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.3 -44.17 61.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.742 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 1.8 pt-20 -69.11 -33.18 73.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.32 -49.74 65.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.354 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.21 -44.75 88.3 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.194 0.521 . . . . 0.0 110.122 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -64.9 -49.17 71.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.703 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.33 -41.13 62.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -58.5 -33.94 70.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.085 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.63 -16.3 57.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.937 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.07 -36.92 17.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.26 -65.94 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 12.5 t70 -66.16 130.31 42.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.905 0.383 . . . . 0.0 110.832 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -39.28 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.34 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.19 -12.15 30.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.54 36.12 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.677 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -74.94 -4.99 41.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.487 0.184 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.16 4.27 44.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.177 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.9 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.4 mt -109.87 127.93 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.185 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.68 169.85 8.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.97 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 p -55.88 -32.31 63.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.409 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -62.05 -50.49 71.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -75.64 -36.94 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.128 0.489 . . . . 0.0 110.834 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.32 -58.21 8.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.558 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.58 -27.43 69.71 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.776 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.4 m -67.45 -55.17 14.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 13.8 p -69.69 -31.59 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -46.8 88.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -26.18 44.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.959 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -58.15 -35.96 72.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.05 -31.25 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.71 42.63 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -142.65 165.04 28.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -121.28 63.25 12.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 -173.63 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.311 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 p -122.08 161.8 22.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 24.7 pm0 -69.02 -28.49 66.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.18 0.514 . . . . 0.0 110.3 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.81 -49.53 58.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.595 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.4 -37.35 86.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD11 ' HA3' ' A' ' 33' ' ' GLY . 21.0 mt -57.39 -50.79 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -67.35 -48.0 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.272 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.99 -51.02 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.494 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.96 -49.73 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.398 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 32' ' ' LEU . 1.1 mt -57.81 -41.86 80.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.5 -26.42 65.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.677 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.1 mt-10 -83.67 -2.19 55.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.89 -33.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 112.084 -177.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 63' ' ' ILE . 56.1 t0 -71.04 144.97 50.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.77 -53.55 7.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.595 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.54 -8.69 59.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.217 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.79 47.71 83.74 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.963 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -97.69 -1.3 43.87 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.663 0.231 . . . . 0.0 111.495 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.86 20.13 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.889 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.4 p -149.97 139.83 21.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.606 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.21 149.34 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.23 170.09 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -53.74 -61.66 4.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -63.55 -37.62 46.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.37 2.047 . . . . 0.0 111.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -60.97 -48.42 81.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.503 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.39 -58.01 9.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.177 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.5 tp -58.28 -55.54 33.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.822 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -51.58 -44.36 62.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.737 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.427 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -55.26 -53.28 58.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.03 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.9 mmt -78.31 -16.82 57.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.76 -30.38 28.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.165 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.37 -27.14 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.871 0.367 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -155.8 163.96 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.44 157.06 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -26.19 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.11 -33.4 59.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -74.55 -34.3 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.318 0.58 . . . . 0.0 109.737 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -49.35 53.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.471 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.747 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.2 mm-40 -63.11 -46.9 85.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.402 0.62 . . . . 0.0 109.653 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.778 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -45.6 70.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.95 -38.67 51.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -33.11 58.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.809 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.66 -36.46 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.673 0.273 . . . . 0.0 111.02 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -70.67 -62.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.549 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.42 117.18 24.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -52.67 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.78 -9.66 59.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.1 70.47 0.56 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -93.54 14.88 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.646 0.26 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.45 68.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.635 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.4 m-85 -160.12 116.92 2.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.928 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.491 ' O ' HD12 ' A' ' 125' ' ' ILE . 3.9 mt -114.59 125.49 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.626 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -104.09 159.58 15.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.981 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.577 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.7 -40.25 19.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.396 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 -59.0 6.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.984 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.56 -37.29 70.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.721 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.04 -50.7 72.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.903 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.769 ' O ' HG22 ' A' ' 110' ' ' THR . 1.1 tpt180 -56.2 -42.8 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -39.19 83.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.642 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 92' ' ' PHE . 44.9 t -72.17 -55.35 13.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.118 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.588 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.4 mmt -49.04 -54.01 17.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.1 t -66.05 -25.42 67.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.09 -30.28 66.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -28.81 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.9 43.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.58 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -150.65 110.54 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.792 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -86.41 101.9 13.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.656 HD12 ' HG2' ' A' ' 120' ' ' GLU . 3.5 mm? -105.57 148.79 26.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.6 t -86.75 163.33 17.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -58.09 -34.17 69.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.61 -39.33 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 7.6 tp10 -64.36 -54.87 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -62.76 -40.59 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.66 -41.49 97.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.0 110.129 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 40.9 mt-10 -72.66 -30.12 64.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.315 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.2 mtp -70.3 -36.25 74.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.857 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 105' ' ' LEU . 3.7 mm -80.21 -54.86 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.639 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.36 -31.76 55.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.005 0.431 . . . . 0.0 110.417 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.18 -21.77 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.888 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.541 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.21 -9.13 17.9 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.248 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.4 t0 -86.97 100.67 12.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.504 0.668 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -75.11 -31.64 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.042 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.99 -9.1 47.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.521 -178.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.47 57.07 11.02 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.5 p30 -114.31 -3.62 13.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.217 0.508 . . . . 0.0 111.47 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.49 5.85 45.06 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.078 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.11 -174.72 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.469 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 141' ' ' PHE . 46.3 t -128.87 124.83 61.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 111.281 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.6 t30 -102.95 -162.6 0.93 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.7 t80 -60.75 -74.45 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 142' ' ' VAL . 2.1 tt0 -49.95 -45.45 51.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.302 0.572 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.6 mt-10 -56.21 -34.52 66.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.728 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -78.99 -47.06 16.98 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.111 0.481 . . . . 0.0 111.608 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.632 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.5 m -64.48 -34.46 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.812 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.411 ' HG3' ' N ' ' A' ' 144' ' ' MET . 1.6 pp0? -71.05 -36.29 72.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.39 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.541 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 1.3 ptt? -83.83 -4.09 58.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.779 0.323 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.609 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -96.68 -35.75 10.92 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.671 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.378 -179.822 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.7 mpp_? . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.825 0.345 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 -67.51 2.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.822 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.9 -50.22 69.9 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.0 -65.28 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.539 0.209 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.407 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.8 -36.68 48.67 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.465 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 13.8 tpp180 -56.14 -48.76 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -63.42 -41.79 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.096 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.3 t -50.63 -51.14 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.57 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.85 ' O ' HG23 ' B' ' 77' ' ' VAL . 2.9 mpt_? -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.507 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.809 HD22 HG11 ' A' ' 91' ' ' VAL . 14.2 mt -56.05 -47.47 77.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.71 0.29 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -67.0 -47.51 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.62 -30.18 62.02 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.075 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 73' ' ' ARG . 96.6 t -76.79 -55.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.726 0.298 . . . . 0.0 111.096 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.711 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.22 -43.73 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.581 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.654 ' HA ' ' HB3' ' B' ' 82' ' ' ALA . 9.3 mmp_? -55.65 -35.54 66.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.267 0.556 . . . . 0.0 109.562 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.76 -37.49 73.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.857 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.05 -17.23 22.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.318 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -78.09 -37.54 46.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.646 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.844 0.354 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.578 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -165.69 174.77 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.848 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.4 165.39 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.8 t -69.08 176.88 2.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.0 -39.04 84.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.8 tt0 -69.79 -56.84 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.848 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -57.82 -44.84 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.972 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.447 HG13 HD13 ' A' ' 69' ' ' LEU . 6.8 tt -69.02 -26.82 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.201 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.86 -43.04 63.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.412 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.62 -25.78 62.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.364 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.73 -49.36 25.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.332 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -44.56 85.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.148 0.499 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.99 -49.11 68.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.886 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.26 -41.28 62.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.74 -34.42 67.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.027 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t -78.59 -14.59 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.99 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.74 -39.26 15.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.147 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.698 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.17 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.234 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 6.5 t0 -63.65 126.28 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.681 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -37.83 83.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -92.09 -12.4 33.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.23 32.75 63.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.811 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' OD1' ' OD2' ' A' ' 20' ' ' ASP . 9.7 p30 -77.07 1.91 16.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.845 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.78 43.37 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.084 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -149.6 132.59 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.52 0.66 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.934 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.1 mp -105.11 118.61 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.437 ' CB ' HG22 ' A' ' 62' ' ' THR . 8.4 t -98.01 163.99 12.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.763 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.0 p -51.73 -25.47 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.891 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -68.11 -50.69 53.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -77.86 -37.82 47.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.248 0.547 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.015 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.16 -44.78 71.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.619 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.0 -28.89 73.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.235 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.0 m -73.53 -59.92 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.4 p -62.7 -30.5 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.2 ttt -61.51 -56.45 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.86 -25.46 66.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -51.4 -47.03 63.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.71 -60.19 2.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.913 0.387 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.19 40.16 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -142.71 170.32 15.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -138.16 59.54 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -178.93 3.93 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.622 2.214 . . . . 0.0 112.495 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 174.24 6.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.45 -29.93 68.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.89 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.12 59.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.147 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.9 OUTLIER -61.31 -40.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.089 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.1 mt -59.41 -50.53 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.933 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 8.2 tt0 -62.98 -39.17 93.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -68.98 -51.19 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.334 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.04 -54.0 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 110.454 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.0 -45.71 92.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.367 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 15.8 t-20 -51.98 -25.96 9.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.271 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.3 mt-10 -82.37 -3.24 55.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.35 -32.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.566 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.4 t0 -63.57 135.69 57.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.105 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.89 -53.32 21.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.557 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -95.81 3.71 53.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.665 -179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.09 59.13 9.87 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.88 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -109.21 -2.5 17.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.852 0.326 . . . . 0.0 111.354 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 17.37 15.93 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.863 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.612 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.51 139.94 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.072 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -104.55 149.44 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.785 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -107.6 171.06 7.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.9 m-85 -55.77 -61.5 6.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.524 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.6 Cg_endo -66.98 -20.25 51.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.436 2.091 . . . . 0.0 112.567 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.24 -37.64 37.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.085 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 4.7 t80 -75.24 -33.95 61.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.294 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.3 tp -76.75 -58.29 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -51.89 -45.67 64.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.142 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.76 -31.26 69.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 41.6 mtt -108.21 15.34 24.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.221 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.81 -40.47 4.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.91 0.386 . . . . 0.0 111.024 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -59.9 -45.12 93.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 111.0 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.836 0.35 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.81 -179.41 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -148.3 156.28 42.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.788 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -50.89 -25.98 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.373 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -73.65 -39.46 64.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' B' ' 77' ' ' VAL . 43.8 mt-10 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.179 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.81 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.21 -38.93 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.32 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -71.13 -49.36 45.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.7 mm-40 -61.2 -46.29 91.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.39 0.614 . . . . 0.0 109.447 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.742 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.6 -49.22 68.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.059 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.08 -38.52 52.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.996 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -30.38 56.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.008 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.49 -37.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -71.42 -62.92 1.23 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.865 0.364 . . . . 0.0 110.483 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.93 120.61 25.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -63.35 -52.56 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.193 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.43 -9.61 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.492 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.96 71.76 0.47 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.884 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.47 14.53 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.679 0.276 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 13.65 61.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.685 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -158.33 116.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.52 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.45 124.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.137 0.494 . . . . 0.0 111.714 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -104.27 161.69 13.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.131 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.572 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -45.56 30.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.528 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.84 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 111.093 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.92 -36.47 65.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.543 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.61 -50.0 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.675 178.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.542 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -56.65 -41.44 77.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.412 178.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -60.57 -39.16 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.61 -54.45 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.817 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 116' ' ' LEU . 10.0 mmt -50.33 -54.11 23.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.21 -24.51 65.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.559 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -69.89 -30.9 68.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.5 -28.7 16.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.15 42.78 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.548 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -153.23 110.28 3.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -91.85 101.44 14.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.0 mm? -96.59 166.98 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 120' ' ' GLU . 12.8 t -94.63 163.79 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -59.75 -41.83 91.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.35 -35.87 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.653 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -65.48 -54.9 21.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.8 m -64.89 -40.02 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.182 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -62.6 -41.95 99.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.3 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.5 mt-10 -72.63 -30.14 64.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.3 mtt -70.91 -35.98 72.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 105' ' ' LEU . 5.2 mm -80.25 -54.87 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.699 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.3 ptm180 -54.05 -31.85 52.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 110.377 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.25 -20.96 46.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.798 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.45 -2.6 20.32 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.471 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.9 t0 -94.87 109.71 21.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.394 0.616 . . . . 0.0 111.204 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.27 7.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.803 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.91 -9.12 44.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.579 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.56 58.23 8.49 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 114.515 0.566 . . . . 0.0 114.515 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.7 p30 -114.24 -4.58 13.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.072 0.436 . . . . 0.0 111.513 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 7.78 42.32 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.955 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.15 -174.88 4.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.673 0.273 . . . . 0.0 110.38 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.7 t -128.18 126.5 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 111.245 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -104.83 -167.81 1.4 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.95 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.2 t80 -58.79 -73.92 0.07 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.57 -45.41 47.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 110.286 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.54 -36.39 69.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.102 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.66 -49.56 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.94 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.81 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.44 -40.63 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.715 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -34.35 70.6 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.652 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.22 8.36 13.54 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.68 0.276 . . . . 0.0 111.246 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.568 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -38.28 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.429 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 121.03 0.443 . . . . 0.0 110.85 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.26 -75.69 0.23 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.905 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.02 -46.76 61.04 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -58.75 -70.85 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.279 . . . . 0.0 110.54 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.11 -34.92 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.842 0.354 . . . . 0.0 110.38 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 4.9 tpp85 -57.1 -53.26 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.635 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.63 -41.65 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.125 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 68' ' ' PHE . 84.2 t -52.2 -53.02 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.283 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.785 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.6 mpt_? -71.91 -44.08 64.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.008 HD22 HG11 ' A' ' 91' ' ' VAL . 19.7 mt -56.2 -49.24 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.9 p -65.48 -47.66 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.583 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.69 -29.39 67.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.302 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' B' ' 73' ' ' ARG . 70.1 t -76.82 -53.46 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.666 0.27 . . . . 0.0 111.246 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.708 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.65 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.364 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.646 ' N ' HD12 ' B' ' 78' ' ' ILE . 3.7 mmp_? -57.03 -34.45 68.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 109.67 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -37.29 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.929 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.47 -10.19 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.03 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -94.67 -28.09 15.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.277 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.501 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.831 0.348 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.481 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -176.8 171.83 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.711 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -128.85 165.33 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.4 t -68.47 169.25 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -55.05 -36.51 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.6 tt0 -71.3 -56.85 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.371 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.711 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.8 OUTLIER -58.54 -45.05 89.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 0.0 110.845 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG13 HD13 ' A' ' 69' ' ' LEU . 6.9 tt -67.54 -26.78 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -43.47 63.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.475 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.96 -25.8 62.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.86 -49.41 25.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.263 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -57.43 -44.66 84.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.19 0.519 . . . . 0.0 110.207 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.34 -49.85 67.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.877 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.28 -40.76 62.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.45 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -55.97 -38.94 71.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.207 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.76 -38.37 15.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.97 0.414 . . . . 0.0 110.388 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.666 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.375 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.6 t70 -63.62 129.02 38.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.862 0.363 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -37.3 83.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.215 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.61 -12.31 29.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.7 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.3 37.86 83.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.649 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -77.02 -1.85 30.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.478 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 -2.57 43.67 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.217 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.6 p -149.47 132.5 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.986 0.393 . . . . 0.0 110.959 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -104.0 120.07 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.028 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.83 164.59 12.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.818 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.0 p -52.53 -25.47 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -70.49 -50.53 36.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.356 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.77 -36.58 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.467 . . . . 0.0 111.005 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -54.25 -47.92 71.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.028 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.53 -27.39 73.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.391 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.9 m -72.05 -51.65 20.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.331 . . . . 0.0 111.218 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.9 p -70.61 -34.96 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.414 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -52.59 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.71 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.56 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -52.13 -37.72 55.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.71 -65.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.56 38.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.7 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -140.5 58.34 10.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 -170.25 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.412 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p -102.15 171.83 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.74 -29.44 67.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.44 56.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.41 -39.75 94.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.727 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.481 HD11 ' HA3' ' A' ' 33' ' ' GLY . 31.7 mt -58.33 -50.59 73.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.77 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 tp60 -64.63 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.09 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.088 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -58.44 -53.77 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.06 -44.73 92.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.415 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 32.4 t30 -52.71 -25.92 12.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.1 mt-10 -82.66 -3.32 56.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.928 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.44 -32.31 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.3 t0 -63.46 135.31 56.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.067 0.461 . . . . 0.0 111.027 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.43 -53.5 28.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.07 4.23 52.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.744 -179.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 59.43 9.39 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.895 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.97 -2.49 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.75 0.275 . . . . 0.0 111.342 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.47 15.75 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.893 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.624 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.8 p -149.46 139.92 22.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.09 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.34 149.61 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.52 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.56 171.03 7.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.634 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.8 m-85 -55.03 -61.52 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.659 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.4 Cg_endo -67.22 -20.28 49.61 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.434 2.089 . . . . 0.0 112.595 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -79.26 -38.08 36.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.168 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.5 t80 -75.1 -33.49 61.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 4' ' ' LEU . 11.6 tp -75.25 -58.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.295 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 53.2 m -51.56 -43.19 62.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -54.15 -43.33 70.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.438 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 36.9 mtt -101.12 14.5 31.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -107.15 -36.7 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -73.62 -26.9 61.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.807 0.337 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.765 ' OD2' HG22 ' B' ' 77' ' ' VAL . 12.4 m-20 -87.45 -178.49 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.2 m -142.66 159.56 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -50.83 -25.97 5.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.387 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -75.85 -37.45 58.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.523 ' HB3' HG21 ' B' ' 77' ' ' VAL . 42.3 mt-10 -65.4 -26.76 68.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.809 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.03 -38.47 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.099 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -71.37 -49.36 42.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.9 mt-10 -61.31 -46.29 90.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.378 0.609 . . . . 0.0 109.442 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.743 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.46 -49.02 68.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.022 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.12 -39.01 55.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.919 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -30.37 58.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.014 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.43 -37.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -70.66 -63.02 1.18 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.895 0.379 . . . . 0.0 110.44 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.55 120.79 26.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -52.58 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.279 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.49 -9.62 59.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.52 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.82 71.76 0.46 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.814 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -92.98 14.5 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.61 16.59 65.75 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.619 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -161.15 116.76 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.303 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.537 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.05 124.28 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.119 0.485 . . . . 0.0 111.65 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -104.26 161.52 13.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.206 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.86 -44.42 29.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.472 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 -58.84 6.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 111.015 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.9 mm-40 -55.02 -38.0 67.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.653 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.899 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.61 -49.48 77.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.744 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.884 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -57.24 -41.72 80.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.334 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.64 -39.36 84.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.2 t -67.15 -55.71 16.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.668 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 mmt -49.07 -54.09 17.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.2 t -67.62 -24.22 65.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -70.57 -30.2 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.07 -28.85 14.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.95 43.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.9 109.77 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -89.59 101.97 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -99.27 165.31 11.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.0 t -98.28 171.15 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.0 -32.46 72.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 -47.63 69.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -60.54 -54.85 40.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.884 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.3 m -57.7 -50.93 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.391 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 121' ' ' VAL . 36.6 t70 -57.47 -39.27 76.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 52.1 mt-10 -72.59 -30.19 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.47 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.03 -36.07 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.82 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.18 -54.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.646 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.9 ptm180 -53.56 -31.74 47.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 0.0 110.516 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.32 -21.1 53.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.44 -10.86 15.64 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.624 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -84.87 110.02 18.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.385 0.612 . . . . 0.0 111.302 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.89 -31.15 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.791 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.32 -9.07 43.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.6 -178.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.06 57.78 9.55 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -114.27 -4.19 13.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.039 0.42 . . . . 0.0 111.515 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 7.51 42.59 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.006 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.88 4.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.419 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.0 t -129.02 126.25 64.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 111.157 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.48 -167.53 1.34 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.062 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.3 t80 -57.71 -73.89 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.56 -45.86 48.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.564 . . . . 0.0 110.306 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.57 -36.48 69.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.157 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.734 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.74 -49.73 11.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.881 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.809 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -56.32 -36.82 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.08 -34.79 71.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.63 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.444 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.7 OUTLIER -87.1 15.36 6.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.701 0.286 . . . . 0.0 110.858 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.1 mtt -126.99 -49.5 1.46 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.328 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.058 0 CA-C-O 121.002 0.429 . . . . 0.0 110.794 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.28 -75.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.64 -45.56 59.92 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.928 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.22 -71.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.699 -0.251 . . . . 0.0 110.586 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.26 -32.96 39.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.611 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.43 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 5.1 tpp85 -58.47 -53.2 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.55 -41.14 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.969 178.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 68' ' ' PHE . 86.4 t -53.14 -50.95 43.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.333 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.725 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.92 -47.06 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.431 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.014 HD22 HG11 ' A' ' 91' ' ' VAL . 33.2 mt -56.67 -45.78 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.808 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -66.77 -47.43 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.804 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.18 -29.83 69.37 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.294 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.765 HG22 ' OD2' ' A' ' 80' ' ' ASP . 79.7 t -76.8 -51.88 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 111.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -67.42 -42.03 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.537 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.642 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.0 mmp_? -57.37 -34.66 69.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.216 0.532 . . . . 0.0 109.763 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -36.81 84.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.877 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.38 -14.19 24.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -91.24 -26.92 18.77 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.545 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -169.95 176.56 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -126.53 165.32 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.3 t -70.4 171.79 9.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.893 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.62 -38.03 68.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.242 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -71.47 -56.75 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.108 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.623 ' H ' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER -58.11 -45.2 87.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.851 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.494 HG13 HD13 ' A' ' 69' ' ' LEU . 5.9 tt -67.14 -26.78 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.98 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.71 -42.87 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.5 -25.78 63.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.91 -49.41 24.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.499 0.19 . . . . 0.0 111.262 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.65 -44.64 85.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.196 0.522 . . . . 0.0 110.117 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.12 -49.08 71.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.746 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.943 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.29 -41.33 62.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.44 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -56.33 -36.7 69.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.129 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.87 -13.85 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.7 -38.29 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.273 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.25 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.319 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.3 t70 -64.97 127.41 31.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.639 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -38.52 91.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.65 -12.26 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 0.0 110.794 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.08 37.94 82.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.641 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -76.88 -1.91 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 -2.33 43.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.173 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 p -149.42 132.42 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.924 0.362 . . . . 0.0 110.745 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.4 mp -104.44 120.33 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.095 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 t -97.78 159.83 14.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.496 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.415 HG21 ' NE2' ' A' ' 49' ' ' GLN . 19.2 p -50.17 -25.45 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -67.69 -50.95 55.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -78.13 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.428 0.633 . . . . 0.0 110.424 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.097 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.21 -50.51 66.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.796 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -64.41 -27.47 71.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.31 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.0 m -69.5 -54.95 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.51 -31.72 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -47.08 87.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 110.413 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -25.57 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 t -55.13 -50.57 68.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -47.78 -58.03 4.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.576 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -142.56 179.73 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.825 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -159.73 58.74 1.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.34 -170.57 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.676 2.25 . . . . 0.0 112.509 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 p -93.9 171.11 9.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 11.7 pt-20 -68.48 -31.44 70.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.291 0.567 . . . . 0.0 110.05 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.03 65.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.892 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 1.4 mt-10 -62.16 -53.33 56.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.657 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.15 -50.79 63.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.351 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 29' ' ' THR . 2.3 tp-100 -57.98 -40.35 80.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.63 -45.12 94.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.264 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -60.8 -52.66 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.203 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.097 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -57.15 -45.86 84.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.126 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.06 -25.99 9.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.351 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -83.02 -3.29 57.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.012 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.919 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.37 -32.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.2 t0 -63.0 136.93 58.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.037 0.446 . . . . 0.0 111.155 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.35 -53.74 26.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.481 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -96.95 4.16 51.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.701 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.68 59.66 8.92 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.735 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.37 -1.17 17.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.726 0.263 . . . . 0.0 111.409 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.24 17.37 15.98 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.877 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.579 ' C ' HD13 ' A' ' 63' ' ' ILE . 10.5 p -149.53 139.96 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.186 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 62' ' ' THR . 2.6 mm -104.47 149.78 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.459 . . . . 0.0 111.705 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.44 168.76 9.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.63 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.2 m-85 -52.53 -61.21 4.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -68.16 -19.81 44.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.11 . . . . 0.0 112.669 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.9 mm-40 -79.27 -37.47 37.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.106 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.7 t80 -75.23 -32.46 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.01 0.433 . . . . 0.0 110.311 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.545 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.1 tp -76.19 -58.07 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 52.5 m -51.61 -43.1 62.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.503 ' HE2' ' HD3' ' B' ' 65' ' ' ARG . 4.4 tmm? -54.14 -44.72 71.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.946 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 33.8 mtt -100.66 15.35 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.537 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -109.99 -31.68 7.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.877 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -61.93 -39.32 91.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.245 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 111.317 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.786 0.326 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -90.9 -175.21 4.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.99 161.72 38.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -50.7 -25.42 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.525 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.7 -46.18 47.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.9 mt-10 -57.43 -26.71 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -73.65 -38.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.188 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -49.49 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.544 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.1 mt-10 -61.18 -46.12 91.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.404 0.621 . . . . 0.0 109.442 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.773 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.6 -49.3 68.11 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.984 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.05 -38.19 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.968 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -30.49 57.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.831 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.051 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.78 -36.77 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.659 0.266 . . . . 0.0 111.006 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -72.23 -62.93 1.26 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.492 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.82 114.07 20.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.827 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -60.96 -50.08 74.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.06 -9.66 59.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.74 72.37 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.839 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -94.33 13.76 22.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.69 0.281 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.48 69.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 4.5 m-85 -166.19 116.77 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.505 HD11 ' HD1' ' A' ' 89' ' ' PHE . 6.2 mt -112.24 124.34 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 0.0 111.863 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -104.43 161.96 13.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.085 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.574 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.8 -44.79 28.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.475 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.79 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.031 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -54.88 -36.29 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.6 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.93 -50.7 71.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.713 178.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.536 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -55.77 -41.47 74.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.385 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -61.05 -39.32 89.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.281 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.97 -53.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.5 -54.04 25.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.28 -25.03 65.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.18 -32.05 72.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.44 -28.78 16.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.36 42.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -140.31 109.81 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -85.28 80.61 9.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.26 161.54 17.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 120' ' ' GLU . 14.3 t -96.76 162.86 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -30.3 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.2 -42.31 88.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 117' ' ' THR . 17.2 mm-40 -63.21 -51.78 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.1 m -61.56 -41.5 90.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.225 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.23 -43.28 99.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.3 mt-10 -72.4 -30.13 64.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.44 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.9 ttm -70.73 -35.4 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 105' ' ' LEU . 5.3 mm -80.3 -54.94 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.556 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.8 ptm180 -54.02 -31.72 52.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.365 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -78.3 -21.01 50.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.904 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 -7.65 16.42 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.1 t0 -88.68 109.89 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.383 0.611 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.6 pt -84.88 -31.1 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.77 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.39 -9.08 43.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.612 -178.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.68 58.11 8.76 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.3 -4.41 13.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 117.036 0.418 . . . . 0.0 111.428 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.59 42.65 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.011 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.1 -174.88 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.417 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.749 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.8 t -127.84 127.28 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 111.224 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -106.17 -168.27 1.41 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.1 t80 -57.98 -73.95 0.07 Allowed 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -49.57 -45.6 47.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 0.0 110.262 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.727 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.109 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.749 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.6 -49.62 11.9 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.02 0.438 . . . . 0.0 111.797 -178.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.1 m -56.47 -36.55 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.615 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' NE2' ' CG2' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -70.96 -33.96 70.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.471 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.8 OUTLIER -88.58 16.58 6.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.804 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.616 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.0 mtt -128.36 -51.38 1.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.215 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.331 -0.203 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.749 -179.69 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.17 -75.77 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.859 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.16 -46.11 56.82 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.238 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.919 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -59.83 -71.55 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.667 0.27 . . . . 0.0 110.589 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.409 ' NE2' ' CD ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.96 -33.38 37.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.473 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.0 tpp180 -57.27 -51.92 67.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.619 HG21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -60.88 -42.62 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.806 178.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.7 t -50.62 -47.68 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.428 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.843 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.13 -48.24 45.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.438 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.051 HD22 HG11 ' A' ' 91' ' ' VAL . 37.4 mt -56.12 -46.45 79.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -66.05 -48.84 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.01 -29.61 59.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.099 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.843 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.1 t -76.71 -56.5 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.686 0.279 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.691 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.49 -43.83 97.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.658 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.0 -33.58 69.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 109.864 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.32 -36.42 83.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.37 -15.98 22.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.39 -25.06 20.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.632 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p30 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.848 0.356 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -177.79 170.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.749 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.31 165.3 17.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -69.31 177.35 2.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -70.92 -56.99 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.263 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.749 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -56.86 -44.72 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 69' ' ' LEU . 6.1 tt -69.29 -26.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.033 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.78 -42.94 62.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -71.75 -27.04 62.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.38 -49.56 40.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.279 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -57.08 -44.81 83.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.167 0.508 . . . . 0.0 110.228 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 39.9 mm-40 -65.15 -50.67 65.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 1.038 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.33 -40.36 58.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.844 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.09 -45.66 79.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.475 -179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 m -70.77 -14.86 62.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.428 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 mt -87.83 -37.4 16.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 0.0 110.619 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.56 -65.0 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.053 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.2 t70 -64.9 132.5 49.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.869 0.366 . . . . 0.0 110.553 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -38.84 81.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.319 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.8 -12.3 31.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.802 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.83 37.57 84.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.633 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -74.25 -4.56 36.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.181 -0.207 . . . . 0.0 111.437 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 0.27 43.99 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.061 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -149.58 132.5 16.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 110.733 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -105.07 127.42 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.5 t -102.02 168.77 9.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -53.55 -40.37 65.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.772 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -55.68 -50.45 70.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.57 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -76.25 -36.37 58.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.926 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.22 -58.4 7.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.573 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -31.99 78.79 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.42 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -61.47 -57.79 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.972 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.78 -30.48 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.319 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -51.99 66.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 110.44 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.66 61.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.786 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -60.87 -45.18 95.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.2 mt -49.35 -60.69 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.073 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.25 41.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.546 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -142.6 171.99 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.848 0.356 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.71 59.33 19.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.5 -170.36 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.551 2.167 . . . . 0.0 112.357 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.3 p -115.88 170.15 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.7 -30.56 69.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 0.0 110.098 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.65 -44.35 57.43 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.035 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -42.33 99.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.043 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 13.3 mt -59.35 -50.56 73.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.07 -48.16 81.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.465 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.35 -51.04 65.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -56.25 -50.75 70.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 32' ' ' LEU . 1.2 mt -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -55.74 -26.45 45.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.515 0.674 . . . . 0.0 110.236 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 51' ' ' MET . 4.0 mt-10 -83.46 -2.03 54.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.535 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.8 -33.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 0.0 112.121 -177.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.539 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.6 t0 -69.97 139.59 52.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -71.98 -53.57 12.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.478 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -93.39 -3.16 53.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.621 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.9 55.86 27.4 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.911 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.1 m120 -105.63 15.6 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.857 0.328 . . . . 0.0 111.11 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 83.41 16.95 67.58 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.908 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.447 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.8 p -149.9 139.8 21.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.718 0.294 . . . . 0.0 110.804 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.7 mm -97.59 149.47 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 111.414 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.67 -178.92 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 8.6 m-85 -62.82 -61.67 7.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.395 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 25.6 Cg_endo -62.19 -34.4 78.83 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.416 2.077 . . . . 0.0 111.942 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -67.78 -47.42 69.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.457 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -61.66 -44.58 96.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.327 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.8 tp -72.66 -58.11 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.9 m -51.71 -45.59 63.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.4 mmt -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.7 mmt -108.47 14.97 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.17 -44.48 3.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -57.08 -45.86 82.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.023 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.84 0.352 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' B' ' 77' ' ' VAL . 0.8 OUTLIER -86.4 -177.37 6.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.911 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 159.23 43.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.77 -26.57 5.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.338 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.47 -41.27 61.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 22.8 mt-10 -59.69 -26.78 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.817 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.1 mm -74.11 -37.63 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.921 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -71.71 -49.41 39.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.88 ' O ' HG13 ' A' ' 91' ' ' VAL . 37.5 mt-10 -61.24 -46.43 90.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 109.395 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.4 -49.17 67.83 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.97 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.27 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.946 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -30.61 62.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.852 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.928 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.52 -37.08 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.98 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.635 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.84 -62.86 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.883 0.373 . . . . 0.0 110.484 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.9 t0 -82.79 115.14 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -59.04 -52.58 65.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.1 -9.58 59.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.42 0.49 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.831 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -93.46 14.43 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.675 0.274 . . . . 0.0 111.203 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.5 16.83 65.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.588 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.3 m-85 -162.38 116.75 1.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.717 0.294 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.528 HD11 ' HD1' ' A' ' 89' ' ' PHE . 5.0 mt -113.31 124.84 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.147 0.498 . . . . 0.0 111.751 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.0 t -104.28 161.53 13.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.171 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.84 -44.87 29.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.434 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.85 -58.82 6.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -55.0 -36.75 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.62 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.7 -49.91 74.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.723 178.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.36 -41.79 76.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.38 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.71 -38.68 85.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.235 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.55 -54.29 24.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.752 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.8 mmt -50.92 -53.97 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.08 -24.65 65.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.53 -31.05 69.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.59 -28.73 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.02 43.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.564 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -147.55 109.82 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -88.2 100.52 13.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -99.18 163.21 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.4 t -98.25 171.67 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.08 -32.75 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.58 -47.91 68.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.691 ' H ' HG23 ' A' ' 117' ' ' THR . 74.7 mm-40 -60.35 -54.84 40.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.85 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.4 m -57.55 -51.02 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 121' ' ' VAL . 20.7 t70 -57.54 -38.84 75.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.982 0.42 . . . . 0.0 110.566 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 32.6 mt-10 -72.86 -30.09 63.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.476 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -71.0 -36.33 72.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.845 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.943 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.32 -54.9 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.692 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.1 ptm180 -53.75 -31.83 49.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.9 pt-20 -78.76 -20.93 48.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.957 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -7.27 16.86 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.476 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.3 t0 -89.05 110.05 20.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.359 0.6 . . . . 0.0 111.272 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.735 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.94 -31.12 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.819 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.496 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.37 -9.14 42.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.605 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.94 57.85 9.34 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.566 0.587 . . . . 0.0 114.566 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.1 p30 -114.3 -4.45 13.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.992 0.396 . . . . 0.0 111.437 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.75 42.06 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.12 -174.92 4.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.475 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.727 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.88 126.56 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.98 -167.57 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.649 ' O ' HG13 ' A' ' 142' ' ' VAL . 54.1 t80 -57.67 -73.89 0.06 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.508 ' O ' HG22 ' A' ' 142' ' ' VAL . 1.7 tt0 -49.5 -45.99 47.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.735 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.6 -36.27 69.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.069 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.727 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.52 -49.68 11.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.817 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.88 -37.08 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.685 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' NE2' ' CG2' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -70.98 -34.32 71.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.657 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.442 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -88.12 15.89 6.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.883 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.611 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -126.85 -51.13 1.46 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.705 -179.781 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.79 0.328 . . . . 0.0 111.059 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.12 -66.01 3.0 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.793 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.13 -50.66 26.94 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.44 -63.5 1.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.476 0.179 . . . . 0.0 110.891 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.68 -36.42 46.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.46 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.9 tpt180 -56.16 -53.2 59.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.613 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -58.46 -42.48 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.276 178.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.568 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.83 -53.44 13.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -73.32 -44.27 59.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.662 -178.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 91' ' ' VAL . 19.4 mt -55.91 -48.46 75.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.168 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.038 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -63.97 -47.97 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.271 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.03 -28.53 58.36 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 73' ' ' ARG . 87.8 t -76.77 -56.18 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.452 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.649 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.97 -43.5 96.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 24.8 mmm180 -58.04 -34.16 69.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.232 0.539 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -36.82 84.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.426 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.905 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.43 -15.33 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.988 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.49 -26.47 19.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.429 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.956 0.408 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.698 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.6 tt0 -160.29 171.96 18.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -118.37 165.47 13.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.6 t -68.55 177.06 2.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.01 -37.75 83.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.8 tt0 -71.39 -56.74 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.637 ' H ' HG23 ' A' ' 5' ' ' THR . 1.1 tt0 -57.86 -44.1 86.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.913 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 69' ' ' LEU . 7.4 tt -68.9 -26.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.96 -43.12 63.39 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -25.75 62.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -74.11 -49.39 24.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.565 0.221 . . . . 0.0 111.226 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -57.62 -44.49 85.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.225 0.536 . . . . 0.0 110.175 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.76 -49.13 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.3 -41.01 62.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.492 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.25 -38.81 69.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.174 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 t -76.8 -14.23 59.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.75 -37.9 16.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.833 0.349 . . . . 0.0 110.455 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.75 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.262 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.0 t70 -64.57 127.01 29.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.637 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -38.66 91.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.35 -12.31 32.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 110.781 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.04 37.64 80.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -76.49 -2.17 30.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 -1.82 43.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.2 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -149.45 132.49 16.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.922 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mt -104.53 120.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.93 161.99 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.568 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -52.26 -25.57 9.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.809 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -67.27 -50.83 58.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.016 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.95 -36.77 48.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.331 0.586 . . . . 0.0 110.572 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.092 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.2 -41.55 68.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.683 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.805 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -72.58 -27.46 69.38 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.195 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -69.07 -51.39 39.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.697 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.6 p -74.45 -33.16 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.7 ttt -57.74 -44.16 85.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.384 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -25.54 44.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 t -56.53 -44.88 81.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.424 HD13 ' CD ' ' B' ' 70' ' ' ARG . 3.6 mt -46.04 -30.12 1.73 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.59 35.18 0.32 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.751 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -142.82 173.6 11.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 28.3 m120 -140.93 63.65 19.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 2.7 Cg_exo -75.85 -171.63 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 112.185 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -100.07 170.94 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.55 -31.36 70.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.22 -44.04 64.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -53.23 57.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.685 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.805 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.27 -50.72 64.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.365 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -60.23 -39.15 85.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.529 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.42 -44.65 90.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -60.27 -52.94 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.217 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.96 -46.25 87.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.299 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -51.58 -26.03 7.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.372 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.4 mt-10 -83.64 -3.32 57.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.36 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -62.9 134.44 56.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.083 0.468 . . . . 0.0 111.101 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -65.5 -53.32 44.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.717 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -97.45 4.37 50.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.817 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.52 60.11 8.7 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.928 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.41 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -110.37 -2.57 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.768 0.284 . . . . 0.0 111.38 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.38 15.95 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.6 p -149.53 139.94 22.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 111.224 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.45 149.6 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.234 0.54 . . . . 0.0 111.802 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.98 172.05 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.487 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.8 m-85 -56.1 -61.49 6.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 41.9 Cg_endo -67.42 -20.34 48.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.469 2.112 . . . . 0.0 112.864 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.23 -37.97 36.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.438 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.7 t80 -75.24 -34.59 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.0 tp -74.97 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.093 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.0 -46.44 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 mmt -61.66 -30.8 70.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.697 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.407 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 6.8 mmt -105.13 13.91 29.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.46 -36.67 4.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -56.48 21.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.829 0.347 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.26 179.34 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.47 155.87 40.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.8 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -25.31 8.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.322 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.11 -35.79 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.223 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' B' ' 77' ' ' VAL . 36.8 mt-10 -66.78 -26.64 67.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.215 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.801 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.25 -37.82 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.0 110.155 179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.71 -49.4 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.585 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.87 ' O ' HG13 ' A' ' 91' ' ' VAL . 44.9 mt-10 -62.4 -44.45 96.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.352 0.596 . . . . 0.0 109.42 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.775 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.77 -50.06 66.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.819 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.92 -37.75 45.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.868 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -30.57 57.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.714 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.5 m -76.63 -36.76 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.665 0.269 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.697 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.1 m-85 -73.56 -62.82 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.545 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.5 t0 -81.9 116.63 21.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -63.24 -52.43 62.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -77.68 -9.63 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.25 70.71 0.58 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -94.62 14.02 22.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 0.0 111.22 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 18.2 67.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.0 m-85 -163.54 116.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.515 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.52 124.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 0.0 111.678 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -104.22 162.06 13.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.197 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -46.56 31.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.37 -58.8 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 111.104 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -54.88 -36.42 65.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.583 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.46 -50.64 71.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.647 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.16 -41.53 75.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.384 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.62 -39.03 86.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.333 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.66 -54.64 19.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.785 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.4 mmt -50.06 -54.05 22.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.697 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.8 t -66.37 -24.62 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.567 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -31.32 69.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.35 -28.8 15.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.65 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.05 109.78 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -91.9 93.74 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.83 158.1 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.1 t -88.34 163.56 15.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -58.93 -39.89 82.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -36.14 83.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.661 ' H ' HG23 ' A' ' 117' ' ' THR . 29.1 mm-40 -64.73 -54.83 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.27 -39.77 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.3 -42.0 98.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.9 mt-10 -72.6 -30.22 64.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.359 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.1 mtt -70.78 -35.88 72.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.96 HD11 HD12 ' A' ' 105' ' ' LEU . 5.4 mm -80.31 -54.89 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.67 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.01 -31.81 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.446 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.12 -21.06 47.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.821 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.05 -4.35 19.04 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.441 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.0 t0 -93.06 109.76 21.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.726 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.04 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.814 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.499 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.36 -9.08 43.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.563 -178.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.59 58.1 8.67 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.31 -4.42 13.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.963 0.382 . . . . 0.0 111.484 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 7.81 42.05 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.06 -174.91 4.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.48 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.82 126.39 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.359 . . . . 0.0 111.198 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.82 -167.59 1.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.636 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.9 t80 -58.15 -73.88 0.07 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 142' ' ' VAL . 2.8 tt0 -49.46 -45.71 47.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.375 0.607 . . . . 0.0 110.333 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.726 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.56 -36.55 69.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.129 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.7 -49.77 11.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.93 0.395 . . . . 0.0 111.983 -179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.801 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -54.82 -40.74 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.69 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -34.47 70.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.719 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.42 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.18 8.29 13.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.607 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -37.78 3.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.073 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.458 -179.83 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.001 0.429 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.11 -76.21 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.888 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.76 -46.33 59.95 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.11 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -58.85 -71.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.245 . . . . 0.0 110.588 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.448 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.37 -36.87 54.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.377 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 ttm-85 -57.31 -48.17 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.641 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -59.55 -40.47 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.132 178.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 68' ' ' PHE . 92.2 t -54.71 -53.59 30.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.521 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.71 -46.4 53.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.336 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 91' ' ' VAL . 16.4 mt -56.04 -46.31 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.618 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.6 p -65.78 -46.6 88.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.391 . . . . 0.0 110.443 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.567 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.2 -30.33 70.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.367 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.723 HG11 ' CB ' ' A' ' 88' ' ' ALA . 42.3 t -75.77 -52.45 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.692 0.282 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.697 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -67.03 -42.67 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.563 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.3 mmp_? -57.33 -34.75 69.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -62.4 -37.22 84.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.523 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.6 t90 -95.54 -14.84 23.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.013 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.16 -27.11 19.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.479 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.594 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.746 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -176.36 176.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -127.4 165.13 20.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.546 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -73.47 170.13 15.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -50.85 -42.21 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.426 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -65.59 -56.91 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.204 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB3' ' CB ' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -60.67 -54.69 42.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' HD12 ' A' ' 4' ' ' LEU . 10.8 tt -56.1 -26.18 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.224 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.24 -42.67 61.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.334 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -35.18 79.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.03 -49.53 60.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.432 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 1.2 mtpp -58.74 -46.49 87.31 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.22 0.533 . . . . 0.0 109.996 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.83 -50.42 72.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.589 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -40.75 62.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.296 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.08 -35.83 67.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -75.0 -16.94 60.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -86.91 -38.78 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.421 . . . . 0.0 110.201 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.656 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.77 -65.69 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.246 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 27' ' ' ILE . 9.0 t70 -65.98 131.04 45.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.883 0.373 . . . . 0.0 110.712 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -36.39 77.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.139 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.92 -12.3 27.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.783 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.28 37.85 83.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.646 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -77.68 -1.9 33.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.12 43.86 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.131 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.6 p -147.48 132.47 18.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.869 0.335 . . . . 0.0 110.795 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.906 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -107.28 119.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.449 ' CB ' HG22 ' A' ' 62' ' ' THR . 4.7 t -98.35 168.41 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.1 p -54.45 -29.34 49.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.641 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -67.22 -50.43 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.279 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.15 -36.18 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.38 -42.83 70.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.847 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.51 -27.32 72.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.052 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.0 m -73.58 -45.24 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.0 p -74.67 -34.9 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.084 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -60.84 -49.45 77.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.755 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -65.33 -30.19 71.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -58.86 -21.14 56.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.897 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' B' ' 74' ' ' LEU . 15.9 mt -72.47 -60.76 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.79 -39.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.504 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.3 mt-30 -140.15 147.88 40.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.991 0.396 . . . . 0.0 111.103 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -99.11 99.42 8.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.93 -168.95 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.302 2.002 . . . . 0.0 111.994 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 169.39 13.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.73 -30.37 68.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.031 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.94 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.126 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.1 mt-10 -62.4 -43.22 99.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.244 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.8 mt -56.79 -50.31 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.5 tt0 -64.26 -39.11 93.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.141 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -66.14 -51.14 60.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.452 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.03 -54.18 49.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.119 0.485 . . . . 0.0 110.348 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.7 -43.89 92.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.683 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 18.8 t-20 -52.53 -25.99 11.92 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.561 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.497 ' O ' ' CE ' ' A' ' 71' ' ' MET . 2.2 mt-10 -83.39 -4.82 58.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.915 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -126.2 -32.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.074 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.7 t0 -64.91 133.54 52.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 111.342 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.13 -53.66 16.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.952 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.74 58.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.24 49.21 81.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.924 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -104.47 -1.37 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.703 0.252 . . . . 0.0 111.482 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.62 15.31 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.254 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 3.2 p -149.06 139.78 22.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 111.085 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.77 149.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.157 0.503 . . . . 0.0 111.691 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.47 173.78 6.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.503 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -57.65 -61.46 7.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.323 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 48.7 Cg_endo -68.41 -26.86 34.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.48 2.12 . . . . 0.0 112.468 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -67.63 -43.5 80.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.089 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 1.9 t80 -75.19 -38.44 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.055 0.455 . . . . 0.0 110.293 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.5 tp -66.0 -58.06 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.071 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 m -51.9 -41.47 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 55' ' ' VAL . 1.8 tpt -60.14 -32.83 71.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.424 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.425 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -108.27 15.32 24.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.148 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.24 -33.12 5.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -58.48 -41.08 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.619 0.247 . . . . 0.0 111.38 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 58.41 171.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -169.69 149.26 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -26.46 5.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.648 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 81' ' ' SER . 13.7 pt-20 -78.09 -25.72 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.734 0.302 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' B' ' 77' ' ' VAL . 5.0 mt-10 -74.15 -28.92 61.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.923 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.29 -32.73 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -49.33 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.413 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.707 ' O ' HG13 ' A' ' 91' ' ' VAL . 10.8 mt-10 -62.99 -47.99 80.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.739 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.28 -44.09 67.99 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.729 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.84 -39.91 54.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.909 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -33.03 58.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.782 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG11 HD22 ' B' ' 74' ' ' LEU . 1.5 m -73.28 -36.97 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.7 OUTLIER -72.89 -63.07 1.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.59 125.29 33.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -52.61 9.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.0 -9.66 58.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.69 68.91 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.875 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -95.07 12.87 27.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 111.341 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.54 16.61 65.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.7 m-85 -157.94 116.95 3.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.644 0.259 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.4 mt -109.41 124.29 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.014 0.435 . . . . 0.0 111.262 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -103.89 157.15 17.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.272 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.75 -43.34 27.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.446 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.72 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 mm-40 -54.97 -39.63 69.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.692 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.05 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.864 179.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.79 ' O ' HG22 ' A' ' 110' ' ' THR . 0.3 OUTLIER -57.61 -41.45 81.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.721 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -61.06 -38.07 84.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.466 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' GLU . 81.7 t -72.77 -56.01 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.063 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 5.9 mmt -48.99 -54.03 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.508 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.79 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.0 t -65.53 -25.25 67.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.376 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.53 -30.31 65.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.837 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.2 -28.82 17.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.58 43.02 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.594 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.53 109.76 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.16 100.34 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -98.17 160.65 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 120' ' ' GLU . 15.4 t -89.57 161.97 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -57.64 -40.72 79.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.12 -36.09 82.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.644 ' H ' HG23 ' A' ' 117' ' ' THR . 13.9 mm-40 -65.71 -54.77 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.99 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.277 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.15 -44.05 97.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 45.1 mt-10 -71.74 -30.2 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.414 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.5 mmm -70.67 -34.55 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.685 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.952 HD11 HD12 ' A' ' 105' ' ' LEU . 4.0 mm -80.23 -54.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.762 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.1 ptt85 -54.91 -31.8 60.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 110.363 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.77 -20.85 52.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.76 -11.34 16.31 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.488 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 125' ' ' ILE . 50.6 t0 -85.51 90.95 8.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.426 0.632 . . . . 0.0 110.785 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.2 pt -63.43 -30.74 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.592 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.61 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -86.94 -9.41 55.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.208 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.19 54.57 18.91 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.422 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.2 p30 -113.93 -5.14 13.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.243 0.521 . . . . 0.0 111.365 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.48 5.8 45.16 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.99 -174.69 4.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.907 0.385 . . . . 0.0 110.595 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.697 HG11 ' CD1' ' A' ' 141' ' ' PHE . 41.3 t -127.24 120.66 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.6 t30 -97.37 -167.72 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.7 t80 -61.63 -74.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.3 OUTLIER -49.89 -43.06 49.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.315 0.579 . . . . 0.0 110.337 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.77 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.3 mt-10 -56.06 -33.69 65.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.617 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.697 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -78.97 -47.19 16.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.233 0.539 . . . . 0.0 111.631 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.6 m -64.8 -36.47 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.023 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -70.53 -36.71 73.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.657 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.535 ' HE1' ' CD2' ' B' ' 81' ' ' TRP . 1.4 ptt? -74.95 -15.2 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.57 ' HG2' HD12 ' A' ' 85' ' ' ILE . 3.9 tpp -95.2 -50.22 5.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.374 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 145' ' ' MET . 13.8 t . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.545 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 2.0 mpp_? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 121.047 0.451 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.01 -76.01 0.21 Allowed Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.928 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.23 -45.81 57.41 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.156 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.915 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.27 -70.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.516 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.28 -32.0 35.32 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.396 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.8 tpt180 -58.65 -52.85 63.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.653 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.31 -42.43 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.684 178.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.4 t -52.67 -50.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.105 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.816 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.58 -49.27 49.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.453 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.032 HD22 HG11 ' A' ' 91' ' ' VAL . 29.4 mt -56.04 -46.3 78.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.149 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.4 p -67.01 -47.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.586 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.8 -30.57 69.66 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.348 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.816 HG23 ' O ' ' B' ' 73' ' ' ARG . 86.7 t -76.75 -52.64 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.657 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.54 -41.7 91.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.581 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.619 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -56.02 -34.25 65.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -38.04 86.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.698 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.931 ' CH2' HD11 ' A' ' 105' ' ' LEU . 5.7 t90 -95.15 -14.74 23.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.901 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.53 -31.93 16.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.409 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.804 0.335 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -176.51 169.06 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.59 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -123.75 165.27 17.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.4 t -71.93 177.09 4.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 17.1 pt-20 -57.3 -43.38 83.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.1 tt0 -64.78 -56.95 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -59.69 -52.96 63.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' THR . 11.2 tt -59.1 -26.55 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.262 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.46 -42.9 61.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.405 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.7 -36.76 84.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.216 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.11 -49.67 64.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.576 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -59.04 -46.05 89.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.506 . . . . 0.0 110.025 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.81 -49.52 72.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.891 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.48 -41.09 63.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.361 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -55.81 -37.31 68.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.061 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -76.12 -15.82 60.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.78 -40.23 14.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.316 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.721 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.2 -63.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.238 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD2' ' OD1' ' A' ' 24' ' ' ASP . 5.9 t0 -65.7 126.61 28.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.37 79.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.313 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -92.16 -12.47 32.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.974 0.416 . . . . 0.0 110.313 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 56.96 32.82 62.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.805 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' OD1' ' OD2' ' A' ' 20' ' ' ASP . 9.1 p30 -76.62 1.27 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.845 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.3 43.31 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.028 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -149.55 132.62 16.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.351 0.576 . . . . 0.0 111.205 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.915 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -105.53 118.4 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.439 ' CB ' HG22 ' A' ' 62' ' ' THR . 7.8 t -97.4 166.0 11.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.615 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.3 p -52.17 -31.16 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.836 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -63.95 -50.45 68.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 111.321 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.7 -36.07 51.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.24 -45.67 72.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.013 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.33 -27.39 73.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.279 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 85.0 m -72.21 -47.14 52.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.721 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.5 p -74.71 -34.97 35.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -60.08 -49.77 76.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -64.41 -30.36 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 t -58.31 -21.29 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' B' ' 74' ' ' LEU . 11.4 mt -71.59 -60.26 2.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.92 -39.0 0.02 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.542 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.8 mt-30 -140.93 147.86 39.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.111 0.455 . . . . 0.0 111.162 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -99.64 99.65 9.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.258 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.44 -168.8 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.356 2.037 . . . . 0.0 111.971 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -85.1 169.82 13.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.65 -30.49 69.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 0.0 110.066 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -44.25 59.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.141 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 51' ' ' MET . 1.3 mt-10 -62.03 -41.1 97.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.266 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.9 mt -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.861 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.4 tt0 -64.24 -39.59 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -66.27 -51.09 60.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.66 -53.42 58.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.381 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.027 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -60.26 -45.35 96.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.497 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 26.7 t-20 -52.07 -26.12 10.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.446 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 2.2 mt-10 -82.96 -3.3 56.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.38 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -64.59 133.22 51.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.053 0.454 . . . . 0.0 111.344 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.11 -53.58 16.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.897 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.66 58.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.07 49.22 80.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.933 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -104.26 -1.47 27.02 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.771 -0.253 . . . . 0.0 111.439 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 17.72 15.01 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.252 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.23 139.82 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.44 149.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 111.985 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.75 170.8 7.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.415 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.487 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.4 m-85 -56.03 -61.55 6.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.533 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -68.24 -18.59 44.9 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.508 2.138 . . . . 0.0 112.68 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.409 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.475 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.4 t80 -75.28 -38.48 60.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 3' ' ' GLN . 12.1 tp -64.45 -55.61 19.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -51.67 -37.26 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.22 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.425 ' HG2' HG13 ' A' ' 55' ' ' VAL . 2.8 tpt -64.08 -32.74 74.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.4 mmt -108.27 15.52 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -119.35 -36.69 3.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.803 0.335 . . . . 0.0 111.291 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -53.31 -54.33 37.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.826 0.346 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.536 ' CB ' HG21 ' A' ' 146' ' ' THR . 11.5 m-20 58.56 161.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.367 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 t -166.2 -167.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -73.55 -26.04 60.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.03 -33.79 59.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' OE1' HG22 ' B' ' 77' ' ' VAL . 4.4 mt-10 -61.24 -45.4 94.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -72.34 -39.14 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.761 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -71.54 -49.47 40.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.799 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 91' ' ' VAL . 58.4 mt-10 -61.36 -45.56 93.89 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 109.313 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.54 -50.51 65.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.894 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.21 -40.8 59.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.833 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -31.76 68.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.443 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.061 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.57 -36.85 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.828 ' CE2' HG22 ' B' ' 78' ' ' ILE . 6.5 m-85 -75.63 -43.28 48.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -112.57 109.29 18.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -42.03 80.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -74.19 -9.71 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.06 68.51 0.77 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.172 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.46 8.82 40.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.47 16.38 65.14 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.296 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 3.6 m-85 -163.86 116.68 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.731 0.3 . . . . 0.0 111.066 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.605 HD11 ' HD1' ' A' ' 89' ' ' PHE . 8.9 mt -111.28 127.38 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 111.788 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.5 m -104.21 158.59 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.059 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -48.0 -41.98 26.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.732 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 111.126 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt-10 -56.67 -37.77 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.591 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -60.82 -47.71 85.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.882 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.746 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.39 -44.47 88.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.559 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 1.3 t60 -58.73 -38.33 78.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.38 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 92' ' ' PHE . 77.6 t -67.31 -55.64 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.0 mmt -49.05 -53.44 20.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.617 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.3 t -68.0 -24.34 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 24.4 t30 -74.54 -31.39 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.664 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.7 -28.72 20.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.18 44.11 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.576 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.85 109.72 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -90.72 99.66 12.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 116' ' ' LEU . 4.4 mm? -101.27 172.51 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.806 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.3 t -96.59 166.58 11.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.829 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.32 -34.07 77.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -35.51 78.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.707 ' H ' HG23 ' A' ' 117' ' ' THR . 52.0 mm-40 -65.64 -50.02 66.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 106' ' ' ARG . 4.2 m -66.77 -39.56 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.13 -42.37 99.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 110.216 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.0 mt-10 -72.74 -30.13 63.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.339 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -36.19 72.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 105' ' ' LEU . 2.8 mm -80.36 -54.5 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 15.7 ptt180 -53.73 -31.92 50.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.431 . . . . 0.0 110.303 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.65 -21.72 44.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.734 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.673 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -106.68 -0.3 23.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.34 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 46.1 t0 -96.24 102.82 14.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.368 0.604 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -76.93 -32.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.157 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.3 -9.05 49.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.88 0.371 . . . . 0.0 111.491 -178.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.54 56.98 11.28 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -114.33 -3.71 13.07 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.145 0.472 . . . . 0.0 111.49 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.5 44.34 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.099 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.76 -174.79 4.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.646 0.26 . . . . 0.0 110.349 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.2 t -129.22 126.99 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.8 t30 -104.61 -167.68 1.38 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.942 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.629 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.5 t80 -56.7 -73.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 142' ' ' VAL . 1.9 tt0 -49.65 -47.13 50.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.23 0.538 . . . . 0.0 110.445 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.5 mt-10 -56.29 -33.72 65.8 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.759 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.67 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.23 -48.93 13.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.063 0.458 . . . . 0.0 111.686 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.844 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -60.29 -41.86 88.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.217 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.48 ' HG3' ' N ' ' A' ' 144' ' ' MET . 0.5 OUTLIER -70.85 -35.63 72.5 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.673 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 2.7 ptm -70.6 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 85' ' ' ILE . 17.8 mtt -105.11 -44.2 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.536 HG21 ' CB ' ' A' ' 80' ' ' ASP . 1.8 t . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.666 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HA ' ' HG3' ' A' ' 51' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 121.007 0.432 . . . . 0.0 110.759 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.61 -76.26 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.9 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.4 -41.46 55.39 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -64.93 -70.31 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.702 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -52.25 -38.82 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.51 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.4 OUTLIER -55.42 -49.88 71.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.67 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.55 -41.58 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.147 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' B' ' 69' ' ' GLN . 89.4 t -53.6 -53.47 25.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.31 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.878 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -71.33 -44.26 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.405 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.061 HD22 HG11 ' A' ' 91' ' ' VAL . 17.7 mt -56.23 -50.43 71.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.596 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -64.09 -47.02 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.59 -32.98 65.76 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.526 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 73' ' ' ARG . 47.4 t -76.75 -53.02 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.828 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -63.29 -43.08 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.524 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.637 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -57.92 -35.07 70.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 109.687 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -36.04 80.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.337 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.697 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 3.1 t90 -95.37 -13.86 24.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -92.03 -31.4 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.659 ' HG3' HD21 ' A' ' 69' ' ' LEU . 3.2 tt0 -176.55 175.23 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -122.27 165.4 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.631 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.7 t -69.64 170.31 11.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.88 -37.29 66.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.321 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.04 -56.8 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.134 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.631 ' H ' HG23 ' A' ' 5' ' ' THR . 1.2 tt0 -57.91 -44.38 86.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.868 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.437 HG13 HD13 ' A' ' 69' ' ' LEU . 7.1 tt -68.04 -26.78 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.8 -43.17 62.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -27.5 63.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.55 -49.41 41.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.239 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -57.06 -45.09 83.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 110.222 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.1 mm-40 -64.38 -51.66 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.21 -40.18 58.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.841 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -56.01 -47.34 77.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -13.62 62.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.3 mt -88.0 -38.3 15.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 110.503 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.12 -64.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.07 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.4 t70 -61.99 128.1 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -38.54 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.279 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.19 -12.25 30.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.824 0.345 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.33 38.44 86.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -77.66 -1.15 29.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.26 -2.53 43.58 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.213 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.1 p -149.42 132.47 16.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 0.0 110.756 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.925 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.73 119.21 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.423 ' CB ' HG22 ' A' ' 62' ' ' THR . 2.0 t -99.15 165.88 11.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.697 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 p -52.33 -32.56 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.885 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -62.13 -50.56 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.329 . . . . 0.0 111.374 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.78 -37.59 48.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 110.974 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.047 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.23 -40.39 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.585 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.2 -30.86 69.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.914 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.6 m -67.58 -53.25 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.1 p -69.76 -30.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.246 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.418 ' HE2' ' HG3' ' A' ' 43' ' ' PRO . 1.9 mtp -60.14 -46.62 89.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.321 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -25.52 44.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -53.64 -50.67 65.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -46.97 -57.88 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.589 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -142.72 178.76 7.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -147.69 58.58 4.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HG3' ' HE2' ' A' ' 36' ' ' MET . 65.9 Cg_endo -73.91 -178.5 3.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.559 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.1 p -98.66 173.76 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.49 -30.2 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.29 60.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.15 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.2 mt-10 -60.71 -42.01 96.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.062 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.0 mt -58.35 -50.53 73.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.6 tp-100 -62.77 -38.63 91.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.89 -51.23 42.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.352 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.467 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.39 -54.1 50.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.047 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.28 -45.26 93.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.477 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 27.7 t30 -52.36 -25.9 10.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.242 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.8 mt-10 -82.35 -3.33 55.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.98 -32.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.5 t0 -63.92 134.82 55.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -66.52 -53.35 35.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.728 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.77 4.2 51.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.813 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.16 59.71 9.11 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.213 -0.517 . . . . 0.0 113.933 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' OD1' ' OD2' ' A' ' 58' ' ' ASP . 1.3 m120 -109.35 -2.72 17.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.771 0.286 . . . . 0.0 111.323 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.22 17.3 16.18 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.927 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.5 p -149.49 139.96 22.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.337 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -104.64 149.56 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.209 0.528 . . . . 0.0 111.725 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 171.72 7.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -55.9 -61.59 6.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.712 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.1 Cg_endo -67.97 -19.48 45.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.753 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.18 -39.07 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.367 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.2 t80 -75.27 -35.74 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.662 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.7 tp -71.99 -58.43 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.085 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.13 -46.69 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mmt -59.71 -30.69 68.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.426 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.26 14.97 24.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.08 -43.0 3.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -48.7 76.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.795 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.772 0.32 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -85.85 -179.95 6.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -150.2 156.21 41.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.84 -38.54 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.261 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 45.4 mt-10 -63.92 -27.86 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.178 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.18 -39.22 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -70.88 -49.32 47.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.4 mt-10 -61.29 -46.44 90.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.34 0.59 . . . . 0.0 109.476 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.748 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.58 -48.85 68.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.068 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.06 -38.86 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.994 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -30.42 57.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.955 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.01 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.53 -37.02 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.705 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.86 -62.89 1.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.494 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.82 121.17 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.33 -52.62 57.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.234 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.04 -9.61 59.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.496 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.13 71.13 0.52 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.864 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.39 14.58 18.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.633 0.254 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.28 66.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.608 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.2 m-85 -161.84 116.75 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.755 0.312 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.6 mt -113.28 124.45 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.115 0.483 . . . . 0.0 111.645 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -104.26 161.63 13.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.16 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -44.52 29.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.442 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.09 -58.87 6.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.03 -36.62 65.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.636 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.934 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.99 -49.49 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.729 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.85 -41.49 78.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 2.4 t60 -60.55 -39.87 89.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.306 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 92' ' ' PHE . 28.1 t -68.72 -51.8 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.749 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.427 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.7 mmt -51.28 -54.05 29.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.802 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.1 t -66.99 -25.08 66.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 15.8 t-20 -70.69 -31.29 68.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.62 -28.8 16.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.51 43.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -152.11 109.78 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.66 95.63 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.018 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.4 mm? -94.07 157.14 16.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 120' ' ' GLU . 11.6 t -88.01 164.02 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.55 -42.69 83.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -62.46 -35.35 79.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 117' ' ' THR . 20.2 mt-10 -65.31 -54.85 23.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.021 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.94 -39.78 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -62.53 -41.88 99.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 110.276 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 5.6 mt-10 -72.66 -30.14 64.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.317 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 2.3 tpp -70.75 -36.09 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.934 HD11 HD12 ' A' ' 105' ' ' LEU . 4.6 mm -80.24 -54.91 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.567 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.43 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -53.65 -31.75 48.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.01 0.433 . . . . 0.0 110.456 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.77 -20.79 52.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.968 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.06 -10.96 15.76 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.55 0.214 . . . . 0.0 111.523 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -85.51 109.67 18.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.429 0.633 . . . . 0.0 111.307 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.13 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.755 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.496 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.05 -9.14 43.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.523 -178.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.31 57.62 10.05 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.8 p30 -114.25 -4.33 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.05 0.425 . . . . 0.0 111.456 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.69 42.45 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.991 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.05 -174.87 4.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.53 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 141' ' ' PHE . 54.0 t -128.34 126.82 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -106.55 -167.36 1.28 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.6 t80 -58.09 -73.98 0.07 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -49.56 -45.64 47.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.375 0.607 . . . . 0.0 110.336 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.55 -36.61 69.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.74 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.64 -49.51 12.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.913 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.85 -40.21 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -34.44 70.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.757 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.424 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.82 8.93 13.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 111.283 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.8 mtt -118.81 -36.32 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -179.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.526 0.036 0 CA-C-O 120.971 0.415 . . . . 0.0 110.774 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.03 -75.81 0.22 Allowed Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.95 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.35 -46.69 63.67 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -58.71 -70.26 0.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.27 . . . . 0.0 110.552 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.46 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.29 -34.09 45.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.205 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 6.6 tpt180 -58.14 -52.18 66.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.38 -41.8 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.053 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 68' ' ' PHE . 90.4 t -53.03 -53.3 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.446 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.826 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.02 -45.01 64.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.436 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.01 HD22 HG11 ' A' ' 91' ' ' VAL . 21.2 mt -55.99 -49.73 72.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.557 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -64.62 -48.62 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.574 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.96 -29.67 59.39 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.151 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.826 HG23 ' O ' ' B' ' 73' ' ' ARG . 98.8 t -76.8 -55.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.604 0.24 . . . . 0.0 111.562 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.705 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.5 pp -61.73 -43.91 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.664 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.6 mmm180 -58.16 -34.26 70.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.229 0.538 . . . . 0.0 109.855 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -62.27 -37.03 83.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.901 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.34 -15.38 23.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.73 -26.26 19.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.501 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.645 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -176.57 170.82 2.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.836 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -124.13 165.36 17.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 8' ' ' GLN . 10.1 t -67.93 166.33 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -54.34 -26.48 30.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -80.36 -56.89 3.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.126 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.836 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.84 -46.57 84.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 69' ' ' LEU . 7.0 tt -65.52 -26.65 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.55 -44.04 62.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.294 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 -25.71 61.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -71.42 -49.39 42.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.298 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -56.35 -44.93 80.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.307 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.4 mm-40 -65.35 -51.44 60.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 1.046 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.18 -40.06 57.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.922 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -57.07 -45.98 82.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -70.94 -13.76 62.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.2 mt -87.99 -38.38 15.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.906 0.384 . . . . 0.0 110.57 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.788 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.31 -64.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.3 t70 -62.52 127.34 30.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.801 0.334 . . . . 0.0 110.432 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -38.69 92.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.9 -12.31 31.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.26 38.38 86.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -77.65 -1.06 29.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.79 43.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.195 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.7 p -149.37 132.49 16.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.939 0.37 . . . . 0.0 110.764 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.38 119.35 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.404 ' HA ' HG22 ' A' ' 62' ' ' THR . 2.9 t -98.75 165.11 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.696 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 p -52.76 -30.45 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.83 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -63.24 -50.61 69.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -77.85 -37.87 47.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.14 -41.39 68.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 -29.42 72.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.9 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.6 m -69.51 -52.05 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.542 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.7 p -69.01 -31.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -47.16 87.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -25.47 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.758 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 t -54.69 -50.72 67.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.51 -58.72 3.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 111.085 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.6 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -142.71 -178.02 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -150.99 58.16 2.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 -177.18 2.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.65 2.233 . . . . 0.0 112.504 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.2 p -99.71 173.6 6.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -68.54 -30.14 68.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.918 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.12 59.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.8 OUTLIER -61.32 -42.51 98.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.076 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.5 -50.53 72.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 28.2 tp60 -63.28 -39.43 94.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.214 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.61 -51.25 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.325 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.79 -53.84 53.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 110.347 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.043 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.31 -45.27 93.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.437 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 10.0 t30 -52.38 -25.92 11.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.257 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.2 mt-10 -82.39 -3.26 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.12 -32.36 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -63.31 136.51 57.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 111.195 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.46 -53.9 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.562 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -95.6 4.24 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.62 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.31 58.74 10.16 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.8 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -109.72 -1.76 17.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.788 0.294 . . . . 0.0 111.301 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.461 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.44 15.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.953 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.586 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.9 p -149.32 139.85 22.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.137 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.59 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -103.95 149.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.082 0.468 . . . . 0.0 111.708 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.38 169.28 8.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.624 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.2 m-85 -53.44 -61.12 5.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.393 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_endo -69.11 -18.44 40.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.486 2.124 . . . . 0.0 112.636 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mm-40 -79.24 -38.85 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.0 t80 -75.26 -34.09 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.622 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.9 tp -73.74 -58.43 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -52.08 -47.81 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.491 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 4.4 mmt -59.55 -28.58 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.43 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.22 13.23 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -110.64 -43.69 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -55.58 -44.26 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 110.859 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.783 0.325 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 -178.84 7.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.039 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.92 155.96 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.51 -24.97 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.362 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.1 -37.25 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.202 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 55.3 mt-10 -64.9 -28.07 69.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.165 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.2 -39.27 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.287 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -70.83 -49.28 47.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 36.1 mt-10 -61.04 -47.0 88.43 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.795 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.43 -48.85 68.4 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.241 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.14 -38.86 54.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.984 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -30.46 56.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.949 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.044 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.44 -37.07 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 111.026 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.4 m-85 -71.62 -62.95 1.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.8 117.95 23.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -60.66 -52.63 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.47 -9.64 59.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.501 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.7 71.65 0.47 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.879 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.38 14.42 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.57 13.72 61.32 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.673 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.9 m-85 -158.07 116.69 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.76 125.1 70.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.792 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 161.86 13.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.237 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.581 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.91 -46.98 32.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.555 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.31 -58.87 5.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.14 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.88 -36.55 65.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.606 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.2 -50.52 72.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.648 178.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.559 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -56.4 -41.85 77.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -60.12 -39.35 85.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.397 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.21 -55.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.694 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.6 mmt -49.94 -54.07 22.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.39 -24.92 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.12 -31.41 70.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.73 -28.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.03 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.27 43.17 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -150.17 109.82 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -90.21 98.82 12.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.3 mm? -88.37 171.22 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 m -98.29 158.96 15.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -56.76 -48.9 76.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -64.18 -31.66 72.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.64 -54.91 32.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.6 m -65.37 -40.46 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.47 -40.99 98.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.094 0.473 . . . . 0.0 110.283 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 9.8 mt-10 -73.02 -30.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.405 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.0 mtp -71.04 -35.74 72.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 105' ' ' LEU . 5.0 mm -80.35 -54.94 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.623 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 ptm180 -53.89 -31.86 51.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 0.0 110.38 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.96 -21.01 47.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.786 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.97 -5.05 18.43 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 121.114 -0.235 . . . . 0.0 111.445 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.4 t0 -92.38 109.7 21.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.41 0.624 . . . . 0.0 111.325 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.74 -31.18 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.793 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.92 -9.12 44.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.554 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.55 58.21 8.51 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.405 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.8 p30 -114.25 -4.53 13.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.04 0.42 . . . . 0.0 111.463 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.38 7.83 42.13 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.967 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.11 -174.81 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.766 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.04 126.67 66.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.261 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -105.29 -168.28 1.44 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.628 ' O ' HG13 ' A' ' 142' ' ' VAL . 59.7 t80 -58.51 -73.98 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.52 -45.52 47.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.348 0.594 . . . . 0.0 110.265 -179.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.51 -36.38 69.11 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.108 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.766 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.71 -49.83 11.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.901 0.381 . . . . 0.0 111.92 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.12 -40.49 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -34.45 70.9 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.705 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.41 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.43 8.6 13.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.647 0.261 . . . . 0.0 111.305 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.574 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -118.51 -37.66 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.396 -179.799 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 121.014 0.435 . . . . 0.0 110.822 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.14 -75.74 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.935 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.48 63.24 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.058 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -59.1 -70.29 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.653 -0.273 . . . . 0.0 110.501 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.08 -34.0 41.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.179 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.8 tpp180 -58.27 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ILE . . . . . 0.621 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.14 -41.81 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.963 178.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.6 t -52.95 -52.62 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.468 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ARG . . . . . 0.863 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.04 -45.78 63.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.331 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 1.044 HD22 HG11 ' A' ' 91' ' ' VAL . 22.7 mt -55.87 -49.26 73.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 110.545 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . 1.046 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -63.97 -48.2 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.56 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' GLY . . . . . 0.569 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.76 -29.82 58.86 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.14 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' VAL . . . . . 0.863 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.2 t -76.77 -56.06 9.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.596 0.236 . . . . 0.0 111.63 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.66 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -60.74 -43.56 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . 0.66 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.05 -33.29 68.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 109.901 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -37.79 88.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.469 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' TRP . . . . . 0.933 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.2 t90 -95.52 -11.37 27.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.153 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -93.29 -31.23 14.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.419 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.562 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.792 0.33 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.407 ' HB2' HG23 ' A' ' 70' ' ' THR . 32.9 p-10 -157.06 85.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -177.54 -179.92 0.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.81 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.783 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -133.55 165.27 25.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 169.4 13.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.075 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -30.29 57.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.518 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -78.45 -56.88 4.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.783 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -59.31 -45.32 91.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.006 0.431 . . . . 0.0 110.481 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 5' ' ' THR . 13.0 tt -65.17 -26.65 40.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.955 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.68 -44.04 62.96 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.442 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -32.71 72.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.257 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -67.6 -49.7 61.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.328 -179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -44.74 92.19 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.254 0.55 . . . . 0.0 110.043 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -65.42 -47.88 74.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.704 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.959 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.4 -41.97 63.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.311 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -56.76 -35.12 68.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.043 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -77.86 -14.64 59.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.927 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.66 -38.5 15.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.631 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.26 -65.58 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.339 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.8 t70 -66.01 132.33 48.32 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.741 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -37.89 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.211 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.01 -12.15 29.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.789 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.51 36.76 79.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.654 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -74.67 -5.11 41.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.523 0.201 . . . . 0.0 111.501 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.18 2.29 44.9 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.124 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 53.1 p -149.43 132.53 16.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.801 0.334 . . . . 0.0 110.877 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -108.97 126.56 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.48 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.03 167.82 10.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 p -54.01 -30.44 47.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.48 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -62.79 -50.39 71.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.204 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.573 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.5 mm-40 -77.73 -36.28 51.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 110.798 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.37 -58.35 7.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.703 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.25 -27.49 69.27 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.555 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -70.99 -60.99 1.93 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 0.0 111.12 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -64.71 -30.76 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.033 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.7 ttt -60.22 -55.22 36.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.77 -25.63 64.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.967 179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.6 t -56.04 -38.37 70.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.047 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.4 mt -57.92 -62.3 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.839 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 167.65 41.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -142.56 167.8 21.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -134.97 59.66 35.67 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.71 -169.98 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.588 2.192 . . . . 0.0 112.289 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.3 p -116.46 167.57 10.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.78 -32.05 71.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.229 0.538 . . . . 0.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.8 -45.62 59.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.405 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.0 OUTLIER -64.17 -43.4 95.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.302 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -55.25 -50.58 69.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.09 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -64.56 -57.03 10.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.47 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -51.19 67.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.182 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.519 ' HE2' ' H ' ' B' ' 66' ' ' GLY . 15.7 mtt -57.64 -47.06 83.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -61.58 -45.68 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.159 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -56.36 -26.53 53.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.529 0.68 . . . . 0.0 110.113 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 51' ' ' MET . 6.6 mt-10 -81.53 -2.14 48.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.351 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.629 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -127.0 -33.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.919 0.39 . . . . 0.0 112.04 -177.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.484 ' N ' HD12 ' A' ' 63' ' ' ILE . 54.1 t0 -72.49 148.5 45.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.251 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.44 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.5 -53.57 7.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.709 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.54 -8.63 58.2 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.34 48.55 79.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.931 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.9 p-10 -96.6 -0.22 48.95 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.643 0.222 . . . . 0.0 111.405 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 15.13 22.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.922 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.48 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.4 p -149.88 139.89 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.56 0.18 . . . . 0.0 110.565 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.595 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.71 147.34 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.497 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -100.52 179.08 4.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.882 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -60.93 -61.69 7.48 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.0 Cg_endo -66.93 -30.94 39.0 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.435 2.09 . . . . 0.0 112.197 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.44 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mt-10 -65.74 -40.61 92.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -75.14 -41.95 57.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.018 0.437 . . . . 0.0 110.335 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -71.17 -53.1 15.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.482 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.556 ' N ' HD23 ' A' ' 69' ' ' LEU . 90.4 m -51.58 -46.34 63.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.182 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.404 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.8 tpp -56.65 -48.33 77.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.932 0.396 . . . . 0.0 110.936 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.9 mmt -85.95 0.15 53.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.595 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.559 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.66 -38.89 11.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.93 0.395 . . . . 0.0 111.076 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.8 mmm180 -55.04 -30.48 59.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.82 149.2 31.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.986 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.84 89.73 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -103.6 -49.7 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.804 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -135.54 114.1 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.746 HG23 HH22 ' B' ' 73' ' ' ARG . 1.4 t -176.74 170.09 2.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -151.75 174.44 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -152.17 155.46 37.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.897 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -54.64 -24.29 20.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 -38.68 60.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.066 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 53.5 mt-10 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.026 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.29 -38.88 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.396 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.56 -49.35 33.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.381 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 64.7 mt-10 -61.06 -45.49 94.55 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.87 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.47 -53.33 53.03 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.997 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.636 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.36 -38.88 55.54 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.833 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.98 -31.46 68.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.25 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.937 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.39 -36.68 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.648 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.535 ' O ' HG21 ' A' ' 108' ' ' VAL . 5.9 m-85 -71.93 -62.9 1.26 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.923 0.392 . . . . 0.0 110.482 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -85.25 129.93 34.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -75.67 -52.6 10.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.238 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -77.37 -9.6 58.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.481 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.21 70.44 0.62 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.898 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -93.43 15.32 16.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.209 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.3 68.89 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.2 m-85 -166.35 116.34 0.95 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.951 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.2 mt -111.66 129.11 67.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.787 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.6 t -104.08 156.5 17.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.197 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.488 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.93 -38.88 17.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.385 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.85 -59.01 6.11 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.057 0.456 . . . . 0.0 110.864 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.52 -36.87 72.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.689 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.845 HD12 HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -61.56 -49.31 77.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.957 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.527 ' O ' HG22 ' A' ' 110' ' ' THR . 2.0 tpt180 -56.75 -44.49 81.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.205 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -58.76 -37.52 76.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.17 178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 92' ' ' PHE . 38.5 t -68.87 -53.77 24.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.674 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.528 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.0 mmt -50.35 -54.12 23.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.815 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.3 t -67.29 -24.87 65.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.594 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.38 -29.99 67.88 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.61 -28.84 14.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.75 43.98 0.13 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.96 125.75 18.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.318 . . . . 0.0 110.817 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -92.31 95.6 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.8 mm? -97.79 150.84 20.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.879 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.813 ' O ' HG22 ' A' ' 121' ' ' VAL . 16.9 m -98.24 159.05 15.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -58.08 -44.38 87.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -34.62 75.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.685 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -65.52 -54.87 22.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.846 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.813 HG22 ' O ' ' A' ' 117' ' ' THR . 2.7 m -64.66 -38.82 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.038 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -62.68 -42.04 99.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.39 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.1 mt-10 -73.03 -30.11 63.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.444 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 1.5 mmt -71.18 -35.07 71.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.726 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.845 HD11 HD12 ' A' ' 105' ' ' LEU . 2.4 mm -80.35 -54.83 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.3 ptm180 -54.04 -31.86 52.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 110.302 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.19 -22.87 57.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.743 179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.46 -11.17 18.77 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -96.35 97.79 9.76 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.484 0.659 . . . . 0.0 111.214 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.405 HG21 ' OE1' ' A' ' 143' ' ' GLN . 0.8 OUTLIER -57.68 -30.57 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.461 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 6.6 p30 -95.74 -9.51 31.62 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.972 -178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 45.98 62.43 3.4 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.505 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.3 p30 -113.68 3.2 15.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.584 0.23 . . . . 0.0 111.447 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.34 2.96 47.79 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.6 -0.81 . . . . 0.0 113.379 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.49 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.09 -177.33 5.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.094 0.447 . . . . 0.0 110.966 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.636 HG12 ' HZ ' ' A' ' 89' ' ' PHE . 82.2 t -130.78 128.58 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.145 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -99.52 -175.07 2.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.736 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.7 t80 -56.82 -72.41 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.018 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.37 -43.26 43.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.152 0.501 . . . . 0.0 110.91 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.55 -36.17 71.28 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.27 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.62 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.38 -49.67 12.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.134 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.6 m -53.97 -42.41 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 120.794 0.33 . . . . 0.0 110.711 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 12.6 pt20 -70.93 -48.6 52.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.231 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.455 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.74 -15.76 54.64 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.454 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.2 mtt -89.83 -42.96 10.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.731 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 147' ' ' ALA . 4.5 t -135.77 -51.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -84.83 53.69 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 111.599 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.909 179.92 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.681 0.277 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.02 -176.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.578 2.186 . . . . 0.0 112.328 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -102.8 -47.13 4.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -150.34 30.84 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.01 -135.52 5.88 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.489 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -109.6 114.62 28.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.519 ' H ' ' HE2' ' A' ' 51' ' ' MET . . . -58.55 -71.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.603 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.57 -50.29 49.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.35 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.629 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -58.3 -67.86 0.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.606 0.241 . . . . 0.0 110.514 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.439 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.99 -35.99 48.32 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.298 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 19.5 tpp85 -56.38 -49.86 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.615 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.35 -42.19 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.006 178.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.5 t -50.72 -50.31 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.558 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.854 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.82 -45.88 63.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.395 -179.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.937 HD22 HG11 ' A' ' 91' ' ' VAL . 19.5 mt -55.87 -50.61 70.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.812 0.339 . . . . 0.0 110.561 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.959 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.3 p -63.02 -47.8 91.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 110.414 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.95 -29.6 59.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.165 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.855 HG11 ' CB ' ' A' ' 88' ' ' ALA . 92.5 t -76.76 -56.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.629 0.252 . . . . 0.0 111.494 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.644 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -59.9 -43.69 92.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.644 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.9 mmm180 -57.81 -35.09 70.36 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.236 0.541 . . . . 0.0 109.673 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -62.86 -35.77 81.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.109 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.763 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.4 t90 -95.19 -9.97 31.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.774 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.77 -36.94 50.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.281 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -148.23 -65.28 0.25 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.018 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.9 66.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.957 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.78 -66.6 1.07 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.776 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.401 ' O ' ' CD2' ' B' ' 86' ' ' PHE . 67.9 t80 -106.29 33.96 3.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.879 -179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.832 0.349 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -66.43 77.6 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.633 ' CG ' HD21 ' A' ' 69' ' ' LEU . 2.5 tt0 -177.39 -175.64 0.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.707 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -137.04 165.17 26.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.594 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.6 t -69.78 171.4 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.929 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.97 -35.81 64.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.444 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -74.27 -56.88 4.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.136 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.707 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -58.38 -41.26 84.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.699 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 5' ' ' THR . 7.5 tt -71.4 -26.38 26.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.029 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.39 -43.22 61.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.514 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -69.34 -33.44 73.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -65.96 -49.65 67.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.467 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.56 -44.82 89.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.202 0.525 . . . . 0.0 110.215 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.03 -48.86 72.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.703 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.897 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.34 -41.45 63.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.497 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.429 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -57.51 -31.73 66.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.957 -179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 m -79.7 -15.08 58.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.892 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.64 -38.79 15.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.109 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.591 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.04 -65.84 0.63 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.35 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -66.57 132.69 48.74 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.863 0.363 . . . . 0.0 110.702 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HG2' ' OE1' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -70.48 -37.3 74.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.18 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.92 -12.28 29.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.764 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.49 37.08 80.42 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.64 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -75.21 -4.2 37.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.505 0.193 . . . . 0.0 111.473 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 -0.23 44.01 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.491 -0.862 . . . . 0.0 113.059 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.3 p -149.54 132.59 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.803 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.808 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mp -107.54 128.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.7 t -103.28 165.13 11.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 p -52.78 -26.65 14.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.688 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -67.53 -50.5 58.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 31' ' ' GLU . 15.3 mm-40 -77.46 -35.41 53.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.206 0.527 . . . . 0.0 110.752 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.012 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.27 -58.36 7.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.773 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -61.0 -27.3 66.89 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.241 -0.891 . . . . 0.0 112.919 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.9 m -69.89 -56.52 6.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.768 0.318 . . . . 0.0 111.52 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.591 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.7 p -67.81 -33.78 63.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.484 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.455 ' HE2' ' HA3' ' B' ' 67' ' ' GLY . 0.0 OUTLIER -59.05 -53.1 62.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.713 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -68.9 -25.77 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.984 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 t -60.41 -36.71 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.7 mt -58.31 -30.65 66.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.23 42.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.524 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -142.6 161.59 37.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -120.23 62.75 8.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.73 -174.13 1.21 Allowed 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.571 2.181 . . . . 0.0 112.355 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.4 p -122.12 167.29 13.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -68.79 -32.26 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.183 0.516 . . . . 0.0 110.084 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.77 60.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.487 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.62 -41.92 95.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.394 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -56.34 -50.79 70.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.186 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -65.46 -50.03 66.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.54 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -51.08 71.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.6 -49.89 75.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.698 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -58.88 -42.32 85.44 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.451 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.261 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -59.18 -26.34 64.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.56 0.695 . . . . 0.0 110.06 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -83.79 -2.16 55.76 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.806 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.86 -33.06 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.497 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.3 t0 -71.15 148.02 47.79 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.481 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.85 -53.45 6.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.646 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -85.36 -8.76 58.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.328 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.49 48.75 78.69 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.933 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -96.96 -1.42 45.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.627 0.251 . . . . 0.0 111.493 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.24 22.16 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.86 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.81 21.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.582 HD11 ' HA ' ' A' ' 52' ' ' ILE . 3.3 mm -95.33 147.21 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.092 0.473 . . . . 0.0 111.663 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.49 176.92 5.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.929 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.429 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 3.3 m-85 -60.21 -61.62 7.56 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 33.4 Cg_endo -64.48 -30.94 61.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.411 2.074 . . . . 0.0 111.771 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 1.9 mt-10 -69.03 -37.09 78.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.336 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.3 t80 -75.12 -39.97 60.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.299 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.633 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.6 tp -76.79 -54.57 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.604 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.1 m -51.58 -44.02 62.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.613 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -54.17 47.12 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.864 0.364 . . . . 0.0 111.011 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.47 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 22.9 mtt -80.31 -8.06 59.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.604 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -87.82 -42.68 12.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.842 0.353 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -59.5 -29.88 68.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.921 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.61 138.28 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.4 mpp? 60.71 93.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -93.83 -59.77 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.687 ' O ' HG23 ' A' ' 79' ' ' THR . 25.8 t0 -130.87 132.07 44.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -169.32 169.68 8.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -149.03 163.29 37.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 157.55 43.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -57.44 -27.78 62.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.09 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -75.2 -34.43 61.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.013 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.2 mt-10 -61.48 -33.84 74.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.811 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.41 -39.02 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.298 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -49.32 33.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.289 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.5 mm-40 -60.9 -44.94 96.46 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.864 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.66 -52.87 58.56 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.883 178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.608 ' HZ ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -51.28 -38.85 55.03 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.865 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -71.49 -31.44 67.12 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.295 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.43 -36.68 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.656 ' CE2' HG22 ' B' ' 78' ' ' ILE . 7.8 m-85 -73.51 -62.81 1.35 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.934 0.397 . . . . 0.0 110.394 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -84.81 118.14 24.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -64.8 -52.64 55.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.27 -9.63 59.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.541 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.81 70.97 0.56 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.867 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -93.21 15.14 16.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.689 0.281 . . . . 0.0 111.238 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.45 66.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.617 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 1.9 m-85 -165.67 116.36 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.882 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.576 HD11 ' HD1' ' A' ' 89' ' ' PHE . 7.7 mt -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.995 0.426 . . . . 0.0 111.866 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.7 t -104.04 156.39 17.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.929 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.478 ' CA ' HG13 ' A' ' 125' ' ' ILE . . . -47.97 -36.63 12.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.446 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -59.06 5.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.105 0.479 . . . . 0.0 110.978 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.4 mm-40 -58.75 -38.92 79.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.749 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.799 HD12 HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -60.17 -48.36 82.05 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.842 179.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 110' ' ' THR . 5.0 tpt85 -56.91 -45.53 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.14 178.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -57.9 -36.63 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.148 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 92' ' ' PHE . 52.6 t -67.43 -54.44 23.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.66 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.703 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.1 mmt -50.36 -54.01 24.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.6 t -67.63 -25.57 65.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.606 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.5 -31.23 71.22 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.82 -28.79 17.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.035 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.18 42.31 0.17 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.552 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.576 ' OE2' HD21 ' A' ' 116' ' ' LEU . 6.2 tt0 -146.72 110.68 5.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.812 0.339 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -88.0 86.01 7.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -80.13 175.64 10.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.811 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 121' ' ' VAL . 3.6 m -98.41 158.68 15.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.706 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -65.95 -35.0 79.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.111 0.481 . . . . 0.0 110.209 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -71.76 -32.98 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.196 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -64.18 -52.98 56.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.54 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 117' ' ' THR . 2.9 m -66.95 -39.18 82.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -64.48 -45.15 88.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.046 0.45 . . . . 0.0 110.373 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 24.3 mt-10 -72.97 -30.16 63.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.622 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.76 -34.46 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.755 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.799 HD11 HD12 ' A' ' 105' ' ' LEU . 2.0 mm -80.27 -54.73 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.463 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.2 ptm180 -53.91 -31.88 51.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.004 0.43 . . . . 0.0 110.284 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -75.33 -23.48 57.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.688 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -102.03 -4.99 25.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 121.066 -0.253 . . . . 0.0 111.442 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -101.45 96.45 7.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.469 0.652 . . . . 0.0 111.273 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.86 -30.84 39.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.611 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 5.0 p30 -95.82 -9.37 31.75 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.791 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 46.7 62.66 3.55 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.355 -0.45 . . . . 0.0 113.613 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.6 p30 -113.7 1.99 15.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.568 0.223 . . . . 0.0 111.434 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.28 4.57 47.09 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -149.98 -177.59 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.994 0.426 . . . . 0.0 111.064 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.692 HG11 ' CD1' ' A' ' 141' ' ' PHE . 82.4 t -130.78 128.69 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.2 t30 -101.13 -174.03 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.786 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 142' ' ' VAL . 24.4 t80 -57.06 -73.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.514 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.38 -42.73 42.99 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.764 -179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -57.43 -37.24 72.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.326 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.692 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -79.43 -49.74 11.87 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.189 -179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.811 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.5 m -53.68 -42.33 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 110.784 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 12.3 pt20 -70.94 -48.18 54.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.267 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.457 ' N ' ' HG3' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -62.66 -15.56 52.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.473 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.589 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.6 mtt -90.59 -42.62 10.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.751 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 147' ' ' ALA . 4.5 t -135.46 -51.17 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -84.97 53.32 2.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.577 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.876 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . 0.728 HG23 ' NH2' ' B' ' 70' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.709 0.29 . . . . 0.0 111.162 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.12 173.89 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -60.18 -43.47 95.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -176.83 79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.84 -83.27 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.518 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.544 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -145.23 120.09 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 110.938 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.67 -70.46 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.601 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 36' ' ' MET . . . -57.9 -46.86 91.94 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.606 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.75 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.2 OUTLIER -52.23 -64.43 0.82 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 110.295 179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.423 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.03 -31.57 61.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.951 0.405 . . . . 0.0 110.005 178.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.728 ' NH2' HG23 ' B' ' 60' ' ' THR . 10.3 tpp180 -54.0 -53.57 51.13 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.39 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.75 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -65.85 -38.62 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.0 t -50.85 -43.11 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 121.351 0.596 . . . . 0.0 110.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.516 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.67 -48.16 27.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.121 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.749 HD22 HG11 ' A' ' 91' ' ' VAL . 62.6 mt -55.75 -46.77 77.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.955 0.407 . . . . 0.0 110.515 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.897 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -66.28 -46.72 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.593 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -58.16 -30.7 64.4 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.156 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 88' ' ' ALA . 69.0 t -76.77 -55.05 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.645 0.26 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.656 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -61.39 -43.03 95.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.501 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.635 ' N ' HD12 ' B' ' 78' ' ' ILE . 9.8 mmp_? -56.58 -37.4 70.56 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.381 0.61 . . . . 0.0 109.518 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.91 -35.74 79.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.374 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.769 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 2.1 t90 -95.03 -9.92 32.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.685 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -77.53 -36.55 52.28 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.385 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.91 -65.87 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.62 65.39 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.827 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.1 OUTLIER -84.81 -65.26 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.847 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' B' ' 86' ' ' PHE . 24.1 t80 -137.28 35.31 2.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.793 0.33 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.97 78.76 1.35 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.613 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -176.98 -178.25 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.553 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -131.68 165.32 23.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.87 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.591 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.7 t -70.6 177.05 3.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.103 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -59.0 -37.99 78.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.264 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -73.48 -56.82 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.942 -179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.591 ' H ' HG23 ' A' ' 5' ' ' THR . 2.3 tt0 -57.71 -40.72 80.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.768 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.1 tt -72.28 -26.57 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.981 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.64 -43.74 62.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.525 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -68.11 -33.05 73.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.15 -49.69 63.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.229 -179.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -59.69 -44.93 93.44 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.218 0.532 . . . . 0.0 109.906 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -63.68 -48.21 78.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.409 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.83 63.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.285 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.56 -38.61 69.57 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.043 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -74.0 -15.66 61.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.1 mt -87.07 -38.3 16.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.923 0.392 . . . . 0.0 110.257 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.547 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -68.36 -65.68 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.276 179.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -66.1 134.02 51.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.694 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -37.91 76.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.256 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.24 -12.14 28.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 110.824 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.65 36.57 79.14 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.724 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -74.58 -5.51 43.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.523 0.201 . . . . 0.0 111.45 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 3.72 44.6 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.52 -0.848 . . . . 0.0 113.044 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -149.45 132.59 16.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.874 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -110.64 126.93 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.467 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.3 t -100.42 168.27 9.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.829 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.5 p -54.32 -30.34 50.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.44 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -64.12 -50.41 68.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.836 0.35 . . . . 0.0 111.185 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' O ' HG12 ' A' ' 35' ' ' VAL . 22.3 mm-40 -76.79 -35.29 57.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.101 0.477 . . . . 0.0 110.909 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.017 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.41 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.805 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -64.08 -27.46 71.44 Favored Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.803 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.5 m -66.89 -60.24 2.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 111.194 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -70.03 -30.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.98 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 25.1 ttt -62.02 -47.2 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.709 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -78.66 -25.72 44.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.998 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 t -57.7 -36.33 71.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.019 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.15 -61.52 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.972 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.81 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.424 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -142.63 161.89 36.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -130.05 60.06 49.47 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.0 -170.07 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.589 2.193 . . . . 0.0 112.281 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 76.8 p -117.52 167.45 11.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.78 -32.11 71.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.252 0.548 . . . . 0.0 110.072 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -45.69 59.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.338 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -44.85 92.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.262 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.9 mt -53.57 -50.59 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.206 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -64.86 -53.04 52.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -56.85 -51.13 70.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.06 -48.31 82.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.679 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.017 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.52 -43.65 91.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.173 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -58.79 -26.38 64.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.559 0.695 . . . . 0.0 109.885 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.0 mt-10 -82.83 -2.24 54.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.663 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.78 -33.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.0 t0 -70.2 153.92 42.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.17 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.401 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.68 -53.5 6.47 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.855 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.58 -8.54 52.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.56 52.02 55.6 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.859 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.43 0.11 44.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.577 0.227 . . . . 0.0 111.45 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.39 24.38 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.871 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.467 HG22 ' HB ' ' A' ' 28' ' ' THR . 3.8 p -149.98 139.9 21.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.542 0.21 . . . . 0.0 110.633 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.616 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.66 149.37 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.039 0.447 . . . . 0.0 111.491 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 178.26 4.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.722 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.6 m-85 -60.79 -61.59 7.68 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.521 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.5 Cg_endo -67.22 -32.68 32.93 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.463 2.109 . . . . 0.0 112.48 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -65.04 -38.76 91.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.6 t80 -75.35 -41.17 57.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.438 . . . . 0.0 110.036 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.613 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.3 tp -68.4 -56.28 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.4 m -51.72 -46.11 63.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.514 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.0 tpp -55.89 -49.6 72.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.809 0.338 . . . . 0.0 111.087 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 15.0 mmt -81.14 -13.39 58.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.435 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -86.24 -35.17 20.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.914 0.387 . . . . 0.0 110.978 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -38.65 90.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.74 134.7 45.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 mpp? 57.71 76.44 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.987 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -74.1 -61.9 1.7 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -133.35 134.95 44.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.7 t -177.38 156.38 1.2 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.28 159.5 35.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -150.25 154.0 37.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -55.17 -26.64 40.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.6 -34.05 67.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.934 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 37.2 mt-10 -66.77 -32.39 73.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.906 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.823 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.25 -38.92 48.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.289 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.2 -49.41 43.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.388 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.878 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.4 mm-40 -61.5 -45.84 92.52 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.766 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.65 -49.32 68.18 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.978 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.1 -38.42 51.72 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.97 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.57 -30.47 57.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.822 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.14 -37.05 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.714 0.292 . . . . 0.0 110.902 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.6 m-85 -73.74 -62.95 1.32 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.855 0.36 . . . . 0.0 110.483 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -84.42 128.48 34.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.787 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -73.17 -52.63 13.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.254 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -78.57 -9.62 59.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.528 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.72 70.61 0.57 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.956 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -93.67 14.87 17.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.65 0.262 . . . . 0.0 111.219 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.73 68.32 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.6 m-85 -162.99 116.94 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.688 0.28 . . . . 0.0 110.935 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.565 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.77 126.67 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.015 0.436 . . . . 0.0 111.499 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.1 m -103.96 156.94 17.45 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.133 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.53 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.62 -41.54 22.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.334 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.17 -58.91 6.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.056 0.455 . . . . 0.0 110.863 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -55.71 -38.46 69.75 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.754 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.886 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.71 -50.76 72.59 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.834 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.518 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -44.15 77.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.133 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -58.06 -37.51 74.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.333 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.78 -53.88 22.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.74 -54.11 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.821 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.6 t -66.45 -25.42 66.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.4 -29.87 68.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.41 -28.76 13.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.22 43.9 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.536 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -149.66 114.15 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.06 103.08 15.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.999 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.525 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.32 163.6 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.768 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.835 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.1 m -98.28 158.82 15.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.5 -42.34 91.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.81 -35.42 74.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.623 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -65.32 -54.83 23.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.774 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.835 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -64.06 -39.9 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.979 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.85 -41.69 98.14 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.2 mt-10 -72.57 -30.1 64.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.356 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.437 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 53.9 ttm -70.85 -34.88 72.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.678 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.886 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.38 -54.93 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.659 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.428 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm85 -54.26 -31.78 54.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.061 0.457 . . . . 0.0 110.41 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -76.13 -22.02 55.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.897 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.72 15.95 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.576 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -83.88 90.82 7.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.472 0.654 . . . . 0.0 111.06 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.736 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -64.1 -30.74 50.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.411 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.601 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.74 -9.46 57.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.17 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.3 54.49 19.67 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 114.786 0.674 . . . . 0.0 114.786 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.9 p30 -113.86 -5.33 13.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.206 0.503 . . . . 0.0 111.371 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.5 6.49 44.15 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.185 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.38 -174.89 4.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.895 0.348 . . . . 0.0 110.566 179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.3 t -128.94 123.68 59.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.958 0.409 . . . . 0.0 111.326 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.544 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.2 -164.73 1.12 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.855 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.575 ' O ' HG13 ' A' ' 142' ' ' VAL . 12.1 t80 -63.12 -73.9 0.1 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.6 -44.27 47.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.346 0.593 . . . . 0.0 110.302 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.736 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.43 -36.06 68.56 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.007 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.77 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -48.66 13.56 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 120.906 0.384 . . . . 0.0 111.496 -179.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.823 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -57.85 -41.2 79.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.363 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 2.5 pp0? -71.34 -35.3 71.13 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.578 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.41 ' CE ' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -81.66 6.31 15.58 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.655 0.264 . . . . 0.0 111.337 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.58 ' SD ' HG13 ' B' ' 77' ' ' VAL . 2.9 mtt -115.75 -31.97 5.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.287 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 147' ' ' ALA . 12.1 t -141.64 -48.83 0.39 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.604 0.24 . . . . 0.0 111.628 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -87.41 79.66 8.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.856 0.36 . . . . 0.0 111.452 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.001 179.858 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.737 0.303 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.12 -174.61 1.01 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.546 2.164 . . . . 0.0 112.288 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -96.56 -31.34 12.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -155.2 39.26 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.6 -135.68 4.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.466 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? -111.93 123.67 50.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.827 0.346 . . . . 0.0 110.787 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -56.06 -67.94 1.95 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.851 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.63 -49.31 70.1 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.598 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.69 -66.22 0.48 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.493 0.187 . . . . 0.0 111.004 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.41 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.74 -36.78 48.46 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.507 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.5 tpt180 -55.88 -50.27 71.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.586 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.12 -41.75 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.138 178.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.8 t -50.45 -52.4 15.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.581 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.828 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.1 mpt_? -70.69 -44.38 67.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.423 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.862 HD22 HG11 ' A' ' 91' ' ' VAL . 15.2 mt -56.03 -51.34 68.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.781 0.324 . . . . 0.0 110.643 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -63.66 -48.09 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.604 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.576 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.87 59.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.042 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.828 HG23 ' O ' ' B' ' 73' ' ' ARG . 78.6 t -76.84 -54.6 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.625 0.25 . . . . 0.0 111.398 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.655 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.9 -44.09 98.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.655 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.23 -35.37 71.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.224 0.535 . . . . 0.0 109.793 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.66 -36.99 80.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.194 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.834 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.9 t90 -95.28 -11.14 28.41 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.798 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.368 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -148.51 -65.4 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.88 66.12 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.021 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.59 -66.65 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.402 ' O ' ' CG ' ' B' ' 86' ' ' PHE . 67.0 t80 -109.53 35.54 3.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.203 -0.904 . . . . 0.0 110.842 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.834 0.35 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -81.77 69.27 8.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.617 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.2 tt0 -173.82 -178.59 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.854 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 69' ' ' LEU . 0.2 OUTLIER -132.3 165.37 24.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' H ' ' A' ' 8' ' ' GLN . 6.5 t -70.21 176.85 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.138 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -59.06 -38.01 78.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.322 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -73.51 -56.79 4.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.996 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.598 ' H ' HG23 ' A' ' 5' ' ' THR . 2.0 tt0 -57.65 -40.75 80.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.775 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 5' ' ' THR . 7.4 tt -72.27 -26.48 24.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.029 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.62 -43.86 62.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.516 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -67.79 -33.48 74.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.205 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.02 -49.61 64.74 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.239 -179.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -59.74 -44.86 93.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.242 0.544 . . . . 0.0 109.887 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -63.1 -49.06 75.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.41 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.948 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.35 -41.43 63.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.27 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -55.83 -38.0 69.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.098 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -75.05 -15.47 60.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.015 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.33 -37.7 16.9 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 110.31 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.92 -65.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.249 179.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.01 133.42 50.78 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.75 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.66 77.12 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.241 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -94.36 -12.2 28.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.785 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.55 36.69 79.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.694 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -74.8 -5.26 42.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.406 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 3.18 44.81 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.496 -0.859 . . . . 0.0 113.069 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 60.7 p -149.48 132.62 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.861 0.362 . . . . 0.0 110.849 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.876 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.68 126.63 66.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.269 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 62' ' ' THR . 9.0 t -99.5 167.3 10.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.821 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.3 p -53.5 -32.14 49.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.57 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -62.67 -50.51 70.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.336 . . . . 0.0 111.265 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . 21.3 mm-40 -75.82 -36.37 59.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.175 0.512 . . . . 0.0 110.731 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.0 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.38 -58.23 8.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.699 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 37' ' ' ARG . . . -62.41 -30.88 77.6 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.665 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.6 m -63.84 -60.95 2.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.361 . . . . 0.0 111.086 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.628 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.2 p -65.68 -30.55 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 19.5 mtp -59.68 -52.14 66.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.626 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.35 -25.66 60.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -55.85 -38.97 70.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.017 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.2 mt -58.06 -63.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.14 40.83 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -141.09 168.37 19.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -135.05 59.48 34.1 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.805 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.43 -169.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.588 2.192 . . . . 0.0 112.277 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 66.9 p -118.1 167.47 11.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -68.82 -32.07 71.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.191 0.519 . . . . 0.0 110.064 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.76 -45.74 59.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.386 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.63 -44.55 93.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.279 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.8 mt -54.03 -50.54 66.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.234 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -64.86 -52.7 55.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.534 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -57.17 -51.03 70.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.275 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.505 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.21 -48.38 81.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.688 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.0 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.35 -43.61 90.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.112 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -58.71 -26.34 63.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.532 0.682 . . . . 0.0 109.991 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 51' ' ' MET . 5.9 mt-10 -82.61 -2.26 53.31 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.591 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.628 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.6 -33.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.474 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.4 t0 -70.95 152.83 43.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.213 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.03 -53.46 6.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.861 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -89.09 -8.67 53.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.4 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.37 51.64 57.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.909 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -98.28 0.24 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.581 0.229 . . . . 0.0 111.402 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.51 24.08 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.866 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.9 p -150.0 139.88 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.536 0.208 . . . . 0.0 110.644 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.5 149.34 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.068 0.461 . . . . 0.0 111.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.26 178.2 4.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.762 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.443 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -61.17 -61.59 7.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.5 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 39.8 Cg_endo -67.1 -31.22 37.12 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.481 2.12 . . . . 0.0 112.468 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -66.58 -38.78 87.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.977 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.8 t80 -75.27 -41.01 58.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 110.038 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD21 ' CG ' ' A' ' 3' ' ' GLN . 8.9 tp -68.81 -56.23 8.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.485 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 67.8 m -51.65 -44.57 63.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.525 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.402 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 1.6 tpp -57.21 -49.92 74.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.065 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 21.2 mmt -79.21 -18.23 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.43 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.523 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.87 -32.75 27.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.068 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.48 -45.16 89.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.95 142.77 42.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.7 ttm 59.92 73.78 0.47 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -76.91 -62.51 1.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.84 126.54 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -177.23 146.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -127.43 177.8 6.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.981 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.6 m -161.29 154.15 20.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.795 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.84 -26.95 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.167 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.59 -37.1 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 19.3 mt-10 -61.7 -30.38 70.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.31 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.252 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.51 -49.36 41.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.425 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.872 ' O ' HG13 ' A' ' 91' ' ' VAL . 9.8 mm-40 -61.45 -45.83 92.62 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.412 0.625 . . . . 0.0 109.445 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.769 ' HB2' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -49.43 67.79 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.956 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.98 -38.68 52.41 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.018 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.16 -30.48 58.12 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.719 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.872 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.4 m -76.31 -37.12 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 120.678 0.275 . . . . 0.0 110.958 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.594 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -72.55 -63.01 1.24 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.864 0.364 . . . . 0.0 110.465 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -83.07 113.71 20.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.854 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.4 mmtm -58.11 -52.56 65.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.291 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -78.71 -9.6 59.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.442 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 46.3 71.79 0.47 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.83 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -94.85 13.46 24.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 111.213 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.08 68.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.548 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.42 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -162.65 116.86 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.732 0.301 . . . . 0.0 111.004 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.55 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -113.5 123.22 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 111.531 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 t -104.2 161.4 14.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.979 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.588 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.71 -43.92 27.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.189 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -58.81 6.61 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.068 0.461 . . . . 0.0 110.908 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' VAL . 32.2 mm-40 -55.11 -37.59 67.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.733 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.66 -50.88 71.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.835 179.092 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.508 ' O ' HG22 ' A' ' 110' ' ' THR . 8.2 tpt85 -56.02 -42.8 77.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -59.09 -37.88 78.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' GLU . 66.8 t -68.92 -54.86 17.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.699 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.536 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.8 mmt -49.08 -54.03 17.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.722 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.1 t -67.21 -25.2 66.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.493 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.33 -30.26 69.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.731 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.38 -28.8 14.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.975 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.7 43.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.531 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -148.98 117.05 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -89.92 107.01 18.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.1 mm? -99.41 161.37 13.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.802 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.827 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.6 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.929 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -59.93 -41.16 91.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.686 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.535 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -64.4 -54.93 25.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.741 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.827 HG22 ' O ' ' A' ' 117' ' ' THR . 2.1 m -62.89 -41.24 91.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.19 -39.48 90.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 110.191 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 11.2 mt-10 -73.1 -30.22 63.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.329 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.21 -35.4 71.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.28 -54.89 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.433 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.5 ptm180 -53.74 -31.73 49.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.98 0.419 . . . . 0.0 110.389 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.92 -21.18 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.965 179.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.94 -9.12 16.38 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.417 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.5 t0 -87.37 110.22 20.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.418 0.627 . . . . 0.0 111.203 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.725 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.86 -31.18 7.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.781 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.1 -9.12 43.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.614 -178.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.08 57.69 9.69 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 114.57 0.588 . . . . 0.0 114.57 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.9 p30 -114.27 -4.27 13.06 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.053 0.427 . . . . 0.0 111.505 178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.7 42.17 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.968 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.94 4.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.332 . . . . 0.0 110.552 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG11 ' CD1' ' A' ' 141' ' ' PHE . 52.2 t -128.31 125.42 64.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.935 0.397 . . . . 0.0 111.156 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.7 t-20 -105.31 -166.32 1.21 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.051 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.2 t80 -59.09 -73.9 0.08 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.2 OUTLIER -49.57 -45.04 47.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.351 0.595 . . . . 0.0 110.33 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.725 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -57.22 -36.65 71.15 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.176 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.741 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.46 -49.08 12.85 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 120.954 0.407 . . . . 0.0 111.877 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.83 -38.88 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.612 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.2 OUTLIER -71.21 -34.25 70.67 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.743 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.424 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -86.37 12.45 10.1 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.738 0.304 . . . . 0.0 111.165 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.586 ' SD ' HG23 ' A' ' 85' ' ' ILE . 2.3 mtt -121.24 -38.98 2.73 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.984 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 147' ' ' ALA . 2.6 t -147.84 -51.57 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.315 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -69.06 74.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.897 0.379 . . . . 0.0 111.376 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.958 179.866 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.76 0.314 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 -168.01 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.589 2.192 . . . . 0.0 112.309 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -106.38 -33.8 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 10.2 mmt-85 -155.52 38.24 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.95 -135.6 4.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.45 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -106.25 128.41 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.783 0.325 . . . . 0.0 110.921 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.32 -66.58 2.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.618 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.71 -49.37 77.0 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.84 -67.15 0.34 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.546 0.212 . . . . 0.0 110.89 179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.439 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 1.0 OUTLIER -51.7 -37.02 48.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.522 -179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.3 tpp85 -55.9 -51.0 69.12 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.596 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.06 -41.61 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.213 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.563 HG12 ' NH1' ' B' ' 73' ' ' ARG . 95.6 t -50.46 -53.4 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.623 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.801 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.52 -43.71 69.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.842 HD22 HG11 ' A' ' 91' ' ' VAL . 16.3 mt -56.22 -53.21 59.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.875 0.369 . . . . 0.0 110.573 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.948 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.6 -46.52 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.719 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.38 -28.32 67.02 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.245 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.801 HG23 ' O ' ' B' ' 73' ' ' ARG . 77.7 t -75.92 -53.27 16.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.67 0.272 . . . . 0.0 110.97 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.653 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -66.35 -40.99 88.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.2 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.1 mmp_? -57.19 -37.59 72.38 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.363 0.601 . . . . 0.0 109.551 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.01 -36.53 79.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.377 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.919 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.12 -9.86 32.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.814 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -76.65 -36.25 57.5 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.287 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -148.5 -64.47 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.025 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.2 65.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.57 -66.77 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.777 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -131.66 35.49 3.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.865 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.829 0.347 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.737 ' CG ' HG23 ' A' ' 70' ' ' THR . 3.2 p30 -96.34 103.55 15.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -177.85 -179.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.703 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -135.85 165.32 25.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.885 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.548 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.09 176.42 3.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.142 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -58.38 -37.89 76.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.369 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -73.12 -56.84 4.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 -179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.703 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -58.26 -42.23 85.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.713 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 5' ' ' THR . 12.2 tt -70.43 -26.77 29.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.003 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -44.12 63.32 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.498 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.13 -32.83 71.03 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.209 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -66.88 -49.76 64.61 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.276 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.69 -44.87 90.42 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.244 0.545 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -65.48 -47.48 75.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.647 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.947 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -42.15 63.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.32 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -57.21 -34.5 68.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.119 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -78.02 -15.36 59.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.976 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.8 mt -87.24 -38.3 16.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.949 0.404 . . . . 0.0 110.245 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.594 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.97 -65.81 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.314 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.9 t70 -66.39 132.35 48.11 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.808 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -38.11 80.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.22 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -93.89 -12.25 29.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.887 0.375 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 36.84 80.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.686 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -74.73 -5.16 41.74 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.421 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 2.44 44.73 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.516 -0.849 . . . . 0.0 113.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 57.0 p -149.47 132.62 16.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -109.21 127.05 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 62' ' ' THR . 4.5 t -100.62 167.59 10.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.963 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 25.2 p -54.4 -28.75 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -64.53 -50.47 67.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.825 0.345 . . . . 0.0 111.143 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -77.15 -36.21 55.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.35 -58.2 8.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.572 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.0 -27.54 70.57 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.732 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.3 m -67.04 -53.28 32.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.594 HG11 ' CD1' ' A' ' 19' ' ' PHE . 14.4 p -72.45 -31.57 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.351 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -45.13 93.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 110.669 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -29.47 45.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.1 t -61.82 -35.11 77.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.91 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.6 mt -58.05 -31.09 66.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.57 42.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.507 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -141.55 172.56 12.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.08 59.96 41.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.43 -170.23 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.591 2.194 . . . . 0.0 112.253 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.1 p -122.12 165.04 16.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.75 -31.15 69.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.186 0.517 . . . . 0.0 110.141 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.67 60.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.333 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.32 -45.25 88.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.223 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.7 mt -53.28 -50.64 64.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.254 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -64.98 -53.88 39.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.606 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -56.33 -51.14 69.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.303 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.499 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -59.28 -47.72 84.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.669 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -59.74 -44.32 93.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.079 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.89 -26.37 62.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.529 0.681 . . . . 0.0 109.978 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.65 -2.2 53.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.766 -1.107 . . . . 0.0 111.634 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.62 -33.25 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 112.043 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.477 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.8 t0 -72.07 148.27 45.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.267 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.36 -53.54 7.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.684 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.67 -8.66 58.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.326 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.3 48.69 78.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.967 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -96.81 -0.19 48.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.589 0.233 . . . . 0.0 111.535 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.476 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.08 22.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.895 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.92 139.88 21.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.559 0.218 . . . . 0.0 110.486 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.603 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.1 mm -94.94 147.44 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.08 0.467 . . . . 0.0 111.518 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.15 178.33 4.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.786 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.459 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -60.28 -61.7 7.41 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.452 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.2 Cg_endo -67.11 -31.51 36.37 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.219 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.8 mt-10 -64.7 -39.84 94.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.961 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.17 -45.03 43.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 110.29 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 70' ' ' THR . 0.2 OUTLIER -67.92 -52.6 34.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.279 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 2' ' ' ASP . 76.6 m -51.6 -49.58 61.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.7 tpp -54.53 -49.5 70.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.014 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.0 mmt -85.0 2.04 44.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.569 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -93.57 -42.13 9.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.899 0.38 . . . . 0.0 110.999 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.8 mmm-85 -53.69 -33.27 54.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.158 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.36 150.49 35.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.978 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 34.3 mtt 61.45 95.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -110.31 -30.86 7.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -153.34 126.35 8.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -177.55 159.13 1.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -141.52 163.62 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.92 152.22 32.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.29 -26.77 19.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.157 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.66 -35.7 67.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.3 mt-10 -64.33 -30.97 72.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.813 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.34 -37.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.119 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -49.46 35.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.519 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.865 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.9 mm-40 -61.88 -46.01 91.27 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.452 0.644 . . . . 0.0 109.359 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.827 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.62 -48.64 69.13 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.839 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.585 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.86 -43.08 59.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.031 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -70.8 -31.59 68.4 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.701 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.3 m -75.54 -37.15 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-O 120.684 0.278 . . . . 0.0 111.064 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.689 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.5 m-85 -76.6 -62.93 1.47 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.871 0.367 . . . . 0.0 110.509 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -83.44 121.9 27.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.782 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -71.24 -52.63 17.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.45 -9.58 59.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.5 68.65 0.86 Allowed Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.936 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -94.41 15.84 16.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.641 0.257 . . . . 0.0 111.272 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.5 69.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.633 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.452 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.5 m-85 -162.47 116.97 1.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.768 0.318 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.585 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -110.63 123.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.979 0.419 . . . . 0.0 111.278 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 t -103.96 157.05 17.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.248 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -41.45 22.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.62 -58.79 6.79 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 108' ' ' VAL . 51.6 mm-40 -55.1 -39.31 69.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.677 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.18 -50.9 72.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.922 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.704 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.55 -42.81 79.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.286 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -36.42 77.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.404 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 104' ' ' GLU . 77.1 t -72.73 -54.79 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.518 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.3 mmt -49.11 -54.02 18.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.645 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' ARG . 10.9 t -66.9 -25.18 66.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.545 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.96 -29.97 68.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.63 -28.78 14.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.68 43.75 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -149.88 112.95 4.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.339 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -90.85 102.23 14.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -94.47 164.48 12.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.794 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.847 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.6 m -98.32 158.81 15.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.875 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -59.32 -42.17 90.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.748 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.75 -35.62 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.649 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.31 -54.87 22.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.756 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.847 HG22 ' O ' ' A' ' 117' ' ' THR . 2.2 m -63.52 -40.66 89.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.937 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -61.65 -41.03 96.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.008 0.433 . . . . 0.0 110.275 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 26.8 mt-10 -72.63 -30.12 64.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.373 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -33.94 69.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.611 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.29 -55.08 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.657 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.419 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 8.8 ptm180 -54.59 -31.82 57.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.034 0.445 . . . . 0.0 110.405 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -76.35 -21.93 55.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.796 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.72 -15.41 15.76 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.606 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -82.44 90.52 6.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.39 0.614 . . . . 0.0 111.04 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.74 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.74 -30.98 51.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.429 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.602 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.0 -9.48 57.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.164 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.88 23.83 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 114.81 0.684 . . . . 0.0 114.81 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 32.2 p30 -113.79 -5.55 13.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.227 0.513 . . . . 0.0 111.303 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 6.66 44.39 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.213 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.58 -174.82 4.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.834 0.35 . . . . 0.0 110.661 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.4 t -127.33 120.81 55.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.975 0.417 . . . . 0.0 111.256 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -98.71 -169.87 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.608 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.514 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.5 t80 -60.12 -73.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.536 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.66 -43.59 47.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.329 0.585 . . . . 0.0 110.286 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.74 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -56.26 -34.72 66.66 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.936 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.45 -48.7 13.49 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.93 0.395 . . . . 0.0 111.22 -179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.813 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.71 -40.41 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.321 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.586 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 2.4 pp0? -71.19 -36.04 71.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.615 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.463 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -82.1 4.92 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.687 0.279 . . . . 0.0 111.261 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.556 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.1 mtt -112.04 -31.62 6.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.028 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 147' ' ' ALA . 5.1 t -146.55 -50.01 0.21 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.464 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.586 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -82.73 80.41 8.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 111.412 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.0 mttp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.035 179.887 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.714 0.292 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.96 -168.04 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.575 2.184 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -98.92 -39.83 8.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.6 mmt85 -155.21 37.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.77 -135.43 4.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.527 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.6 mpp_? -110.5 123.37 49.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.791 0.329 . . . . 0.0 110.787 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.15 -68.23 1.76 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.819 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.58 -52.72 46.79 Favored Glycine 0 CA--C 1.517 0.166 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.641 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.37 -62.78 1.42 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.509 0.195 . . . . 0.0 110.871 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.81 -35.2 43.38 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.39 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.563 ' HE ' HD11 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -56.6 -53.27 59.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.593 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -58.69 -42.28 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.238 178.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.1 t -50.43 -52.86 14.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.672 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.79 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -69.92 -45.57 67.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.543 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.78 HD22 HG11 ' A' ' 91' ' ' VAL . 40.7 mt -55.79 -52.61 63.38 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.656 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.947 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -61.84 -47.62 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 110.429 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.575 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.24 -28.89 59.38 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.205 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.82 HG11 ' CB ' ' A' ' 88' ' ' ALA . 79.8 t -76.78 -56.15 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.689 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.42 -43.75 94.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.662 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.03 -34.64 70.28 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.22 0.533 . . . . 0.0 109.783 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.19 -37.25 82.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.293 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.906 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.7 t90 -95.25 -11.1 28.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.744 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.29 -36.21 58.49 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.188 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -149.28 -65.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.051 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -69.74 67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.058 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.23 -66.55 1.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.776 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' B' ' 86' ' ' PHE . 67.6 t80 -101.72 31.38 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.815 0.341 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.4 ' HB2' HG23 ' A' ' 70' ' ' THR . 6.5 p-10 -175.06 79.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.635 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.6 tt0 -177.02 -178.92 0.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.735 HD22 ' NE2' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -134.81 165.11 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.861 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.2 t -71.37 177.28 4.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.132 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.36 -38.98 78.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 tt0 -71.9 -56.77 5.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.044 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.735 ' NE2' HD22 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -58.63 -43.36 89.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.738 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.509 HG22 ' O ' ' A' ' 5' ' ' THR . 7.0 tt -69.04 -26.44 32.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.062 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.42 -43.37 61.97 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.543 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -68.22 -33.47 74.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.246 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -66.63 -49.74 65.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.44 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -59.17 -44.85 92.16 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.264 0.554 . . . . 0.0 110.047 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -64.45 -48.5 75.06 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.576 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -41.7 63.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.316 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.29 -38.28 71.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.05 -15.67 61.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.967 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -86.62 -38.6 16.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 110.199 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -68.38 -65.85 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.437 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.2 t70 -65.44 132.64 49.45 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.839 0.352 . . . . 0.0 110.707 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -37.14 75.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.166 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.3 -12.27 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.19 36.96 77.7 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.636 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -75.45 -4.21 38.31 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.224 -0.19 . . . . 0.0 111.5 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 1.72 44.64 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.048 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.0 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.851 0.358 . . . . 0.0 110.678 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.844 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.9 mt -108.18 121.53 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.254 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 62' ' ' THR . 1.5 t -97.88 167.5 10.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.0 p -54.34 -35.53 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.6 mtpt -56.77 -50.43 72.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.158 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.83 -37.91 47.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.128 0.489 . . . . 0.0 110.768 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.918 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.55 -43.31 71.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.909 -179.611 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.4 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.36 -27.5 72.64 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.202 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -72.34 -49.75 32.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.2 p -72.32 -33.54 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.0 mtp -60.41 -45.71 92.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.958 0.409 . . . . 0.0 110.677 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -25.92 44.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -58.05 -37.11 73.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.031 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.51 -30.75 65.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.893 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.79 41.54 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.448 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -142.61 163.22 33.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.896 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.51 61.84 12.08 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.73 -170.93 0.5 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.567 2.178 . . . . 0.0 112.277 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 44.3 p -122.11 167.01 13.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.82 -31.98 71.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.207 0.527 . . . . 0.0 110.138 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.85 -45.67 59.85 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.341 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -43.33 94.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.208 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.3 mt -55.15 -50.67 68.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -52.31 58.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.432 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.67 -51.15 70.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.249 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.472 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.69 -47.76 83.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.813 0.339 . . . . 0.0 110.754 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.918 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.98 -45.11 99.12 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.198 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.27 -26.48 51.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.599 0.714 . . . . 0.0 110.143 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.8 mt-10 -82.75 -2.06 53.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.496 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.64 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.61 -33.14 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -177.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.505 ' N ' HD12 ' A' ' 63' ' ' ILE . 52.9 t0 -72.25 148.57 45.35 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.317 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -79.37 -53.57 6.79 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.715 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.15 -8.66 58.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.3 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.55 48.42 81.26 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.968 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.2 p-10 -97.31 -0.88 45.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.543 0.211 . . . . 0.0 111.421 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.485 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.33 15.51 21.12 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.939 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 28' ' ' THR . 2.8 p -149.73 139.79 22.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.12 149.39 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.913 0.387 . . . . 0.0 111.301 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -103.26 175.92 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.977 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -58.65 -61.64 7.28 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.157 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.2 Cg_endo -63.98 -33.83 61.48 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.374 2.049 . . . . 0.0 111.756 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -68.71 -36.46 78.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.391 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -75.33 -40.15 58.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.349 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD21 ' CG ' ' A' ' 3' ' ' GLN . 4.6 tp -76.78 -53.08 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.586 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.4 HG23 ' HB2' ' A' ' 2' ' ' ASP . 98.7 m -51.46 -49.98 60.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.487 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 55' ' ' VAL . 2.1 tpp -53.47 -48.05 69.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.943 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.9 mmt -88.64 10.44 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.52 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -105.21 -36.39 7.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.86 0.362 . . . . 0.0 111.042 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -57.13 -40.12 76.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.948 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.44 149.71 47.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.967 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 26.8 mtm 60.81 91.81 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -104.6 -31.57 9.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -155.05 124.94 6.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -176.59 164.81 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.24 167.58 22.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -153.69 152.52 30.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.777 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -25.49 23.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.108 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -74.58 -38.13 62.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 47.3 mt-10 -60.23 -31.27 70.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.814 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.34 -39.38 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.291 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -70.93 -49.35 46.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.338 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.2 mt-10 -61.05 -46.19 91.68 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.61 -49.44 67.81 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.149 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.03 -38.55 52.05 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.917 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -76.65 -30.53 56.88 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.866 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.95 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.23 -36.94 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.708 0.289 . . . . 0.0 110.898 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -72.41 -62.91 1.27 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.5 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.62 119.35 24.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.793 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -62.34 -52.61 62.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.52 -9.65 59.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.461 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.63 0.47 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.854 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.08 14.44 17.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.663 0.268 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.65 16.76 66.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.4 m-85 -161.55 116.68 2.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.771 0.319 . . . . 0.0 110.945 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.512 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.7 mt -113.92 124.66 70.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.086 0.47 . . . . 0.0 111.656 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.8 t -104.28 161.15 14.29 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.132 178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.89 -43.94 29.12 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.268 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.07 -58.93 6.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.931 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.36 -37.61 67.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.671 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.933 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.36 -50.86 71.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.844 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.541 ' O ' HG22 ' A' ' 110' ' ' THR . 8.3 tpt85 -55.74 -43.61 76.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.117 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -58.1 -38.88 77.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.382 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.1 t -68.25 -54.92 18.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.783 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.617 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.4 mmt -49.41 -54.06 19.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.869 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.5 t -67.7 -25.17 65.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.581 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -68.53 -30.36 69.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.26 -28.73 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.013 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.41 43.46 0.14 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.584 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -152.79 110.77 3.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -83.73 115.8 22.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.005 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -105.81 163.31 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.792 ' O ' HG22 ' A' ' 121' ' ' VAL . 7.6 m -98.27 158.76 15.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.59 -40.81 93.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.637 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -69.92 -35.56 74.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.568 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -64.96 -54.88 23.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.709 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -63.38 -40.49 89.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.963 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.71 -40.06 93.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.11 0.481 . . . . 0.0 110.171 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 14.2 mt-10 -72.9 -30.15 63.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.289 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.459 ' HG2' ' CE2' ' B' ' 81' ' ' TRP . 46.1 ttm -71.01 -35.79 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.879 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 105' ' ' LEU . 4.2 mm -80.4 -54.91 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.579 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.436 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.7 ptm180 -53.44 -31.79 46.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.996 0.427 . . . . 0.0 110.46 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -77.96 -21.58 50.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.942 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.95 -8.56 17.55 Favored 'General case' 0 C--O 1.231 0.091 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.452 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 125' ' ' ILE . 35.9 t0 -88.54 110.27 20.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.456 0.645 . . . . 0.0 111.312 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.724 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.22 7.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.765 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.86 -9.09 44.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.562 -178.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.9 57.94 9.18 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.4 p30 -114.23 -4.19 13.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.033 0.416 . . . . 0.0 111.505 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 7.59 42.45 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.996 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.414 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.13 -174.96 4.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 110.458 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.14 126.62 66.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.881 0.372 . . . . 0.0 111.202 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.94 -167.54 1.33 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.638 ' O ' HG13 ' A' ' 142' ' ' VAL . 56.1 t80 -58.52 -73.94 0.07 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.516 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.47 -45.74 47.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.617 . . . . 0.0 110.32 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.724 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.44 -36.4 68.95 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.146 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.62 -49.59 11.92 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.98 0.419 . . . . 0.0 111.965 -179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.814 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.28 -40.53 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.734 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.503 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.29 -34.28 70.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.713 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.02 8.9 13.82 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.649 0.261 . . . . 0.0 111.328 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.575 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.0 mtt -118.18 -38.9 3.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.767 0.317 . . . . 0.0 111.034 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -139.88 -51.66 0.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.189 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.503 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -82.45 58.41 4.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.936 0.398 . . . . 0.0 111.248 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.907 179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.734 0.302 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.19 172.14 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.571 2.18 . . . . 0.0 112.312 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.48 -41.79 5.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -148.9 31.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -117.16 -135.17 5.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.9 mpp_? -115.46 122.97 47.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.321 . . . . 0.0 110.767 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.68 -68.39 1.71 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.752 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.49 -49.75 75.17 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.46 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.64 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -56.64 -66.42 0.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.477 0.179 . . . . 0.0 110.87 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.437 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -51.79 -38.96 57.74 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.329 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.432 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -54.58 -49.52 70.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.623 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -61.58 -41.99 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.18 178.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.46 -53.07 13.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.556 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.869 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -68.9 -46.46 68.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.42 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.95 HD22 HG11 ' A' ' 91' ' ' VAL . 20.6 mt -55.72 -53.57 54.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.741 0.305 . . . . 0.0 110.736 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.8 p -60.32 -47.2 93.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.965 0.412 . . . . 0.0 110.434 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.565 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.33 -30.3 61.28 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.086 -1.054 . . . . 0.0 112.112 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.869 HG23 ' O ' ' B' ' 73' ' ' ARG . 93.6 t -75.26 -55.39 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.606 0.241 . . . . 0.0 111.446 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -61.06 -43.98 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.3 mmm180 -58.2 -35.3 71.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.226 0.536 . . . . 0.0 109.728 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -61.14 -37.12 81.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.252 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.884 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.4 t90 -95.32 -10.09 31.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.854 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.62 -36.1 57.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.297 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -148.54 -64.57 0.24 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.112 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.32 65.75 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.985 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.86 -70.65 0.79 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -106.22 32.0 4.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.832 0.348 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 70' ' ' THR . 2.0 p-10 -157.31 66.15 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.893 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 1.4 tt0 -176.93 169.63 2.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.737 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -127.69 165.25 20.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.95 0.405 . . . . 0.0 110.839 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.538 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -70.09 177.33 3.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.96 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.8 -37.12 78.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.85 -56.94 4.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.116 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.737 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -57.99 -41.48 83.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.423 . . . . 0.0 110.758 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' THR . 6.8 tt -71.93 -26.44 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.092 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.49 -43.4 62.19 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.478 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -69.35 -33.11 72.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.14 -49.67 66.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.436 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.68 -45.0 90.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.208 0.528 . . . . 0.0 110.168 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -64.88 -48.44 74.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.607 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.37 -41.64 63.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.447 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.2 -33.98 65.82 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.022 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.9 t -77.48 -14.74 59.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.7 mt -87.72 -39.08 15.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.927 0.394 . . . . 0.0 110.045 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.631 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -67.36 -65.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.374 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.401 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -66.43 132.47 48.36 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.874 0.368 . . . . 0.0 110.705 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -37.25 74.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.177 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.02 -12.16 29.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.742 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.39 36.93 79.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.632 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -74.89 -4.45 38.01 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.446 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.01 44.09 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.125 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.8 p -149.46 132.53 16.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.876 0.338 . . . . 0.0 110.899 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.878 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mp -106.22 127.27 61.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.443 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.6 t -101.97 167.7 9.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.8 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.5 p -54.26 -31.51 53.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.556 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -62.67 -50.43 71.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.811 0.338 . . . . 0.0 111.222 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' O ' HG12 ' A' ' 35' ' ' VAL . 15.6 mm-40 -77.15 -35.8 55.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.13 0.49 . . . . 0.0 110.855 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.34 -58.17 8.42 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.752 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -27.44 68.8 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.685 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.8 m -70.18 -54.21 13.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.1 p -74.49 -31.1 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 24.1 ttt -61.02 -44.78 96.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.642 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.68 -25.68 44.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.941 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.2 t -56.75 -36.43 69.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.0 mt -56.99 -31.47 65.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.476 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -142.61 160.88 39.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.833 0.349 . . . . 0.0 110.885 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -123.4 62.22 22.02 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.88 -170.11 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.56 2.173 . . . . 0.0 112.314 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -121.34 167.23 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.76 -32.14 71.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.229 0.538 . . . . 0.0 110.132 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.6 60.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.384 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -43.3 94.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.293 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 16.1 mt -55.27 -50.75 68.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -64.72 -52.32 57.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.467 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.42 -51.12 70.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.263 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.481 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -58.88 -48.08 82.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -60.73 -44.37 97.11 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.279 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -57.07 -26.45 60.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.556 0.693 . . . . 0.0 110.033 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.3 mt-10 -82.92 -2.06 53.94 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.559 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.71 -32.99 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -177.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.5 ' N ' HD12 ' A' ' 63' ' ' ILE . 51.9 t0 -72.22 149.28 44.73 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.343 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.06 -53.55 6.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.665 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -85.49 -8.72 58.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.292 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.59 48.91 77.96 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.93 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -97.5 -0.77 45.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.627 0.251 . . . . 0.0 111.496 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.477 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.21 15.53 21.29 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.885 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.443 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.7 p -149.88 139.77 21.88 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.608 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -95.01 149.27 4.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.002 0.43 . . . . 0.0 111.412 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -103.88 172.91 6.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -56.39 -61.58 6.42 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.243 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 31.1 Cg_endo -63.94 -33.04 64.91 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.368 2.046 . . . . 0.0 111.862 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -69.62 -35.73 75.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.411 179.536 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.8 t80 -75.28 -40.6 58.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.262 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.515 HD11 ' HG ' ' A' ' 4' ' ' LEU . 6.5 tp -76.78 -53.99 7.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.587 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 2' ' ' ASP . 62.4 m -51.37 -45.2 62.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.526 -178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.439 ' HE2' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -54.32 -52.62 60.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.882 0.372 . . . . 0.0 110.865 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.488 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 21.9 mtt -80.02 -10.35 59.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.533 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -84.66 -33.33 23.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.899 0.38 . . . . 0.0 110.845 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 -57.88 -43.81 86.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.963 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.82 150.98 47.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 11.7 mtt 61.0 92.74 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -106.72 -34.87 7.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -149.35 111.57 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.3 t -176.79 142.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.38 -178.31 4.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.2 m -162.15 161.92 28.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.63 -27.38 39.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.23 -42.46 75.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.973 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 20.0 mt-10 -59.25 -33.09 70.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -74.36 -37.99 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.244 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -49.41 41.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.481 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 57.9 mt-10 -62.04 -46.41 89.27 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.58 -48.09 69.52 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.781 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -50.85 -43.15 59.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -71.1 -32.17 68.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.72 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.003 HG11 HD22 ' B' ' 74' ' ' LEU . 1.3 m -75.0 -36.62 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.733 0.301 . . . . 0.0 111.002 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.722 ' CE2' HG22 ' B' ' 78' ' ' ILE . 3.1 m-85 -74.65 -62.92 1.37 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.496 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -84.68 132.23 34.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.814 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -76.62 -52.59 9.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -80.54 -9.61 59.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.495 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.46 70.21 0.66 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.902 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -94.24 15.32 17.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.625 0.25 . . . . 0.0 111.204 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 19.44 69.18 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.696 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -160.39 117.04 2.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.549 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.5 mt -112.17 123.22 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.229 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.0 t -103.96 157.72 16.91 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.308 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.68 -41.52 22.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.12 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.75 -58.77 6.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.08 0.467 . . . . 0.0 110.78 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' O ' HG23 ' A' ' 108' ' ' VAL . 48.9 mm-40 -55.13 -39.08 69.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.707 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.991 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.52 -50.9 72.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.92 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.657 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 tpt85 -56.43 -42.31 77.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.146 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -60.25 -36.22 77.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.32 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 104' ' ' GLU . 67.5 t -72.58 -54.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.762 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.516 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.1 mmt -49.54 -54.03 20.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.657 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.4 t -66.94 -25.46 66.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.525 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -68.65 -30.01 68.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -96.64 -28.77 14.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.24 43.89 0.12 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -149.59 114.88 5.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -91.6 101.5 14.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -93.83 163.56 13.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.821 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.839 ' O ' HG22 ' A' ' 121' ' ' VAL . 10.3 m -98.3 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.904 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -59.38 -42.07 90.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.741 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -69.73 -35.85 75.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.15 -54.86 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.74 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.839 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -63.6 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.966 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -61.49 -41.42 97.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.082 0.467 . . . . 0.0 110.313 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 34.8 mt-10 -72.42 -30.15 64.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.266 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.407 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -70.72 -34.41 71.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.647 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.991 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.27 -55.17 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.708 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.3 ptm180 -54.38 -31.8 55.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 0.0 110.415 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -75.47 -21.6 57.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.892 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -18.09 14.49 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.66 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -79.05 90.59 4.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.461 0.648 . . . . 0.0 111.052 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -63.94 -30.91 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.6 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -85.28 -9.46 57.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.123 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 51.06 53.61 26.4 Favored Glycine 0 C--N 1.333 0.396 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.7 p30 -113.78 -5.55 13.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.232 0.516 . . . . 0.0 111.271 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 6.24 44.64 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.219 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.06 -174.88 4.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.863 0.363 . . . . 0.0 110.669 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 47.0 t -127.36 120.59 55.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.006 0.432 . . . . 0.0 111.274 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.412 ' HB3' ' HG3' ' A' ' 140' ' ' GLU . 5.5 t30 -98.98 -169.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.64 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.513 ' O ' HG13 ' A' ' 142' ' ' VAL . 53.2 t80 -59.53 -73.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.4 OUTLIER -49.62 -43.62 46.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.405 0.622 . . . . 0.0 110.331 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.746 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.1 mt-10 -56.3 -34.75 66.79 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.928 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.41 -48.45 13.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.0 0.428 . . . . 0.0 111.293 -179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.9 m -58.8 -39.79 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.403 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -71.19 -35.07 71.45 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.567 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.478 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.4 OUTLIER -84.77 11.1 9.75 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.667 0.27 . . . . 0.0 111.184 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.543 ' SD ' HG13 ' B' ' 77' ' ' VAL . 1.4 mtt -119.26 -39.56 2.89 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 147' ' ' ALA . 12.0 t -148.88 -48.54 0.15 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.479 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.613 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -71.59 75.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.883 0.373 . . . . 0.0 111.406 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.949 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.74 0.305 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 164.11 35.96 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.61 2.206 . . . . 0.0 112.317 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.57 -65.16 0.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -132.03 113.07 12.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.48 -96.82 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.539 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.579 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -139.3 116.82 11.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.843 0.354 . . . . 0.0 110.992 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.97 -71.46 1.14 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.586 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -54.29 -48.2 65.1 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.59 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.933 0.397 . . . . 0.0 110.151 179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.418 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.8 OUTLIER -55.07 -31.7 61.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.967 0.413 . . . . 0.0 110.009 178.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . . . . . . . . . 9.4 tpp85 -53.78 -53.56 50.59 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.409 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.739 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.34 -38.55 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.605 HG23 ' O ' ' B' ' 68' ' ' PHE . 99.4 t -50.61 -43.11 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.283 0.563 . . . . 0.0 110.742 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.715 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -74.94 -46.45 35.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.051 -179.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.003 HD22 HG11 ' A' ' 91' ' ' VAL . 32.8 mt -55.85 -48.28 75.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.373 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.1 p -65.07 -48.24 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.477 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.584 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.58 -29.63 57.95 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.017 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 88' ' ' ALA . 81.7 t -76.88 -54.62 12.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.611 0.243 . . . . 0.0 111.58 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.722 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.58 -43.91 97.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.653 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.0 mmm180 -57.68 -34.44 69.4 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.239 0.542 . . . . 0.0 109.784 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.52 -37.42 83.65 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.22 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.932 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.3 -10.48 30.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.852 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.31 -36.09 58.5 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -148.79 -64.42 0.24 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.059 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.31 65.61 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.93 -66.72 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -107.23 34.46 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.926 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.893 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.858 0.361 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -172.55 96.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.681 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.8 tt0 -177.26 179.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.77 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -130.87 165.32 23.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.901 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 8' ' ' GLN . 8.7 t -69.11 177.33 2.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.928 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -60.48 -36.34 78.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.298 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.432 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -73.22 -56.95 4.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.77 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -57.89 -41.95 83.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.006 0.432 . . . . 0.0 110.686 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 5' ' ' THR . 7.2 tt -71.36 -26.43 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.093 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.48 -43.53 62.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.14 -32.82 70.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.53 -49.68 68.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.456 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -58.46 -45.1 89.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.193 0.521 . . . . 0.0 110.23 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -64.67 -48.81 73.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.691 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.36 -41.39 63.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.471 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.81 -38.68 70.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.999 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 t -74.14 -13.92 60.89 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.933 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.6 mt -87.69 -39.74 14.73 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.954 0.406 . . . . 0.0 110.151 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.45 -65.9 0.61 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.356 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.0 t70 -65.39 132.88 50.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -37.62 74.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.24 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.73 -12.26 29.61 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.893 0.378 . . . . 0.0 110.7 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.64 37.21 82.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -74.77 -4.55 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.244 -0.183 . . . . 0.0 111.38 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.23 0.15 44.16 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.116 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.8 p -149.55 132.5 16.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.796 0.331 . . . . 0.0 110.892 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.862 HG22 HD12 ' A' ' 32' ' ' LEU . 1.9 mt -105.52 127.38 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.197 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.8 t -102.41 168.44 9.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.823 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.405 HG21 ' NE2' ' A' ' 49' ' ' GLN . 28.5 p -54.78 -34.35 62.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.48 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -50.49 73.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.248 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -77.19 -36.53 54.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.158 0.504 . . . . 0.0 110.826 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.3 -58.21 8.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.823 -179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.52 64.23 Favored Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.793 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -72.04 -59.97 2.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.844 0.354 . . . . 0.0 111.172 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -64.33 -30.56 50.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.174 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 mtp -60.93 -56.43 21.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.674 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -25.63 66.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.95 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.4 t -57.77 -38.66 75.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.64 -35.65 68.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.913 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.72 43.59 0.12 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -142.6 163.39 32.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.891 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.43 61.17 27.27 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.09 -170.17 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.59 2.193 . . . . 0.0 112.248 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 73.0 p -122.11 166.92 13.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.83 -31.96 71.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.084 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.78 -45.45 59.1 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.436 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.4 OUTLIER -65.53 -41.9 92.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.364 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 15.5 mt -56.63 -50.95 70.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' NE2' HG21 ' A' ' 29' ' ' THR . 0.7 OUTLIER -65.59 -57.04 9.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.407 -179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.97 -51.06 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.147 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 19.2 mtt -58.19 -46.84 85.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.775 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.959 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.83 -45.82 97.33 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.029 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -56.13 -26.53 50.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.538 0.685 . . . . 0.0 110.042 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.7 mt-10 -82.15 -2.19 51.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.467 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.607 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.25 -32.99 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 0.0 111.934 -177.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.499 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.8 t0 -72.74 152.72 41.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.183 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.518 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.33 -53.55 6.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.651 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.54 -8.74 57.29 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.316 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.91 49.93 70.31 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.853 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.0 p-10 -97.27 -0.2 47.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.424 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.5 24.11 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.825 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.3 p -149.84 139.86 22.0 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.58 149.43 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.973 0.416 . . . . 0.0 111.422 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -103.87 174.78 5.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.925 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.43 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 1.0 OUTLIER -58.06 -61.58 7.18 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.207 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.1 Cg_endo -63.62 -33.82 65.72 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.383 2.055 . . . . 0.0 111.81 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.518 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -69.15 -36.25 77.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.427 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.29 -40.11 58.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.28 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.681 HD21 ' CG ' ' A' ' 3' ' ' GLN . 6.4 tp -76.7 -54.7 6.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.536 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.5 m -51.61 -43.3 62.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.427 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -55.18 33.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.883 0.373 . . . . 0.0 110.975 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.444 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 11.6 mtt -79.08 -11.47 59.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.516 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -85.08 -38.25 19.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.835 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -63.13 -30.46 71.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.07 140.61 29.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 7.4 mtm 60.23 78.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mtmt -85.42 -61.86 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.868 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.5 118.08 23.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -171.68 161.32 6.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.64 179.05 7.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -160.85 154.44 22.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -25.52 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -39.7 65.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.006 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 60.2 mt-10 -59.95 -30.45 69.09 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.818 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.21 -38.89 48.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.308 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.01 -49.4 45.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.438 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 50.7 mt-10 -61.59 -45.81 92.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.783 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.66 -48.89 69.01 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.966 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.04 -38.74 53.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.001 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -76.51 -30.5 57.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.995 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.28 -36.88 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 110.971 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.715 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -73.29 -62.91 1.31 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.511 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -83.48 119.1 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.8 mmtt -62.7 -52.62 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -79.8 -9.72 59.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.471 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.0 71.3 0.49 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.956 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -93.48 14.55 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.685 0.279 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.18 67.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.582 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 6.6 m-85 -162.37 116.89 1.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.741 0.305 . . . . 0.0 110.942 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.551 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.6 mt -113.21 124.38 69.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.069 0.461 . . . . 0.0 111.539 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 m -104.11 160.08 15.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.954 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.583 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -43.54 28.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.193 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.28 -58.83 6.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.019 0.437 . . . . 0.0 110.84 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -55.22 -37.34 67.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.671 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.958 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.68 -50.78 72.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.795 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.513 ' O ' HG22 ' A' ' 110' ' ' THR . 8.4 tpt85 -55.91 -43.14 77.04 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.06 -37.41 76.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.382 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.65 -53.52 26.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.626 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.8 mmt -51.16 -54.16 27.89 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.781 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.0 t -66.52 -25.72 66.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.549 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -68.24 -30.04 69.0 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.775 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.79 -28.79 14.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.39 0.13 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.575 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -152.37 109.77 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.875 0.369 . . . . 0.0 110.878 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -86.48 110.55 19.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.978 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.489 HD12 ' CG ' ' A' ' 120' ' ' GLU . 3.8 mm? -101.36 166.06 10.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.8 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.0 m -98.35 158.73 15.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.904 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -60.41 -40.51 91.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -69.83 -36.42 75.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.552 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' CG ' HD12 ' A' ' 116' ' ' LEU . 5.3 tp10 -64.39 -55.04 23.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.725 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.8 HG22 ' O ' ' A' ' 117' ' ' THR . 2.3 m -62.94 -40.97 90.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -61.35 -39.03 89.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.1 0.476 . . . . 0.0 110.123 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.7 mt-10 -73.4 -30.15 63.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.3 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.16 -35.5 71.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.958 HD11 HD12 ' A' ' 105' ' ' LEU . 4.3 mm -80.31 -55.02 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.589 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.8 ptm180 -53.95 -31.81 51.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.016 0.436 . . . . 0.0 110.386 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -79.24 -21.31 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.15 -2.33 21.03 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.331 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.9 t0 -94.61 104.92 16.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.448 0.642 . . . . 0.0 111.135 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.73 HG12 ' HA ' ' A' ' 140' ' ' GLU . 1.3 pt -79.04 -31.66 14.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.092 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.1 -9.1 46.91 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.55 -178.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.422 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.15 57.1 10.57 Favored Glycine 0 C--N 1.332 0.337 0 N-CA-C 114.628 0.611 . . . . 0.0 114.628 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.7 p30 -114.23 -4.04 13.11 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.104 0.452 . . . . 0.0 111.408 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 6.93 43.79 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.087 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.423 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.08 -174.74 4.81 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.792 0.329 . . . . 0.0 110.613 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.731 HG11 ' CD1' ' A' ' 141' ' ' PHE . 49.3 t -128.13 125.28 64.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.931 0.396 . . . . 0.0 111.212 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.7 t30 -105.12 -165.24 1.11 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.939 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.61 ' O ' HG13 ' A' ' 142' ' ' VAL . 13.2 t80 -60.09 -73.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.6 -44.82 47.44 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.334 0.588 . . . . 0.0 110.383 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.73 ' HA ' HG12 ' A' ' 130' ' ' ILE . 2.5 mt-10 -57.39 -35.66 70.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.077 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.731 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.44 -48.61 13.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.994 0.426 . . . . 0.0 111.673 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.818 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -56.81 -38.65 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.55 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.628 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 2.3 pp0? -71.2 -35.1 71.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.627 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.421 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.4 OUTLIER -86.36 12.85 9.2 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.726 0.298 . . . . 0.0 111.088 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.6 ' SD ' HG23 ' A' ' 85' ' ' ILE . 1.9 mtt -120.73 -38.47 2.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.923 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.455 HG23 ' N ' ' A' ' 147' ' ' ALA . 10.2 t -149.19 -48.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.313 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -72.07 75.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.435 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.968 179.884 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.704 0.288 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.17 156.78 7.22 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.597 2.198 . . . . 0.0 112.309 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 38.2 mtt180 -75.05 -40.99 59.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.76 83.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.02 -91.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.47 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.58 ' HD2' HG22 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -142.2 105.42 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 110.928 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.58 -75.0 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.692 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.99 -50.48 27.24 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.668 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.734 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.28 -65.78 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.888 0.375 . . . . 0.0 110.089 179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.454 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.8 OUTLIER -54.1 -31.81 53.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.023 0.44 . . . . 0.0 110.045 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.6 tpp85 -54.07 -53.61 50.81 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.443 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.734 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.73 -37.78 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.612 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.3 t -50.47 -45.65 25.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.366 0.603 . . . . 0.0 110.861 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.833 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -75.48 -45.66 37.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.338 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.995 HD22 HG11 ' A' ' 91' ' ' VAL . 29.8 mt -55.97 -46.68 78.55 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.979 0.419 . . . . 0.0 110.267 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.9 p -66.42 -48.92 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.499 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.585 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.93 -28.11 57.5 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 119.881 -1.152 . . . . 0.0 111.866 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.833 HG23 ' O ' ' B' ' 73' ' ' ARG . 95.9 t -76.83 -54.59 12.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 111.419 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.715 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -62.86 -44.08 99.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -58.0 -35.36 71.12 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.265 0.555 . . . . 0.0 109.761 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.18 -37.3 79.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.216 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.913 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.7 t90 -95.38 -11.25 28.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.831 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.04 -35.57 59.42 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.342 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -148.45 -65.07 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.106 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -70.15 65.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -75.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.78 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.68 31.69 5.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.918 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.772 0.32 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -146.39 36.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.676 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.9 tt0 -158.14 179.55 9.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.828 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.806 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -129.22 165.29 21.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.9 t -70.07 177.31 3.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -59.93 -36.85 77.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.339 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -73.33 -56.93 4.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.806 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.59 -41.16 80.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.049 0.452 . . . . 0.0 110.738 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' THR . 6.0 tt -72.33 -26.24 24.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.228 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.32 -44.41 61.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.788 -178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 6.4 pm0 -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.07 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -65.18 -49.71 68.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.417 -179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -58.38 -45.12 88.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.16 0.505 . . . . 0.0 110.303 179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.85 -48.65 73.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.715 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.32 -41.42 62.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.486 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.5 -38.84 69.7 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.066 -179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -74.2 -13.76 60.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.004 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 15' ' ' ALA . 8.4 mt -87.75 -39.8 14.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.68 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.95 -65.89 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.392 179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 6.8 t70 -65.34 133.16 50.79 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.844 0.354 . . . . 0.0 110.736 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.61 -37.62 73.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.19 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -93.64 -12.25 29.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 110.735 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.65 37.28 82.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.688 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -74.69 -4.58 38.23 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.211 -0.195 . . . . 0.0 111.389 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.25 0.21 44.09 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.064 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 45.9 p -149.58 132.53 16.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.851 0.358 . . . . 0.0 110.879 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.857 HG22 HD12 ' A' ' 32' ' ' LEU . 2.0 mt -105.33 126.92 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.458 ' HA ' HG22 ' A' ' 62' ' ' THR . 6.9 t -101.87 168.1 9.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.819 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.8 p -53.81 -37.21 63.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.644 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -57.27 -50.52 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.357 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.96 -36.67 56.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.144 0.497 . . . . 0.0 110.821 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.956 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.42 -58.11 8.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.859 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.06 -27.49 64.94 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.833 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.5 m -71.32 -60.29 2.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.805 0.336 . . . . 0.0 111.197 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.68 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.1 p -63.84 -30.49 50.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.15 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.9 mtp -61.03 -56.49 20.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.59 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -25.6 66.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.991 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 43.8 t -57.22 -38.13 73.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.57 -30.94 63.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.953 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.0 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.583 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -142.63 166.16 25.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -120.34 60.99 7.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.43 165.22 33.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.544 2.163 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.6 p -102.87 165.33 11.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.826 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.05 -29.35 67.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.277 0.561 . . . . 0.0 110.274 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.68 -50.86 53.87 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.638 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.45 -37.6 87.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.706 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 19.6 mt -57.51 -51.01 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.771 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -56.67 10.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.33 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -54.91 -51.02 67.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.163 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.507 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 59.4 mtt -59.03 -46.11 89.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.794 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.956 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -60.64 -45.91 96.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.953 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -55.96 -26.56 48.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.555 0.693 . . . . 0.0 110.03 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.4 mt-10 -82.12 -2.11 50.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.442 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.36 -32.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.905 0.383 . . . . 0.0 111.99 -177.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.501 ' N ' HD12 ' A' ' 63' ' ' ILE . 50.9 t0 -72.82 152.17 41.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.223 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -80.87 -53.54 6.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.679 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -86.52 -8.6 57.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.282 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.84 49.79 71.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.891 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -97.34 -0.25 46.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.536 0.208 . . . . 0.0 111.444 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 14.64 23.76 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.881 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.2 p -149.85 139.86 22.0 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.61 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.2 mm -94.82 149.32 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.458 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -103.68 174.83 5.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.952 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 2.6 m-85 -57.94 -61.67 6.95 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.7 Cg_endo -63.74 -33.75 64.57 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.392 2.062 . . . . 0.0 111.812 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -69.06 -36.12 77.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.438 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 4.0 t80 -75.27 -40.04 59.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.295 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.676 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.0 tp -76.72 -54.93 5.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.451 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 56.0 m -51.67 -43.42 62.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.519 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.14 -55.5 30.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.805 0.336 . . . . 0.0 111.007 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.491 ' HE1' ' CG2' ' B' ' 72' ' ' VAL . 17.6 mtt -76.95 -17.3 58.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.442 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.579 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -81.58 -31.63 32.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -30.61 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.28 146.17 27.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.947 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.4 mtt 61.67 85.09 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -64.0 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.812 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -129.57 124.51 34.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -176.56 172.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -152.96 -178.48 6.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.52 157.68 30.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -54.61 -26.43 32.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.136 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.64 -41.97 71.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 66.6 mt-10 -59.54 -31.82 69.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.828 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -74.28 -39.28 49.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.257 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -49.35 46.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.468 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.3 mm-40 -61.39 -46.21 91.12 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.375 0.607 . . . . 0.0 109.404 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.8 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.53 -48.95 68.6 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.07 -38.58 52.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.023 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -76.56 -30.53 57.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.82 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.013 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.35 -36.97 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.675 0.274 . . . . 0.0 111.077 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -73.34 -62.97 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.838 0.352 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -83.94 129.98 34.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -74.83 -52.66 10.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.233 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -78.63 -9.7 59.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.01 70.54 0.6 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.94 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -93.87 15.04 17.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.698 0.285 . . . . 0.0 111.217 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.52 19.58 69.02 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.608 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.2 m-85 -163.96 116.92 1.43 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.688 0.28 . . . . 0.0 110.896 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 89' ' ' PHE . 3.1 mt -111.27 126.55 68.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.547 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.7 t -104.0 156.85 17.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.158 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.73 -40.91 21.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.351 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.48 -58.92 6.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 110.801 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -55.87 -38.13 69.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.706 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.906 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.03 -50.74 72.52 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.845 179.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 110' ' ' THR . 8.0 tpt85 -55.72 -44.17 77.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -37.21 74.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.289 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 51.7 t -69.41 -53.58 24.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.732 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.546 ' HB3' HD23 ' A' ' 116' ' ' LEU . 8.2 mmt -50.3 -54.08 23.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.4 t -67.14 -25.62 66.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.53 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -68.29 -29.95 68.84 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.841 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.73 -28.78 14.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.013 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 133.87 43.89 0.13 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.566 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -149.36 116.78 6.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -91.75 102.84 15.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.983 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.546 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.4 mm? -95.54 163.71 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.787 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.4 m -98.29 158.77 15.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.872 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.01 -42.2 93.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.687 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -69.8 -34.01 73.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.643 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -65.89 -54.87 20.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 117' ' ' THR . 2.4 m -64.52 -40.0 87.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -62.26 -41.41 98.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 110.34 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.7 mt-10 -72.91 -30.17 63.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.415 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.6 mtp -71.45 -34.3 70.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.671 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.906 HD11 HD12 ' A' ' 105' ' ' LEU . 3.2 mm -80.33 -54.91 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.631 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.0 ptm180 -54.51 -31.77 56.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.043 0.449 . . . . 0.0 110.347 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.99 -21.7 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.824 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.78 -14.36 16.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 120.994 -0.282 . . . . 0.0 111.435 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 125' ' ' ILE . 49.0 t0 -84.07 89.65 7.31 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 121.449 0.642 . . . . 0.0 110.965 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.741 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.0 OUTLIER -62.93 -30.8 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.419 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.595 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.3 OUTLIER -85.8 -9.48 56.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.163 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.47 54.17 21.72 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.802 0.681 . . . . 0.0 114.802 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.9 p30 -113.84 -5.38 13.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.207 0.504 . . . . 0.0 111.307 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 6.29 44.54 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.316 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.428 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.83 -174.82 4.45 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.937 0.368 . . . . 0.0 110.712 179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.75 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.5 t -128.6 123.56 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.989 0.424 . . . . 0.0 111.304 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.1 t30 -102.74 -164.95 1.13 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' O ' HG13 ' A' ' 142' ' ' VAL . 16.2 t80 -62.44 -74.06 0.1 Allowed 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.68 -44.29 47.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.367 0.603 . . . . 0.0 110.329 -179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.741 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.48 -35.82 68.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.006 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.75 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.17 -48.34 14.43 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 111.418 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.828 ' N ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -59.15 -40.31 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.437 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.62 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -71.41 -34.78 70.65 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.577 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.41 ' HG2' ' HA ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -83.54 9.53 11.15 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.642 0.258 . . . . 0.0 111.279 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.583 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.5 mtt -119.21 -39.16 2.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.122 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.457 HG23 ' N ' ' A' ' 147' ' ' ALA . 11.8 t -148.55 -48.56 0.15 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.477 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.62 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -71.56 74.62 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.884 0.374 . . . . 0.0 111.403 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.2 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.943 179.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.683 0.278 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.18 -176.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.591 2.194 . . . . 0.0 112.32 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -97.08 -63.02 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.74 31.41 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -104.89 -108.41 3.31 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.521 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.71 117.39 21.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.403 . . . . 0.0 110.989 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' B' ' 70' ' ' ARG . . . -71.81 -71.88 1.0 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.532 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.7 -49.47 46.94 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.459 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.729 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -52.16 -64.0 0.96 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.008 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.42 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.7 OUTLIER -56.32 -31.76 64.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 178.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.417 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 tpp180 -52.84 -53.55 47.09 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.331 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.729 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -66.93 -38.7 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.629 HG23 ' O ' ' B' ' 68' ' ' PHE . 98.9 t -50.62 -44.5 25.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.316 0.579 . . . . 0.0 110.884 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.82 ' O ' HG23 ' B' ' 77' ' ' VAL . 5.1 mpt_? -75.24 -47.22 29.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.313 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.013 HD22 HG11 ' A' ' 91' ' ' VAL . 33.1 mt -55.81 -46.57 78.04 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.931 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -65.99 -48.72 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.38 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.588 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.75 -28.26 56.74 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.855 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.82 HG23 ' O ' ' B' ' 73' ' ' ARG . 99.3 t -76.85 -55.44 10.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.65 0.262 . . . . 0.0 111.525 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.91 -44.13 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.7 mmm180 -57.77 -35.14 70.37 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.257 0.551 . . . . 0.0 109.767 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -36.48 81.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.188 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.855 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.31 -10.46 30.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.785 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -76.89 -36.22 56.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -148.23 -64.8 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.028 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 65.68 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -74.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.76 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -106.69 34.16 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.926 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.872 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.826 0.346 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -132.0 80.86 1.94 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.705 ' CG ' HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -176.22 172.78 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -120.3 165.4 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.774 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -71.81 177.36 4.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.783 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HA ' HG22 ' A' ' 9' ' ' ILE . 16.1 pt-20 -58.32 -41.99 85.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.292 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.9 tt0 -67.14 -57.11 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.801 0.334 . . . . 0.0 111.233 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -58.08 -44.68 87.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.018 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.438 HG13 HD13 ' A' ' 69' ' ' LEU . 7.6 tt -69.64 -26.59 31.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.251 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.6 -43.47 62.53 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.453 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -70.75 -32.81 70.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -66.07 -49.61 67.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.274 -179.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -45.05 90.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.169 0.509 . . . . 0.0 110.211 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -64.75 -48.82 73.17 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.7 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.43 -41.12 62.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.399 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -54.08 -40.51 67.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.401 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.9 t -75.9 -12.94 60.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.167 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.4 mt -87.13 -40.34 14.72 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 110.425 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.716 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.76 -66.03 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.222 179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -68.69 133.21 48.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.837 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -40.9 88.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.347 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -91.03 -12.13 36.71 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.833 0.349 . . . . 0.0 110.723 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 58.28 38.7 91.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.69 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -73.51 -5.78 42.31 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.435 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 6.32 42.33 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.215 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 61.5 p -149.83 133.19 16.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.801 0.3 . . . . 0.0 110.74 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -100.04 117.22 44.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.817 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HA ' HG22 ' A' ' 62' ' ' THR . 8.9 t -89.18 159.07 17.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.725 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.8 p -54.72 -34.33 62.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.36 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.51 -50.42 73.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 111.046 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -76.08 -36.69 58.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.029 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.85 -44.43 73.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.095 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.434 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.85 -27.4 73.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.321 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.4 m -71.92 -49.68 35.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.341 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG11 ' CD1' ' A' ' 19' ' ' PHE . 8.6 p -72.43 -35.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.161 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 36.3 ttm -58.94 -45.22 90.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.391 . . . . 0.0 110.799 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -25.59 44.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.06 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.8 t -54.64 -38.09 66.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.173 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.0 mt -57.77 -30.15 65.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.986 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.87 42.34 0.22 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -142.62 161.75 37.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 0.0 110.915 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -119.66 62.79 7.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.801 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.69 176.38 8.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.61 2.207 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.2 p -109.38 168.27 9.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.68 -32.15 71.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.279 0.561 . . . . 0.0 110.079 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.93 -45.92 60.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.451 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.313 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.434 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.3 mt -59.64 -50.66 72.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.05 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -64.78 -43.44 93.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.335 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.31 -51.14 62.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.155 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.503 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -57.64 -52.13 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.713 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.029 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -58.11 -42.28 82.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.015 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -59.66 -26.43 65.53 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.513 0.673 . . . . 0.0 109.893 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 51' ' ' MET . 2.9 mt-10 -83.03 -2.21 54.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.719 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.35 -33.16 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.683 -0.407 . . . . 0.0 112.078 -177.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.483 ' N ' HD12 ' A' ' 63' ' ' ILE . 49.7 t0 -70.54 154.62 41.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.399 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.514 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -81.62 -53.75 5.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.802 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -89.14 -8.65 53.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.362 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.2 51.67 57.79 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.848 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.6 p-10 -100.06 1.13 42.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.574 0.226 . . . . 0.0 111.437 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.35 15.02 22.56 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.975 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.6 p -150.02 139.72 21.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.604 0.24 . . . . 0.0 110.88 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.626 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 3.0 mm -96.54 149.89 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.94 172.85 6.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.2 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.452 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -53.55 -61.55 4.94 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.775 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.01 -26.3 37.42 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.49 2.127 . . . . 0.0 112.673 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 15.6 mm-40 -73.71 -38.31 64.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' B' ' 68' ' ' PHE . 1.9 t80 -75.41 -43.32 50.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 110.37 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.705 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.4 tp -70.08 -57.06 5.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.811 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 93.3 m -51.44 -53.78 33.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.649 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.9 tpp -54.26 -38.72 66.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.915 0.388 . . . . 0.0 110.912 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 5.8 mmt -97.91 14.53 26.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.244 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.22 -36.01 5.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 111.071 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -55.49 -55.76 28.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.265 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.31 42.03 1.5 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.22 29.46 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.107 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -82.71 -67.92 0.75 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.64 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 49.9 -175.68 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.365 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -132.41 38.72 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.831 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.59 -175.15 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.7 t -168.4 -166.99 0.74 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -67.36 -29.15 68.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.031 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.51 -26.57 63.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.132 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -71.1 -45.16 64.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.09 0.472 . . . . 0.0 110.83 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.725 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -74.6 -33.64 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.593 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -49.37 52.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.368 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.757 ' O ' HG13 ' A' ' 91' ' ' VAL . 46.3 mm-40 -62.41 -48.47 79.56 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.415 0.626 . . . . 0.0 109.698 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.774 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.38 -44.54 68.72 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.953 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.47 57.8 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.928 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.56 -32.35 58.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.946 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.91 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.9 -36.65 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-O 120.678 0.275 . . . . 0.0 111.024 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.585 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -72.94 -63.08 1.24 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.037 0.446 . . . . 0.0 110.487 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -86.23 128.57 34.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.84 -52.72 8.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.982 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -76.86 -9.75 58.9 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.413 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.52 69.74 0.63 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.006 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -93.27 14.35 18.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.675 0.274 . . . . 0.0 111.284 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 17.3 66.56 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.604 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.46 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.8 m-85 -158.45 116.94 3.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.694 0.283 . . . . 0.0 110.972 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.529 ' O ' HD12 ' A' ' 125' ' ' ILE . 2.7 mt -110.36 124.31 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -103.91 157.45 17.08 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.255 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.566 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.77 -42.94 26.92 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.387 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.25 -58.68 7.15 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.04 0.448 . . . . 0.0 110.868 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 108' ' ' VAL . 41.7 mm-40 -55.0 -39.23 68.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.629 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.971 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.17 -50.71 72.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.888 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.757 ' O ' HG22 ' A' ' 110' ' ' THR . 0.0 OUTLIER -57.64 -41.01 80.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.674 179.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.63 -39.03 86.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.513 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 104' ' ' GLU . 79.7 t -72.8 -55.34 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.147 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 6.5 mmt -49.03 -54.0 17.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.854 0.359 . . . . 0.0 110.613 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.3 t -65.41 -25.42 67.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.433 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -69.98 -30.98 68.46 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.903 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.53 -28.83 15.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.35 42.31 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.554 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -144.0 109.77 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 0.0 110.813 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -88.88 94.14 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.63 147.11 28.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.682 ' O ' HG22 ' A' ' 121' ' ' VAL . 12.5 t -85.88 163.37 18.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -59.72 -31.03 69.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -67.64 -45.97 73.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.599 ' H ' HG23 ' A' ' 117' ' ' THR . 49.2 mm-40 -61.12 -54.87 39.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.036 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 117' ' ' THR . 1.6 m -62.23 -38.3 80.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.225 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -61.44 -43.59 98.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 110.345 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 71.5 mt-10 -71.77 -30.2 65.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.401 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.4 mtp -70.71 -34.0 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.731 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 105' ' ' LEU . 4.1 mm -80.31 -54.94 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.585 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 11.5 ptt180 -55.14 -31.93 61.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.059 0.457 . . . . 0.0 110.385 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.3 -21.12 54.02 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.888 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.632 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -104.56 -14.51 15.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.433 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.95 93.73 7.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.395 0.616 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.748 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.1 pt -66.43 -31.27 52.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.51 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.618 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -85.83 -9.37 57.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.123 -179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.22 54.76 18.31 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.697 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.413 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 31.7 p30 -113.98 -5.18 13.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.194 0.497 . . . . 0.0 111.367 178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.42 6.35 44.58 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.069 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -145.91 -174.77 4.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.35 . . . . 0.0 110.547 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 141' ' ' PHE . 42.3 t -127.3 120.51 55.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.018 0.437 . . . . 0.0 111.496 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 7.3 t30 -96.07 -167.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.354 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.2 t80 -62.36 -73.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.58 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.5 OUTLIER -49.74 -43.3 47.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.303 0.573 . . . . 0.0 110.414 -179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.748 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.2 mt-10 -55.9 -33.49 64.68 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.489 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -79.07 -45.45 20.07 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.104 0.478 . . . . 0.0 111.683 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.8 m -65.52 -38.02 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.158 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.704 ' HA ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -70.43 -36.07 73.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.57 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.797 ' HE3' ' CG ' ' B' ' 81' ' ' TRP . 6.1 ptm -73.35 -21.42 60.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.08 0.467 . . . . 0.0 110.068 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.447 ' O ' ' HB ' ' A' ' 146' ' ' THR . 1.2 tpp -88.63 -49.48 6.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.288 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 145' ' ' MET . 11.3 t 179.56 -38.73 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.498 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.704 ' HB2' ' HA ' ' A' ' 143' ' ' GLN . . . 54.35 51.59 14.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.907 0.385 . . . . 0.0 111.291 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.885 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.742 0.306 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 146.97 62.04 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.562 2.175 . . . . 0.0 112.341 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -60.25 -31.58 70.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -176.38 76.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.02 -132.82 2.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.538 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -110.74 132.73 53.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 110.828 -180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.38 -64.88 3.41 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.673 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.86 -49.34 55.43 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.391 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.626 ' CZ ' HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -53.22 -68.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.533 0.206 . . . . 0.0 110.887 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -51.8 -38.84 57.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.771 0.319 . . . . 0.0 110.455 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.7 tpt180 -56.06 -48.28 76.33 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.671 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -61.56 -40.28 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.262 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.523 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.1 t -53.44 -53.46 24.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.816 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.873 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.95 -49.08 40.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.354 -178.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.91 HD22 HG11 ' A' ' 91' ' ' VAL . 18.9 mt -55.96 -44.15 78.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 12.5 p -67.6 -48.97 74.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 110.752 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.578 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -55.96 -31.26 58.4 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.035 -1.079 . . . . 0.0 112.079 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.873 HG23 ' O ' ' B' ' 73' ' ' ARG . 49.1 t -76.79 -54.94 12.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.696 0.284 . . . . 0.0 111.731 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.657 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -62.1 -43.85 98.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.657 ' N ' HD12 ' B' ' 78' ' ' ILE . 22.5 mmm180 -57.96 -31.71 67.14 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.125 0.488 . . . . 0.0 109.997 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.94 -37.12 85.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.356 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.935 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.5 t90 -95.26 -15.72 22.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.888 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.2 -31.6 16.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.31 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -138.29 -74.47 0.39 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.339 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -69.17 67.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.138 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.95 -69.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.19 -33.87 75.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.915 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -101.94 43.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.651 ' CG ' HD21 ' A' ' 69' ' ' LEU . 1.1 tt0 -158.81 178.7 9.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -127.85 165.34 20.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.514 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.2 t -72.43 177.4 4.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.971 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' HA ' HG22 ' A' ' 9' ' ' ILE . 17.2 pt-20 -57.36 -42.85 82.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.418 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -66.3 -56.97 8.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.185 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 2.2 tp60 -59.16 -49.05 79.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.514 HG22 ' O ' ' A' ' 5' ' ' THR . 10.9 tt -63.61 -26.24 40.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.254 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.3 -44.17 61.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.742 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 8' ' ' GLN . 1.8 pt-20 -69.11 -33.18 73.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.26 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -66.32 -49.74 65.98 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.354 -179.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -58.21 -44.75 88.3 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.194 0.521 . . . . 0.0 110.122 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -64.9 -49.17 71.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.703 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.905 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.33 -41.13 62.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.476 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.444 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER -58.5 -33.94 70.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.085 -179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -78.63 -16.3 57.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.937 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.4 mt -87.07 -36.92 17.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.911 0.386 . . . . 0.0 110.249 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -69.26 -65.94 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.28 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 12.5 t70 -66.16 130.31 42.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.905 0.383 . . . . 0.0 110.832 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -39.28 92.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.34 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -93.19 -12.15 30.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.54 36.12 76.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.677 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -74.94 -4.99 41.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.487 0.184 . . . . 0.0 111.444 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.16 4.27 44.48 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.527 -0.844 . . . . 0.0 113.177 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.9 p -149.47 132.56 16.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.944 0.372 . . . . 0.0 111.028 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.4 mt -109.87 127.93 66.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.185 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 62' ' ' THR . 1.4 t -101.68 169.85 8.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.97 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.3 p -55.88 -32.31 63.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.409 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -62.05 -50.49 71.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.142 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -75.64 -36.94 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.128 0.489 . . . . 0.0 110.834 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.062 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.32 -58.21 8.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.558 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.58 -27.43 69.71 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.776 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.4 m -67.45 -55.17 14.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 0.0 111.157 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 19' ' ' PHE . 13.8 p -69.69 -31.59 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -46.8 88.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.72 -26.18 44.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.959 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.3 t -58.15 -35.96 72.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.003 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 mt -58.05 -31.25 66.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.71 42.63 0.2 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.47 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -142.65 165.04 28.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -121.28 63.25 12.69 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.2 -173.63 0.82 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.573 2.182 . . . . 0.0 112.311 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 p -122.08 161.8 22.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.885 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 24.7 pm0 -69.02 -28.49 66.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.18 0.514 . . . . 0.0 110.3 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.81 -49.53 58.37 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.595 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.4 -37.35 86.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.714 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD11 ' HA3' ' A' ' 33' ' ' GLY . 21.0 mt -57.39 -50.79 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.4 tp60 -67.35 -48.0 68.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.272 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -57.99 -51.02 71.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.111 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.494 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -60.96 -49.73 76.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.398 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.062 HD11 HD13 ' A' ' 32' ' ' LEU . 1.1 mt -57.81 -41.86 80.7 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.514 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.979 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -59.5 -26.42 65.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.521 0.677 . . . . 0.0 110.034 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 51' ' ' MET . 3.1 mt-10 -83.67 -2.19 55.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.803 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -126.89 -33.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.969 0.414 . . . . 0.0 112.084 -177.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 63' ' ' ILE . 56.1 t0 -71.04 144.97 50.22 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.22 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -78.77 -53.55 7.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.595 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.54 -8.69 59.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.217 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 56.79 47.71 83.74 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.963 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -97.69 -1.3 43.87 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.663 0.231 . . . . 0.0 111.495 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 15.86 20.13 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.889 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 28' ' ' THR . 3.4 p -149.97 139.83 21.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.606 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.9 mm -95.21 149.34 4.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.23 170.09 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.921 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -53.74 -61.66 4.87 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.301 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 30.0 Cg_endo -63.55 -37.62 46.64 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.37 2.047 . . . . 0.0 111.969 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.48 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -60.97 -48.42 81.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.503 179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -62.39 -58.01 9.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.177 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.651 HD21 ' CG ' ' A' ' 3' ' ' GLN . 7.5 tp -58.28 -55.54 33.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.822 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.5 m -51.58 -44.36 62.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.737 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.427 ' HE3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -55.26 -53.28 58.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.03 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.9 mmt -78.31 -16.82 57.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.384 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -82.76 -30.38 28.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.361 . . . . 0.0 111.165 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.37 -27.14 14.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.131 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.79 160.3 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.9 ttp 64.11 78.78 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -114.11 124.55 52.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.648 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.2 t0 64.61 106.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 t -166.26 166.64 16.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -155.8 163.96 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.44 157.06 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.46 -26.19 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.056 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -76.11 -33.4 59.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -74.55 -34.3 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.318 0.58 . . . . 0.0 109.737 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -49.35 53.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.471 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.747 ' O ' HG13 ' A' ' 91' ' ' VAL . 6.2 mm-40 -63.11 -46.9 85.18 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.402 0.62 . . . . 0.0 109.653 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.778 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.59 -45.6 70.07 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.996 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.95 -38.67 51.97 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.729 179.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.64 -33.11 58.35 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.855 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.809 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -73.66 -36.46 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.673 0.273 . . . . 0.0 111.02 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.711 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.9 m-85 -70.67 -62.95 1.2 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 110.549 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -85.42 117.18 24.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.757 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.04 -52.67 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.414 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -79.78 -9.66 59.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.527 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.1 70.47 0.56 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.944 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -93.54 14.88 17.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.646 0.26 . . . . 0.0 111.154 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.6 18.45 68.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.635 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 8.4 m-85 -160.12 116.92 2.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.928 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.491 ' O ' HD12 ' A' ' 125' ' ' ILE . 3.9 mt -114.59 125.49 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.056 0.455 . . . . 0.0 111.626 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.6 m -104.09 159.58 15.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.981 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.577 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.7 -40.25 19.68 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.396 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.53 -59.0 6.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.062 0.458 . . . . 0.0 110.984 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.56 -37.29 70.35 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.721 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.876 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.04 -50.7 72.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.903 179.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.769 ' O ' HG22 ' A' ' 110' ' ' THR . 1.1 tpt180 -56.2 -42.8 77.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.347 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -59.72 -39.19 83.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.642 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 92' ' ' PHE . 44.9 t -72.17 -55.35 13.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.118 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.588 ' HB3' HD23 ' A' ' 116' ' ' LEU . 6.4 mmt -49.04 -54.01 17.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 0.0 110.751 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 106' ' ' ARG . 11.1 t -66.05 -25.42 67.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.467 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.09 -30.28 66.36 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.79 -28.81 17.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.9 43.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.58 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -150.65 110.54 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.829 0.347 . . . . 0.0 110.792 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.4 mtmt -86.41 101.9 13.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.058 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.656 HD12 ' HG2' ' A' ' 120' ' ' GLU . 3.5 mm? -105.57 148.79 26.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.772 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.6 t -86.75 163.33 17.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.914 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -58.09 -34.17 69.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.61 -39.33 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.656 ' HG2' HD12 ' A' ' 116' ' ' LEU . 7.6 tp10 -64.36 -54.87 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 117' ' ' THR . 2.5 m -62.76 -40.59 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -61.66 -41.49 97.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.091 0.472 . . . . 0.0 110.129 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 40.9 mt-10 -72.66 -30.12 64.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.315 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 83.2 mtp -70.3 -36.25 74.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.857 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.876 HD11 HD12 ' A' ' 105' ' ' LEU . 3.7 mm -80.21 -54.86 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.639 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.36 -31.76 55.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.005 0.431 . . . . 0.0 110.417 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.18 -21.77 45.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.888 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.541 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.21 -9.13 17.9 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.248 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 125' ' ' ILE . 41.4 t0 -86.97 100.67 12.77 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.504 0.668 . . . . 0.0 111.105 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.719 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -75.11 -31.64 25.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.878 -1.056 . . . . 0.0 112.042 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.504 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.99 -9.1 47.23 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.521 -178.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.453 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.47 57.07 11.02 Favored Glycine 0 C--N 1.333 0.383 0 N-CA-C 114.725 0.65 . . . . 0.0 114.725 178.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 16.5 p30 -114.31 -3.62 13.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.217 0.508 . . . . 0.0 111.47 178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.49 5.85 45.06 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.078 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.11 -174.72 4.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.756 0.312 . . . . 0.0 110.469 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG11 ' CD1' ' A' ' 141' ' ' PHE . 46.3 t -128.87 124.83 61.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.873 0.368 . . . . 0.0 111.281 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 3.6 t30 -102.95 -162.6 0.93 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.064 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 142' ' ' VAL . 11.7 t80 -60.75 -74.45 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.578 ' HA ' HG22 ' A' ' 142' ' ' VAL . 2.1 tt0 -49.95 -45.45 51.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.302 0.572 . . . . 0.0 110.46 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.719 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.6 mt-10 -56.21 -34.52 66.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.728 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.615 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -78.99 -47.06 16.98 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.111 0.481 . . . . 0.0 111.608 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.632 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.5 m -64.48 -34.46 69.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.812 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.702 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.6 pp0? -71.05 -36.29 72.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.39 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.541 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 1.3 ptt? -83.83 -4.09 58.38 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.779 0.323 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.609 ' HG2' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -96.68 -35.75 10.92 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.671 179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 147' ' ' ALA . 10.6 t -159.94 -46.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.378 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.702 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -68.19 74.39 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 111.376 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.939 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -174.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.577 2.185 . . . . 0.0 112.364 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -48.4 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 33.1 mmt-85 -150.08 40.26 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.86 -135.89 4.37 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.423 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 1.7 mpp_? -112.75 125.26 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.76 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.09 -67.51 2.16 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.822 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -60.9 -50.22 69.9 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.532 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.617 ' O ' HG22 ' B' ' 71' ' ' ILE . 0.1 OUTLIER -56.0 -65.28 0.63 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.539 0.209 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.407 ' NE2' ' NE ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.8 -36.68 48.67 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.465 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.4 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 13.8 tpp180 -56.14 -48.76 75.64 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.617 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -63.42 -41.79 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.096 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.519 HG23 ' O ' ' B' ' 68' ' ' PHE . 96.3 t -50.63 -51.14 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.57 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.85 ' O ' HG23 ' B' ' 77' ' ' VAL . 2.9 mpt_? -71.72 -45.91 60.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.507 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.809 HD22 HG11 ' A' ' 91' ' ' VAL . 14.2 mt -56.05 -47.47 77.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.71 0.29 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.905 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.5 p -67.0 -47.51 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 110.791 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.62 -30.18 62.02 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.106 -1.045 . . . . 0.0 112.075 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.85 HG23 ' O ' ' B' ' 73' ' ' ARG . 96.6 t -76.79 -55.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.726 0.298 . . . . 0.0 111.096 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.711 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -60.22 -43.73 93.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.581 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.654 ' HA ' ' HB3' ' B' ' 82' ' ' ALA . 9.3 mmp_? -55.65 -35.54 66.06 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.267 0.556 . . . . 0.0 109.562 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.76 -37.49 73.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.857 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.05 -17.23 22.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.318 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -78.09 -37.54 46.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.891 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.82 -69.42 0.83 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.646 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.422 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 9.9 mmpt? -43.52 -79.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.493 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.3 OUTLIER 69.74 -63.44 0.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.337 179.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.28 35.99 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.043 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.251 -0.881 . . . . 0.0 111.172 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.861 0.362 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -104.81 42.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.578 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -165.69 174.77 9.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.848 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.4 165.39 17.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.808 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.525 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.8 t -69.08 176.88 2.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.767 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -60.0 -39.04 84.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.8 tt0 -69.79 -56.84 6.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.848 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -57.82 -44.84 86.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.972 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.447 HG13 HD13 ' A' ' 69' ' ' LEU . 6.8 tt -69.02 -26.82 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.201 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.86 -43.04 63.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.412 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.62 -25.78 62.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.364 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.73 -49.36 25.95 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.332 -179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.48 -44.56 85.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.148 0.499 . . . . 0.0 110.274 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.99 -49.11 68.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.886 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.856 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.26 -41.28 62.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.399 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.489 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.74 -34.42 67.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.027 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 37.9 t -78.59 -14.59 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.99 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.74 -39.26 15.08 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.147 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.17 -65.65 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.234 179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 6.5 t0 -63.65 126.28 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.681 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -37.83 83.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.368 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -92.09 -12.4 33.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.23 32.75 63.92 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.811 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -77.07 1.91 16.63 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.845 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.78 43.37 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.431 -0.89 . . . . 0.0 114.084 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.4 p -149.6 132.59 16.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.52 0.66 . . . . 0.0 111.34 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.934 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.1 mp -105.11 118.61 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.866 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.437 ' CB ' HG22 ' A' ' 62' ' ' THR . 8.4 t -98.01 163.99 12.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.763 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.0 p -51.73 -25.47 7.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.891 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -68.11 -50.69 53.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.852 0.358 . . . . 0.0 111.065 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -77.86 -37.82 47.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.248 0.547 . . . . 0.0 110.574 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.015 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.16 -44.78 71.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.619 -179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.0 -28.89 73.97 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.235 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.0 m -73.53 -59.92 2.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.66 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.4 p -62.7 -30.5 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.475 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 12.2 ttt -61.51 -56.45 19.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.45 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.86 -25.46 66.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.733 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.8 t -51.4 -47.03 63.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.244 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.8 mt -48.71 -60.19 2.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.913 0.387 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 165.19 40.16 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.602 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -142.71 170.32 15.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -138.16 59.54 18.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.27 -178.93 3.93 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.622 2.214 . . . . 0.0 112.495 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.4 p -99.67 174.24 6.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -68.45 -29.93 68.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.89 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.88 -45.12 59.89 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.147 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.9 OUTLIER -61.31 -40.87 95.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.089 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.1 mt -59.41 -50.53 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.933 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 8.2 tt0 -62.98 -39.17 93.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.173 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -68.98 -51.19 42.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.334 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.04 -54.0 51.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.058 0.456 . . . . 0.0 110.454 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.0 -45.71 92.06 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.367 179.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 15.8 t-20 -51.98 -25.96 9.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.271 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.3 mt-10 -82.37 -3.24 55.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.953 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.934 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.35 -32.35 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.566 ' N ' HD12 ' A' ' 63' ' ' ILE . 43.4 t0 -63.57 135.69 57.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.105 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.89 -53.32 21.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.557 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -95.81 3.71 53.5 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.665 -179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.09 59.13 9.87 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.88 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.21 -2.5 17.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.852 0.326 . . . . 0.0 111.354 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.25 17.37 15.93 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.863 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.612 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.51 139.94 22.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.072 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.618 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -104.55 149.44 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.137 0.494 . . . . 0.0 111.785 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -107.6 171.06 7.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.566 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.9 m-85 -55.77 -61.5 6.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.524 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 39.6 Cg_endo -66.98 -20.25 51.14 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.436 2.091 . . . . 0.0 112.567 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.24 -37.64 37.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.085 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' ' CE ' ' A' ' 72' ' ' MET . 4.7 t80 -75.24 -33.95 61.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.029 0.442 . . . . 0.0 110.294 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.3 tp -76.75 -58.29 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.3 m -51.89 -45.67 64.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.142 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.1 mmt -59.76 -31.26 69.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.721 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 41.6 mtt -108.21 15.34 24.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.221 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.81 -40.47 4.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.91 0.386 . . . . 0.0 111.024 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -59.9 -45.12 93.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.22 59.18 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.987 0.423 . . . . 0.0 111.0 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -163.5 44.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -122.39 69.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.91 -175.2 2.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.963 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.2 p -89.51 -167.54 1.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.936 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.81 -179.41 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.2 m -148.3 156.28 42.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.788 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -50.89 -25.98 5.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.373 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -73.65 -39.46 64.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.168 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' HB3' HG21 ' B' ' 77' ' ' VAL . 43.8 mt-10 -63.11 -27.94 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.179 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.81 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.21 -38.93 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.32 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -71.13 -49.36 45.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.498 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 91' ' ' VAL . 21.7 mm-40 -61.2 -46.29 91.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.39 0.614 . . . . 0.0 109.447 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.742 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.6 -49.22 68.26 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.059 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.08 -38.52 52.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.996 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -30.38 56.89 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.853 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.008 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.49 -37.05 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 111.005 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.708 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.5 m-85 -71.42 -62.92 1.23 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.865 0.364 . . . . 0.0 110.483 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -82.93 120.61 25.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -63.35 -52.56 61.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.193 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.43 -9.61 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.492 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.96 71.76 0.47 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.884 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -93.47 14.53 18.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.679 0.276 . . . . 0.0 111.183 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.66 13.65 61.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.685 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.438 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.8 m-85 -158.33 116.72 3.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.68 0.276 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.52 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.45 124.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.137 0.494 . . . . 0.0 111.714 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.8 t -104.27 161.69 13.83 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.131 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.572 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -45.56 30.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.528 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.13 -58.84 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.988 0.423 . . . . 0.0 111.093 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -54.92 -36.47 65.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.543 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.963 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.61 -50.0 74.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.675 178.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.542 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -56.65 -41.44 77.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.412 178.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -60.57 -39.16 86.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 49.1 t -67.61 -54.45 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.817 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.407 ' HB3' HD23 ' A' ' 116' ' ' LEU . 10.0 mmt -50.33 -54.11 23.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.21 -24.51 65.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.559 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -69.89 -30.9 68.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.5 -28.7 16.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.081 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.15 42.78 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.548 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -153.23 110.28 3.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 0.0 110.845 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.3 mtmt -91.85 101.44 14.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.0 mm? -96.59 166.98 11.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.653 HG23 ' H ' ' A' ' 120' ' ' GLU . 12.8 t -94.63 163.79 13.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -59.75 -41.83 91.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.073 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -61.35 -35.87 78.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.653 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -65.48 -54.9 21.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.952 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.542 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.8 m -64.89 -40.02 87.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.182 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -62.6 -41.95 99.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.422 . . . . 0.0 110.3 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 33.5 mt-10 -72.63 -30.14 64.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 24.3 mtt -70.91 -35.98 72.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.799 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 105' ' ' LEU . 5.2 mm -80.25 -54.87 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.699 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.3 ptm180 -54.05 -31.85 52.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 110.377 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.25 -20.96 46.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.798 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.45 -2.6 20.32 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.471 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.9 t0 -94.87 109.71 21.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.394 0.616 . . . . 0.0 111.204 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.27 7.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.803 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.91 -9.12 44.36 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.579 -178.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.416 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.56 58.23 8.49 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 114.515 0.566 . . . . 0.0 114.515 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.404 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.7 p30 -114.24 -4.58 13.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.072 0.436 . . . . 0.0 111.513 178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.35 7.78 42.32 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.955 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.15 -174.88 4.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.673 0.273 . . . . 0.0 110.38 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.753 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.7 t -128.18 126.5 66.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.961 0.41 . . . . 0.0 111.245 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.2 t-20 -104.83 -167.81 1.4 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.95 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.2 t80 -58.79 -73.92 0.07 Allowed 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.57 -45.41 47.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.395 0.617 . . . . 0.0 110.286 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.54 -36.39 69.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.102 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.753 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.66 -49.56 11.94 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.957 0.408 . . . . 0.0 111.94 -179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.81 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.44 -40.63 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.715 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.611 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.28 -34.35 70.6 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.652 179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.416 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.22 8.36 13.54 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.68 0.276 . . . . 0.0 111.246 -179.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.568 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -38.28 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -148.96 -52.3 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.429 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.611 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -67.58 74.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.92 0.391 . . . . 0.0 111.394 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.938 179.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.67 0.271 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.04 155.22 65.52 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.519 2.146 . . . . 0.0 112.29 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 81.3 mtt-85 -61.95 -53.55 54.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 24.8 mmt-85 -144.82 81.92 1.66 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.37 -123.61 0.71 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.509 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.5 OUTLIER -115.41 103.72 11.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 0.0 110.85 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.26 -75.69 0.23 Allowed Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.905 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.02 -46.76 61.04 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.934 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -58.75 -70.85 0.13 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.643 -0.279 . . . . 0.0 110.54 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.458 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.11 -34.92 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.842 0.354 . . . . 0.0 110.38 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 4.9 tpp85 -57.1 -53.26 60.1 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.635 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.63 -41.65 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.125 178.474 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 68' ' ' PHE . 84.2 t -52.2 -53.02 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.283 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.785 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.6 mpt_? -71.91 -44.08 64.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.453 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.008 HD22 HG11 ' A' ' 91' ' ' VAL . 19.7 mt -56.2 -49.24 74.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.856 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.9 p -65.48 -47.66 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.583 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.69 -29.39 67.05 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.178 -1.01 . . . . 0.0 112.302 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.785 HG23 ' O ' ' B' ' 73' ' ' ARG . 70.1 t -76.82 -53.46 14.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.666 0.27 . . . . 0.0 111.246 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.708 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.65 -42.15 92.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.364 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.646 ' N ' HD12 ' B' ' 78' ' ' ILE . 3.7 mmp_? -57.03 -34.45 68.22 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.255 0.55 . . . . 0.0 109.67 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -37.29 86.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.388 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.929 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.47 -10.19 30.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.03 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -94.67 -28.09 15.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.277 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.98 -70.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.501 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 0.0 OUTLIER -51.35 -77.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.245 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.4 OUTLIER 70.45 -62.6 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.249 179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -103.67 32.89 3.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.187 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 1.2 ptm180 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.109 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -102.12 75.66 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.481 ' N ' ' HB1' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -176.8 171.83 2.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.916 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.711 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -128.85 165.33 21.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.4 t -68.47 169.25 11.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.682 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -55.05 -36.51 65.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 3.6 tt0 -71.3 -56.85 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.371 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.711 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.8 OUTLIER -58.54 -45.05 89.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.88 0.371 . . . . 0.0 110.845 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG13 HD13 ' A' ' 69' ' ' LEU . 6.9 tt -67.54 -26.78 36.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.115 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.79 -43.47 63.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.475 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -70.96 -25.8 62.88 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.395 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.86 -49.41 25.15 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.263 -179.545 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -57.43 -44.66 84.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.19 0.519 . . . . 0.0 110.207 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -65.34 -49.85 67.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.881 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.877 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.28 -40.76 62.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.45 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.7 OUTLIER -55.97 -38.94 71.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.207 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 m -76.74 -13.62 60.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.053 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mt -87.76 -38.37 15.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.97 0.414 . . . . 0.0 110.388 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.666 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -64.56 -65.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.375 179.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 8.6 t70 -63.62 129.02 38.42 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.862 0.363 . . . . 0.0 110.65 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -37.3 83.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.215 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -93.61 -12.31 29.74 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.7 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.3 37.86 83.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.649 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -77.02 -1.85 30.98 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.478 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.24 -2.57 43.67 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.217 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.6 p -149.47 132.5 16.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.986 0.393 . . . . 0.0 110.959 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -104.0 120.07 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.028 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.83 164.59 12.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.818 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 49.0 p -52.53 -25.47 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.841 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -70.49 -50.53 36.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.847 0.356 . . . . 0.0 111.356 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.77 -36.58 50.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.08 0.467 . . . . 0.0 111.005 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -54.25 -47.92 71.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.028 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.53 -27.39 73.56 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.391 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.9 m -72.05 -51.65 20.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.794 0.331 . . . . 0.0 111.218 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.607 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.9 p -70.61 -34.96 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.414 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -52.59 64.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.845 0.355 . . . . 0.0 110.71 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -25.56 66.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -52.13 -37.72 55.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.198 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -57.71 -65.86 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.56 38.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.513 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.7 166.65 24.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.843 0.354 . . . . 0.0 110.882 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -140.5 58.34 10.01 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.837 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 -170.25 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.595 2.196 . . . . 0.0 112.412 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.9 p -102.15 171.83 7.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -68.74 -29.44 67.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.44 56.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.815 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -62.41 -39.75 94.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.727 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.481 HD11 ' HA3' ' A' ' 33' ' ' GLY . 31.7 mt -58.33 -50.59 73.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.77 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 2.3 tp60 -64.63 -38.25 90.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.899 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -66.09 -51.19 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.088 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -58.44 -53.77 54.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -59.06 -44.73 92.08 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.513 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.415 179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 32.4 t30 -52.71 -25.92 12.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.1 mt-10 -82.66 -3.32 56.13 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.005 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.928 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.44 -32.31 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.3 t0 -63.46 135.31 56.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.067 0.461 . . . . 0.0 111.027 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.43 -53.5 28.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.07 4.23 52.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.744 -179.184 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 59.43 9.39 Favored Glycine 0 CA--C 1.518 0.27 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.895 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.97 -2.49 17.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.75 0.275 . . . . 0.0 111.342 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.47 15.75 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.893 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.624 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.8 p -149.46 139.92 22.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 111.09 179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.34 149.61 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.191 0.52 . . . . 0.0 111.925 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.56 171.03 7.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.634 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.8 m-85 -55.03 -61.52 5.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.659 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 40.4 Cg_endo -67.22 -20.28 49.61 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.434 2.089 . . . . 0.0 112.595 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -79.26 -38.08 36.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.168 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.5 t80 -75.1 -33.49 61.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 4' ' ' LEU . 11.6 tp -75.25 -58.16 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.295 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.434 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 53.2 m -51.56 -43.19 62.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.4 tmm? -54.15 -43.33 70.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.438 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 36.9 mtt -101.12 14.5 31.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.51 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -107.15 -36.7 6.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 0.0 110.888 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -73.62 -26.9 61.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.252 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.53 62.72 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.0 tpp -180.0 61.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.95 0.405 . . . . 0.0 111.024 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -136.15 78.79 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -132.73 -169.14 2.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.8 p -91.3 -168.25 2.0 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.935 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.765 ' OD2' HG22 ' B' ' 77' ' ' VAL . 12.4 m-20 -87.45 -178.49 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.954 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.2 m -142.66 159.56 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.5 pm0 -50.83 -25.97 5.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.387 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -75.85 -37.45 58.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.784 0.326 . . . . 0.0 111.085 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.523 ' HB3' HG21 ' B' ' 77' ' ' VAL . 42.3 mt-10 -65.4 -26.76 68.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.145 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.809 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.03 -38.47 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.013 0.435 . . . . 0.0 110.099 179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -71.37 -49.36 42.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.511 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.877 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.9 mt-10 -61.31 -46.29 90.92 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.378 0.609 . . . . 0.0 109.442 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.743 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.46 -49.02 68.31 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.022 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.12 -39.01 55.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.919 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.16 -30.37 58.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.861 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.014 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.43 -37.04 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 120.694 0.283 . . . . 0.0 110.958 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.559 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -70.66 -63.02 1.18 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.895 0.379 . . . . 0.0 110.44 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -83.55 120.79 26.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.807 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -52.58 62.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.279 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.49 -9.62 59.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.52 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.82 71.76 0.46 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.814 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -92.98 14.5 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.668 0.271 . . . . 0.0 111.215 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.61 16.59 65.75 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.619 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.1 m-85 -161.15 116.76 2.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.735 0.303 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.537 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.05 124.28 69.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.119 0.485 . . . . 0.0 111.65 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.5 t -104.26 161.52 13.98 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.206 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.86 -44.42 29.22 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.472 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.13 -58.84 6.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.022 0.439 . . . . 0.0 111.015 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.9 mm-40 -55.02 -38.0 67.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.653 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.899 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -60.61 -49.48 77.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.744 178.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.884 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -57.24 -41.72 80.11 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.334 178.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.64 -39.36 84.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.364 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 104' ' ' GLU . 70.2 t -67.15 -55.71 16.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.668 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.2 mmt -49.07 -54.09 17.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.705 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.2 t -67.62 -24.22 65.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -70.57 -30.2 66.84 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.834 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -95.07 -28.85 14.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.039 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.95 43.05 0.11 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.9 109.77 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -89.59 101.97 14.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.997 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -99.27 165.31 11.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' HG22 ' A' ' 121' ' ' VAL . 9.0 t -98.28 171.15 8.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.828 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -68.0 -32.46 72.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.59 -47.63 69.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.696 ' H ' HG23 ' A' ' 117' ' ' THR . 6.9 mm-40 -60.54 -54.85 40.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.863 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.884 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.3 m -57.7 -50.93 75.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.391 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 121' ' ' VAL . 36.6 t70 -57.47 -39.27 76.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.034 0.445 . . . . 0.0 110.685 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.425 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 52.1 mt-10 -72.59 -30.19 64.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.47 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.409 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -71.03 -36.07 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.82 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.899 HD11 HD12 ' A' ' 105' ' ' LEU . 4.5 mm -80.18 -54.92 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.646 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.425 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 5.9 ptm180 -53.56 -31.74 47.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.029 0.442 . . . . 0.0 110.516 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.32 -21.1 53.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.035 179.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.44 -10.86 15.64 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.624 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -84.87 110.02 18.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.385 0.612 . . . . 0.0 111.302 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.89 -31.15 6.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.791 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.32 -9.07 43.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.6 -178.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.419 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.06 57.78 9.55 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.597 0.599 . . . . 0.0 114.597 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.0 p30 -114.27 -4.19 13.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 117.039 0.42 . . . . 0.0 111.515 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.45 7.51 42.59 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.006 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.419 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.07 -174.88 4.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.419 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.0 t -129.02 126.25 64.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.941 0.4 . . . . 0.0 111.157 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.48 -167.53 1.34 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.062 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.3 t80 -57.71 -73.89 0.07 Allowed 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.8 OUTLIER -49.56 -45.86 48.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.283 0.564 . . . . 0.0 110.306 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.57 -36.48 69.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.157 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.734 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.74 -49.73 11.62 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.881 -179.001 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.809 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -56.32 -36.82 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.521 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -71.08 -34.79 71.49 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.63 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.444 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.7 OUTLIER -87.1 15.36 6.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.701 0.286 . . . . 0.0 110.858 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.1 mtt -126.99 -49.5 1.46 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.328 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.3 t -163.2 30.77 0.09 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -144.87 55.29 1.24 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.006 0.431 . . . . 0.0 111.264 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.994 179.851 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . 0.427 HG23 ' HD2' ' B' ' 61' ' ' PRO . 87.7 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.654 0.264 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' B' ' 60' ' ' THR . 52.4 Cg_exo -52.71 -175.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.456 2.104 . . . . 0.0 112.346 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -103.16 -45.86 4.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -154.0 31.26 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.25 -134.92 6.38 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.462 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -101.51 103.41 14.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.002 0.429 . . . . 0.0 110.794 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.28 -75.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.877 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.64 -45.56 59.92 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.182 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.928 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.22 -71.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.699 -0.251 . . . . 0.0 110.586 179.388 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.433 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.26 -32.96 39.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.611 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.43 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 5.1 tpp85 -58.47 -53.2 60.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.55 -41.14 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.969 178.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.533 HG23 ' O ' ' B' ' 68' ' ' PHE . 86.4 t -53.14 -50.95 43.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.333 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.725 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.92 -47.06 55.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.431 -179.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.014 HD22 HG11 ' A' ' 91' ' ' VAL . 33.2 mt -56.67 -45.78 81.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.808 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.877 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -66.77 -47.43 82.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.804 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.577 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.18 -29.83 69.37 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.294 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.765 HG22 ' OD2' ' A' ' 80' ' ' ASP . 79.7 t -76.8 -51.88 18.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 111.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.642 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.7 pp -67.42 -42.03 86.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.537 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.642 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.0 mmp_? -57.37 -34.66 69.05 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.216 0.532 . . . . 0.0 109.763 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -36.81 84.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.485 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.877 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.0 t90 -95.38 -14.19 24.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -91.24 -26.92 18.77 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.372 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.55 -71.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.618 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -50.85 -74.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.259 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' B' ' 85' ' ' ASN . 0.5 OUTLIER 70.63 -61.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.242 179.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.43 29.57 3.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.112 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.285 -0.864 . . . . 0.0 111.068 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.843 0.354 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -167.22 35.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.545 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -169.95 176.56 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.88 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.612 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -126.53 165.32 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.803 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.3 t -70.4 171.79 9.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.893 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -55.62 -38.03 68.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.242 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -71.47 -56.75 5.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.108 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.623 ' H ' HG23 ' A' ' 5' ' ' THR . 0.8 OUTLIER -58.11 -45.2 87.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.851 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.494 HG13 HD13 ' A' ' 69' ' ' LEU . 5.9 tt -67.14 -26.78 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.98 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.71 -42.87 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.334 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.5 -25.78 63.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.395 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -73.91 -49.41 24.94 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.499 0.19 . . . . 0.0 111.262 -179.525 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -57.65 -44.64 85.81 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.196 0.522 . . . . 0.0 110.117 179.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -65.12 -49.08 71.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.746 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.943 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.29 -41.33 62.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.44 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -56.33 -36.7 69.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.129 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.87 -13.85 59.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -87.7 -38.29 15.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.273 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.655 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -66.25 -65.9 0.62 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.319 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.3 t70 -64.97 127.41 31.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.843 0.354 . . . . 0.0 110.639 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -38.52 91.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.65 -12.26 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.853 0.359 . . . . 0.0 110.794 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.08 37.94 82.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.641 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -76.88 -1.91 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 -2.33 43.47 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 113.173 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.4 p -149.42 132.42 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.924 0.362 . . . . 0.0 110.745 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.929 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.4 mp -104.44 120.33 54.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.095 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 t -97.78 159.83 14.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.496 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.415 HG21 ' NE2' ' A' ' 49' ' ' GLN . 19.2 p -50.17 -25.45 3.59 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -67.69 -50.95 55.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -78.13 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.428 0.633 . . . . 0.0 110.424 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.097 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.21 -50.51 66.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.796 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -64.41 -27.47 71.75 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.31 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.0 m -69.5 -54.95 11.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.743 0.306 . . . . 0.0 110.92 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.58 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.51 -31.72 53.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -47.08 87.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.902 0.382 . . . . 0.0 110.413 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -25.57 44.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 t -55.13 -50.57 68.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -47.78 -58.03 4.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.157 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.96 40.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.576 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -142.56 179.73 6.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.822 0.344 . . . . 0.0 110.825 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -159.73 58.74 1.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.866 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.34 -170.57 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.676 2.25 . . . . 0.0 112.509 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.3 p -93.9 171.11 9.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 48' ' ' LEU . 11.7 pt-20 -68.48 -31.44 70.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.291 0.567 . . . . 0.0 110.05 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.68 -44.03 65.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.892 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' O ' ' HE3' ' A' ' 51' ' ' MET . 1.4 mt-10 -62.16 -53.33 56.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.657 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.15 -50.79 63.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.351 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 29' ' ' THR . 2.3 tp-100 -57.98 -40.35 80.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -62.63 -45.12 94.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.264 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.421 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -60.8 -52.66 64.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.203 179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.097 HD11 HD13 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -57.15 -45.86 84.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.126 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.06 -25.99 9.91 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.351 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.0 OUTLIER -83.02 -3.29 57.09 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.012 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.919 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.37 -32.24 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' N ' HD12 ' A' ' 63' ' ' ILE . 46.2 t0 -63.0 136.93 58.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.037 0.446 . . . . 0.0 111.155 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -67.35 -53.74 26.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.481 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -96.95 4.16 51.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.701 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.68 59.66 8.92 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.735 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -110.37 -1.17 17.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.726 0.263 . . . . 0.0 111.409 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.24 17.37 15.98 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.877 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.579 ' C ' HD13 ' A' ' 63' ' ' ILE . 10.5 p -149.53 139.96 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 0.0 111.186 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 ' C ' ' A' ' 62' ' ' THR . 2.6 mm -104.47 149.78 7.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.065 0.459 . . . . 0.0 111.705 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.44 168.76 9.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.63 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.2 m-85 -52.53 -61.21 4.91 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 44.0 Cg_endo -68.16 -19.81 44.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.464 2.11 . . . . 0.0 112.669 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.9 mm-40 -79.27 -37.47 37.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.106 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 68' ' ' PHE . 4.7 t80 -75.23 -32.46 61.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.01 0.433 . . . . 0.0 110.311 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.545 HD21 ' HG3' ' A' ' 3' ' ' GLN . 11.1 tp -76.19 -58.07 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.281 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 73' ' ' ALA . 52.5 m -51.61 -43.1 62.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.503 ' HE2' ' HD3' ' B' ' 65' ' ' ARG . 4.4 tmm? -54.14 -44.72 71.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.946 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.443 ' CE ' ' CZ ' ' A' ' 68' ' ' PHE . 33.8 mtt -100.66 15.35 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.537 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.612 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -109.99 -31.68 7.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.876 0.369 . . . . 0.0 110.877 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -61.93 -39.32 91.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.245 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 46.6 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.359 . . . . 0.0 111.317 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.8 mtt -149.04 73.61 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.983 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.53 40.85 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.789 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.08 -169.44 1.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.0 p -99.68 -165.82 1.27 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -90.9 -175.21 4.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.998 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.99 161.72 38.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -50.7 -25.42 4.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.525 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -73.7 -46.18 47.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.131 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 43.9 mt-10 -57.43 -26.71 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.209 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -73.65 -38.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.188 179.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.54 -49.49 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.544 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.874 ' O ' HG13 ' A' ' 91' ' ' VAL . 4.1 mt-10 -61.18 -46.12 91.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.404 0.621 . . . . 0.0 109.442 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.773 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.6 -49.3 68.11 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.984 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.05 -38.19 49.97 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.968 179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -30.49 57.15 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.831 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.051 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.78 -36.77 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.659 0.266 . . . . 0.0 111.006 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.691 ' CE2' HG22 ' B' ' 78' ' ' ILE . 1.8 m-85 -72.23 -62.93 1.26 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.869 0.366 . . . . 0.0 110.492 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.82 114.07 20.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.827 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -60.96 -50.08 74.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.206 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.06 -9.66 59.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.534 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.74 72.37 0.39 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.839 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -94.33 13.76 22.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.69 0.281 . . . . 0.0 111.148 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 19.48 69.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.542 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 4.5 m-85 -166.19 116.77 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.505 HD11 ' HD1' ' A' ' 89' ' ' PHE . 6.2 mt -112.24 124.34 68.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 0.0 111.863 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.7 t -104.43 161.96 13.64 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.085 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.574 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.8 -44.79 28.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.475 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.26 -58.79 6.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.037 0.446 . . . . 0.0 111.031 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -54.88 -36.29 64.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.6 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.93 -50.7 71.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.713 178.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.536 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -55.77 -41.47 74.09 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.385 178.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -61.05 -39.32 89.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.281 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.97 -53.91 26.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.75 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 9.8 mmt -50.5 -54.04 25.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.704 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.28 -25.03 65.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.554 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.18 -32.05 72.02 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.44 -28.78 16.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.36 42.15 0.14 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -140.31 109.81 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.81 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -85.28 80.61 9.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.26 161.54 17.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.623 HG23 ' H ' ' A' ' 120' ' ' GLU . 14.3 t -96.76 162.86 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.806 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -30.3 71.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.034 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -66.2 -42.31 88.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.623 ' H ' HG23 ' A' ' 117' ' ' THR . 17.2 mm-40 -63.21 -51.78 64.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.993 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.1 m -61.56 -41.5 90.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.225 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -62.23 -43.28 99.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 23.3 mt-10 -72.4 -30.13 64.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.44 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 4.9 ttm -70.73 -35.4 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 105' ' ' LEU . 5.3 mm -80.3 -54.94 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.556 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 9.8 ptm180 -54.02 -31.72 52.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.049 0.452 . . . . 0.0 110.365 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -78.3 -21.01 50.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.904 179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 -7.65 16.42 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.1 t0 -88.68 109.89 20.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.383 0.611 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.727 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.6 pt -84.88 -31.1 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.77 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.5 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.39 -9.08 43.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.612 -178.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.414 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.68 58.11 8.76 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 114.54 0.576 . . . . 0.0 114.54 178.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.3 -4.41 13.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 117.036 0.418 . . . . 0.0 111.428 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.59 42.65 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.011 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.1 -174.88 4.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.755 0.312 . . . . 0.0 110.417 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.749 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.8 t -127.84 127.28 68.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.923 0.392 . . . . 0.0 111.224 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -106.17 -168.27 1.41 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.968 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.643 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.1 t80 -57.98 -73.95 0.07 Allowed 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.489 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -49.57 -45.6 47.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.343 0.592 . . . . 0.0 110.262 -179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.727 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.7 mt-10 -56.73 -36.3 69.56 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.109 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.749 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.6 -49.62 11.9 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 121.02 0.438 . . . . 0.0 111.797 -178.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.1 m -56.47 -36.55 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.615 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -70.96 -33.96 70.97 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.471 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.8 OUTLIER -88.58 16.58 6.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 110.804 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.616 ' SD ' HG23 ' A' ' 85' ' ' ILE . 5.0 mtt -128.36 -51.38 1.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.215 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.4 t -156.97 27.88 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.749 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -144.05 54.46 1.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 111.357 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.968 179.864 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.758 0.313 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.39 173.65 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.542 2.161 . . . . 0.0 112.327 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -95.03 -47.52 6.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -151.28 31.08 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -134.83 6.63 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.559 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.54 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -103.77 103.82 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 110.83 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.17 -75.77 0.22 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.859 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.16 -46.11 56.82 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.238 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.919 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -59.83 -71.55 0.13 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.667 0.27 . . . . 0.0 110.589 179.412 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.409 ' NE2' ' CD ' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.96 -33.38 37.45 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.473 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 10.0 tpp180 -57.27 -51.92 67.42 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.619 HG21 ' CE2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -60.88 -42.62 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.806 178.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.526 HG23 ' O ' ' B' ' 68' ' ' PHE . 97.7 t -50.62 -47.68 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.428 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.843 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.13 -48.24 45.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.438 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.051 HD22 HG11 ' A' ' 91' ' ' VAL . 37.4 mt -56.12 -46.45 79.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -66.05 -48.84 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.58 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.01 -29.61 59.51 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.099 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.843 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.1 t -76.71 -56.5 8.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.686 0.279 . . . . 0.0 111.573 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.691 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.6 pp -61.49 -43.83 97.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.658 ' N ' HD12 ' B' ' 78' ' ' ILE . 21.7 mmm180 -58.0 -33.58 69.09 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.2 0.524 . . . . 0.0 109.864 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.32 -36.42 83.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.427 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.6 t90 -95.37 -15.98 22.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.92 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.39 -25.06 20.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -121.72 -71.41 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.632 -178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.22 -68.24 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.822 0.344 . . . . 0.0 111.194 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.47 -61.76 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.229 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -97.08 29.65 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.013 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.148 179.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.813 0.34 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -102.13 74.88 1.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -177.79 170.29 1.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.863 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.749 HD13 ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -123.31 165.3 17.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.523 HG23 ' H ' ' A' ' 8' ' ' GLN . 9.7 t -69.31 177.35 2.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.802 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.83 -38.72 82.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -70.92 -56.99 5.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.263 -179.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.749 ' NE2' HD13 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -56.86 -44.72 82.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.909 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG13 HD13 ' A' ' 69' ' ' LEU . 6.1 tt -69.29 -26.81 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.033 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.78 -42.94 62.81 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.25 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -71.75 -27.04 62.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.196 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.38 -49.56 40.92 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.279 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -57.08 -44.81 83.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.167 0.508 . . . . 0.0 110.228 179.738 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.519 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 39.9 mm-40 -65.15 -50.67 65.09 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.785 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 1.038 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.33 -40.36 58.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.844 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.43 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.09 -45.66 79.32 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.475 -179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.3 m -70.77 -14.86 62.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.428 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.0 mt -87.83 -37.4 16.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 0.0 110.619 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.56 -65.0 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.053 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 7.2 t70 -64.9 132.5 49.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.869 0.366 . . . . 0.0 110.553 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -38.84 81.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.319 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -92.8 -12.3 31.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.889 0.376 . . . . 0.0 110.802 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.83 37.57 84.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.633 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -74.25 -4.56 36.82 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.181 -0.207 . . . . 0.0 111.437 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.29 0.27 43.99 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.061 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.6 p -149.58 132.5 16.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.785 0.326 . . . . 0.0 110.733 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 32' ' ' LEU . 2.1 mt -105.07 127.42 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.378 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.5 t -102.02 168.77 9.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.773 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.8 p -53.55 -40.37 65.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.772 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -55.68 -50.45 70.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.57 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -76.25 -36.37 58.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.118 0.485 . . . . 0.0 110.926 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -54.22 -58.4 7.52 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.573 -179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.11 -31.99 78.79 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.42 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -61.47 -57.79 10.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 110.972 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.1 p -67.78 -30.48 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.319 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -51.99 66.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.909 0.385 . . . . 0.0 110.44 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -25.66 61.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.786 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.3 t -60.87 -45.18 95.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.2 mt -49.35 -60.69 2.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.073 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.25 41.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.546 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -142.6 171.99 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.848 0.356 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.71 59.33 19.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.837 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.5 -170.36 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.551 2.167 . . . . 0.0 112.357 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.3 p -115.88 170.15 8.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -68.7 -30.56 69.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.198 0.523 . . . . 0.0 110.098 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.65 -44.35 57.43 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.035 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.05 -42.33 99.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.043 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 13.3 mt -59.35 -50.56 73.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.07 -48.16 81.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.465 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.35 -51.04 65.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.157 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -56.25 -50.75 70.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.857 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 32' ' ' LEU . 1.2 mt -60.64 -44.77 97.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.49 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.11 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -55.74 -26.45 45.67 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.515 0.674 . . . . 0.0 110.236 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 51' ' ' MET . 4.0 mt-10 -83.46 -2.03 54.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.535 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.681 HG11 ' CE2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.8 -33.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 0.0 112.121 -177.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.539 ' N ' HD12 ' A' ' 63' ' ' ILE . 53.6 t0 -69.97 139.59 52.85 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.02 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -71.98 -53.57 12.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.478 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -93.39 -3.16 53.76 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.621 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.9 55.86 27.4 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.911 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.63 15.6 26.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.857 0.328 . . . . 0.0 111.11 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 83.41 16.95 67.58 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.908 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.447 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.8 p -149.9 139.8 21.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.718 0.294 . . . . 0.0 110.804 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 ' CZ ' ' B' ' 68' ' ' PHE . 2.7 mm -97.59 149.47 5.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.973 0.416 . . . . 0.0 111.414 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.67 -178.92 3.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' N ' ' HD2' ' A' ' 66' ' ' PRO . 8.6 m-85 -62.82 -61.67 7.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.395 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 25.6 Cg_endo -62.19 -34.4 78.83 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.416 2.077 . . . . 0.0 111.942 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -67.78 -47.42 69.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.457 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD2' ' CE2' ' B' ' 68' ' ' PHE . 3.2 t80 -61.66 -44.58 96.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.327 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.546 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.8 tp -72.66 -58.11 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.389 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 82.9 m -51.71 -45.59 63.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.172 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.4 mmt -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.653 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.7 mmt -108.47 14.97 24.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -111.17 -44.48 3.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.827 0.346 . . . . 0.0 110.991 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -57.08 -45.86 82.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.023 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.7 68.65 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.853 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.26 35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -105.91 43.11 1.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.47 -175.7 3.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.0 p -96.29 -167.31 1.56 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.973 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.651 ' OD2' HG22 ' B' ' 77' ' ' VAL . 0.8 OUTLIER -86.4 -177.37 6.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.911 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 159.23 43.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.77 -26.57 5.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.338 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -74.47 -41.27 61.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 22.8 mt-10 -59.69 -26.78 65.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.817 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.1 mm -74.11 -37.63 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.921 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -71.71 -49.41 39.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.267 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.88 ' O ' HG13 ' A' ' 91' ' ' VAL . 37.5 mt-10 -61.24 -46.43 90.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.352 0.596 . . . . 0.0 109.395 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.813 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.4 -49.17 67.83 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.97 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.97 -40.27 57.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.946 179.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -30.61 62.24 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.852 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.928 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.52 -37.08 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 120.692 0.282 . . . . 0.0 110.98 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.635 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.84 -62.86 1.27 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.883 0.373 . . . . 0.0 110.484 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.413 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.9 t0 -82.79 115.14 21.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -59.04 -52.58 65.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.258 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -79.1 -9.58 59.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.513 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.4 71.42 0.49 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.831 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -93.46 14.43 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.675 0.274 . . . . 0.0 111.203 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.5 16.83 65.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.588 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.3 m-85 -162.38 116.75 1.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.717 0.294 . . . . 0.0 110.849 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.528 HD11 ' HD1' ' A' ' 89' ' ' PHE . 5.0 mt -113.31 124.84 70.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.147 0.498 . . . . 0.0 111.751 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.0 t -104.28 161.53 13.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.171 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.586 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.84 -44.87 29.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.434 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.85 -58.82 6.48 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.053 0.454 . . . . 0.0 111.072 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -55.0 -36.75 65.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.62 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.943 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.7 -49.91 74.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.723 178.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.85 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.36 -41.79 76.73 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.38 178.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -60.71 -38.68 85.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.235 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 37.8 t -67.55 -54.29 24.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.752 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.8 mmt -50.92 -53.97 28.13 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.695 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.08 -24.65 65.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.542 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.53 -31.05 69.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.59 -28.73 15.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.02 43.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.564 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -147.55 109.82 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 110.837 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -88.2 100.52 13.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.2 mm? -99.18 163.21 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.776 ' O ' HG22 ' A' ' 121' ' ' VAL . 8.4 t -98.25 171.67 8.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.08 -32.75 73.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -67.58 -47.91 68.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.038 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.691 ' H ' HG23 ' A' ' 117' ' ' THR . 74.7 mm-40 -60.35 -54.84 40.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.85 HG11 ' HB2' ' A' ' 106' ' ' ARG . 5.4 m -57.55 -51.02 75.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.383 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.415 ' N ' HG23 ' A' ' 121' ' ' VAL . 20.7 t70 -57.54 -38.84 75.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.982 0.42 . . . . 0.0 110.566 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.417 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 32.6 mt-10 -72.86 -30.09 63.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.476 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -71.0 -36.33 72.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.845 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.943 HD11 HD12 ' A' ' 105' ' ' LEU . 4.7 mm -80.32 -54.9 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.692 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.417 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.1 ptm180 -53.75 -31.83 49.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.032 0.444 . . . . 0.0 110.52 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 124' ' ' MET . 7.9 pt-20 -78.76 -20.93 48.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.957 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.2 -7.27 16.86 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.476 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.3 t0 -89.05 110.05 20.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.359 0.6 . . . . 0.0 111.272 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.735 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.94 -31.12 6.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.819 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.496 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.37 -9.14 42.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.605 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.421 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.94 57.85 9.34 Favored Glycine 0 C--N 1.333 0.4 0 N-CA-C 114.566 0.587 . . . . 0.0 114.566 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.1 p30 -114.3 -4.45 13.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.992 0.396 . . . . 0.0 111.437 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.46 7.75 42.06 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.984 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.418 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.12 -174.92 4.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.779 0.323 . . . . 0.0 110.475 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.727 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.88 126.56 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.1 t30 -105.98 -167.57 1.33 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.649 ' O ' HG13 ' A' ' 142' ' ' VAL . 54.1 t80 -57.67 -73.89 0.06 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.508 ' O ' HG22 ' A' ' 142' ' ' VAL . 1.7 tt0 -49.5 -45.99 47.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.334 0.587 . . . . 0.0 110.322 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.735 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.6 -36.27 69.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.069 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.727 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.52 -49.68 11.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.994 0.426 . . . . 0.0 111.851 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.817 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.88 -37.08 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.685 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.664 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.1 OUTLIER -70.98 -34.32 71.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.657 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.442 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.6 OUTLIER -88.12 15.89 6.85 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.752 0.311 . . . . 0.0 110.883 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.611 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -126.85 -51.13 1.46 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.132 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 14.6 t -158.38 28.65 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.705 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.664 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -144.29 54.56 1.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . 0.713 HG22 ' HD2' ' B' ' 61' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.656 0.265 . . . . 0.0 111.149 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.713 ' HD2' HG22 ' B' ' 60' ' ' THR . 65.4 Cg_exo -51.07 98.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.553 2.168 . . . . 0.0 112.401 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 67.1 mtm-85 -59.94 -31.22 69.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -147.68 30.59 0.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.834 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.09 -135.28 4.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.478 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -126.95 128.3 46.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.059 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.12 -66.01 3.0 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.793 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.13 -50.66 26.94 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.432 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.681 ' CE2' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -52.44 -63.5 1.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.476 0.179 . . . . 0.0 110.891 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' B' ' 73' ' ' ARG . 0.9 OUTLIER -51.68 -36.42 46.41 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.46 -179.893 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.46 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.9 tpt180 -56.16 -53.2 59.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.613 ' O ' HG12 ' B' ' 75' ' ' VAL . 0.4 OUTLIER -58.46 -42.48 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.276 178.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.568 HG23 ' O ' ' B' ' 68' ' ' PHE . 94.0 t -50.83 -53.44 13.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.836 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.859 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.4 OUTLIER -73.32 -44.27 59.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.662 -178.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.928 HD22 HG11 ' A' ' 91' ' ' VAL . 19.4 mt -55.91 -48.46 75.63 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.858 0.361 . . . . 0.0 110.168 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.038 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -63.97 -47.97 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.271 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.57 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.03 -28.53 58.36 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.025 -1.084 . . . . 0.0 112.064 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.859 HG23 ' O ' ' B' ' 73' ' ' ARG . 87.8 t -76.77 -56.18 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.653 0.263 . . . . 0.0 111.452 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.649 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.6 pp -60.97 -43.5 96.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 24.8 mmm180 -58.04 -34.16 69.78 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.232 0.539 . . . . 0.0 109.918 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.67 -36.82 84.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.426 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.905 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.5 t90 -95.43 -15.33 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.988 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.49 -26.47 19.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.429 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.48 -71.77 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.627 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -51.06 -74.54 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.315 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.411 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.5 OUTLIER 70.98 -61.63 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.247 179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.53 29.66 3.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.137 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.824 0.345 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.85 48.02 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.698 ' HG3' HD21 ' A' ' 69' ' ' LEU . 2.6 tt0 -160.29 171.96 18.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.843 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -118.37 165.47 13.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.834 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.637 HG23 ' H ' ' A' ' 8' ' ' GLN . 5.6 t -68.55 177.06 2.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.834 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.01 -37.75 83.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.01 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.8 tt0 -71.39 -56.74 5.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.637 ' H ' HG23 ' A' ' 5' ' ' THR . 1.1 tt0 -57.86 -44.1 86.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.913 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.514 HG13 HD13 ' A' ' 69' ' ' LEU . 7.4 tt -68.9 -26.9 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.005 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.96 -43.12 63.39 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.316 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.28 -25.75 62.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -74.11 -49.39 24.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.565 0.221 . . . . 0.0 111.226 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -57.62 -44.49 85.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.225 0.536 . . . . 0.0 110.175 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -65.76 -49.13 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.818 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.881 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.3 -41.01 62.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.492 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -55.25 -38.81 69.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.174 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.2 t -76.8 -14.23 59.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mt -87.75 -37.9 16.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.833 0.349 . . . . 0.0 110.455 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' HB3' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -65.75 -65.1 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.262 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 9.0 t70 -64.57 127.01 29.69 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.849 0.357 . . . . 0.0 110.637 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.88 -38.66 91.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.241 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.35 -12.31 32.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.842 0.353 . . . . 0.0 110.781 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.04 37.64 80.73 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.6 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.9 p-10 -76.49 -2.17 30.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.22 -1.82 43.74 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.2 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.1 p -149.45 132.49 16.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 0.0 110.735 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.922 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.6 mt -104.53 120.55 55.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.0 t -97.93 161.99 13.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.568 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.7 p -52.26 -25.57 9.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.809 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -67.27 -50.83 58.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.016 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -77.95 -36.77 48.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.331 0.586 . . . . 0.0 110.572 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.092 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.2 -41.55 68.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.683 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.805 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -72.58 -27.46 69.38 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.195 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -69.07 -51.39 39.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.697 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.569 HG11 ' CD1' ' A' ' 19' ' ' PHE . 9.6 p -74.45 -33.16 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.286 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.7 ttt -57.74 -44.16 85.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.991 0.424 . . . . 0.0 110.384 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -25.54 44.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.69 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.1 t -56.53 -44.88 81.27 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.424 HD13 ' CD ' ' B' ' 70' ' ' ARG . 3.6 mt -46.04 -30.12 1.73 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.877 0.37 . . . . 0.0 111.2 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.59 35.18 0.32 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.751 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -142.82 173.6 11.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.748 0.309 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.444 ' N ' ' HD3' ' A' ' 43' ' ' PRO . 28.3 m120 -140.93 63.65 19.39 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 2.7 Cg_exo -75.85 -171.63 1.11 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.88 2.387 . . . . 0.0 112.185 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 82.8 p -100.07 170.94 8.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.798 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -68.55 -31.36 70.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.251 0.548 . . . . 0.0 110.05 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.22 -44.04 64.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.014 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.5 -53.23 57.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.685 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.805 HD13 ' CA ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -53.27 -50.72 64.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.365 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -60.23 -39.15 85.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.529 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.42 -44.65 90.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.297 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -60.27 -52.94 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.217 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.092 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -57.96 -46.25 87.73 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.299 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -51.58 -26.03 7.97 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.372 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.428 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.4 mt-10 -83.64 -3.32 57.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.074 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.36 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -62.9 134.44 56.22 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.083 0.468 . . . . 0.0 111.101 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -65.5 -53.32 44.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.717 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -97.45 4.37 50.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.817 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.52 60.11 8.7 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.928 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -110.37 -2.57 16.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.768 0.284 . . . . 0.0 111.38 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.23 17.38 15.95 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.958 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.6 p -149.53 139.94 22.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.874 0.369 . . . . 0.0 111.224 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -105.45 149.6 8.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.234 0.54 . . . . 0.0 111.802 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -107.98 172.05 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.487 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.8 m-85 -56.1 -61.49 6.42 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 41.9 Cg_endo -67.42 -20.34 48.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.469 2.112 . . . . 0.0 112.864 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.23 -37.97 36.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.438 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.7 t80 -75.24 -34.59 61.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 110.623 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.698 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.0 tp -74.97 -58.29 3.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.093 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.0 -46.44 64.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.242 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.8 mmt -61.66 -30.8 70.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.697 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.407 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 6.8 mmt -105.13 13.91 29.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.46 -36.67 4.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.09 -56.48 21.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.126 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 43.98 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 5.4 mmt -150.21 66.85 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -133.08 39.06 3.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.744 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.5 -168.49 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.006 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.53 -174.88 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -72.26 179.34 3.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.47 155.87 40.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.8 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.06 -25.31 8.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.322 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -75.11 -35.79 61.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.223 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.583 ' HB3' HG21 ' B' ' 77' ' ' VAL . 36.8 mt-10 -66.78 -26.64 67.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.215 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.801 HG21 ' N ' ' A' ' 142' ' ' VAL . 1.0 OUTLIER -74.25 -37.82 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.002 0.429 . . . . 0.0 110.155 179.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -71.71 -49.4 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.585 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.87 ' O ' HG13 ' A' ' 91' ' ' VAL . 44.9 mt-10 -62.4 -44.45 96.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.352 0.596 . . . . 0.0 109.42 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.775 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.77 -50.06 66.89 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.819 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.546 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.92 -37.75 45.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.868 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.48 -30.57 57.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.714 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 87' ' ' GLU . 1.5 m -76.63 -36.76 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 120.665 0.269 . . . . 0.0 111.02 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.697 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.1 m-85 -73.56 -62.82 1.35 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.792 0.329 . . . . 0.0 110.545 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 100' ' ' ILE . 5.5 t0 -81.9 116.63 21.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -63.24 -52.43 62.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.157 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -77.68 -9.63 59.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.499 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.25 70.71 0.58 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.884 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -94.62 14.02 22.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.648 0.261 . . . . 0.0 111.22 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.55 18.2 67.6 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.613 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.0 m-85 -163.54 116.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.716 0.293 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.515 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.52 124.91 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.114 0.483 . . . . 0.0 111.678 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -104.22 162.06 13.51 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.197 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -46.56 31.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.37 -58.8 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.029 0.442 . . . . 0.0 111.104 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -54.88 -36.42 65.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.583 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.46 -50.64 71.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.647 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.505 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.16 -41.53 75.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.384 178.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -60.62 -39.03 86.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.333 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.66 -54.64 19.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.785 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.4 mmt -50.06 -54.05 22.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.697 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.8 t -66.37 -24.62 66.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.567 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -31.32 69.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.35 -28.8 15.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.981 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 135.65 42.95 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.05 109.78 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.4 mttt -91.9 93.74 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -92.83 158.1 16.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.661 HG23 ' H ' ' A' ' 120' ' ' GLU . 13.1 t -88.34 163.56 15.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -58.93 -39.89 82.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.04 -36.14 83.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.661 ' H ' HG23 ' A' ' 117' ' ' THR . 29.1 mm-40 -64.73 -54.83 25.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.27 -39.77 86.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.215 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -62.3 -42.0 98.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.06 0.457 . . . . 0.0 110.395 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 29.9 mt-10 -72.6 -30.22 64.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.359 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 3.1 mtt -70.78 -35.88 72.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.81 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.96 HD11 HD12 ' A' ' 105' ' ' LEU . 5.4 mm -80.31 -54.89 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.67 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -54.01 -31.81 52.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 0.0 110.446 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -79.12 -21.06 47.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.821 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.05 -4.35 19.04 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 121.147 -0.221 . . . . 0.0 111.441 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.0 t0 -93.06 109.76 21.24 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.404 0.621 . . . . 0.0 111.189 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.726 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.85 -31.04 6.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.814 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.499 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.36 -9.08 43.1 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.563 -178.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.59 58.1 8.67 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.3 p30 -114.31 -4.42 13.01 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.963 0.382 . . . . 0.0 111.484 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.43 7.81 42.05 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.997 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.06 -174.91 4.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.714 0.292 . . . . 0.0 110.48 179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.755 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.5 t -128.82 126.39 64.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.855 0.359 . . . . 0.0 111.198 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -105.82 -167.59 1.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.636 ' O ' HG13 ' A' ' 142' ' ' VAL . 60.9 t80 -58.15 -73.88 0.07 Allowed 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 142' ' ' VAL . 2.8 tt0 -49.46 -45.71 47.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.375 0.607 . . . . 0.0 110.333 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.726 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.56 -36.55 69.42 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.129 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.755 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.7 -49.77 11.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.93 0.395 . . . . 0.0 111.983 -179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.801 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -54.82 -40.74 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.69 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.609 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.24 -34.47 70.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.719 179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.42 ' HE2' ' HE3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.18 8.29 13.64 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.719 0.295 . . . . 0.0 111.35 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.607 ' SD ' HG13 ' B' ' 77' ' ' VAL . 3.4 mtt -118.39 -37.78 3.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.073 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t -148.8 -52.53 0.17 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.458 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -68.01 74.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 111.415 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.971 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . 0.595 HG23 ' OE1' ' A' ' 87' ' ' GLU . 6.1 p . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.724 0.297 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.91 -168.11 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.556 2.171 . . . . 0.0 112.334 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -100.99 -64.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.938 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.38 31.32 4.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.871 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.78 -134.35 7.82 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -97.28 102.46 14.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.824 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.11 -76.21 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.888 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.76 -46.33 59.95 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.11 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -58.85 -71.02 0.13 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.711 -0.245 . . . . 0.0 110.588 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.448 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.37 -36.87 54.86 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.377 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 11.8 ttm-85 -57.31 -48.17 79.64 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.641 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -59.55 -40.47 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.132 178.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 68' ' ' PHE . 92.2 t -54.71 -53.59 30.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.521 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -72.71 -46.4 53.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.336 -179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.543 HD22 HG11 ' A' ' 91' ' ' VAL . 16.4 mt -56.04 -46.31 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.706 0.289 . . . . 0.0 110.618 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.6 p -65.78 -46.6 88.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.92 0.391 . . . . 0.0 110.443 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.567 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -60.2 -30.33 70.52 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.195 -1.002 . . . . 0.0 112.367 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.723 HG11 ' CB ' ' A' ' 88' ' ' ALA . 42.3 t -75.77 -52.45 18.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.692 0.282 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.697 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -67.03 -42.67 88.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.563 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.649 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.3 mmp_? -57.33 -34.75 69.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.292 0.568 . . . . 0.0 109.771 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -62.4 -37.22 84.92 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.523 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.942 ' CH2' HD11 ' A' ' 105' ' ' LEU . 2.6 t90 -95.54 -14.84 23.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.013 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -90.16 -27.11 19.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.479 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.5 -71.6 0.72 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.594 -178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -49.56 -69.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.236 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 70.23 -61.75 0.45 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.271 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.38 29.72 3.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.025 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 0.0 111.095 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.774 0.321 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -105.7 80.07 1.51 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.746 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -176.36 176.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -127.4 165.13 20.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.546 ' O ' HG22 ' A' ' 9' ' ' ILE . 12.6 t -73.47 170.13 15.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.845 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -50.85 -42.21 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.426 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -65.59 -56.91 9.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.204 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' HB3' ' CB ' ' A' ' 4' ' ' LEU . 1.0 OUTLIER -60.67 -54.69 42.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.759 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' HD12 ' A' ' 4' ' ' LEU . 10.8 tt -56.1 -26.18 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.224 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.24 -42.67 61.16 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.334 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -35.18 79.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -68.03 -49.53 60.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.432 -179.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 1.2 mtpp -58.74 -46.49 87.31 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.22 0.533 . . . . 0.0 109.996 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -61.83 -50.42 72.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.589 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.935 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.39 -40.75 62.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.296 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -56.08 -35.83 67.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.066 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -75.0 -16.94 60.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.909 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.9 mt -86.91 -38.78 16.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.983 0.421 . . . . 0.0 110.201 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.656 ' HD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -64.77 -65.69 0.64 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.246 179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 27' ' ' ILE . 9.0 t70 -65.98 131.04 45.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.883 0.373 . . . . 0.0 110.712 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -36.39 77.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.139 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.92 -12.3 27.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.783 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.28 37.85 83.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.646 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 47.7 p-10 -77.68 -1.9 33.34 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.2 -3.12 43.86 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.131 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 63.6 p -147.48 132.47 18.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.869 0.335 . . . . 0.0 110.795 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.906 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -107.28 119.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.449 ' CB ' HG22 ' A' ' 62' ' ' THR . 4.7 t -98.35 168.41 10.23 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.797 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 58.1 p -54.45 -29.34 49.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.641 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -67.22 -50.43 60.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.872 0.368 . . . . 0.0 111.279 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.15 -36.18 58.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.069 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.38 -42.83 70.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.847 -179.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.51 -27.32 72.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.052 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.0 m -73.58 -45.24 54.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.776 0.322 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG11 ' HD1' ' A' ' 19' ' ' PHE . 7.0 p -74.67 -34.9 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.084 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -60.84 -49.45 77.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.755 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -65.33 -30.19 71.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 t -58.86 -21.14 56.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.897 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CD1' ' B' ' 74' ' ' LEU . 15.9 mt -72.47 -60.76 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.79 -39.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.504 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.3 mt-30 -140.15 147.88 40.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.991 0.396 . . . . 0.0 111.103 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -99.11 99.42 8.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.26 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.93 -168.95 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.302 2.002 . . . . 0.0 111.994 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 169.39 13.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -68.73 -30.37 68.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.17 0.509 . . . . 0.0 110.031 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.9 -44.47 59.94 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.126 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.1 mt-10 -62.4 -43.22 99.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.244 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.8 mt -56.79 -50.31 72.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.954 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.5 tt0 -64.26 -39.11 93.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.141 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -66.14 -51.14 60.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.136 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.452 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.03 -54.18 49.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.119 0.485 . . . . 0.0 110.348 179.659 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.7 -43.89 92.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.571 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.683 179.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 18.8 t-20 -52.53 -25.99 11.92 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.561 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.497 ' O ' ' CE ' ' A' ' 71' ' ' MET . 2.2 mt-10 -83.39 -4.82 58.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.005 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.915 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -126.2 -32.02 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.074 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.538 ' N ' HD12 ' A' ' 63' ' ' ILE . 44.7 t0 -64.91 133.54 52.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.081 0.467 . . . . 0.0 111.342 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.404 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -70.13 -53.66 16.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.952 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.74 58.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.446 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.24 49.21 81.12 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.924 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -104.47 -1.37 26.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.703 0.252 . . . . 0.0 111.482 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.62 15.31 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.254 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 3.2 p -149.06 139.78 22.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 0.0 111.085 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.77 149.54 7.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.157 0.503 . . . . 0.0 111.691 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.47 173.78 6.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.503 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -57.65 -61.46 7.25 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.323 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 48.7 Cg_endo -68.41 -26.86 34.42 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.48 2.12 . . . . 0.0 112.468 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -67.63 -43.5 80.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.089 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 1.9 t80 -75.19 -38.44 60.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.055 0.455 . . . . 0.0 110.293 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.746 HD21 ' HG3' ' A' ' 3' ' ' GLN . 9.5 tp -66.0 -58.06 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.071 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 m -51.9 -41.47 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 55' ' ' VAL . 1.8 tpt -60.14 -32.83 71.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.424 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.425 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -108.27 15.32 24.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.148 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -114.24 -33.12 5.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.353 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.7 mmm180 -58.48 -41.08 84.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.192 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 40.96 1.77 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.78 138.78 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.0 mttt -148.8 31.03 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.858 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 t0 62.42 100.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -117.84 -7.41 10.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.38 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 58.41 171.56 0.06 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.067 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -169.69 149.26 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.59 -26.46 5.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.648 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG2' ' HB3' ' A' ' 81' ' ' SER . 13.7 pt-20 -78.09 -25.72 47.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.734 0.302 . . . . 0.0 111.096 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' B' ' 77' ' ' VAL . 5.0 mt-10 -74.15 -28.92 61.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.923 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.693 ' N ' HD13 ' A' ' 85' ' ' ILE . 0.2 OUTLIER -74.29 -32.73 32.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -49.33 51.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.413 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.707 ' O ' HG13 ' A' ' 91' ' ' VAL . 10.8 mt-10 -62.99 -47.99 80.76 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.477 0.656 . . . . 0.0 109.696 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.739 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.28 -44.09 67.99 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.729 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.559 ' CE2' ' CB ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -50.84 -39.91 54.59 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.909 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -33.03 58.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.782 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG11 HD22 ' B' ' 74' ' ' LEU . 1.5 m -73.28 -36.97 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.073 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE2' HG22 ' B' ' 78' ' ' ILE . 0.7 OUTLIER -72.89 -63.07 1.24 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.05 0.452 . . . . 0.0 110.364 179.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -85.59 125.29 33.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -52.61 9.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.073 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.0 -9.66 58.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.39 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 44.69 68.91 0.82 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.875 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -95.07 12.87 27.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.651 0.262 . . . . 0.0 111.341 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.54 16.61 65.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.524 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 7.7 m-85 -157.94 116.95 3.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.644 0.259 . . . . 0.0 110.874 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 89' ' ' PHE . 2.4 mt -109.41 124.29 65.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.014 0.435 . . . . 0.0 111.262 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -103.89 157.15 17.29 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.272 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.75 -43.34 27.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.446 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -58.72 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.042 0.448 . . . . 0.0 110.842 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.504 ' O ' HG23 ' A' ' 108' ' ' VAL . 1.9 mm-40 -54.97 -39.63 69.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.692 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -59.05 -50.74 72.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.864 179.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.79 ' O ' HG22 ' A' ' 110' ' ' THR . 0.3 OUTLIER -57.61 -41.45 81.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.721 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -61.06 -38.07 84.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.466 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 104' ' ' GLU . 81.7 t -72.77 -56.01 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.063 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 5.9 mmt -48.99 -54.03 17.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.508 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.79 HG22 ' O ' ' A' ' 106' ' ' ARG . 12.0 t -65.53 -25.25 67.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.376 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.53 -30.31 65.76 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.837 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.2 -28.82 17.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.13 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.58 43.02 0.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.594 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.53 109.76 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 110.79 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -92.16 100.34 12.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.996 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -98.17 160.65 14.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.644 HG23 ' H ' ' A' ' 120' ' ' GLU . 15.4 t -89.57 161.97 15.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.854 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -57.64 -40.72 79.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.12 -36.09 82.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.644 ' H ' HG23 ' A' ' 117' ' ' THR . 13.9 mm-40 -65.71 -54.77 22.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.99 -40.02 87.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.277 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -62.15 -44.05 97.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.026 0.441 . . . . 0.0 110.526 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 45.1 mt-10 -71.74 -30.2 65.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.414 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.5 mmm -70.67 -34.55 72.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.685 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.952 HD11 HD12 ' A' ' 105' ' ' LEU . 4.0 mm -80.23 -54.93 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.762 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.422 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 4.1 ptt85 -54.91 -31.8 60.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.097 0.475 . . . . 0.0 110.363 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.77 -20.85 52.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.912 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.497 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -105.76 -11.34 16.31 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.488 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 125' ' ' ILE . 50.6 t0 -85.51 90.95 8.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.426 0.632 . . . . 0.0 110.785 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.77 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.2 pt -63.43 -30.74 50.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.592 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.61 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -86.94 -9.41 55.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.208 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 50.19 54.57 18.91 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 114.694 0.638 . . . . 0.0 114.694 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 30.2 p30 -113.93 -5.14 13.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.243 0.521 . . . . 0.0 111.365 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.48 5.8 45.16 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.164 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -144.99 -174.69 4.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.907 0.385 . . . . 0.0 110.595 179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.697 HG11 ' CD1' ' A' ' 141' ' ' PHE . 41.3 t -127.24 120.66 55.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.005 0.431 . . . . 0.0 111.444 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 5.6 t30 -97.37 -167.72 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.504 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 142' ' ' VAL . 55.7 t80 -61.63 -74.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HA ' HG22 ' A' ' 142' ' ' VAL . 0.3 OUTLIER -49.89 -43.06 49.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.315 0.579 . . . . 0.0 110.337 -179.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.77 ' HG2' HD11 ' A' ' 130' ' ' ILE . 3.3 mt-10 -56.06 -33.69 65.22 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.617 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.697 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -78.97 -47.19 16.77 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.233 0.539 . . . . 0.0 111.631 -179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.663 ' HA ' HG21 ' A' ' 85' ' ' ILE . 2.6 m -64.8 -36.47 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.023 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.696 ' HA ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -70.53 -36.71 73.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.657 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.535 ' HE1' ' CD2' ' B' ' 81' ' ' TRP . 1.4 ptt? -74.95 -15.2 60.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.965 0.412 . . . . 0.0 110.279 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.57 ' HG2' HD12 ' A' ' 85' ' ' ILE . 3.9 tpp -95.2 -50.22 5.15 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.374 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 145' ' ' MET . 13.8 t -177.47 -39.42 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.545 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.696 ' HB2' ' HA ' ' A' ' 143' ' ' GLN . . . 54.06 53.06 11.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.964 0.411 . . . . 0.0 111.252 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.883 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.689 0.281 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.94 165.12 32.23 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.526 2.151 . . . . 0.0 112.31 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 19.7 mtt-85 -60.57 -37.31 80.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.83 80.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 -93.14 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 2.0 mpp_? -140.81 103.03 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.047 0.451 . . . . 0.0 110.77 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.01 -76.01 0.21 Allowed Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.928 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.23 -45.81 57.41 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.156 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.915 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.4 OUTLIER -60.27 -70.86 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.683 -0.258 . . . . 0.0 110.516 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.434 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.28 -32.0 35.32 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.396 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 3.8 tpt180 -58.65 -52.85 63.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.653 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.31 -42.43 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.684 178.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.4 t -52.67 -50.2 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.105 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.816 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -70.58 -49.27 49.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.453 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.032 HD22 HG11 ' A' ' 91' ' ' VAL . 29.4 mt -56.04 -46.3 78.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.149 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.935 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.4 p -67.01 -47.93 80.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 111.099 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.586 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -59.8 -30.57 69.66 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.122 -1.037 . . . . 0.0 112.348 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.816 HG23 ' O ' ' B' ' 73' ' ' ARG . 86.7 t -76.75 -52.64 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.657 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -65.54 -41.7 91.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.581 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.619 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -56.02 -34.25 65.65 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.314 0.578 . . . . 0.0 109.631 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.86 -38.04 86.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.698 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.931 ' CH2' HD11 ' A' ' 105' ' ' LEU . 5.7 t90 -95.15 -14.74 23.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.901 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.53 -31.93 16.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.74 -73.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.409 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -67.79 69.48 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.419 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.2 OUTLIER -86.93 -63.48 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.845 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -89.63 -32.06 17.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.863 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.824 0.345 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -93.37 79.05 4.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HG3' HD21 ' A' ' 69' ' ' LEU . 4.6 tt0 -176.51 169.06 2.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.59 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -123.75 165.27 17.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 9' ' ' ILE . 14.4 t -71.93 177.09 4.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.807 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 17.1 pt-20 -57.3 -43.38 83.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.303 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.1 tt0 -64.78 -56.95 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.167 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -59.69 -52.96 63.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.929 0.395 . . . . 0.0 110.855 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 5' ' ' THR . 11.2 tt -59.1 -26.55 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.262 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.46 -42.9 61.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.405 -179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -65.7 -36.76 84.55 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.216 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -67.11 -49.67 64.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.576 -179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' CD2' ' A' ' 12' ' ' PHE . 0.7 OUTLIER -59.04 -46.05 89.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.164 0.506 . . . . 0.0 110.025 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -63.81 -49.52 72.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.783 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.891 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -52.48 -41.09 63.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.361 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.5 OUTLIER -55.81 -37.31 68.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.061 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -76.12 -15.82 60.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.932 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.78 -40.23 14.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.316 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.721 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -65.2 -63.83 1.01 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.238 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 5.9 t0 -65.7 126.61 28.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.552 179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.37 79.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.313 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 p30 -92.16 -12.47 32.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.974 0.416 . . . . 0.0 110.313 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 56.96 32.82 62.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.805 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -76.62 1.27 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.845 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.35 -1.3 43.31 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.383 -0.913 . . . . 0.0 114.028 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.7 p -149.55 132.62 16.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.351 0.576 . . . . 0.0 111.205 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.915 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.3 mp -105.53 118.4 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.977 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.439 ' CB ' HG22 ' A' ' 62' ' ' THR . 7.8 t -97.4 166.0 11.75 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.615 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.3 p -52.17 -31.16 30.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.836 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -63.95 -50.45 68.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.798 0.333 . . . . 0.0 111.321 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.7 -36.07 51.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.011 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.027 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.24 -45.67 72.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.013 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -69.33 -27.39 73.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.279 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 37' ' ' ARG . 85.0 m -72.21 -47.14 52.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 0.0 111.361 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.721 HG11 ' CD1' ' A' ' 19' ' ' PHE . 6.5 p -74.71 -34.97 35.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.142 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -60.08 -49.77 76.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -64.41 -30.36 71.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.8 t -58.31 -21.29 48.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' B' ' 74' ' ' LEU . 11.4 mt -71.59 -60.26 2.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.312 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -158.92 -39.0 0.02 OUTLIER Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.542 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 2.8 mt-30 -140.93 147.86 39.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.111 0.455 . . . . 0.0 111.162 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -99.64 99.65 9.22 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.258 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.44 -168.8 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.356 2.037 . . . . 0.0 111.971 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -85.1 169.82 13.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.852 0.358 . . . . 0.0 110.97 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -68.65 -30.49 69.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 0.0 110.066 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.82 -44.25 59.15 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.141 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 51' ' ' MET . 1.3 mt-10 -62.03 -41.1 97.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.266 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 33' ' ' GLY . 16.9 mt -59.64 -50.54 73.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.861 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 11.4 tt0 -64.24 -39.59 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -66.27 -51.09 60.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.108 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.454 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.66 -53.42 58.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.001 0.429 . . . . 0.0 110.381 179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.027 HD11 HD13 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -60.26 -45.35 96.34 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.557 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.497 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 26.7 t-20 -52.07 -26.12 10.3 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.446 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 2.2 mt-10 -82.96 -3.3 56.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.956 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.38 -32.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.528 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -64.59 133.22 51.85 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.053 0.454 . . . . 0.0 111.344 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.11 -53.58 16.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.897 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -85.14 -8.66 58.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.402 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.07 49.22 80.93 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.933 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -104.26 -1.47 27.02 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.771 -0.253 . . . . 0.0 111.439 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.502 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.3 17.72 15.01 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.252 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.571 ' C ' HD13 ' A' ' 63' ' ' ILE . 5.2 p -149.23 139.82 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.823 0.344 . . . . 0.0 111.024 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -103.44 149.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.192 0.52 . . . . 0.0 111.985 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.75 170.8 7.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.415 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.487 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 1.4 m-85 -56.03 -61.55 6.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.533 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 45.7 Cg_endo -68.24 -18.59 44.9 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.508 2.138 . . . . 0.0 112.68 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -38.76 34.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.409 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 3.4 t80 -75.28 -38.48 60.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.842 0.353 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 3' ' ' GLN . 12.1 tp -64.45 -55.61 19.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.143 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -51.67 -37.26 49.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.22 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.425 ' HG2' HG13 ' A' ' 55' ' ' VAL . 2.8 tpt -64.08 -32.74 74.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.4 mmt -108.27 15.52 24.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.59 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -119.35 -36.69 3.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.803 0.335 . . . . 0.0 111.291 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -53.31 -54.33 37.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.339 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 39.31 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 2.3 tpt -160.52 137.51 9.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.035 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -148.22 30.95 0.84 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.17 101.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -110.99 -14.02 14.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.172 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.536 ' CB ' HG21 ' A' ' 146' ' ' THR . 11.5 m-20 58.56 161.42 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.367 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.5 t -166.2 -167.49 1.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.584 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -73.55 -26.04 60.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.062 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.03 -33.79 59.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' OE1' HG22 ' B' ' 77' ' ' VAL . 4.4 mt-10 -61.24 -45.4 94.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.844 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -72.34 -39.14 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.761 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -71.54 -49.47 40.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.799 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 91' ' ' VAL . 58.4 mt-10 -61.36 -45.56 93.89 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.46 0.647 . . . . 0.0 109.313 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.846 ' O ' HG22 ' A' ' 91' ' ' VAL . . . -53.54 -50.51 65.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.894 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.605 ' HD1' HD11 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -51.21 -40.8 59.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.833 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.65 -31.76 68.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.443 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.061 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.57 -36.85 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.034 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.828 ' CE2' HG22 ' B' ' 78' ' ' ILE . 6.5 m-85 -75.63 -43.28 48.71 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.577 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -112.57 109.29 18.75 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.661 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.28 -42.03 80.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -74.19 -9.71 58.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.327 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 43.06 68.51 0.77 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.118 -0.563 . . . . 0.0 113.172 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -94.46 8.82 40.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.659 0.266 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.47 16.38 65.14 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.296 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 3.6 m-85 -163.86 116.68 1.44 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.731 0.3 . . . . 0.0 111.066 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.605 HD11 ' HD1' ' A' ' 89' ' ' PHE . 8.9 mt -111.28 127.38 68.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.095 0.474 . . . . 0.0 111.788 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.5 m -104.21 158.59 16.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.059 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.539 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -48.0 -41.98 26.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.732 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.93 -59.15 5.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.011 0.434 . . . . 0.0 111.126 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 108' ' ' VAL . 2.0 mt-10 -56.67 -37.77 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.591 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.802 HD12 HD11 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -60.82 -47.71 85.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.882 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.746 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -58.39 -44.47 88.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.559 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 1.3 t60 -58.73 -38.33 78.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.38 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.733 HG21 ' O ' ' A' ' 92' ' ' PHE . 77.6 t -67.31 -55.64 16.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.836 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 8.0 mmt -49.05 -53.44 20.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.617 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 106' ' ' ARG . 14.3 t -68.0 -24.34 65.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.504 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 24.4 t30 -74.54 -31.39 62.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.664 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -88.7 -28.72 20.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.045 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 136.18 44.11 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.576 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -155.85 109.72 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -90.72 99.66 12.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 116' ' ' LEU . 4.4 mm? -101.27 172.51 6.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.806 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 120' ' ' GLU . 10.3 t -96.59 166.58 11.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.829 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.32 -34.07 77.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.67 -35.51 78.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.865 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.707 ' H ' HG23 ' A' ' 117' ' ' THR . 52.0 mm-40 -65.64 -50.02 66.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 106' ' ' ARG . 4.2 m -66.77 -39.56 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.18 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.13 -42.37 99.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 110.216 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 64.0 mt-10 -72.74 -30.13 63.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.339 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -36.19 72.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 105' ' ' LEU . 2.8 mm -80.36 -54.5 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.55 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 15.7 ptt180 -53.73 -31.92 50.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.006 0.431 . . . . 0.0 110.303 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -79.65 -21.72 44.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.734 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.673 ' HB1' ' SD ' ' A' ' 144' ' ' MET . . . -106.68 -0.3 23.74 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.34 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 132' ' ' GLY . 46.1 t0 -96.24 102.82 14.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.368 0.604 . . . . 0.0 111.031 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.717 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.3 pt -76.93 -32.16 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.157 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.498 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -90.3 -9.05 49.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.88 0.371 . . . . 0.0 111.491 -178.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.54 56.98 11.28 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 114.689 0.636 . . . . 0.0 114.689 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 17.1 p30 -114.33 -3.71 13.07 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.145 0.472 . . . . 0.0 111.49 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.5 44.34 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.099 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -150.76 -174.79 4.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.646 0.26 . . . . 0.0 110.349 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG11 ' CD1' ' A' ' 141' ' ' PHE . 53.2 t -129.22 126.99 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 111.241 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.8 t30 -104.61 -167.68 1.38 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.942 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.629 ' O ' HG13 ' A' ' 142' ' ' VAL . 10.5 t80 -56.7 -73.77 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 142' ' ' VAL . 1.9 tt0 -49.65 -47.13 50.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.23 0.538 . . . . 0.0 110.445 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.5 mt-10 -56.29 -33.72 65.8 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.759 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.67 ' HB3' HG22 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -79.23 -48.93 13.32 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.063 0.458 . . . . 0.0 111.686 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.844 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.0 m -60.29 -41.86 88.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.217 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.688 ' HA ' ' HB2' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -70.85 -35.63 72.5 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.663 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.673 ' SD ' ' HB1' ' A' ' 128' ' ' ALA . 2.7 ptm -70.6 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.029 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 85' ' ' ILE . 17.8 mtt -105.11 -44.2 4.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.536 HG21 ' CB ' ' A' ' 80' ' ' ASP . 1.8 t 177.37 -37.89 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.666 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.688 ' HB2' ' HA ' ' A' ' 143' ' ' GLN . . . 54.71 41.89 31.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.842 0.353 . . . . 0.0 111.321 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.915 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.764 0.316 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.97 163.89 36.78 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.561 2.174 . . . . 0.0 112.31 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -84.24 -40.05 18.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -151.91 79.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.943 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.43 -129.45 1.03 Allowed Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.469 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.454 ' HA ' ' HG3' ' A' ' 51' ' ' MET . 0.0 OUTLIER -106.52 103.18 12.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.759 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.61 -76.26 0.22 Allowed Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.9 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -52.4 -41.46 55.39 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.21 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -64.93 -70.31 0.24 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.614 -0.293 . . . . 0.0 110.702 179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 1.0 OUTLIER -52.25 -38.82 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.327 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.51 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 0.4 OUTLIER -55.42 -49.88 71.24 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.67 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.55 -41.58 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.147 178.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' B' ' 69' ' ' GLN . 89.4 t -53.6 -53.47 25.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.31 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.878 ' O ' HG23 ' B' ' 77' ' ' VAL . 3.0 mpt_? -71.33 -44.26 65.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.405 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.061 HD22 HG11 ' A' ' 91' ' ' VAL . 17.7 mt -56.23 -50.43 71.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.858 0.361 . . . . 0.0 110.596 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 15' ' ' ALA . 13.8 p -64.09 -47.02 92.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -57.59 -32.98 65.76 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.526 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.878 HG23 ' O ' ' B' ' 73' ' ' ARG . 47.4 t -76.75 -53.02 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.828 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.7 pp -63.29 -43.08 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.524 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.637 ' N ' HD12 ' B' ' 78' ' ' ILE . 4.2 mmp_? -57.92 -35.07 70.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.245 0.545 . . . . 0.0 109.687 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -36.04 80.75 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.337 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.697 ' CZ3' HD11 ' A' ' 105' ' ' LEU . 3.1 t90 -95.37 -13.86 24.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.912 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -92.03 -31.4 15.59 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -74.31 0.38 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -67.82 70.19 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.039 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.76 -65.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.93 -34.01 21.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.894 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -105.46 72.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.659 ' HG3' HD21 ' A' ' 69' ' ' LEU . 3.2 tt0 -176.55 175.23 1.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -122.27 165.4 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.631 HG23 ' H ' ' A' ' 8' ' ' GLN . 7.7 t -69.64 170.31 11.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -54.88 -37.29 66.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.321 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -72.04 -56.8 5.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.134 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.631 ' H ' HG23 ' A' ' 5' ' ' THR . 1.2 tt0 -57.91 -44.38 86.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.868 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.437 HG13 HD13 ' A' ' 69' ' ' LEU . 7.1 tt -68.04 -26.78 35.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.885 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.8 -43.17 62.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.248 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.45 -27.5 63.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.234 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.55 -49.41 41.02 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.239 -179.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -57.06 -45.09 83.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.129 0.49 . . . . 0.0 110.222 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.1 mm-40 -64.38 -51.66 62.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.75 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 1.045 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.21 -40.18 58.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.841 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -56.01 -47.34 77.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.336 -179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.87 -13.62 62.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.3 mt -88.0 -38.3 15.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.838 0.352 . . . . 0.0 110.503 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.754 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.12 -64.88 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.07 179.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.4 t70 -61.99 128.1 34.55 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.782 0.325 . . . . 0.0 110.456 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.27 -38.54 91.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.279 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.19 -12.25 30.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.824 0.345 . . . . 0.0 110.813 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.33 38.44 86.64 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.559 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.4 p-10 -77.66 -1.15 29.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.26 -2.53 43.58 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.411 -0.9 . . . . 0.0 113.213 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.1 p -149.42 132.47 16.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.329 . . . . 0.0 110.756 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.925 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.73 119.21 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.034 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.423 ' CB ' HG22 ' A' ' 62' ' ' THR . 2.0 t -99.15 165.88 11.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.697 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 31.6 p -52.33 -32.56 38.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.885 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -62.13 -50.56 71.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.79 0.329 . . . . 0.0 111.374 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -77.78 -37.59 48.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.164 0.507 . . . . 0.0 110.974 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.047 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.23 -40.39 67.63 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.585 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -70.2 -30.86 69.24 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.914 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.6 m -67.58 -53.25 29.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.816 0.341 . . . . 0.0 110.501 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.754 HG11 ' CD1' ' A' ' 19' ' ' PHE . 10.1 p -69.76 -30.94 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.246 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.418 ' HE2' ' HG3' ' A' ' 43' ' ' PRO . 1.9 mtp -60.14 -46.62 89.04 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.398 . . . . 0.0 110.321 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -25.52 44.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.684 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 t -53.64 -50.67 65.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.233 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.4 mt -46.97 -57.88 4.54 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.067 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.25 41.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.589 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -142.72 178.76 7.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.88 0.371 . . . . 0.0 110.951 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -147.69 58.58 4.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.695 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HG3' ' HE2' ' A' ' 36' ' ' MET . 65.9 Cg_endo -73.91 -178.5 3.87 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.663 2.242 . . . . 0.0 112.559 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.1 p -98.66 173.76 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.989 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.49 -30.2 68.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.89 -45.29 60.13 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.15 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 1.2 mt-10 -60.71 -42.01 96.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.062 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 HD11 ' HA3' ' A' ' 33' ' ' GLY . 17.0 mt -58.35 -50.53 73.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.868 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 3.6 tp-100 -62.77 -38.63 91.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.129 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.89 -51.23 42.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.352 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.467 ' HE3' ' HB3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.39 -54.1 50.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.085 0.469 . . . . 0.0 110.395 179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.047 HD11 HD13 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -59.28 -45.26 93.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.477 179.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 27.7 t30 -52.36 -25.9 10.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.242 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.8 mt-10 -82.35 -3.33 55.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.911 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.2 OUTLIER -128.98 -32.53 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.545 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.5 t0 -63.92 134.82 55.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.066 0.46 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -66.52 -53.35 35.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.728 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -96.77 4.2 51.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.813 -179.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 53.16 59.71 9.11 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.213 -0.517 . . . . 0.0 113.933 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -109.35 -2.72 17.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.771 0.286 . . . . 0.0 111.323 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.473 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.22 17.3 16.18 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.927 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.598 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.5 p -149.49 139.96 22.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.337 . . . . 0.0 111.02 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.601 HD11 HG23 ' A' ' 52' ' ' ILE . 2.3 mm -104.64 149.56 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.209 0.528 . . . . 0.0 111.725 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.52 171.72 7.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m-85 -55.9 -61.59 6.13 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.712 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 65' ' ' PHE . 44.1 Cg_endo -67.97 -19.48 45.94 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.515 2.143 . . . . 0.0 112.753 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -79.18 -39.07 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.367 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.2 t80 -75.27 -35.74 61.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.878 0.37 . . . . 0.0 110.662 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 3' ' ' GLN . 10.7 tp -71.99 -58.43 3.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.085 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.9 m -52.13 -46.69 65.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.175 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.3 mmt -59.71 -30.69 68.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.784 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.426 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.26 14.97 24.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -112.08 -43.0 3.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 -48.7 76.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.972 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.02 64.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.795 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.51 31.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -104.12 46.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.757 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.31 -175.12 4.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.038 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.1 p -97.28 -166.1 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.946 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -85.85 -179.95 6.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -150.2 156.21 41.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.803 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.48 -25.52 6.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -73.84 -38.54 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.261 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 45.4 mt-10 -63.92 -27.86 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.178 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.812 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.18 -39.22 49.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -70.88 -49.32 47.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.459 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.885 ' O ' HG13 ' A' ' 91' ' ' VAL . 27.4 mt-10 -61.29 -46.44 90.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.34 0.59 . . . . 0.0 109.476 179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.748 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.58 -48.85 68.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.068 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.06 -38.86 54.1 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.994 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.57 -30.42 57.02 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.955 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.01 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.53 -37.02 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 120.663 0.268 . . . . 0.0 111.042 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.705 ' CE2' HG22 ' B' ' 78' ' ' ILE . 2.0 m-85 -71.86 -62.89 1.26 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.838 0.351 . . . . 0.0 110.494 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.82 121.17 26.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -64.33 -52.62 57.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.234 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -79.04 -9.61 59.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.496 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.13 71.13 0.52 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.864 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -93.39 14.58 18.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.633 0.254 . . . . 0.0 111.146 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.59 17.28 66.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.608 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.2 m-85 -161.84 116.75 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.755 0.312 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.6 mt -113.28 124.45 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.115 0.483 . . . . 0.0 111.645 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -104.26 161.63 13.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.16 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.85 -44.52 29.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.442 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.09 -58.87 6.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.013 0.435 . . . . 0.0 110.989 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -55.03 -36.62 65.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.636 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.934 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.99 -49.49 75.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.729 178.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -56.85 -41.49 78.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 2.4 t60 -60.55 -39.87 89.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.306 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 92' ' ' PHE . 28.1 t -68.72 -51.8 41.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.749 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.427 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.7 mmt -51.28 -54.05 29.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.802 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 106' ' ' ARG . 13.1 t -66.99 -25.08 66.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.718 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 107' ' ' HIS . 15.8 t-20 -70.69 -31.29 68.12 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.784 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -92.62 -28.8 16.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.51 43.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -152.11 109.78 3.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -91.66 95.63 10.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.018 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 109' ' ' MET . 3.4 mm? -94.07 157.14 16.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.633 HG23 ' H ' ' A' ' 120' ' ' GLU . 11.6 t -88.01 164.02 15.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.822 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -57.55 -42.69 83.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -62.46 -35.35 79.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 117' ' ' THR . 20.2 mt-10 -65.31 -54.85 23.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.021 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.5 m -64.94 -39.78 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.199 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -62.53 -41.88 99.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 0.0 110.276 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 5.6 mt-10 -72.66 -30.14 64.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.317 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 2.3 tpp -70.75 -36.09 72.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.934 HD11 HD12 ' A' ' 105' ' ' LEU . 4.6 mm -80.24 -54.91 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.567 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.0 ptm180 -53.65 -31.75 48.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.01 0.433 . . . . 0.0 110.456 -179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.77 -20.79 52.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.968 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.06 -10.96 15.76 Favored 'General case' 0 N--CA 1.457 -0.095 0 CA-C-O 120.55 0.214 . . . . 0.0 111.523 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 125' ' ' ILE . 32.9 t0 -85.51 109.67 18.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.429 0.633 . . . . 0.0 111.307 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.729 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.81 -31.13 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.755 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.496 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -92.05 -9.14 43.83 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.523 -178.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 50.31 57.62 10.05 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 17.8 p30 -114.25 -4.33 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.05 0.425 . . . . 0.0 111.456 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.37 7.69 42.45 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.991 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.422 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.05 -174.87 4.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.724 0.297 . . . . 0.0 110.53 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.74 HG11 ' CD1' ' A' ' 141' ' ' PHE . 54.0 t -128.34 126.82 66.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.885 0.374 . . . . 0.0 111.205 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 2.0 t30 -106.55 -167.36 1.28 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.645 ' O ' HG13 ' A' ' 142' ' ' VAL . 58.6 t80 -58.09 -73.98 0.07 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -49.56 -45.64 47.85 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.375 0.607 . . . . 0.0 110.336 -179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.729 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.9 mt-10 -56.55 -36.61 69.47 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.159 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.74 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.64 -49.51 12.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.938 0.399 . . . . 0.0 111.913 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.812 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.2 m -55.85 -40.21 60.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.7 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.604 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.3 -34.44 70.63 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.757 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.413 ' HG3' ' O ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -83.82 8.93 13.24 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 111.283 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.578 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.8 mtt -118.81 -36.32 3.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.1 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t -150.4 -52.61 0.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.391 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -68.43 75.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.933 0.397 . . . . 0.0 111.367 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.936 179.877 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.698 0.285 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.11 -172.57 0.63 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.501 2.134 . . . . 0.0 112.304 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -99.91 -56.51 2.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 8.7 mmt85 -141.75 35.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.79 -134.82 6.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -94.54 103.21 15.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.774 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.03 -75.81 0.22 Allowed Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.95 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.35 -46.69 63.67 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.088 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.911 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -58.71 -70.26 0.16 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.661 -0.27 . . . . 0.0 110.552 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.46 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.29 -34.09 45.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.858 0.361 . . . . 0.0 110.205 179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.446 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 6.6 tpt180 -58.14 -52.18 66.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -56.38 -41.8 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.053 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 68' ' ' PHE . 90.4 t -53.03 -53.3 22.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.446 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.826 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.02 -45.01 64.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.436 -179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.01 HD22 HG11 ' A' ' 91' ' ' VAL . 21.2 mt -55.99 -49.73 72.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.35 . . . . 0.0 110.557 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.045 HG21 ' HB2' ' A' ' 15' ' ' ALA . 14.6 p -64.62 -48.62 84.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.574 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.96 -29.67 59.39 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.151 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.826 HG23 ' O ' ' B' ' 73' ' ' ARG . 98.8 t -76.8 -55.35 11.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.604 0.24 . . . . 0.0 111.562 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.705 HG22 ' CE2' ' A' ' 92' ' ' PHE . 2.5 pp -61.73 -43.91 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.664 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.6 mmm180 -58.16 -34.26 70.11 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.229 0.538 . . . . 0.0 109.855 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -62.27 -37.03 83.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.444 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.901 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.8 t90 -95.34 -15.38 23.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.042 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' B' ' 79' ' ' ARG . . . -90.73 -26.26 19.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.501 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.42 -72.07 0.7 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.645 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 3.0 mmpt? -49.61 -69.58 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.27 -62.36 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.258 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.27 30.47 3.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.015 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.223 -0.894 . . . . 0.0 111.176 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -69.73 69.46 0.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.448 ' HG3' HD21 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -176.57 170.82 2.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.836 HD13 ' OE1' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -124.13 165.36 17.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.902 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 8' ' ' GLN . 10.1 t -67.93 166.33 15.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -54.34 -26.48 30.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.535 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -80.36 -56.89 3.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.126 -179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.836 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -57.84 -46.57 84.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.844 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.46 HG13 HD13 ' A' ' 69' ' ' LEU . 7.0 tt -65.52 -26.65 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.947 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 7' ' ' GLU . . . -51.55 -44.04 62.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.294 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -72.5 -25.71 61.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.161 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -71.42 -49.39 42.25 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.298 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -56.35 -44.93 80.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.307 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 14.4 mm-40 -65.35 -51.44 60.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.844 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 1.046 ' HB2' HG21 ' B' ' 75' ' ' VAL . . . -51.18 -40.06 57.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.922 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.522 ' CE2' ' HA ' ' A' ' 65' ' ' PHE . 0.9 OUTLIER -57.07 -45.98 82.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.299 -179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.8 m -70.94 -13.76 62.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 14' ' ' GLU . 3.2 mt -87.99 -38.38 15.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.906 0.384 . . . . 0.0 110.57 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.788 ' CD1' HG11 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -63.31 -64.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.075 179.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' HB3' ' HA2' ' A' ' 23' ' ' GLY . 11.3 t70 -62.52 127.34 30.87 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.801 0.334 . . . . 0.0 110.432 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -38.69 92.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.333 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.9 -12.31 31.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 20' ' ' ASP . . . 57.26 38.38 86.02 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.605 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -77.65 -1.06 29.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.3 -2.79 43.44 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.195 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.7 p -149.37 132.49 16.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.939 0.37 . . . . 0.0 110.764 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.918 ' CG2' HD12 ' A' ' 32' ' ' LEU . 1.2 mp -104.38 119.35 53.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.029 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.404 ' HA ' HG22 ' A' ' 62' ' ' THR . 2.9 t -98.75 165.11 11.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.696 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.5 p -52.76 -30.45 32.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.83 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -63.24 -50.61 69.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 0.0 111.266 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -77.85 -37.87 47.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.241 0.543 . . . . 0.0 110.843 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -54.14 -41.39 68.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.545 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.75 -29.42 72.68 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.9 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.6 m -69.51 -52.05 30.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.807 0.337 . . . . 0.0 110.542 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.788 HG11 ' CD1' ' A' ' 19' ' ' PHE . 7.7 p -69.01 -31.05 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -47.16 87.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.993 0.425 . . . . 0.0 110.281 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -25.47 44.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.758 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 t -54.69 -50.72 67.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.3 mt -47.51 -58.72 3.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 111.085 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 163.67 41.18 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.6 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -142.71 -178.02 5.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.949 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -150.99 58.16 2.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.762 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.92 -177.18 2.73 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.65 2.233 . . . . 0.0 112.504 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 48.2 p -99.71 173.6 6.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.941 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -68.54 -30.14 68.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.918 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.87 -45.12 59.8 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.156 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HB3' ' HE3' ' A' ' 51' ' ' MET . 0.8 OUTLIER -61.32 -42.51 98.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.076 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.1 mt -57.5 -50.53 72.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.981 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 53' ' ' ASN . 28.2 tp60 -63.28 -39.43 94.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.214 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -67.61 -51.25 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.325 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' B' ' 65' ' ' ARG . 0.0 OUTLIER -57.79 -53.84 53.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 110.347 179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.043 HD11 HD13 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -59.31 -45.27 93.35 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.437 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 49' ' ' GLN . 10.0 t30 -52.38 -25.92 11.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.257 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' B' ' 65' ' ' ARG . 1.2 mt-10 -82.39 -3.26 55.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.912 HG21 ' CE2' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -129.12 -32.36 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.541 ' N ' HD12 ' A' ' 63' ' ' ILE . 45.0 t0 -63.31 136.51 57.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 111.195 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 67' ' ' GLU . . . -68.46 -53.9 20.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.562 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -95.6 4.24 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.62 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.31 58.74 10.16 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.8 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -109.72 -1.76 17.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.788 0.294 . . . . 0.0 111.301 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.461 ' C ' HG21 ' A' ' 52' ' ' ILE . . . 104.26 17.44 15.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.953 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.586 ' C ' HD13 ' A' ' 63' ' ' ILE . 4.9 p -149.32 139.85 22.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.872 0.368 . . . . 0.0 111.137 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.59 HD11 HG23 ' A' ' 52' ' ' ILE . 2.4 mm -103.95 149.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.082 0.468 . . . . 0.0 111.708 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -107.38 169.28 8.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.624 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.522 ' HA ' ' CE2' ' A' ' 16' ' ' PHE . 2.2 m-85 -53.44 -61.12 5.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.393 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 65' ' ' PHE . 51.9 Cg_endo -69.11 -18.44 40.06 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.486 2.124 . . . . 0.0 112.636 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 57' ' ' ALA . 2.6 mm-40 -79.24 -38.85 34.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 4.0 t80 -75.26 -34.09 61.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.622 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 12' ' ' PHE . 10.9 tp -73.74 -58.43 3.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.057 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.3 m -52.08 -47.81 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.143 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.491 ' HE2' ' O ' ' A' ' 55' ' ' VAL . 4.4 mmt -59.55 -28.58 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.43 ' HG3' ' CE1' ' A' ' 68' ' ' PHE . 3.6 mmt -108.22 13.23 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.605 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -110.64 -43.69 3.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -55.58 -44.26 76.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.29 65.13 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.01 0.433 . . . . 0.0 110.859 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.83 31.14 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -102.31 41.41 1.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.79 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.75 -175.45 5.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.035 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.5 p -100.86 -166.72 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.957 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.57 -178.84 7.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.039 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.92 155.96 36.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.51 -24.97 9.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.362 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -74.1 -37.25 64.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.202 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 55.3 mt-10 -64.9 -28.07 69.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.165 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.808 HG21 ' N ' ' A' ' 142' ' ' VAL . 0.9 OUTLIER -74.2 -39.27 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.287 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -70.83 -49.28 47.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.888 ' O ' HG13 ' A' ' 91' ' ' VAL . 36.1 mt-10 -61.04 -47.0 88.43 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.795 ' CB ' HG11 ' B' ' 77' ' ' VAL . . . -53.43 -48.85 68.4 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.241 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CE2' ' HB2' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -51.14 -38.86 54.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.984 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.6 -30.46 56.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.949 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.044 HG11 HD22 ' B' ' 74' ' ' LEU . 1.4 m -76.44 -37.07 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.696 0.284 . . . . 0.0 111.026 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.518 ' CZ ' HG22 ' B' ' 78' ' ' ILE . 1.4 m-85 -71.62 -62.95 1.23 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.88 0.371 . . . . 0.0 110.491 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.8 117.95 23.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.854 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -60.66 -52.63 64.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.187 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.47 -9.64 59.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.501 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 45.7 71.65 0.47 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.879 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -93.38 14.42 18.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 111.148 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.57 13.72 61.32 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.673 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 135' ' ' GLN . 5.9 m-85 -158.07 116.69 3.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.686 0.279 . . . . 0.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HD1' ' A' ' 89' ' ' PHE . 4.9 mt -113.76 125.1 70.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.792 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -104.25 161.86 13.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.237 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.581 ' N ' HG13 ' A' ' 125' ' ' ILE . . . -47.91 -46.98 32.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.555 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.31 -58.87 5.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.007 0.432 . . . . 0.0 111.14 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -54.88 -36.55 65.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.606 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -61.2 -50.52 72.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.648 178.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.559 ' HB2' HG11 ' A' ' 121' ' ' VAL . 0.4 OUTLIER -56.4 -41.85 77.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.429 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -60.12 -39.35 85.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.397 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 39.9 t -67.21 -55.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.694 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.514 ' HB3' HD23 ' A' ' 116' ' ' LEU . 9.6 mmt -49.94 -54.07 22.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 106' ' ' ARG . 15.1 t -67.39 -24.92 65.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -69.12 -31.41 70.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.828 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -93.73 -28.8 15.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.03 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.27 43.17 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.528 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -150.17 109.82 4.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.824 0.345 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -90.21 98.82 12.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.957 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 109' ' ' MET . 4.3 mm? -88.37 171.22 10.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 29.3 m -98.29 158.96 15.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -56.76 -48.9 76.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.83 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -64.18 -31.66 72.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -62.64 -54.91 32.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.559 HG11 ' HB2' ' A' ' 106' ' ' ARG . 3.6 m -65.37 -40.46 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.075 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -62.47 -40.99 98.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.094 0.473 . . . . 0.0 110.283 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 126' ' ' ARG . 9.8 mt-10 -73.02 -30.15 63.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.405 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 38.0 mtp -71.04 -35.74 72.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.797 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 105' ' ' LEU . 5.0 mm -80.35 -54.94 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.623 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.418 ' CD ' ' HA ' ' A' ' 123' ' ' GLU . 10.2 ptm180 -53.89 -31.86 51.36 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.991 0.424 . . . . 0.0 110.38 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.96 -21.01 47.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.786 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.97 -5.05 18.43 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 121.114 -0.235 . . . . 0.0 111.445 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 34.4 t0 -92.38 109.7 21.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.41 0.624 . . . . 0.0 111.325 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.721 HD11 ' HG2' ' A' ' 140' ' ' GLU . 1.5 pt -84.74 -31.18 7.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.793 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD1' ' C ' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -91.92 -9.12 44.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.554 -178.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 49.55 58.21 8.51 Favored Glycine 0 C--N 1.333 0.385 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' OD1' ' HG3' ' A' ' 135' ' ' GLN . 18.8 p30 -114.25 -4.53 13.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 117.04 0.42 . . . . 0.0 111.463 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.38 7.83 42.13 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.967 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -151.11 -174.81 4.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.696 0.284 . . . . 0.0 110.353 179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.766 HG11 ' CD1' ' A' ' 141' ' ' PHE . 55.9 t -128.04 126.67 66.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.91 0.386 . . . . 0.0 111.261 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 141' ' ' PHE . 1.3 t-20 -105.29 -168.28 1.44 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.943 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.628 ' O ' HG13 ' A' ' 142' ' ' VAL . 59.7 t80 -58.51 -73.98 0.07 Allowed 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -49.52 -45.52 47.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.348 0.594 . . . . 0.0 110.265 -179.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.721 ' HG2' HD11 ' A' ' 130' ' ' ILE . 2.8 mt-10 -56.51 -36.38 69.11 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.108 179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.766 ' CD1' HG11 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -79.71 -49.83 11.5 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.901 0.381 . . . . 0.0 111.92 -179.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.808 ' N ' HG21 ' A' ' 85' ' ' ILE . 3.3 m -55.12 -40.49 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.719 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -71.19 -34.45 70.9 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.705 179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.41 ' HE2' ' CE ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -83.43 8.6 13.32 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.647 0.261 . . . . 0.0 111.305 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.574 ' SD ' HG23 ' A' ' 85' ' ' ILE . 3.7 mtt -118.51 -37.66 3.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.065 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 t -149.34 -52.48 0.16 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.396 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -67.86 74.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 31.1 mttp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.923 179.842 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' THR . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.735 0.303 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.33 149.15 62.84 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.592 2.195 . . . . 0.0 112.287 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 mtm-85 -60.29 -51.03 71.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -151.17 73.31 1.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.13 -132.88 2.15 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.522 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' B' ' 68' ' ' PHE . 0.0 OUTLIER -97.29 103.67 15.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.014 0.435 . . . . 0.0 110.822 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.14 -75.74 0.22 Allowed Glycine 0 N--CA 1.452 -0.245 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.935 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.48 63.24 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.058 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.912 ' CE2' HG21 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -59.1 -70.29 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.653 -0.273 . . . . 0.0 110.501 179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLN . . . . . 0.455 ' O ' ' HB ' ' B' ' 72' ' ' VAL . 0.9 OUTLIER -52.08 -34.0 41.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.906 0.384 . . . . 0.0 110.179 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' B' ' 74' ' ' LEU . 2.8 tpp180 -58.27 -51.69 68.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ILE . . . . . 0.621 HG22 ' O ' ' B' ' 68' ' ' PHE . 0.4 OUTLIER -57.14 -41.81 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.963 178.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 68' ' ' PHE . 88.6 t -52.95 -52.62 27.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.468 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ARG . . . . . 0.863 ' O ' HG23 ' B' ' 77' ' ' VAL . 0.0 OUTLIER -71.04 -45.78 63.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.331 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 1.044 HD22 HG11 ' A' ' 91' ' ' VAL . 22.7 mt -55.87 -49.26 73.83 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.766 0.317 . . . . 0.0 110.545 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . 1.046 HG21 ' HB2' ' A' ' 15' ' ' ALA . 15.0 p -63.97 -48.2 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.935 0.397 . . . . 0.0 110.56 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . 0.569 ' N ' HG13 ' B' ' 75' ' ' VAL . . . -56.76 -29.82 58.86 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.14 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' VAL . . . . . 0.863 HG23 ' O ' ' B' ' 73' ' ' ARG . 88.2 t -76.77 -56.06 9.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.596 0.236 . . . . 0.0 111.63 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.66 HD12 ' N ' ' B' ' 79' ' ' ARG . 2.5 pp -60.74 -43.56 95.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . 0.66 ' N ' HD12 ' B' ' 78' ' ' ILE . 23.2 mmm180 -58.05 -33.29 68.85 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.184 0.516 . . . . 0.0 109.901 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.61 -37.79 88.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.469 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' TRP . . . . . 0.933 ' CH2' HD11 ' A' ' 105' ' ' LEU . 3.2 t90 -95.52 -11.37 27.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.153 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' B' ' 78' ' ' ILE . . . -93.29 -31.23 14.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.419 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.32 -71.33 0.74 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.562 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' LYS . . . . . 0.4 ' HB3' ' HB3' ' B' ' 87' ' ' ARG . 0.0 OUTLIER -47.27 -80.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.245 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . 0.423 ' ND2' ' N ' ' B' ' 85' ' ' ASN . 0.3 OUTLIER 68.78 -67.27 0.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.081 179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -117.86 40.39 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ARG . . . . . 0.4 ' HB3' ' HB3' ' B' ' 84' ' ' LYS . 14.1 ptt85 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_